Clustering O 0 2.2323991544226374e-09
of O 0 1.370849767035054e-09
missense O 0 1.1847824943345131e-08
mutations O 0 1.6366494964836775e-11
in O 0 3.431011030841091e-11
the O 0 7.742501111351885e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 3.5904659512198123e-07
in O 0 1.0913509679300049e-10
a O 0 4.131199202173086e-11
sporadic B-Disease 1 0.9998779296875
T I-Disease 1 0.9999996423721313
- I-Disease 0 5.809781214338727e-05
cell I-Disease 1 0.8190000653266907
leukaemia I-Disease 1 0.9999632835388184
. O 0 1.0773708147837624e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.8292762555524875e-13
is O 0 1.4281243153118836e-14
a O 0 9.549103857902502e-14
recessive B-Disease 0 2.850622793371116e-10
multi I-Disease 0 3.2076213756226934e-06
- I-Disease 0 3.919176378985867e-06
system I-Disease 0 7.217460370156914e-05
disorder I-Disease 0 1.6011477782740258e-05
caused O 0 5.749169803420662e-12
by O 0 8.092661198284834e-15
mutations O 0 7.318061765295217e-14
in O 0 4.776647285174851e-13
the O 0 2.875972376914504e-11
ATM O 0 1.5715558632223292e-08
gene O 0 5.188281054779864e-11
at O 0 3.360648703765179e-10
11q22 O 0 2.277271926587332e-09
- O 0 6.119860174180758e-10
q23 O 0 1.519491976686993e-09
( O 0 1.4298863742351342e-12
ref O 0 1.0034111042056537e-10
. O 0 9.547907169754621e-13
3 O 0 1.0614033263411926e-10
) O 0 9.663735740447765e-13
. O 0 8.266563822356687e-11

The O 0 6.5472596233462355e-09
risk O 0 1.694179374567284e-08
of O 0 4.368775119445445e-09
cancer B-Disease 0 4.986209205526393e-07
, O 0 5.801341698696838e-11
especially O 0 2.0270851663894973e-10
lymphoid B-Disease 0 3.1253701308742166e-05
neoplasias I-Disease 1 0.8657854199409485
, O 0 9.10540393084247e-11
is O 0 1.3548588249576166e-12
substantially O 0 2.132345949118486e-12
elevated O 0 1.8747483565562106e-09
in O 0 1.7591318401954936e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 9.532062961170595e-08
and O 0 4.752150062348193e-12
has O 0 6.582858173495576e-13
long O 0 1.439320396808691e-13
been O 0 2.7216345971077353e-14
associated O 0 9.960743167780617e-13
with O 0 1.8511589830461084e-12
chromosomal O 1 1.0
instability O 1 1.0
. O 0 2.788226822758588e-07

By O 0 2.432199407154112e-11
analysing O 0 1.5884319637393673e-08
tumour B-Disease 1 1.0
DNA O 0 2.1903818758772786e-09
from O 0 2.2494929096533722e-12
patients O 0 2.8873247109179045e-13
with O 0 9.456936508845867e-14
sporadic B-Disease 1 0.9985107779502869
T I-Disease 1 0.9999879598617554
- I-Disease 0 7.981207090779208e-06
cell I-Disease 1 0.5443016290664673
prolymphocytic I-Disease 1 0.9992015957832336
leukaemia I-Disease 1 1.0
( O 0 1.6660813839664002e-09
T B-Disease 0 6.390145017576288e-07
- I-Disease 0 1.1670054922419126e-09
PLL I-Disease 0 5.1819796453855815e-08
) O 0 1.9674556038171143e-14
, O 0 5.7963303143229554e-15
a O 0 9.021325082358284e-14
rare O 0 1.718055385457884e-11
clonal B-Disease 0 8.819716512675768e-09
malignancy I-Disease 0 1.2825956297035646e-08
with O 0 1.6497357137063712e-13
similarities O 0 1.6940960786970827e-11
to O 0 4.084656658048802e-12
a O 0 8.073318125134676e-10
mature B-Disease 0 1.5044055601265427e-07
T I-Disease 0 5.399918518378399e-05
- I-Disease 0 1.7015500120010074e-08
cell I-Disease 0 1.3578672906078282e-06
leukaemia I-Disease 0 0.00019371048256289214
seen O 0 1.0491917057375844e-10
in O 0 2.3037542706827452e-10
A B-Disease 1 1.0
- I-Disease 1 0.8860738277435303
T I-Disease 1 1.0
, O 0 1.002981443558315e-12
we O 0 5.0995818489220704e-14
demonstrate O 0 7.85772542952895e-14
a O 0 1.038575387528936e-14
high O 0 5.569188773341116e-14
frequency O 0 7.238286033918462e-13
of O 0 2.0185998705901653e-11
ATM O 0 2.2058996407281484e-08
mutations O 0 2.50803849910497e-10
in O 0 1.4656804658841338e-09
T B-Disease 0 2.8594189643627033e-05
- I-Disease 0 6.495022830677044e-07
PLL I-Disease 0 2.366902663197834e-05
. O 0 6.139458719189861e-09

In O 0 1.1116560449941915e-10
marked O 0 2.2935474353058538e-10
contrast O 0 3.771829203136345e-12
to O 0 2.672947854807234e-13
the O 0 3.3722306197470076e-11
ATM O 0 4.156203914362777e-08
mutation O 0 3.381053770290521e-11
pattern O 0 1.3533955900424388e-10
in O 0 1.7446999400760888e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999955892562866
T I-Disease 1 1.0
, O 0 2.874150570320033e-12
the O 0 1.7741643657670503e-12
most O 0 5.703724625716116e-15
frequent O 0 1.0015070234714249e-13
nucleotide O 0 4.0219355623705155e-12
changes O 0 1.3286736077686156e-12
in O 0 1.4624082110212266e-12
this O 0 3.17162789087444e-12
leukaemia B-Disease 0 2.363149178563617e-06
were O 0 5.186544971280682e-09
missense O 0 1.350562683910539e-06
mutations O 0 5.195537866597988e-08
. O 0 2.6067267455687215e-08

These O 0 5.549540826876864e-10
clustered O 0 2.786938013699114e-09
in O 0 3.538653745027709e-11
the O 0 9.011690005333861e-11
region O 0 8.895020831012346e-11
corresponding O 0 1.1535144367469385e-10
to O 0 4.599631786561531e-11
the O 0 4.15509043838469e-10
kinase O 0 3.9397124451667764e-10
domain O 0 4.5424930483761727e-10
, O 0 3.085796158527887e-12
which O 0 1.4279942788138211e-13
is O 0 3.905475457464426e-14
highly O 0 1.514766366809625e-13
conserved O 0 1.13157356748661e-12
in O 0 8.724751823785404e-12
ATM O 0 4.268389020012364e-08
- O 0 1.1771228436430192e-10
related O 0 8.129244673249492e-12
proteins O 0 3.537368152301684e-13
in O 0 1.8188686234238416e-12
mouse O 0 1.840507329875507e-10
, O 0 7.959640433742587e-13
yeast O 0 2.407797294878833e-10
and O 0 8.296228287685281e-11
Drosophila O 0 6.094528437472491e-09
. O 0 9.503262621279873e-10

The O 0 2.500398821325689e-08
resulting O 0 4.022496113975649e-08
amino O 0 1.1053359116885986e-07
- O 0 1.244579106440824e-08
acid O 0 8.64209870332644e-10
substitutions O 0 2.4545248056284663e-09
are O 0 4.796488293351553e-12
predicted O 0 2.2349118389275446e-10
to O 0 4.0238979140926057e-13
interfere O 0 1.6326710816638723e-11
with O 0 3.146525791655752e-12
ATP O 0 1.536050042716397e-08
binding O 0 5.080173434701685e-11
or O 0 4.5097335154425933e-13
substrate O 0 2.4172613563577805e-11
recognition O 0 1.7147269715245272e-10
. O 0 9.532199474193703e-10

Two O 0 4.4271472599000106e-10
of O 0 3.936034165263891e-09
seventeen O 0 6.217580050815741e-08
mutated O 0 3.6450739315796454e-08
T B-Disease 0 1.794287669554251e-07
- I-Disease 0 1.3464265258278374e-09
PLL I-Disease 0 5.476623599065533e-08
samples O 0 1.591516675392146e-11
had O 0 4.015144553642935e-12
a O 0 8.017540624460917e-13
previously O 0 1.1048369163990657e-10
reported O 0 1.2471288890480992e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
allele O 0 7.865411788543497e-08
. O 0 4.968699673923993e-09

In O 0 1.1541878564003127e-10
contrast O 0 6.689923615077475e-11
, O 0 7.712839047990805e-12
no O 0 6.284601311579152e-11
mutations O 0 6.393168112961423e-12
were O 0 5.494263030647595e-12
detected O 0 1.0414811374426236e-11
in O 0 1.791353870794765e-11
the O 0 2.700089318796728e-10
p53 O 0 4.903030065284142e-11
gene O 0 7.565303418444191e-12
, O 0 3.8724543862354854e-13
suggesting O 0 3.666997695078722e-12
that O 0 3.20139504099079e-13
this O 0 2.908873229096054e-12
tumour B-Disease 1 1.0
suppressor O 0 1.2407323168872608e-08
is O 0 3.09426963218673e-13
not O 0 2.165171559024518e-14
frequently O 0 2.538720373247011e-14
altered O 0 3.1551018308401124e-12
in O 0 1.5772552534876194e-12
this O 0 2.5601196509961177e-11
leukaemia B-Disease 0 6.851689249742776e-05
. O 0 3.3354027095811034e-08

Occasional O 0 1.8522715805602274e-08
missense O 0 6.196246005174544e-08
mutations O 0 3.073790874608129e-11
in O 0 2.3425235709528813e-11
ATM O 0 1.1747077621748758e-07
were O 0 2.2726537318717988e-10
also O 0 2.0545563948065615e-12
found O 0 3.040562322319945e-13
in O 0 3.460102863950265e-12
tumour B-Disease 1 1.0
DNA O 0 6.8397789654284225e-09
from O 0 9.693197850282886e-13
patients O 0 2.4464433842456834e-13
with O 0 2.2543624681858193e-13
B B-Disease 0 0.00021680891222786158
- I-Disease 0 1.927094217535341e-08
cell I-Disease 1 0.9255605340003967
non I-Disease 1 0.9999986886978149
- I-Disease 0 0.00237497640773654
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 9.540245810057968e-05
( O 0 7.821215463471587e-13
B B-Disease 0 6.184115441953963e-10
- I-Disease 0 2.0073454617269837e-12
NHL I-Disease 0 6.078478692606026e-11
) O 0 5.332827109321824e-15
and O 0 5.684330366432719e-14
a O 0 6.9523440823782146e-12
B B-Disease 0 4.075984882945249e-09
- I-Disease 0 4.0978717641415585e-10
NHL I-Disease 0 9.38764443958462e-09
cell O 0 1.5453714752311498e-08
line O 0 8.195548240053085e-09
. O 0 4.030817346567517e-10

The O 0 3.240916701674479e-10
evidence O 0 1.5278318887812503e-10
of O 0 1.2764150847388578e-10
a O 0 1.4146005330659128e-12
significant O 0 5.789643504200415e-12
proportion O 0 6.099522276148406e-11
of O 0 3.945647808478725e-09
loss O 0 1.291962536953406e-08
- O 0 7.625068909611343e-10
of O 0 1.4204156286723446e-06
- O 0 6.662625451347992e-10
function O 0 3.092258227255229e-09
mutations O 0 6.6848050532530845e-12
and O 0 3.654880760019241e-13
a O 0 6.405077206464438e-13
complete O 0 6.066288360528915e-09
absence O 0 1.1287002443793881e-08
of O 0 2.490929462695135e-09
the O 0 3.35326926816093e-12
normal O 0 3.898758919873568e-12
copy O 0 4.5708567139590706e-12
of O 0 2.8871956908593788e-11
ATM O 0 1.9442264465041603e-10
in O 0 7.090017592123465e-13
the O 0 3.3560717139363705e-12
majority O 0 3.4424674482530504e-12
of O 0 1.3416652511200056e-10
mutated O 0 7.924663592007164e-09
tumours B-Disease 1 1.0
establishes O 0 4.743442860721814e-10
somatic O 0 4.6227299765888574e-10
inactivation O 0 2.4985109092767743e-08
of O 0 6.373644945156798e-10
this O 0 2.794922767616198e-13
gene O 0 3.7952011867382895e-13
in O 0 1.647484367895205e-13
the O 0 4.8200761958161475e-12
pathogenesis O 0 1.9817392171717074e-08
of O 0 1.3337589921391668e-09
sporadic B-Disease 1 0.806342363357544
T I-Disease 1 0.5932372212409973
- I-Disease 0 7.571994160571194e-07
PLL I-Disease 0 9.155359293799847e-06
and O 0 1.5165263489436143e-10
suggests O 0 3.749158622445847e-11
that O 0 8.839772989120698e-13
ATM O 0 4.449226764791092e-09
acts O 0 7.709610727602012e-10
as O 0 6.335801328027912e-11
a O 0 8.110204730016335e-10
tumour B-Disease 1 1.0
suppressor O 0 3.2254406505671795e-06
. O 0 3.2576579211962553e-09

As O 0 3.018148231337392e-10
constitutional O 0 5.9511492622732476e-08
DNA O 0 1.1697867119409011e-09
was O 0 8.798503592366558e-11
not O 0 1.2296329861445632e-13
available O 0 1.7630995404957495e-12
, O 0 5.752424903603115e-13
a O 0 4.555088597979484e-11
putative O 0 7.027993120800602e-08
hereditary O 1 0.9868211150169373
predisposition O 0 1.584687015565578e-05
to O 0 1.4249588176085126e-08
T B-Disease 1 0.5763607025146484
- I-Disease 0 1.31767833977392e-07
PLL I-Disease 0 2.9735758744209306e-06
will O 0 5.459185187239868e-12
require O 0 1.075900436450783e-12
further O 0 8.053250449314986e-13
investigation O 0 2.7295392508730476e-12
. O 0 8.208191938641196e-12
. O 0 3.073839238698639e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 1.3520755146601005e-06
kinase O 0 3.316762420269015e-09
is O 0 4.59144061746436e-13
involved O 0 5.229541605799529e-15
in O 0 9.864027319559862e-15
the O 0 8.950830257103276e-14
modulation O 0 1.2020796684442114e-12
of O 0 2.3190067921508017e-11
the O 0 2.6105936856701817e-11
Ca2 O 0 1.3804654641624836e-10
+ O 0 5.618910337013006e-10
homeostasis O 0 9.865074090953385e-09
in O 0 4.024686972581293e-10
skeletal O 0 4.328023351263255e-06
muscle O 0 6.768752314201265e-07
cells O 0 8.43290024477028e-08
. O 0 3.3711791136425973e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9964242577552795
DM B-Disease 1 1.0
) O 0 3.931646241212006e-12
, O 0 3.8465771908836877e-14
the O 0 7.41866258095053e-13
most O 0 4.057525582884525e-12
prevalent O 0 0.0021044283639639616
muscular B-Disease 1 0.9999998807907104
disorder I-Disease 0 0.0072934809140861034
in O 0 9.553705049292205e-12
adults O 0 7.328569175124588e-13
, O 0 4.1665577780493346e-14
is O 0 9.346242855166886e-14
caused O 0 3.343333943028881e-11
by O 0 5.331584566198311e-12
( O 0 3.691552272200305e-12
CTG O 0 1.1185333548269227e-08
) O 0 1.4491537716999556e-14
n O 0 1.9160400262924204e-12
- O 0 4.656687904204537e-13
repeat O 0 4.238298947911723e-12
expansion O 0 3.716304878848692e-13
in O 0 4.309572514929645e-14
a O 0 8.004731724469902e-14
gene O 0 1.9325395504785764e-14
encoding O 0 8.705808697637846e-14
a O 0 1.2164818631588137e-11
protein O 0 9.74451769275575e-11
kinase O 0 2.2995318982310664e-09
( O 0 5.164312311123354e-10
DM B-Disease 1 0.9999998807907104
protein O 0 1.3286807210022289e-09
kinase O 0 2.6034147060371993e-10
; O 0 9.825319811224142e-13
DMPK O 0 1.4055773434051844e-08
) O 0 2.999273870712624e-14
and O 0 2.7163758777580017e-14
involves O 0 7.275752130766686e-14
changes O 0 2.8954537877566577e-13
in O 0 1.2164512019213758e-12
cytoarchitecture O 0 2.386332909054545e-09
and O 0 1.7802846696834962e-10
ion O 0 8.159646824879019e-08
homeostasis O 0 2.3351969957730034e-06
. O 0 4.2049876469718583e-08

To O 0 3.426420258634266e-11
obtain O 0 7.479879216010232e-11
clues O 0 1.6146234349534438e-10
to O 0 2.2857749222039703e-13
the O 0 9.892017760471106e-13
normal O 0 5.238883979408193e-12
biological O 0 1.138265089822843e-11
role O 0 1.8017631657485378e-12
of O 0 1.0449657111832877e-10
DMPK O 0 1.0804127015262566e-07
in O 0 6.043265887711868e-11
cellular O 0 1.3457127634453059e-09
ion O 0 4.70001015884236e-09
homeostasis O 0 4.6992958857572376e-08
, O 0 5.051370433051261e-11
we O 0 1.9003869658473782e-11
have O 0 3.3751354575756176e-13
compared O 0 1.8560662989192123e-12
the O 0 2.5869551292800885e-11
resting O 0 2.7485635989421553e-10
[ O 0 1.425529399384784e-12
Ca2 O 0 3.4009194115405816e-13
+ O 0 2.207279931748518e-12
] O 0 2.573135498076806e-12
i O 0 2.457630453311932e-13
, O 0 5.0051621545553916e-15
the O 0 6.010999803376244e-14
amplitude O 0 1.2063861194733239e-12
and O 0 9.532222016925274e-13
shape O 0 3.6796177216302794e-11
of O 0 6.149695336299388e-11
depolarization O 0 4.865322589253651e-10
- O 0 2.136572863076225e-11
induced O 0 3.4378841440307895e-10
Ca2 O 0 2.9544277180965084e-12
+ O 0 3.787249160114303e-12
transients O 0 8.401229018017986e-11
, O 0 1.5386609290824436e-14
and O 0 2.4319452633886178e-14
the O 0 5.80839955126311e-13
content O 0 1.7048276852726918e-12
of O 0 1.5520250362666133e-10
ATP O 0 1.2113275715819327e-08
- O 0 1.4222059294133338e-11
driven O 0 1.0781544927673803e-11
ion O 0 2.4584017113693513e-11
pumps O 0 2.285484995701026e-11
in O 0 3.2685649326014143e-11
cultured O 0 5.230614608109363e-09
skeletal O 0 1.3622824326375849e-06
muscle O 0 3.105296686456427e-09
cells O 0 2.147818173314775e-10
of O 0 1.5118774010502989e-09
wild O 0 2.645303176507241e-08
- O 0 1.7329379251029842e-11
type O 0 3.1593127419737854e-11
and O 0 5.512432958015845e-12
DMPK O 0 1.1936391786093736e-07
[ O 0 2.4244564689190895e-10
- O 0 2.3212957944718227e-10
/ O 0 7.209861152546182e-09
- O 0 3.244369661814517e-09
] O 0 1.0696633578888282e-09
knockout O 0 1.1742416972992942e-05
mice O 0 1.1581389713910539e-07
. O 0 9.36015931429779e-10

In O 0 1.2011325267735629e-09
vitro O 0 2.2984596625974518e-07
- O 0 1.1403421318334495e-08
differentiated O 0 5.280373471805433e-09
DMPK O 0 1.7044204696503584e-06
[ O 0 8.097869597101237e-10
- O 0 4.2613887418774254e-10
/ O 0 6.922305395562489e-09
- O 0 5.449463658102616e-10
] O 0 3.8810135660760636e-11
myotubes O 0 1.3752258221089164e-09
exhibit O 0 1.73208614118181e-10
a O 0 2.965240206154185e-11
higher O 0 1.530182508480138e-10
resting O 0 8.99014973576584e-10
[ O 0 4.967849048798101e-12
Ca2 O 0 3.940445192363029e-12
+ O 0 2.5945797593740494e-11
] O 0 3.1048080773032893e-11
i O 0 4.710844995342578e-12
than O 0 2.144290875503302e-13
do O 0 7.566858923301056e-13
wild O 0 5.720670048781074e-10
- O 0 2.8690565548328273e-12
type O 0 4.692309041320897e-12
myotubes O 0 2.531800880056778e-10
because O 0 2.823615907060484e-13
of O 0 3.2322586447641743e-12
an O 0 8.569689825387722e-15
altered O 0 4.619778951747699e-13
open O 0 5.479046903678064e-12
probability O 0 1.3726085155638112e-12
of O 0 9.529608872849149e-12
voltage O 0 1.6361328958325316e-09
- O 0 3.303979312363481e-11
dependent O 0 1.0169012333582916e-11
l O 0 1.7883828098974597e-12
- O 0 1.2434821781200783e-13
type O 0 4.389246128014279e-13
Ca2 O 0 5.24465020024234e-13
+ O 0 7.847545313230397e-13
and O 0 3.8952931049988926e-13
Na O 0 2.8874505564324693e-10
+ O 0 2.0156940352955566e-12
channels O 0 3.5393153685614465e-11
. O 0 1.763272861055043e-10

The O 0 2.5438271933353462e-08
mutant O 0 4.644245876761488e-08
myotubes O 0 6.911476901905189e-08
exhibit O 0 3.984391039324464e-09
smaller O 0 7.31821270250066e-11
and O 0 6.823806276978761e-12
slower O 0 8.253644989686393e-11
Ca2 O 0 3.549968695740202e-12
+ O 0 7.440602821373599e-12
responses O 0 4.51644743739571e-13
upon O 0 2.00615912770985e-12
triggering O 0 3.4028238560246393e-11
by O 0 5.628767376785089e-14
acetylcholine O 0 9.240823384271124e-11
or O 0 4.120942736357547e-12
high O 0 8.286269448376515e-10
external O 0 3.810135762449818e-09
K O 0 5.720433016165316e-09
+ O 0 4.480247561833295e-10
. O 0 3.7405603614537597e-10

In O 0 4.202658498986267e-10
addition O 0 1.1456713355784132e-10
, O 0 4.750800013803014e-12
we O 0 5.539496270544342e-13
observed O 0 1.6703671323718694e-13
that O 0 1.6522281843866322e-15
these O 0 3.092307861529242e-15
Ca2 O 0 3.7924660157076517e-13
+ O 0 7.633311517596386e-12
transients O 0 1.5300541389429156e-10
partially O 0 2.0279116927368612e-11
result O 0 4.108282182328782e-13
from O 0 1.3586770157027455e-14
an O 0 3.14220276080373e-15
influx O 0 8.50418775113701e-14
of O 0 5.435444629109387e-12
extracellular O 0 1.2633007704168642e-12
Ca2 O 0 4.5393165138199465e-13
+ O 0 5.206108981414825e-13
through O 0 1.287239087023606e-13
the O 0 6.478678270943616e-12
l O 0 1.2694214169411966e-12
- O 0 1.4881906742082035e-13
type O 0 4.0961149944986064e-13
Ca2 O 0 8.975246761078193e-13
+ O 0 5.0047496528982105e-12
channel O 0 7.702463666880988e-11
. O 0 1.4829085182022084e-10

Neither O 0 2.4801646958394485e-08
the O 0 5.612911802010956e-10
content O 0 3.939544870878997e-11
nor O 0 6.81658965384635e-11
the O 0 2.1954395766632384e-12
activity O 0 1.3511586814674015e-11
of O 0 4.340233034083596e-11
Na O 0 6.715729750084165e-09
+ O 0 8.250103378237839e-11
/ O 0 4.528012409465987e-10
K O 0 1.3302217660715598e-10
+ O 0 3.296593900636857e-12
ATPase O 0 1.417526252628365e-11
and O 0 4.381586239665669e-12
sarcoplasmic O 0 4.212207804776824e-10
reticulum O 0 4.259940317163924e-11
Ca2 O 0 3.386998667642693e-11
+ O 0 3.663385220176174e-11
- O 0 5.945804612550454e-12
ATPase O 0 2.0867767583365726e-11
are O 0 1.0885303075580666e-13
affected O 0 2.1186705005411116e-13
by O 0 1.6568697368962715e-12
DMPK O 0 3.7636264096363448e-06
absence O 0 1.650269467745602e-07
. O 0 4.364977268522807e-09

In O 0 1.611818123414821e-09
conclusion O 0 1.3563655754111892e-09
, O 0 1.0363191207951594e-11
our O 0 6.957000080187736e-12
data O 0 5.346278975082441e-12
suggest O 0 1.2171798942015033e-12
that O 0 2.0758259477657304e-13
DMPK O 0 1.292071374336956e-07
is O 0 9.032951253304389e-13
involved O 0 4.433619473615501e-14
in O 0 1.5208982077213884e-13
modulating O 0 1.648812510135489e-11
the O 0 1.213490159052144e-11
initial O 0 8.542074166062452e-12
events O 0 1.1884783521903808e-12
of O 0 4.864271138660392e-11
excitation O 0 8.406783713610366e-09
- O 0 1.2011240002607337e-08
contraction O 0 2.859953163181217e-09
coupling O 0 9.560677804998363e-10
in O 0 2.4428706280055223e-10
skeletal O 0 5.128145403432427e-06
muscle O 0 2.6443049705449084e-07
. O 0 1.396352367066811e-09
. O 0 2.621773909083913e-09

Constitutional O 0 4.175014328211546e-05
RB1 O 0 0.0007568063447251916
- O 0 4.603342418363354e-08
gene O 0 3.2254812709631153e-10
mutations O 0 4.373915118982552e-11
in O 0 5.559568430624218e-12
patients O 0 2.520350464788046e-12
with O 0 9.856440750383166e-13
isolated O 0 1.543617855759294e-07
unilateral B-Disease 0 0.3892081081867218
retinoblastoma I-Disease 1 0.9999972581863403
. O 0 1.1756462754419772e-06

In O 0 3.0814761853292794e-10
most O 0 3.509013565827779e-11
patients O 0 1.321425282564681e-12
with O 0 1.0688330645894362e-13
isolated O 0 6.4881855443843506e-09
unilateral B-Disease 0 6.290461169555783e-05
retinoblastoma I-Disease 1 0.9997556805610657
, O 0 9.572204834329412e-11
tumor B-Disease 0 8.134876594567686e-08
development O 0 5.107320677488758e-10
is O 0 7.119121508665852e-14
initiated O 0 2.0768647218671887e-12
by O 0 1.8914673972046658e-13
somatic O 0 1.1201206628896898e-10
inactivation O 0 2.0119916399607973e-08
of O 0 5.70064995208952e-10
both O 0 3.4364713765583366e-12
alleles O 0 1.4079866829733167e-12
of O 0 3.748867050124005e-10
the O 0 5.291393101458652e-09
RB1 O 0 1.3590872185886838e-05
gene O 0 6.660341611564036e-09
. O 0 1.267829397022524e-08

However O 0 1.0764957814046738e-08
, O 0 4.815493490073486e-11
some O 0 4.012028990280081e-12
of O 0 3.631482892174631e-10
these O 0 3.053909902739349e-11
patients O 0 1.3767045663193311e-11
can O 0 1.5261237369321168e-12
transmit O 0 5.742271103059693e-10
retinoblastoma B-Disease 0 5.327749477146426e-06
predisposition O 0 1.0898252078561654e-08
to O 0 3.3174740732277996e-11
their O 0 5.620657272942253e-10
offspring O 0 4.66238270213637e-10
. O 0 4.290839905607413e-10

To O 0 8.491116663955633e-12
determine O 0 6.999231489529523e-12
the O 0 5.328216708989919e-13
frequency O 0 1.1317591828985396e-12
and O 0 3.31798309530576e-13
nature O 0 1.2943653961150492e-11
of O 0 2.14094700301537e-10
constitutional O 0 7.885553259256994e-07
RB1 O 0 5.01729482493829e-05
- O 0 3.4693268258223497e-09
gene O 0 5.618789808425895e-11
mutations O 0 5.775327698714916e-12
in O 0 1.9658298426594722e-12
patients O 0 1.2308443110217726e-12
with O 0 2.1861244097528404e-13
isolated O 0 1.1693187751404821e-08
unilateral B-Disease 0 5.178154424356762e-06
retinoblastoma I-Disease 0 0.0017913184128701687
, O 0 6.854712630843807e-11
we O 0 1.1464642603320474e-11
analyzed O 0 1.731622831235846e-11
DNA O 0 1.663857523981349e-10
from O 0 8.27744643661088e-12
peripheral O 0 8.394898287633623e-08
blood O 0 8.06915714801626e-11
and O 0 9.742585904692902e-11
from O 0 1.5916358508949457e-10
tumor B-Disease 0 1.514209202468919e-06
tissue O 0 2.022739096219084e-07
. O 0 2.3433315732290794e-08

The O 0 1.3623489836245284e-10
analysis O 0 3.544084470341602e-11
of O 0 1.592618303902782e-08
tumors B-Disease 1 1.0
from O 0 7.205303714785671e-11
54 O 0 1.5046106582872198e-09
( O 0 2.417495240450429e-12
71 O 0 1.7314527589462614e-09
% O 0 5.870338503494166e-12
) O 0 2.7638930708462524e-14
of O 0 1.1632042551390498e-11
76 O 0 1.87747506430469e-09
informative O 0 2.6061372504493363e-10
patients O 0 4.9764244808292446e-11
showed O 0 8.509998261629903e-10
loss O 0 1.8314175731504179e-09
of O 0 5.446484152571429e-09
constitutional O 0 1.8665411971596768e-06
heterozygosity O 0 4.01127499571885e-06
( O 0 4.0975980941659884e-10
LOH O 1 0.9999176263809204
) O 0 6.832652499344505e-11
at O 0 2.667626120000932e-09
intragenic O 0 3.925192118003906e-07
loci O 0 4.124725805354501e-08
. O 0 3.3249978770300004e-08

Three O 0 6.73277478213663e-09
of O 0 3.349632393678803e-08
13 O 0 3.335867688747385e-07
uninformative O 0 0.00040251784957945347
patients O 0 2.8154595099749713e-08
had O 0 3.899285339059588e-09
constitutional O 0 1.5304138969440828e-06
deletions O 0 5.275463763609878e-07
. O 0 1.0615282519665925e-07

For O 0 4.054584223922575e-09
39 O 0 4.4249148345443245e-08
randomly O 0 7.377470856440027e-10
selected O 0 1.0220634116819838e-08
tumors B-Disease 1 1.0
, O 0 2.3031665463690842e-09
SSCP O 0 0.0001367842487525195
, O 0 1.0650419435265235e-09
hetero O 0 1.0540809114445437e-08
- O 0 3.253388877744179e-11
duplex O 0 2.8799371221133185e-10
analysis O 0 6.88331932684888e-13
, O 0 3.096204594251438e-14
sequencing O 0 7.939398379182283e-13
, O 0 2.7468194277284474e-13
and O 0 1.253211618680583e-12
Southern O 0 3.046161239916856e-11
blot O 0 6.025314136515192e-10
analysis O 0 1.2242609703783103e-11
were O 0 1.2349837298641919e-11
used O 0 6.219557204326098e-13
to O 0 2.20180536129877e-12
identify O 0 1.0902669045353974e-10
mutations O 0 3.2513449710336317e-09
. O 0 5.844082995309918e-09

Mutations O 0 2.661251774505047e-10
were O 0 1.9190435698868136e-11
detected O 0 1.2552935253762332e-11
in O 0 4.14853698268991e-12
21 O 0 8.170509824267924e-10
( O 0 1.2220347346894589e-12
91 O 0 4.008529896903923e-10
% O 0 1.1002246856628428e-11
) O 0 2.99231532564434e-13
of O 0 6.005980712764369e-10
23 O 0 2.828293645507074e-06
tumors B-Disease 1 1.0
with O 0 1.2203973831503845e-08
LOH O 1 1.0
. O 0 1.2499857859893382e-07

In O 0 1.1207280659064622e-09
6 O 0 2.0316042181889316e-08
( O 0 5.652938620676062e-12
38 O 0 7.522171080465156e-11
% O 0 7.0066448303041096e-12
) O 0 2.0325721086702359e-13
of O 0 2.5996732544442125e-10
16 O 0 3.5320044844411314e-07
tumors B-Disease 1 1.0
without O 0 2.1615789158602183e-09
LOH O 1 0.9999946355819702
, O 0 1.9385738674049247e-12
one O 0 2.1506394213242908e-13
mutation O 0 5.386234535643963e-13
was O 0 1.1300292299121217e-12
detected O 0 1.2861401397015748e-12
, O 0 1.6554348224260412e-13
and O 0 2.6273552561004165e-13
in O 0 8.598453546393436e-12
9 O 0 4.337060044434793e-09
( O 0 5.019058085808936e-13
56 O 0 4.6041698231746864e-11
% O 0 1.1161831008077439e-11
) O 0 2.2090899801704283e-13
of O 0 6.52652210053617e-10
the O 0 2.2813422262402128e-08
tumors B-Disease 1 1.0
without O 0 5.265930802522689e-09
LOH O 1 0.9999815225601196
, O 0 5.216459209034241e-12
both O 0 4.8882928954663285e-12
mutations O 0 3.022156136456289e-11
were O 0 3.8337596985904554e-10
found O 0 2.440276869464242e-10
. O 0 2.6421200782777987e-09

Thus O 0 3.8018216352853074e-10
, O 0 1.1995876297507535e-12
a O 0 2.78710241734606e-13
total O 0 1.886143801907436e-12
of O 0 8.134336260123831e-11
45 O 0 2.0135941525278866e-10
mutations O 0 2.9804252815734955e-11
were O 0 3.097840040044986e-11
identified O 0 7.157554410275324e-11
in O 0 8.529172923488204e-10
tumors B-Disease 1 1.0
of O 0 7.206445843621623e-06
36 O 0 3.9913711589179e-06
patients O 0 2.6463382596375595e-07
. O 0 3.249498803370443e-08

Thirty O 0 7.847205552025116e-08
- O 0 1.3360250683547292e-09
nine O 0 1.2448134745213224e-09
of O 0 7.284833847265304e-10
the O 0 1.5138848508122749e-10
mutations O 0 3.238727688814613e-11
- O 0 2.2762880122484397e-11
including O 0 1.139153354978717e-11
34 O 0 8.364713921515943e-10
small O 0 7.991441536292498e-11
mutations O 0 6.52795040245735e-11
, O 0 1.7543686989252016e-11
2 O 0 1.1274910782788083e-08
large O 0 4.255930330376856e-10
structural O 0 4.234724474372342e-05
alterations O 0 1.4780159744987031e-06
, O 0 6.768666183099015e-11
and O 0 7.285233527554169e-11
hypermethylation O 0 0.004195495042949915
in O 0 1.7202755486778187e-07
3 O 1 0.7041861414909363
tumors O 1 1.0
- O 0 1.0191273380755206e-09
were O 0 2.423697006981307e-11
not O 0 3.654181788431167e-14
detected O 0 8.428023903772619e-13
in O 0 5.828675758191848e-13
the O 0 8.001350450259626e-12
corresponding O 0 1.3741974225212061e-10
peripheral O 0 1.089663470565938e-07
blood O 0 4.258090269271264e-10
DNA O 0 2.4109475305067463e-08
. O 0 2.412515076599675e-09

In O 0 4.414877907699122e-10
6 O 0 8.128886008762493e-09
( O 0 1.7097838986637748e-12
17 O 0 4.0234874459921244e-11
% O 0 7.999256096923035e-13
) O 0 4.064467268609026e-15
of O 0 2.181073681037371e-12
the O 0 2.5685420804166803e-11
36 O 0 2.6025806509899496e-10
patients O 0 1.1406927485912988e-11
, O 0 6.98358634376034e-13
a O 0 2.3028599426683227e-12
mutation O 0 2.176759640593051e-12
was O 0 2.396445888952492e-12
detected O 0 1.1739154570297727e-12
in O 0 5.501789345288555e-13
constitutional O 0 1.2256921033682033e-09
DNA O 0 1.388138215485668e-10
, O 0 4.3202740647105276e-13
and O 0 7.190716121499574e-13
1 O 0 4.504513428926771e-10
of O 0 1.5501286365626754e-10
these O 0 5.787917888022687e-13
mutations O 0 1.486905352532722e-13
is O 0 2.3252924650878082e-14
known O 0 5.694553037666542e-14
to O 0 3.993236541129444e-14
be O 0 1.663106230422734e-13
associated O 0 2.2173651803569783e-12
with O 0 5.175723131328747e-13
reduced O 0 8.842658161256622e-09
expressivity O 0 1.6343285835773713e-07
. O 0 6.714705236277041e-09

The O 0 2.2112263409201915e-10
presence O 0 5.36844223589239e-12
of O 0 1.508115299309054e-10
a O 0 2.9074104235249365e-11
constitutional O 0 6.691323761742751e-08
mutation O 0 1.466244486936219e-10
was O 0 3.352362831776645e-11
not O 0 2.06387065369764e-14
associated O 0 6.062236487542477e-14
with O 0 5.499402067630013e-15
an O 0 1.0609194390511466e-14
early O 0 6.625848758545771e-10
age O 0 7.116040534604906e-10
at O 0 1.852130360191495e-08
treatment O 0 4.894170757552274e-08
. O 0 6.3340075406870255e-09

In O 0 2.3400176019094943e-08
1 O 0 4.883279984824185e-07
patient O 0 1.1792724130543775e-08
, O 0 3.9431083398433486e-11
somatic O 0 2.141039168179759e-08
mosaicism O 0 2.1024332852448424e-07
was O 0 6.839980665196421e-11
demonstrated O 0 1.2316850013863179e-12
by O 0 6.433476544060639e-15
molecular O 0 6.347769532233372e-13
analysis O 0 9.615613562547268e-14
of O 0 4.882049625676288e-12
DNA O 0 1.80735027638379e-11
and O 0 7.132121716130202e-12
RNA O 0 8.152545305506465e-10
from O 0 1.509047470316105e-10
peripheral O 0 4.218773597131076e-07
blood O 0 1.1170024905027276e-08
. O 0 2.4081808547293804e-08

In O 0 2.446084224061451e-09
2 O 0 2.5057842023556987e-08
patients O 0 1.3033333960688065e-11
without O 0 7.452472883598404e-13
a O 0 7.207481681793804e-13
detectable O 0 1.2372018076689528e-08
mutation O 0 7.110416422317911e-12
in O 0 1.183551412257955e-12
peripheral O 0 2.0214811158325574e-08
blood O 0 1.6411946454630844e-11
, O 0 1.1046525022831433e-12
mosaicism O 0 5.688875148734951e-07
was O 0 3.8865344276217684e-10
suggested O 0 1.4289267468922673e-12
because O 0 1.1645639151364878e-13
1 O 0 4.122627239588894e-11
of O 0 1.0822669149757047e-11
the O 0 1.0593519117474415e-11
patients O 0 4.89012042664827e-12
showed O 0 6.464727420052441e-09
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 4.7966734750826134e-11
the O 0 1.4205990550575365e-10
other O 0 1.159942476271214e-12
later O 0 1.6042356332235386e-10
developed O 0 2.1925292137403574e-10
bilateral B-Disease 0 1.3185528224823884e-08
retinoblastoma I-Disease 0 5.667076038662344e-06
. O 0 2.540219945501576e-08

In O 0 1.1917988818055392e-09
conclusion O 0 1.935772431238547e-09
, O 0 2.2855545581124126e-11
our O 0 4.715971710367306e-11
results O 0 1.7042464661720658e-11
emphasize O 0 2.0504859962744426e-11
that O 0 6.618901119467141e-14
the O 0 1.5240002185570867e-12
manifestation O 0 8.971016707270962e-10
and O 0 3.026630812294484e-12
transmissibility O 0 2.585462954840523e-09
of O 0 1.8730959838730854e-10
retinoblastoma B-Disease 0 5.933529778623381e-10
depend O 0 2.38624723279679e-12
on O 0 1.3418079147786699e-11
the O 0 9.79168243882278e-13
nature O 0 4.4775945104436055e-12
of O 0 5.051823195878491e-11
the O 0 3.3491293072174244e-11
first O 0 4.030354175399431e-11
mutation O 0 1.7070638305693997e-11
, O 0 7.352904092886026e-13
its O 0 2.8744573995348466e-12
time O 0 3.821541607468282e-12
in O 0 1.232780804522049e-11
development O 0 1.7397212837000353e-10
, O 0 2.3634000572564373e-12
and O 0 6.089382904167495e-12
the O 0 6.517450468201957e-11
number O 0 3.250791302811251e-10
and O 0 2.2543217292891882e-11
types O 0 1.4066781073296397e-10
of O 0 1.698112539472163e-09
cells O 0 1.004436898238703e-11
that O 0 3.173199279293132e-13
are O 0 2.8147544516542167e-13
affected O 0 3.03362413314745e-12
. O 0 1.3585960481621306e-11
. O 0 2.8064346402345564e-09

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9938056468963623
the I-Disease 0 1.7878279834349087e-07
fifth I-Disease 0 1.2592623477303277e-07
component I-Disease 0 2.0428142732953347e-08
of I-Disease 0 6.829301213429062e-08
complement I-Disease 0 1.3064365589343652e-08
in O 0 2.532643961217218e-08
man O 0 1.3331332127108908e-07
. O 0 4.378587803444134e-08

I O 0 0.00032627678592689335
. O 0 5.262911031422846e-07

Clinical O 0 2.5324275156890508e-06
, O 0 3.1367022867989647e-10
immunochemical O 0 4.788874434780155e-07
, O 0 3.2190952681254714e-10
and O 0 1.7641879623830903e-10
family O 0 8.158545367065173e-11
studies O 0 1.0829824814706512e-09
. O 0 1.1577212077895638e-08

The O 0 9.16346110102495e-10
first O 0 4.333995662353374e-11
recognized O 0 1.8381218769292218e-10
human O 0 4.940149400667337e-10
kindred O 0 7.908630550446105e-08
with O 0 1.7275000874228397e-10
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999973773956299
the I-Disease 0 9.675687806520727e-07
fifth I-Disease 0 4.2371357267256826e-07
component I-Disease 0 3.3594730552977126e-08
of I-Disease 0 8.102061883619172e-07
complement I-Disease 0 1.939345679602411e-07
( O 0 4.693470501138108e-09
C5 O 0 0.27610328793525696
) O 0 2.5594557723218614e-11
is O 0 1.4927351021931656e-11
described O 0 5.866784835717453e-10
. O 0 1.0101792291550282e-08

The O 0 1.727719478594736e-08
proband O 0 2.4753873617555655e-07
, O 0 9.00073071630203e-11
a O 0 2.861139797305512e-11
20 O 0 7.345117569723669e-11
- O 0 2.6414862051155064e-12
year O 0 9.322071109832408e-13
- O 0 8.496754515252558e-12
old O 0 1.7053813222700498e-11
black O 0 3.078322644532727e-13
female O 0 3.911879704172026e-14
with O 0 3.9196211380765345e-12
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 1.3180017049307935e-05
age O 0 6.218363068910548e-08
11 O 0 3.445903473675571e-08
, O 0 2.0978470696708662e-11
lacked O 0 1.8972394855154562e-07
serum O 0 5.405357050847215e-09
hemolytic O 0 9.574278010404669e-07
complement O 0 5.647932121988219e-10
activity O 0 4.89603302344932e-10
, O 0 8.461299694749458e-13
even O 0 6.649564254258833e-13
during O 0 8.494262931924013e-11
remission O 0 5.972840426693438e-07
. O 0 3.2703457719662765e-09

C5 O 0 0.0007876401068642735
was O 0 1.9775329818116916e-08
undetectable O 0 1.581647879334014e-08
in O 0 6.000904634317905e-11
her O 0 1.5513396773789156e-12
serum O 0 2.7918711179714117e-12
by O 0 6.874528615634368e-13
both O 0 1.6545714451310367e-11
immunodiffusion O 0 1.9353936409061134e-07
and O 0 2.3611059773998022e-09
hemolytic O 0 0.0010777432471513748
assays O 0 7.43182283713395e-07
. O 0 4.7587811025096016e-08

Other O 0 2.8289337886122645e-11
complement O 0 9.421478354421087e-12
components O 0 3.931288281022738e-11
were O 0 1.518771111479189e-12
normal O 0 2.314736726946598e-12
during O 0 1.7012252067141742e-12
remission O 0 3.84795173502539e-09
of O 0 1.6435581784435271e-09
lupus O 0 1.3403387129073963e-05
, O 0 1.4037780660114407e-10
but O 0 7.324499895489112e-10
C1 O 0 7.797117973495915e-07
, O 0 1.3111206564886402e-10
C4 O 0 0.0003160621563438326
, O 0 2.4450194646696843e-10
C2 O 0 1.13942242307985e-08
, O 0 7.818505391721242e-12
and O 0 1.638383734237081e-10
C3 O 0 0.0001972325990209356
levels O 0 3.3114417874458013e-07
fell O 0 4.169011447174853e-07
during O 0 2.1728068233528575e-08
exacerbations O 0 0.07022751122713089
. O 0 1.3336379822703748e-07

A O 0 1.6902318748179823e-05
younger O 0 9.795494193554077e-09
half O 0 5.273468772770684e-09
- O 0 2.6509232586846565e-09
sister O 0 1.1690016732401887e-09
, O 0 6.77247494196287e-11
who O 0 9.433854392115748e-11
had O 0 2.3016591410573994e-10
no O 0 1.9115784510859157e-09
underlying O 1 0.9999865293502808
disease O 1 0.9999978542327881
, O 0 2.089524907267215e-11
was O 0 4.523353691610055e-09
also O 0 2.5395963110241837e-11
found O 0 4.562251184475619e-12
to O 0 7.128585482324423e-12
lack O 0 8.94170682386175e-07
immunochemically O 0 0.00016081133799161762
detectable O 1 0.9996877908706665
C5 O 0 0.11646709591150284
. O 0 2.7463288532203478e-08

By O 0 7.210668728774294e-10
hemolytic O 0 7.182573608588427e-05
assay O 0 7.924983691509624e-08
, O 0 4.076898540983365e-11
she O 0 3.2550073747472652e-12
exhibited O 0 4.012668253228213e-10
1 O 0 4.968330191701398e-09
- O 0 5.722628534238217e-12
2 O 0 1.3538312831906651e-11
% O 0 1.7161673557947177e-13
of O 0 2.5434049397837777e-12
the O 0 9.29464491483678e-12
normal O 0 7.100001697679659e-10
serum O 0 2.9212304797354705e-10
C5 O 0 7.178126537610297e-08
level O 0 4.97084873263276e-10
and O 0 8.929429461471128e-14
normal O 0 3.2129947574038864e-12
concentrations O 0 4.8304758630546285e-12
of O 0 1.7427458781638094e-11
other O 0 5.570944638759456e-13
complement O 0 4.7102183264868813e-11
components O 0 8.710481225193689e-09
. O 0 8.976566157059551e-09

C5 O 0 0.00012446369510143995
levels O 0 1.492543866277174e-08
of O 0 2.27199734581518e-08
other O 0 2.8313846059391246e-11
family O 0 4.491025260011661e-11
members O 0 2.2257262005664913e-11
were O 0 2.4865565162457415e-10
either O 0 9.461388617015842e-11
normal O 0 2.1399928495924314e-09
or O 0 1.0861049039301296e-11
approximately O 0 1.854043307769615e-11
half O 0 5.6506122697586036e-11
- O 0 2.723934099113645e-11
normal O 0 1.9583580590509797e-10
, O 0 6.230908801072021e-13
consistent O 0 1.2307492525120978e-10
with O 0 7.598343612288949e-13
autosomal O 0 3.121853442422662e-09
codominant O 0 1.1944871758373665e-08
inheritance O 0 6.62704613407783e-11
of O 0 6.33437538533066e-11
the O 0 3.76117713363211e-11
gene O 0 1.3875725013434703e-09
determining O 0 3.873100240525673e-07
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.5280251091098762e-06

Normal O 0 4.201863248454174e-06
hemolytic O 0 0.00014124196604825556
titers O 0 6.11448228937661e-07
were O 0 2.4786961372313954e-10
restored O 0 7.40340788674132e-10
to O 0 8.206543626078366e-13
both O 0 1.4155916890079556e-11
homozygous O 0 0.013646227307617664
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 3.0875200174307338e-09
C5D B-Disease 1 1.0
) O 0 3.670221407608282e-13
sera O 0 7.797777701323838e-11
by O 0 4.6944432797449073e-14
addition O 0 7.467327537563628e-13
of O 0 5.81807414745672e-11
highly O 0 2.0450735549459864e-10
purified O 0 1.0547038797881214e-09
human O 0 5.496860300269191e-09
C5 O 0 1.5579958926537074e-05
. O 0 1.0200263744764015e-08

In O 0 4.423950539234056e-09
specific O 0 5.12124342932907e-09
C5 O 0 2.497340119589353e-06
titrations O 0 9.379196086456432e-09
, O 0 5.703449865168686e-12
however O 0 3.641842036272713e-12
, O 0 2.0699902295723271e-13
it O 0 4.71272699413116e-14
was O 0 1.7194258170039056e-11
noted O 0 2.097901930300794e-12
that O 0 2.586827609486319e-14
when O 0 6.765441885100282e-14
limited O 0 6.271973500455996e-13
amounts O 0 1.1239159559625622e-12
of O 0 3.0085614555197537e-10
C5 O 0 1.1131555766041856e-07
were O 0 3.263768075245643e-11
assayed O 0 6.574457644958898e-11
in O 0 1.5549184119098558e-12
the O 0 1.950036703293745e-12
presence O 0 1.3612358852957418e-12
of O 0 3.098561962566748e-10
low O 0 1.7800115159616325e-08
dilutions O 0 1.5761735028263502e-07
of O 0 3.27041021819241e-07
either O 0 1.6410425587309874e-06
C5D B-Disease 1 1.0
serum O 0 4.372228801230449e-08
, O 0 1.1673967348357905e-10
curving O 0 1.1681190459356117e-09
rather O 0 7.655528771674525e-13
than O 0 8.228530026408928e-14
linear O 0 5.157163238123097e-11
dose O 0 7.650723388152869e-10
- O 0 2.4419796046393216e-11
response O 0 3.5852982908923803e-12
plots O 0 1.3806655818626723e-10
were O 0 1.604748799122202e-11
consistently O 0 1.955250848381662e-12
obtained O 0 8.348061283046382e-13
, O 0 3.2168807006204003e-13
suggesting O 0 1.5450618215395728e-12
some O 0 5.066446394363933e-13
inhibitory O 0 2.276881128082664e-09
effect O 0 2.518395092465653e-08
. O 0 2.6788331553007083e-09

Further O 0 1.2637021984396313e-10
studies O 0 1.7033919413877996e-11
suggested O 0 6.201212286727209e-12
that O 0 6.847309720094119e-13
low O 0 4.186275770479142e-09
dilutions O 0 7.623307851645222e-07
of O 0 0.0001398863532813266
C5D B-Disease 1 1.0
serum O 0 4.5734296350019576e-08
contain O 0 6.586862166813034e-10
a O 0 1.1935629568027295e-11
factor O 0 1.95967135747932e-12
( O 0 7.438949629900993e-14
or O 0 6.501700219874174e-13
factors O 0 1.5781407430859318e-11
) O 0 8.052171668153363e-14
interfering O 0 4.509013388359628e-12
at O 0 8.92136142738309e-10
some O 0 8.173306649539303e-12
step O 0 3.245234359017246e-10
in O 0 2.0052723370689307e-11
the O 0 3.049511199115784e-10
hemolytic O 0 1.854705828918668e-06
assay O 0 1.3883256144708866e-07
of O 0 6.188062116052606e-07
C5 O 0 2.0026907805004157e-05
, O 0 3.784564328590534e-11
rather O 0 7.865471295109838e-12
than O 0 1.1878823662561655e-12
a O 0 6.256829082618154e-11
true O 0 8.809326601522116e-09
C5 O 0 2.545360621297732e-05
inhibitor O 0 1.5367064065685554e-08
or O 0 1.4672237036439384e-10
inactivator O 0 4.616923661160399e-07
. O 0 4.449695722996694e-08

Of O 0 2.135733296881881e-07
clinical O 0 8.546638127882034e-05
interest O 0 1.1682146094926793e-07
are O 0 3.514700336326726e-11
( O 0 1.0302269020517896e-12
a O 0 5.77494215642238e-12
) O 0 6.807640388906133e-14
the O 0 2.6550231197602914e-12
documentation O 0 3.852651975222443e-09
of O 0 1.7936541141239104e-08
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 0 1.666311000292353e-08
vasculitis B-Disease 1 1.0
, O 0 2.1339563449629395e-09
and O 0 1.0438458957651164e-05
arthritis B-Disease 1 1.0
in O 0 1.0054519439250953e-09
an O 0 1.8215906213980837e-12
individual O 0 1.1625128637504645e-10
lacking O 0 0.2096182405948639
C5 O 0 0.018481681123375893
( O 0 2.7382149282370594e-13
and O 0 2.0029769130184422e-13
its O 0 1.1509288530900386e-12
biologic O 0 6.644794714461e-10
functions O 0 3.911898582842355e-12
) O 0 2.204550417203902e-15
, O 0 5.551337045757963e-15
and O 0 7.582342821102137e-14
( O 0 3.6322097537793904e-14
b O 0 2.1158324658293592e-12
) O 0 2.8694134707998777e-15
a O 0 4.831945526204487e-14
remarkable O 0 2.2743168025946003e-12
propensity O 0 3.869881498586025e-11
to O 0 3.400620984892605e-13
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.1963983623242136e-11
the O 0 4.58757381041619e-12
proband O 0 7.411234403953415e-10
, O 0 3.2468949404118597e-13
even O 0 3.2620892207076146e-14
during O 0 2.144593503434697e-13
periods O 0 5.899773031226019e-11
of O 0 1.2576810426434548e-10
low O 0 1.2301138996306804e-09
- O 0 8.852297367356599e-12
dose O 0 4.4402975740709394e-10
or O 0 4.688238512684517e-12
alternate O 0 5.191728713604959e-10
- O 0 9.308404047558838e-10
day O 0 7.235606003241912e-10
corticosteroid O 0 8.17962281871587e-05
therapy O 0 6.975668043196492e-07
. O 0 6.978110866917575e-10

Other O 0 1.5447384690836508e-11
observations O 0 5.2732601271698876e-12
indicate O 0 1.4730048777944482e-11
that O 0 5.378309559864181e-13
the O 0 3.8299519111717473e-10
C5D B-Disease 1 1.0
state O 0 1.6524457149835747e-11
is O 0 1.2173766226857008e-13
compatible O 0 4.395976204579766e-12
with O 0 6.934732431037368e-15
normal O 0 3.793032294502341e-12
coagulation O 0 1.473015286135304e-12
function O 0 2.1142362166548523e-11
and O 0 1.2055161285450672e-13
the O 0 1.0490925619541236e-12
capacity O 0 4.667965666782514e-12
to O 0 3.209789747361802e-13
mount O 0 9.98779725591703e-09
a O 0 1.2540264382465693e-09
neutrophilic O 0 4.85660602862481e-05
leukocytosis O 0 9.996975677495357e-06
during O 0 3.4857777109209565e-08
pyogenic B-Disease 0 0.009189221076667309
infection I-Disease 0 6.838490662630647e-06
. O 0 8.142661545029739e-10
. O 0 4.5214734178955496e-09

Susceptibility O 0 7.878405995143112e-06
to O 0 8.444987997791031e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.00016985410184133798
twins O 0 3.647425046438002e-07
: O 0 9.646204191318675e-13
the O 0 3.5875967994980495e-12
role O 0 2.9301671766041038e-12
of O 0 1.0135711714376328e-10
genes O 0 5.917215502304618e-12
, O 0 1.592420748215695e-12
HLA O 0 4.66218930128548e-09
, O 0 9.980089671346448e-12
and O 0 3.583262853101843e-11
the O 0 1.2789428405213243e-09
environment O 0 3.007726689929768e-08
. O 0 3.8208405328532535e-09

OBJECTIVE O 0 1.009616880764952e-06
To O 0 6.5215255071193745e-12
determine O 0 5.450196283868225e-12
the O 0 1.3521376943451124e-12
relative O 0 5.6889779345703495e-12
effects O 0 2.7654437073643123e-10
of O 0 7.136779361927026e-11
genetic O 0 3.0511460025195447e-10
and O 0 1.14541015561187e-12
environmental O 0 1.3945444798935114e-10
factors O 0 2.222022045528238e-12
in O 0 1.5592603163500085e-12
susceptibility O 0 1.8951310210013617e-07
to O 0 1.600108667787481e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.0005725623923353851
AS B-Disease 1 1.0
) O 0 9.855561679261715e-12
. O 0 8.055225236835994e-11

METHODS O 0 5.810136940453958e-07
Twins O 0 8.057018874296773e-08
with O 0 3.5159677252982746e-11
AS B-Disease 1 0.9999998807907104
were O 0 3.1028069003014025e-11
identified O 0 1.2012086204188366e-12
from O 0 3.4791668244299467e-13
the O 0 1.1943805319769574e-11
Royal O 0 5.4424136308739435e-09
National O 0 5.401092266765772e-07
Hospital O 0 4.97882574563846e-05
for O 0 9.892017871493408e-09
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 1.383979082447695e-07
. O 0 6.349357040136283e-09

Clinical O 0 6.089325665925571e-07
and O 0 8.738762491411478e-11
radiographic O 0 1.1477201411480564e-07
examinations O 0 3.652938929121774e-08
were O 0 3.052838537520586e-11
performed O 0 3.6026138669487118e-12
to O 0 1.750202494868111e-13
establish O 0 3.070562207274641e-11
diagnoses O 0 1.4153725302890052e-08
, O 0 5.933206616987041e-12
and O 0 1.254408521500494e-10
disease O 0 3.098781598964706e-05
severity O 0 1.2542910781121464e-06
was O 0 6.079513004131343e-10
assessed O 0 1.5942479975050716e-11
using O 0 2.4708048649603465e-13
a O 0 1.1178998265276574e-12
combination O 0 1.5212943751952146e-11
of O 0 1.539051525112356e-10
validated O 0 2.1846835451810875e-08
scoring O 0 1.074368682907334e-08
systems O 0 1.2930230752772331e-07
. O 0 1.3140437182812548e-08

HLA O 0 3.6526745361697976e-07
typing O 0 1.3288227185270785e-09
for O 0 3.943153442653724e-11
HLA O 0 4.465269043407716e-09
- O 0 9.978723403136769e-11
B27 O 0 6.689978016005682e-10
, O 0 2.0305038032908396e-12
HLA O 0 8.092862491260178e-11
- O 0 2.7030133773614518e-12
B60 O 0 4.045017445997168e-11
, O 0 1.3869453003613474e-13
and O 0 1.4640346498052265e-13
HLA O 0 1.016041473178575e-09
- O 0 1.6043794071052275e-10
DR1 O 0 2.028135213549831e-06
was O 0 2.2948766151276168e-11
performed O 0 1.300343188161135e-12
by O 0 1.1694816122453933e-12
polymerase O 0 3.925758329526019e-11
chain O 0 4.3449313591459315e-10
reaction O 0 1.5130116126985116e-12
with O 0 1.588515695935891e-13
sequence O 0 3.263394762753613e-11
- O 0 1.690432689660515e-11
specific O 0 2.330391955795985e-12
primers O 0 1.022019552321396e-10
, O 0 5.985101737132625e-13
and O 0 4.670744693791029e-12
zygosity O 0 7.469822094208212e-09
was O 0 7.58122953303797e-10
assessed O 0 2.7710986283402406e-10
using O 0 1.1736741786783078e-11
microsatellite O 0 3.7215066583939915e-08
markers O 0 1.3424780398452185e-08
. O 0 1.022270090800248e-08

Genetic O 0 2.2146727118865783e-08
and O 0 4.71920211242427e-11
environmental O 0 7.814782154724753e-11
variance O 0 1.1268701249900204e-11
components O 0 2.0906022746292052e-10
were O 0 2.1967644717180157e-11
assessed O 0 6.195789020724263e-11
with O 0 5.943397358466884e-13
the O 0 7.20610099369523e-11
program O 0 4.722020344183342e-11
Mx O 0 4.39501657290009e-10
, O 0 1.1304813422180482e-13
using O 0 1.129778050761943e-14
data O 0 3.150127186012097e-13
from O 0 6.26126076984021e-14
this O 0 1.0382544467452213e-14
and O 0 3.485089278797149e-14
previous O 0 4.5495465034184335e-12
studies O 0 1.75369202666531e-12
of O 0 1.5663802199750165e-10
twins O 0 2.9313231841854304e-09
with O 0 4.172178574846086e-11
AS B-Disease 1 1.0
. O 0 1.9967414388588622e-08

RESULTS O 0 4.193502434191032e-08
Six O 0 6.130643770418942e-10
of O 0 1.1182682557731027e-09
8 O 0 3.426272598971991e-07
monozygotic O 0 1.1066485967603512e-06
( O 0 8.703037179813577e-10
MZ O 1 0.8768585920333862
) O 0 1.1416401851649383e-10
twin O 0 3.338279839226743e-07
pairs O 0 3.251392766134842e-10
were O 0 2.902353357647769e-10
disease O 0 2.5479898795310874e-06
concordant O 0 2.374638654600858e-07
, O 0 1.943471859139345e-12
compared O 0 1.0533713658278376e-12
with O 0 6.093051410638317e-13
4 O 0 3.148927874008223e-08
of O 0 3.800598502579078e-09
15 O 0 1.2873595522933101e-09
B27 O 0 2.2945199074086986e-09
- O 0 3.156554184702287e-11
positive O 0 2.847956896354087e-12
dizygotic O 0 2.354836325935139e-09
( O 0 1.9067544852063856e-12
DZ O 0 7.942249879988594e-08
) O 0 7.496125031467016e-13
twin O 0 9.581306859018923e-10
pairs O 0 2.5912353859847137e-12
( O 0 1.7961864905591957e-13
27 O 0 2.2395374443817673e-10
% O 0 2.163238685404245e-11
) O 0 7.7708625396012e-14
and O 0 2.0032682110371347e-12
4 O 0 1.2309471220106616e-09
of O 0 2.2979711467030484e-09
32 O 0 5.442385031528829e-08
DZ O 0 0.08230260759592056
twin O 0 2.0661678945543827e-07
pairs O 0 2.8295922896437453e-11
overall O 0 1.1997015603171235e-09
( O 0 5.244252514885472e-12
12 O 0 2.9459171213552793e-10
. O 0 6.235239321389363e-12
5 O 0 3.3281291611508834e-10
% O 0 1.6674849001585557e-11
) O 0 2.0976178693316028e-12
. O 0 1.719695497115481e-10

Nonsignificant O 0 1.3114117791701574e-06
increases O 0 2.0075237305849924e-10
in O 0 6.327848401516123e-13
similarity O 0 1.8375030230027845e-12
with O 0 6.957785703246315e-15
regard O 0 8.972046738366102e-13
to O 0 2.6204273736248236e-14
age O 0 3.7097085819892683e-11
at O 0 5.754883236619435e-09
disease O 0 2.4232306259364123e-06
onset O 0 2.651507031714573e-07
and O 0 4.5381217230258675e-13
all O 0 3.722732571428272e-13
of O 0 2.5077597984313194e-11
the O 0 2.798446023521972e-11
disease O 0 4.296339639608959e-08
severity O 0 1.2278641214891195e-08
scores O 0 3.517337809899601e-10
assessed O 0 1.2889404821248007e-11
were O 0 2.5666003610619326e-13
noted O 0 1.15928772657925e-12
in O 0 3.595394468258739e-11
disease O 1 0.5840561985969543
- O 0 8.621705092082266e-07
concordant O 0 0.0006413891678676009
MZ O 1 1.0
twins O 0 6.324967927184844e-08
compared O 0 5.7790550123115736e-11
with O 0 2.3309179239539013e-11
concordant O 0 0.07397688180208206
DZ O 1 0.9999988079071045
twins O 0 1.836964293033816e-05
. O 0 6.447219647043312e-08

HLA O 0 1.1089073268522043e-05
- O 0 1.1530801202752627e-08
B27 O 0 6.235748362115601e-09
and O 0 9.332215555879486e-12
B60 O 0 7.223553422086582e-10
were O 0 2.55134411861202e-12
associated O 0 3.6916208479877144e-13
with O 0 2.7114891752787022e-14
the O 0 1.0767035700520733e-11
disease O 0 2.073115901168876e-09
in O 0 1.2162725254033502e-12
probands O 0 4.512065387984876e-09
, O 0 3.01443874202445e-13
and O 0 1.2743259680987606e-13
the O 0 1.453798019468433e-12
rate O 0 6.662774498789048e-11
of O 0 5.1415274815447276e-11
disease O 0 1.7667456830849915e-08
concordance O 0 1.2409014094050264e-10
was O 0 1.4379992856194956e-11
significantly O 0 2.743656809991307e-13
increased O 0 9.154611964323767e-12
among O 0 6.9171209558793745e-12
DZ O 0 0.39789000153541565
twin O 0 7.065680733830959e-07
pairs O 0 4.271849800979721e-12
in O 0 2.057765416396684e-11
which O 0 2.9616340629923243e-11
the O 0 3.4761691303231146e-09
co O 0 1.9042654741951992e-07
- O 0 4.984903156923792e-09
twin O 0 7.714130667579866e-09
was O 0 9.100854791999069e-11
positive O 0 1.6336606546707433e-12
for O 0 7.635492173425906e-13
both O 0 3.029237277685226e-11
B27 O 0 7.217307995688316e-08
and O 0 3.4122709102746285e-09
DR1 O 0 0.4001041650772095
. O 0 3.4533844228690214e-08

Additive O 0 8.260003880877775e-08
genetic O 0 5.3228030871821375e-09
effects O 0 1.0778065551164673e-08
were O 0 5.517229468426921e-12
estimated O 0 2.6332150977921576e-13
to O 0 3.2733124496103815e-15
contribute O 0 4.1814611533496845e-14
97 O 0 7.78909645116066e-11
% O 0 2.058337658303322e-12
of O 0 1.06314523157236e-11
the O 0 3.464890700743961e-12
population O 0 1.069094086262462e-13
variance O 0 5.385099657861936e-11
. O 0 8.047105759523276e-10

CONCLUSION O 0 1.93458546959846e-07
Susceptibility O 0 1.618152012383689e-08
to O 0 1.830487705856143e-10
AS B-Disease 1 0.9999998807907104
is O 0 1.9342423496215844e-11
largely O 0 9.068418932445255e-11
genetically O 0 1.2385598623099181e-11
determined O 0 2.7039826541036538e-12
, O 0 2.773283447506103e-13
and O 0 5.406408285467401e-13
the O 0 7.464344420338165e-11
environmental O 0 2.121494269147206e-08
trigger O 0 3.595053144067606e-10
for O 0 6.2272760732728916e-12
the O 0 1.7499524052055904e-09
disease O 0 5.496922767633805e-06
is O 0 2.3937610574287227e-11
probably O 0 6.921664630343827e-11
ubiquitous O 0 1.7637690419292085e-08
. O 0 8.191515910027647e-09

HLA O 0 3.994359758507926e-06
- O 0 2.817251987252689e-09
B27 O 0 1.9295240960559568e-09
accounts O 0 1.2758637462501055e-12
for O 0 3.6462328924409537e-13
a O 0 7.007416023309399e-13
minority O 0 3.9572690827341384e-13
of O 0 9.033128411939373e-12
the O 0 1.6268767583094146e-11
overall O 0 1.3254914943416907e-09
genetic O 0 4.770401851317274e-09
susceptibility O 0 1.8214832309126905e-08
to O 0 1.1189227322461193e-10
AS B-Disease 1 1.0
. O 0 3.092483780164912e-08

Cell O 0 3.151402552248328e-06
cycle O 0 4.3408647343312623e-07
- O 0 5.307515760222259e-09
dependent O 0 4.1341574608111387e-10
colocalization O 0 8.605131540662114e-08
of O 0 6.746866176854383e-08
BARD1 O 0 6.317898805718869e-05
and O 0 3.4410332916401387e-10
BRCA1 O 0 1.6054347087846033e-11
proteins O 0 7.393007240468277e-14
in O 0 5.458297659341471e-13
discrete O 0 6.715931699652344e-10
nuclear O 0 9.558276587995351e-07
domains O 0 7.580138117191382e-08
. O 0 3.575437546032845e-08

Germ O 0 3.536241592883016e-06
- O 0 1.0349754830940583e-08
line O 0 9.918198484726304e-10
mutations O 0 2.414952612883603e-11
of O 0 2.616028227375722e-10
the O 0 1.6285548465333477e-09
BRCA1 O 0 3.154667194138483e-09
gene O 0 4.540325407309531e-11
predispose O 0 5.7639266623499275e-12
women O 0 6.286698863312151e-15
to O 0 9.346308923736772e-15
early O 0 8.395106476655201e-08
- O 1 0.8886582851409912
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 5.301303396265666e-09
compromising O 0 7.342718788549973e-08
the O 0 2.8606241819773004e-09
genes O 0 8.091936842813396e-11
presumptive O 0 5.303214756224861e-09
function O 0 4.843360157380516e-10
as O 0 1.3275039921489817e-11
a O 0 5.260945845630971e-11
tumor B-Disease 0 3.060118913822407e-08
suppressor O 0 2.709533930556063e-07
. O 0 3.1315863235903407e-09

Although O 0 2.3733870424536008e-09
the O 0 1.6659089385751003e-10
biochemical O 0 1.3899272843787003e-09
properties O 0 4.479431581216886e-08
of O 0 1.522388686225895e-07
BRCA1 O 0 6.480727510194129e-09
polypeptides O 0 8.924169736523879e-10
are O 0 2.1406713207605677e-12
not O 0 3.117194273972307e-13
understood O 0 4.9408793029170894e-12
, O 0 2.5549270273213243e-13
their O 0 6.601971031493237e-13
expression O 0 5.308844076151731e-12
pattern O 0 2.1627108090505054e-11
and O 0 2.1147068471338848e-12
subcellular O 0 4.1851603072018406e-08
localization O 0 1.1079490036536299e-07
suggest O 0 2.931913045678414e-11
a O 0 2.3537909902421328e-12
role O 0 2.8753785377005903e-12
in O 0 1.5681012044410636e-11
cell O 0 1.7272061825224228e-07
- O 0 2.6056481416958377e-08
cycle O 0 3.893238442742586e-07
regulation O 0 1.971655592569732e-06
. O 0 4.9324127004979346e-09

When O 0 2.0837092051806394e-08
resting O 0 4.4180168856655655e-07
cells O 0 2.103971163958107e-10
are O 0 5.578579048357013e-13
induced O 0 2.1460819232821393e-10
to O 0 8.101035304814569e-14
proliferate O 0 1.6884726039209652e-12
, O 0 8.133642007525713e-14
the O 0 4.2294135858475523e-13
steady O 0 9.197982653308401e-12
- O 0 2.197942924940608e-14
state O 0 3.243878689968005e-14
levels O 0 2.735720937979691e-12
of O 0 4.273184182803508e-13
BRCA1 O 0 1.2084099996687026e-13
increase O 0 9.058338897493991e-15
in O 0 1.6217754949306856e-13
late O 0 5.711947581588106e-10
G1 O 0 7.901668208631918e-11
and O 0 3.069206401615926e-13
reach O 0 3.1746480444461156e-12
a O 0 8.862462630085388e-13
maximum O 0 2.073878152542008e-10
during O 0 4.249052221183547e-10
S O 0 3.7901322968991735e-08
phase O 0 4.282766496999102e-08
. O 0 5.046993045709769e-09

Moreover O 0 4.155300459274258e-08
, O 0 2.506680418790097e-10
in O 0 8.948509155892737e-10
S O 0 6.762494564327426e-08
phase O 0 1.986159148259503e-08
cells O 0 2.5222096633470414e-10
, O 0 1.4089626167168579e-11
BRCA1 O 0 2.8590627088043163e-10
polypeptides O 0 1.310273278765095e-10
are O 0 2.4780600748480763e-12
hyperphosphorylated O 0 2.355299066891803e-09
and O 0 2.9871861928487675e-11
accumulate O 0 1.950397525776748e-12
into O 0 1.0376457722574561e-12
discrete O 0 1.2144800720648163e-09
subnuclear O 0 3.362111442584137e-07
foci O 0 2.9405669010884594e-06
termed O 0 3.84264389197142e-08
" O 0 1.1716719150456356e-08
BRCA1 O 0 2.8930804418791922e-09
nuclear O 0 6.701095145444924e-08
dots O 0 7.665904355746989e-09
. O 0 9.764360875408329e-09

" O 0 8.244057880801847e-07
BRCA1 O 0 4.5261003833729774e-08
associates O 0 4.1358766411647707e-10
in O 0 3.075290456316937e-12
vivo O 0 1.7750767522528577e-10
with O 0 2.570040534555229e-12
a O 0 4.5436543416599307e-10
structurally O 0 1.5138114761725774e-08
related O 0 1.1308977088120287e-09
protein O 0 2.9914247079432243e-07
termed O 0 3.572405091745168e-07
BARD1 O 0 0.02657577022910118
. O 0 9.878898765691702e-08

Here O 0 8.302727394493559e-09
we O 0 1.042832747238931e-11
show O 0 1.4212433313565143e-11
that O 0 1.363553231914158e-13
the O 0 4.942085803094631e-12
steady O 0 1.1704802405088088e-10
- O 0 1.1258426916432862e-12
state O 0 4.730191390488192e-13
levels O 0 3.391866301716284e-11
of O 0 2.977959198680047e-11
BARD1 O 0 6.931503548912588e-08
, O 0 9.841675000996086e-13
unlike O 0 2.2247787379719997e-12
those O 0 1.0150307244022327e-12
of O 0 3.3757910355980414e-10
BRCA1 O 0 3.312234375663081e-10
, O 0 1.1559955466824978e-12
remain O 0 3.2511059816497934e-11
relatively O 0 2.2305646370755772e-13
constant O 0 2.162822178297663e-11
during O 0 3.673154558292424e-10
cell O 0 7.317329675515793e-08
cycle O 0 2.4800794307111573e-08
progression O 0 1.5011522691565915e-07
. O 0 1.557785345163154e-09

However O 0 7.135411816960868e-09
, O 0 1.1632492191715471e-10
immunostaining O 0 1.666577986725315e-08
revealed O 0 6.970129473593545e-10
that O 0 5.6669942176401644e-12
BARD1 O 0 1.7661197659890604e-07
resides O 0 3.755472877120525e-10
within O 0 1.5074767822920165e-10
BRCA1 O 0 2.730425954777793e-11
nuclear O 0 4.701980471644163e-10
dots O 0 3.481624927595406e-12
during O 0 8.684577362805257e-11
S O 0 3.0587281596439198e-09
phase O 0 1.1387244480687286e-09
of O 0 1.1074008376965594e-09
the O 0 2.6294247335023613e-10
cell O 0 1.3583901781188956e-09
cycle O 0 5.316023177215357e-10
, O 0 8.0143140387956e-13
but O 0 3.360746197392933e-13
not O 0 1.7918441253331197e-13
during O 0 4.7460563257217814e-11
the O 0 2.978437496636843e-10
G1 O 0 2.160697754050034e-08
phase O 0 2.8403896124018502e-08
. O 0 1.764047463659324e-09

Nevertheless O 0 1.6353232012988883e-07
, O 0 5.517392653864306e-10
BARD1 O 0 1.20070342291001e-06
polypeptides O 0 2.3575328356173486e-09
are O 0 8.620864438979581e-13
found O 0 2.9094029973825847e-14
exclusively O 0 8.899113813475718e-14
in O 0 2.733356618302152e-13
the O 0 3.348788477422482e-12
nuclear O 0 2.064197701656667e-10
fractions O 0 4.085606852832768e-12
of O 0 1.1866516103076208e-10
both O 0 7.694501286126254e-12
G1 O 0 1.703562624300048e-09
- O 0 1.5772358419319232e-10
and O 0 1.232750984625497e-10
S O 0 4.1126433814042684e-08
- O 0 6.2758603869284e-10
phase O 0 1.7021474008060977e-08
cells O 0 1.8841044280293318e-09
. O 0 7.262760948201219e-10

Therefore O 0 2.48515430456564e-09
, O 0 2.7536573715680746e-11
progression O 0 5.791725432580108e-10
to O 0 1.0973325546836943e-11
S O 0 3.4846463492499424e-09
phase O 0 1.2924227243971131e-09
is O 0 1.829067902995793e-13
accompanied O 0 6.509539001581244e-14
by O 0 2.447216589801255e-14
the O 0 6.476537513754044e-13
aggregation O 0 1.559730317991781e-12
of O 0 3.098028777959172e-11
nuclear O 0 2.9637462262144254e-08
BARD1 O 0 6.70225745125208e-07
polypeptides O 0 1.1161144897187114e-08
into O 0 1.7778346850239046e-10
BRCA1 O 0 1.3623340233692716e-09
nuclear O 0 5.314082329732628e-08
dots O 0 1.2110941582932355e-08
. O 0 2.5358149358112314e-08

This O 0 2.4539617560215277e-10
cell O 0 1.19625420680336e-08
cycle O 0 3.821292615668881e-09
- O 0 9.556589547488059e-11
dependent O 0 1.6297092148009895e-11
colocalization O 0 4.8759152271316e-09
of O 0 1.5972871914016196e-09
BARD1 O 0 1.2258409697096795e-05
and O 0 9.426336794460255e-11
BRCA1 O 0 7.521167022517261e-11
indicates O 0 2.7223381968838334e-12
a O 0 2.2138015162362357e-13
role O 0 1.1563307819942303e-12
for O 0 5.5029574647091906e-12
BARD1 O 0 4.149486358073773e-06
in O 0 5.204779274237126e-09
BRCA1 O 0 1.911246414465495e-07
- O 0 1.4702171036162781e-08
mediated O 0 1.0069503559861914e-06
tumor B-Disease 0 1.9386834537726827e-06
suppression O 0 4.5063370635034516e-05
. O 0 9.257663080575185e-09

Ethnic O 0 6.262566909498446e-09
differences O 0 2.309378022147257e-09
in O 0 4.759384553132406e-10
the O 0 6.263713547838279e-09
HFE O 0 2.8545149689307436e-05
codon O 0 7.739748753010645e-08
282 O 0 1.8189659556355764e-08
( O 0 1.4540886272840226e-09
Cys O 0 0.00033532644738443196
/ O 0 3.585741069400683e-06
Tyr O 0 1.0954501021842589e-06
) O 0 4.812821322031091e-11
polymorphism O 0 1.7826275566790173e-08
. O 0 4.318091662014467e-09

Recent O 0 1.4591472474734246e-10
studies O 0 1.8091609807480147e-11
have O 0 5.452990489707155e-13
shown O 0 1.4353740418471261e-11
that O 0 3.009341942306065e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.6731965146732364e-08
HH B-Disease 0 0.048894740641117096
) O 0 2.6562894678977544e-12
is O 0 2.7509356012762887e-13
likely O 0 1.531511733838392e-13
to O 0 1.2332258457969317e-14
be O 0 1.8082345516756693e-13
caused O 0 1.4924097114371593e-12
by O 0 3.645161971745081e-13
homozygosity O 0 2.0139641065952674e-09
for O 0 9.411869721087651e-12
a O 0 3.027267325705907e-11
Cys282Tyr O 0 3.913486423812174e-09
mutation O 0 7.769566240378722e-12
in O 0 3.2543553355607324e-12
the O 0 1.4331807962619791e-10
HFE O 0 3.6832889804827573e-07
gene O 0 1.6028775529086658e-10
located O 0 2.1105637237894825e-09
4 O 0 1.1486026352258705e-07
. O 0 1.0940990335939205e-08

5 O 0 3.254323701185058e-06
Mb O 0 2.315166057087481e-05
telomeric O 0 5.727603820560034e-06
to O 0 3.928144032272485e-09
HLA O 0 1.784346932254266e-05
- O 0 2.41982121451656e-07
A O 0 4.6852981938627636e-08
. O 0 3.1584361792624804e-09

Population O 0 7.881269421805559e-12
studies O 0 3.5410689137871376e-12
of O 0 6.935090696158497e-11
this O 0 1.250193254042492e-13
polymorphism O 0 7.932186157910692e-11
are O 0 8.779731634636981e-14
facilitated O 0 2.0136679595907786e-13
by O 0 2.400955953149597e-13
the O 0 6.695485745694674e-12
fact O 0 7.402436411237112e-13
that O 0 1.9746335643000545e-13
the O 0 3.979222507055624e-11
Cys282Tyr O 0 1.24312521165848e-07
mutation O 0 1.8358592424050357e-09
creates O 0 1.4515136315118582e-10
a O 0 2.411082999920211e-10
Rsal O 0 3.70034399566066e-07
restriction O 0 9.91154962548535e-08
site O 0 3.704078466171268e-08
. O 0 3.863469100195971e-09

We O 0 7.681663638514635e-10
have O 0 1.7384655997751408e-12
studied O 0 3.328121112033955e-11
the O 0 1.28644567221059e-10
codon O 0 1.8583645733372123e-09
282 O 0 1.1738097160929328e-09
( O 0 3.5663005881758636e-10
Cys O 0 3.576426752260886e-05
/ O 0 1.3390811659519386e-07
Tyr O 0 4.6868504632868735e-09
) O 0 4.992712379593353e-14
polymorphism O 0 1.5292735610836217e-12
in O 0 8.122913827028969e-14
different O 0 8.42782603687614e-14
ethnic O 0 9.384448079741148e-11
groups O 0 1.9815180052340509e-10
. O 0 2.7091491272557278e-09

In O 0 2.837830803681385e-10
agreement O 0 6.168058841460322e-10
with O 0 2.7300390680745634e-12
previous O 0 2.3401591775495945e-09
observations O 0 5.594997798397117e-10
the O 0 5.246601819663965e-09
Tyr O 0 4.374172135612753e-08
allele O 0 7.693184284063292e-11
appeared O 0 5.371384587116168e-11
to O 0 2.9606257224458477e-13
be O 0 5.320843592115931e-13
rare O 0 4.214407989255875e-11
or O 0 2.4624000755091302e-11
absent O 0 2.694668044256332e-09
in O 0 5.743199665841914e-11
Asiatic O 0 1.2243422276014826e-08
( O 0 1.2464366561451556e-12
Indian O 0 3.4406050924973286e-11
, O 0 2.119952867765673e-12
Chinese O 0 4.4506905105823336e-11
) O 0 8.823231858676173e-13
populations O 0 6.915026884435349e-11
. O 0 4.660835606351554e-10

The O 0 8.764908243641401e-10
highest O 0 3.6780758994048313e-10
allele O 0 9.536258501613437e-13
frequency O 0 5.708608499105372e-12
( O 0 5.029570510073356e-13
7 O 0 8.624376213184348e-11
. O 0 1.3785793253479062e-13
5 O 0 1.0100966937875988e-11
% O 0 5.152143902481532e-13
) O 0 1.0783995732803388e-14
was O 0 6.225067336607104e-12
found O 0 5.3390842094658275e-12
in O 0 4.2499091051917404e-11
Swedes O 0 3.13164832732582e-07
. O 0 3.082002208998347e-08

Saamis O 0 9.920852335199015e-07
( O 0 2.6831681321226597e-10
2 O 0 1.5088582605571332e-09
% O 0 1.0487490216537498e-11
) O 0 7.34802165945278e-14
and O 0 3.953534548351012e-13
Mordvinians O 0 8.652654148733063e-10
( O 0 2.3312534086321335e-13
1 O 0 1.4655924043815993e-11
. O 0 3.670709772924351e-14
8 O 0 5.2992228660730945e-12
% O 0 1.6879661730861972e-13
) O 0 4.361551792880737e-15
had O 0 5.545205137083564e-13
significantly O 0 1.503574825409415e-13
lower O 0 7.462817690206958e-12
frequencies O 0 1.9463059636182223e-12
of O 0 2.64634009150555e-10
the O 0 1.1810185052141264e-09
Tyr O 0 1.0656707871703475e-07
allele O 0 1.4621482913312889e-09
. O 0 9.79812453394402e-10

Comparisons O 0 2.0984324000661303e-10
with O 0 2.3994877265676173e-12
allele O 0 7.680689417810527e-12
frequencies O 0 2.7306535938659282e-12
based O 0 4.723095829370361e-13
on O 0 5.4775243368831994e-11
prevalence O 0 1.0306293596329397e-09
estimates O 0 2.096373855758893e-12
of O 0 3.785791818922135e-11
HH B-Disease 0 0.00011712153354892507
showed O 0 1.7124742157648143e-07
some O 0 5.108222005112406e-12
disagreements O 0 3.2996625431991333e-09
with O 0 6.38259237129013e-12
the O 0 3.680707405528949e-10
RFLP O 0 4.202828751687093e-09
data O 0 8.306092619259076e-11
, O 0 4.681643961390591e-12
particularly O 0 1.9087348021584738e-11
in O 0 1.8731317885656296e-10
Finns O 0 5.631919748338987e-07
. O 0 3.819632965473829e-08

The O 0 9.208497431245632e-08
newly O 0 4.694099686730624e-08
described O 0 1.3572041268616886e-09
HFE O 0 1.0415270480734762e-05
marker O 0 6.053114276483029e-08
provides O 0 2.7639971908466343e-11
a O 0 5.112042299887376e-12
new O 0 7.897129998546415e-12
approach O 0 3.1575176501208446e-11
to O 0 4.596426321154534e-13
the O 0 2.2524553836694716e-12
screening O 0 3.793323294365436e-11
of O 0 1.1569451646709084e-10
HH B-Disease 0 5.453991320791829e-07
as O 0 1.861850257300901e-11
well O 0 1.2976962169772288e-13
as O 0 3.8926764508182346e-14
studies O 0 7.220040402133518e-14
of O 0 8.618977927199456e-12
the O 0 7.184656515557553e-13
relationship O 0 1.962587027842886e-14
between O 0 1.830370707431306e-12
the O 0 6.94208190932244e-10
HFE O 0 3.3816313589341007e-06
Tyr O 0 1.72098353345973e-08
allele O 0 5.43704387068189e-11
and O 0 3.140182775265843e-12
different O 0 8.65684329776073e-11
disorders O 1 0.9999984502792358
including O 0 2.4273469989566365e-07
cancer B-Disease 1 0.9999998807907104

Autosomal B-Disease 1 0.9999988079071045
dominant I-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 0 0.4456644356250763
associated O 0 2.3316026193098693e-11
with O 0 1.0231218812700033e-13
a O 0 8.90997605557109e-12
missense O 0 2.0435850789368715e-09
mutation O 0 8.944285416478959e-12
encoding O 0 4.122074643425622e-12
Gly23 O 0 1.219490428638892e-07
- O 0 1.1194259030844478e-07
- O 0 2.2602407057092933e-08
> O 0 2.8052106415543676e-08
Val O 0 3.72342179311147e-09
in O 0 2.25339441550787e-10
neurophysin O 0 1.3738313100475352e-06
II O 0 2.539057459216565e-05
. O 0 1.7166168930771164e-08

Autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 7.722882056082625e-11
ADNDI B-Disease 0 2.34685285249725e-06
) O 0 2.67102149859727e-13
is O 0 6.3895049461863e-14
an O 0 3.197538262812716e-13
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 6.59227225696668e-07
by O 0 1.3213049578075786e-11
progressive O 1 0.9213374257087708
degeneration O 1 1.0
of O 0 2.592032330994698e-07
the O 0 3.52299772687914e-10
magnocellular O 0 7.889387809711934e-09
neurons O 0 4.203103143307629e-12
of O 0 7.77805181373381e-11
the O 0 3.290734351679703e-11
hypothalamus O 0 5.113147405477747e-11
leading O 0 5.758215432249969e-11
to O 0 2.329510824690406e-13
decreased O 0 1.511818101262996e-11
ability O 0 1.3082734223214543e-13
to O 0 1.4941036418063963e-13
produce O 0 3.347264132536054e-11
the O 0 3.582868446372345e-10
hormone O 0 7.856212902446202e-10
arginine O 0 6.29309770960873e-10
vasopressin O 0 3.9854530786698206e-10
( O 0 1.499352204892279e-11
AVP O 0 2.6994019464154917e-08
) O 0 6.7468149123062204e-12
. O 0 3.596150599527448e-10

Affected O 0 2.192053649707759e-09
individuals O 0 3.1582989262063377e-12
are O 0 3.2029221397507357e-13
not O 0 5.333208917893129e-13
symptomatic O 0 5.616981879619232e-10
at O 0 1.1313523035072492e-10
birth O 0 5.171902350831203e-10
, O 0 6.8174535027693e-13
but O 0 8.120191259848586e-13
usually O 0 4.842452480668946e-11
develop O 0 1.2196602483527386e-07
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999983310699463
at O 0 2.2071008061175235e-06
1 O 0 0.0008990474743768573
- O 0 6.852526723832852e-08
6 O 0 8.798046025049189e-08
yr O 0 1.5802086750227318e-07
of O 0 1.4961343275388117e-09
age O 0 3.745581178549173e-09
. O 0 1.531035742630138e-09

The O 0 3.5454320035377407e-10
genetic O 0 2.626607542577375e-10
locus O 0 2.0240253917336304e-10
of O 0 6.717519873689071e-10
the O 0 5.126628455087712e-09
disease O 0 2.403166399744805e-05
is O 0 2.5929669869584338e-11
the O 0 1.632965429543276e-09
AVP O 0 1.980852903216146e-05
- O 0 1.802034788056517e-08
neurophysin O 0 1.3757481838183594e-06
II O 0 0.00016144385153893381
( O 0 3.1462155797301605e-11
NPII O 0 2.5943990067389677e-07
) O 0 4.617365517711747e-13
gene O 0 1.916336013485509e-12
, O 0 4.0302730228668204e-13
and O 0 1.1784942596446135e-12
mutations O 0 1.0739470077125723e-11
that O 0 1.1152589268759172e-12
cause O 0 3.872307363650407e-09
ADNDI B-Disease 0 0.06334950029850006
have O 0 1.621220345471297e-11
been O 0 5.05305161862396e-13
found O 0 1.6645366319014213e-14
in O 0 3.633151993229916e-14
both O 0 1.6286384946825189e-13
the O 0 3.6237159106722316e-12
signal O 0 2.0506395193020666e-10
peptide O 0 5.3915434616857993e-11
of O 0 1.2648891933864093e-09
the O 0 5.8291429461121425e-09
prepro O 0 8.479615644318983e-05
- O 0 1.2900591173092835e-05
AVP O 0 4.287058982299641e-05
- O 0 1.152092998779608e-08
NPII O 0 1.2488138736443943e-06
precursor O 0 1.0674952477529587e-08
and O 0 3.007710747127135e-11
within O 0 3.076808807733755e-09
NPII O 0 1.1945863661821932e-05
itself O 0 2.4699442491282753e-08
. O 0 1.6949357473095006e-08

An O 0 1.5836316633044412e-11
affected O 0 3.4932287618083535e-10
girl O 0 1.542031724532933e-09
who O 0 1.7020407652723613e-11
presented O 0 1.2000328508676716e-10
at O 0 1.4781172952282873e-09
9 O 0 6.439876965025348e-10
months O 0 1.9050423131355965e-12
of O 0 7.60857557513539e-11
age O 0 7.755475428528058e-11
and O 0 1.2268954949212763e-11
her O 0 1.3225808469241596e-11
similarly O 0 1.9215644353476335e-10
affected O 0 8.023699066272982e-11
younger O 0 4.285962904027052e-11
brother O 0 1.0465439626017314e-09
and O 0 3.606206167017234e-10
father O 0 4.920345242354074e-10
were O 0 5.076446485396957e-10
all O 0 1.2201814211798556e-11
found O 0 6.821993057265496e-13
to O 0 1.5465263076240576e-13
have O 0 1.8482157265135163e-13
a O 0 9.61602108703885e-13
novel O 0 1.1252764345326405e-11
missense O 0 1.993315734694079e-09
mutation O 0 1.299875138083273e-11
( O 0 2.516669869463001e-13
G1758 O 0 1.0229131985894924e-09
- O 0 1.073364508386021e-09
- O 0 6.774765748396305e-10
> O 0 1.136333471762896e-09
T O 0 1.567425356174823e-11
) O 0 2.445664963084739e-16
encoding O 0 1.9285920381311925e-14
the O 0 3.0438713615604795e-12
amino O 0 4.995539745755728e-11
acid O 0 5.0898694980983095e-12
substitution O 0 1.159828552643738e-10
Gly23 O 0 1.598165688676545e-08
- O 0 3.3253200193428256e-09
- O 0 9.726697225431735e-10
> O 0 4.276356602161968e-09
Val O 0 3.183681540619432e-09
within O 0 2.4741815263240596e-09
NPII O 0 6.194029538164614e-06
. O 0 5.010813097783284e-09

The O 0 1.965177709450927e-08
mutation O 0 1.092438584038291e-09
was O 0 4.0412098667452767e-10
confirmed O 0 1.9672072998355716e-11
by O 0 2.500861063375881e-12
restriction O 0 1.8153293313005747e-09
endonuclease O 0 2.6958415944022818e-08
analysis O 0 3.0084812419062246e-10
. O 0 1.4769505618517087e-09

A O 0 7.087154472174007e-07
T1 O 0 2.3863393039391667e-07
- O 0 3.245381047234375e-11
weighted O 0 1.0559145571797934e-11
magnetic O 0 1.8331204609811635e-12
resonance O 0 8.115004436655415e-13
imaging O 0 1.5687638965644624e-09
of O 0 1.1763592056013294e-07
the O 0 4.798474719791557e-07
fathers O 0 1.5107791284663108e-07
pituitary O 0 8.737873145037156e-07
gland O 0 3.418344007855012e-08
demonstrates O 0 3.7303435340696467e-10
an O 0 6.458185548841033e-12
attenuated O 0 2.195865391740881e-07
posterior O 0 8.214158953023798e-08
pituitary O 0 0.0003140170592814684
bright O 0 7.52490359445801e-06
spot O 0 8.349882409675047e-05
. O 0 4.454570046164008e-08

This O 0 8.632641823602683e-10
mutation O 0 6.852520217925928e-10
may O 0 9.508800864754807e-12
be O 0 2.301901616368063e-13
valuable O 0 6.220364392843514e-13
for O 0 5.52725081686984e-14
developing O 0 1.8447370367380422e-12
models O 0 5.4453642116258916e-12
of O 0 7.815691149826165e-11
dominantly B-Disease 0 6.016207976244914e-07
inherited I-Disease 0 2.2398357941710856e-06
neurodegeneration I-Disease 1 1.0
, O 0 7.766128885811074e-12
as O 0 4.062441030273922e-13
the O 0 8.038380074418261e-13
early O 0 3.946524010367547e-11
age O 0 1.1239122479911323e-11
of O 0 1.519497166979633e-10
onset O 0 0.1480160355567932
of O 0 2.4117854991345666e-05
symptoms O 1 0.9972245693206787
suggests O 0 8.676596940926373e-11
that O 0 1.0542974371134661e-13
this O 0 4.5407365476153594e-13
mutation O 0 1.1236920421930918e-10
may O 0 1.3899550781182324e-11
be O 0 2.7422825295275732e-12
particularly O 0 1.1618222659978694e-12
deleterious O 0 1.7006981933853638e-10
to O 0 8.016198815852249e-12
the O 0 1.6537212710332483e-09
magnocellular O 0 4.397469410832855e-07
neuron O 0 1.2378484903763365e-08
. O 0 2.3184505704154645e-10
. O 0 3.0042393017737368e-09

Frequent O 0 3.15149173424345e-09
inactivation O 0 6.44497231405694e-06
of O 0 6.541058610309847e-07
PTEN O 0 0.35882768034935
/ O 0 3.976830339524895e-05
MMAC1 O 0 0.0014067689189687371
in O 0 2.95194411137345e-08
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.791716037289007e-06

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.6186297857601062e-09
the O 0 2.0318231819249633e-10
most O 0 7.69828905483605e-12
common O 0 8.847984567239564e-10
male B-Disease 0 5.255346938876082e-12
cancer I-Disease 0 5.305088399826241e-12
in O 0 1.025940790655433e-11
the O 0 4.082004734229372e-10
Western O 0 1.6347518894122004e-08
world O 0 1.7782485206563337e-10
, O 0 2.5509195450412747e-13
yet O 0 5.511357429460739e-13
many O 0 3.393569740538574e-14
of O 0 9.392681077358134e-12
the O 0 1.9852008491944018e-12
major O 0 3.0740954920505104e-11
genetic O 0 5.793623220062827e-11
events O 0 2.6484682502658785e-12
involved O 0 1.7120151325246413e-13
in O 0 4.670368367216959e-13
the O 0 1.0260073173007367e-11
progression O 0 5.966114269284617e-09
of O 0 6.957365239479429e-10
this O 0 1.4131591730137671e-10
often O 0 1.2073525512690253e-09
fatal O 0 0.0006937508005648851
cancer B-Disease 0 1.741943151500891e-06
remain O 0 6.293331011875125e-08
to O 0 5.1726890132330894e-11
be O 0 4.105695228240336e-10
elucidated O 0 4.964182608091505e-06
. O 0 1.948754224656568e-08

Numerous O 0 7.625897691099226e-10
cytogenetic O 0 9.398527822668257e-07
and O 0 1.8435147852713385e-10
allelotype O 0 6.488770054602355e-08
studies O 0 6.487782533426412e-11
have O 0 1.0325954501178014e-12
reported O 0 9.549000045544487e-13
frequent O 0 2.0257932484279983e-11
loss O 0 1.008573113914224e-09
of O 0 4.234830264238099e-09
heterozygosity O 0 1.043157226376934e-05
on O 0 3.054253170375887e-07
chromosomal O 1 0.9999014139175415
arm O 0 2.481899628037354e-07
10q O 0 9.005654533211782e-08
in O 0 1.2128527071553208e-09
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.7501486000765e-07

Deletion O 0 1.7255491258083566e-08
mapping O 0 1.6234809052662058e-09
studies O 0 1.3064650750127527e-10
have O 0 1.4073241703937978e-11
unambiguously O 0 7.069961838190864e-10
identified O 0 5.047980089489812e-11
a O 0 1.704087218556971e-11
region O 0 1.8220648601019462e-10
of O 0 1.0369509695351553e-09
chromosome O 0 3.066111364802282e-09
10q23 O 0 2.518797392880856e-09
to O 0 1.1160037737684148e-12
be O 0 1.7772963005827092e-13
the O 0 1.0363522106454637e-12
minimal O 0 8.829748487926281e-09
area O 0 7.70592090137967e-10
of O 0 4.545231691022167e-10
loss O 0 6.973832711310024e-08
. O 0 1.9749473167962606e-08

A O 0 6.083045178684188e-08
new O 0 6.316655531968252e-10
tumor B-Disease 0 8.655497651943733e-09
suppressor O 0 8.928005001962447e-09
gene O 0 8.091673858734438e-11
, O 0 6.178414550805922e-12
PTEN O 0 7.857626656004868e-07
/ O 0 4.077907433952532e-08
MMAC1 O 0 1.0999684491252992e-05
, O 0 1.429554478266093e-11
was O 0 1.5566765931840365e-10
isolated O 0 2.753700878432852e-10
recently O 0 1.1511291919674704e-11
at O 0 1.074598656586323e-11
this O 0 8.327601879831812e-15
region O 0 6.72020056789735e-13
of O 0 1.2280074526693774e-11
chromosome O 0 5.137824610201847e-10
10q23 O 0 6.856678003153149e-10
and O 0 3.984035323867374e-12
found O 0 8.890579787125541e-14
to O 0 7.140223471074209e-15
be O 0 8.77555779508609e-15
inactivated O 0 1.9252469410369066e-11
by O 0 3.192515289672862e-14
mutation O 0 7.804321425219918e-12
in O 0 9.300514351717748e-12
three O 0 1.907653057742209e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.5502694249153137
lines O 0 1.1504131869344292e-08
. O 0 6.867540980337594e-10

We O 0 1.8885307540017493e-08
screened O 0 9.085082979254366e-07
80 O 0 4.37623356219774e-07
prostate B-Disease 0 0.1002519428730011
tumors I-Disease 1 0.9999997615814209
by O 0 5.335460372124512e-12
microsatellite O 0 8.026033171404379e-09
analysis O 0 1.8331700740725765e-11
and O 0 2.6371216408499487e-12
found O 0 1.1320441112294688e-12
chromosome O 0 1.4153980765208019e-10
10q23 O 0 3.7471944991374073e-10
to O 0 6.066348378491737e-12
be O 0 4.606064661627496e-12
deleted O 0 7.119128203614267e-12
in O 0 2.10006382943273e-12
23 O 0 1.004035632412581e-09
cases O 0 1.6530518620605505e-10
. O 0 2.2127464305299327e-09

We O 0 4.149214305471105e-10
then O 0 1.4323322259160443e-12
proceeded O 0 1.4121223721602627e-13
with O 0 6.674280811184985e-16
sequence O 0 3.5406871662022055e-14
analysis O 0 4.638583150939381e-14
of O 0 2.625193812333393e-11
the O 0 4.3691706502757555e-11
entire O 0 1.1716757564173008e-09
PTEN O 0 2.2281682277025538e-07
/ O 0 1.1288595835878823e-08
MMAC1 O 0 2.2186054593476e-07
coding O 0 2.5672908243734582e-09
region O 0 1.3340381577187088e-10
and O 0 1.1136434656389138e-12
tested O 0 4.255909860639839e-12
for O 0 1.7558666380677185e-13
homozygous O 0 3.7006411823803376e-11
deletion O 0 6.790011261581519e-12
with O 0 4.714974680759994e-14
new O 0 5.154249856781368e-12
intragenic O 0 1.1322703885596752e-09
markers O 0 4.493664468308012e-11
in O 0 5.474144900395606e-13
these O 0 6.927650049752196e-14
23 O 0 2.9950764091069004e-11
cases O 0 1.554049532288826e-12
with O 0 1.175577972641062e-12
10q23 O 0 3.49027509116695e-08
loss O 0 3.2271092464952744e-08
of O 0 1.1776432273791215e-07
heterozygosity O 0 3.574078073143028e-05
. O 0 9.834492686877638e-08

The O 0 3.261876185822743e-11
identification O 0 8.105989837692285e-12
of O 0 7.534232959738318e-11
the O 0 1.361854726211753e-11
second O 0 1.0767246816367759e-10
mutational O 0 1.763802792709157e-08
event O 0 6.777428063209356e-10
in O 0 2.6604891900650074e-11
10 O 0 9.93523319170464e-11
( O 0 9.383937854198776e-13
43 O 0 4.794828423193565e-10
% O 0 1.1885663564470406e-09
) O 0 4.239321949039976e-10
tumors B-Disease 1 1.0
establishes O 0 7.77479982616569e-08
PTEN O 0 7.143984475987963e-06
/ O 0 2.99651503610221e-08
MMAC1 O 0 4.222943914555799e-07
as O 0 6.055539750193795e-12
a O 0 2.0476708436495406e-12
main O 0 7.266665047467313e-11
inactivation O 0 2.5889270727219582e-09
target O 0 7.527711787247426e-11
of O 0 2.6936581437597695e-11
10q O 0 7.198690088472404e-09
loss O 0 1.3274649157679619e-09
in O 0 1.209140287894428e-10
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.440401379923742e-09
. O 0 2.382749109131055e-09

Risk O 0 5.4836868379481984e-09
reversals O 0 4.892697705316529e-11
in O 0 7.860847931785708e-13
predictive O 0 2.842066582076086e-10
testing O 0 3.423509919997514e-09
for O 0 7.009061331331168e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.874614407095578e-08

The O 0 1.152658350711544e-11
first O 0 1.247844926346997e-12
predictive O 0 8.147629099175546e-11
testing O 0 3.106989665546678e-10
for O 0 1.0254116444841088e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.6220285708269953e-13
HD B-Disease 0 4.483128313026441e-10
) O 0 4.432738135833883e-15
was O 0 9.633714317816913e-14
based O 0 9.277750924018956e-15
on O 0 6.086236115782073e-12
analysis O 0 3.9501350324391837e-13
of O 0 1.9929868519397154e-11
linked O 0 1.1748978179237923e-10
polymorphic O 0 8.17763010085848e-11
DNA O 0 7.75798609381484e-12
markers O 0 1.9209579673468147e-12
to O 0 1.361744240589366e-13
estimate O 0 5.334239126797424e-12
the O 0 6.816205586068769e-13
likelihood O 0 1.5875450259938972e-11
of O 0 1.8184542760479872e-10
inheriting O 0 1.483321659945247e-10
the O 0 1.0643672748722466e-10
mutation O 0 1.6490831269977413e-11
for O 0 7.517118871813722e-12
HD B-Disease 0 1.7064420489987242e-06
. O 0 1.9001651807570852e-08

Limits O 0 3.0498850112081755e-09
to O 0 3.5293365452382375e-12
accuracy O 0 1.0576646503057674e-10
included O 0 4.530185254703056e-12
recombination O 0 3.0163423299887915e-13
between O 0 1.1820218198330124e-12
the O 0 3.6073328352204115e-11
DNA O 0 2.4444680654656104e-11
markers O 0 1.203980058012144e-11
and O 0 3.5235518929671583e-12
the O 0 4.3774872615642835e-11
mutation O 0 1.6958514453824236e-11
, O 0 1.9992982963623618e-12
pedigree O 0 8.42041575355168e-11
structure O 0 7.752669062277562e-10
, O 0 1.2023409611677804e-12
and O 0 1.6095239290664365e-12
whether O 0 2.9259786867713578e-12
DNA O 0 3.0862569444511934e-11
samples O 0 2.9311340681015263e-12
were O 0 1.1139117406244736e-11
available O 0 2.4125817663089855e-11
from O 0 1.4455184271788823e-10
family O 0 4.4525608200451927e-10
members O 0 4.675464460035528e-10
. O 0 1.2534149718135268e-08

With O 0 4.007478376921725e-12
direct O 0 6.123862528184532e-11
tests O 0 3.616419316787578e-11
for O 0 9.600902971945713e-13
the O 0 1.3527368461496714e-11
HD B-Disease 0 1.071784012651733e-07
mutation O 0 1.2704442532707194e-11
, O 0 2.0050523470271225e-13
we O 0 1.7873112115752293e-13
have O 0 1.0031104568405773e-14
assessed O 0 3.200662391372733e-13
the O 0 5.998080856864721e-14
accuracy O 0 1.3376248025886994e-11
of O 0 1.2510817902489091e-11
results O 0 6.503250086879742e-13
obtained O 0 2.5307734423732353e-13
by O 0 5.335884728854823e-13
linkage O 0 3.432059914043606e-10
approaches O 0 2.6100674399565094e-10
when O 0 2.0735477137406866e-12
requested O 0 5.021894792373027e-12
to O 0 9.287924162409977e-13
do O 0 1.4543332900809891e-12
so O 0 2.5418020485157115e-14
by O 0 9.869717348086338e-14
the O 0 1.9617443086650255e-11
test O 0 5.188620644247521e-10
individuals O 0 6.649186843482591e-12
. O 0 1.9630561620687104e-09

For O 0 6.72787991984336e-10
six O 0 1.1262475674289618e-10
such O 0 4.4564304503558194e-12
individuals O 0 1.3058602593360447e-13
, O 0 3.3878154730333787e-13
there O 0 8.91277611610175e-13
was O 0 3.149109445432785e-11
significant O 0 6.589758686642577e-12
disparity O 0 1.3666165421533094e-11
between O 0 3.2730426442056926e-12
the O 0 2.400702969751478e-10
tests O 0 3.7118070839170514e-09
. O 0 1.9453441080230505e-09

Three O 0 9.54730183799768e-10
went O 0 5.160196159259556e-10
from O 0 6.664651903270924e-12
a O 0 1.5626165292270677e-11
decreased O 0 6.136890995378508e-10
risk O 0 2.222184242173242e-11
to O 0 1.496039247616144e-14
an O 0 5.377749501679456e-15
increased O 0 6.063074955292569e-12
risk O 0 4.711242507227098e-11
, O 0 3.722134159591696e-14
while O 0 5.2240509688288375e-14
in O 0 2.8474230894144636e-13
another O 0 1.709007935168927e-12
three O 0 3.351312500080028e-12
the O 0 1.1128971355578443e-10
risk O 0 1.8233174969850552e-09
was O 0 7.504004084779581e-10
decreased O 0 2.4458524094939094e-08
. O 0 4.281881960110923e-09

Knowledge O 0 1.2050985098710498e-08
of O 0 1.6955629789094928e-08
the O 0 9.149083574078176e-11
potential O 0 7.201782573074134e-12
reasons O 0 1.5437106454241345e-11
for O 0 2.2394484541516518e-13
these O 0 1.8354063860653684e-14
changes O 0 1.9047105201657616e-13
in O 0 3.344975934693045e-13
results O 0 1.5749585880256434e-12
and O 0 9.012364151402691e-14
impact O 0 6.9075487517389345e-12
of O 0 1.7410016137087148e-11
these O 0 2.930411718404108e-13
risk O 0 7.1029879027129095e-12
reversals O 0 8.900056906735454e-12
on O 0 1.437385765967747e-10
both O 0 3.058905906350162e-11
patients O 0 2.0455094215665603e-11
and O 0 1.799631277332736e-11
the O 0 5.90138871103818e-09
counseling O 0 5.916532819227882e-10
team O 0 1.0257960279813627e-11
can O 0 1.228845177740981e-13
assist O 0 2.287166983583333e-12
in O 0 2.7134735430811574e-12
the O 0 1.470214748555687e-11
development O 0 1.9778394200198335e-11
of O 0 1.1305774025305304e-11
strategies O 0 1.1215845092948928e-11
for O 0 1.0027442201229753e-12
the O 0 2.5746536846948942e-11
prevention O 0 2.9823826741548487e-10
and O 0 3.1927360603402344e-13
, O 0 8.478355279124827e-14
where O 0 3.167322090366631e-13
necessary O 0 5.518684467742396e-11
, O 0 4.878679925324203e-12
management O 0 1.3355988537355756e-10
of O 0 4.81210793434883e-10
a O 0 6.91358914561846e-11
risk O 0 8.58980248041874e-11
reversal O 0 2.0672855788328448e-11
in O 0 1.9059171016584664e-13
any O 0 1.3964808042582488e-12
predictive O 0 1.805852273273345e-10
testing O 0 2.3927317904792744e-09
program O 0 8.681849128500119e-10
. O 0 6.19061538142951e-11
. O 0 1.2366278001607611e-09

A O 0 2.0492836316776675e-09
novel O 0 4.188459995502214e-11
common O 0 5.016535797874866e-11
missense O 0 2.5907944678493777e-09
mutation O 0 1.4597783051795155e-11
G301C O 0 1.138020441771026e-10
in O 0 2.2415874711967376e-11
the O 0 1.8258917988678292e-10
N O 0 2.3561225859225488e-08
- O 0 1.111794434294211e-09
acetylgalactosamine O 0 2.4082919480861165e-07
- O 0 1.9529029060549874e-08
6 O 0 7.260482703941307e-08
- O 0 1.1626286600119329e-09
sulfate O 0 9.010629464789588e-10
sulfatase O 0 2.91611286229454e-07
gene O 0 2.734508175450401e-10
in O 0 9.713751331075215e-11
mucopolysaccharidosis B-Disease 0 1.3824182133248542e-05
IVA I-Disease 1 1.0
. O 0 4.556121098175936e-07

Mucopolysaccharidosis B-Disease 0 0.0015639353077858686
IVA I-Disease 1 1.0
( O 0 0.0003562471829354763
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.078099415297018e-10
is O 0 1.4160826374357005e-12
an O 0 1.4343771396335692e-12
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 1.1654750498024669e-09
by O 0 5.500373377251289e-13
a O 0 2.3795061476761248e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 7.935064827435667e-10
N O 0 1.775158864347759e-07
- O 0 7.054659079130943e-10
acetylgalactosamine O 0 4.133247841764387e-07
- O 0 5.175457395978356e-09
6 O 0 4.4064869086923864e-08
- O 0 6.324720192019129e-10
sulfate O 0 1.9996550248979617e-10
sulfatase O 0 3.9298251408581564e-07
( O 0 1.8043193675265634e-11
GALNS O 0 5.453711082736845e-07
) O 0 2.969536075370094e-11
. O 0 3.291313332987045e-10

In O 0 5.174418116205004e-10
previous O 0 2.4857516045528882e-09
studies O 0 7.954927688791358e-11
, O 0 3.2127144694582555e-11
we O 0 3.6574507311648574e-11
have O 0 2.3071993534434787e-12
found O 0 2.1261564557562007e-12
two O 0 5.129141469190079e-13
common O 0 6.2959481378355164e-12
mutations O 0 1.493662832308118e-12
in O 0 4.562285878945138e-12
Caucasians O 0 2.9361912901038068e-09
and O 0 9.88509968324891e-12
Japanese O 0 1.361182171422115e-07
, O 0 1.4399156866851115e-10
respectively O 0 7.944836788453813e-09
. O 0 4.7141259784666545e-08

To O 0 2.600809012598404e-10
characterize O 0 1.776784719353941e-09
the O 0 5.085449283903642e-10
mutational O 0 3.469930831556667e-08
spectrum O 0 1.836902158158793e-10
in O 0 1.073815407252876e-12
various O 0 1.0243800165760097e-12
ethnic O 0 3.18337509130906e-11
groups O 0 1.9656908479409596e-12
, O 0 2.3977431910619795e-13
mutations O 0 5.725420680093019e-13
in O 0 3.0291604728033272e-12
the O 0 1.3817615107658554e-10
GALNS O 0 7.398177217510238e-07
gene O 0 1.4393006231294692e-10
in O 0 3.7777850292464166e-11
Colombian O 0 2.17868455365533e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 4.5730547526545706e-07
were O 0 1.0622195484311092e-10
investigated O 0 2.3722904196610273e-10
, O 0 2.5982085406772715e-12
and O 0 3.893987562952894e-12
genetic O 0 3.5107960982827535e-10
backgrounds O 0 1.8966933926223284e-11
were O 0 4.708545185694302e-12
extensively O 0 3.3532483972691096e-13
analyzed O 0 1.0551489152896276e-12
to O 0 1.2878652137782165e-13
identify O 0 9.474996742059316e-13
racial O 0 5.117457239217638e-12
origin O 0 2.4050948949430606e-13
, O 0 1.5831310058462417e-14
based O 0 2.2211384139813987e-14
on O 0 3.272819515398595e-11
mitochondrial O 0 3.274992776969299e-11
DNA O 0 8.96803031141813e-12
( O 0 1.9968850520617892e-13
mtDNA O 0 3.614121155126604e-12
) O 0 2.0232474549908286e-12
lineages O 0 4.803716868728714e-10
. O 0 5.089760612975169e-09

Three O 0 8.160510600596638e-10
novel O 0 1.1917853370846387e-09
missense O 0 5.295252947234985e-08
mutations O 0 8.922259459032134e-11
never O 0 1.854396844414019e-11
identified O 0 9.061354639718078e-13
previously O 0 8.792727830553293e-12
in O 0 6.152023335204149e-13
other O 0 5.211004289748869e-14
populations O 0 7.438144609787922e-13
and O 0 2.3939777569169374e-13
found O 0 4.1687375665171167e-13
in O 0 1.4083090162791967e-12
16 O 0 2.554687017486401e-10
out O 0 1.1389621884516643e-11
of O 0 4.5904319234679747e-10
19 O 0 4.9036923854828274e-08
Colombian O 0 1.867199898697436e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 3.403926385203704e-08
alleles O 0 1.4333276752986901e-11
account O 0 2.396720192102131e-12
for O 0 1.3292041078916128e-11
84 O 0 1.4232074363462743e-07
. O 0 3.998583864017746e-08

2 O 0 1.950896333369201e-08
% O 0 5.2749124512807555e-11
of O 0 1.3994899683567041e-10
the O 0 1.6585810849734095e-11
alleles O 0 2.7263120146864273e-13
in O 0 1.792504729716815e-12
this O 0 2.6545371803465834e-12
study O 0 2.228959378181017e-11
. O 0 7.908472765549845e-10

The O 0 1.9245852911353722e-08
G301C O 0 5.98945533170081e-08
and O 0 3.5986344459892905e-10
S162F O 0 1.377476355202134e-08
mutations O 0 4.197657152427148e-11
account O 0 1.6092752130880683e-12
for O 0 1.0893580308646289e-11
68 O 0 1.4122517200121365e-07
. O 0 1.6961775983759253e-08

4 O 0 8.544402589905076e-07
% O 0 4.0399479317443365e-09
and O 0 5.748451714637781e-10
10 O 0 2.2305275848566453e-08
. O 0 2.946133648151772e-08

5 O 0 1.3718156388620173e-08
% O 0 8.149679542324151e-11
of O 0 4.9066811724785e-10
mutations O 0 3.084162092381604e-11
, O 0 5.684618140794351e-12
respectively O 0 2.0462675998089708e-10
, O 0 9.400530701086929e-12
whereas O 0 2.6625705112914844e-11
the O 0 3.0353752844547444e-10
remaining O 0 2.993179393229184e-08
F69V O 0 3.050787654501619e-06
is O 0 1.9294440177508587e-12
limited O 0 2.593074626550118e-12
to O 0 2.6691932626839165e-13
a O 0 9.234123014845164e-12
single O 0 6.171680527744527e-11
allele O 0 1.3470686788252806e-09
. O 0 2.222907191651302e-09

The O 0 1.6714732931077947e-09
skewed O 0 1.3513939967069177e-10
prevalence O 0 7.680462377201991e-10
of O 0 3.175600407634427e-11
G301C O 0 1.9679248508541747e-10
in O 0 5.9341572454518765e-12
only O 0 5.530989728719238e-12
Colombian O 0 3.011531246599475e-09
patients O 0 5.1814945563333215e-12
and O 0 2.4486654565981925e-13
haplotype O 0 1.0644722082953084e-11
analysis O 0 4.807367069530055e-13
by O 0 2.40341627892951e-13
restriction O 0 1.960835140091266e-11
fragment O 0 1.637029379240873e-12
length O 0 1.871529054777929e-13
polymorphisms O 0 5.200703149382813e-12
in O 0 7.643568937509837e-12
the O 0 1.9172043119741744e-10
GALNS O 0 2.0661580890646292e-07
gene O 0 9.277769524862478e-11
suggest O 0 4.064597183134344e-12
that O 0 2.2923763581816914e-13
G301C O 0 1.699705931557105e-10
originated O 0 1.8789561920251607e-11
from O 0 8.021246861167342e-12
a O 0 7.86130605057167e-11
common O 0 3.5256866870447823e-10
ancestor O 0 6.1408282903130385e-09
. O 0 2.1109753944870135e-08

Investigation O 0 1.0656129312280882e-09
of O 0 1.3377085217314288e-08
the O 0 4.3753439760152446e-10
genetic O 0 1.822332562628759e-10
background O 0 6.015340569404115e-12
by O 0 2.539110198138128e-12
means O 0 2.023172462894962e-10
of O 0 1.5061010216754767e-09
mtDNA O 0 1.3883580396445439e-10
lineages O 0 1.1467178769042352e-11
indicate O 0 5.6408966039867e-12
that O 0 3.667829928666322e-12
all O 0 4.5697104433806146e-10
our O 0 2.621163730509579e-09
patients O 0 6.540273097405125e-12
are O 0 6.107848872938942e-14
probably O 0 1.647534647770954e-13
of O 0 1.047973253315293e-11
native O 0 5.592839386059367e-11
American O 0 9.610925388869873e-09
descent O 0 8.587404636273277e-07

Low O 0 5.335099029224466e-10
frequency O 0 1.904165020105708e-10
of O 0 1.3808347798516252e-09
BRCA1 O 0 7.811417623848627e-10
germline O 0 2.30311270055239e-10
mutations O 0 1.930429557525648e-13
in O 0 3.8080626027720346e-14
45 O 0 5.948620762641355e-11
German O 1 0.9999910593032837
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 9.092956076983683e-08
. O 0 1.863711140970281e-08

In O 0 2.7338860342229765e-11
this O 0 1.4810095966440173e-13
study O 0 8.447589009601478e-14
we O 0 8.11317430338826e-14
investigated O 0 1.8241148608960644e-12
45 O 0 1.0275393730330151e-10
German O 1 0.9840519428253174
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.834213139323865e-11
for O 0 1.256651813857923e-11
germline O 0 6.082195191936535e-09
mutations O 0 3.1754293205316086e-12
in O 0 2.518130669260099e-12
the O 0 2.1211603307147442e-10
BRCA1 O 0 1.096881696582841e-09
gene O 0 4.682568777170104e-10
. O 0 1.3492441608420336e-09

We O 0 4.1616179946579734e-10
identified O 0 5.4435813495734564e-11
four O 0 1.1976540419122994e-11
germline O 0 2.4858368696811795e-09
mutations O 0 4.787567911557211e-12
in O 0 5.276499289580405e-12
three O 0 7.11316339163659e-10
breast B-Disease 0 8.797420741757378e-05
cancer I-Disease 0 1.4153530401017633e-06
families O 0 1.2254050855628473e-12
and O 0 8.136567808403328e-12
in O 0 8.549148589054312e-08
one O 1 1.0
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 8.803518625200013e-08
. O 0 3.3362102143386085e-12
among O 0 6.690526225486965e-14
these O 0 1.2964148255346225e-13
were O 0 9.538736987779739e-12
one O 0 1.901974237827897e-12
frameshift O 0 2.496227891057856e-09
mutation O 0 2.2987230174909e-11
, O 0 2.1852959979778985e-12
one O 0 6.991052702021161e-12
nonsense O 0 5.2307345121960225e-09
mutation O 0 1.8213283659029855e-10
, O 0 2.4186527346897746e-12
one O 0 1.9999314704310933e-12
novel O 0 9.954348109686428e-12
splice O 0 2.242701802046554e-09
site O 0 1.6979626038526874e-10
mutation O 0 2.054337949752849e-11
, O 0 8.433779933106345e-13
and O 0 6.934584417112033e-12
one O 0 8.40132546864325e-11
missense O 0 1.7365954363413039e-06
mutation O 0 1.1874660543753635e-07
. O 0 2.459915826591441e-08

The O 0 1.8817063462961414e-08
missense O 0 5.483416884999315e-07
mutation O 0 1.3078419458523172e-09
was O 0 4.3553298745280244e-09
also O 0 1.976376180767847e-11
found O 0 5.898588475300448e-12
in O 0 5.201856306813468e-11
2 O 0 4.073687023264938e-07
. O 0 2.0502699982216654e-08

8 O 0 5.68388088595384e-07
% O 0 8.186514244279408e-10
of O 0 9.642097120732274e-10
the O 0 4.7062669733533014e-11
general O 0 4.785023072217953e-11
population O 0 3.9929032844866763e-13
, O 0 3.092310749911592e-13
suggesting O 0 8.606734574166663e-13
that O 0 5.663292778528353e-14
it O 0 1.5710842999824837e-13
is O 0 4.672114474815747e-13
not O 0 8.316122096507783e-12
disease O 0 7.152787873110356e-08
associated O 0 1.458410392451981e-09
. O 0 2.2762600693226887e-09

The O 0 3.888298849563654e-10
average O 0 6.300673177639382e-11
age O 0 4.891347327173889e-10
of O 0 2.1310652797978946e-08
disease O 0 0.004128116182982922
onset O 0 0.0001693923259153962
in O 0 1.9535008333182446e-10
those O 0 1.7419982123456634e-11
families O 0 8.214938061398835e-13
harbouring O 0 2.6393662366785975e-08
causative O 0 4.017022092739353e-08
mutations O 0 1.0464182853553439e-09
was O 0 2.816532118643522e-09
between O 0 2.3523583081441757e-09
32 O 0 5.500779707290349e-07
. O 0 7.965810766563663e-08

3 O 0 2.10653251997428e-06
and O 0 4.647947804414798e-09
37 O 0 8.703975140633702e-08
. O 0 4.06856166534908e-08

4 O 0 1.5088915006344905e-07
years O 0 1.8776030730194293e-10
, O 0 6.532344110077304e-12
whereas O 0 1.0037780502625271e-11
the O 0 2.5127391486967632e-11
family O 0 5.1864979325189076e-12
harbouring O 0 1.6683717518617414e-08
the O 0 7.429265536096352e-10
missense O 0 1.3056336456429563e-07
mutation O 0 4.3958714446290514e-10
had O 0 6.448203516279394e-12
an O 0 2.953031504561638e-15
average O 0 1.2607444385345778e-12
age O 0 4.2408240114033546e-11
of O 0 1.0193690336279815e-08
onset O 1 0.9995416402816772
of O 0 0.000935632735490799
51 O 0 2.2505203105538385e-06
. O 0 1.4330379372040625e-07

2 O 0 3.482559804979246e-06
years O 0 6.081443615357784e-08
. O 0 5.3704912517105186e-08

These O 0 3.387586391956354e-11
findings O 0 5.544785117161943e-12
show O 0 6.75249647863474e-11
that O 0 2.842822765386499e-12
BRCA1 O 0 1.0707057462866487e-10
is O 0 4.422456595810226e-13
implicated O 0 9.824663868909789e-13
in O 0 8.269205090637166e-13
a O 0 1.0182981844894523e-12
small O 0 7.46384901041848e-14
fraction O 0 3.5452454773959863e-12
of O 0 1.6844089714140864e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.599671420997154e-11
suggesting O 0 1.0334156273772432e-11
the O 0 1.728035466455613e-12
involvement O 0 2.0682204213140487e-11
of O 0 1.1465435545421343e-10
another O 0 1.2247934437492614e-11
susceptibility O 0 1.1840053382172755e-08
gene O 0 3.6585201534933276e-10
( O 0 1.6971328856141277e-11
s O 0 4.2555125645549197e-08
) O 0 2.083450079126692e-09

Paternal O 0 1.0577245745935215e-07
transmission O 0 3.510012538754381e-05
of O 1 0.9994339346885681
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.19932225346565247

We O 0 3.101697565455197e-09
report O 0 1.7065494850587726e-11
a O 0 2.662670648204135e-12
rare O 0 1.445666416438618e-11
case O 0 4.283778626962276e-12
of O 0 2.2992065196181244e-10
paternally O 0 0.0004324661276768893
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9965536594390869
DM B-Disease 1 1.0
) O 0 1.4331480446827527e-10
. O 0 4.125917385522371e-10

The O 0 1.825580397962767e-08
proband O 0 3.3257407494602376e-07
is O 0 3.354883038042544e-11
a O 0 6.3691664789478075e-12
23 O 0 1.282418060633006e-10
year O 0 4.1117721207017954e-12
old O 0 4.2934540367411955e-09
, O 0 6.362179671981494e-10
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.0785632831300518e-08
who O 0 6.37752461951635e-10
suffers O 1 0.9999997615814209
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 2.6206780603388324e-05

He O 0 1.5078908954802017e-10
presented O 0 8.953170427261625e-10
with O 0 9.559469882347571e-11
respiratory O 1 1.0
and O 0 3.7112053430377046e-09
feeding O 0 1.212087941127038e-08
difficulties O 0 3.43562703619682e-07
at O 0 2.1294295038387645e-06
birth O 0 4.911971700494178e-06
. O 0 1.0642875736266433e-07

His O 0 2.742978466585555e-08
two O 0 1.1365421492826044e-08
sibs O 0 0.14538410305976868
suffer O 0 3.581437013622235e-08
from O 0 2.669874599181554e-10
childhood O 1 0.82749342918396
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 3.0304607207654044e-05

Their O 0 2.223929040923167e-09
late O 0 9.228784847437055e-09
father O 0 6.505800065337297e-11
had O 0 8.293096070977057e-11
the O 0 2.4530234614406066e-12
adult O 0 2.1172699010696405e-12
type O 0 6.871756635939974e-11
of O 0 1.8207158802852064e-07
DM B-Disease 1 1.0
, O 0 5.169266403814987e-11
with O 0 8.013431931908066e-12
onset O 1 0.6809101700782776
around O 0 2.0201156303301104e-09
30 O 0 2.097409135259909e-09
years O 0 9.109613063884581e-10
. O 0 3.986017738100145e-09

Only O 0 3.9530959061728765e-10
six O 0 3.688668467893841e-11
other O 0 4.795001675990222e-14
cases O 0 4.3606557167258364e-14
of O 0 6.198244174859813e-12
paternal O 0 1.2106865510119746e-10
transmission O 0 5.322004312802164e-07
of O 0 0.3739660680294037
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 2.3770851953486272e-08
been O 0 2.045306458919871e-11
reported O 0 4.5237286139254707e-11
recently O 0 2.569897405990673e-09
. O 0 4.959562538431328e-09

We O 0 9.672324052800718e-10
review O 0 8.595833767000016e-11
the O 0 7.62213816368762e-12
sex O 0 6.229410975770733e-13
related O 0 4.0143615428339663e-13
effects O 0 7.13279157960045e-11
on O 0 9.180075449810587e-11
transmission O 0 3.14713616944573e-07
of O 0 1.4441770872508641e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00014821731019765139

Decreased O 0 2.744107385765915e-09
fertility O 0 4.6073084236653017e-10
of O 0 1.3190438324928166e-11
males O 0 7.718743585917107e-15
with O 0 1.1271048994837031e-14
adult O 0 4.4065662230252656e-10
onset O 1 0.9999970197677612
DM B-Disease 1 1.0
and O 0 3.4168393808764463e-11
contraction O 0 1.5440507761255162e-09
of O 0 4.119809382530093e-09
the O 0 8.267573431419706e-11
repeat O 0 1.291899504041183e-10
upon O 0 5.942879001408219e-12
male O 0 2.294672969433559e-13
transmission O 0 6.393798793365157e-13
contribute O 0 4.530091444110082e-15
to O 0 3.3981491394646096e-14
the O 0 4.172447110040167e-12
almost O 0 3.474632474104178e-12
absent O 0 1.8799170553585043e-11
occurrence O 0 1.790547571323131e-11
of O 0 3.5239571677392334e-11
paternal O 0 6.999786306138844e-10
transmission O 0 1.981502919079503e-06
of O 0 0.0003037372080143541
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00013658405805472285

Also O 0 9.709070214469762e-10
the O 0 9.365600656119355e-11
fathers O 0 3.630456005265792e-11
of O 0 2.136316297474128e-11
the O 0 1.4856171848265376e-11
reported O 0 7.646459854182552e-11
congenitally O 0 1.8242373300836334e-07
affected O 0 7.887739766898605e-11
children O 0 3.0668670727984626e-12
showed O 0 7.105109278704447e-10
, O 0 3.708532179264035e-12
on O 0 1.870983368235102e-09
average O 0 1.6209428244096102e-10
, O 0 5.450749920865583e-11
shorter O 0 2.9535982548622997e-09
CTG O 0 6.840975288469053e-07
repeat O 0 2.5902176403747035e-08
lengths O 0 1.9059391842546347e-09
and O 0 3.166435646670407e-12
hence O 0 3.684533927961198e-11
less O 0 3.771605857488813e-12
severe O 0 3.220997371045087e-07
clinical O 0 0.07539334148168564
symptoms O 0 1.2419370250427164e-05
than O 0 1.4368354054293542e-13
the O 0 2.770746956523573e-12
mothers O 0 3.996469225431981e-13
of O 0 6.099178779216119e-13
children O 0 1.8510247588171547e-12
with O 0 1.2433850615778397e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.002446305938065052

We O 0 3.4618818922638184e-10
conclude O 0 1.4602830056276161e-10
that O 0 7.859883669478554e-14
paternal O 0 5.846016726263059e-11
transmission O 0 7.79536257766722e-09
of O 0 3.7694528600695776e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 2.998537418363867e-09
rare O 0 1.704946461789092e-10
and O 0 4.704601508712103e-13
preferentially O 0 3.445822457665698e-13
occurs O 0 7.308965986694421e-14
with O 0 1.3189814095527358e-14
onset O 0 0.3354300558567047
of O 1 0.9998107552528381
DM B-Disease 1 1.0
past O 0 5.9445806499525133e-08
30 O 0 1.200637228526702e-10
years O 0 1.2309804868146368e-12
in O 0 2.6982641381650962e-12
the O 0 6.197537621988047e-11
father O 0 7.504172283567812e-11
. O 0 1.0820568746572334e-10
. O 0 1.2786574021816932e-09

The O 0 5.9514668748761324e-08
RB1 O 0 1.8246795661980286e-05
gene O 0 7.811417623848627e-10
mutation O 0 4.9185221867587003e-11
in O 0 6.809673051139109e-12
a O 0 1.4325275687898653e-10
child O 0 3.352455646421504e-09
with O 0 1.899019386186751e-09
ectopic B-Disease 1 0.9999996423721313
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 5.786436759080971e-06

The O 0 1.2362858115011477e-07
RB1 O 0 1.4805827959207818e-05
gene O 0 5.315576867559457e-10
mutation O 0 1.3886804900442584e-11
was O 0 1.0983753837012777e-11
investigated O 0 2.2086499296136708e-11
in O 0 2.224694907460023e-11
a O 0 5.942409342374333e-10
child O 0 9.716892179767456e-09
with O 0 9.031104752921237e-10
ectopic B-Disease 1 0.9918637275695801
intracranial I-Disease 0 0.30774056911468506
retinoblastoma I-Disease 0 3.2133991680893814e-06
using O 0 5.974611430592525e-12
DNA O 0 4.89336739531443e-12
obtained O 0 2.172651978032264e-13
from O 0 9.388556555453564e-13
both O 0 6.426519906510553e-12
the O 0 3.1970673330938837e-10
pineal B-Disease 0 0.00010112261225003749
and I-Disease 0 1.2336313082172978e-09
retinal I-Disease 1 0.9993984699249268
tumours I-Disease 1 1.0
of O 0 4.2414694689796306e-07
the O 0 8.699457154648371e-09
patient O 0 1.075742872558294e-07
. O 0 1.843052643835108e-08

A O 0 5.9136731067610526e-08
nonsense O 0 3.4892366329586366e-08
mutation O 0 2.7689642245753987e-10
in O 0 2.6634493222044142e-11
exon O 0 3.609607501786627e-09
17 O 0 1.402569171915502e-09
( O 0 1.7955364842517363e-12
codon O 0 1.5249548152018733e-11
556 O 0 5.6102947808278625e-12
) O 0 4.594469336233198e-14
of O 0 5.271251490857054e-11
the O 0 1.638887692223534e-09
RB1 O 0 1.2037612577842083e-06
gene O 0 1.3536718967976924e-10
was O 0 3.742615661828097e-10
found O 0 1.0127352515626464e-12
to O 0 6.893011823220357e-14
be O 0 1.60946153323141e-13
present O 0 1.3989708913877963e-12
homozygously O 0 1.7800003693224653e-09
in O 0 1.9524269354032064e-11
both O 0 1.3426296532892401e-11
the O 0 2.9666108458670237e-10
retinal B-Disease 0 1.4682026971968298e-07
and I-Disease 0 1.9657453442789574e-10
the I-Disease 0 3.5145518495482975e-08
pineal I-Disease 1 0.999998927116394
tumours I-Disease 1 1.0
. O 0 2.022715790417351e-07

The O 0 3.0968503317296836e-09
same O 0 2.8141572405715465e-10
mutation O 0 1.2072137733909472e-10
was O 0 1.2282588834899855e-10
present O 0 1.127261391870027e-11
heterozygously O 0 7.829111581258985e-09
in O 0 6.945892472298709e-11
the O 0 2.53811555106509e-10
DNA O 0 4.464210945354097e-10
from O 0 1.5080568738223832e-11
the O 0 1.1885906148201286e-10
constitutional O 0 4.171842604705489e-08
cells O 0 1.3532839779339945e-11
of O 0 1.0171461589658648e-10
the O 0 5.23641893734883e-11
patient O 0 7.990740014118813e-11
, O 0 4.348218399924386e-12
proving O 0 3.6487776688964857e-10
it O 0 3.72892905789457e-13
to O 0 1.4840635231133659e-13
be O 0 1.7791389021748483e-12
of O 0 9.614729151730117e-11
germline O 0 6.677768116247762e-09
origin O 0 1.8750405395007164e-10
. O 0 8.591936606627826e-10

The O 0 2.5965625205515153e-09
initial O 0 2.4228303807660723e-09
mutation O 0 7.468972662572071e-11
was O 0 2.6651618412198985e-11
shown O 0 1.9650461813291997e-12
to O 0 2.7266654645946575e-13
have O 0 6.034528345771895e-13
occurred O 0 1.324727549878446e-10
in O 0 4.8224028936783014e-12
the O 0 4.614590098928062e-10
paternally O 0 2.0556962798679024e-09
derived O 0 1.0567330344102288e-10
RB1 O 0 1.098982579605945e-06
allele O 0 2.8357654002775234e-09
. O 0 4.641409478978176e-09

The O 0 6.074543534850818e-09
mutation O 0 3.298658568517965e-11
is O 0 1.1855707388042092e-13
in O 0 2.441323781587207e-14
an O 0 4.7600621598390454e-15
area O 0 1.4412696730525809e-11
of O 0 1.0432510411106932e-10
the O 0 8.296307391075786e-11
gene O 0 6.070781464334596e-12
that O 0 4.881125343324244e-13
encodes O 0 2.3928879711032636e-12
the O 0 3.123851871622563e-11
protein O 0 2.8404500973522318e-11
- O 0 9.879671733492579e-12
binding O 0 1.5543202142032086e-11
region O 0 2.7647616834824973e-11
known O 0 1.945014678830792e-12
as O 0 4.0114837992176466e-13
the O 0 2.831545328069174e-12
pocket O 0 5.473359543373135e-10
region O 0 3.289040220733064e-11
and O 0 5.399856776999723e-12
has O 0 1.240105240718492e-12
been O 0 4.6643141822858e-13
detected O 0 6.10122976446581e-12
in O 0 2.1127032415191316e-12
other O 0 1.4623274379593765e-12
cases O 0 4.2562667799950216e-12
of O 0 5.93544269289481e-10
retinoblastoma B-Disease 0 2.6943823172587145e-07
. O 0 1.3088351513701468e-09
. O 0 1.0581660880859545e-08

Low O 0 7.263100343379847e-08
levels O 0 9.697557201704399e-10
of O 0 1.763239276808548e-10
beta O 0 7.986208139243445e-09
hexosaminidase O 0 2.1318871290532115e-07
A O 0 6.352116055374779e-10
in O 0 5.253322950260486e-12
healthy O 0 1.566803631281033e-11
individuals O 0 2.2183611623539413e-14
with O 0 8.947079188637019e-13
apparent O 0 8.897184306988493e-05
deficiency O 1 0.9999929666519165
of O 1 0.9993686079978943
this O 0 5.946213832430658e-08
enzyme O 0 2.123931608366547e-08
. O 0 8.261622497229837e-09

Appreciable O 0 2.902974358676147e-07
beta O 0 9.325257366299411e-08
hexosaminidase O 0 3.043738843189203e-07
A O 0 1.1890294970839932e-08
( O 0 2.624671964143732e-12
hex O 0 4.429050015630764e-09
A O 0 3.722851749099476e-10
) O 0 2.1588952142919532e-14
activity O 0 1.4773681410173989e-12
has O 0 8.140532789958216e-14
been O 0 3.4775744024891087e-13
detected O 0 9.667708300575839e-11
in O 0 8.379976573769099e-11
cultured O 0 8.407461393744597e-08
skin O 0 9.940949894371442e-07
fibroblasts O 0 4.938147867505904e-06
and O 0 7.823435788090194e-10
melanoma B-Disease 0 0.0004017725877929479
tissue O 0 5.079923703910083e-10
from O 0 1.128033604025358e-11
healthy O 0 2.8583210798238667e-10
individuals O 0 2.173645615442029e-14
previously O 0 1.1878903416473463e-10
reported O 0 3.15542245110656e-11
as O 0 8.945007234917313e-11
having O 0 1.5866763192207145e-07
deficiency B-Disease 1 0.9997833371162415
of I-Disease 1 0.9999172687530518
hex I-Disease 0 0.001898404909297824
A I-Disease 0 2.801722853718047e-09
activity O 0 8.708474913410313e-12
indistinguishable O 0 2.3961662190020994e-13
from O 0 8.452254848239781e-16
that O 0 2.6941137554976143e-16
of O 0 1.9994575927665542e-13
patients O 0 1.5518132568878573e-12
with O 0 2.592226433506539e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 8.031978637745851e-08
TSD B-Disease 1 0.9999384880065918
) O 0 4.812584775137907e-10
. O 0 7.516442579458271e-09

Identification O 0 5.266734603992518e-09
and O 0 1.982516095733189e-10
quantitation O 0 4.696294581663096e-06
of O 0 3.974969899900316e-07
hex O 0 3.9124734030338e-06
A O 0 4.1262524064222816e-08
, O 0 6.9005170501290625e-12
amounting O 0 1.3401198553641969e-11
to O 0 3.14573540827201e-11
3 O 0 1.3342041427222284e-07
. O 0 1.4618674271105192e-08

5 O 0 5.846883937010716e-07
% O 0 2.306271262852988e-08
- O 0 5.644588796371863e-08
6 O 0 3.879095800130017e-07
. O 0 2.127394083117906e-08

9 O 0 2.3199525855943648e-08
% O 0 2.6653904777740323e-11
of O 0 1.6831872701184025e-11
total O 0 8.943471657696378e-11
beta O 0 1.547473704732738e-09
hexosaminidase O 0 2.8189506284803656e-09
activity O 0 1.194998683340387e-10
, O 0 4.874919912190023e-13
has O 0 5.0037803897085356e-14
been O 0 2.4111611077420707e-14
obtained O 0 5.667380085193352e-13
by O 0 1.0714590673033264e-11
cellulose O 0 4.942722625855822e-06
acetate O 0 4.0731269024263383e-08
gel O 0 8.558571074068766e-10
electrophoresis O 0 9.457473693075258e-11
, O 0 2.2674657290666644e-11
DEAE O 0 4.6446800183730375e-07
- O 0 8.908642712412984e-10
cellulose O 0 4.7130829017305587e-08
ion O 0 2.2474194727450936e-10
- O 0 1.7007459676698922e-11
exchange O 0 4.478363426624332e-12
chromatography O 0 1.6186859795250252e-12
, O 0 3.452039001872187e-13
radial O 0 3.420079844329571e-11
immunodiffusion O 0 1.6786105838662024e-09
, O 0 7.933240869784086e-12
and O 0 1.0021180413266606e-10
radioimmunoassay O 0 6.504189968836727e-07
. O 0 2.524300590778239e-08

Previous O 0 1.5160172551986761e-05
family O 0 1.7316840184022908e-09
studies O 0 2.1195427357678653e-10
suggested O 0 1.3960933797907416e-10
that O 0 9.014363149158211e-13
these O 0 7.924178349084932e-13
individuals O 0 2.1663374490544368e-13
may O 0 1.0803534455927633e-10
be O 0 1.8067955118161727e-11
compound O 0 4.835191136365324e-10
heterozygotes O 0 1.1996757753873766e-10
for O 0 2.1991653290087676e-12
the O 0 3.4472789206541066e-11
common O 0 2.0450724447229618e-11
mutant O 0 3.022320393952782e-09
TSD B-Disease 0 2.0629822472528758e-07
gene O 0 1.301425633926101e-11
and O 0 7.417063382746114e-13
a O 0 3.0791760200626905e-12
rare O 0 1.1525819881841315e-10
( O 0 1.5010798593700914e-12
allelic O 0 2.5808317705156014e-09
) O 0 4.4176871362433534e-12
mutant O 0 1.224788359621698e-08
gene O 0 1.4993460695222893e-08
. O 0 8.824394548412329e-09

Thus O 0 1.6024503945999413e-09
, O 0 1.3161010475881696e-11
the O 0 1.3709582080689842e-11
postulated O 0 2.5354543464750634e-10
rate O 0 1.3164933032605575e-10
mutant O 0 1.2743035793238988e-10
gene O 0 4.558685026689879e-12
appears O 0 3.3981053648018955e-13
to O 0 8.417669434212204e-15
code O 0 6.594744417437806e-14
for O 0 9.51176732321389e-14
the O 0 1.4234210598401686e-12
expression O 0 1.353010412041833e-11
of O 0 4.415330601137413e-11
low O 0 8.504314613633213e-11
amounts O 0 4.480755610297704e-12
of O 0 8.028019360395433e-10
hex O 0 4.941059046359442e-07
A O 0 2.1036946407093637e-07
. O 0 1.4801154080146262e-08

Heterozygotes O 0 2.6837753352992877e-07
for O 0 6.433283905593612e-10
the O 0 7.272852875495062e-10
rare O 0 4.972641187706017e-10
mutant O 0 3.0203726186783797e-09
may O 0 2.851186821362095e-11
be O 0 3.7287089648535554e-13
indistinguishable O 0 3.75256206316954e-12
from O 0 1.4318124322895004e-13
heterozygotes O 0 2.1128868099573594e-10
for O 0 4.03847788543743e-12
the O 0 4.745352444324169e-10
common O 0 2.108133667633183e-09
TSD B-Disease 0 3.9412229853041936e-06
mutant O 0 4.587145596701703e-08
. O 0 4.674566511653211e-09

However O 0 2.2363785823209525e-10
, O 0 1.7724968628257676e-12
direct O 0 1.2839005900100453e-11
visualization O 0 1.0648957271541803e-09
and O 0 8.43943664952107e-11
quantitation O 0 1.2648420124605764e-05
of O 0 1.3701443322133855e-06
hex O 0 9.433306900064053e-07
A O 0 9.080937113381538e-10
by O 0 2.9934456064091564e-13
the O 0 3.7627678750595805e-12
methods O 0 1.5314928145104822e-11
described O 0 8.678727875244263e-12
may O 0 2.6007817861134486e-12
prevent O 0 7.397189631663803e-12
false O 0 4.222276694942906e-11
- O 0 2.9030215731307152e-11
positive O 0 5.7855369800519085e-12
prenatal O 0 8.095033088295622e-09
diagnosis O 0 5.734514196831242e-09
of O 0 1.4285147509340845e-09
TSD B-Disease 0 1.604611679795198e-05
in O 0 2.2961824108769235e-10
fetuses O 0 6.810667030343609e-10
having O 0 1.2420847336769292e-11
the O 0 5.13695926074309e-11
incomplete O 0 3.520118196931321e-09
hex B-Disease 0 0.00021462950098793954
A I-Disease 0 0.00010717302211560309
deficiency I-Disease 0 0.0011256792349740863
of O 0 0.00026184137095697224
the O 0 1.2244496971902663e-08
type O 0 1.8022676684381622e-09
described O 0 1.662543366864888e-11
in O 0 1.5477763168347813e-11
the O 0 7.741793872639846e-10
four O 0 1.5525262186955047e-09
healthy O 0 5.6689728467063105e-08
individuals O 0 2.9013307312197867e-09

The O 0 5.844933070875413e-08
tumor B-Disease 0 3.369503644989891e-07
suppressor O 0 2.519409463275224e-07
gene O 0 1.7661280216074715e-09
Smad4 O 0 4.304349374706362e-07
/ O 0 2.572405151113344e-07
Dpc4 O 0 3.065078431063739e-07
is O 0 1.4677456298961555e-12
required O 0 7.509247130360608e-13
for O 0 4.354208237456608e-13
gastrulation O 0 5.751240372831035e-09
and O 0 6.004863273290084e-12
later O 0 5.4401556176530974e-11
for O 0 3.2924778355092332e-12
anterior O 0 2.0822769897232973e-10
development O 0 6.706254440658199e-10
of O 0 1.2375503954942246e-09
the O 0 7.2666689332479e-10
mouse O 0 7.009088420772969e-09
embryo O 0 4.3488967982341364e-09
. O 0 6.473623859193367e-09

Mutations O 0 3.1319447035826897e-09
in O 0 1.3198756532162292e-09
the O 0 1.848911423962818e-08
SMAD4 O 0 0.0006302911788225174
/ O 0 2.0199826394673437e-05
DPC4 O 0 5.717619205825031e-05
tumor B-Disease 0 6.86240113623171e-08
suppressor O 0 4.8565631516339636e-09
gene O 0 7.793759561336433e-12
, O 0 2.951075256558966e-13
a O 0 3.2682391949007128e-12
key O 0 1.6165904170861722e-09
signal O 0 6.3763234692260085e-09
transducer O 0 4.68751215620955e-09
in O 0 1.3243990626410351e-10
most O 0 1.9147952320941464e-11
TGFbeta O 0 1.084810492102406e-06
- O 0 2.698515189081263e-09
related O 0 2.1605309208361234e-10
pathways O 0 2.9431201920004924e-10
, O 0 9.263308842861681e-14
are O 0 2.04312668976444e-15
involved O 0 5.184135981145489e-15
in O 0 5.79433284122674e-14
50 O 0 7.061867583757486e-12
% O 0 4.556131166788546e-11
of O 0 1.0314404619293782e-07
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 7.4228023549949285e-06

Homozygous O 0 9.299960765929427e-07
Smad4 O 0 1.4226459825295024e-05
mutant O 0 3.600592208385933e-06
mice O 0 1.9767560388572747e-06
die O 0 1.1552396372849216e-08
before O 0 1.839903646105867e-10
day O 0 1.04876207718263e-09
7 O 0 2.8518255135168147e-07
. O 0 1.2974867402704149e-08

5 O 0 3.6313693385636725e-07
of O 0 3.6843005091213854e-08
embryogenesis O 0 2.520698217267636e-06
. O 0 1.0897009161681126e-07

Mutant O 0 4.4330750625931614e-08
embryos O 0 6.240912675536947e-09
have O 0 4.789899379908924e-11
reduced O 0 1.563040530339066e-10
size O 0 2.2429561680192833e-11
, O 0 2.5331523337279727e-11
fail O 0 7.788436562350398e-09
to O 0 3.301283205137118e-11
gastrulate O 0 4.3828953266711324e-07
or O 0 3.926479141824757e-10
express O 0 6.674527597283486e-11
a O 0 2.156346802506537e-11
mesodermal O 0 5.303407046852726e-09
marker O 0 1.5954542131879634e-09
, O 0 1.719103592118243e-12
and O 0 2.960717608579966e-12
show O 0 7.737748775049624e-10
abnormal O 0 2.8137202789935145e-08
visceral O 0 3.1972635383681336e-07
endoderm O 0 2.3420905108650913e-06
development O 0 1.815080885592124e-08
. O 0 3.4082512367916706e-09

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 1.4802418490944547e-06
the O 0 5.295623939360894e-09
Smad4 O 0 5.717954081774224e-06
- O 0 6.740113889236454e-08
deficient O 0 3.1680171819203906e-09
embryos O 0 5.067041231043845e-11
results O 0 2.4771587558980457e-11
from O 0 6.1961633740503785e-12
reduced O 0 2.846239910425652e-09
cell O 0 2.078032634855731e-09
proliferation O 0 6.190314039145051e-09
rather O 0 5.717999316222355e-13
than O 0 2.5792554737510444e-14
increased O 0 2.4013522073595972e-11
apoptosis O 0 7.898169229747509e-08
. O 0 9.278481871710653e-10

Aggregation O 0 7.058539086557403e-09
of O 0 1.1150867784692764e-08
mutant O 0 9.737880191096338e-08
Smad4 O 0 5.1401611926849e-06
ES O 0 1.0954606295854319e-05
cells O 0 3.59172032393662e-11
with O 0 9.166803600912932e-13
wild O 0 6.828845044992704e-08
- O 0 2.8152216113852546e-09
type O 0 1.5878715231565366e-08
tetraploid O 0 1.7507966276752995e-06
morulae O 0 9.689515536592808e-06
rescues O 0 4.7285524829021597e-07
the O 0 1.3901852113917812e-08
gastrulation B-Disease 0 0.0029203349258750677
defect I-Disease 0 0.0016709323972463608
. O 0 8.11349210039225e-08

These O 0 2.411221222686777e-10
results O 0 1.779062730467018e-10
indicate O 0 3.207877366517842e-11
that O 0 8.180539036971302e-13
Smad4 O 0 1.582610487105285e-08
is O 0 7.0376916100345355e-12
initially O 0 1.2526738544030303e-12
required O 0 1.0118157532526886e-13
for O 0 4.960004371741718e-14
the O 0 3.6308263795699347e-13
differentiation O 0 4.230254601472749e-12
of O 0 1.3969184316231509e-11
the O 0 9.027582500986675e-12
visceral O 0 7.047719075004011e-10
endoderm O 0 6.7015264448855305e-09
and O 0 1.3649798522377687e-12
that O 0 2.3918828072691523e-13
the O 0 2.6501370542497682e-11
gastrulation B-Disease 0 3.0335468181874603e-07
defect I-Disease 0 3.286147887138213e-08
in O 0 1.383309439217939e-10
the O 0 2.4131823206374747e-09
epiblast O 0 4.0555719351687e-06
is O 0 7.946845265172087e-11
secondary O 0 2.3970025964104025e-09
and O 0 2.4780424240367083e-11
non O 0 2.2512534769703052e-07
- O 0 1.0621071133698479e-08
cell O 0 4.775001229972986e-07
autonomous O 0 2.2572987745661521e-07
. O 0 1.417706929629503e-08

Rescued O 0 4.195778728899313e-07
embryos O 0 8.296584752542913e-09
show O 0 3.404640480653143e-08
severe O 0 7.843130151741207e-05
anterior O 0 1.4593190655887156e-07
truncations O 0 0.00041230375063605607
, O 0 1.9228038605767495e-10
indicating O 0 2.6502813277318182e-09
a O 0 1.1230535945649933e-10
second O 0 5.756966570125144e-10
important O 0 8.837928305860387e-11
role O 0 4.5314838686971726e-11
for O 0 6.186023221443904e-11
Smad4 O 0 3.8523273815371795e-07
in O 0 6.488961590278564e-10
anterior O 0 4.3197228016822464e-09
patterning O 0 8.475062429624813e-09
during O 0 2.5292360206208286e-08
embryogenesis O 0 3.078206646023318e-06
. O 0 5.566539940105031e-08

Prevalence O 0 1.18234993351507e-06
of O 0 1.668047211467183e-08
p16 O 0 5.3772533092910635e-09
and O 0 3.8079686626169007e-10
CDK4 O 0 1.1446760254330002e-05
germline O 0 2.201369397880626e-07
mutations O 0 2.0871828571022988e-11
in O 0 1.2911155651551542e-11
48 O 0 5.665816615874064e-08
melanoma B-Disease 1 1.0
- O 0 0.0004202447598800063
prone O 0 1.8714661109697772e-06
families O 0 1.915766850713041e-11
in O 0 8.312039390112602e-10
France O 0 0.00012084675836376846
. O 0 1.8800436691890354e-06

The O 0 3.749621768633915e-08
French O 0 2.562924964877311e-05
Familial B-Disease 1 0.9999949932098389
Melanoma I-Disease 1 1.0
Study O 0 3.5130703679442377e-08
Group O 0 1.484208933533182e-08
. O 0 1.5842051226400145e-08

Germline O 0 7.460127449121501e-07
mutations O 0 1.2665496429420386e-10
in O 0 2.439493745898247e-11
the O 0 1.319799408650013e-10
p16 O 0 8.865773670763133e-10
and O 0 1.7774549887494828e-10
CDK4 O 0 7.208659098978387e-06
genes O 0 9.13902009624934e-11
have O 0 9.988882550965306e-13
been O 0 2.2758821194811263e-13
reported O 0 5.270341454921557e-13
in O 0 1.6795976501976506e-12
a O 0 1.45376826896082e-11
subset O 0 1.5756896232232975e-07
of O 0 6.912214445264908e-08
melanoma B-Disease 0 0.10386862605810165
pedigrees O 0 4.7846562267750414e-08
, O 0 2.711017695056217e-11
but O 0 4.045709513927909e-12
their O 0 1.0517136640741942e-11
prevalence O 0 2.069908511259655e-08
is O 0 5.104878650873113e-13
not O 0 2.3579147532051814e-13
well O 0 5.441834483033148e-12
known O 0 7.713670813203066e-10
. O 0 1.0406585815303515e-08

We O 0 3.3666666676701595e-10
searched O 0 5.3325531490511224e-11
for O 0 3.4948365273783366e-13
such O 0 4.27118193244147e-12
germline O 0 5.148362625106984e-09
mutations O 0 1.4710170581633264e-11
in O 0 6.037801768971063e-12
48 O 0 7.09536207565975e-09
French O 0 0.0203038789331913
melanoma B-Disease 1 1.0
- O 0 0.0003441406588535756
prone O 0 6.17609288156018e-08
families O 0 2.414604974299017e-13
selected O 0 2.0997182399902503e-13
according O 0 5.0213627608144615e-14
to O 0 3.6219294843051544e-14
two O 0 1.0198214343316858e-13
major O 0 1.1303622621250398e-10
criteria O 0 7.112380462359624e-09
families O 0 2.927460384565331e-14
with O 0 1.3633236690447931e-14
at O 0 4.255857333212987e-10
least O 0 1.60003000432285e-11
three O 0 2.0368352837696335e-11
affected O 0 9.133826334162265e-11
members O 0 4.01987254247671e-12
( O 0 5.770127756675458e-13
n O 0 1.8051851125022722e-09
= O 0 1.2321991205155314e-09
20 O 0 5.855837342805259e-11
) O 0 4.077405527471746e-14
or O 0 1.1353172904831482e-13
families O 0 1.4120622836429845e-14
with O 0 4.7630255046050146e-14
two O 0 6.610265286532968e-12
affected O 0 2.946319924146401e-11
members O 0 2.5668659905941915e-12
, O 0 9.129150343664683e-13
one O 0 1.4354281652195766e-12
of O 0 4.472222037144036e-10
them O 0 6.705940490403517e-12
affected O 0 3.456678953489556e-12
before O 0 7.018495593730245e-12
the O 0 1.891018418243018e-11
age O 0 3.4646615437727846e-11
of O 0 2.0034766901044776e-10
50 O 0 2.8881539521075084e-11
( O 0 1.8337207566190145e-13
n O 0 4.4321553371862166e-11
= O 0 9.462453737230092e-11
28 O 0 1.6447239403749592e-10
) O 0 5.844001498001017e-14
, O 0 6.876361188356411e-14
and O 0 2.3906194406876635e-13
one O 0 1.6076267921050214e-13
additional O 0 2.0545524916787405e-12
minor O 0 9.966065306343808e-09
criterion O 0 0.00016022847557906061
. O 0 3.7845556022375604e-08

Sixteen O 0 3.699920014810232e-08
different O 0 7.355885345283752e-11
p16 O 0 3.8083918241227366e-09
germline O 0 8.186112232522191e-09
mutations O 0 1.4104360041011788e-11
were O 0 8.946878828075544e-12
found O 0 4.3374977004226323e-13
in O 0 1.2430795325382715e-12
21 O 0 4.306163758904802e-10
families O 0 5.720955935546723e-13
, O 0 1.4946317837896683e-12
while O 0 1.4071336110199617e-11
one O 0 1.6319612328175026e-11
germline O 0 1.965177709450927e-08
mutation O 0 2.853297459415316e-11
, O 0 5.073931726162773e-13
Arg24His O 0 6.456151613321026e-09
, O 0 1.5511158329983843e-11
was O 0 1.3830905865042098e-10
detected O 0 1.189690707059654e-10
in O 0 9.112787607845618e-11
the O 0 3.6058642738368007e-09
CDK4 O 0 3.5249930078862235e-05
gene O 0 6.787252715412251e-08
. O 0 2.0423703617211686e-08

The O 0 8.87485432365942e-11
frequency O 0 7.50795189907727e-11
of O 0 3.799117687108833e-10
p16 O 0 1.4251176627677609e-10
gene O 0 1.1866984825359417e-11
mutation O 0 7.74964131495387e-13
in O 0 2.3347954971296436e-13
our O 0 3.203239539936731e-13
sample O 0 8.042133311288863e-14
( O 0 3.267662697500548e-14
44 O 0 4.261400694122175e-12
% O 0 3.1529061046003948e-12
) O 0 2.532211094453951e-14
is O 0 3.2922300411027117e-14
among O 0 1.259142682290661e-14
the O 0 6.21301241791189e-13
highest O 0 3.2763439183902676e-10
rates O 0 2.7509119981949937e-11
yet O 0 2.5132351169805667e-13
reported O 0 1.8490866119085653e-13
and O 0 1.7220627051076076e-13
the O 0 7.46280381241915e-12
CDK4 O 0 1.939020251029433e-07
mutation O 0 2.1195324141631833e-12
is O 0 5.064936846126654e-14
the O 0 1.5932554212581829e-13
second O 0 3.928917521184294e-12
mutation O 0 6.58783249306294e-13
detected O 0 6.925830351930951e-13
in O 0 5.923117898931629e-13
this O 0 6.341319613509255e-13
gene O 0 7.250079009368804e-11
worldwide O 0 9.882169527131168e-10
. O 0 6.951041964242677e-09

In O 0 4.0030362358223215e-10
summary O 0 3.751310018174081e-08
, O 0 2.1456472015790595e-11
our O 0 6.81705429952939e-12
results O 0 1.2422974975112577e-12
show O 0 5.497753727962129e-12
frequent O 0 4.545764806240804e-12
involvement O 0 9.352034424647826e-11
of O 0 1.1152477830123075e-09
the O 0 3.5650291052569116e-10
p16 O 0 5.322993712475466e-10
gene O 0 6.644132466426811e-11
in O 0 1.1207526226519882e-11
familial B-Disease 0 1.977130210661926e-07
melanoma I-Disease 0 8.473766683891881e-06
and O 0 1.9681981738850496e-11
confirm O 0 1.746810196490145e-10
the O 0 2.213978028686725e-10
role O 0 7.467990809084668e-11
of O 0 4.739367120976112e-09
the O 0 9.895414265770341e-09
CDK4 O 0 0.0005182689055800438
gene O 0 1.431424867526232e-09
as O 0 9.045442866950637e-11
a O 0 4.600423653133845e-10
melanoma B-Disease 0 1.30095841086586e-05
- O 0 1.9196175315983055e-08
predisposing O 0 3.3607810223657e-07
gene O 0 2.3349160382934997e-09
. O 0 3.674555659749501e-10
. O 0 3.295448358642261e-09

Progression O 0 3.9912734450808784e-07
of O 0 4.1066158473768155e-08
somatic O 0 2.2792551135353278e-07
CTG O 0 4.4460310277827375e-07
repeat O 0 8.558015962556453e-10
length O 0 3.833514668899474e-12
heterogeneity O 0 1.5863259317239198e-10
in O 0 3.712594467963903e-12
the O 0 1.507933188038546e-11
blood O 0 6.9290051127324226e-12
cells O 0 5.92233651008911e-10
of O 0 3.7856966628169175e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9951081871986389
. O 0 6.082102821380886e-09

The O 0 1.864078162661098e-11
genetic O 0 5.08124896325679e-11
basis O 0 4.926204999478045e-10
of O 0 0.39910033345222473
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9994457364082336
DM B-Disease 1 1.0
) O 0 1.983610975128669e-12
is O 0 4.7258692185275786e-14
the O 0 1.5008701475648784e-13
expansion O 0 1.1078010904441715e-11
of O 0 3.287873445723122e-11
an O 0 9.977723942206085e-13
unstable O 0 1.7775507732409324e-09
CTG O 0 9.801235023587651e-08
repeat O 0 2.044590718952577e-09
in O 0 2.4667530171273988e-11
the O 0 1.8128995527000313e-10
34 O 0 1.451699871424239e-09
UTR O 0 6.521433988382341e-06
of O 0 2.6472919856246335e-08
the O 0 1.0191302379780609e-07
DM B-Disease 1 0.9999991655349731
protein O 0 9.384528709688311e-09
kinase O 0 1.9426817932099993e-09
gene O 0 1.2827948425719882e-10
on O 0 1.8610283314401954e-09
chromosome O 0 1.9718457977546677e-08
19 O 0 1.2622345479940122e-07
. O 0 1.636071189636823e-08

One O 0 2.953805255945241e-10
of O 0 4.194620206732225e-09
the O 0 4.5175485574588947e-10
principal O 0 1.5324886248890834e-08
features O 0 2.1734605226697568e-09
of O 0 4.6906002637570055e-08
the O 0 6.865876912343083e-06
DM B-Disease 1 1.0
mutation O 0 1.0823840490559178e-08
is O 0 1.7839402914957003e-12
an O 0 4.169825292346663e-14
extraordinarily O 0 3.8495852339170966e-11
high O 0 1.3456716851933948e-09
level O 0 2.7310480277265015e-07
of O 0 9.420180191455074e-09
somatic O 0 1.4701519148729858e-06
mosaicism O 0 3.233491588616744e-05
, O 0 2.2472757162106394e-12
due O 0 4.329783753753702e-10
to O 0 3.211547239083401e-13
an O 0 4.3554603554405574e-14
extremely O 0 5.499439337079692e-13
high O 0 3.7128776615713566e-12
degree O 0 1.4297251160755309e-09
of O 0 6.97677970951105e-10
somatic O 0 4.702691125402225e-09
instability O 0 1.0555147866853076e-09
both O 0 3.1185757101703793e-12
within O 0 3.8791487383393886e-11
and O 0 1.548383600155634e-12
between O 0 1.2106904020980913e-11
different O 0 4.8386669670996696e-11
tissues O 0 5.284463977517362e-09
. O 0 7.270068991260814e-09

This O 0 7.325572093375143e-11
instability O 0 8.437465837118907e-09
appears O 0 1.5801287361894012e-11
to O 0 2.654535662463542e-13
be O 0 6.916101263736152e-13
biased O 0 1.6868309049913877e-12
towards O 0 3.7916124775473625e-13
further O 0 4.544494392345194e-14
expansion O 0 7.575927732372811e-13
and O 0 3.2267608317303534e-14
continuous O 0 1.5512317819155186e-10
throughout O 0 4.0335838835670046e-11
the O 0 7.594221779205768e-11
life O 0 5.503450559857237e-12
of O 0 4.591953206567467e-11
an O 0 1.9161668779466012e-13
individual O 0 7.500873294881416e-13
, O 0 3.116541963735231e-12
features O 0 6.948890907132466e-10
that O 0 3.8576169168746954e-12
could O 0 1.4158718685333693e-12
be O 0 2.8208258821761818e-14
associated O 0 1.2177434895958156e-13
with O 0 2.3121927617453415e-14
the O 0 1.8934763479361294e-11
progressive O 0 2.1581524123348572e-08
nature O 0 3.2438479680152454e-10
of O 0 1.1540850497482324e-09
the O 0 4.296911271239878e-09
disease O 0 8.617927960585803e-06
. O 0 5.838166838856296e-09

Although O 0 2.028187479075072e-10
increasing O 0 1.698318048692915e-11
measured O 0 6.273077543528238e-12
allele O 0 5.096842002269564e-13
size O 0 2.047708926250849e-13
between O 0 9.049851254668007e-13
patients O 0 6.382908958324496e-12
clearly O 0 7.532899136278651e-14
correlates O 0 1.799117122912742e-14
with O 0 8.012723893255808e-17
an O 0 8.083119610362031e-17
increased O 0 8.978289710000545e-14
severity O 0 6.635182403513795e-10
of O 0 1.6050137885414983e-09
symptoms O 0 4.208831398955226e-07
and O 0 9.341079342320424e-13
an O 0 8.434672773595386e-15
earlier O 0 7.364725149172635e-12
age O 0 6.00537050643446e-11
of O 0 1.824437712016902e-09
onset O 0 9.473007594351657e-06
, O 0 6.575392357335841e-13
this O 0 2.5171003654881133e-14
correlation O 0 9.951306272071303e-13
is O 0 8.140501619145757e-14
not O 0 3.886934245062208e-14
precise O 0 2.3687716718678864e-11
and O 0 3.3123822695130256e-12
measured O 0 2.075907327980797e-11
allele O 0 3.6142178659603896e-12
length O 0 5.126875052968716e-12
cannot O 0 1.4494704264969571e-12
be O 0 1.8830289500522575e-14
used O 0 3.0502132886660186e-15
as O 0 3.65280036239749e-15
an O 0 1.0048908777440585e-15
accurate O 0 9.43347223253399e-12
predictor O 0 2.4127035924692564e-09
of O 0 1.9293870667791424e-10
age O 0 8.442709864553422e-10
of O 0 1.6489156706711583e-08
onset O 0 0.0021547956857830286
. O 0 6.5301257734518e-08

In O 0 2.898508377757736e-10
order O 0 3.90405902050972e-11
to O 0 6.198099217029351e-13
further O 0 5.934471664081897e-13
characterize O 0 2.4935164610190297e-12
the O 0 2.115704486604919e-11
dynamics O 0 8.566863191061813e-11
of O 0 5.84459840524687e-08
DM B-Disease 1 1.0
CTG O 0 3.1518680771114305e-05
repeat O 0 1.2676818705870119e-08
somatic O 0 3.286240390920625e-09
instability O 0 8.653149863313558e-10
, O 0 5.43618806653906e-13
we O 0 1.7386271458988412e-13
have O 0 5.4622080038831296e-15
studied O 0 4.817812815360867e-13
repeat O 0 9.401283571075503e-12
length O 0 1.1852111902587587e-13
changes O 0 1.069771238281815e-13
over O 0 1.1911669838427646e-13
time O 0 2.088781621625846e-13
in O 0 1.1300686081350264e-11
111 O 0 0.011756516993045807
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 4.147077681260214e-10
with O 0 7.976623613741626e-15
varying O 0 1.6949322804646338e-12
clinical O 0 2.984000158079425e-09
severity O 0 4.5835772510827155e-08
and O 0 1.6252235668368087e-11
CTG O 0 1.2612117927801592e-07
repeat O 0 3.3463340431971744e-10
size O 0 1.1559514196540777e-12
over O 0 6.227795514533729e-13
time O 0 8.367573127443517e-13
intervals O 0 8.970258563723021e-11
of O 0 1.340220934231695e-09
1 O 0 7.435652094045508e-08
- O 0 7.350306474585011e-10
7 O 0 2.42616926549033e-09
years O 0 1.3224805972544829e-10
. O 0 1.0313135900830162e-09

We O 0 1.586357045724185e-09
have O 0 3.2710518321765747e-12
found O 0 2.2581796729845977e-13
a O 0 8.034712625044557e-14
direct O 0 2.322511323885057e-12
progression O 0 9.776431886265868e-10
of O 0 6.861308743388861e-10
the O 0 1.647228360657227e-11
size O 0 1.5994401983410178e-12
heterogeneity O 0 1.9006997364900968e-10
over O 0 1.9586334290555563e-11
time O 0 1.5976693926167407e-11
related O 0 3.263475947812289e-11
to O 0 1.5670367781162042e-11
initial O 0 7.439876270609602e-09
CTG O 0 1.621892920411483e-06
repeat O 0 2.162613865763774e-09
size O 0 1.3491038147739332e-11
and O 0 9.398069345314952e-13
the O 0 5.052147936113194e-12
time O 0 2.907453357930967e-12
interval O 0 1.278633088297454e-09
and O 0 2.3043506339193165e-11
always O 0 9.814180718104026e-12
biased O 0 3.1162626732555987e-12
towards O 0 9.117386750093215e-13
further O 0 1.0712828193981672e-12
expansion O 0 5.020903692809497e-10
. O 0 1.705604435464636e-09

Attempts O 0 1.7255119555414922e-09
to O 0 1.6148813189453826e-11
mathematically O 0 2.0956245072589752e-10
model O 0 4.939223682831617e-11
the O 0 1.0381932813441352e-10
dynamics O 0 1.30877961246334e-10
have O 0 1.1441967165404243e-11
proved O 0 1.702860075170065e-10
only O 0 6.113122594936238e-12
partially O 0 2.409695998295547e-09
successful O 0 2.9723182248808655e-11
suggesting O 0 9.861202132643854e-12
that O 0 8.278195972677774e-14
individual O 0 2.4085961225711952e-14
specific O 0 3.097245767150203e-13
genetic O 0 3.892037039876506e-11
and O 0 5.207452524746969e-12
/ O 0 2.8185636047339813e-09
or O 0 1.1704193170203325e-11
environmental O 0 2.409917776446946e-08
factors O 0 1.9918704186050462e-10
also O 0 3.1960157177018944e-12
play O 0 9.676987683393534e-11
a O 0 1.0360385292729202e-11
role O 0 3.021030691233162e-12
in O 0 2.739523538575206e-11
somatic O 0 3.1291580881998016e-08
mosaicism O 0 5.692560307579697e-07
. O 0 5.929570168206055e-10
. O 0 6.341804859033573e-09

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 5.702436300936142e-09
Palestinian O 0 3.383136260026731e-08
Arabs O 0 1.1857183679353511e-08
. O 0 1.984364317308973e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 0.49696090817451477
AGU B-Disease 1 1.0
) O 0 5.5699806746078995e-12
is O 0 1.915921983780891e-13
a O 0 1.4682355808579017e-12
rare O 0 3.1233856390144865e-08
disorder B-Disease 1 0.999996542930603
of I-Disease 0 0.0037626849953085184
glycoprotein I-Disease 0 2.865578835553606e-06
metabolism I-Disease 0 0.00794157013297081
caused O 0 5.170344152816142e-10
by O 0 8.807090798833295e-13
the O 0 8.903228376766492e-09
deficiency B-Disease 1 0.9999853372573853
of I-Disease 1 0.982364296913147
the I-Disease 0 0.00010138483776245266
lysosomal I-Disease 1 0.9365462064743042
enzyme I-Disease 0 1.5304694178652767e-09
aspartylglucosaminidase I-Disease 0 5.19400238374601e-08
( O 0 2.5039742848620428e-11
AGA O 0 6.934200769137533e-08
) O 0 1.9244392537864918e-11
. O 0 5.369297784163507e-10

AGU B-Disease 1 1.0
is O 0 6.933745244630529e-10
inherited O 0 4.298058353668921e-09
as O 0 9.48080329521428e-12
an O 0 2.245223538338559e-12
autosomal O 0 1.1773982805607375e-05
recessive O 0 1.3795001052585576e-07
trait O 0 1.8433882198465312e-10
and O 0 1.0841795126600995e-12
occurs O 0 4.5158619682225676e-13
with O 0 1.2053798917658308e-14
a O 0 1.3853305438557562e-12
high O 0 1.6991021437040565e-11
frequency O 0 5.880203268748829e-11
in O 0 1.3119530635485877e-11
Finland O 0 2.937339926845084e-09
because O 0 8.210341434500279e-11
of O 0 1.052353315600385e-08
a O 0 1.3189143110992063e-09
founder O 0 6.385524553564892e-09
effect O 0 1.973388386034003e-08
. O 0 5.396168401006207e-09

While O 0 1.542923233621707e-09
very O 0 2.0015811924567473e-11
few O 0 4.8478679404162506e-11
patients O 0 1.07148408201585e-10
with O 0 5.077259723762495e-10
AGU B-Disease 1 1.0
have O 0 1.4927807254205838e-11
been O 0 4.996268156143291e-13
reported O 0 7.292956386364957e-13
from O 0 1.0172692766277636e-12
non O 0 5.990652862664092e-09
- O 0 1.8596320663921695e-11
Finnish O 0 1.0057644717065273e-09
origin O 0 7.688339548339584e-12
, O 0 5.708257759702573e-13
we O 0 4.2657023746617284e-12
diagnosed O 0 3.6552438853476588e-09
the O 0 3.229530184944984e-11
disorder O 0 2.9503059550961552e-08
in O 0 1.0397820625340781e-11
8 O 0 4.6080511850732364e-08
patients O 0 4.650494832975083e-12
originating O 0 4.717552737343311e-12
from O 0 2.1114313422665454e-11
3 O 0 2.1685966089535214e-07
unrelated O 0 5.572249328622547e-10
families O 0 2.9992637063172567e-13
, O 0 4.10149399252685e-13
all O 0 3.299682575785834e-12
Palestinian O 0 9.497568009830815e-11
Arabs O 0 2.6038789180393707e-12
from O 0 8.115205556158411e-13
the O 0 7.882261683633818e-12
region O 0 3.1429588098763617e-11
of O 0 1.9748774837680116e-10
Jerusalem O 0 1.3071722548829712e-07
. O 0 5.75646730283097e-08

The O 0 1.120339154780936e-09
clinical O 0 5.825049811392091e-06
diagnosis O 1 0.9742410182952881
of O 1 0.9999920129776001
AGU B-Disease 1 1.0
is O 0 5.96462390589636e-09
often O 0 1.086914737900846e-12
difficult O 0 6.409354384034893e-13
, O 0 4.2877797124495076e-14
in O 0 1.5468479090934711e-13
particular O 0 3.2540558247105833e-13
early O 0 6.085647263898153e-11
in O 0 1.313559937904385e-12
the O 0 9.074469474457114e-12
course O 0 2.4801810605268315e-10
of O 0 8.854462996144008e-11
the O 0 2.5817806226235973e-10
disease O 0 2.1088343515884844e-08
, O 0 1.9080413247649086e-13
and O 0 3.596748821086543e-13
most O 0 5.304691148150242e-13
of O 0 2.976154878098214e-10
the O 0 1.8074933771927704e-09
patients O 0 4.020237198698595e-10
are O 0 1.1650399612053719e-12
diagnosed O 0 1.336544347418922e-10
after O 0 3.710245999322126e-11
the O 0 1.18599310927614e-10
age O 0 4.1995815158735184e-10
of O 0 1.2176212038639278e-08
5 O 0 9.787392940552309e-08
years O 0 2.6517883444654444e-09
. O 0 8.450736999066066e-09

However O 0 7.292160209004805e-10
, O 0 8.147748968567736e-12
since O 0 7.075839220105351e-11
these O 0 9.189653378538498e-12
patients O 0 5.558285602613733e-12
excrete O 0 9.162966913001114e-11
early O 0 1.2114671765761642e-10
large O 0 8.878908892839821e-13
amounts O 0 1.2566679467862496e-12
of O 0 8.781536608992724e-11
aspartylglucosamine O 0 2.155066347597767e-09
in O 0 5.3108517583666526e-11
urine O 0 6.579974412557199e-12
, O 0 8.109167498734568e-14
biochemical O 0 1.2727385985400463e-11
screening O 0 5.004697767319044e-10
is O 0 2.8845025326629248e-12
easy O 0 2.5400128181307657e-11
by O 0 3.48958925991405e-12
urine O 0 3.794698236192495e-11
chromatography O 0 4.429197633659676e-11
. O 0 1.497692525553873e-10
. O 0 3.807063109206865e-09

Detection O 0 1.4825679350849441e-08
of O 0 2.8727939471728803e-10
heterozygous O 0 1.1454287518475326e-10
carriers O 0 1.151420647195478e-12
of O 0 6.704562599546549e-11
the O 0 2.2470815963515633e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.9528054668048753e-08
ATM O 0 4.97849214298185e-07
) O 0 2.630102895456038e-13
gene O 0 6.345651001188335e-13
by O 0 4.486465994719968e-13
G2 O 0 1.531352111783235e-08
phase O 0 1.6582379913643308e-09
chromosomal O 0 1.0145956963469871e-07
radiosensitivity O 0 8.847284505009156e-08
of O 0 3.9565993148471534e-08
peripheral O 0 1.4405633919523098e-05
blood O 0 2.9538123058614474e-09
lymphocytes O 0 1.3965290257544893e-08
. O 0 2.2867954196925666e-09

In O 0 4.325807367422385e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.33689738167553e-12
patients O 0 2.0840310813868834e-12
, O 0 9.801650119258161e-15
mutations O 0 4.596502554119787e-14
in O 0 1.7276227648986564e-13
a O 0 4.740804103453566e-13
single O 0 1.9423971979459775e-12
gene O 0 1.5383837866783656e-12
, O 0 1.2233634515568942e-13
ATM O 0 1.4892181932069093e-10
, O 0 1.0797826933799104e-14
result O 0 2.624890864562357e-13
in O 0 3.427213753678243e-13
an O 0 3.402903514526656e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 3.8721408024411375e-11
embraces O 0 4.249503873787752e-11
a O 0 1.1108934003809315e-13
variety O 0 1.5309720722070375e-12
of O 0 1.2418999856267376e-11
clinical O 0 5.660455659750596e-09
features O 0 1.0656184962209991e-10
and O 0 1.2385971154965647e-12
manifests O 0 3.060848016017692e-12
extreme O 0 2.0421092372657768e-08
radiosensitivity O 0 3.1879798711997864e-07
and O 0 1.3190092074122362e-10
a O 0 3.8539801905379534e-10
strong O 0 1.3406197263421404e-09
pre O 1 0.6555055379867554
- O 0 5.387644819165871e-07
disposition O 0 6.768172625015723e-06
to O 0 4.537594300302317e-09
malignancy B-Disease 1 0.9782297611236572
. O 0 3.261918735120162e-08

Heterozygotes O 0 5.917509682262789e-08
for O 0 1.5058788938038248e-10
the O 0 4.537868969478609e-10
ATM O 0 2.679079713630017e-08
gene O 0 1.1903845964500448e-11
have O 0 5.012253090873331e-14
no O 0 7.921862086668688e-14
clinical O 0 6.522896806027134e-11
expression O 0 2.5520183188909584e-10
of O 0 2.463222244841745e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.616186434156731e-11
may O 0 2.9827567499252083e-11
be O 0 1.1565452588679914e-11
cancer B-Disease 0 3.595564379565985e-08
prone O 0 6.971801608246508e-11
with O 0 6.340796485961031e-14
a O 0 1.3238048678088088e-11
moderate O 0 4.741507741989892e-10
increase O 0 6.433608853995132e-12
in O 0 4.457008980635058e-12
in O 0 5.7862239305483953e-11
vitro O 0 3.830051582554006e-07
radiosensitivity O 0 9.147233868134208e-06
. O 0 2.763885653678244e-08

We O 0 6.305520550142774e-10
performed O 0 2.5646856860461753e-10
a O 0 5.592028923251391e-11
blind O 0 7.167298976540337e-10
chromosomal O 0 1.1204294381172986e-08
analysis O 0 1.84284601467688e-11
on O 0 1.0873745237560684e-09
G2 O 0 1.3177582580681246e-08
- O 0 5.4113419474532964e-12
phase O 0 5.265674701826484e-11
lymphocytes O 0 1.7775820962753763e-12
from O 0 9.254425838937236e-14
7 O 0 1.1262137888934376e-09
unrelated O 0 3.768270460113854e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.617487808251553e-09
, O 0 1.894088591481921e-13
13 O 0 3.2616211814717744e-11
obligate O 0 1.2879840305402013e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
T I-Disease 1 1.0
heterozygotes O 0 9.663085887012812e-10
( O 0 6.126303433870656e-15
parents O 0 2.4722022406244203e-15
of O 0 1.1298045290118741e-13
the O 0 5.359855896787391e-13
patients O 0 3.0145983907943485e-14
) O 0 8.97817866398116e-16
, O 0 1.1412872803393502e-14
and O 0 4.647903156101973e-13
14 O 0 1.7582320321896105e-10
normal O 0 2.833179524319718e-10
controls O 0 4.3622283563138353e-10
following O 0 3.058269956723869e-11
X O 0 4.35285496536153e-09
- O 0 4.299478741781604e-12
irradiation O 0 1.2321414721849777e-11
with O 0 3.3211359552233477e-13
1 O 0 2.720830227787019e-10
Gy O 0 3.176172880259287e-09
in O 0 3.837770216636588e-13
order O 0 9.668952921301766e-13
to O 0 1.0856730282577526e-13
evaluate O 0 2.801013327530244e-12
this O 0 6.466092310024318e-14
cytogenetic O 0 5.845305905971543e-10
method O 0 2.1486612836185692e-11
as O 0 2.230076583467633e-12
a O 0 1.96427422938239e-12
tool O 0 3.4832605549928175e-11
for O 0 2.1920085104681908e-12
detection O 0 4.20189083527589e-09
of O 0 4.318767121702649e-09
ATM O 0 1.8645272348294384e-06
carriers O 0 4.129761865812043e-09
. O 0 2.8995548184695963e-09

Both O 0 1.1240961157454876e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
homozygotes O 0 1.5847798806589708e-07
and O 0 1.5320062926593714e-12
heterozygotes O 0 3.6896835586830434e-10
showed O 0 5.312571129539867e-12
significantly O 0 2.0796452870875358e-14
increased O 0 6.563422494301058e-14
levels O 0 1.257615105804133e-12
of O 0 2.7332225024934154e-12
radiation O 0 1.831979830058117e-07
- O 0 1.6668124658281158e-09
induced O 0 5.205735220670249e-08
chromatid O 0 1.3490677019944997e-07
damage O 0 9.352418395280893e-09
relative O 0 4.696169841889031e-11
to O 0 2.619269547348563e-13
that O 0 2.489960277893277e-13
of O 0 3.0319785571109037e-10
normal O 0 3.96044264050488e-08
controls O 0 6.235923137865029e-07
. O 0 7.507129140549296e-09

These O 0 5.567317440391406e-11
results O 0 4.2867560196002685e-11
show O 0 1.6496941313004498e-10
that O 0 5.483981758286349e-12
the O 0 8.748105573275211e-10
G2 O 0 4.561525202007033e-07
- O 0 6.417658071633525e-10
phase O 0 5.932899060923091e-09
chromosomal O 0 2.1245075743081543e-07
radiosensitivity O 0 4.764848071658889e-08
assay O 0 5.438498540399905e-10
can O 0 1.2430955245203157e-13
be O 0 1.058974566700956e-14
used O 0 2.501725574000969e-15
for O 0 6.596828965520999e-15
the O 0 4.935470435118994e-13
detection O 0 1.8273106361377245e-09
of O 0 2.831195615726756e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 2.143003939636401e-06
. O 0 5.101715050415123e-09

In O 0 3.389507841067285e-10
combination O 0 2.635298923525653e-10
with O 0 6.498625422513005e-13
molecular O 0 1.3526556541521018e-09
genetic O 0 4.125681463129638e-10
analyses O 0 1.7015409914389323e-11
, O 0 4.729622726448723e-13
this O 0 1.8621287508919365e-13
test O 0 5.5336093346403104e-11
may O 0 2.293036637304735e-13
be O 0 1.1394993631942858e-14
of O 0 1.1483451993130056e-13
value O 0 8.717473357761074e-14
in O 0 4.240410834830321e-15
studies O 0 1.3185965177815034e-14
of O 0 5.843803631104538e-13
familial B-Disease 0 4.236070522134483e-11
and I-Disease 0 7.510482687156372e-12
sporadic I-Disease 0 2.3024092570267385e-06
cancers I-Disease 0 2.641305627548718e-07
aimed O 0 3.243736668157027e-10
at O 0 7.60097540464244e-11
determination O 0 8.937570822320495e-11
of O 0 8.821057218000306e-10
the O 0 2.4036066539889767e-11
potential O 0 9.563787262134582e-12
involvement O 0 1.7777185973288923e-11
of O 0 7.523441425405508e-09
ATM O 0 1.38382683871896e-05
mutations O 0 8.073318125134676e-10
in O 0 2.220312822487358e-10
tumor B-Disease 0 9.033228707266971e-06
risk O 0 2.1115999970788835e-07
or O 0 4.651827534285502e-11
development O 0 1.8448956140559858e-08
. O 0 7.158377224314449e-10
. O 0 2.7360288257227694e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.552491468714834e-08
identification O 0 2.001564025633229e-09
and O 0 1.2708773920386274e-12
detection O 0 3.1034255165707236e-09
of O 0 5.085810883542763e-09
founder O 0 1.4522960611884628e-08
- O 0 1.6279576298128262e-10
effect O 0 5.502626687636791e-10
mutations O 0 1.6649352252776084e-12
in O 0 9.25111333024975e-13
the O 0 2.116753994307885e-11
ATM O 0 9.504209863564483e-09
gene O 0 1.9634587358763333e-11
in O 0 1.7642401211812042e-12
ethnic O 0 1.3812319343831092e-10
populations O 0 2.2033619373473812e-10
. O 0 1.0702468911105711e-09

To O 0 2.3109352972894293e-11
facilitate O 0 6.368392618805174e-11
the O 0 1.195007200832654e-11
evaluation O 0 3.3291435580506956e-11
of O 0 1.7573402455450804e-10
ATM O 0 3.925599756371412e-08
heterozygotes O 0 3.6200445419076743e-10
for O 0 6.066484120603732e-13
susceptibility O 0 1.186373221884196e-10
to O 0 1.8773279100974677e-13
other O 0 1.4710554822883193e-12
diseases O 0 0.0015535139245912433
, O 0 6.213652639294742e-13
such O 0 7.059797191288908e-11
as O 0 7.711673077892556e-09
breast B-Disease 0 0.0002729427651502192
cancer I-Disease 0 9.342352313979063e-06
, O 0 1.2190723430727246e-10
we O 0 6.235337246529582e-11
have O 0 7.1533160254586e-13
attempted O 0 9.539101279709694e-12
to O 0 2.8525860601598396e-14
define O 0 1.6262491570398496e-12
the O 0 2.4610933950508507e-12
most O 0 2.774700025407091e-14
common O 0 2.893222296397775e-14
mutations O 0 4.540108455744311e-15
and O 0 2.976465094563902e-15
their O 0 1.2194256462070858e-14
frequencies O 0 1.5945452423726802e-12
in O 0 1.75749870212627e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.1538257328747026e-12
homozygotes O 0 2.8967728216144906e-10
from O 0 1.2416311739611025e-13
10 O 0 3.842680080384797e-12
ethnic O 0 1.721545822563897e-11
populations O 0 3.891813954437495e-11
. O 0 3.3558958389967586e-10

Both O 0 2.2552562595201664e-10
genomic O 0 7.362348952710818e-09
mutations O 0 9.662565192414263e-11
and O 0 5.584053618806761e-12
their O 0 7.257076883870894e-12
effects O 0 8.477402113626908e-10
on O 0 5.589984586329422e-10
cDNA O 0 7.119193679017144e-09
were O 0 1.5455819957210792e-10
characterized O 0 3.0187081723198617e-09
. O 0 9.009911927648773e-09

Protein O 0 1.7896079285151245e-08
- O 0 4.5840881091052665e-10
truncation O 0 1.5382665807806006e-08
testing O 0 1.5816229437248808e-09
of O 0 5.527241442315756e-10
the O 0 7.023158443697497e-11
entire O 0 7.795814688238423e-11
ATM O 0 8.388664207714669e-10
cDNA O 0 2.1158912122398732e-10
detected O 0 2.2747387307120448e-11
92 O 0 6.320569068130055e-11
( O 0 6.170191311008488e-13
66 O 0 1.6306457573112e-10
% O 0 1.1297539292964842e-11
) O 0 2.581092078349917e-13
truncating O 0 9.207962725632513e-10
mutations O 0 2.7659526145168423e-12
in O 0 5.308094675610109e-12
140 O 0 3.5183828073215295e-11
mutant O 0 4.552971610838341e-10
alleles O 0 1.542053811032229e-11
screened O 0 1.7141042363277847e-08
. O 0 2.688409939111125e-09

The O 0 8.288822073154734e-08
haplotyping O 0 0.00010941651271423325
of O 0 2.10227972274879e-05
patients O 0 2.1436941111119268e-09
with O 0 2.2181360914697024e-11
identical O 0 1.68374203468602e-08
mutations O 0 1.5725887259065985e-10
indicates O 0 1.1446686654092986e-10
that O 0 5.075925573957973e-13
almost O 0 1.6579199818567147e-11
all O 0 7.74404585596189e-12
of O 0 6.031316002186315e-10
these O 0 3.0197098619365315e-13
represent O 0 5.48737921421405e-13
common O 0 1.2693680741943103e-12
ancestry O 0 1.7123580114616899e-13
and O 0 1.1078554523411e-12
that O 0 1.1737184574950321e-12
very O 0 3.987364691898643e-12
few O 0 1.0686104778834249e-10
spontaneously O 0 7.538890345326621e-11
recurring O 0 4.808376363740763e-09
ATM O 0 1.8375649233348668e-06
mutations O 0 1.4782075563601893e-09
exist O 0 6.940284791312479e-09
. O 0 1.0637776881594618e-08

Assays O 0 2.2086057427372907e-09
requiring O 0 8.728268108271209e-11
minimal O 0 4.1190686972392143e-10
amounts O 0 9.259905125666434e-13
of O 0 8.208301226220183e-12
genomic O 0 4.0415643054458883e-10
DNA O 0 3.352838007231185e-10
were O 0 8.01415010742712e-12
designed O 0 3.2935583513943323e-12
to O 0 1.692056596832442e-13
allow O 0 1.3455514914079147e-12
rapid O 0 2.669104347263751e-11
screening O 0 1.064833724667702e-11
for O 0 9.195465569544758e-14
common O 0 4.0359217703955785e-12
ethnic O 0 2.7950586289904322e-11
mutations O 0 1.4184113605875126e-10
. O 0 1.0839744657431538e-09

These O 0 1.1589616766283228e-10
rapid O 0 4.860796209982254e-10
assays O 0 1.1452365444863943e-10
detected O 0 1.3830844455831048e-11
mutations O 0 7.777450558577037e-13
in O 0 4.3765227444696186e-13
76 O 0 2.1001540784215678e-10
% O 0 1.8978369223376923e-11
of O 0 4.1096281933050705e-10
Costa O 0 2.48727883445099e-05
Rican O 0 3.8421239878516644e-06
patients O 0 3.4505431845133216e-10
( O 0 1.3526813946295596e-13
3 O 0 7.663191609053044e-11
) O 0 6.48720045577319e-15
, O 0 1.3034159085975171e-14
50 O 0 2.5045259919795337e-13
% O 0 2.6789093404526454e-13
of O 0 1.7796522935875636e-11
Norwegian O 0 8.496674297475693e-08
patients O 0 1.4999766706491613e-10
( O 0 3.7939126124562905e-13
1 O 0 1.2606111987611968e-10
) O 0 8.522223793089485e-15
, O 0 5.1308779375539276e-15
25 O 0 3.318919574932244e-13
% O 0 4.1654789968877115e-13
of O 0 2.6351166040883278e-11
Polish O 0 1.2995275078253599e-08
patients O 0 2.2443652492043498e-10
( O 0 3.188707165067278e-13
4 O 0 8.235815918133937e-10
) O 0 3.0847337352665413e-14
, O 0 1.3214793944174835e-14
and O 0 6.624319419824137e-14
14 O 0 1.8476499843989025e-11
% O 0 6.898029890345381e-12
of O 0 3.741117138300609e-10
Italian O 0 4.098142198927235e-07
patients O 0 5.350609399989992e-10
( O 0 9.18633658725243e-13
1 O 0 5.680071413216581e-10
) O 0 3.9559237233633554e-14
, O 0 3.087588575111967e-14
as O 0 1.6535602368698138e-13
well O 0 1.8101808301005523e-13
as O 0 1.1159307391995707e-13
in O 0 6.288024029417472e-13
patients O 0 6.072839713738842e-13
of O 0 5.0538857820914274e-11
Amish O 0 3.586754004913928e-09
/ O 0 3.267957460195703e-09
Mennonite O 0 5.629318344801959e-09
and O 0 2.2788772605086827e-11
Irish O 0 2.1655734983028196e-09
English O 0 2.6897588600860445e-09
backgrounds O 0 1.0659590543582453e-08
. O 0 1.1059006155278439e-08

Additional O 0 5.440033978842962e-10
mutations O 0 6.747783581895206e-11
were O 0 1.2438296052852404e-11
observed O 0 4.455631610195132e-12
in O 0 4.645086832538725e-12
Japanese O 0 1.93133575798754e-09
, O 0 8.796316973425089e-12
Utah O 0 1.628759904725996e-09
Mormon O 0 3.109276031088015e-11
, O 0 6.855032492168733e-13
and O 0 4.986870833813273e-13
African O 0 2.1735826680191472e-11
American O 0 2.2518818754146963e-10
patients O 0 7.147135661078607e-10
. O 0 1.992935594330447e-09

These O 0 3.165742668009841e-11
assays O 0 6.459445478501635e-11
should O 0 5.263179215370117e-13
facilitate O 0 1.608461953038487e-12
screening O 0 4.437757383790597e-10
for O 0 5.019412441242821e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999891519546509
T I-Disease 1 0.9999994039535522
heterozygotes O 0 8.087898129005566e-10
in O 0 2.2735348217776952e-13
the O 0 2.0120056066098152e-13
populations O 0 1.092405178359894e-13
studied O 0 4.719712468070902e-12
. O 0 1.1806704919292699e-11
. O 0 5.367935540512292e-10

The O 0 2.6935933874483453e-06
von B-Disease 1 0.9999464750289917
Hippel I-Disease 1 0.9999929666519165
- I-Disease 0 0.07215140014886856
Lindau I-Disease 0 0.000567554438021034
tumor I-Disease 0 6.3141197870209e-07
suppressor O 0 3.439343743139034e-08
gene O 0 1.3254192882117266e-11
is O 0 8.448459081844897e-14
required O 0 2.950838629434821e-13
for O 0 1.1631815302615145e-12
cell O 0 1.4715068052950642e-09
cycle O 0 2.982492253167379e-09
exit O 0 4.732321201572631e-09
upon O 0 2.0110255474770078e-11
serum O 0 2.581421187919375e-10
withdrawal O 0 7.088571507551933e-09
. O 0 8.777421567351951e-10

The O 0 4.338334136377853e-09
inactivation O 0 1.6135803662109538e-06
of O 0 2.1783449710710556e-07
the O 0 4.699134237284852e-08
von B-Disease 1 0.9999849796295166
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999979734420776
Lindau I-Disease 1 0.9999972581863403
( I-Disease 0 5.105962941343023e-07
VHL I-Disease 0 0.0007503110682591796
) I-Disease 0 1.2400118432065454e-10
tumor I-Disease 0 6.994093837420223e-08
suppressor O 0 2.74369625685722e-07
gene O 0 6.810367825238473e-10
predisposes O 0 4.6389621310982676e-11
affected O 0 4.078755128783529e-12
individuals O 0 4.8938450846272314e-15
to O 0 3.600707582031466e-14
the O 0 7.415076885841643e-11
human O 1 0.9977169036865234
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.5303503906813343e-12
is O 0 9.14681877331805e-14
associated O 0 6.56214882779893e-13
with O 0 7.577589272202145e-13
sporadic B-Disease 1 1.0
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 8.929021966253003e-10
RCC B-Disease 0 0.00029808288672938943
) O 0 3.185749927747672e-11
and O 0 9.380730636721069e-10
brain B-Disease 1 0.6159704923629761
hemangioblastomas I-Disease 0 0.18085317313671112
. O 0 2.161741292638908e-07

VHL O 1 0.928133487701416
- O 0 1.0392521971880342e-06
negative O 0 3.129832393256038e-08
786 O 0 1.0687704161682632e-06
- O 0 2.194911985498038e-06
0 O 0 2.056204948530649e-06
RCC B-Disease 0 1.4532413842971437e-05
cells O 0 3.7906636163320684e-10
are O 0 7.79628315031311e-13
tumorigenic O 0 3.3539138133420465e-09
in O 0 6.267005664417624e-11
nude O 0 5.434239724877443e-09
mice O 0 1.559502804671098e-10
which O 0 8.805642033680311e-14
is O 0 1.4654559372094013e-14
suppressed O 0 2.3519151036432984e-12
by O 0 1.3536699159603233e-13
the O 0 2.1496122590280997e-11
reintroduction O 0 2.1719035459000224e-08
of O 0 4.035727751983131e-09
VHL B-Disease 0 1.5446572433575056e-05
. O 0 4.318489388310809e-08

Remarkably O 0 1.2356716183603567e-07
, O 0 1.533120679020339e-11
this O 0 2.8842423241415283e-13
occurs O 0 1.9794008012524733e-12
without O 0 5.4325008033706546e-12
affecting O 0 9.37421060914767e-12
the O 0 1.472687249925997e-11
growth O 0 7.824301206937889e-10
rate O 0 9.0847135369998e-10
and O 0 6.600690046626445e-12
cell O 0 8.979751164872596e-09
cycle O 0 5.814662973335771e-09
profile O 0 7.685499459064715e-11
of O 0 6.423266918353931e-10
these O 0 1.8440544230502454e-12
cells O 0 2.827535297914019e-12
in O 0 1.2273980659963102e-12
culture O 0 3.4644184743193307e-10
. O 0 4.555351373891625e-10

The O 0 1.1057407789394347e-07
786 O 0 8.081028113338107e-08
- O 0 1.0472554379248322e-08
0 O 0 5.089411114767017e-09
cell O 0 8.272436069489686e-10
line O 0 2.0588813987032495e-10
, O 0 6.10445071227983e-13
like O 0 7.646918038020645e-13
many O 0 8.172460646584112e-13
cancer B-Disease 0 8.871334222781968e-11
cells O 0 6.440275396313311e-12
, O 0 2.494133643105717e-13
fails O 0 1.8823855668648193e-11
to O 0 3.452012709969504e-13
exit O 0 8.278059127064807e-09
the O 0 6.123967999371871e-11
cell O 0 1.5400380970476135e-10
cycle O 0 2.2904860300099195e-11
upon O 0 5.635175485962929e-12
serum O 0 4.440210352174567e-11
withdrawal O 0 2.2710950897675275e-09
. O 0 4.634189143537526e-10

Here O 0 5.733376884364816e-09
, O 0 5.2950300394316585e-12
it O 0 2.2685695485222084e-14
is O 0 1.7028621199075998e-15
shown O 0 1.2048374518664091e-14
that O 0 3.844844330880195e-15
reintroduction O 0 6.01419677948023e-11
of O 0 8.947834660710807e-12
the O 0 6.811962799391225e-11
wild O 0 1.55882347030456e-08
- O 0 7.984924388360071e-10
type O 0 2.836306078890516e-09
VHL B-Disease 0 5.546905299524951e-07
gene O 0 1.139714642106604e-10
restores O 0 1.7265622265227876e-09
the O 0 6.290058057745185e-11
ability O 0 3.517336075176125e-11
of O 0 4.258874142237801e-08
VHL O 1 0.9989442229270935
- O 0 2.7362461878510658e-06
negative O 0 1.19517821417503e-07
RCC B-Disease 0 0.002172630513086915
cancer I-Disease 0 9.830551483958061e-09
cells O 0 1.3272862843527466e-11
to O 0 1.8551744342121257e-12
exit O 0 7.958308145816773e-08
the O 0 3.6422417859505174e-10
cell O 0 7.111702338136183e-09
cycle O 0 8.048932631510297e-10
and O 0 3.0006669891891047e-12
enter O 0 3.157928363251017e-10
G0 O 0 2.2666394272619073e-07
/ O 0 5.172553496635146e-10
quiescence O 0 6.977928013185419e-09
in O 0 5.730714167095918e-11
low O 0 1.2363478241184112e-08
serum O 0 2.9694087189113816e-09
. O 0 2.266698384545407e-09

Both O 0 1.370416953250242e-07
VHL O 0 0.0015692247543483973
- O 0 6.059641322053722e-08
positive O 0 1.18331844323194e-09
and O 0 1.9893655611724625e-09
VHL O 0 0.00023048122238833457
- O 0 1.7257004714110735e-08
negative O 0 2.1306660880071604e-09
RCC B-Disease 0 1.6258884443232091e-06
cells O 0 5.912674239105797e-10
exit O 0 1.0346127510274528e-07
the O 0 7.244771449421705e-11
cell O 0 2.959817113623586e-10
cycle O 0 4.9829401022050135e-11
by O 0 9.381466957447682e-13
contact O 0 1.23376531213637e-09
inhibition O 0 1.1441792224786695e-07
. O 0 1.6932933943891726e-09

The O 0 7.771152610303034e-08
cyclin O 0 7.365076726273401e-08
- O 0 5.2500248592934895e-09
dependent O 0 4.626620198067144e-10
kinase O 0 1.622812217938474e-09
inhibitor O 0 5.094245025816235e-10
, O 0 6.782616460664082e-13
p27 O 0 2.621812766889775e-10
, O 0 2.2593514244825114e-13
accumulates O 0 2.821957619837667e-13
upon O 0 1.5465057077827804e-13
serum O 0 4.641665741003664e-13
withdrawal O 0 1.2869064321130441e-11
, O 0 3.2997045986424625e-14
only O 0 2.0214248162711904e-14
in O 0 3.5505540835981814e-14
the O 0 9.669081941360291e-13
presence O 0 6.279993886026958e-13
of O 0 1.5182289869741794e-09
VHL B-Disease 0 5.321375056155375e-07
, O 0 2.4602674498358512e-12
as O 0 8.308413093800759e-13
a O 0 1.0664612639169069e-12
result O 0 8.349053219613989e-12
of O 0 7.655945322149194e-11
the O 0 1.6393268686965e-11
stabilization O 0 1.035488850220645e-08
of O 0 4.5527652758892145e-09
the O 0 1.1602057981008329e-08
protein O 0 9.944954371121639e-08
. O 0 1.4123063607485165e-08

We O 0 9.257834499010187e-10
propose O 0 1.197499460703355e-10
that O 0 1.567973995000166e-13
the O 0 6.476750993161806e-12
loss O 0 7.666642320991457e-11
of O 0 1.5874951353467281e-09
wild O 0 2.0076565476756514e-07
- O 0 3.089664302180495e-09
type O 0 7.452062078527888e-09
VHL B-Disease 0 2.5538333829899784e-06
gene O 0 1.9439472601079366e-11
results O 0 4.0226875649973515e-12
in O 0 8.423540185688305e-13
a O 0 1.928105028067839e-12
specific O 0 2.441313644296894e-11
cellular O 0 1.2907921700389124e-06
defect O 0 9.579374591339729e-07
in O 0 5.4939410659704535e-11
serum O 0 8.076675439561143e-10
- O 0 7.025038328833944e-10
dependent O 0 1.7674110786014552e-10
growth O 0 2.711805224819841e-10
control O 0 1.4325748365351387e-09
, O 0 3.7394992159246743e-13
which O 0 6.09623679662108e-13
may O 0 1.3187117196833409e-11
initiate O 0 1.4015094640384973e-10
tumor B-Disease 0 1.1454430293156292e-08
formation O 0 1.2015634043294199e-09
. O 0 3.359048372786333e-09

This O 0 3.33303176724975e-11
is O 0 1.1364184333145788e-12
corrected O 0 8.194535328076569e-12
by O 0 1.0250517611370275e-13
the O 0 8.699875021778158e-12
reintroduction O 0 3.979196083747638e-09
of O 0 1.253557813107875e-09
wild O 0 5.096977133689506e-07
- O 0 2.7568200167138457e-08
type O 0 7.901181930947132e-08
VHL B-Disease 0 0.0017566601745784283
, O 0 9.855439797590293e-10
implicating O 0 2.498218520941009e-07
VHL B-Disease 0 4.9718473746906966e-05
as O 0 9.978572135249664e-11
the O 0 1.2820512707012455e-10
first O 0 6.416773362660777e-11
tumor B-Disease 0 3.6468361663821725e-10
suppressor O 0 2.8364235959976725e-10
involved O 0 8.95807625127254e-13
in O 0 2.940031247969377e-12
the O 0 9.334997358445563e-11
regulation O 0 3.952554727959523e-09
of O 0 5.185733620294286e-09
cell O 0 1.9999356837274718e-08
cycle O 0 8.456880529195132e-09
exit O 0 1.7489922399249735e-08
, O 0 2.6016734881902093e-13
which O 0 5.208142673639865e-14
is O 0 4.835596577020332e-14
consistent O 0 2.155601652037431e-12
with O 0 7.09242167491568e-14
its O 0 1.1665947721728465e-11
gatekeeper O 0 6.619835790644402e-10
function O 0 7.543234092910467e-11
in O 0 3.836111116262142e-12
the O 0 2.428631185047436e-10
kidney O 0 2.3883359290266526e-07
. O 0 6.14138739862824e-10
. O 0 4.797978014892124e-09

Piebaldism B-Disease 1 1.0
with O 0 2.874704932764871e-06
deafness B-Disease 1 1.0
: O 0 1.1091928070472434e-10
molecular O 0 7.111016636640599e-11
evidence O 0 3.2796794793843453e-12
for O 0 4.434924649743266e-13
an O 0 8.645415655074429e-13
expanded O 0 2.4372866391786374e-07
syndrome O 1 0.9999451637268066
. O 0 2.486076198238152e-07

In O 0 3.8201827812223144e-10
a O 0 1.502482166459984e-10
South O 0 3.392309766425683e-09
African O 0 2.798858367292212e-10
girl O 0 1.150350578682513e-10
of O 0 2.9287175462577864e-10
Xhosa O 0 5.604830022321039e-08
stock O 0 1.2232159729563818e-10
with O 0 3.3067264204600377e-12
severe O 0 2.0671033780672587e-05
piebaldism B-Disease 0 1.873105065897107e-05
and O 0 5.363279265147014e-10
profound O 1 0.9999477863311768
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 1.3798370224193945e-09
identified O 0 1.5568502433407905e-12
a O 0 1.0754279275914866e-13
novel O 0 1.309422513993963e-12
missense O 0 4.1519535032286115e-10
substitution O 0 6.254780582359842e-10
at O 0 5.567978855758327e-10
a O 0 3.081692193096508e-11
highly O 0 1.289073188470713e-11
conserved O 0 7.051722400452931e-11
residue O 0 6.671428742777152e-09
in O 0 9.901333225537101e-11
the O 0 1.0902107688837148e-10
intracellular O 0 6.255767431850856e-11
kinase O 0 1.0951882734033802e-09
domain O 0 1.4949191884383595e-09
of O 0 4.709830037086249e-08
the O 0 2.141128874200149e-08
KIT O 0 3.139990667477832e-06
proto O 0 2.105282277398146e-07
- O 0 1.1888185547093144e-08
oncogene O 0 1.1302539348889695e-07
, O 0 6.146376463345149e-11
R796G O 0 4.261474373379315e-08
. O 0 5.730304675211073e-09

Though O 0 5.998919583305451e-09
auditory B-Disease 0 1.3588077081294614e-06
anomalies I-Disease 0 4.5873468934587436e-07
have O 0 8.5677090422287e-12
been O 0 8.445144540278338e-13
observed O 0 2.120114630729808e-12
in O 0 4.0225340419697275e-12
mice O 0 2.0231299968642702e-10
with O 0 1.7166330206278002e-12
dominant O 0 1.9250644527346594e-06
white O 0 8.75179484438604e-10
spotting O 0 2.2415738598624557e-08
( O 0 1.2051293296622134e-10
W O 0 2.239215245936066e-05
) O 0 2.4978339709103015e-12
due O 0 1.2665170245895752e-08
to O 0 8.129869694117886e-11
KIT O 0 4.8916434025159106e-05
mutations O 0 8.746804947001863e-10
, O 0 4.4856687808625395e-10
deafness B-Disease 1 1.0
is O 0 3.097136783147825e-11
not O 0 1.2121125500877405e-13
typical O 0 2.4665729528305924e-12
in O 0 1.8120746873503957e-12
human O 0 8.091736308779574e-11
piebaldism B-Disease 0 9.121374233700408e-08
. O 0 6.71204158919636e-09

Thus O 0 4.2075006673192306e-11
, O 0 9.942156283361883e-14
the O 0 6.982117656392436e-14
occurrence O 0 7.985438005286838e-11
of O 0 2.786769393026134e-08
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 3.3124001319606577e-09
this O 0 2.2751670339382635e-12
patient O 0 7.961284409496727e-12
extends O 0 4.694732558437054e-13
considerably O 0 3.7358184850743575e-14
the O 0 7.181720631599733e-14
phenotypic O 0 2.2072021987895596e-10
range O 0 1.9338662615719926e-11
of O 0 3.32274902037355e-11
piebaldism B-Disease 0 1.0493367952335575e-08
due O 0 7.251141198594269e-08
to O 0 1.1586477610681101e-10
KIT O 0 1.8468833786755567e-06
gene O 0 2.732874690436482e-11
mutation O 0 1.931108268085624e-12
in O 0 2.0566450560817462e-13
humans O 0 8.143643094940534e-13
and O 0 3.850432884859589e-13
tightens O 0 4.138533959974211e-11
the O 0 1.1015133033129287e-12
clinical O 0 1.054188472626727e-10
similarity O 0 9.148293234062521e-12
between O 0 6.240188921147194e-12
piebaldism B-Disease 0 3.5780558516051997e-09
and O 0 3.1059790156495737e-12
the O 0 1.1048379008546383e-12
various O 0 7.986740067043863e-13
forms O 0 8.830985248620138e-11
of O 0 1.843748798080469e-08
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999799728393555
. O 0 1.9693802144615802e-08
. O 0 1.1542270073050531e-07

Cycloheximide O 0 2.5368217393406667e-07
facilitates O 0 1.5932911934246619e-10
the O 0 2.7370477412302918e-11
identification O 0 2.0960322366647688e-10
of O 0 5.906509170650054e-10
aberrant O 0 4.186824498209063e-10
transcripts O 0 1.0927193871967944e-10
resulting O 0 8.76814332945175e-12
from O 0 1.1453008680328836e-12
a O 0 1.0294810143252064e-11
novel O 0 3.741122342471037e-11
splice O 0 5.5270539256468965e-09
- O 0 5.475938591459339e-10
site O 0 2.541080124096595e-10
mutation O 0 1.0732057603712875e-11
in O 0 2.4617790445047305e-12
COL17A1 O 0 6.622076398343779e-07
in O 0 4.5709283580386284e-11
a O 0 6.733037738460013e-11
patient O 0 8.195262801713454e-10
with O 0 3.7621815385247004e-11
generalized O 1 0.9999802112579346
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 4.392104813177866e-07

Patients O 0 4.055653590739894e-08
with O 0 1.2301037966011563e-10
generalized O 1 0.8041321635246277
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999996423721313
often O 0 1.0600270661242917e-11
show O 0 6.501653816021191e-12
decreased O 0 9.39134187083468e-11
expression O 0 3.3856245584829026e-10
of O 0 1.8922687861078202e-09
type O 0 1.1106885189349214e-08
XVII O 0 9.514225496332074e-08
collagen O 0 6.0189311312797145e-09
, O 0 2.3851837172017554e-11
a O 0 2.7448479253400215e-11
transmembrane O 0 2.382107011644763e-10
hemidesmosomal O 0 1.385552006460955e-09
protein O 0 1.6543063793839075e-11
encoded O 0 3.0891275323331746e-13
by O 0 3.7301550737112166e-12
COL17A1 O 0 9.85159317679063e-07
. O 0 8.111879168382075e-09

This O 0 1.2441553343123246e-10
report O 0 1.0750721493590909e-11
documents O 0 9.831623362654973e-12
a O 0 1.6438010674857395e-11
novel O 0 4.729014402293785e-11
splice O 0 5.26462518024573e-09
- O 0 2.0222579166784271e-10
site O 0 1.3312116686758912e-10
mutation O 0 1.5590827240341554e-11
in O 0 8.781197123608475e-12
COL17A1 O 0 1.424814172423794e-06
in O 0 1.9163196030014262e-10
a O 0 2.8327473700073824e-10
patient O 0 3.5418443733448157e-09
with O 0 1.0048992193922857e-10
generalized O 1 0.9999969005584717
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
, O 0 3.212789756457113e-10
and O 0 1.8767426848698143e-11
applies O 0 3.465646172817749e-11
a O 0 4.84901181707631e-12
new O 0 5.845255703074148e-12
methodology O 0 1.199030111309618e-11
to O 0 1.4196135315457797e-13
define O 0 9.9259281349795e-12
and O 0 1.915163123575314e-12
characterize O 0 5.393497801153835e-11
the O 0 3.875791007579288e-11
resulting O 0 3.5508710555243184e-11
mRNA O 0 5.399717895038236e-10
splice O 0 1.0294000318822327e-08
variants O 0 6.025064447356954e-09
. O 0 1.1012005529664748e-08

Mutational O 0 3.1054202054292546e-07
analysis O 0 2.0141588397137866e-10
of O 0 1.9076166424270014e-08
COL17A1 O 0 0.000706224178429693
identified O 0 2.6843022027378538e-08
a O 0 1.706844221516235e-09
maternally O 0 3.2488778334283097e-09
inherited O 0 1.8381692612479128e-08
G O 0 4.21956428908743e-06
- O 0 6.075983094433468e-08
to O 0 1.017267425851287e-08
- O 0 1.6861093854458886e-06
T O 0 1.1863862425798288e-07
transversion O 0 5.098546651538527e-08
at O 0 7.510361776930097e-10
the O 0 2.9567969600519106e-11
- O 0 2.6579417920086224e-12
1 O 0 1.9670421541606586e-11
position O 0 3.8926136619599205e-12
of O 0 2.6673789912945445e-11
exon O 0 7.087517239767749e-09
32 O 0 4.350116267204385e-09
. O 0 4.540970710564807e-09

This O 0 2.7447513151201974e-09
acceptor O 0 3.270524961962451e-10
splice O 0 4.652073926081357e-08
- O 0 2.9051958616577167e-09
site O 0 2.1408419481616647e-09
mutation O 0 1.213081163298213e-10
led O 0 3.295268918845906e-11
to O 0 3.1726565818956942e-12
the O 0 4.288399843566104e-11
formation O 0 2.291150255628871e-11
of O 0 3.597508957398077e-10
aberrant O 0 1.0148053231073817e-10
transcripts O 0 8.404306417464369e-11
present O 0 2.2841688609998023e-11
at O 0 9.044830662219283e-09
extremely O 0 1.8135332124913361e-09
low O 0 2.7244718125984946e-07
levels O 0 3.4587378650030587e-07
. O 0 1.0601297617540695e-08

Based O 0 1.4799161895950874e-10
on O 0 2.173220048362623e-09
our O 0 2.7572262181752016e-11
recent O 0 8.916210868584185e-13
finding O 0 2.1713149941232635e-12
that O 0 3.7173823047575993e-13
cycloheximide O 0 6.856864409598984e-09
stabilized O 0 3.192048403377612e-09
mutant O 0 5.328102958834791e-10
COL17A1 O 0 2.0370247710843614e-08
transcripts O 0 5.8150120135769257e-11
in O 0 6.263605085987667e-13
keratinocytes O 0 3.9934940770924854e-11
homozygous O 0 1.1028803738322157e-11
for O 0 2.561300564002389e-12
a O 0 3.0130505729308865e-11
frameshift O 0 1.1104809516382375e-08
mutation O 0 1.861505741218572e-11
, O 0 1.840472896698711e-13
the O 0 5.2316844433020204e-12
effects O 0 2.0477374462757325e-08
of O 0 8.017988761821471e-08
the O 0 2.5300352923807168e-09
splice O 0 1.4765936029448312e-08
- O 0 2.9686086921998367e-10
site O 0 1.9459144018352248e-10
mutation O 0 4.934249189791906e-12
on O 0 2.0803267095081956e-11
splicing O 0 6.006149050330478e-11
of O 0 4.891133054130137e-10
COL17A1 O 0 8.32059683375519e-08
transcripts O 0 3.973535944723494e-10
were O 0 8.243288864007159e-12
determined O 0 8.590646098129151e-13
using O 0 4.642206215786648e-13
reverse O 0 2.878421667684705e-10
transcriptase O 0 5.701169050742472e-11
polymerase O 0 4.65376868985512e-12
chain O 0 6.551325454351442e-11
reaction O 0 1.1961102681229407e-12
of O 0 2.0719290172444005e-10
total O 0 4.5719250607589856e-10
RNA O 0 2.91806190322319e-10
from O 0 5.5288382379281575e-12
keratinocytes O 0 3.139838666843531e-10
incubated O 0 3.743558241176004e-10
for O 0 2.91095064719471e-11
2 O 0 4.404352438314163e-08
. O 0 5.731244812068326e-09

5 O 0 1.4303728335107735e-07
h O 0 8.76634598245829e-10
in O 0 1.304746154867642e-11
the O 0 2.387104403034357e-11
presence O 0 6.317359829699498e-12
or O 0 1.3205189546006135e-11
absence O 0 6.145492115194884e-09
of O 0 3.104303303302913e-08
10 O 0 9.054946126241248e-09
microg O 0 2.0152181434696104e-07
cycloheximide O 0 2.2061044546717312e-07
per O 0 1.1340535177595257e-09
ml O 0 4.249202589790002e-08
. O 0 3.511186230653607e-09

Using O 0 3.5564495792783646e-11
this O 0 3.4177309420069246e-12
approach O 0 8.05823741067968e-11
, O 0 9.471346233344557e-13
an O 0 2.9916704964022545e-13
abnormally O 0 7.591412914953466e-11
spliced O 0 4.902508954351958e-10
transcript O 0 1.2386509595785355e-09
was O 0 2.0142933154776443e-10
identified O 0 7.05915794568801e-13
that O 0 5.617503024432733e-15
contains O 0 5.961787189140769e-14
an O 0 3.263238898526923e-15
extra O 0 1.3510061125376893e-12
264 O 0 9.154083741025332e-13
bases O 0 1.0484729404125481e-11
upstream O 0 1.1347507135328616e-12
from O 0 1.4590454495630456e-12
exon O 0 2.1183141352132395e-10
32 O 0 1.971383993548681e-11
, O 0 2.7163929200609005e-13
resulting O 0 2.5790266190012234e-12
in O 0 5.236575929823406e-12
a O 0 1.7932588747271438e-10
premature O 0 1.0287910523487653e-09
termination O 0 2.5357844712914357e-09
codon O 0 3.025590888938723e-09
27 O 0 6.606934999098257e-09
bp O 0 2.215786026882327e-10
downstream O 0 6.25034052292861e-11
from O 0 3.342198739986202e-11
the O 0 1.2904374235844784e-09
cryptic O 0 6.079330816533002e-09
splice O 0 1.3988861269353947e-07
site O 0 5.9070448088505145e-08
. O 0 1.3483830052507528e-08

Three O 0 5.082901655129035e-09
other O 0 6.146189113209743e-11
splice O 0 1.393198001409246e-08
variants O 0 3.9828845777023503e-10
, O 0 8.276120240513496e-12
including O 0 6.656521254339021e-12
one O 0 1.344281782243717e-12
derived O 0 1.1718389117138656e-13
from O 0 1.5150504548838706e-12
the O 0 4.360412725334939e-11
skipping O 0 5.349242160335166e-10
of O 0 5.822584081549564e-10
exon O 0 3.2688300954930583e-09
32 O 0 5.542908354527754e-10
, O 0 2.7948188902060522e-11
were O 0 5.474445896602731e-10
also O 0 1.1574020908344806e-10
identified O 0 4.3015010997571324e-10
. O 0 5.881902964688379e-09

These O 0 1.4864001696146545e-10
results O 0 7.64102114914067e-11
indicate O 0 4.7040748032967095e-12
the O 0 2.7899973997769223e-12
usefulness O 0 1.8040208216163478e-10
of O 0 2.4862232064770673e-11
cycloheximide O 0 1.5874467296228545e-09
treatment O 0 8.237693513435396e-12
in O 0 5.985763642558928e-13
evaluating O 0 6.397022234844174e-12
the O 0 1.0557756058293677e-11
abnormal O 0 3.7143527836791534e-11
processing O 0 3.571964668491745e-10
of O 0 5.769696387325496e-10
mRNA O 0 1.1533737159785673e-10
due O 0 2.3782449343201506e-09
to O 0 2.3276124083704275e-11
splice O 0 8.75111449971655e-09
- O 0 2.715790647922489e-10
site O 0 1.2481746192172238e-10
mutations O 0 1.85084131180957e-12
, O 0 1.724100463090794e-13
because O 0 3.810505784605095e-13
( O 0 4.78941051314935e-13
i O 0 1.387923109774647e-11
) O 0 1.9244335129359885e-13
aberrant O 0 3.3873473470613646e-11
splicing O 0 7.790077610758672e-11
often O 0 4.0709087847663056e-14
generates O 0 4.439458241127514e-14
a O 0 1.5128789063525994e-12
premature O 0 1.4612129214941483e-11
termination O 0 5.600215777223916e-11
codon O 0 6.973344124361347e-11
, O 0 4.186778148566189e-13
( O 0 3.068256572750193e-14
ii O 0 2.1407417505336923e-11
) O 0 5.6507329739864665e-14
transcripts O 0 1.1289590789997916e-11
with O 0 1.912706321452462e-12
premature O 0 2.8361857307146465e-10
termination O 0 4.1421113067263704e-11
codons O 0 7.705869796426068e-12
can O 0 5.941377760870087e-14
occur O 0 5.884292077033837e-13
at O 0 1.6570451955022492e-10
low O 0 8.815848495657974e-09
or O 0 5.1421523289407745e-12
undetectable O 0 1.1837777691425799e-07
levels O 0 5.75003100689031e-10
due O 0 5.926065194117314e-10
to O 0 4.449328004554193e-13
nonsense O 0 6.22006196548952e-11
- O 0 2.384662833952028e-13
mediated O 0 4.8405754231317655e-12
mRNA O 0 8.154990354877767e-13
decay O 0 9.214528445822268e-11
, O 0 2.4783411542612932e-14
and O 0 1.097611923767984e-13
( O 0 4.2890556828812515e-14
iii O 0 7.248582810370774e-12
) O 0 4.927566736806846e-14
the O 0 2.5285552731485472e-12
levels O 0 4.645549916970637e-11
of O 0 2.9032319950883512e-11
these O 0 3.7220226900558373e-13
transcripts O 0 2.3180603270223088e-11
can O 0 1.380658283013647e-13
be O 0 8.39862101848117e-14
increased O 0 6.756212343056456e-13
by O 0 6.076319135350783e-12
cycloheximide O 0 2.2922165499039693e-07
. O 0 1.2361286216844292e-08

A O 0 4.161328348573079e-08
deletion O 0 2.5859463459454446e-09
mutation O 0 3.836735096296451e-11
in O 0 3.4567977820476603e-12
COL17A1 O 0 7.892145248433735e-08
in O 0 4.5919181651532526e-11
five O 0 4.685246288160805e-11
Austrian O 0 1.4327695474491975e-08
families O 0 1.4106350636200471e-11
with O 0 6.546603537049833e-11
generalized O 1 0.9999885559082031
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999996423721313
represents O 0 5.9070419666795715e-09
propagation O 0 9.81028506430448e-07
of O 0 4.0552667002202725e-08
an O 0 1.2976431561229074e-11
ancestral O 0 1.2435421581358241e-08
allele O 0 9.246810428464869e-09
. O 0 1.4437287809698773e-08

Patients O 0 1.9065764078618486e-08
with O 0 6.001305702385551e-11
generalized O 1 0.9893737435340881
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 1.2404193228121585e-09
a O 0 6.533219104598587e-11
usually O 0 5.298303028949958e-12
nonlethal O 0 2.8323705603128246e-09
form O 0 1.1617835166122248e-10
of O 0 3.2696672036536256e-08
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9997860789299011
, O 0 3.9653724748234254e-11
have O 0 2.399693508139955e-12
generalized O 0 3.81448383990346e-09
blistering B-Disease 0 6.38156393506506e-07
, O 0 4.3009946715244496e-09
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.0676907358231347e-08
patchy B-Disease 1 1.0
alopecia I-Disease 1 0.9999996423721313
, O 0 1.5646900441979028e-10
and O 0 5.0803916629149626e-09
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 1.1869527952512726e-05

Skin B-Disease 0 2.482383388269227e-05
fragility I-Disease 0 7.437437307089567e-05
in O 0 1.2670116067425852e-09
most O 0 4.549859187324978e-12
cases O 0 6.656645178647336e-13
is O 0 5.092291944564821e-14
due O 0 2.384592349968795e-11
to O 0 2.428720202382606e-13
mutations O 0 3.322999156656764e-13
in O 0 1.5416735813303384e-12
the O 0 8.463370629319122e-12
gene O 0 8.798481908323108e-12
encoding O 0 2.367940565850546e-11
type O 0 2.3817130490044747e-09
XVII O 0 1.2600419552200037e-07
collagen O 0 7.389078238162483e-09
( O 0 9.01389102248018e-11
COL17A1 O 0 6.073173608456273e-07
) O 0 3.082568228451876e-11
. O 0 4.434947964426783e-10

Recently O 0 1.0684403584093616e-08
, O 0 3.223296282661714e-11
we O 0 3.0642593497332005e-12
reported O 0 3.81855441364265e-12
five O 0 7.474940805218822e-12
Austrian O 0 1.0153755169994838e-08
families O 0 1.405551022792828e-11
with O 0 5.661896992914528e-11
generalized O 1 0.9999426603317261
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 2.6797530860989127e-09
share O 0 4.9843660449022664e-11
the O 0 1.069426658339978e-09
same O 0 1.3214934924121735e-08
COL17A1 O 1 0.9811137318611145
mutation O 0 3.1316841386797023e-07
. O 0 1.028442397910112e-08

Affected O 0 3.430647987912039e-09
individuals O 0 2.7131476319081083e-12
in O 0 6.783490436035322e-11
three O 0 9.958493057959927e-11
families O 0 1.0218236846937234e-12
are O 0 1.3484643902796772e-13
homozygous O 0 2.408186497437903e-11
for O 0 1.1125230077457804e-11
4003delTC O 0 3.5508136431161574e-09
, O 0 8.587406827298416e-12
whereas O 0 1.9526281633264198e-11
those O 0 1.1539931336901343e-12
in O 0 5.660361502429767e-12
two O 0 4.623362803712894e-11
others O 0 2.5171056905470834e-10
are O 0 3.247635146919059e-11
compound O 0 2.8580299016311983e-08
heterozygotes O 0 2.5577304541002377e-07
. O 0 1.8983538296879487e-08

To O 0 4.169887352079016e-11
determine O 0 2.2822440118308585e-11
if O 0 1.2999116756964857e-12
the O 0 1.6026862996454394e-12
occurrence O 0 1.1181610498622874e-10
of O 0 2.3396493076255354e-10
4003delTC O 0 5.203605324410887e-10
in O 0 9.682337397121099e-12
these O 0 6.942891899418269e-13
unrelated O 0 4.359803316977828e-12
families O 0 2.378102767063451e-14
signifies O 0 4.548538195398022e-13
propagation O 0 7.094763110337965e-10
of O 0 1.1079649420153714e-09
an O 0 1.7723244746803424e-12
ancestral O 0 1.274549799035185e-09
allele O 0 2.002402965661787e-10
or O 0 5.950719778047286e-11
a O 0 5.629809396445751e-10
mutational O 0 0.00013691892672795802
hot O 1 0.9905340671539307
spot O 0 3.8354140997398645e-05
, O 0 2.8554863334973035e-11
haplotypes O 0 1.6272694303154367e-09
were O 0 5.725426382996446e-11
determined O 0 1.0988488764740456e-11
for O 0 1.8992554924601723e-12
polymorphisms O 0 5.714195339123762e-09
both O 0 8.95432686331965e-11
within O 0 1.449066999725801e-08
and O 0 7.0045040878596865e-09
flanking O 0 9.835662058321759e-05
COL17A1 O 0 0.42659202218055725
. O 0 5.758135444011714e-07

Five O 0 3.94671069159358e-08
intragenic O 0 3.555322791726212e-07
polymorphisms O 0 6.234585470110687e-08
were O 0 9.061644767882626e-10
chosen O 0 3.082879784788162e-11
based O 0 5.126408325617504e-11
on O 0 3.8535358015678867e-08
their O 0 4.502780370785331e-09
informativeness O 0 1.6295394971166388e-06
. O 0 5.5749552529960056e-08

One O 0 1.2682906946892558e-09
of O 0 4.523371011089239e-09
these O 0 8.237095901197922e-12
, O 0 1.3150640515782741e-12
not O 0 3.7456095083182595e-13
previously O 0 1.7941167648749534e-11
reported O 0 7.891347297839246e-12
, O 0 8.332953251033448e-12
was O 0 3.895107791862529e-09
2988 O 0 8.142728802340571e-07
A O 0 1.026034723849989e-07
or O 0 6.323390422391384e-11
C O 0 6.5346092981144466e-09
that O 0 2.9236021156092695e-12
introduces O 0 1.781112583809641e-11
a O 0 2.6537372559837236e-12
new O 0 2.975260446000383e-12
restriction O 0 4.0866299927388994e-11
site O 0 1.8248813918320117e-11
for O 0 5.529829632394678e-12
Eco0109 O 0 5.397478375357423e-08
I O 0 3.040205172055721e-07
. O 0 6.4584786407806405e-09

All O 0 1.2528550419332873e-09
the O 0 3.210952059795602e-10
4003delTC O 0 6.432560040181556e-10
alleles O 0 4.8831303584018215e-12
showed O 0 4.1175507448087956e-11
the O 0 6.437315524382425e-12
same O 0 2.1111764680198375e-12
haplotype O 0 7.80474226913519e-11
for O 0 1.121060536068974e-11
these O 0 1.4685445567930167e-11
five O 0 3.1081631712837066e-10
polymorphic O 0 1.3405641041686067e-08
markers O 0 3.6228659183734635e-08
. O 0 1.8825820902179657e-08

Fourteen O 0 1.4715713803070685e-07
microsatellite O 0 1.6700758465049148e-07
polymorphisms O 0 1.6947507219811087e-07
were O 0 1.2791696590852553e-09
selected O 0 4.146221907475045e-11
based O 0 1.4335956033395547e-11
on O 0 6.766259108559325e-09
their O 0 1.482792638674013e-10
high O 0 1.000334926004598e-09
heterozygosity O 0 1.465955179469347e-08
and O 0 2.091789935709798e-11
their O 0 9.604313871980352e-12
location O 0 2.204182836251789e-09
within O 0 1.1801380983555987e-09
10q23 O 0 7.157742487606811e-08
- O 0 4.25254285119081e-08
q25 O 0 4.4025216539012035e-07
near O 0 3.559740662240074e-06
COL17A1 O 0 0.00014459865633398294
. O 0 9.235603215529409e-08

Three O 0 5.370895395095943e-10
families O 0 3.4394091307649033e-12
shared O 0 1.1617784859141445e-11
microsatellite O 0 1.0245930326391317e-08
polymorphisms O 0 2.0610132267506742e-08
covering O 0 1.204000881216416e-07
at O 0 1.3211412408509204e-07
most O 0 1.374247105001558e-10
19 O 0 7.320316797176929e-08
cM O 0 3.781861934726294e-09
, O 0 5.554099281185332e-12
whereas O 0 8.625835289099992e-12
the O 0 5.739749647792891e-11
others O 0 3.7758667720266814e-12
shared O 0 2.0855181730866645e-12
smaller O 0 6.782939552911482e-13
regions O 0 8.94121495592648e-12
consistent O 0 1.9562301778464075e-10
with O 0 2.7228197994888514e-13
cross O 0 9.780940640746749e-11
- O 0 4.608094721775258e-12
over O 0 1.4923414067002927e-12
events O 0 1.4468905674275279e-12
during O 0 1.0213525337976481e-11
passage O 0 8.908072196556205e-12
of O 0 1.349587000314123e-12
this O 0 5.589226523554543e-14
mutation O 0 4.841025583873781e-13
through O 0 3.9324392266809616e-13
several O 0 1.331297398710074e-11
generations O 0 3.3768018936619626e-10
. O 0 2.787895025946341e-09

These O 0 4.1322495425433203e-10
results O 0 2.493091011412929e-10
indicate O 0 1.4310549273366391e-11
that O 0 6.825052133695164e-13
4003delTC O 0 1.0712150055880443e-09
occurs O 0 2.9821478619851405e-11
on O 0 4.545665510669039e-10
a O 0 1.7293982218502535e-11
single O 0 4.1084351198872326e-11
ancestral O 0 1.6556646331711278e-10
allele O 0 1.0764741875668449e-10
. O 0 9.499651065780768e-11
. O 0 1.625219070433559e-09

The O 0 4.6427402367044124e-08
haptoglobin O 0 6.045465283932572e-07
- O 0 7.8814919035608e-09
gene O 0 1.697017248947219e-10
deletion O 0 8.719586719330152e-10
responsible O 0 4.202097281247319e-10
for O 0 1.142579086899076e-10
anhaptoglobinemia B-Disease 0 1.910571654661908e-06
. O 0 1.5653684215521935e-07

We O 0 3.868276809981808e-09
have O 0 8.676575950772314e-12
found O 0 5.81396313471122e-13
an O 0 6.904907553931597e-14
allelic O 0 1.9638650705644523e-09
deletion O 0 6.912037053830034e-10
of O 0 1.0475949885346836e-08
the O 0 3.5786631435996696e-09
haptoglobin O 0 5.790682422457394e-08
( O 0 3.869497430808444e-11
Hp O 0 7.287599412819645e-10
) O 0 1.0705188905474339e-12
gene O 0 1.6217452727951276e-12
from O 0 1.3608620523866688e-12
an O 0 3.753046593120424e-13
individual O 0 3.0430469342285216e-12
with O 0 6.555575526867585e-11
anhaptoglobinemia B-Disease 0 0.00013556757767219096
. O 0 4.36174218521046e-07

The O 0 6.69299637934273e-08
Hp O 0 1.0940614636467672e-08
gene O 0 3.839136300531898e-11
cluster O 0 5.49849055175855e-11
consists O 0 2.650338065332547e-12
of O 0 8.96119116411409e-12
coding O 0 1.3071181637069884e-10
regions O 0 6.684034437043351e-10
of O 0 1.665395821248694e-08
the O 0 2.0632893171779187e-09
alpha O 0 5.695867666410948e-10
chain O 0 7.571385185478618e-11
and O 0 6.999721982592355e-13
beta O 0 8.520566890934944e-11
chain O 0 1.5234320749346608e-10
of O 0 1.1901446494988477e-10
the O 0 7.143779318097288e-11
haptoglobin O 0 1.5335843706054675e-09
gene O 0 2.4760805385215523e-12
( O 0 2.6912300106528633e-14
Hp O 0 1.984360375670291e-12
) O 0 8.846072440912064e-15
and O 0 1.1792829083048795e-13
of O 0 8.243702248611484e-11
the O 0 1.453402953544014e-10
alpha O 0 9.457437610826958e-11
chain O 0 2.0172643069860108e-11
and O 0 5.427547517325437e-13
beta O 0 9.63609955717537e-11
chain O 0 3.281754035189266e-10
of O 0 1.3848802660199055e-10
the O 0 1.588727205348306e-10
haptoglobin O 0 1.4447039120568661e-08
- O 0 4.390690588884638e-11
related O 0 1.9659244718250868e-11
gene O 0 7.524276340875602e-12
( O 0 2.734895101184909e-13
Hpr O 0 5.864290164581121e-10
) O 0 2.9483184014848784e-13
, O 0 2.249448863940115e-13
in O 0 3.759898208749446e-12
tandem O 0 8.433342357783147e-10
from O 0 1.0632877217586767e-10
the O 0 1.576226971167216e-08
5 O 0 8.278771019831765e-07
side O 0 5.371125553210732e-07
. O 0 7.325593465168367e-09

Southern O 0 7.459019002453715e-08
blot O 0 1.43889508308348e-07
and O 0 4.0563150061068143e-10
PCR O 0 3.4491303146921837e-09
analyses O 0 1.7211065905797795e-10
have O 0 9.176005224750816e-13
indicated O 0 1.5926424675599682e-12
that O 0 2.090183393390916e-14
the O 0 5.594220833099461e-13
individual O 0 9.593570546534511e-15
with O 0 3.619098022569073e-14
anhaptoglobinemia B-Disease 0 3.102121892695209e-10
was O 0 2.9972021392543624e-11
homozygous O 0 4.233871499920161e-12
for O 0 4.926798986143455e-13
the O 0 1.6096037263463314e-12
gene O 0 1.4378662106448448e-13
deletion O 0 2.536920868691228e-13
and O 0 2.178668182006068e-14
that O 0 6.580039501956998e-15
the O 0 8.596464469087794e-13
gene O 0 5.879288484007816e-13
deletion O 0 3.922657337840363e-12
was O 0 1.1642874164774497e-11
included O 0 1.9960101280136477e-12
at O 0 1.2437306740054055e-10
least O 0 2.27063246677206e-12
from O 0 2.7541497728267306e-12
the O 0 1.2878990929277023e-10
promoter O 0 1.41642502171635e-07
region O 0 1.5685941434639972e-08
of O 0 5.0199702172903926e-08
Hp O 0 3.544225180007743e-08
to O 0 8.303387977193211e-10
Hpr O 0 4.831434807783808e-07
alpha O 0 1.2914845193279234e-08
but O 0 1.3592908049142594e-11
not O 0 6.541442192607716e-13
to O 0 3.8398811040563086e-12
Hpr O 0 1.5639397332734006e-08
beta O 0 4.6006016773958436e-09
( O 0 9.037126082189761e-12
Hpdel O 0 4.084937543780143e-08
) O 0 3.7337584413155156e-11
. O 0 7.130714352321377e-10

In O 0 4.740277614878607e-10
addition O 0 6.447173350743185e-11
, O 0 1.2301689181204445e-11
we O 0 1.0500620338527167e-11
found O 0 2.7423974549578567e-12
seven O 0 3.3298149394039855e-12
individuals O 0 1.719108423594174e-14
with O 0 1.053314607844108e-13
hypohaptoglobinemia B-Disease 0 7.489566300478145e-09
in O 0 2.1160122265495573e-10
three O 0 3.9492954045927675e-11
families O 0 2.5586721326756323e-13
, O 0 6.74488134615181e-13
and O 0 4.288070332841842e-12
the O 0 2.4081922567198433e-10
genotypes O 0 1.0572703601496869e-08
of O 0 1.233822928270456e-07
six O 0 2.896520356898691e-09
of O 0 2.025711332009905e-08
the O 0 2.629415796207013e-09
seven O 0 1.9962749508994904e-10
individuals O 0 1.0895777552769048e-12
were O 0 6.557429599318709e-10
found O 0 5.5718644975666365e-11
to O 0 3.81903710044984e-11
be O 0 1.2809471261476801e-09
Hp2 O 0 0.00017589141498319805
/ O 0 0.00017473033221904188
Hpdel O 0 0.002102296333760023
. O 0 9.805495437831269e-07

The O 0 7.259053358410483e-09
phenotypes O 0 1.7304887522939794e-09
and O 0 1.1282896492104122e-11
genotypes O 0 2.72586897498428e-10
in O 0 1.3981126152640133e-11
one O 0 2.235421049656683e-12
of O 0 3.291526773363529e-10
these O 0 4.186365663849667e-12
three O 0 1.9526356226373665e-11
families O 0 2.2477932872227296e-13
showed O 0 5.45777478766496e-10
the O 0 1.1887477668892643e-09
father O 0 4.9248497641096733e-11
to O 0 7.444109564880286e-12
be O 0 3.672486967309929e-11
hypohaptoglobinemic B-Disease 0 7.861463480196562e-09
( O 0 5.919190918662887e-12
Hp2 O 0 1.1154483559039363e-08
) O 0 1.6479126006482825e-12
and O 0 5.419005955770162e-12
Hp2 O 0 9.50415923739456e-08
/ O 0 5.0428006659331004e-08
Hpdel O 0 1.3655277371071861e-06
, O 0 1.1887379969266476e-10
the O 0 5.276102332807397e-10
mother O 0 2.0322056537569466e-11
to O 0 5.872208969082138e-12
be O 0 1.8274867730205813e-11
Hp2 O 0 1.1227274399061571e-07
- O 0 2.512473562532591e-09
1 O 0 2.3379953528746e-09
and O 0 7.768766532856297e-12
Hp1 O 0 2.4463467696023145e-08
/ O 0 2.920095498737396e-09
Hp2 O 0 4.677386655771443e-08
, O 0 6.5919080090293125e-12
one O 0 8.50078633787138e-13
of O 0 1.2524434267469076e-10
the O 0 8.548125401963702e-11
two O 0 5.6774663095837674e-12
children O 0 9.336003107748847e-13
to O 0 6.251502679237297e-13
be O 0 1.1062407066775304e-11
hypohaptoglobinemic B-Disease 0 5.270083036634787e-08
( O 0 2.9587148703269506e-11
Hp2 O 0 1.8929291911717883e-07
) O 0 5.118862798914048e-12
and O 0 8.305613141690316e-12
Hp2 O 0 1.20333154995933e-07
/ O 0 5.793167545675715e-08
Hpdel O 0 9.260807019018102e-07
, O 0 2.8165508120236993e-11
and O 0 6.337623568303252e-12
the O 0 1.1113083370206667e-10
other O 0 5.66709092847395e-12
child O 0 7.550542656387105e-12
to O 0 8.815359466701755e-13
be O 0 1.7650216357911752e-11
Hp1 O 0 4.172455092543714e-08
and O 0 6.699552024258537e-11
Hp1 O 0 8.62782485455682e-07
/ O 0 1.5102676798051107e-07
Hpdel O 0 3.807638790931378e-07
, O 0 1.45683829583243e-11
showing O 0 2.6447050105460335e-10
an O 0 5.269738638513655e-13
anomalous O 0 1.1589091908348337e-09
inheritance O 0 6.876742508765687e-10
of O 0 1.7900518400892906e-08
Hp O 0 1.4129933667561545e-08
phenotypes O 0 1.715234843047142e-09
in O 0 2.560628931114195e-10
the O 0 1.8787502664707745e-09
child O 0 5.496060828669158e-10
with O 0 2.497898554665312e-10
Hp1 O 0 0.0007342711905948818
. O 0 1.2709667771559907e-06

The O 0 1.9940740969559556e-07
Hp2 O 0 1.3411337931756862e-05
/ O 0 2.7738096832763404e-06
Hpdel O 0 7.465721409971593e-07
individuals O 0 3.5227609024302e-11
had O 0 3.411878835013482e-10
an O 0 7.056814984793269e-13
extremely O 0 3.386591354570534e-11
low O 0 3.0696398756191456e-09
level O 0 1.0676360773231863e-07
of O 0 1.1609275318846812e-08
Hp O 0 2.6985975676296903e-09
( O 0 7.888935273266118e-13
mean O 0 8.245427778053038e-12
+ O 0 1.1801070103761857e-12
/ O 0 9.401821335353056e-12
- O 0 1.9471600980897064e-12
SD O 0 1.322884163323934e-10
= O 0 6.899292769035892e-12
0 O 0 2.5190721904266855e-12
. O 0 1.9619581905828444e-14
049 O 0 6.293931088113824e-12
+ O 0 1.420393615008883e-13
/ O 0 3.600841630077567e-12
- O 0 1.6830449794252855e-12
0 O 0 8.392960805514438e-12
. O 0 2.0084205566012203e-13
043 O 0 1.6397967705916727e-10
mg O 0 1.2403755106360492e-11
/ O 0 4.520052301199007e-12
ml O 0 6.99176990175826e-13
; O 0 8.100687470734779e-16
n O 0 3.5552249620825205e-13
= O 0 6.55283119432859e-13
6 O 0 1.0485524124317913e-12
) O 0 8.895061570798361e-17
, O 0 7.129002507984576e-17
compared O 0 2.2126794188684812e-16
with O 0 3.606387827327401e-16
the O 0 3.3893536848655925e-13
level O 0 3.481307603303563e-11
( O 0 4.536766910767393e-15
1 O 0 9.020726331708528e-13
. O 0 1.1818717628642086e-14
64 O 0 7.111795961162182e-13
+ O 0 1.8296681444235352e-13
/ O 0 2.4700378461334216e-12
- O 0 6.314645529560681e-13
1 O 0 1.801227136194461e-12
. O 0 4.7818862178349367e-14
07 O 0 2.170114348637453e-12
mg O 0 1.6996661023060966e-11
/ O 0 2.507729700979011e-12
ml O 0 4.0260012663072275e-13
) O 0 1.2351407967082606e-16
obtained O 0 1.1103843844016085e-14
from O 0 1.431643161225321e-13
52 O 0 6.561917675895756e-11
healthy O 0 1.0101935954409669e-10
volunteers O 0 3.1936510727637035e-12
having O 0 8.668636121422768e-12
phenotype O 0 2.2650666064993885e-11
Hp2 O 0 2.878126403871306e-09
, O 0 4.912716500965475e-12
whereas O 0 9.13601833074651e-12
the O 0 3.1194043875748534e-11
serum O 0 4.5499479184307745e-11
Hp O 0 3.37868316657719e-10
level O 0 1.0597799970923916e-08
of O 0 1.166364088645011e-10
an O 0 1.0669348298733214e-13
individual O 0 2.6516210559733577e-13
with O 0 2.635618069277146e-12
Hp1 O 0 1.5432793816216872e-06
/ O 0 8.915941407394712e-07
Hpdel O 0 4.764948243973777e-06
was O 0 1.7508722294223844e-07
0 O 0 2.9637584475494805e-07
. O 0 4.666797615016094e-09

50 O 0 2.1911017000775246e-08
mg O 0 6.592423318352303e-08
/ O 0 1.1571869684701142e-08
ml O 0 1.2425789286396594e-09
, O 0 3.7302951526319017e-13
which O 0 7.526206898368984e-14
was O 0 4.012419303062176e-12
approximately O 0 2.6892558817846746e-13
half O 0 7.320187208129103e-13
the O 0 1.3718337446913531e-12
level O 0 1.5660069074829863e-10
of O 0 6.506259420113736e-11
Hp O 0 3.366112943936628e-11
in O 0 1.1654644263559e-12
control O 0 3.7450723078258363e-10
sera O 0 9.214831675485868e-10
from O 0 1.6998631235248807e-12
the O 0 1.1173632331884509e-11
Hp1 O 0 6.4675269584313355e-09
phenotype O 0 5.297355956668248e-11
( O 0 1.4844627805633837e-13
1 O 0 1.0242671294458106e-11
. O 0 5.5945597818036347e-14
26 O 0 1.3239639419515559e-11
+ O 0 1.1838584583132028e-12
/ O 0 2.5822767535377267e-11
- O 0 7.078131050025638e-12
0 O 0 1.2329548840228632e-11
. O 0 9.836978508235422e-14
33 O 0 2.9134930145530147e-12
mg O 0 2.7062647262043882e-11
/ O 0 4.4267293823618825e-12
ml O 0 6.383368226364761e-13
; O 0 1.5980807562004538e-15
n O 0 7.179013243249766e-13
= O 0 8.259904804401585e-13
9 O 0 2.962310301571347e-12
) O 0 1.3298632206502881e-15
, O 0 4.1844270392144955e-15
showing O 0 4.764738516932487e-12
a O 0 3.3344414469144157e-12
gene O 0 9.398881846423013e-12
- O 0 2.6105936856701817e-11
dosage O 0 1.990265063867014e-09
effect O 0 4.0908143539297726e-09
. O 0 2.4499352546669684e-10

The O 0 2.713013280697396e-08
other O 0 1.2129725002196778e-10
allele O 0 1.5540482789511145e-10
( O 0 8.075681616481756e-12
Hp2 O 0 2.3134967719329325e-08
) O 0 2.6988613167217013e-12
of O 0 3.5781222429420723e-10
individuals O 0 1.13437839850683e-12
with O 0 3.565442038833133e-11
Hp2 O 0 0.0757221058011055
/ O 0 0.03553927689790726
Hpdel O 0 0.24523788690567017
was O 0 3.784412001550663e-07
found O 0 4.242603837689707e-11
to O 0 4.510378615735222e-13
have O 0 2.3358645204717143e-13
, O 0 2.2927992647915965e-14
in O 0 3.034096953714871e-13
all O 0 5.120190729734908e-12
exons O 0 7.941337365480194e-09
, O 0 1.9338137861868443e-12
no O 0 3.133770326568808e-11
mutation O 0 7.363727683173948e-12
, O 0 9.325729072437103e-14
by O 0 7.902700304047994e-13
DNA O 0 1.848719094477147e-10
sequencing O 0 2.459387971054383e-10
. O 0 1.9199974943262532e-09

On O 0 8.531487516449943e-09
the O 0 2.1268228497794972e-11
basis O 0 3.8877706609596885e-11
of O 0 1.7593122791925708e-10
the O 0 1.8218485747789614e-11
present O 0 3.94376068260649e-12
study O 0 1.1661137550370015e-12
, O 0 9.203559138762363e-13
the O 0 1.3405671538124775e-11
mechanism O 0 5.652717183224354e-10
of O 0 6.569272348322386e-10
anhaptoglobinemia B-Disease 0 3.0454803123802776e-08
and O 0 3.7387132278965396e-10
the O 0 7.461146145359976e-10
mechanism O 0 1.934185256402543e-09
of O 0 5.991883655909191e-10
anomalous O 0 1.2992987796778266e-09
inheritance O 0 1.0837304387223412e-09
of O 0 2.8261121443051707e-08
Hp O 0 7.673763491311547e-08
phenotypes O 0 3.791874902958625e-08
were O 0 4.214203208618983e-09
well O 0 2.9557343239616785e-09
explained O 0 9.812233514594482e-08
. O 0 6.178426303904416e-08

However O 0 8.342157187257726e-09
, O 0 6.25346510685354e-11
the O 0 1.6486939591331407e-10
mechanism O 0 5.53015455651007e-09
of O 0 6.145609354746284e-09
hypohaptoglobinemia B-Disease 0 1.9258603060734458e-05
remains O 0 7.577270025649341e-06
unknown O 0 2.3669117581448518e-05

ATM O 0 3.6907084677295643e-07
mutations O 0 6.91912985240073e-11
and O 0 2.5538564318861035e-12
phenotypes O 0 1.1771795760395776e-09
in O 0 2.4678580956560836e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 1.2434181462239735e-09
in O 0 1.2023834705665593e-10
the O 0 1.3883766358802063e-10
British O 0 1.8933184187108765e-10
Isles O 0 2.3513131441887936e-09
: O 0 6.574099988346238e-13
expression O 0 5.058096736593187e-12
of O 0 3.440839410270846e-12
mutant O 0 1.8018052327928302e-11
ATM O 0 1.8645555932561564e-10
and O 0 1.440074933758105e-14
the O 0 1.7040401479196526e-13
risk O 0 1.0159047214575168e-11
of O 0 5.0399275031143276e-11
leukemia B-Disease 1 1.0
, O 0 1.4938502772565698e-06
lymphoma B-Disease 1 1.0
, O 0 7.817012601663009e-07
and O 0 2.8093123546568677e-05
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.012971682474017143

We O 0 3.5103273066106055e-10
report O 0 3.96475040298494e-12
the O 0 7.741338494716976e-13
spectrum O 0 4.6626293104257144e-11
of O 0 3.217959787527036e-10
59 O 0 8.510809834660904e-10
ATM O 0 4.546881982037121e-09
mutations O 0 4.76706564847551e-12
observed O 0 2.2476282987571317e-11
in O 0 2.5406547976558613e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.7112162381538454e-12
patients O 0 8.927475729156309e-13
in O 0 3.423045809476666e-13
the O 0 1.7729102907981797e-11
British O 0 1.248584902135974e-09
Isles O 0 6.031322072885814e-07
. O 0 1.7056571266493847e-08

Of O 0 4.460662239580415e-07
51 O 0 4.473429555673647e-07
ATM O 0 3.6933179217157885e-06
mutations O 0 5.469352193365751e-10
identified O 0 3.731487341340767e-11
in O 0 9.911115331218134e-12
families O 0 8.35256885357849e-13
native O 0 1.1690182676049599e-11
to O 0 1.6757481903842408e-12
the O 0 1.2327110165966104e-10
British O 0 1.2087373324476403e-09
Isles O 0 6.110430206263118e-08
, O 0 9.465703221245292e-11
11 O 0 4.2824126467166934e-09
were O 0 6.36781238849693e-10
founder O 0 6.015614228971344e-09
mutations O 0 1.0321155388681724e-11
, O 0 1.3041036349761836e-12
and O 0 1.917970556680748e-12
2 O 0 9.928570188222352e-10
of O 0 1.230451296407864e-10
these O 0 1.4176472495908143e-12
11 O 0 1.466389926152445e-10
conferred O 0 6.483344971996985e-10
a O 0 1.6278017128668054e-11
milder O 0 3.5547625953924467e-10
clinical O 0 2.513863561759422e-09
phenotype O 0 4.372403480945586e-12
with O 0 8.446586291998518e-15
respect O 0 9.46959416263382e-13
to O 0 2.1505368286937193e-13
both O 0 2.895280196146821e-11
cerebellar B-Disease 1 0.9999994039535522
degeneration I-Disease 1 1.0
and O 0 1.108043101716305e-09
cellular O 0 7.512245758789504e-08
features O 0 6.318998657661723e-08
. O 0 1.0562001051539482e-08

We O 0 1.8549142777324334e-10
report O 0 4.911919829209133e-12
, O 0 1.3917258187903792e-13
in O 0 2.3990711760929484e-12
two O 0 3.655681035663605e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
families O 0 5.034275513821074e-12
, O 0 2.1275224691783695e-13
an O 0 8.01160556624346e-14
ATM O 0 1.448942565929201e-08
mutation O 0 8.849972144009399e-11
( O 0 3.27309712536486e-13
7271T O 0 1.917205283419321e-09
- O 0 8.17160383803639e-09
- O 0 2.3560133843858466e-09
> O 0 5.196208796576229e-09
G O 0 4.864320057862415e-10
) O 0 2.7046388810210778e-15
that O 0 4.822070689050454e-16
may O 0 2.4343294917285492e-15
be O 0 1.5343571705593123e-16
associated O 0 3.5155430143387852e-16
with O 0 5.16600795406192e-17
an O 0 1.1574691989340213e-16
increased O 0 8.830774653190154e-13
risk O 0 1.4929409097863555e-10
of O 0 7.443222704850427e-10
breast B-Disease 0 4.6161181899151416e-07
cancer I-Disease 0 2.4221282757252993e-09
in O 0 6.313966016691097e-11
both O 0 4.802789069224822e-11
homozygotes O 0 2.9248685251559436e-08
and O 0 5.963317513402178e-12
heterozygotes O 0 9.274731538333469e-10
( O 0 1.8190967666659869e-13
relative O 0 1.5811364717510656e-10
risk O 0 5.056298713057572e-10
12 O 0 3.657869146467263e-11
. O 0 5.983115478752632e-13
7 O 0 6.620720083283516e-10
; O 0 9.200293521818836e-13
P O 0 2.875185423079074e-09
= O 0 1.8815959207385546e-11
. O 0 4.684428300989751e-13
0025 O 0 6.312641381844841e-11
) O 0 1.6037296189256927e-15
, O 0 1.7172198577591522e-15
although O 0 6.2117741404462985e-15
there O 0 4.9466259945596044e-14
is O 0 7.71844966548441e-15
a O 0 1.7878225484248278e-13
less O 0 4.528543338933044e-12
severe O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 5.892111885202889e-12
in O 0 1.6315594158033248e-15
terms O 0 3.027863604374709e-14
of O 0 2.9517211022405884e-14
the O 0 2.176865357081132e-14
degree O 0 1.7870582791346123e-10
of O 0 1.1376519726269407e-09
cerebellar B-Disease 1 0.9999990463256836
degeneration I-Disease 1 1.0
. O 0 7.236523202891476e-08

This O 0 6.601046098619889e-11
mutation O 0 4.210479187527483e-11
( O 0 1.211447500475138e-12
7271T O 0 1.1613255912479303e-09
- O 0 3.870535003613895e-09
- O 0 3.0469313738734627e-09
> O 0 9.22186949026127e-09
G O 0 2.007386701308178e-09
) O 0 6.756900828376643e-15
also O 0 2.261008974786664e-15
allows O 0 6.185311454745535e-16
expression O 0 1.2666152577733153e-13
of O 0 1.4324415134950308e-12
full O 0 3.731378921123518e-12
- O 0 4.0653087450201464e-13
length O 0 1.1146033369272695e-13
ATM O 0 6.465500912433697e-10
protein O 0 1.1417855376449904e-11
at O 0 1.5262641844815406e-11
a O 0 1.2361613468958588e-12
level O 0 9.570635256528348e-11
comparable O 0 8.61266787055559e-12
with O 0 2.6238483702921943e-14
that O 0 1.159134637232495e-13
in O 0 3.6750429088794334e-12
unaffected O 0 5.352674303793492e-09
individuals O 0 1.8888510547321324e-12
. O 0 1.7665863216720368e-09

In O 0 1.156841428207045e-10
addition O 0 1.090297557099218e-11
, O 0 1.473211960409393e-12
we O 0 3.9115011143259215e-13
have O 0 2.702330038613452e-14
studied O 0 4.394377223215784e-11
18 O 0 2.096895514114294e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.035520777076698e-11
, O 0 5.0190429069785214e-15
in O 0 1.1897653476029661e-14
15 O 0 1.7970131676106615e-12
families O 0 7.739086776211313e-15
, O 0 2.3284435970581836e-14
who O 0 1.4009093364519831e-12
developed O 0 3.344289609685802e-07
leukemia B-Disease 1 1.0
, O 0 0.00101383903529495
lymphoma B-Disease 1 1.0
, O 0 1.1809497379999812e-07
preleukemic O 1 0.9999998807907104
T O 1 0.9996166229248047
- O 0 3.980683782600636e-09
cell O 0 9.861048866355304e-09
proliferation O 0 7.280950740096159e-07
, O 0 8.717627856570653e-13
or O 0 1.0262413141504112e-09
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 4.870763237185827e-10
mostly O 0 1.8780094666881464e-12
in O 0 4.545365819841329e-12
childhood O 0 8.634280135311201e-08
. O 0 2.5730280128755112e-08

A O 0 3.0770451076023164e-08
wide O 0 6.373037653162328e-10
variety O 0 2.0551541024538267e-10
of O 0 9.28154886281618e-09
ATM O 0 1.039334392771707e-06
mutation O 0 5.169141226168961e-10
types O 0 7.970023946368698e-11
, O 0 1.3221968008306217e-12
including O 0 1.2753119740804841e-11
missense O 0 6.213845438196586e-08
mutations O 0 2.030901002925134e-10
and O 0 1.5861868762900855e-10
in O 0 1.2998392362462141e-09
- O 0 4.639993278487964e-09
frame O 0 9.702595171745543e-09
deletions O 0 9.55030721172534e-10
, O 0 5.724574633769741e-11
were O 0 3.5728503489096397e-10
seen O 0 2.346576266631928e-10
in O 0 8.138278245750641e-11
these O 0 4.545439857839284e-10
patients O 0 4.752247928507813e-09
. O 0 8.756691372013847e-09

We O 0 5.656761725703063e-10
also O 0 6.857255648723415e-13
show O 0 4.139224499179889e-13
that O 0 5.313069642310644e-15
25 O 0 4.3623549325806643e-13
% O 0 3.2070236765692484e-13
of O 0 4.79120597363103e-11
all O 0 2.209078608927939e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.4568701800499184e-09
carried O 0 8.231222127508264e-12
in O 0 8.784044672194291e-12
- O 0 3.580011287418472e-11
frame O 0 4.3086775813883094e-10
deletions O 0 4.277298307209243e-11
or O 0 1.2821582337507742e-11
missense O 0 5.362116084484114e-09
mutations O 0 4.0202199208527745e-11
, O 0 1.9368185440876706e-12
many O 0 7.754934932061031e-13
of O 0 2.1393888882670353e-09
which O 0 2.2829318296890833e-11
were O 0 4.6762559102742074e-11
also O 0 2.4822833133604505e-13
associated O 0 2.755971720367484e-13
with O 0 1.2063188447285211e-13
expression O 0 1.184252557129284e-10
of O 0 7.286696246389113e-10
mutant O 0 2.2224165618922598e-08
ATM O 0 1.4156364613882033e-06
protein O 0 3.799491210543238e-08
. O 0 2.4745876459064675e-09

The O 0 5.934449820443888e-09
DMPK O 0 2.3668167159485165e-06
gene O 0 1.5680250431415743e-09
of O 0 2.006705246415663e-09
severely O 0 0.18150335550308228
affected O 1 0.9999949932098389
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999990463256836
is O 0 9.179130372460875e-11
hypermethylated O 0 1.7760809711830916e-08
proximal O 0 2.6276950060299953e-10
to O 0 3.6746763943350247e-13
the O 0 5.31804591683005e-12
largely O 0 2.3635276028000085e-11
expanded O 0 4.9143026453757344e-11
CTG O 0 2.0825062563289976e-07
repeat O 0 8.389775985051529e-08
. O 0 7.728932160944169e-09

Using O 0 5.740726782832439e-10
methylation O 0 1.7023916143443785e-07
- O 0 9.387035149188705e-09
sensitive O 0 2.618925076802725e-09
restriction O 0 5.333684605091094e-10
enzymes O 0 1.6826094337285546e-11
, O 0 1.006542180333192e-12
we O 0 5.29682526138886e-13
characterized O 0 1.392708973320389e-12
the O 0 4.956715376688847e-13
methylation O 0 3.852853799890532e-11
pattern O 0 1.2581987535176253e-11
on O 0 1.0846521597551728e-10
the O 0 1.838850252622315e-11
5 O 0 1.8141654845038602e-10
side O 0 6.048477690923093e-11
of O 0 5.267241157125291e-11
the O 0 6.812014841095504e-11
CTG O 0 2.6530241115096942e-08
repeat O 0 2.188601799790746e-10
in O 0 1.513526109997443e-11
the O 0 4.782003265590973e-11
DMPK O 0 5.328494623313418e-08
gene O 0 2.982504651236062e-12
of O 0 6.561777163294202e-12
normal O 0 8.444005911156793e-12
individuals O 0 9.719365950630089e-15
and O 0 4.8932317480701246e-14
of O 0 1.2136434912601857e-10
patients O 0 1.0014690188242525e-09
affected O 0 5.142620995712832e-09
with O 0 0.0016529669519513845
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.0577619891094514e-09
showing O 0 2.1779328340798543e-10
expansions O 0 1.3005733157100963e-09
of O 0 1.9245842697301896e-09
the O 0 6.185153500481988e-10
repetitive O 0 2.5110232115821418e-08
sequence O 0 4.5967247785938525e-09
. O 0 4.338541081949643e-09

The O 0 2.7981034378399272e-08
gene O 0 3.006851989617587e-10
segment O 0 6.386845913253225e-11
analyzed O 0 1.683064386644173e-12
corresponds O 0 3.750993114205736e-13
to O 0 2.7423332701892456e-13
the O 0 2.151244633818994e-11
genomic O 0 3.0000135708974085e-09
SacI O 0 1.3812907582178013e-06
- O 0 2.1354098489467788e-09
HindIII O 0 2.0748652573843174e-08
fragment O 0 6.396492224780559e-10
carrying O 0 3.3192035231444095e-10
exons O 0 1.6488033338646346e-07
11 O 0 4.685136900661746e-08
- O 0 1.8831423531651126e-08
15 O 0 3.839859630261344e-08
. O 0 1.6150872639286717e-08

There O 0 2.660725195724467e-09
is O 0 1.8776593127545205e-11
constitutive O 0 1.5998911084835754e-09
methylation O 0 3.8531955404152995e-09
in O 0 1.3722695202389446e-10
intron O 0 9.139569101535017e-09
12 O 0 7.192537676559141e-10
at O 0 1.0017798396377842e-10
restriction O 0 1.574286707939354e-11
sites O 0 2.701307493663263e-12
of O 0 4.6789235680355645e-11
SacII O 0 1.0489006108116428e-08
and O 0 4.803924966156892e-11
HhaI O 0 2.9465606843359637e-08
, O 0 1.2253962601571633e-11
localized O 0 4.160223276983288e-09
1 O 0 8.445580235161287e-09
, O 0 2.1861713828119633e-12
159 O 0 6.815926295589136e-11
- O 0 5.4696837337164794e-11
1 O 0 3.2827993101669506e-10
, O 0 1.4394913212811833e-12
232 O 0 5.892066782392513e-12
bp O 0 7.93066914223095e-12
upstream O 0 3.0398446346918684e-12
of O 0 6.323076784386927e-11
the O 0 3.473019372091102e-10
CTG O 0 4.515158309459366e-07
repeat O 0 8.888551228380948e-09
, O 0 1.8953949521005597e-11
whereas O 0 2.077024142954631e-11
most O 0 4.2486240220407367e-13
, O 0 2.846619424554109e-13
if O 0 4.1264702158733124e-13
not O 0 2.1959701852064528e-13
all O 0 2.7010652828979298e-12
, O 0 7.860023396033533e-13
of O 0 6.645082401002256e-11
the O 0 1.481864457530957e-11
other O 0 2.0314866867703063e-13
sites O 0 1.0188232202335001e-11
of O 0 1.689195866516613e-10
SacII O 0 4.804042319506152e-08
, O 0 7.648180699870721e-11
HhaI O 0 1.5272836151325464e-07
, O 0 1.6399562263735845e-10
and O 0 8.389956090981698e-11
HpaII O 0 9.645490450793659e-08
in O 0 1.6551657266994368e-10
this O 0 7.586343012122576e-12
region O 0 3.379688751081744e-10
are O 0 4.650805348477283e-12
unmethylated O 0 2.7752959042004477e-08
, O 0 2.1937484381145955e-12
in O 0 1.7805409924243065e-12
normal O 0 1.785896430739342e-10
individuals O 0 8.447846507617443e-14
and O 0 1.8869138022903353e-12
most O 0 3.620572374893327e-12
of O 0 1.1305397729088895e-09
the O 0 1.3611971994009764e-08
patients O 0 9.591618610471642e-10
. O 0 2.6268995867440026e-09

In O 0 4.505473424898376e-11
a O 0 4.255406357150937e-12
number O 0 1.051304529542385e-11
of O 0 1.0228586866389833e-09
young O 0 6.673916280730552e-11
and O 0 1.2179829367298112e-09
severely O 0 0.00013494296581484377
affected O 0 2.9469413576066472e-09
patients O 0 6.128516027992248e-10
, O 0 6.069959639087852e-12
however O 0 1.2241169189408652e-10
, O 0 1.6194764713289844e-12
complete O 0 2.820370603728861e-09
methylation O 0 2.5414800930434467e-08
of O 0 2.493162343242261e-10
these O 0 3.748752339365752e-14
restriction O 0 1.22572297363982e-12
sites O 0 6.603910669179813e-13
was O 0 1.7507719232701113e-11
found O 0 1.0318433390707482e-12
in O 0 1.880389290456752e-12
the O 0 8.805991352778264e-11
mutated O 0 5.076978837337265e-10
allele O 0 2.00514427284304e-09
. O 0 3.4460594378060705e-09

In O 0 5.676475955951332e-10
most O 0 6.768029713055679e-12
of O 0 1.9177784360557837e-10
these O 0 3.71853329378391e-12
patients O 0 1.9228568390317058e-12
, O 0 3.607106746541383e-14
the O 0 1.1752955379751295e-12
onset O 0 1.0189762633672217e-06
of O 0 2.29158629849735e-08
the O 0 5.0051319533395144e-08
disease O 1 0.9999998807907104
was O 0 3.870725413435139e-05
congenital O 1 1.0
. O 0 7.802343134244438e-06

Preliminary O 0 1.8941763713087312e-08
in O 0 3.8224937104480716e-10
vivo O 0 4.410648912767101e-08
footprinting O 0 6.019570832904719e-07
data O 0 9.663012612293187e-10
gave O 0 6.678274599991596e-10
evidence O 0 2.830748968563057e-10
for O 0 7.156326226054333e-11
protein O 0 1.812920230603865e-10
- O 0 4.820354532197868e-11
DNA O 0 1.2036770018208909e-11
contact O 0 4.201756564209402e-12
in O 0 4.0489365332740945e-12
normal O 0 1.3830456224717125e-10
genes O 0 5.412134499241383e-13
at O 0 5.980026803603655e-12
an O 0 2.321593438325831e-13
Sp1 O 0 1.3592332592793355e-08
consensus O 0 8.297051240502284e-11
binding O 0 6.9021620016651575e-12
site O 0 6.722922132190723e-12
upstream O 0 4.0725265499329255e-13
of O 0 9.2312355676194e-12
the O 0 9.673869344473118e-11
CTG O 0 9.411527912561723e-08
repeat O 0 8.002671858520216e-10
and O 0 2.9025330316317932e-12
for O 0 7.823767133284532e-13
a O 0 1.3824243399324088e-12
significant O 0 1.2589333221735277e-11
reduction O 0 2.7331223950710637e-09
of O 0 3.2154259810290853e-10
this O 0 3.098592617298973e-13
interaction O 0 1.090465500015736e-12
in O 0 1.0500334325994065e-12
cells O 0 4.841413186150445e-13
with O 0 2.490321317216715e-13
a O 0 7.316788841471578e-11
hypermethylated O 0 1.1493740714740852e-07
DMPK O 0 2.5781630029086955e-05
gene O 0 3.797366865398999e-09
. O 0 2.4325672032254886e-10
. O 0 2.2034554181260546e-09

The O 0 1.084010023078008e-06
hemochromatosis B-Disease 1 1.0
gene O 0 6.984049449876295e-10
product O 0 1.8398368939465115e-10
complexes O 0 1.0620467179311976e-11
with O 0 3.633555587488624e-13
the O 0 7.42017003396711e-11
transferrin O 0 3.1282434420631944e-09
receptor O 0 3.212322421952685e-11
and O 0 4.8473846464558434e-12
lowers O 0 3.593929043255173e-10
its O 0 8.624564278893188e-13
affinity O 0 5.796623489366659e-13
for O 0 2.7315758162338444e-12
ligand O 0 1.0377201181688278e-10
binding O 0 4.0433686954166603e-10
. O 0 2.538657617456863e-10

We O 0 6.103366145815414e-10
recently O 0 3.491561900714757e-11
reported O 0 2.5048138476563286e-12
the O 0 3.1174338284423175e-12
positional O 0 1.7153656273194429e-09
cloning O 0 3.0692814956267966e-10
of O 0 7.717434330478667e-11
a O 0 5.817005731267866e-12
candidate O 0 2.633900562931668e-11
gene O 0 3.8314423855823065e-10
for O 0 1.0345885925744369e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9998706579208374
HFE O 1 0.7245708107948303
. O 0 1.9470116185971165e-08

The O 0 5.368665512150983e-09
gene O 0 2.443218717618212e-11
product O 0 5.7135789155449146e-11
, O 0 9.3496705603352e-13
a O 0 3.0827488999018993e-12
member O 0 6.1749273229383395e-12
of O 0 1.4107812140728981e-10
the O 0 3.206007403999678e-10
major O 0 2.3690509109997038e-08
histocompatibility O 0 5.594575895884191e-07
complex O 0 2.67342187498798e-07
class O 0 1.931920734499215e-10
I O 0 4.237989958966182e-09
- O 0 7.927693917997303e-11
like O 0 2.351426345303942e-12
family O 0 1.042967470200884e-12
, O 0 4.1254076977442766e-13
was O 0 5.906314326509232e-11
found O 0 1.9447325694255113e-12
to O 0 2.471507156917574e-13
have O 0 1.3580695812712151e-12
a O 0 9.568585507269134e-12
mutation O 0 4.776825462959877e-11
, O 0 4.875108129687167e-12
Cys O 0 1.5974272855601157e-06
- O 0 1.1355042239813429e-08
282 O 0 1.242541625146032e-08
- O 0 3.5464093883774694e-08
- O 0 3.7087286575143708e-09
> O 0 3.7554461762567826e-09
Tyr O 0 1.9670891582279637e-09
( O 0 2.98071605646464e-14
C282Y O 0 1.786398611501594e-12
) O 0 1.3138886027815456e-15
, O 0 4.734038025446723e-16
in O 0 6.734180016599494e-15
85 O 0 5.164681182723285e-12
% O 0 3.176555806588821e-12
of O 0 4.443955620159201e-11
patient O 0 1.2428919005103012e-09
chromosomes O 0 1.5930063934632699e-09
. O 0 4.6772865580635425e-09

This O 0 1.8414134106414792e-10
mutation O 0 5.797318181066657e-10
eliminates O 0 5.673859604371501e-09
the O 0 7.927860451450996e-11
ability O 0 1.3529277524682026e-11
of O 0 3.962035144411402e-09
HFE O 0 1.305718683397572e-06
to O 0 2.7324054477362303e-11
associate O 0 4.746086301743446e-10
with O 0 2.9570039992987684e-12
beta2 O 0 3.589682819438167e-06
- O 0 1.7652979522608803e-07
microglobulin O 0 4.780884410138242e-06
( O 0 1.1951718781322285e-10
beta2m O 0 1.5877510861628252e-07
) O 0 1.1200943818290288e-11
and O 0 5.494611363121571e-11
prevents O 0 3.307852602940642e-10
cell O 0 1.5312825496494042e-07
- O 0 1.1037863956175897e-09
surface O 0 9.147604340675741e-10
expression O 0 1.8053857075983615e-08
. O 0 1.461849974404572e-09

A O 0 6.835738730615049e-08
second O 0 4.5656331493226787e-10
mutation O 0 6.594850967406307e-12
that O 0 3.1489960920956517e-14
has O 0 6.200130063223688e-14
no O 0 3.1166771095360313e-13
effect O 0 1.9492641875618055e-11
on O 0 4.904098793723222e-10
beta2m O 0 8.08272346830563e-08
association O 0 9.578231263684955e-11
, O 0 1.0443091703893348e-12
H63D O 0 4.91479781317139e-08
, O 0 2.9298709725705807e-12
was O 0 2.6139168954331105e-11
found O 0 3.1420262984298286e-13
in O 0 2.42726601621876e-13
eight O 0 1.0222822588445979e-11
out O 0 2.1880236338034376e-12
of O 0 9.28501497909906e-10
nine O 0 1.0888154378108084e-08
patients O 0 2.6291526247779196e-11
heterozygous O 0 8.825024738756682e-11
for O 0 4.8636216581909864e-11
the O 0 1.0692553509272784e-09
C282Y O 0 1.3807795085085672e-07
mutant O 0 2.4537777676414407e-07
. O 0 1.643772229442675e-08

In O 0 4.0923184285723835e-10
this O 0 6.133748890746471e-12
report O 0 8.676311405442227e-12
, O 0 8.588516182961303e-13
we O 0 1.2507472271425235e-12
demonstrate O 0 1.3685989841416557e-11
in O 0 2.942759230739611e-11
cultured O 0 4.711837586768297e-10
293 O 0 3.911156398750393e-10
cells O 0 5.069412112312932e-10
overexpressing O 0 4.3398011939643766e-07
wild O 0 1.9431223563515232e-07
- O 0 3.9958811259843685e-10
type O 0 2.3473464838552616e-10
or O 0 3.3853385372761835e-11
mutant O 0 1.1490623563759073e-08
HFE O 0 8.226591035054298e-07
proteins O 0 1.0147577222952009e-12
that O 0 8.486784951015902e-14
both O 0 5.808875516016831e-13
the O 0 6.708041760949968e-11
wild O 0 1.4873915432644935e-08
- O 0 1.0368673974969767e-10
type O 0 1.5706523581737741e-10
and O 0 2.7650745582086245e-10
H63D O 0 1.3010576367378235e-05
HFE O 0 3.0676274036522955e-06
proteins O 0 1.016181843532804e-11
form O 0 8.124285098831674e-12
stable O 0 2.4325438885419715e-10
complexes O 0 5.895236989544861e-12
with O 0 1.2883983701965362e-13
the O 0 1.1762228691036825e-10
transferrin O 0 1.4386214886030757e-08
receptor O 0 1.7772855409603494e-10
( O 0 4.776294377367707e-12
TfR O 0 3.25431237513385e-08
) O 0 1.3173140529787464e-11
. O 0 6.905501170884065e-10

The O 0 1.6539555502959047e-08
C282Y O 0 1.0680801665330364e-07
mutation O 0 9.370824116672338e-10
nearly O 0 5.075311351743217e-11
completely O 0 1.2912935998254937e-10
prevents O 0 2.8284254278976295e-12
the O 0 3.358352831939193e-11
association O 0 4.134628403540397e-11
of O 0 4.1411024609416813e-10
the O 0 1.993789994214623e-10
mutant O 0 1.0464487054662186e-08
HFE O 0 3.131694938929286e-06
protein O 0 4.208401682692653e-10
with O 0 3.942369434378756e-12
the O 0 2.916088037707709e-09
TfR O 0 9.279361620428972e-06
. O 0 6.486319392706719e-08

Studies O 0 1.393463011645224e-09
on O 0 3.4966705086958427e-09
cell O 0 8.05218836053001e-10
- O 0 4.347488948702738e-12
associated O 0 7.561134877931419e-12
transferrin O 0 6.319511025587587e-10
at O 0 1.7165954768749714e-10
37 O 0 4.4701985169037783e-11
degrees O 0 4.036389888995018e-09
C O 0 3.322042640974132e-09
suggest O 0 4.062086604583737e-12
that O 0 9.683805135812101e-14
the O 0 1.2171827781792821e-11
overexpressed O 0 6.957822762387877e-08
wild O 0 6.475207214862166e-08
- O 0 6.768476334961804e-10
type O 0 9.276730494889307e-10
HFE O 0 1.0125445726316684e-07
protein O 0 6.568338321161216e-12
decreases O 0 3.343610924157886e-13
the O 0 1.7398845493683812e-13
affinity O 0 2.4337839686291995e-13
of O 0 6.81087131138014e-11
the O 0 2.29234034532233e-10
TfR O 0 2.1824677176596197e-08
for O 0 8.366465853448801e-11
transferrin O 0 2.8367901450110367e-07
. O 0 1.5582585888296308e-08

The O 0 8.857446687215997e-07
overexpressed O 0 4.20320538978558e-05
H63D O 0 0.001310240477323532
protein O 0 4.6778572126982e-09
does O 0 2.789523603427546e-12
not O 0 1.9911306490313224e-13
have O 0 1.2514427292836458e-14
this O 0 1.5699354395499695e-15
effect O 0 2.006488074648982e-12
, O 0 3.3229468439019416e-14
providing O 0 1.3672355890677335e-13
the O 0 1.2681042739319526e-13
first O 0 1.0079248227061813e-13
direct O 0 2.662446001513996e-13
evidence O 0 2.4501462057152645e-13
for O 0 5.1739838677561725e-14
a O 0 7.28487908017994e-13
functional O 0 1.6472041786119718e-10
consequence O 0 1.1408717720540196e-10
of O 0 2.5459603869570913e-10
the O 0 1.9529802219864223e-09
H63D O 0 3.0273929951363243e-05
mutation O 0 5.147235881963752e-08
. O 0 1.3683609800807517e-08

Addition O 0 5.138451331099247e-10
of O 0 1.637045166091866e-08
soluble O 0 9.116834576161637e-08
wild O 0 3.1208695872919634e-05
- O 0 1.6617381959349586e-07
type O 0 7.143910920603957e-07
HFE O 1 0.9982764720916748
/ O 0 7.782017746649217e-06
beta2m O 0 7.0572758659182e-07
heterodimers O 0 1.2728619935842289e-08
to O 0 3.1093814589072677e-12
cultured O 0 1.3696540429597448e-11
cells O 0 1.1945872893312504e-12
also O 0 2.2138300443058992e-14
decreased O 0 3.834697316629221e-13
the O 0 1.1281936756341038e-13
apparent O 0 1.5939613995027968e-12
affinity O 0 1.2896769156084398e-13
of O 0 1.1644879505112726e-10
the O 0 6.852281242419878e-11
TfR O 0 2.8998259349322097e-09
for O 0 1.185046743894247e-12
its O 0 7.672632060945483e-13
ligand O 0 3.0290665266850814e-13
under O 0 6.101800054808537e-12
steady O 0 4.750877469206216e-10
- O 0 3.187298298554242e-12
state O 0 9.56443908448068e-13
conditions O 0 2.9708251414461984e-09
, O 0 3.2039849289303146e-13
both O 0 4.86527810227011e-13
in O 0 7.592220255259186e-12
293 O 0 8.407544799249322e-11
cells O 0 2.213381561366745e-11
and O 0 9.708448454881502e-12
in O 0 5.071820741164856e-10
HeLa O 0 9.244112106898683e-07
cells O 0 2.8432283194490537e-09
. O 0 2.390724507250752e-09

Furthermore O 0 9.148931057190168e-10
, O 0 9.194369224307941e-12
at O 0 3.558064259889804e-11
4 O 0 1.547883210495371e-10
degrees O 0 2.275630572867726e-09
C O 0 6.010785646992645e-09
, O 0 2.1212877374804373e-12
the O 0 2.3718551428464352e-11
added O 0 1.0713369774650872e-10
soluble O 0 1.1104036440334752e-10
complex O 0 6.219922910055686e-10
of O 0 6.431480903401621e-10
HFE O 0 1.2866631550423335e-05
/ O 0 2.101839413626294e-08
beta2m O 0 4.124238017766402e-08
inhibited O 0 1.2608661337232263e-10
binding O 0 4.1628700486739945e-11
of O 0 8.143961893747331e-11
transferrin O 0 2.1396988625355107e-09
to O 0 4.217544022355746e-11
HeLa O 0 1.5794101670962846e-07
cell O 0 9.64813651194163e-09
TfR O 0 2.7881624120595916e-08
in O 0 2.434715276611321e-11
a O 0 3.769292170052729e-11
concentration O 0 1.0003240014100356e-08
- O 0 5.464454666537222e-09
dependent O 0 1.1732232962913258e-09
manner O 0 6.810047192828961e-09
. O 0 3.912374424430709e-09

Scatchard O 0 1.5202197118924232e-06
plots O 0 1.6825605797521348e-08
of O 0 7.521060219062292e-09
these O 0 3.1129300526178127e-12
data O 0 3.3173408464648446e-11
indicate O 0 1.1744668605706554e-11
that O 0 2.751267529771395e-12
the O 0 7.654022415870543e-10
added O 0 1.3555794264874521e-09
heterodimer O 0 3.3714475655699516e-10
substantially O 0 5.23567734306285e-12
reduced O 0 1.0166994850180355e-11
the O 0 4.374920293658685e-13
affinity O 0 1.930158290142092e-12
of O 0 3.084393018770726e-10
TfR O 0 4.763258232287626e-08
for O 0 1.9294828235150163e-10
transferrin O 0 2.546473751863232e-07
. O 0 2.1554866336259693e-08

These O 0 2.7567700899844283e-10
results O 0 7.32402125058762e-11
establish O 0 5.325803686950792e-11
a O 0 2.934328344542103e-12
molecular O 0 4.0384627066070156e-12
link O 0 5.097174852336517e-12
between O 0 6.064393345134311e-12
HFE O 0 7.005882594057766e-07
and O 0 8.949233715194183e-12
a O 0 5.0426392228519745e-11
key O 0 6.412167685709846e-09
protein O 0 4.40755591746278e-11
involved O 0 3.2801920901714965e-12
in O 0 4.417655477539917e-11
iron O 0 1.0469702260706981e-07
transport O 0 6.657036033530517e-10
, O 0 3.285088347182441e-12
the O 0 8.060128259268495e-11
TfR O 0 1.135985598921252e-07
, O 0 1.629441720440994e-11
and O 0 1.2375396714336961e-11
raise O 0 1.269964515493438e-11
the O 0 1.182369740310163e-11
possibility O 0 4.947935811072668e-11
that O 0 1.1225400356430423e-13
alterations O 0 7.163945825450213e-11
in O 0 3.98134650247961e-12
this O 0 5.415510704806503e-13
regulatory O 0 8.981905774696486e-10
mechanism O 0 1.8375968524608766e-09
may O 0 3.396100067831753e-11
play O 0 6.73290936892279e-11
a O 0 3.9840201450369594e-12
role O 0 2.155186402605369e-12
in O 0 2.048893823700104e-12
the O 0 3.298601669587953e-11
pathogenesis O 0 1.3695824918613653e-06
of O 0 4.070067006978206e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 6.167171022752882e-07
. O 0 7.758146125524945e-09

Genomic O 0 5.617116016765067e-08
organization O 0 1.0411926432141172e-08
of O 0 2.2930249699015803e-08
the O 0 1.3921540364947305e-08
UBE3A O 0 0.00010856595326913521
/ O 0 2.1849641598237213e-06
E6 O 0 1.0231332453258801e-05
- O 0 2.0650345433637085e-08
AP O 0 1.4955750771150633e-07
gene O 0 1.0679054862627879e-10
and O 0 3.5062421716025582e-12
related O 0 9.275575446610063e-11
pseudogenes O 0 1.0955486118291446e-07
. O 0 1.672590244083949e-08

The O 0 3.036484130802819e-08
UBE3A O 0 3.4786596643243684e-06
gene O 0 3.450826291384601e-10
encodes O 0 1.8539230914327298e-11
the O 0 1.7351149683708655e-10
E6 O 0 2.2649497566362697e-07
- O 0 9.39462996285556e-09
AP O 0 6.168006621010136e-07
ubiquitin O 0 8.465982581640219e-09
- O 0 1.1247754949650357e-09
protein O 0 6.532932528280355e-11
ligase O 0 1.5412855453728058e-12
and O 0 7.513961241406575e-13
has O 0 1.1509852316030078e-13
recently O 0 6.425683010853611e-13
been O 0 1.0624792332828564e-13
shown O 0 3.420329205408232e-14
to O 0 6.78104465550518e-15
be O 0 6.964401115267665e-14
mutated O 0 1.9294449718487705e-11
in O 0 1.3182673008760304e-10
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.427008377660968e-07
who O 0 1.0261683863754811e-10
lack O 0 3.6666767755377805e-07
15q11 O 0 5.708935759685119e-07
- O 0 9.027354863633263e-09
q13 O 0 3.023682637603997e-08
deletions O 0 1.8501380427693448e-09
or O 0 7.543017599420665e-11
chromosome O 0 7.779294719512109e-08
15 O 0 2.882199510167993e-07
paternal O 0 1.494932007517491e-06
uniparental B-Disease 0 0.0680520310997963
disomy I-Disease 0 0.0007980456575751305
. O 0 4.4541368993122887e-07

Previous O 0 1.1206522287920961e-07
UBE3A O 0 1.9459148461464792e-06
cDNA O 0 4.195556346786589e-09
analysis O 0 7.5626779144633e-12
has O 0 1.1214913410917057e-13
shown O 0 2.0216918688188007e-13
a O 0 1.059058439903393e-12
coding O 0 1.3177821334142692e-10
region O 0 6.815640413160295e-11
of O 0 1.9017294683454367e-10
approximately O 0 5.848648648720811e-11
2 O 0 6.562164855949959e-08
. O 0 9.40789934844588e-09

6 O 0 1.162077069238876e-06
kb O 0 2.4889991436793935e-06
and O 0 3.113479474237124e-10
a O 0 6.234864846632604e-10
3 O 0 6.593769086293833e-08
- O 0 8.263920103779299e-10
untranslated O 0 5.341570954442432e-07
region O 0 1.2096805779293618e-09
( O 0 5.601356184437023e-12
UTR O 0 1.807663778663482e-07
) O 0 3.6912546587039574e-13
of O 0 4.067546646724374e-11
< O 0 1.4581712504124766e-09
50 O 0 6.243358607882499e-11
bp O 0 4.115947166427603e-12
, O 0 1.2453714004056343e-13
whereas O 0 2.9328609311117526e-13
Northern O 0 5.089024687765509e-12
analysis O 0 7.546632589672253e-14
has O 0 2.539592139556325e-14
indicated O 0 6.740585737144422e-13
mRNA O 0 1.1796165173133533e-12
sizes O 0 2.3097795377735597e-12
of O 0 1.7673403018836353e-10
5 O 0 7.387813383274988e-08
- O 0 2.3378492031156384e-08
8 O 0 7.763626541645863e-08
kb O 0 2.4991077225422487e-06
. O 0 2.6838463895728637e-08

We O 0 2.5456754482178212e-09
have O 0 9.668935574067006e-13
analyzed O 0 1.7871884256791953e-13
additional O 0 2.1682555382228352e-13
cDNA O 0 3.178219909472091e-10
clones O 0 2.4590690594905595e-10
and O 0 2.4644097526560493e-12
provide O 0 2.689209803192344e-13
evidence O 0 2.403394757516386e-12
for O 0 1.0669475285912666e-12
an O 0 1.4041462220379386e-12
additional O 0 3.295057005026081e-10
0 O 0 2.773862490812462e-07
. O 0 8.31400992495901e-09

5 O 0 1.1026763502286485e-07
kb O 0 1.0969156392093282e-06
of O 0 1.4927636016182078e-07
5 O 0 8.963050959209795e-07
- O 0 4.544629916836129e-08
UTR O 0 4.188684670225484e-06
and O 0 6.799176499594495e-11
> O 0 2.271753674065735e-09
2 O 0 1.9546533280845324e-09
kb O 0 1.1406058320062584e-07
of O 0 4.498988204204579e-08
3 O 0 1.0197646588494536e-05
- O 0 1.0236396974505624e-06
UTR O 0 0.00013452426355797797
. O 0 1.4310025164832041e-08

We O 0 8.526358508120779e-10
have O 0 5.525588125075698e-13
established O 0 1.662796311231729e-12
the O 0 7.425967393087651e-13
genomic O 0 2.1341138578545582e-10
organization O 0 1.590725468014753e-10
of O 0 1.3230312401191213e-09
UBE3A O 0 7.801588708389318e-07
and O 0 2.263904862187527e-11
the O 0 1.6778758937796567e-11
sequence O 0 5.968703309378043e-11
of O 0 2.1292441143572205e-09
intron O 0 8.882672091203858e-07
- O 0 3.978508118507307e-07
exon O 0 1.276433891916895e-07
borders O 0 4.556901078700548e-09
. O 0 4.670698494635417e-09

We O 0 2.8392683759648207e-08
have O 0 5.960704846375009e-11
also O 0 6.434639713420731e-12
mapped O 0 3.329246878180925e-10
two O 0 2.9515171556804276e-11
highly O 0 8.10029057718431e-11
homologous O 0 1.921057930787118e-11
processed O 0 1.566986818080096e-10
pseudogenes O 0 3.3227904872035197e-09
, O 0 3.039974175167437e-11
UBE3AP1 O 0 1.4953953950680443e-06
and O 0 7.536018475917672e-10
UBE3AP2 O 0 3.069242666242644e-06
, O 0 9.564954731033914e-12
to O 0 5.711481092761372e-13
chromosomes O 0 8.611156059046277e-12
2 O 0 2.3632670820283863e-10
and O 0 2.6320213369901424e-12
21 O 0 1.7362405957399574e-10
, O 0 3.8006051214165004e-13
respectively O 0 4.634255219154726e-12
, O 0 3.6463301995859343e-13
and O 0 1.3428954129257598e-12
determined O 0 1.5421714252839003e-11
their O 0 1.4301981474118541e-11
genomic O 0 1.2546586880546329e-08
organization O 0 7.09252034880592e-09
. O 0 1.3748803873170345e-08

These O 0 6.829008469821929e-10
results O 0 1.5504657280285272e-10
will O 0 3.163608697925868e-13
form O 0 3.033216174974998e-14
the O 0 5.341869524846943e-14
basis O 0 2.9368353452255413e-13
for O 0 1.5111240573737958e-14
studies O 0 3.8672342915881466e-14
of O 0 3.1832518392060916e-12
mutation O 0 2.6815333807606034e-12
and O 0 8.109079271782782e-13
imprinting O 0 2.146219379994818e-08
of O 0 7.40320231784608e-08
UBE3A O 0 0.0019575217738747597
. O 0 3.3298286439276126e-07

Mutation O 0 3.37447314535666e-09
spectrum O 0 9.33151333981641e-10
and O 0 6.651549450120697e-11
genotype O 0 2.3238719393248175e-08
- O 0 4.081150528634225e-09
phenotype O 0 4.727952473970731e-10
analyses O 0 2.0406306852627232e-11
in O 0 8.229950575200373e-12
Cowden B-Disease 0 0.07141100615262985
disease I-Disease 0 0.0003221615043003112
and O 0 1.714776098893367e-10
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.469576570491739e-10
two O 0 1.7916050865096622e-09
hamartoma B-Disease 1 0.9999971389770508
syndromes I-Disease 1 0.8766955733299255
with O 0 1.8656530542671135e-08
germline O 1 0.9871394038200378
PTEN O 1 0.9946264624595642
mutation O 0 3.8946720337662555e-07
. O 0 6.840952693210056e-09

The O 0 2.020517285927781e-06
tumour B-Disease 1 1.0
suppressor O 0 1.9860810425598174e-05
gene O 0 1.3276681087859288e-08
PTEN O 0 8.307195571433112e-07
, O 0 1.099974972218476e-11
which O 0 4.509509356643432e-13
maps O 0 3.1471037581498607e-11
to O 0 9.797740743722194e-12
10q23 O 0 5.941735281567162e-08
. O 0 8.931019479518909e-09

3 O 0 2.0107984610717722e-08
and O 0 1.7129249407776825e-11
encodes O 0 3.805917386801028e-12
a O 0 1.7977477145825205e-11
403 O 0 1.0881411223462312e-11
amino O 0 3.531360204256373e-10
acid O 0 4.3812377337193453e-11
dual O 0 1.612174838072633e-09
specificity O 0 9.325432870355144e-09
phosphatase O 0 2.9936900318716653e-06
( O 0 7.998200990400051e-10
protein O 0 3.155617989136772e-09
tyrosine O 0 4.54365656210598e-09
phosphatase O 0 8.922047101123098e-09
; O 0 1.0697840183149232e-12
PTPase O 0 1.1575924663276282e-09
) O 0 4.57999727010959e-14
, O 0 3.028371824143061e-14
was O 0 1.3293277069392762e-12
shown O 0 1.10254329537679e-12
recently O 0 3.5167439706856873e-12
to O 0 2.984005458093325e-13
play O 0 2.961148340419051e-11
a O 0 7.0747162468631775e-12
broad O 0 1.0186605725603926e-10
role O 0 3.293570928139533e-12
in O 0 2.258845367697493e-11
human O 0 3.3600351390106198e-09
malignancy B-Disease 0 9.729106750455685e-06
. O 0 1.2109786950986745e-08

Somatic O 0 3.4754198168229777e-06
PTEN O 0 4.055169483763166e-06
deletions O 0 6.838614674542498e-10
and O 0 8.214410054940835e-12
mutations O 0 1.2030750744587704e-12
were O 0 3.4671766326044295e-13
observed O 0 2.305693613466331e-13
in O 0 8.810736970739363e-13
sporadic B-Disease 0 0.01047954335808754
breast I-Disease 1 0.9997890591621399
, I-Disease 0 6.357621540331593e-09
brain I-Disease 1 1.0
, I-Disease 0 2.205175860581221e-06
prostate I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999951124191284
cell O 0 0.18146702647209167
lines O 0 5.570876052130025e-11
and O 0 2.664406781142936e-13
in O 0 2.175979231869296e-12
several O 0 3.6675239234451595e-11
primary O 0 6.547951215907233e-06
tumours B-Disease 1 1.0
such O 0 9.087082475378594e-11
as O 0 7.153572734175384e-10
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 5.693012099072803e-06
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999984502792358
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 2.6167376745434012e-06

In O 0 1.7836538912519018e-09
addition O 0 3.797842873520807e-10
, O 0 1.2112869041125407e-10
PTEN O 0 9.226216093338735e-07
was O 0 1.486108902604144e-09
identified O 0 9.309406544255605e-12
as O 0 8.510212391558969e-13
the O 0 2.288786131107723e-12
susceptibility O 0 5.674502881469756e-11
gene O 0 1.376289165098965e-12
for O 0 7.424282542911609e-13
two O 0 1.7193675649895823e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9999983310699463
( O 0 1.4660368405361446e-11
CD B-Disease 0 0.0005750894779339433
; O 0 2.0113793963716375e-10
MIM O 0 5.970720849290956e-06
158350 O 0 3.401135373337638e-08
) O 0 5.285441138577762e-13
and O 0 3.846625275250037e-12
Bannayan B-Disease 0 2.4498822881469096e-07
- I-Disease 0 9.460553940243699e-08
Zonana I-Disease 0 2.484344076947309e-05
( I-Disease 0 2.020313950856778e-11
BZS I-Disease 0 2.7669668156704574e-07
) I-Disease 0 6.324686867981155e-13
or I-Disease 0 3.7489278174873686e-12
Ruvalcaba I-Disease 0 2.1518189896596596e-07
- I-Disease 0 1.4583409324586682e-07
Riley I-Disease 0 2.504958501958754e-06
- I-Disease 0 0.15786147117614746
Smith I-Disease 0 1.4165224229145679e-06
syndrome I-Disease 1 0.9999982118606567
( O 0 7.1040251459209e-10
MIM O 0 0.000983373960480094
153480 O 0 4.907602942694211e-06
) O 0 2.9765293008132687e-10
. O 0 4.271669240552001e-09

Constitutive O 0 2.464401234192337e-07
DNA O 0 3.2462512677966515e-09
from O 0 4.3765938789741554e-11
37 O 0 9.626330843559572e-10
CD B-Disease 0 2.41652344357135e-07
families O 0 2.267728105992406e-12
and O 0 4.550449426987679e-12
seven O 0 7.151867986721072e-10
BZS B-Disease 0 6.36680761090247e-06
families O 0 5.428751198577331e-12
was O 0 1.830815915537798e-10
screened O 0 6.905702232273825e-09
for O 0 4.553527277462166e-10
germline O 0 3.298970796095091e-06
PTEN O 0 2.7973381293122657e-05
mutations O 0 2.1348000700527336e-08
. O 0 8.21191559197132e-09

PTEN O 0 4.530989463091828e-05
mutations O 0 7.512511168705771e-10
were O 0 3.612786111939492e-11
identified O 0 8.9324489645215e-13
in O 0 2.9048480201104843e-12
30 O 0 1.8884135921659606e-10
of O 0 3.506354318005833e-09
37 O 0 3.451993357828087e-09
( O 0 9.194790762112603e-12
81 O 0 1.4375071133443384e-09
% O 0 2.6217963564056923e-11
) O 0 2.1731660253872936e-13
CD B-Disease 0 1.3925842701212332e-08
families O 0 1.9092571219760796e-13
, O 0 8.581961638727542e-14
including O 0 2.065585766666822e-12
missense O 0 3.48791129312076e-09
and O 0 1.0379952453121177e-10
nonsense O 0 1.8811752156011607e-08
point O 0 3.6979426187855324e-09
mutations O 0 3.694891181210691e-12
, O 0 6.933946147293091e-13
deletions O 0 1.517144916640678e-11
, O 0 2.7157052648330016e-12
insertions O 0 8.044247212790623e-11
, O 0 2.7339382493996034e-11
a O 0 1.6923173973282246e-10
deletion O 0 5.32513588780148e-10
/ O 0 1.3419807487480284e-09
insertion O 0 3.698413242325671e-10
and O 0 1.0234401104369795e-09
splice O 0 5.659346129505138e-07
site O 0 1.0522734328333172e-07
mutations O 0 1.5152615162605798e-08
. O 0 2.0567171077345847e-08

These O 0 2.2334288585224016e-10
mutations O 0 5.900099159239502e-11
were O 0 6.871206381653394e-11
scattered O 0 2.2708210312138988e-10
over O 0 1.1807926858509177e-10
the O 0 3.858724728633689e-10
entire O 0 2.735389692531953e-10
length O 0 2.6609561776247403e-11
of O 0 2.7846531747144354e-09
PTEN O 0 7.009250566625269e-07
, O 0 1.3441971060540459e-12
with O 0 4.0864365927553714e-14
the O 0 4.2245543001306896e-12
exception O 0 3.3458836829619587e-12
of O 0 2.4564144121552722e-11
the O 0 5.782558026162787e-12
first O 0 6.9706011796011325e-12
, O 0 2.0635184099643267e-12
fourth O 0 2.065340565238216e-09
and O 0 1.1342973782468846e-10
last O 0 1.3871021664613181e-08
exons O 0 6.729632787028095e-06
. O 0 1.3480260463438754e-07

A O 0 9.119249284594844e-07
hot O 0 1.7085736772060045e-06
spot O 0 9.700470826601304e-08
for O 0 1.483426298465318e-10
PTEN O 0 4.6240444362410926e-07
mutation O 0 1.2835505228125932e-11
in O 0 2.9236021156092695e-12
CD B-Disease 0 5.004492891202972e-07
was O 0 2.8145866193263203e-10
identified O 0 4.085536596531991e-12
in O 0 7.766543484721833e-12
exon O 0 2.797979181679011e-09
5 O 0 4.317932955633097e-10
that O 0 4.5110066398436344e-13
contains O 0 7.897581894011907e-12
the O 0 6.61520074829447e-11
PTPase O 0 2.7965988635969552e-08
core O 0 7.746763230898068e-08
motif O 0 6.488441450791527e-10
, O 0 3.3422209769727595e-13
with O 0 9.380460953356887e-14
13 O 0 8.155993241887316e-11
of O 0 2.647884966844316e-10
30 O 0 1.0952964230037665e-10
( O 0 4.3820020311988173e-13
43 O 0 2.2788685868913028e-11
% O 0 5.963863517616241e-12
) O 0 2.03473644725706e-13
CD B-Disease 0 1.0164645125598781e-08
mutations O 0 1.8133056904970357e-12
identified O 0 2.365718298341646e-12
in O 0 5.55729941231764e-12
this O 0 3.857611105551051e-11
exon O 0 1.2881577049483894e-07
. O 0 6.201150259954602e-09

Seven O 0 3.544331494964581e-09
of O 0 5.403017144800515e-09
30 O 0 1.0549351392441508e-09
( O 0 3.78058001571091e-12
23 O 0 6.833177357279396e-10
% O 0 2.3776437416134222e-11
) O 0 2.542782878787314e-13
were O 0 9.89800515854844e-12
within O 0 5.972791705666225e-11
the O 0 8.957846270307712e-11
core O 0 3.374783474896503e-08
motif O 0 4.123195673777502e-10
, O 0 3.2813793457604767e-13
the O 0 3.3301703408761263e-12
majority O 0 3.0009588564139378e-12
( O 0 7.334578907766676e-14
five O 0 2.05916208563528e-12
of O 0 1.3884163263533367e-10
seven O 0 8.91682734593946e-12
) O 0 5.256564836728962e-14
of O 0 1.497197678335116e-11
which O 0 5.663763295166158e-12
were O 0 1.719161063507002e-10
missense O 0 5.426753801884843e-08
mutations O 0 1.4676070081431902e-10
, O 0 2.242126276308376e-11
possibly O 0 3.173129814459941e-11
pointing O 0 3.387412225719366e-11
to O 0 5.182618657145754e-13
the O 0 1.4355849842218049e-11
functional O 0 1.6072132513755832e-09
significance O 0 6.759419135526912e-10
of O 0 8.062177037082563e-10
this O 0 1.69776744746164e-11
region O 0 1.9362893510788126e-09
. O 0 6.1167364506786726e-09

Germline O 0 6.585830124095082e-05
PTEN O 0 2.5893050406011753e-05
mutations O 0 4.874741166283059e-10
were O 0 3.441615742394433e-11
identified O 0 1.1966442376928899e-12
in O 0 3.0499908154624222e-12
four O 0 1.7409884298102973e-11
of O 0 1.6994734508557485e-09
seven O 0 1.4217084176593175e-09
( O 0 1.1716813283491057e-11
57 O 0 1.6548762360457658e-09
% O 0 4.89266294145807e-10
) O 0 6.33109051295655e-11
BZS B-Disease 0 3.7209040328889387e-06
families O 0 1.7415829195455146e-11
studied O 0 1.2407323168872608e-08
. O 0 3.90430336949521e-08

Interestingly O 0 6.131150254162776e-09
, O 0 9.681584700604873e-11
none O 0 1.715767389276479e-10
of O 0 7.599775808664333e-10
these O 0 4.930881224163297e-12
mutations O 0 8.49455054907633e-12
was O 0 9.79623188124279e-11
observed O 0 2.1364873412088592e-11
in O 0 3.210754578875097e-11
the O 0 1.0589207288802527e-09
PTPase O 0 3.6906626519339625e-06
core O 0 4.7099565563257784e-05
motif O 0 1.4372139958140906e-06
. O 0 6.620472703389169e-08

It O 0 2.0437047887345017e-10
is O 0 9.015880923779473e-12
also O 0 1.0281852409407821e-12
worthy O 0 1.029469131469396e-11
of O 0 2.3254259629013063e-10
note O 0 3.4413794730570046e-11
that O 0 1.972638361252138e-13
a O 0 4.7465607833085954e-12
single O 0 7.727449929939567e-11
nonsense O 0 7.242264121742892e-09
point O 0 1.590319653743677e-09
mutation O 0 7.345310124029503e-12
, O 0 1.7430832168277566e-13
R233X O 0 1.7284823572438768e-10
, O 0 8.862378604417021e-13
was O 0 4.9496227429168815e-12
observed O 0 1.7796412130413608e-12
in O 0 6.419092687948158e-13
the O 0 8.288947653256606e-12
germline O 0 3.937023207445378e-10
DNA O 0 3.1220113300145513e-11
from O 0 8.001591468402569e-13
two O 0 3.828852599557786e-12
unrelated O 0 2.547971833521956e-10
CD B-Disease 0 1.2643427908187732e-05
families O 0 3.4541109555918936e-11
and O 0 1.7924996209561783e-10
one O 0 4.0554501978817825e-09
BZS B-Disease 0 0.03619435429573059
family O 0 7.497116172316964e-08
. O 0 1.7465994517351646e-07

Genotype O 0 5.41793099273491e-07
- O 0 1.4513877211186355e-08
phenotype O 0 3.725082187155948e-10
studies O 0 1.3649180743979805e-11
were O 0 5.3638365450636716e-12
not O 0 4.9649069984404257e-14
performed O 0 5.0727179401466316e-11
on O 0 2.5680548798590053e-09
this O 0 5.597831660014707e-12
small O 0 6.753977238593833e-11
group O 0 1.2955664319136417e-10
of O 0 1.2540152027895601e-08
BZS B-Disease 0 0.01985466666519642
families O 0 1.1287470957910273e-09
. O 0 1.569222618513777e-08

However O 0 3.2556641826886334e-09
, O 0 5.982984940811065e-11
genotype O 0 8.922199867811287e-09
- O 0 1.5258292407338558e-09
phenotype O 0 4.3517239811663444e-10
analysis O 0 1.697806305267502e-11
inthe O 0 3.187061281550996e-08
group O 0 3.473534307407711e-11
of O 0 1.6833944238570098e-09
CD B-Disease 1 0.9995366334915161
families O 0 5.517145334338336e-12
revealed O 0 3.153070166073135e-11
two O 0 1.8650801389408223e-12
possible O 0 6.772501309759704e-11
associations O 0 3.6280541071409544e-11
worthy O 0 5.741066511077975e-10
of O 0 3.582159457948819e-09
follow O 0 8.212564656107091e-11
- O 0 3.322647712522553e-11
up O 0 3.1943211097062996e-12
in O 0 1.5119904026722475e-12
independent O 0 4.5678866938958507e-11
analyses O 0 5.717509132807663e-09
. O 0 1.5417972676345926e-08

The O 0 1.974848506947069e-09
first O 0 6.927796114553075e-10
was O 0 1.2988528030888347e-09
an O 0 1.9779967594391046e-12
association O 0 1.6742612851672334e-10
noted O 0 3.663790451580162e-11
in O 0 3.775523296778438e-11
the O 0 3.1169020142662873e-10
group O 0 5.4506871238757526e-11
of O 0 4.985033497106883e-10
CD B-Disease 1 0.9991356730461121
families O 0 4.434590888946488e-11
with O 0 6.446242428737037e-10
breast B-Disease 1 0.999998927116394
disease I-Disease 1 0.9999998807907104
. O 0 4.822104529011995e-07

A O 0 6.036817157273333e-10
correlation O 0 2.525760850469183e-11
was O 0 1.9641628601352323e-11
observed O 0 3.470683213480791e-13
between O 0 1.0085055484948188e-13
the O 0 9.111823708746192e-13
presence O 0 8.546502806676404e-13
/ O 0 3.2747132783228494e-10
absence O 0 1.1821340573092698e-09
of O 0 3.168694195920807e-09
a O 0 2.489299322228078e-10
PTEN O 0 8.113242415674904e-07
mutation O 0 2.3338627905267195e-11
and O 0 3.2157642434332834e-13
the O 0 3.759425062921373e-12
type O 0 9.477124640611123e-10
of O 0 9.515169807627899e-08
breast O 0 9.018297714646906e-05
involvement O 0 5.153444817551645e-07
( O 0 5.125572410946688e-09
unaffected O 1 0.9999781847000122
versus O 1 0.9999872446060181
benign O 1 1.0
versus O 0 0.0004523794341366738
malignant O 0 7.269623893080279e-05
) O 0 1.2532869186898665e-10
. O 0 3.780975088574223e-09

Specifically O 0 3.147800076153118e-11
and O 0 1.8518016980939578e-12
more O 0 3.770291031961713e-15
directly O 0 2.048438560431614e-14
, O 0 7.143686819388942e-14
an O 0 1.2842716256775133e-13
association O 0 1.3181540581275186e-10
was O 0 4.729936442515736e-10
also O 0 2.477326341027847e-13
observed O 0 6.565200585863934e-14
between O 0 5.5373809921058226e-14
the O 0 3.024828922493922e-13
presence O 0 1.8525000869233643e-13
of O 0 7.1903494443248395e-12
a O 0 1.4778515911029189e-10
PTEN O 0 0.037183623760938644
mutation O 0 1.2129289927997888e-07
and O 0 1.1209723815852612e-08
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.5179183467116673e-06

Secondly O 0 1.534969307215306e-08
, O 0 1.1502804264651445e-10
there O 0 3.082150507038861e-11
appeared O 0 8.341703716663318e-11
to O 0 1.5688414922634258e-13
be O 0 2.7316942653211884e-13
an O 0 1.1410920223043491e-13
interdependent O 0 1.4114196478232088e-09
association O 0 4.3414914024930695e-11
between O 0 2.0058692554170143e-11
mutations O 0 2.0475001902275913e-11
upstream O 0 1.9786232114543667e-12
and O 0 7.26746137227896e-13
within O 0 1.5263407204813007e-10
the O 0 3.2788069481703985e-10
PTPase O 0 3.2685829864931293e-07
core O 0 5.0630287660169415e-06
motif O 0 4.5477598575871525e-08
, O 0 2.4850474109050502e-11
the O 0 1.5933550312485778e-10
core O 0 1.6924419199426666e-08
motif O 0 2.704305390732742e-10
containing O 0 6.413723285109141e-12
the O 0 1.6867996582847766e-11
majority O 0 1.0125541897998414e-11
of O 0 2.426464307259124e-10
missense O 0 1.3575620627648277e-08
mutations O 0 7.300005738786197e-11
, O 0 6.781843749775751e-12
and O 0 7.605293131374147e-12
the O 0 2.3060138520936135e-10
involvement O 0 3.124413505695145e-10
of O 0 5.170741168569748e-09
all O 0 2.4287147293300393e-10
major O 0 1.8193302864233374e-08
organ O 0 0.4441851079463959
systems O 0 0.00012232217704877257
( O 0 1.7728816192885688e-09
central O 1 0.9999449253082275
nervous O 1 0.9969059824943542
system O 1 0.9986287355422974
, O 0 6.335058255757531e-09
thyroid O 1 1.0
, O 0 2.7278539960207127e-07
breast O 1 1.0
, O 0 1.847404746513348e-06
skin O 1 1.0
and O 1 0.9825544953346252
gastrointestinal O 1 1.0
tract O 1 0.9998020529747009
) O 0 5.961091342765457e-11
. O 0 3.307444096378731e-09

However O 0 5.05545507678562e-08
, O 0 4.791717370111748e-11
these O 0 1.021531275367804e-12
observations O 0 3.2722890369596414e-11
would O 0 8.045179106241918e-12
need O 0 1.3834109639093706e-12
to O 0 3.250122881329892e-13
be O 0 5.190532790903812e-13
confirmed O 0 1.0133497773540112e-12
by O 0 1.8993994202985698e-13
studying O 0 4.9153688931602435e-12
a O 0 1.2076777295214058e-12
larger O 0 1.5296257641593536e-13
number O 0 2.6811395985315567e-12
of O 0 6.358225057567779e-10
CD B-Disease 0 7.161610847106203e-05
families O 0 2.317009500929501e-10
. O 0 3.718084951032097e-09

Molecular O 0 6.421027501346543e-05
defects O 1 0.9994484782218933
leading O 0 5.236781008832736e-10
to O 0 1.7695781905774366e-12
human O 0 2.012223720981865e-10
complement B-Disease 0 1.7372791205616522e-08
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.2501480961546463e-09
an O 0 8.405003581145321e-13
African O 0 1.5417839227538366e-10
- O 0 5.544745218521996e-11
American O 0 5.326880603284678e-11
family O 0 1.4650872182109254e-10
. O 0 2.1353243617738826e-09

Complement B-Disease 0 1.873069948032935e-07
component I-Disease 1 0.9999967813491821
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 4.770253636543487e-10
C6D B-Disease 0 7.903268851805478e-06
) O 0 1.403535707794612e-12
was O 0 3.4444461172178364e-11
diagnosed O 0 9.439884290918243e-11
in O 0 6.2601924512295515e-12
a O 0 9.283341456667316e-12
16 O 0 2.0218761387358342e-10
- O 0 3.1184208861001483e-12
year O 0 1.4342814045817387e-12
- O 0 6.2070812899273076e-12
old O 0 7.662782214312713e-11
African O 0 3.542448973048451e-11
- O 0 8.8348512533587e-13
American O 0 3.703511293213363e-13
male O 0 5.154817545038881e-13
with O 0 2.985623900886303e-12
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.4657147495711342e-08

The O 0 6.128638574409706e-08
patients O 0 5.333145591812638e-10
father O 0 1.2591117037885624e-10
and O 0 3.7221134507881004e-10
two O 0 5.628177368599552e-10
brothers O 0 4.809158227203625e-08
also O 0 8.868174528053885e-10
had O 0 1.4616937660250073e-09
C6D B-Disease 0 4.6462118916679174e-05
, O 0 3.1317150261944704e-11
but O 0 2.1951464083957983e-12
gave O 0 2.5068032719066657e-11
no O 0 5.362680351866933e-12
history O 0 7.134815308007525e-12
of O 0 3.106629398175187e-09
meningitis B-Disease 1 1.0
or O 0 1.1311861863871897e-10
other O 0 2.9305825127723395e-11
neisserial B-Disease 0 0.0010441142367199063
infection I-Disease 1 0.998302698135376
. O 0 1.6941123703873018e-07

By O 0 1.0448082676806081e-10
using O 0 2.939572890658937e-11
exon O 0 2.281371536128063e-09
- O 0 2.170566677783814e-11
specific O 0 1.7348560088503717e-11
polymerase O 0 4.5486461819344015e-11
chain O 0 2.126476106312225e-09
reaction O 0 1.7060450274719585e-11
( O 0 2.843027191706121e-13
PCR O 0 1.9644176910138533e-11
) O 0 5.2374096948465745e-14
/ O 0 7.4808744268684e-12
single O 0 1.460956529364399e-11
- O 0 5.615272569842178e-12
strand O 0 1.7148929845611782e-11
conformation O 0 1.1461881790908457e-12
polymorphism O 0 1.2293662182000231e-12
as O 0 6.01701034916996e-14
a O 0 4.8050085232290846e-14
screening O 0 1.251782965477899e-12
step O 0 4.3360581509881146e-13
and O 0 1.0384089455548005e-14
nucleotide O 0 7.519867974842276e-13
sequencing O 0 4.3279938552291675e-13
of O 0 1.1069314215239601e-10
target O 0 1.1365979268873616e-09
exons O 0 8.469261736365752e-09
, O 0 5.801404929367537e-12
we O 0 2.3191030259356316e-12
determined O 0 3.143094942301139e-12
that O 0 1.2707579942743824e-13
the O 0 7.113074886044846e-12
proband O 0 2.205044813408108e-09
was O 0 8.966226650031217e-10
a O 0 2.1565771737841466e-11
compound O 0 1.5396740826734145e-10
heterozygote O 0 7.222561437814079e-10
for O 0 1.665040848253252e-11
two O 0 3.904016276923272e-10
C6 O 0 2.7153457267559133e-05
gene O 0 8.939063711466133e-09
mutations O 0 5.689573256972835e-09
. O 0 5.951940718063042e-09

The O 0 1.1571207103600045e-08
first O 0 7.038530314140701e-10
, O 0 7.44107206407385e-12
1195delC O 0 4.1309730636207576e-10
located O 0 1.731802062865384e-10
in O 0 1.8762489825685513e-11
exon O 0 4.242802109644117e-09
7 O 0 5.478062448105447e-09
, O 0 1.358979010053496e-12
is O 0 1.2988602435346636e-13
a O 0 1.5030931685942883e-13
novel O 0 2.7213038138011736e-13
mutation O 0 1.799907472415166e-13
, O 0 2.3236343133902632e-14
while O 0 1.3958754670802959e-13
the O 0 1.7643880063575312e-12
second O 0 1.689530113035964e-11
, O 0 3.8742053727440495e-13
1936delG O 0 4.7889765070197043e-11
in O 0 1.4900726486022364e-11
exon O 0 4.0647742949317944e-09
12 O 0 2.1404651662226826e-10
, O 0 2.5419692392669724e-12
has O 0 1.297815804476854e-12
been O 0 7.006654371283227e-13
described O 0 4.703500609826161e-12
before O 0 3.5973474633160807e-12
to O 0 2.5653387834140284e-12
cause O 0 1.1804149879779402e-09
C6D B-Disease 0 2.1409425698948326e-06
in O 0 1.9033687820302347e-11
an O 0 5.347173441874742e-13
unrelated O 0 8.786031346907919e-10
African O 0 5.531670677072498e-10
- O 0 1.8736391604878833e-10
American O 0 2.0580373516487782e-10
individual O 0 3.0429339603621486e-10
. O 0 2.00075209733086e-08

Both O 0 1.0465160960038133e-09
mutations O 0 5.785874002128821e-10
result O 0 1.2504909607802261e-10
in O 0 6.868585561425888e-11
premature O 0 3.725666442022657e-09
termination O 0 3.387357283557435e-09
codons O 0 4.187250102205553e-09
and O 0 1.345568989563617e-09
C6 O 0 2.4510589355486445e-05
null O 0 1.5883810533523501e-07
alleles O 0 4.055587810025685e-10
. O 0 1.620269918234385e-09

Allele O 0 3.1722620086327424e-09
- O 0 1.3425126288435507e-10
specific O 0 1.773018364070733e-11
PCR O 0 1.9186054134312513e-10
indicated O 0 1.1214838953332862e-11
that O 0 4.4628478701198154e-14
the O 0 2.812415881778274e-12
probands O 0 1.1295660407029118e-08
two O 0 1.3310720581305446e-10
brothers O 0 1.2931180570774359e-09
also O 0 1.8608737814562737e-11
inherited O 0 5.821559206919957e-11
the O 0 4.756350868717618e-11
1195delC O 0 1.5977443812431602e-09
mutation O 0 7.612607592910603e-12
from O 0 6.857922433059493e-13
their O 0 4.8514916042852185e-12
heterozygous O 0 7.562479809042344e-11
mother O 0 6.477195516052525e-12
and O 0 2.3028820603926414e-12
the O 0 1.0049126808464592e-10
1936delG O 0 4.565060773842333e-09
mutation O 0 4.235068892799454e-11
from O 0 2.2166756277752775e-12
their O 0 6.805128942993788e-12
homozygous O 0 3.037218254675622e-09
father O 0 1.028449658768693e-09
. O 0 8.362879833079262e-10
. O 0 6.555757270376716e-09

PAX6 O 0 0.003132934682071209
mutations O 0 2.438811748106673e-07
reviewed O 0 5.5667630505240595e-08
. O 0 3.8256626311294895e-08

Mutations O 0 8.489445590953437e-09
in O 0 2.390058817525187e-09
PAX6 O 0 0.00010905516683124006
are O 0 1.4436880510504402e-11
responsible O 0 3.427995387550453e-11
for O 0 9.785190019373502e-12
human O 0 4.572223488708005e-09
aniridia B-Disease 1 1.0
and O 0 2.0180206394826428e-09
have O 0 7.062649076683414e-12
also O 0 6.740148803668911e-13
been O 0 2.397880613687342e-13
found O 0 8.766160133942894e-14
in O 0 3.261288266352691e-13
patients O 0 4.163930214084316e-13
with O 0 3.180761589446218e-13
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.1878767414152946e-10
with O 0 2.2863611093271174e-07
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 3.1200975136869147e-09
with O 0 6.854677381262775e-10
autosomal B-Disease 1 0.9998958110809326
dominant I-Disease 1 0.9434601664543152
keratitis I-Disease 1 1.0
, O 0 1.8568045712097359e-10
and O 0 4.311404705470423e-11
with O 0 6.57850052210307e-10
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.0016520071076229215

No O 0 3.669963000163534e-09
locus O 0 1.2900976953389431e-09
other O 0 4.4782693178757604e-12
than O 0 5.372567625158697e-13
chromosome O 0 4.393878594299849e-09
11p13 O 0 1.207444597639551e-07
has O 0 6.303897404080772e-10
been O 0 1.4844055151730373e-10
implicated O 0 1.483669714863467e-10
in O 0 5.586424101089449e-10
aniridia B-Disease 1 1.0
, O 0 1.8457181338860096e-09
and O 0 6.009383546334846e-10
PAX6 O 0 0.00014623593597207218
is O 0 1.2324664899754367e-10
clearly O 0 2.5074584769635422e-11
the O 0 1.4923763613783336e-11
major O 0 1.1866861937548379e-09
, O 0 6.791565573815994e-12
if O 0 2.771027331205378e-12
not O 0 8.690417634647785e-13
only O 0 2.4427424059197955e-12
, O 0 4.733740743140258e-12
gene O 0 1.158475468332476e-10
responsible O 0 6.06766548116866e-09
. O 0 5.950419712519306e-09

Twenty O 0 8.811750262793794e-08
- O 0 1.399197091522808e-09
eight O 0 2.2051697967651052e-10
percent O 0 5.7771704087272724e-11
of O 0 9.13257747203744e-10
identified O 0 8.987993460607413e-09
PAX6 O 0 0.000673378468491137
mutations O 0 4.011063481357269e-09
are O 0 8.869439210856811e-11
C O 0 7.674605876673013e-05
- O 0 0.0001292630040552467
T O 0 8.680662517690507e-07
changes O 0 7.232018317537836e-10
at O 0 6.983489897471884e-10
CpG O 0 6.506219563107152e-08
dinucleotides O 0 3.107038404337459e-09
, O 0 1.0912248752173448e-12
20 O 0 7.551521907789294e-12
% O 0 1.255575396257036e-12
are O 0 9.630939437881708e-14
splicing O 0 2.644478247493254e-10
errors O 0 5.788319157318256e-08
, O 0 6.231577320131576e-12
and O 0 1.2337822820687738e-12
more O 0 9.607450875441167e-15
than O 0 4.268945765460719e-14
30 O 0 1.1573131342146326e-11
% O 0 6.378697917086562e-12
are O 0 3.255384243422421e-13
deletion O 0 1.1766688318148866e-11
or O 0 1.4977194831566898e-12
insertion O 0 4.214881915709512e-11
events O 0 1.227727808306156e-09
. O 0 3.391095404481348e-08

There O 0 9.095810216130928e-10
is O 0 1.0408416316332048e-11
a O 0 2.0607937231686968e-11
noticeably O 0 1.2975051588703934e-10
elevated O 0 1.7767499971288458e-10
level O 0 3.90315280096587e-10
of O 0 6.023621879069907e-11
mutation O 0 2.9427690752953373e-12
in O 0 4.346377424635506e-12
the O 0 7.83450734842539e-12
paired O 0 2.6466706430638975e-12
domain O 0 1.3432001821564454e-12
compared O 0 2.35908433629875e-13
with O 0 4.847638675024857e-14
the O 0 9.125676603272126e-11
rest O 0 1.162490659289972e-10
of O 0 6.169035837721992e-10
the O 0 5.083035103936595e-10
gene O 0 1.2393078785422063e-09
. O 0 2.952826649860185e-09

Increased O 0 2.3851484676207235e-10
mutation O 0 4.3359468793191525e-11
in O 0 5.823422039724635e-12
the O 0 5.920368362222206e-11
homeodomain O 0 6.03150374089978e-09
is O 0 6.74745524210929e-13
accounted O 0 1.0538360982470518e-11
for O 0 7.123973719963539e-13
by O 0 4.976137123885449e-12
the O 0 3.5091760053340693e-10
hypermutable O 0 1.583802315963112e-07
CpG O 0 6.094599484640639e-06
dinucleotide O 0 7.4519641657389e-07
in O 0 1.0680288653475145e-08
codon O 0 1.5225295157961227e-07
240 O 0 1.2180207953349509e-08
. O 0 1.028273644010369e-08

Very O 0 7.781943422990878e-10
nearly O 0 6.408554242831599e-11
all O 0 1.321667861958753e-11
mutations O 0 1.2787537521929959e-11
appear O 0 2.4812478460756182e-12
to O 0 4.088161829462339e-13
cause O 0 6.77632949752649e-10
loss O 0 3.0680653573256222e-09
of O 0 9.377980170199862e-09
function O 0 2.380577512894888e-09
of O 0 4.017538801637244e-10
the O 0 5.067154595223e-12
mutant O 0 1.6740910740997705e-11
allele O 0 1.9064551369865623e-13
, O 0 2.3645248289189645e-14
and O 0 1.4658780984303128e-14
more O 0 9.140740168427021e-16
than O 0 1.2407664719065684e-14
80 O 0 4.325339131999728e-12
% O 0 2.9189608629492936e-12
of O 0 2.9270644241741195e-10
exonic O 0 4.005805109841276e-08
substitutions O 0 9.128083844345269e-10
result O 0 5.278961157095807e-10
in O 0 1.7037013466669748e-10
nonsense O 0 4.935313668852359e-08
codons O 0 8.052394662172446e-08
. O 0 8.345690361011293e-09

In O 0 3.3818376987682086e-09
a O 0 9.616710205939683e-11
gene O 0 5.348696312246215e-12
with O 0 1.2982707086033746e-13
such O 0 4.9850693017994274e-11
extraordinarily O 0 2.517451247463498e-10
high O 0 9.509646403671468e-10
sequence O 0 2.3478599273096812e-11
conservation O 0 2.497487459895975e-11
throughout O 0 7.371439613226838e-13
evolution O 0 5.208604814815887e-12
, O 0 3.2631051181432336e-13
there O 0 3.6022703917004684e-12
are O 0 1.3377977111511674e-12
presumed O 0 4.2920618170683156e-09
undiscovered O 0 1.70666180565604e-06
missense O 0 1.3245754644231056e-06
mutations O 0 2.157447553940983e-09
, O 0 6.677965819212872e-11
these O 0 1.6087757861993346e-11
are O 0 1.4112157623036303e-12
hypothesized O 0 9.74268734264816e-13
to O 0 6.206661026060198e-14
exist O 0 1.3498501795494722e-11
in O 0 3.491614983253122e-11
as O 0 1.535614968517507e-10
- O 0 2.6490062920991875e-10
yet O 0 5.765160918103085e-11
unidentified O 0 5.379661160986871e-10
phenotypes O 0 5.844080219752357e-10
. O 0 6.787632261806564e-11
. O 0 1.921961478856815e-09

Genetic O 0 1.2677254801474191e-08
heterogeneity O 0 1.3684392285995273e-08
and O 0 5.0375922183709676e-11
penetrance O 0 4.2265373423333585e-08
analysis O 0 3.5658229841084577e-11
of O 0 4.715544399402916e-09
the O 0 2.745919047697498e-09
BRCA1 O 0 2.867923010185791e-09
and O 0 1.248329356551281e-10
BRCA2 O 0 1.0706640019009228e-08
genes O 0 2.2502504026800096e-10
in O 0 3.4282408023500466e-09
breast B-Disease 1 0.9974911212921143
cancer I-Disease 0 0.08731663972139359
families O 0 4.369266726200749e-09
. O 0 1.2719478945655283e-06

The O 0 8.649460505694151e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.004415734205394983
Consortium O 0 1.5509752415709954e-07
. O 0 2.9941613632900044e-08

The O 0 9.500666225958909e-11
contribution O 0 4.544241372084201e-11
of O 0 5.050756479718643e-10
BRCA1 O 0 9.415792590061756e-10
and O 0 3.965160838559356e-11
BRCA2 O 0 1.825601181337788e-08
to O 0 1.2358662981881707e-09
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 2.160728399758227e-06
assessed O 0 2.632534641666684e-11
by O 0 3.896390859698534e-14
linkage O 0 4.55842863456013e-10
and O 0 8.142058533465446e-13
mutation O 0 1.2631513673574957e-12
analysis O 0 2.80129872342336e-14
in O 0 1.473773360294306e-13
237 O 0 1.5789770749577436e-12
families O 0 2.3239800722393324e-14
, O 0 3.300736623585397e-14
each O 0 3.1582457765829634e-15
with O 0 8.640927329130882e-14
at O 0 5.817855086576174e-10
least O 0 8.049661631703842e-12
four O 0 4.552715409528174e-12
cases O 0 8.730960399105925e-12
of O 0 4.269366229436855e-07
breast B-Disease 0 0.012697828002274036
cancer I-Disease 0 1.1884426953656657e-07
, O 0 1.269000204397186e-12
collected O 0 8.544074735911122e-13
by O 0 9.360131593416643e-12
the O 0 1.595630692463601e-06
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.001930316910147667
Consortium O 0 4.650306362208312e-09
. O 0 3.671951409600638e-09

Families O 0 4.3152981188399053e-10
were O 0 9.28834023583569e-11
included O 0 1.869204964422e-11
without O 0 2.6028772887043417e-11
regard O 0 9.63780444340756e-12
to O 0 5.64276341039234e-14
the O 0 1.1980647593792804e-12
occurrence O 0 1.1442420344565107e-08
of O 0 1.9905788576579653e-05
ovarian B-Disease 1 1.0
or I-Disease 0 1.7228710476047127e-06
other I-Disease 0 9.731842283144942e-07
cancers I-Disease 1 1.0
. O 0 8.827932106214575e-06

Overall O 0 2.7729581120183866e-07
, O 0 2.060288828431567e-09
disease O 0 0.00018498428107704967
was O 0 6.709008459893084e-09
linked O 0 1.38263478444145e-09
to O 0 7.1730759353128004e-12
BRCA1 O 0 3.3572259555691986e-11
in O 0 1.4454720244101021e-13
an O 0 2.8689647550960698e-15
estimated O 0 1.2515483712328274e-13
52 O 0 4.40530945056139e-12
% O 0 1.6636876338377293e-12
of O 0 1.1474492189744723e-10
families O 0 3.070271901300936e-13
, O 0 2.382480606029358e-13
to O 0 5.889681646033262e-13
BRCA2 O 0 5.263252073756108e-12
in O 0 1.6945371158778172e-13
32 O 0 7.571655975813218e-12
% O 0 1.2276884153381018e-12
of O 0 5.398726257710429e-11
families O 0 1.4090094921977853e-13
, O 0 1.9078083568230958e-13
and O 0 3.0245979874311824e-13
to O 0 1.8660753823250553e-13
neither O 0 1.496375419407503e-11
gene O 0 2.668577435849945e-13
in O 0 2.351909357371784e-13
16 O 0 1.3836280211843022e-11
% O 0 4.953407475860594e-13
( O 0 1.4988497029351337e-14
95 O 0 5.1473360296316883e-11
% O 0 9.035851060434918e-12
confidence O 0 1.4593036778975943e-09
interval O 0 2.813686394986803e-09
[ O 0 6.520611828264578e-10
CI O 0 8.674108471495856e-07
] O 0 4.2169004399461585e-11
6 O 0 9.664997968616973e-11
% O 0 2.6656994753931906e-12
- O 0 1.835177409342803e-12
28 O 0 1.4173316166543604e-11
% O 0 2.289812220043763e-12
) O 0 4.453893715427801e-14
, O 0 1.5783679701772413e-13
suggesting O 0 7.686111296034692e-12
other O 0 5.516408510541915e-12
predisposition O 0 3.90887633372472e-09
genes O 0 4.827404587182116e-10
. O 0 2.2315009839957156e-09

The O 0 1.4825048966216059e-09
majority O 0 4.6926601493524345e-11
( O 0 5.377919247082086e-13
81 O 0 5.1705584258598947e-11
% O 0 1.6644271681395817e-12
) O 0 1.2999971142158093e-14
of O 0 2.0313532106408516e-11
the O 0 2.237077751487959e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.4332308390384583e-10
were O 0 5.955497379972474e-12
due O 0 1.4820357163713993e-09
to O 0 1.4518720427292298e-12
BRCA1 O 0 1.713722393159589e-11
, O 0 2.795630209533745e-14
with O 0 2.739801590353856e-14
most O 0 1.0744873957593826e-12
others O 0 8.207013627720139e-13
( O 0 3.086523007664321e-14
14 O 0 4.645177992257388e-11
% O 0 5.99854410934797e-12
) O 0 2.3973683281608427e-13
due O 0 3.0787694615952432e-09
to O 0 4.0703893033899874e-10
BRCA2 O 0 1.8614374042158488e-08
. O 0 2.917634578381012e-09

Conversely O 0 2.753996364290856e-09
, O 0 8.72373614319022e-12
the O 0 5.957769434045135e-12
majority O 0 2.677746045731677e-12
of O 0 4.834810676812573e-11
families O 0 1.0429948327532121e-13
with O 0 5.414354403189547e-13
male B-Disease 0 1.656934589533421e-10
and I-Disease 0 3.9569053589261216e-10
female I-Disease 0 1.812531280620533e-08
breast I-Disease 1 0.998060405254364
cancer I-Disease 1 0.9999903440475464
were O 0 1.5381953062387765e-06
due O 1 0.9989705085754395
to O 0 6.035505428769739e-10
BRCA2 O 0 2.8063329438055007e-09
( O 0 9.641237461166519e-13
76 O 0 3.390725034080333e-09
% O 0 1.3143131027959498e-10
) O 0 5.5713302894722094e-12
. O 0 6.11532158245609e-10

The O 0 6.715098477272363e-10
largest O 0 2.16356182969335e-10
proportion O 0 4.189099414575459e-11
( O 0 1.7118397628232418e-12
67 O 0 1.8959647185567974e-09
% O 0 2.2341094252364968e-11
) O 0 1.7099624667615831e-13
of O 0 1.0030934416427328e-10
families O 0 4.864257325924715e-13
due O 0 1.0118641480261203e-09
to O 0 1.9754330549820454e-12
other O 0 1.4919145563049852e-12
genes O 0 1.563620435386659e-12
was O 0 1.057763460154959e-10
found O 0 4.680792971105407e-13
in O 0 4.1611909772955313e-13
families O 0 5.269250086850337e-15
with O 0 3.585978695518251e-14
four O 0 7.1510822437226285e-12
or O 0 7.743199527746047e-13
five O 0 1.7856458499332373e-12
cases O 0 1.5711600857143404e-12
of O 0 2.0625822827469165e-08
female O 0 2.4464915426847256e-08
breast B-Disease 0 0.00014587857003789395
cancer I-Disease 0 0.0002162345772376284
only O 0 1.2033672192046652e-07
. O 0 3.3364563023496885e-07

These O 0 7.876794355654582e-11
estimates O 0 1.3991323377648968e-10
were O 0 1.0441901683588828e-11
not O 0 2.814163832520755e-13
substantially O 0 2.0329374034872005e-12
affected O 0 5.506902442733996e-13
either O 0 1.9422182232723545e-13
by O 0 6.17685359783314e-14
changing O 0 1.832561012660161e-12
the O 0 2.556605318074223e-12
assumed O 0 2.0289525268224473e-11
penetrance O 0 1.7549998121424437e-09
model O 0 1.9619228117107035e-12
for O 0 2.6813544874021433e-12
BRCA1 O 0 6.573677800020272e-12
or O 0 2.8140872268610055e-14
by O 0 5.3245158526367756e-14
including O 0 3.727892994298543e-12
or O 0 4.409523787773928e-11
excluding O 0 9.743524209682164e-09
BRCA1 O 0 7.05594116467978e-09
mutation O 0 3.9421776953929566e-10
data O 0 9.124394018122928e-10
. O 0 4.206012427232508e-09

Among O 0 2.035170504344208e-10
those O 0 1.3179875593682944e-11
families O 0 8.727243645638427e-13
with O 0 9.547984798630171e-12
disease O 0 0.14323416352272034
due O 0 1.0888291399169248e-05
to O 0 7.633504939263958e-11
BRCA1 O 0 2.620452743684609e-10
that O 0 4.1788957277216765e-13
were O 0 1.6006212197675063e-12
tested O 0 5.600915239413473e-13
by O 0 4.152467554378349e-14
one O 0 3.3322717957369463e-13
of O 0 5.6779025925379756e-11
the O 0 2.853972266847471e-11
standard O 0 6.910320232700329e-11
screening O 0 2.59660955931329e-11
methods O 0 1.1259077004055484e-11
, O 0 1.8048784038507404e-13
mutations O 0 1.5538265119019457e-13
were O 0 4.730471114648693e-13
detected O 0 1.0919328592359778e-12
in O 0 1.2688259731080676e-12
the O 0 1.058703645584469e-11
coding O 0 6.578797923095792e-11
sequence O 0 1.2168183127769794e-11
or O 0 1.8300181248848135e-12
splice O 0 6.365235422078896e-11
sites O 0 1.6943633995847307e-12
in O 0 8.021513141220904e-14
an O 0 5.45760522684775e-15
estimated O 0 4.881805680187479e-13
63 O 0 1.1361762225492456e-11
% O 0 1.37837506165861e-12
( O 0 3.504486672102451e-14
95 O 0 1.8444433480535594e-10
% O 0 4.826776478505934e-11
CI O 0 2.761739210654923e-07
51 O 0 1.7322944467768053e-10
% O 0 2.168638359167918e-11
- O 0 1.5866157346278165e-11
77 O 0 4.2239843567326574e-11
% O 0 1.0517578127866578e-11
) O 0 1.0701677174637658e-12
. O 0 1.0044987064361521e-10

The O 0 4.863877300920194e-09
estimated O 0 5.476468931120415e-11
sensitivity O 0 6.730983825864456e-11
was O 0 1.8319126771082495e-10
identical O 0 2.8202639876240276e-12
for O 0 1.9776865420925022e-13
direct O 0 3.69041169151485e-12
sequencing O 0 1.166790709189458e-11
and O 0 4.5694446490496254e-12
other O 0 1.0970060797255154e-11
techniques O 0 3.1940903255645026e-08
. O 0 3.2731865218238454e-08

The O 0 6.063061164240935e-09
penetrance O 0 3.871604349114932e-06
of O 0 3.305781319795642e-07
BRCA2 O 0 3.1034135261620577e-09
was O 0 6.773819699601447e-11
estimated O 0 4.2057712022237903e-13
by O 0 9.260959512279177e-14
maximizing O 0 1.4643161683203232e-10
the O 0 1.0024545776810001e-10
LOD O 0 2.654573563631857e-06
score O 0 3.0343345613914607e-09
in O 0 2.527439368904538e-10
BRCA2 O 0 3.9342253899121715e-09
- O 0 6.321379530938032e-10
mutation O 0 1.1340009486993097e-10
families O 0 1.9314461325876248e-13
, O 0 1.501648875775266e-13
over O 0 6.0933914164396086e-12
all O 0 3.250151189848616e-11
possible O 0 1.7181260858478709e-09
penetrance O 0 5.059737304691225e-06
functions O 0 8.150686880981084e-08
. O 0 2.423349521052387e-08

The O 0 5.283652682042117e-11
estimated O 0 5.686450442465851e-12
cumulative O 0 3.282475402599516e-09
risk O 0 2.385272646066028e-09
of O 0 2.8993172307423265e-09
breast B-Disease 0 2.81501996823863e-07
cancer I-Disease 0 9.823991398150156e-09
reached O 0 2.500845974751087e-09
28 O 0 4.204921744133117e-09
% O 0 2.8822532468358864e-12
( O 0 2.2055438597960893e-14
95 O 0 9.210241597168434e-11
% O 0 1.0948740178373662e-11
CI O 0 1.3442542012853664e-07
9 O 0 3.016490945917383e-10
% O 0 1.0636841884723025e-12
- O 0 1.52917649788413e-13
44 O 0 1.1150923798696963e-13
% O 0 4.9867641754245545e-14
) O 0 5.167899881558951e-17
by O 0 1.034703366992976e-15
age O 0 1.6731987973958584e-13
50 O 0 1.5299701338743893e-13
years O 0 2.9198211638206337e-14
and O 0 2.3435656762655147e-14
84 O 0 7.03740928378882e-12
% O 0 4.62692221776112e-13
( O 0 1.2839084857123664e-14
95 O 0 2.990150488324517e-11
% O 0 6.675542497253106e-12
CI O 0 3.6403285719188716e-08
43 O 0 1.91564993035076e-11
% O 0 1.8659980245000485e-12
- O 0 2.542617809006553e-13
95 O 0 3.392524759379678e-12
% O 0 1.3535150105749294e-13
) O 0 3.675708474335101e-16
by O 0 1.5169919628191947e-14
age O 0 1.6753655754375707e-11
70 O 0 2.4700971823499174e-10
years O 0 1.2739537202932638e-10
. O 0 8.544722707171104e-10

The O 0 7.386556255539745e-09
corresponding O 1 0.9998276233673096
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9998078942298889
were O 0 1.473271193930259e-08
0 O 0 1.3442222268622572e-07
. O 0 1.940618998830246e-09

4 O 0 1.701634566586563e-08
% O 0 4.0454185140648136e-11
( O 0 4.30303714752181e-13
95 O 0 1.880326727654591e-10
% O 0 5.726693078078604e-11
CI O 0 7.116955771380162e-07
0 O 0 3.0172273013384654e-10
% O 0 1.7343786996859567e-12
- O 0 2.351276996454682e-13
1 O 0 6.092725607885485e-13
% O 0 9.849438871109301e-15
) O 0 9.493441048069017e-18
by O 0 1.9426525944732007e-16
age O 0 6.844982344605607e-14
50 O 0 3.5158416569801634e-14
years O 0 3.4443538126494424e-15
and O 0 8.743179113644348e-15
27 O 0 3.1788952980366103e-12
% O 0 2.0854853759709469e-13
( O 0 4.088805066282484e-15
95 O 0 1.2009068219021035e-11
% O 0 4.638677029294991e-12
CI O 0 2.747942673408943e-08
0 O 0 6.202232477603431e-11
% O 0 1.0669231340423857e-12
- O 0 1.8807041156625875e-13
47 O 0 6.406519195353844e-13
% O 0 1.2854038037961313e-13
) O 0 6.7675513147763e-16
by O 0 1.8493431273663118e-14
age O 0 1.6946553535457376e-11
70 O 0 3.2043320774555184e-10
years O 0 2.3159799078520393e-10
. O 0 1.2129152127116072e-09

The O 0 5.173362294108586e-10
lifetime O 0 6.358348958457327e-09
risk O 0 9.258037181325562e-08
of O 0 1.030264229484601e-06
breast B-Disease 1 0.9987831711769104
cancer I-Disease 0 1.839046490204055e-05
appears O 0 9.010899665318206e-11
similar O 0 1.2494787106007155e-12
to O 0 1.344320163000623e-12
the O 0 1.9067063483646507e-09
risk O 0 7.152293868273318e-09
in O 0 1.9786733015947355e-11
BRCA1 O 0 1.5133182901250208e-11
carriers O 0 3.014402895590122e-14
, O 0 2.0540293166966712e-14
but O 0 2.3857258941821502e-14
there O 0 2.473940919744261e-13
was O 0 8.9062889008229e-12
some O 0 5.004420068990302e-14
suggestion O 0 8.147841776273701e-12
of O 0 4.2075166267752095e-11
a O 0 1.157967402520832e-10
lower O 0 1.866655940929718e-09
risk O 0 1.0114622334134182e-10
in O 0 1.3903474725684983e-11
BRCA2 O 0 1.2397494142390997e-10
carriers O 0 2.0697623302756707e-12
< O 0 4.218817239998174e-10
50 O 0 1.9770095283089262e-11
years O 0 1.1596067855945691e-11
of O 0 9.456629923576543e-10
age O 0 1.4348316312862153e-08
. O 0 6.887050041370912e-09

Eye B-Disease 0 0.34828802943229675
movement I-Disease 0 1.2430828974174801e-05
abnormalities I-Disease 0 4.08062624046579e-06
correlate O 0 2.399740475778067e-11
with O 0 8.293434840787872e-13
genotype O 0 8.634128079165748e-09
in O 0 4.969218370121098e-10
autosomal O 0 0.0816182792186737
dominant O 1 0.9996402263641357
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.9999959468841553
. O 0 1.936992788387215e-07

We O 0 5.251607593237395e-09
compared O 0 7.810195823410027e-10
horizontal O 0 2.7603295649214488e-08
eye O 0 3.8131079804770707e-07
movements O 0 4.0972505388481295e-08
( O 0 1.644874514372674e-10
visually O 0 2.788473341119868e-10
guided O 0 6.455691536899621e-10
saccades O 0 2.0334442751845927e-07
, O 0 1.5132490746583294e-11
antisaccades O 0 1.1691448698059048e-08
, O 0 3.5790125203771783e-12
and O 0 7.41618680528966e-13
smooth O 0 6.50228898502192e-11
pursuit O 0 6.724336365504513e-11
) O 0 2.8088264746321985e-14
in O 0 4.0113610133216127e-13
control O 0 1.9076183688238046e-10
subjects O 0 1.2262989235178878e-11
( O 0 2.729444274762738e-13
n O 0 1.8279965041667623e-10
= O 0 3.218389443837566e-10
14 O 0 1.6403378655382994e-10
) O 0 9.05164208560641e-14
and O 0 4.821489887028851e-13
patients O 0 1.467204585907031e-13
with O 0 1.4848160610650245e-14
three O 0 3.209379376839516e-13
forms O 0 7.286397180061854e-12
of O 0 6.674327202027541e-10
autosomal O 0 3.1426629902853165e-06
dominant O 0 9.057433999259956e-06
cerebellar B-Disease 1 0.9999852180480957
ataxias I-Disease 0 0.4369744658470154
type I-Disease 0 0.021760689094662666
I I-Disease 0 2.466850128257647e-05
spinocerebellar B-Disease 1 0.998516857624054
ataxias I-Disease 0 7.299191111087566e-06
1 I-Disease 0 3.3400888810319884e-07
and I-Disease 0 2.7276254171981762e-11
2 I-Disease 0 1.0343079726027327e-09
( O 0 4.123031939733818e-13
SCA1 B-Disease 0 3.147418992099915e-09
, O 0 1.112382430092096e-12
n O 0 3.201434950472759e-11
= O 0 3.5957646582485125e-11
11 O 0 3.578864288256156e-11
; O 0 1.5985489028400718e-13
SCA2 B-Disease 0 6.984475775517751e-10
, O 0 3.476168463321938e-13
n O 0 9.191950152420691e-12
= O 0 1.4474819780285753e-11
10 O 0 4.131678072588629e-12
) O 0 5.6355781993073714e-14
and O 0 4.3580655577357685e-12
SCA3 B-Disease 1 1.0
/ O 0 1.2768990131917235e-07
Machado B-Disease 0 6.402747487754823e-08
- I-Disease 0 3.993155583970065e-09
Joseph I-Disease 0 1.1619021300646182e-08
disease I-Disease 0 2.10440357477637e-05
( O 0 8.413283958397244e-12
MJD B-Disease 1 1.0
) O 0 4.277718316288842e-13
( O 0 3.684739010223134e-14
n O 0 4.1864792882373436e-11
= O 0 2.38464831214813e-10
16 O 0 5.300835326238484e-10
) O 0 1.6169795537257503e-12
. O 0 1.1848896863675407e-10

In O 0 4.174857348715477e-09
SCA1 B-Disease 0 1.5903408439044142e-06
, O 0 4.5708416218648296e-11
saccade O 0 6.567496324549893e-09
amplitude O 0 1.4695987482493678e-10
was O 0 3.815098237325287e-11
significantly O 0 2.668292290678581e-13
increased O 0 4.275043047428234e-13
, O 0 1.5189471859120007e-13
resulting O 0 1.1130197458131263e-11
in O 0 4.6461702540856464e-11
hypermetria B-Disease 0 7.207004273368511e-07
. O 0 2.4804673870448823e-08

The O 0 8.504533965947303e-09
smooth O 0 7.255551270901606e-09
pursuit O 0 9.378945620142076e-09
gain O 0 3.388843650142803e-09
was O 0 4.964730404566353e-09
decreased O 0 3.790110625345733e-08
. O 0 6.308531474985557e-09

In O 0 7.690698744511337e-09
SCA2 B-Disease 0 3.9434339669242036e-06
, O 0 1.1937228983072146e-10
saccade O 0 1.3047531055576655e-08
velocity O 0 4.706143252874995e-10
was O 0 1.1589843529336008e-09
markedly O 0 7.433404447532155e-10
decreased O 0 7.97010812902954e-09
. O 0 2.154622480432522e-09

The O 0 1.7858485523714052e-10
percentage O 0 5.1990790145284294e-11
of O 0 3.7095618243832007e-10
errors O 0 2.743057905263413e-07
in O 0 1.4801034842193417e-09
antisaccades O 0 4.2537033095868537e-07
was O 0 3.081225274925714e-09
greatly O 0 3.8790040515594704e-13
increased O 0 9.597973457675657e-13
and O 0 2.638030852791795e-13
was O 0 4.830568237079724e-12
significantly O 0 2.929616591635861e-14
correlated O 0 9.909366621534133e-14
with O 0 1.2478864614545986e-14
age O 0 2.2814357347744618e-10
at O 0 4.117392791158636e-07
disease O 1 0.9859760999679565
onset O 1 0.9568693041801453
. O 0 4.0794557065737536e-08

In O 0 1.4217510502234632e-10
addition O 0 4.422205657217404e-12
, O 0 1.0872360954247706e-12
a O 0 2.536514563927089e-13
correlation O 0 1.0707639202384156e-12
between O 0 4.524882638717864e-12
smooth O 0 2.941211996176918e-10
pursuit O 0 3.453756725058099e-10
gain O 0 2.3360050005472033e-11
and O 0 4.5140017483451256e-13
the O 0 2.1285668540260705e-12
number O 0 3.353667690775275e-11
of O 0 5.987417228681124e-10
trinucleotide O 0 2.5994833663389727e-07
repeats O 0 1.0986577869687153e-08
was O 0 6.360862414567237e-08
found O 0 3.5159377631543975e-09
. O 0 9.697711078615612e-09

In O 0 1.4704293960221548e-07
SCA3 B-Disease 1 1.0
, O 0 2.1173992337253367e-08
gaze B-Disease 0 2.98816507893207e-06
- I-Disease 0 1.3178140534364502e-07
evoked I-Disease 0 2.8863356149599895e-08
nystagmus I-Disease 0 2.2088563127908856e-05
was O 0 1.8256490763590705e-09
often O 0 8.391387628162161e-13
present O 0 2.812394414575259e-12
as O 0 5.193357462823789e-12
was O 0 3.9837050325175483e-10
saccade O 0 5.956850301913619e-08
hypometria O 0 6.550260422955034e-08
and O 0 4.7968566618816766e-11
smooth O 0 1.1564362800697836e-09
pursuit O 0 4.29332258633508e-09
gain O 0 2.6338431435846132e-09
was O 0 2.2265818078182065e-09
markedly O 0 1.2624187251120134e-09
decreased O 0 7.1760979380997014e-09
. O 0 2.3155615203052093e-09

Three O 0 4.3395731452733344e-10
major O 0 4.462834102270108e-09
criteria O 0 1.652139403063302e-08
, O 0 1.1585434001037953e-11
saccade O 0 1.5436208977703814e-09
amplitude O 0 4.701906572424086e-11
, O 0 1.7133683794662291e-12
saccade O 0 4.369473116661027e-10
velocity O 0 1.5649908452486372e-11
, O 0 7.745473641802836e-13
and O 0 3.831363394948828e-13
presence O 0 7.839754019578482e-12
of O 0 6.5361054346624314e-09
gaze B-Disease 0 1.546618022985058e-06
- I-Disease 0 2.8502613602654492e-08
evoked I-Disease 0 1.9143808760446746e-09
nystagmus I-Disease 0 1.6782232137302344e-07
, O 0 9.206122192698118e-13
permitted O 0 3.945619438810999e-12
the O 0 3.8756415611518324e-12
correct O 0 1.1654916615144728e-11
assignment O 0 3.8238019521574795e-12
of O 0 5.167038671927138e-11
90 O 0 2.576654445363147e-10
% O 0 4.758780609154245e-12
of O 0 6.974076177668209e-11
the O 0 6.625870685450508e-11
SCA1 B-Disease 0 2.7164308136207183e-08
, O 0 6.884159583532556e-13
90 O 0 1.1857934772985246e-11
% O 0 7.898917522668192e-13
of O 0 1.1614972005025148e-11
the O 0 3.831674214027636e-11
SCA2 B-Disease 0 8.256775174686481e-08
, O 0 6.002272789039365e-13
and O 0 3.7807728952773956e-13
93 O 0 1.4859006386425122e-11
% O 0 1.110491473083064e-12
of O 0 5.3178968173472896e-11
the O 0 2.38237513050521e-10
patients O 0 1.8420938385776964e-11
with O 0 1.9719519420147158e-11
SCA3 B-Disease 1 1.0
to O 0 9.840933623550541e-11
their O 0 6.842956062902417e-11
genetically O 0 6.137523267391032e-10
confirmed O 0 1.0217759277564298e-10
patient O 0 4.084794724690255e-09
group O 0 2.473142524106464e-10
and O 0 2.911250407411359e-11
, O 0 3.752606905771394e-11
therefore O 0 5.646069167752898e-10
, O 0 7.772412054241062e-12
may O 0 4.5861411890335546e-11
help O 0 7.364107587615187e-12
orient O 0 1.2814414418471642e-08
diagnoses O 0 7.034682614204257e-09
of O 0 5.6971312112352734e-09
SCA1 B-Disease 0 6.159004897199338e-06
, O 0 2.8318652978143177e-11
SCA2 B-Disease 0 4.347012634298153e-07
, O 0 1.5072172676600104e-11
and O 0 4.540238671135732e-11
SCA3 B-Disease 1 1.0
at O 0 1.2151983863617488e-09
early O 0 1.8945756075083864e-10
clinical O 0 1.8036923066233612e-08
stages O 0 1.159516003212957e-07
of O 0 7.487652275983692e-09
the O 0 1.5101834449637863e-08
diseases O 0 0.0018737787613645196
. O 0 6.119720286079655e-10
. O 0 4.314683277328868e-09

Genetic O 0 6.304461952488793e-10
basis O 0 1.2370873769818047e-10
and O 0 7.167985280852329e-13
molecular O 0 1.2812738370282517e-10
mechanism O 0 3.3385576525546412e-09
for O 0 1.3624907424514276e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 4.472798991628224e-06

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999951124191284
causes O 0 1.4107744306102177e-08
more O 0 4.069653414175839e-13
than O 0 1.501754992062898e-13
300 O 0 2.2200225598817402e-12
, O 0 4.738056193047402e-13
000 O 0 7.067773449831449e-11
sudden O 0 2.2947245492677126e-10
deaths O 0 1.9090696037893373e-11
each O 0 6.181378786650552e-14
year O 0 4.346060729180923e-13
in O 0 1.663158673281817e-11
the O 0 1.2989469500013229e-09
USA O 0 3.117570912536394e-08
alone O 0 8.718306077071247e-10
. O 0 1.5426201427359842e-09

In O 0 6.794059759229754e-10
approximately O 0 2.363542139782737e-10
5 O 0 4.585087420849732e-09
- O 0 8.66893778983524e-11
12 O 0 6.23837162483376e-11
% O 0 3.867843111765579e-12
of O 0 8.384256830473724e-12
these O 0 8.698306696230604e-14
cases O 0 9.556392407007036e-14
, O 0 1.6270232367334228e-14
there O 0 8.705642679180184e-14
are O 0 5.001631297714762e-15
no O 0 1.7044439861238492e-12
demonstrable O 1 0.9999812841415405
cardiac O 1 1.0
or O 0 1.2146101653343067e-06
non O 1 1.0
- O 1 0.9575333595275879
cardiac O 1 1.0
causes O 0 3.542515969456872e-07
to O 0 8.307145119360038e-13
account O 0 1.155256581586786e-13
for O 0 2.728600765472544e-13
the O 0 1.1104708298736998e-11
episode O 0 3.7826880516789174e-11
, O 0 1.2344456240629548e-13
which O 0 1.8236641377241715e-14
is O 0 5.700918405561863e-15
therefore O 0 5.1479762293304976e-14
classified O 0 2.644216768286911e-13
as O 0 2.798291286187915e-11
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 3.019953709326728e-08
IVF B-Disease 1 1.0
) O 0 1.19729837155802e-10
. O 0 1.1808699573734316e-09

A O 0 4.492571648029298e-09
distinct O 0 9.37786306942634e-11
group O 0 3.5319240587750045e-11
of O 0 3.3989280723289994e-07
IVF B-Disease 1 1.0
patients O 0 9.96684661913605e-07
has O 0 1.501765205247363e-11
been O 0 1.0743685672012782e-12
found O 0 4.0899768516617155e-14
to O 0 4.738686182272252e-14
present O 0 1.8818711779861053e-12
with O 0 1.9130200895611793e-12
a O 0 5.051055129712267e-10
characteristic O 0 3.9624760006518045e-07
electrocardiographic O 0 6.691229827993084e-06
pattern O 0 1.5033314184620394e-06
. O 0 4.05198079533875e-08

Because O 0 1.8921135769289776e-09
of O 0 7.00275677445461e-08
the O 0 2.4176696200584047e-09
small O 0 7.0097191939844095e-12
size O 0 2.2745423166464773e-12
of O 0 4.4466877402449256e-10
most O 0 4.2754853477045e-12
pedigrees O 0 2.0727511373941354e-10
and O 0 5.635820369415123e-12
the O 0 5.5651726282857084e-11
high O 0 1.3257696052093593e-09
incidence O 0 1.3438364021567395e-07
of O 0 2.6546727038834206e-09
sudden B-Disease 0 1.3324119585433891e-08
death I-Disease 0 8.123243411262138e-09
, O 0 2.1754065562817892e-12
however O 0 9.741572782814845e-13
, O 0 3.4615448121820894e-14
molecular O 0 1.4443132453911822e-11
genetic O 0 1.405465240716941e-11
studies O 0 5.5645969603002055e-12
of O 0 1.9202952117325367e-08
IVF B-Disease 1 1.0
have O 0 6.524764062376676e-11
not O 0 1.2719953128986772e-12
yet O 0 2.2283471942663446e-11
been O 0 2.5509854645333618e-11
done O 0 2.345457716934618e-10
. O 0 3.920674007673597e-09

Because O 0 9.287126623291897e-09
IVF B-Disease 1 1.0
causes O 0 1.5632261920472956e-06
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9780304431915283
, O 0 2.0526096013856465e-12
we O 0 3.955292040072611e-13
investigated O 0 1.2684701379550578e-12
whether O 0 3.553475872927758e-13
malfunction O 0 4.474598469528246e-08
of O 0 4.2578301995277457e-10
ion O 0 2.3699658902032184e-10
channels O 0 1.9482170043882974e-10
could O 0 4.534060280003693e-11
cause O 0 4.469083991764933e-10
the O 0 2.7083713743936144e-11
disorder O 0 3.1768910419005536e-11
by O 0 1.416556555757821e-14
studying O 0 6.496468944391931e-13
mutations O 0 8.660066207980682e-14
in O 0 4.132401072807351e-13
the O 0 2.654315656158701e-11
cardiac O 0 2.5407978228031425e-06
sodium O 0 2.5393093849856996e-08
channel O 0 1.2717752895241574e-07
gene O 0 1.5601351321947732e-08
SCN5A O 0 7.116886081348639e-06
. O 0 9.23567000654657e-09

We O 0 1.6125284441059762e-09
have O 0 3.152280736787305e-12
now O 0 3.2913962896320703e-13
identified O 0 1.5425295589455157e-12
a O 0 7.34323712947571e-12
missense O 0 7.944882973731637e-09
mutation O 0 7.702199295023249e-11
, O 0 2.4228822073646405e-12
a O 0 9.410092496886513e-12
splice O 0 4.477020532078768e-09
- O 0 2.902557916240056e-10
donor O 0 2.0992409199838136e-10
mutation O 0 3.249297220175862e-10
, O 0 6.928921954425793e-13
and O 0 1.4561819632052941e-12
a O 0 2.5585479915268827e-11
frameshift O 0 3.623175537370571e-09
mutation O 0 1.7686907710992572e-12
in O 0 3.529334756304653e-13
the O 0 3.1475401712083295e-12
coding O 0 1.1886291950702343e-10
region O 0 2.9510106164254424e-11
of O 0 1.100053173552773e-10
SCN5A O 0 1.3273205468067317e-07
in O 0 1.828129037040327e-10
three O 0 1.2426666362586047e-09
IVF B-Disease 1 1.0
families O 0 2.6940449870949124e-10
. O 0 4.6656407626244345e-09

We O 0 1.0508359460370542e-10
show O 0 8.18683402320497e-12
that O 0 2.111162197208742e-14
sodium O 0 7.438906261814093e-14
channels O 0 3.0331003008678137e-14
with O 0 2.531863472132398e-14
the O 0 2.8320868220022e-11
missense O 0 1.617115330532215e-08
mutation O 0 6.266360347284561e-11
recover O 0 4.181898230481984e-11
from O 0 1.0104025905885439e-12
inactivation O 0 1.4625535449397375e-08
more O 0 3.118798351086499e-14
rapidly O 0 1.640736022523112e-13
than O 0 9.032872851934791e-15
normal O 0 2.1366411244450045e-12
and O 0 8.884392380852438e-14
that O 0 1.3903196085726655e-13
the O 0 4.0108451282439006e-11
frameshift O 0 4.2312318981885255e-08
mutation O 0 6.54707815739286e-11
causes O 0 6.904967049525812e-12
the O 0 1.3583732229316414e-11
sodium O 0 2.3979195365453343e-11
channel O 0 7.570475496487816e-11
to O 0 3.494471422296752e-12
be O 0 1.0150873197556365e-11
non O 0 4.550855692286859e-09
- O 0 6.1226979042317e-10
functional O 0 8.262241379952684e-08
. O 0 1.078085620775937e-09

Our O 0 1.9387358385358766e-09
results O 0 3.4242969570996706e-11
indicate O 0 2.2956369877952243e-12
that O 0 6.435738037326513e-14
mutations O 0 5.817268867135128e-13
in O 0 1.8999331188179758e-12
cardiac O 0 4.601850491781079e-07
ion O 0 3.6081071463911485e-09
- O 0 3.798320824532908e-10
channel O 0 7.896169135213071e-11
genes O 0 2.1579945133371609e-13
contribute O 0 3.3445898486053572e-15
to O 0 4.943435899073655e-15
the O 0 3.7133431095640046e-13
risk O 0 5.328666327630849e-12
of O 0 8.250414240684734e-12
developing O 0 5.690101723132557e-10
IVF B-Disease 1 1.0
. O 0 4.521436558491132e-10
. O 0 1.1068729266483501e-09

Molecular O 0 7.164278059690332e-10
heterogeneity O 0 2.942173171760487e-09
in O 0 1.1150005918558747e-10
mucopolysaccharidosis B-Disease 0 4.625274812042335e-07
IVA I-Disease 1 1.0
in O 0 1.6007274394880255e-09
Australia O 0 3.4340638666030543e-10
and O 0 3.233269988550669e-12
Northern O 0 1.465417676094205e-09
Ireland O 0 1.269135907477903e-08
: O 0 7.84632168265853e-12
nine O 0 1.0584799703394765e-10
novel O 0 7.615366670599144e-12
mutations O 0 3.718221477239103e-12
including O 0 2.558224465598613e-12
T312S O 0 1.8233243803678079e-09
, O 0 1.502813845588591e-11
a O 0 2.120334116617606e-11
common O 0 8.770869447394247e-12
allele O 0 4.691780818022462e-12
that O 0 1.5636791991444077e-13
confers O 0 4.131999187251267e-09
a O 0 3.372991330685693e-10
mild O 0 7.89745263318764e-06
phenotype O 0 7.860822393013223e-08
. O 0 1.6747474518297167e-09

Mucopolysaccharidosis B-Disease 0 0.0008006148273125291
IVA I-Disease 1 1.0
( O 0 5.530165435629897e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 9.655749116932455e-11
is O 0 1.0345432193206716e-12
an O 0 1.5563751459488073e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 4.534272068923428e-09
by O 0 4.371800772957901e-13
a O 0 1.2552756611938776e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 3.0816935114863497e-10
N O 0 1.2157640583154716e-07
- O 0 7.170128935030107e-10
acetylgalactosamine O 0 4.796328880729561e-07
- O 0 6.21549034462987e-09
6 O 0 4.4736257365229903e-08
- O 0 4.3975656449646294e-10
sulfate O 0 2.6324054047677237e-10
sulfatase O 0 3.3201251881109783e-07
( O 0 1.2966040567607973e-11
GALNS O 0 3.374983919002261e-07
) O 0 1.7090806200825703e-11
. O 0 2.520930131311161e-10

Previous O 0 1.2066159182921865e-09
studies O 0 6.695655141442103e-11
of O 0 7.810433966248809e-10
patients O 0 8.350900700115904e-12
from O 0 1.755633182234928e-12
a O 0 8.692013254985032e-12
British O 0 3.453400898578707e-10
- O 0 2.6891830429143226e-10
Irish O 0 2.305428764559636e-10
population O 0 2.3378746312995025e-13
showed O 0 1.114732091356263e-11
that O 0 1.2809200857118175e-13
the O 0 1.2695116659300343e-11
I113F O 0 1.4658257940780572e-09
mutation O 0 1.2304458667233842e-11
is O 0 1.039209950731701e-13
the O 0 3.1032831469476885e-13
most O 0 5.975916376327328e-14
common O 0 8.45671839846962e-13
single O 0 2.6486516105372893e-11
mutation O 0 3.4266572912500237e-10
among O 0 1.3051101865890757e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 3.2928915061347652e-06
and O 0 1.0752033811900485e-11
produces O 0 5.364586205813815e-11
a O 0 5.033740785309604e-11
severe O 0 0.0687747597694397
clinical O 1 0.9692797064781189
phenotype O 0 7.904142194092856e-07
. O 0 1.757140100089316e-09

We O 0 1.4571613360381264e-10
studied O 0 1.1689296752770417e-10
mutations O 0 3.1367226524525726e-12
in O 0 4.21413251516789e-12
the O 0 4.029631836544034e-11
GALNS O 0 5.3212836803595565e-08
gene O 0 1.1478732894754096e-11
from O 0 3.4002317563126827e-13
23 O 0 1.7430493159942273e-10
additional O 0 5.730323437980189e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.7329709578461916e-07
( O 0 4.717270953198682e-13
15 O 0 1.3782231432502012e-11
from O 0 8.774830363190989e-13
Australia O 0 3.841245724278686e-11
, O 0 3.2100407401647324e-13
8 O 0 4.8611087377636863e-11
from O 0 1.2427026638631156e-12
Northern O 0 1.973514407449528e-10
Ireland O 0 2.2849848402284323e-10
) O 0 2.982649663276632e-14
, O 0 1.3530109582086773e-14
with O 0 3.924103321337148e-15
various O 0 3.390040852202514e-12
clinical O 0 2.5562306404935953e-07
phenotypes O 0 5.773375555406801e-09
( O 0 9.047508402193483e-12
severe O 0 3.2343855309591163e-06
, O 0 2.6217011200868612e-11
16 O 0 1.6769721167264606e-09
cases O 0 7.8982142007189e-12
; O 0 3.120251724098716e-13
intermediate O 0 1.3505564722127161e-10
, O 0 1.5366293036177953e-13
4 O 0 1.0409056949711726e-10
cases O 0 1.0862784196458142e-12
; O 0 5.171737062041604e-13
mild O 0 7.155680492587635e-08
, O 0 7.285090933284444e-12
3 O 0 1.605822141925728e-09
cases O 0 2.5046907256576212e-11
) O 0 2.8982068481231416e-12
. O 0 3.507998058704942e-10

We O 0 4.984779700123454e-09
found O 0 5.530697427813536e-11
two O 0 1.5514285819570595e-12
common O 0 5.8005748641842825e-12
mutations O 0 5.817546422891284e-13
that O 0 3.3567085607399613e-14
together O 0 1.0773598403375842e-13
accounted O 0 2.5526986774382365e-11
for O 0 1.2584213185395932e-12
32 O 0 9.29794713444565e-11
% O 0 1.5041501030821358e-11
of O 0 4.288393806728408e-10
the O 0 3.796720160487155e-10
44 O 0 1.574978203411348e-10
unrelated O 0 7.40560668344159e-11
alleles O 0 1.0475009531649149e-12
in O 0 2.2643785718007292e-12
these O 0 2.1135588071374833e-11
patients O 0 1.5373029238485714e-10
. O 0 1.7908569072133673e-09

One O 0 4.915505225078221e-10
is O 0 3.9197633854015645e-12
the O 0 3.173396267985851e-11
T312S O 0 2.3672475091274237e-09
mutation O 0 4.13051363945538e-11
, O 0 4.653216288848239e-13
a O 0 7.762126445071127e-13
novel O 0 1.928410339399611e-12
mutation O 0 2.155186402605369e-12
found O 0 6.08612552716048e-14
exclusively O 0 4.847012548270246e-13
in O 0 8.542025593805125e-12
milder O 0 2.1229702440450637e-07
patients O 0 7.109559607698657e-09
. O 0 4.511377049709608e-09

The O 0 2.582044267285255e-08
other O 0 3.131673045886352e-11
is O 0 2.0545171466879175e-12
the O 0 7.826860687343284e-12
previously O 0 9.296014652493412e-11
described O 0 3.390158986871228e-11
I113F O 0 7.823973136034112e-10
that O 0 1.5641364072005448e-12
produces O 0 3.7417145770657356e-11
a O 0 8.705623028015808e-11
severe O 0 3.4017841244349256e-05
phenotype O 0 3.521732594435889e-07
. O 0 5.631015209672796e-09

The O 0 6.114974748783197e-09
I113F O 0 3.602566067684165e-08
and O 0 8.225796432892452e-11
T312S O 0 1.3682454058638882e-09
mutations O 0 1.1273258368471595e-11
accounted O 0 9.957216474953956e-12
for O 0 1.898158279861617e-12
8 O 0 6.035389965575177e-10
( O 0 1.2042591316513418e-13
18 O 0 1.7383736811149575e-11
% O 0 1.0690007906655197e-12
) O 0 9.086163929811295e-15
and O 0 3.257781956526873e-13
6 O 0 2.1339510714035725e-10
( O 0 6.319088725588798e-14
14 O 0 7.2347705083741776e-12
% O 0 5.569032648228278e-13
) O 0 7.837604331273514e-15
of O 0 3.2207994951627406e-12
44 O 0 1.7654931336319457e-11
unrelated O 0 1.4210508637868546e-11
alleles O 0 6.728947911024963e-13
, O 0 1.4285180026732403e-12
respectively O 0 2.1773265135305309e-10
. O 0 1.7438549493320465e-09

The O 0 4.006063036854357e-09
relatively O 0 1.740614041789712e-10
high O 0 3.4572891771667e-10
residual O 0 5.91244372571964e-07
GALNS O 0 7.150058081606403e-06
activity O 0 1.6903053401406964e-09
seen O 0 5.640294221259667e-12
when O 0 1.5081876990775261e-13
the O 0 1.4984108788820838e-12
T312S O 0 2.9002876489325757e-11
mutant O 0 5.014708787109967e-11
cDNA O 0 3.8547226521856714e-10
is O 0 6.596457863446148e-13
overexpressed O 0 4.6529453900934215e-11
in O 0 4.157827240055395e-13
mutant O 0 3.013441579602372e-11
cells O 0 8.510146797327534e-13
provides O 0 2.6160477050677505e-14
an O 0 8.595188481715392e-16
explanation O 0 2.438067922463233e-13
for O 0 2.6363609103956243e-13
the O 0 1.0833269004084656e-10
mild O 0 6.987212941567122e-07
phenotype O 0 6.935887419956543e-10
in O 0 5.931509623746667e-12
patients O 0 6.907255800311929e-13
with O 0 6.626517639728852e-14
this O 0 8.483961796978967e-12
mutation O 0 1.2376684122017423e-09
. O 0 7.031634163823242e-10

The O 0 9.445575571698228e-11
distribution O 0 2.7803820443900173e-12
and O 0 4.495286182681045e-14
relative O 0 5.851945447318818e-13
frequencies O 0 7.269984852835421e-13
of O 0 4.212495283151263e-11
the O 0 4.89654428115216e-11
I113F O 0 5.291340143820378e-10
and O 0 1.9634587358763333e-11
T312S O 0 7.70484787082637e-10
mutations O 0 2.2140095746331356e-12
in O 0 1.8560838629944065e-12
Australia O 0 1.0464750593852656e-11
corresponded O 0 1.5148474109220184e-13
to O 0 3.2824936345432487e-13
those O 0 2.587672914486361e-13
observed O 0 1.7973834226525653e-12
in O 0 3.464447912576718e-12
Northern O 0 1.9566490649935986e-09
Ireland O 0 1.642684743785594e-08
and O 0 3.307257939733077e-11
are O 0 3.205672218561245e-13
unique O 0 6.948774238305089e-13
to O 0 9.137437036394261e-14
these O 0 1.7847766179465013e-13
two O 0 2.695670021837099e-13
populations O 0 3.7119409651044377e-13
, O 0 3.5764021410165936e-14
suggesting O 0 1.6455592314126855e-13
that O 0 5.863204751354809e-14
both O 0 4.951046083528921e-13
mutations O 0 5.876533634707748e-12
were O 0 3.416213839591009e-11
probably O 0 1.3033625827912898e-12
introduced O 0 3.0100507589919667e-12
to O 0 2.4483152592964796e-13
Australia O 0 1.4958017463539974e-11
by O 0 6.466045689330902e-13
Irish O 0 5.985110740347466e-10
migrants O 0 4.097726932078549e-12
during O 0 3.811525314117992e-12
the O 0 2.3201569138153744e-11
19th O 0 3.6182099538706325e-09
century O 0 2.7827484316844675e-08
. O 0 2.8610623203917385e-08

Haplotype O 0 2.340901339437096e-08
analysis O 0 1.833625751235246e-10
using O 0 1.548137035234376e-10
6 O 0 2.4808459286873585e-08
RFLPs O 0 2.1214093592902827e-08
provides O 0 3.4893099694344176e-12
additional O 0 4.936412064705797e-13
data O 0 1.3340495158206678e-12
that O 0 1.1311564613583278e-13
the O 0 2.3977960242338447e-11
I113F O 0 9.78236380788644e-10
mutation O 0 6.181172327451856e-12
originated O 0 1.3539598045161916e-12
from O 0 7.106358687267167e-13
a O 0 1.8889096883856205e-11
common O 0 1.0001856287633615e-10
ancestor O 0 3.6623268862001623e-09
. O 0 1.4316687391158212e-08

The O 0 1.3337342785746387e-08
other O 0 4.407673531714451e-11
9 O 0 1.4049153840289819e-08
novel O 0 6.858191792247226e-11
mutations O 0 1.099205275412185e-11
identified O 0 4.074393166603185e-12
in O 0 9.371077048028753e-13
these O 0 1.8621653698203122e-12
23 O 0 1.2835108975650655e-08
patients O 0 4.322273094992113e-11
were O 0 1.5570203112935666e-11
each O 0 2.90300620456492e-14
limited O 0 1.3036616057504613e-11
to O 0 3.6340704751003372e-12
a O 0 7.19821924288766e-10
single O 0 4.289181454453228e-09
family O 0 8.126726513957294e-10
. O 0 1.1465534299759383e-08

These O 0 2.2310051375762363e-11
data O 0 4.541269443825158e-11
provide O 0 2.5117879781308416e-13
further O 0 8.216218910740355e-14
evidence O 0 6.24006651472192e-13
for O 0 2.7157142095009246e-13
extensive O 0 2.445271485296274e-10
allelic O 0 3.6498444266896968e-09
heterogeneity O 0 1.5946753917361889e-09
in O 0 2.0320956028996306e-09
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
in O 0 1.3022363187786823e-09
British O 0 1.4341885901103524e-08
- O 0 2.2863865467570577e-08
Irish O 0 3.2012428263783477e-09
patients O 0 2.4083044586342695e-12
and O 0 5.26251337971094e-14
provide O 0 4.5371844980103895e-14
evidence O 0 1.722980265406182e-12
for O 0 6.847936388949816e-13
their O 0 3.250509019933623e-12
transmission O 0 2.3708612850725785e-10
to O 0 7.720252930866478e-13
Australia O 0 2.930481898810733e-11
by O 0 6.771448094085308e-13
British O 0 2.8061830636971763e-09
- O 0 3.6807024095253382e-09
Irish O 0 2.5373423362395897e-09
migrants O 0 4.100058834111131e-11
. O 0 5.668269239395007e-12
. O 0 4.418020116414567e-10

Identification O 0 7.078735375642964e-09
of O 0 9.317395743835277e-09
constitutional O 0 3.1693082291894825e-06
WT1 O 0 2.9349188480409794e-05
mutations O 0 1.6989733231387305e-10
, O 0 3.4656690494835884e-13
in O 0 6.543314067658512e-13
patients O 0 1.3414669765635101e-12
with O 0 6.050941540360066e-13
isolated O 0 1.8778879393721581e-06
diffuse B-Disease 1 0.9999350309371948
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.407369793621216e-11
and O 0 1.1755146281291345e-13
analysis O 0 5.564148317441231e-13
of O 0 1.3363811446343021e-10
genotype O 0 1.7287798970144763e-09
/ O 0 1.6532419877535176e-09
phenotype O 0 6.716488042818325e-12
correlations O 0 6.974920315795663e-13
by O 0 2.4763377519344473e-14
use O 0 2.1523804873829766e-12
of O 0 1.473140359697922e-10
a O 0 1.1074721001369525e-10
computerized O 0 8.257671879619011e-08
mutation O 0 1.6331398455804447e-09
database O 0 2.1478767653348996e-09
. O 0 3.8960887849270875e-09

Constitutional O 0 1.6061315477600147e-07
mutations O 0 4.828583644034268e-10
of O 0 1.452034936733071e-09
the O 0 1.3266042708792725e-09
WT1 O 0 4.779324740411539e-07
gene O 0 4.03698602324809e-11
, O 0 1.7299580821680816e-12
encoding O 0 4.084868901466088e-11
a O 0 5.547244330550427e-10
zinc O 0 9.498015884901179e-08
- O 0 6.702871502284324e-08
finger O 0 3.711710405696067e-07
transcription O 0 1.0733143085417396e-07
factor O 0 1.5062990854630698e-09
involved O 0 3.802681260156593e-12
in O 0 5.4840472440975674e-11
renal O 1 1.0
and O 0 2.8944477370451693e-10
gonadal O 1 0.9999812841415405
development O 0 3.591670960645388e-08
, O 0 5.667422911179165e-13
are O 0 3.41649519547578e-14
found O 0 2.986452502396625e-14
in O 0 6.552940292172196e-14
most O 0 2.1423039394969506e-13
patients O 0 1.725205807205643e-13
with O 0 1.7104037370457847e-12
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.767748128462699e-07
DDS B-Disease 1 1.0
) O 0 1.6201694499895503e-11
, O 0 3.066171015003727e-12
or O 0 4.5284614946794477e-10
diffuse B-Disease 1 0.9999951124191284
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.9578660914731927e-09
DMS B-Disease 0 1.0076621492771665e-06
) O 0 1.2345154534591264e-14
associated O 0 3.289877322388418e-13
with O 0 5.009388628733624e-13
pseudohermaphroditism B-Disease 1 1.0
and O 0 4.257196817292197e-10
/ O 0 5.5751684158167336e-08
or O 0 3.2948682671118945e-10
Wilms B-Disease 0 0.25516045093536377
tumor I-Disease 0 3.2502724934602156e-05
( O 0 1.2389013148705885e-09
WT B-Disease 1 1.0
) O 0 5.1150979285541354e-11
. O 0 1.0444122233721487e-09

Most O 0 1.4045555829511613e-09
mutations O 0 1.4308244589145147e-09
in O 0 9.605134465573428e-09
DDS B-Disease 1 1.0
patients O 0 8.371984705490831e-08
lie O 0 8.890517655402164e-09
in O 0 1.9514152793664863e-10
exon O 0 7.722643147189956e-08
8 O 0 6.784677708537856e-08
or O 0 6.826738480070205e-11
exon O 0 3.937295378619865e-09
9 O 0 6.3789507009914814e-09
, O 0 7.484613623320868e-12
encoding O 0 3.463863362807018e-10
zinc O 0 6.956801001933854e-08
finger O 0 8.535818665222905e-07
2 O 0 8.926022019295488e-06
or O 0 1.9487318425603917e-08
zinc O 0 1.386613348586252e-07
finger O 0 5.270576366456226e-07
3 O 0 1.1164406288344253e-07
, O 0 3.8032324685410845e-12
respectively O 0 1.0448138014484964e-11
, O 0 1.777553934123946e-13
with O 0 1.2369296667653906e-13
a O 0 4.514764256891013e-11
hot O 0 9.863662775444482e-09
spot O 0 8.390411920800034e-09
( O 0 2.305966290312711e-13
R394W O 0 3.053537284136709e-11
) O 0 8.010398036073854e-14
in O 0 4.6050372716488486e-12
exon O 0 9.697026293054023e-09
9 O 0 2.8069232271832334e-08
. O 0 5.813443060276313e-09

We O 0 9.691769609077028e-10
analyzed O 0 3.3431871854228135e-11
a O 0 3.950453679457677e-12
series O 0 2.460700393447368e-11
of O 0 7.403435642316936e-10
24 O 0 3.1276123024781555e-08
patients O 0 2.1755912349430417e-10
, O 0 1.0770117436775806e-11
10 O 0 1.3640753804278205e-10
with O 0 2.160962554731416e-11
isolated B-Disease 0 3.116090738330968e-05
DMS I-Disease 0 0.3216469883918762
( O 0 5.974138406195095e-10
IDMS B-Disease 0 1.9383582184673287e-05
) O 0 3.3445182387459305e-12
, O 0 1.094812825466751e-12
10 O 0 1.9103810547371758e-11
with O 0 1.24360903519527e-11
DDS B-Disease 1 1.0
, O 0 1.226930536335491e-11
and O 0 3.9920831397533e-12
4 O 0 1.0720980769818311e-09
with O 0 2.744910722329852e-11
urogenital B-Disease 1 0.9999992847442627
abnormalities I-Disease 1 0.9921890497207642
and O 0 1.0693124163907441e-09
/ O 0 1.037519996316405e-05
or O 0 1.7812411670092843e-06
WT B-Disease 1 1.0
. O 0 3.279648979059857e-07

We O 0 8.303486787042402e-09
report O 0 8.410468432806795e-10
WT1 O 0 2.3209763639897574e-06
heterozygous O 0 8.577527577102728e-10
mutations O 0 3.416930627331283e-11
in O 0 1.1890275222747881e-11
16 O 0 1.1148655332249291e-08
patients O 0 3.0525024174998805e-10
, O 0 5.231784623582758e-12
4 O 0 1.6244294798184455e-08
of O 0 1.2685091199671206e-08
whom O 0 3.321660724253661e-10
presented O 0 7.3136008360563665e-09
with O 0 2.5800344083393156e-09
IDMS B-Disease 0 0.08654286712408066
. O 0 1.3978379342916014e-07

One O 0 8.181331723200458e-10
male O 0 6.198153101877324e-11
and O 0 6.4887695910842424e-12
two O 0 5.665894142747874e-11
female O 0 9.171783887929053e-10
IDMS B-Disease 1 0.9992417097091675
patients O 0 1.9249697391643394e-09
with O 0 8.50006523500646e-11
WT1 O 1 0.9999964237213135
mutations O 0 2.3581709740483348e-07
underwent O 0 1.090336900233524e-05
normal O 0 5.587507075688336e-06
puberty O 0 1.6559572031837888e-05
. O 0 2.183266012423246e-09

Two O 0 1.5288799559698418e-08
mutations O 0 8.147819086090635e-10
associated O 0 7.018181036322346e-10
with O 0 9.856750832204497e-11
IDMS B-Disease 0 0.00034466615761630237
are O 0 2.189075526751183e-12
different O 0 4.24559238947856e-14
from O 0 1.3041782280856506e-12
those O 0 2.8067676221404936e-12
described O 0 2.3416671379727916e-10
in O 0 2.7113115308452507e-08
DDS B-Disease 1 1.0
patients O 0 4.650371465686476e-06
. O 0 2.942949173245779e-08

No O 0 1.0583759149085381e-06
WT1 O 0 4.235830783727579e-05
mutations O 0 5.90323179228136e-10
were O 0 2.1428251534283405e-11
detected O 0 1.6499860505669872e-11
in O 0 8.133277905331138e-12
the O 0 3.818004801203756e-10
six O 0 3.373096024716915e-09
other O 0 1.8600453399741923e-09
IDMS B-Disease 1 0.9999997615814209
patients O 0 1.4874900200467778e-09
, O 0 1.3723467891593732e-12
suggesting O 0 2.582739751233465e-11
genetic O 0 2.8966623544235404e-10
heterogeneity O 0 4.086314397966362e-09
of O 0 6.544188746460122e-09
this O 0 1.439669272684796e-09
disease O 0 0.002962586237117648
. O 0 6.9094174826034305e-09

We O 0 1.754604794790282e-09
analyzed O 0 3.4249453273460517e-10
genotype O 0 2.321243863789846e-09
/ O 0 2.289518796771972e-09
phenotype O 0 3.552497185310699e-11
correlations O 0 1.873913350880496e-11
, O 0 2.8923516142906336e-13
on O 0 4.9546382621667995e-12
the O 0 3.6664849758713536e-13
basis O 0 2.2560497307116956e-12
of O 0 5.425883700671541e-12
the O 0 2.155572812259643e-12
constitution O 0 1.7490829964939003e-11
of O 0 1.374983876756275e-10
a O 0 1.572912772251911e-10
WT1 O 0 2.2441047065058228e-07
mutation O 0 1.3662542451553517e-11
database O 0 7.77069294327637e-12
of O 0 3.194818021245993e-10
84 O 0 1.614994715737339e-08
germ O 0 2.8795484467991628e-05
- O 0 2.387370443557302e-07
line O 0 9.51280743066718e-09
mutations O 0 1.033616681828109e-11
, O 0 1.1480123492460526e-13
to O 0 3.711939271038543e-14
compare O 0 3.4207223642210294e-13
the O 0 1.6638939575111533e-12
distribution O 0 1.6343409264818476e-11
and O 0 4.727638636473075e-13
type O 0 5.144509471199932e-11
of O 0 2.4516508267957704e-10
mutations O 0 2.6208200106653257e-12
, O 0 9.803711797451778e-14
according O 0 4.751610549794637e-14
to O 0 1.487614556278799e-13
the O 0 2.437921566011969e-11
different O 0 2.745450047858533e-11
symptoms O 0 3.959041805501329e-06
. O 0 8.814267538070908e-09

This O 0 9.579638471368668e-11
demonstrated O 0 5.02832164794853e-10
( O 0 5.7402945244366954e-12
1 O 0 5.990958285018166e-10
) O 0 2.2760948941574766e-13
the O 0 3.220516952076591e-12
association O 0 6.507109304512704e-13
between O 0 1.5858636018967198e-13
mutations O 0 2.0835450606580125e-13
in O 0 3.63785715960796e-12
exons O 0 7.645038380132974e-09
8 O 0 5.0144173258104274e-09
and O 0 3.919638225102773e-11
9 O 0 1.9124255956626257e-08
and O 0 1.0870754296732343e-10
DMS B-Disease 0 1.7763655435487635e-08
; O 0 5.989349641244424e-13
( O 0 1.0023459249023856e-13
2 O 0 3.6464314207007575e-11
) O 0 3.9304575083975654e-14
among O 0 1.746541008606356e-13
patients O 0 4.996640037488453e-13
with O 0 2.8728335357310064e-13
DMS B-Disease 0 2.178944846775721e-08
, O 0 1.0420721089417911e-13
a O 0 1.3387670149984238e-13
higher O 0 3.012484196558002e-13
frequency O 0 7.58552834261017e-13
of O 0 7.077540636890589e-11
exon O 0 2.2779538255690568e-09
8 O 0 5.37161259916985e-10
mutations O 0 4.817943786983303e-12
among O 0 2.7217190632332355e-13
46 O 0 2.898064774270459e-11
, O 0 6.545139864116978e-12
XY O 0 6.700430077444253e-08
patients O 0 3.176755950309862e-12
with O 0 2.7287308697332424e-13
female O 0 1.1301110871761444e-12
phenotype O 0 1.3607485797872965e-11
than O 0 6.228837703872031e-14
among O 0 4.700332462657941e-13
46 O 0 6.149405429312083e-10
, O 0 1.437007457472106e-10
XY O 0 9.055447662831284e-06
patients O 0 1.1897944435235175e-11
with O 0 1.6007454964415274e-13
sexual O 0 8.809716844915272e-12
ambiguity O 0 3.51924350772137e-10
or O 0 2.8833763501823206e-11
male O 0 3.819946095551252e-12
phenotype O 0 4.4286037510776755e-12
; O 0 8.795470184423324e-14
and O 0 2.1145051855298025e-12
( O 0 4.0969276040268843e-13
3 O 0 2.020287964699108e-10
) O 0 1.4860796648157384e-14
statistically O 0 8.340963011423119e-13
significant O 0 4.253546028853278e-13
evidence O 0 3.0228577887342345e-12
that O 0 3.2117537795972595e-14
mutations O 0 1.5526532696260448e-13
in O 0 3.2273300785284897e-12
exons O 0 1.2170825236523797e-08
8 O 0 6.150393527803999e-09
and O 0 4.237816000896011e-11
9 O 0 5.388752999380131e-09
preferentially O 0 1.750651706933226e-11
affect O 0 1.4840481274425166e-11
amino O 0 7.880578134500382e-12
acids O 0 1.856227133535237e-14
with O 0 2.378981394339638e-15
different O 0 4.431015694335641e-14
functions O 0 7.403121865534601e-11
. O 0 2.9883602536973086e-11
. O 0 8.147881813691527e-10

The O 0 6.719986345160578e-08
185delAG O 0 6.296284595919133e-07
BRCA1 O 0 1.0154375118531789e-08
mutation O 0 1.7555101469723944e-11
originated O 0 1.414425217574622e-12
before O 0 1.2159338206446657e-12
the O 0 5.689105328325617e-13
dispersion O 0 7.176634286842898e-12
of O 0 3.3323007547769734e-11
Jews O 0 2.9493885632392303e-12
in O 0 2.5338323019624687e-12
the O 0 1.0847799221391785e-11
diaspora O 0 5.660709401222874e-11
and O 0 5.793822019373174e-11
is O 0 8.054606460972114e-12
not O 0 4.763357243364741e-12
limited O 0 5.2723198029625e-10
to O 0 2.672850274443306e-10
Ashkenazim O 0 2.0790107555512805e-06
. O 0 3.093357037187161e-08

The O 0 6.245461481313441e-09
185delAG O 0 9.022073754749727e-08
mutation O 0 7.579465943763353e-10
in O 0 1.530780918690411e-10
BRCA1 O 0 1.0490876223290257e-10
is O 0 9.720964810021326e-14
detected O 0 1.9846821668750847e-12
in O 0 9.383292753906147e-13
Ashkenazi O 0 1.8480648868862692e-12
Jews O 0 8.675706501945143e-14
both O 0 4.4666886563158453e-14
in O 0 6.841542957158886e-12
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.579057061462663e-05
in O 0 6.97882973632602e-10
the O 0 1.2128545390233114e-10
general O 0 3.3042771296898366e-10
population O 0 8.61033553484214e-12
. O 0 2.025280360085091e-10

All O 0 9.618884355688806e-09
tested O 0 5.291625360115404e-09
Ashkenazi O 0 1.6529517754548806e-09
mutation O 0 2.4979067425601187e-11
carriers O 0 5.645737241426196e-13
share O 0 7.492780267764898e-13
the O 0 9.724535413035973e-12
same O 0 3.0834796521661545e-11
allelic O 0 1.2996019371769307e-08
pattern O 0 5.246211021159297e-09
at O 0 7.435564164381958e-09
the O 0 1.789948522734619e-09
BRCA1 O 0 3.6794669533435354e-09
locus O 0 7.832697157539315e-09
. O 0 3.678695126296816e-09

Our O 0 1.7798306162220001e-09
previous O 0 3.311779461778741e-10
study O 0 1.0013032070155248e-12
showed O 0 2.4856637581560648e-11
that O 0 1.1821565861630523e-13
this O 0 9.11197983385903e-13
Ashkenazi O 0 1.2383627456813429e-09
mutation O 0 1.3472890858512443e-10
also O 0 2.4171402726591573e-12
occurs O 0 1.5872436557370223e-13
in O 0 2.3845991370743946e-13
Iraqi O 0 1.468600414888943e-11
Jews O 0 2.0619408958033603e-12
with O 0 1.8698092390818238e-13
a O 0 2.3025317763547548e-11
similar O 0 2.0139437340027655e-10
allelic O 0 2.644844983024086e-07
pattern O 0 5.980289756735147e-07
. O 0 8.201713086464224e-08

We O 0 4.281318410903623e-09
extended O 0 5.128875102400343e-10
our O 0 5.147100454183651e-11
analysis O 0 1.1764349260381946e-12
to O 0 1.535950294902222e-12
other O 0 1.1834120489107036e-11
non O 0 3.779910073831161e-08
- O 0 2.6599475400068684e-10
Ashkenazi O 0 3.5860252267649884e-11
subsets O 0 5.689247739582015e-09
354 O 0 1.353116924063258e-10
of O 0 1.394975523982822e-10
Moroccan O 0 1.676221472735051e-08
origin O 0 1.6004825242887932e-10
, O 0 1.9166879888787847e-11
200 O 0 6.4552453660216e-11
Yemenites O 0 4.212549598037185e-08
and O 0 2.969662293850206e-10
150 O 0 2.8490790282553746e-10
Iranian O 0 5.510756295734609e-10
Jews O 0 3.4780591740002365e-09
. O 0 1.5495006167043357e-08

Heteroduplex O 0 2.0087327357032336e-07
analysis O 0 4.10819989138389e-11
complemented O 0 1.268526516468027e-11
by O 0 7.55048096528349e-13
direct O 0 3.983429558429563e-11
DNA O 0 2.4639471019050063e-10
sequencing O 0 7.62109542140621e-11
of O 0 2.6129873820224248e-09
abnormally O 0 3.9939912488407003e-10
migrating O 0 1.543666409975497e-11
bands O 0 1.7882354486076224e-09
were O 0 1.5064025582489649e-09
employed O 0 2.764827922163704e-09
. O 0 1.4388739089099545e-08

Four O 0 2.6048665446865016e-09
of O 0 3.246276136792403e-09
Moroccan O 0 6.754127923613851e-08
origin O 0 1.1783718445457225e-10
( O 0 2.1153482611391272e-12
1 O 0 8.785423083468302e-11
. O 0 2.3646975219962507e-13
1 O 0 2.4112751725868797e-11
% O 0 5.325067101678849e-13
) O 0 7.632252204640023e-15
and O 0 3.6372725035864473e-13
none O 0 7.095950910196436e-11
of O 0 7.471000484926549e-10
the O 0 6.314547218444488e-10
Yemenites O 0 1.1458385351659217e-08
or O 0 3.1151869278600586e-12
Iranians O 0 5.998913865656874e-11
was O 0 1.6226535393126795e-10
a O 0 9.456927428652673e-12
carrier O 0 9.667095249299429e-12
of O 0 2.3557336636947923e-10
the O 0 9.041256077146897e-10
185delAG O 0 5.94096469797023e-08
mutation O 0 1.8008632807209324e-08
. O 0 3.3041966940317025e-09

BRCA1 O 0 3.6518594015433337e-07
allelic O 0 1.897272028372754e-07
patterns O 0 5.5883666583156355e-09
were O 0 7.661291739902154e-11
determined O 0 4.664192643222265e-12
for O 0 2.912098513718764e-12
four O 0 7.085897407027586e-12
of O 0 5.5183687480697685e-11
these O 0 2.1652303431110576e-13
individuals O 0 7.857781503110058e-15
and O 0 2.860094702305388e-13
for O 0 4.9221048244174614e-12
12 O 0 2.955010958149984e-10
additional O 0 6.118561907131337e-11
non O 0 1.1750999817650154e-07
- O 0 4.363634731330279e-10
Ashkenazi O 0 4.761642816153433e-11
185delAG O 0 3.6055874952367617e-10
mutation O 0 8.09165859316785e-11
carriers O 0 1.0559763783876686e-12
who O 0 2.9129817048084705e-12
had O 0 2.2485622253043402e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9992496371269226

Six O 0 1.9313276879984187e-06
non O 0 3.422475856496021e-05
- O 0 1.5015784171623636e-08
Ashkenazi O 0 1.2578592611944828e-09
individuals O 0 4.295239023396208e-13
shared O 0 2.784221742047066e-10
the O 0 1.929093551567007e-09
common O 0 2.0454840043981903e-09
Ashkenazi O 0 4.407272324868927e-10
haplotype O 0 5.316958873180511e-09
, O 0 1.4303169759699585e-09
four O 0 3.7961953580634145e-08
had O 0 2.2174246439021772e-08
a O 0 2.6080965165320436e-10
closely O 0 1.790759381059548e-11
related O 0 2.0730199501439728e-10
pattern O 0 3.125590808394918e-08
, O 0 2.611360606918911e-11
and O 0 2.7017622514224904e-11
the O 0 3.0714906174011958e-09
rest O 0 1.3881549243421887e-09
( O 0 1.085164293493368e-12
n O 0 2.2248657083334678e-10
= O 0 2.6400381880620216e-10
6 O 0 3.508660584294887e-10
) O 0 2.870093892366407e-14
displayed O 0 8.013142233087578e-12
a O 0 1.5834352926069606e-11
distinct O 0 2.3274847327225956e-10
BRCA1 O 0 1.563443818852761e-09
allelic O 0 3.522195157756869e-08
pattern O 0 4.045331891688875e-08
. O 0 1.976975028128436e-08

We O 0 2.3897248069282284e-10
conclude O 0 1.1188650700377778e-10
that O 0 3.24341627774144e-13
the O 0 2.2208877098472968e-11
185delAG O 0 4.8609678060529404e-08
BRCA1 O 0 7.275548608021154e-09
mutation O 0 2.847165211927738e-11
occurs O 0 3.7839688522313397e-13
in O 0 7.191017529703525e-13
some O 0 2.5452198942205184e-12
non O 0 8.985389285953715e-07
- O 0 1.002035077135588e-08
Ashkenazi O 0 5.290653470879647e-10
populations O 0 1.0502983899263185e-11
at O 0 8.688039870863307e-11
rates O 0 9.45653624850884e-11
comparable O 0 3.2443291109185424e-11
with O 0 3.3916559881788655e-13
that O 0 1.5230537317445503e-11
of O 0 1.0744490452907485e-07
Ashkenazim O 0 2.7714402222045464e-06
. O 0 1.4484563770622572e-08

The O 0 5.525757629243344e-09
majority O 0 1.5114383355996353e-10
of O 0 1.0464661359677052e-09
Jewish O 0 1.1402023769591096e-09
185delAG O 0 2.1537611871735862e-07
mutation O 0 2.9088274011712656e-09
carriers O 0 1.1612224203039201e-11
have O 0 1.2002376089531586e-12
a O 0 2.581128019651935e-12
common O 0 1.0021366549095578e-11
allelic O 0 1.1597449667277715e-09
pattern O 0 6.164789234652801e-10
, O 0 1.425738758824291e-12
supporting O 0 9.781906187833478e-12
the O 0 1.0201071237725401e-10
founder O 0 9.298218306419415e-10
effect O 0 4.533649455851219e-09
notion O 0 1.2745619004661535e-09
, O 0 1.531863069552386e-12
but O 0 1.9931787069351475e-13
dating O 0 1.8474343149027517e-12
the O 0 4.308919540618739e-12
mutations O 0 1.831525653795546e-13
origin O 0 7.35402204085113e-14
to O 0 3.970118979119801e-14
an O 0 2.9904769253356195e-14
earlier O 0 2.3539897461843928e-11
date O 0 5.804136726794695e-09
than O 0 1.083221012887492e-11
currently O 0 4.4392198250697845e-11
estimated O 0 5.02360486542841e-10
. O 0 4.162405975449701e-09

However O 0 1.194374932289577e-09
, O 0 5.991318118708788e-12
the O 0 5.883644266235777e-12
different O 0 1.9832318296289508e-13
allelic O 0 1.6293688620550029e-09
pattern O 0 1.379434344528363e-09
at O 0 5.306229677870533e-09
the O 0 9.418469337774127e-10
BRCA1 O 0 1.3912235252711014e-10
locus O 0 5.926763246844047e-11
even O 0 1.3412494856077095e-12
in O 0 1.0197364870914716e-12
some O 0 1.1285085279449936e-12
Jewish O 0 3.542165172287781e-11
mutation O 0 5.736619859697534e-11
carriers O 0 3.261314829305917e-12
, O 0 3.0712340223087997e-12
might O 0 5.2664652153144864e-12
suggest O 0 4.979792619930201e-12
that O 0 4.4867397557685207e-13
the O 0 1.6819485040842075e-11
mutation O 0 5.6871122394719364e-12
arose O 0 5.721948522635634e-13
independently O 0 6.9543732751642384e-12
. O 0 2.9242618743152704e-11
. O 0 1.3873343585046882e-09

Crystal O 0 1.5779090745127178e-07
structure O 0 1.2498817092421177e-08
of O 0 1.179032267373259e-07
the O 0 5.723174467675562e-07
hemochromatosis B-Disease 1 1.0
protein O 0 4.146884862166189e-07
HFE O 0 1.9116871499136323e-06
and O 0 7.398515827761187e-12
characterization O 0 5.103024253161337e-11
of O 0 2.5507287948478563e-10
its O 0 1.698318048692915e-11
interaction O 0 8.031717652068338e-12
with O 0 4.584582279781868e-12
transferrin O 0 6.155865150958562e-08
receptor O 0 3.5560256961275627e-09
. O 0 1.3168128809581958e-09

HFE O 1 0.9965282082557678
is O 0 2.9127527056971303e-09
an O 0 3.7869325730799375e-11
MHC O 0 1.3406306287322423e-08
- O 0 8.584467026118148e-10
related O 0 8.027008502331512e-10
protein O 0 3.2983454856250205e-10
that O 0 1.0615008763474598e-13
is O 0 2.908981174974852e-14
mutated O 0 5.1466216542412485e-14
in O 0 3.0997573214827656e-13
the O 0 4.2694103807860984e-10
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.6618790823486052e-06

HFE O 0 3.08668472825957e-06
binds O 0 5.214668540726164e-12
to O 0 2.3160969669921982e-12
transferrin O 0 2.9086763553287653e-10
receptor O 0 2.948365076388404e-12
( O 0 2.088482652876783e-13
TfR O 0 4.343763404524026e-10
) O 0 1.7997313912060907e-14
and O 0 4.2826795576675e-14
reduces O 0 4.817665905966495e-13
its O 0 1.9298405646954453e-13
affinity O 0 4.0550093664826203e-13
for O 0 5.092358132396946e-11
iron O 0 2.7136428570884163e-07
- O 0 5.132906877314269e-10
loaded O 0 1.548738914891601e-11
transferrin O 0 3.616131560857383e-10
, O 0 3.064107344588618e-12
implicating O 0 1.033162333463622e-09
HFE O 0 4.1176854210789315e-06
in O 0 1.5583179191480667e-08
iron O 0 0.0003192026342730969
metabolism O 0 9.898390089801978e-06
. O 0 1.1381647624375546e-08

The O 0 5.053334461990744e-07
2 O 0 5.000598321203142e-06
. O 0 6.382166617413532e-08

6 O 0 0.00015743085532449186
A O 0 1.524490897963915e-07
crystal O 0 8.47126884195859e-08
structure O 0 2.0820170476554267e-08
of O 0 2.5175019402468024e-08
HFE O 0 3.1874192245595623e-06
reveals O 0 7.034554189155884e-11
the O 0 5.273742813977078e-12
locations O 0 1.8190231265702295e-10
of O 0 1.2510352576100559e-07
hemochromatosis B-Disease 1 1.0
mutations O 0 1.730826326706847e-08
and O 0 2.1095324098663326e-10
a O 0 1.1232276220241033e-09
patch O 0 6.49534267722629e-05
of O 0 0.009413149207830429
histidines O 1 0.9910880327224731
that O 0 6.125501217368878e-10
could O 0 2.650051358910055e-11
be O 0 1.5087524328841195e-12
involved O 0 9.091095931612614e-13
in O 0 2.7352786702294907e-11
pH O 0 6.519597661736043e-08
- O 0 6.8320988866332755e-09
dependent O 0 1.3767376128015485e-09
interactions O 0 3.436579909532611e-10
. O 0 1.221211687330026e-09

We O 0 1.018642059591457e-08
also O 0 4.758492558321059e-11
demonstrate O 0 1.2803211268952452e-10
that O 0 1.677172116465453e-11
soluble O 0 4.906590245212783e-09
TfR O 0 3.096498062404862e-07
and O 0 2.350684091823041e-10
HFE O 0 1.8759799331746763e-06
bind O 0 9.392541605590665e-11
tightly O 0 7.477715113779482e-10
at O 0 2.9191027373087763e-10
the O 0 1.1234198987741806e-10
basic O 0 2.981089153308858e-08
pH O 0 1.928321058386473e-09
of O 0 6.364173188444511e-09
the O 0 7.379553634834224e-10
cell O 0 3.839621121048964e-10
surface O 0 4.954392798794949e-12
, O 0 3.215776711758267e-13
but O 0 4.829773733727727e-13
not O 0 1.5216649554977701e-12
at O 0 5.083335419264756e-10
the O 0 9.983640580912834e-10
acidic O 0 2.557896783272895e-09
pH O 0 3.908421586373834e-09
of O 0 9.067873563139983e-09
intracellular O 0 5.524590918071226e-08
vesicles O 0 5.529597615350212e-07
. O 0 1.3048776281721075e-08

TfR O 0 0.00017450822633691132
HFE O 0 1.7648160792305134e-05
stoichiometry O 0 1.793175208320008e-08
( O 0 9.492931440924224e-11
2 O 0 1.9853287902549255e-09
1 O 0 2.4045021529417454e-10
) O 0 1.3490553143449997e-14
differs O 0 1.7567366764298202e-14
from O 0 6.57572751133241e-14
TfR O 0 3.888640243143726e-10
transferrin O 0 4.2453558030119964e-11
stoichiometry O 0 8.415502322778323e-11
( O 0 8.617675258289215e-13
2 O 0 1.287280282369352e-10
2 O 0 6.898059901061515e-11
) O 0 2.1121288312081488e-14
, O 0 1.8296880666384546e-14
implying O 0 1.6267756998249172e-13
a O 0 8.333787083819252e-14
different O 0 1.4500323142728477e-15
mode O 0 2.826894968110949e-11
of O 0 4.702361330183313e-12
binding O 0 7.330838193431166e-12
for O 0 2.079449026165525e-12
HFE O 0 1.2973784180303483e-07
and O 0 4.095023365541239e-12
transferrin O 0 3.7412883902021576e-10
to O 0 7.246619970757706e-12
TfR O 0 4.791057506281504e-08
, O 0 3.2634864862574053e-12
consistent O 0 4.958195659598985e-11
with O 0 2.1457443027256273e-12
our O 0 1.6539665470549636e-10
demonstration O 0 5.084986653969281e-09
that O 0 2.4061878791531432e-12
HFE O 0 1.2497903867370042e-07
, O 0 4.485389924063776e-12
transferrin O 0 7.936790669127447e-10
, O 0 9.733961900404431e-12
and O 0 2.4243627938513868e-11
TfR O 0 8.213658020395087e-08
form O 0 1.231333923712441e-10
a O 0 3.946706850221915e-10
ternary O 0 4.7425979232684767e-07
complex O 0 1.1896463547600433e-06
. O 0 2.0841703474161477e-08

Identification O 0 6.119335593801623e-10
of O 0 1.0322918075900134e-09
three O 0 1.366293363169735e-11
novel O 0 7.291792170072142e-12
mutations O 0 2.2144486765129923e-12
and O 0 9.763335973023146e-13
a O 0 6.006739159888919e-13
high O 0 6.741991080000398e-12
frequency O 0 2.8290201778413682e-11
of O 0 7.276682589818506e-10
the O 0 3.2406013983354853e-10
Arg778Leu O 0 1.8709221194512793e-07
mutation O 0 1.6084053533482745e-10
in O 0 1.285483611918048e-11
Korean O 0 1.9454265753893196e-08
patients O 0 2.944112661995568e-11
with O 0 7.252773034926996e-12
Wilson B-Disease 0 1.4922193258826155e-05
disease I-Disease 1 0.9999337196350098
. O 0 8.36207405541245e-08

Four O 0 4.640462680782775e-09
mutations O 0 2.9254906830367133e-10
- O 0 7.87298393145619e-10
- O 0 2.2810267563677655e-10
R778L O 0 3.088697964059861e-09
, O 0 2.2041205666178953e-12
A874V O 0 2.7626970156013897e-10
, O 0 5.777153386753164e-13
L1083F O 0 7.585333750004253e-11
, O 0 1.931085093264187e-13
and O 0 5.6019272743788526e-14
2304delC O 0 7.836524831827951e-12
- O 0 1.452040961427703e-12
- O 0 6.908876140458708e-13
in O 0 9.338104291559124e-13
the O 0 3.641329945902605e-11
copper O 0 1.4726411201593237e-09
- O 0 9.103754555761512e-11
transporting O 0 1.7928519779886187e-10
enzyme O 0 7.047043504293526e-11
, O 0 1.602931849753464e-11
P O 0 6.034198349880171e-07
- O 0 1.460378484807734e-09
type O 0 2.970177437333632e-10
ATPase O 0 2.33067898314232e-10
( O 0 7.590376894725526e-13
ATP7B O 0 2.386133779452848e-08
) O 0 5.539493831089454e-14
, O 0 2.1576272059699135e-14
were O 0 1.871386211141704e-13
identified O 0 3.4060997295207174e-13
in O 0 1.136206038108989e-12
Korean O 0 6.886564207775336e-09
Patients O 0 6.503628885434765e-11
with O 0 2.2673704927478333e-11
Wilson B-Disease 0 8.057269951677881e-06
disease I-Disease 1 0.9994841814041138
. O 0 4.0410288448811116e-08

Arg778Leu O 0 6.701298502775899e-07
, O 0 1.9209928092678297e-10
the O 0 7.125924850193144e-11
most O 0 3.6746064632948994e-13
frequently O 0 9.890031231040569e-14
reported O 0 9.645431155169693e-13
mutation O 0 3.33882032264865e-12
of O 0 1.182487580075886e-10
this O 0 3.6011298110150136e-12
enzyme O 0 1.6090204255775342e-12
, O 0 1.823630358050235e-13
was O 0 2.4664048581257703e-11
found O 0 2.5394676595943966e-13
in O 0 1.5722984708903959e-13
six O 0 2.9700044507086076e-12
of O 0 6.087458315207073e-11
eight O 0 1.8234556919960454e-10
unrelated O 0 1.1810698252734397e-10
patients O 0 3.9381963402168596e-13
studied O 0 7.314371330835456e-12
, O 0 1.0558812531995601e-13
an O 0 3.3825561946419e-15
allele O 0 6.50179888227187e-13
frequency O 0 1.557125123285985e-10
of O 0 8.108801630157814e-09
37 O 0 9.378501886203594e-08
. O 0 3.2616384260109044e-08

5 O 0 6.554121512181155e-08
% O 0 4.898863537050602e-10
, O 0 2.0913459766042086e-12
which O 0 2.566536664184299e-13
is O 0 8.64300425391755e-14
considerably O 0 3.026808133559794e-13
higher O 0 2.971035743815076e-12
than O 0 3.239884082588754e-14
those O 0 8.007846772836724e-14
in O 0 3.0981630021881257e-12
other O 0 5.889325485619601e-12
Asian O 0 5.051796758692717e-10
populations O 0 8.810006196791065e-11
. O 0 6.562697052459043e-10

The O 0 1.385221715111129e-09
novel O 0 5.2155064989012345e-11
single O 0 5.478871870079338e-11
nucleotide O 0 3.160350869890749e-10
deletion O 0 2.2217785944356194e-10
, O 0 3.440472082574808e-12
2304delC O 0 1.4102571332941238e-09
, O 0 2.761884124180547e-11
was O 0 3.518646207734122e-10
found O 0 7.972848076187589e-12
in O 0 2.32739053723785e-11
one O 0 1.1691526913271133e-10
patient O 0 1.3677137644663162e-08
. O 0 4.254838970041419e-08

Since O 0 1.044426212182259e-09
a O 0 4.14904569034924e-11
mutation O 0 1.0753039951516552e-11
at O 0 9.250557958528915e-11
cDNA O 0 4.463532210507992e-09
nucleotide O 0 1.1064281046913038e-08
2302 O 0 8.954353916124091e-07
( O 0 1.4722569951358677e-12
2302insC O 0 1.2172483854211436e-10
) O 0 1.289028345868859e-12
had O 0 2.723009318028602e-11
been O 0 5.297009792598617e-12
previously O 0 1.9855965482928895e-10
described O 0 2.805484664025748e-11
, O 0 4.762246911919898e-13
this O 0 9.660081437025403e-14
region O 0 5.813392822684449e-11
of O 0 6.399958341063439e-10
the O 0 1.656679460282362e-09
ATP7B O 0 8.173404239641968e-06
gene O 0 8.782043425803465e-10
may O 0 7.744625080130518e-11
be O 0 3.549196526952958e-12
susceptible O 0 9.135829592832323e-11
to O 0 1.5213108550682364e-12
gene O 0 3.857181241073704e-09
rearrangements O 0 3.2249574815068627e-06
causing O 0 6.087471774662845e-06
Wilson B-Disease 0 8.158094715327024e-06
disease I-Disease 1 0.9681344628334045
. O 0 2.6533074404255785e-08

Disruption O 0 4.588852107190178e-07
of O 0 3.836418827063426e-08
splicing O 0 4.146320620179722e-09
regulated O 0 2.78142980869589e-10
by O 0 2.1106128997305795e-12
a O 0 4.900916825145707e-11
CUG O 0 7.38398114208394e-07
- O 0 9.095514896806378e-10
binding O 0 6.823152709500846e-09
protein O 0 7.284994296696823e-08
in O 0 1.1249927212020339e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.9593185243138578e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999831914901733
DM B-Disease 1 1.0
) O 0 5.636522498742025e-11
is O 0 6.778464508444548e-13
caused O 0 3.1242792641189565e-12
by O 0 6.944335514610933e-13
a O 0 3.493773326201932e-11
CTG O 0 1.7033423560519623e-08
expansion O 0 4.2219224644091113e-11
in O 0 9.383973632870468e-13
the O 0 4.84772682066148e-12
3 O 0 2.6420077237077066e-10
untranslated O 0 2.565588630432103e-08
region O 0 3.371048995504111e-10
of O 0 2.2591795101334355e-09
the O 0 6.452608403151316e-08
DM B-Disease 1 1.0
gene O 0 7.835449622461965e-08
. O 0 1.1006272337965584e-08

One O 0 3.01413130565642e-11
model O 0 1.4317655394613382e-10
of O 0 8.145993746211388e-08
DM B-Disease 1 1.0
pathogenesis O 0 0.24686788022518158
suggests O 0 2.9394175982133675e-10
that O 0 4.956337532231736e-13
RNAs O 0 1.6867232610628946e-10
from O 0 2.682634323014632e-11
the O 0 3.7328612423337404e-11
expanded O 0 5.734778971144827e-12
allele O 0 1.103123885640156e-12
create O 0 5.097493607775228e-13
a O 0 2.4651901613798044e-12
gain O 0 4.46195268233307e-11
- O 0 3.2961237905748675e-11
of O 0 1.2765356771637926e-08
- O 0 6.146540915130672e-11
function O 0 7.031898674458859e-11
mutation O 0 6.540693551007615e-13
by O 0 3.9983885343278236e-14
the O 0 3.957799366016701e-12
inappropriate O 0 1.098990798538424e-12
binding O 0 8.996847537801056e-12
of O 0 2.5459412356099165e-10
proteins O 0 1.2835204904124153e-12
to O 0 3.439553329653844e-12
the O 0 1.4250151059158611e-09
CUG O 0 2.0042556570842862e-05
repeats O 0 3.183046430876857e-07
. O 0 3.822686878152126e-08

Data O 0 1.5827854582539658e-08
presented O 0 6.386255524404305e-09
here O 0 2.4209631521721064e-10
indicate O 0 1.1318072347388242e-11
that O 0 2.9092380631270953e-13
the O 0 1.7081223588344407e-11
conserved O 0 5.915798961808605e-10
heterogeneous O 0 1.4322797392551934e-09
nuclear O 0 1.0460239963094864e-07
ribonucleoprotein O 0 5.806420233511744e-08
, O 0 8.491152919676281e-11
CUG O 0 4.6493335048580775e-07
- O 0 4.374810236296156e-10
binding O 0 7.920488709345364e-10
protein O 0 3.3420666234462715e-10
( O 0 1.3063840374055724e-12
CUG O 0 1.3304152446380613e-07
- O 0 3.545560234297085e-10
BP O 0 1.1616705514194692e-10
) O 0 2.392488435826439e-14
, O 0 4.310476807304134e-14
may O 0 4.880260149990601e-13
mediate O 0 3.2515771325458687e-11
the O 0 1.40440201135128e-10
trans O 0 4.735984937553894e-10
- O 0 6.693689352799126e-11
dominant O 0 2.1677749872939245e-10
effect O 0 2.6230831395857024e-10
of O 0 3.6056560515085323e-10
the O 0 1.9102981696494936e-10
RNA O 0 4.2480818862600245e-09
. O 0 1.054108467180015e-09

CUG O 1 0.941909670829773
- O 0 4.906657522951718e-06
BP O 0 7.419614433956667e-08
was O 0 1.0694164442881515e-09
found O 0 3.5713886275406947e-12
to O 0 4.0601460453253135e-14
bind O 0 5.743071084885268e-14
to O 0 1.0209795655398077e-13
the O 0 9.165461792304264e-12
human O 0 1.560771178965581e-09
cardiac O 1 0.9999998807907104
troponin O 0 0.0021958474535495043
T O 0 8.280532028948073e-07
( O 0 2.8237557691407345e-13
cTNT O 0 8.266295981051996e-11
) O 0 2.515996342744662e-14
pre O 0 3.9086059389070726e-10
- O 0 3.887857483869661e-12
messenger O 0 5.459547202345261e-13
RNA O 0 1.151734740564847e-12
and O 0 3.975089368454289e-14
regulate O 0 1.836366887546237e-13
its O 0 1.844793198410577e-12
alternative O 0 2.7059460228073817e-10
splicing O 0 4.76620920508708e-09
. O 0 7.424307835179889e-10

Splicing O 0 1.013792050308382e-09
of O 0 3.024581030075524e-09
cTNT O 0 9.207830231616754e-08
was O 0 2.278841471081705e-08
disrupted O 0 4.455514954315731e-06
in O 0 4.3950376493739896e-07
DM B-Disease 1 1.0
striated O 0 0.1606707125902176
muscle O 0 0.024319857358932495
and O 0 3.9147426633689975e-08
in O 0 9.084731300568194e-10
normal O 0 3.2997000687373657e-09
cells O 0 7.799603844726999e-12
expressing O 0 7.378725993927027e-13
transcripts O 0 2.339920271432483e-11
that O 0 6.056448745295206e-13
contain O 0 7.654631095643794e-11
CUG O 0 1.543326447972504e-06
repeats O 0 5.05691133412256e-08
. O 0 1.4161880557139739e-08

Altered O 0 3.884552057797919e-08
expression O 0 1.7428573029221184e-09
of O 0 3.345065557880389e-09
genes O 0 1.0451430693114716e-10
regulated O 0 7.096008225460082e-10
posttranscriptionally O 0 1.1282913270349582e-08
by O 0 3.804201120782835e-10
CUG O 0 0.17465586960315704
- O 0 3.557303784873511e-07
BP O 0 6.300090227284727e-09
therefore O 0 1.9421759339666167e-11
may O 0 2.180740830970418e-12
contribute O 0 5.521142354067421e-13
to O 0 8.378730348423957e-11
DM B-Disease 1 1.0
pathogenesis O 0 0.00018578644085209817
. O 0 9.063338968218204e-10
. O 0 2.210696070648055e-09

Identification O 0 2.860573722340831e-10
of O 0 8.325272138343109e-10
a O 0 2.8712808172737248e-11
novel O 0 2.4764832545765003e-11
nonsense O 0 8.141465834832218e-10
mutation O 0 8.329298188669565e-12
and O 0 3.490000172537422e-13
a O 0 1.2171984340586528e-12
missense O 0 3.19115789348956e-10
substitution O 0 7.989124639617984e-11
in O 0 6.685991170429784e-12
the O 0 7.007049107610186e-11
vasopressin O 0 4.0248407384702034e-10
- O 0 2.6365859495669497e-10
neurophysin O 0 2.9173692794870476e-08
II O 0 1.8570331050682398e-08
gene O 0 1.4150431043927214e-12
in O 0 2.607237342688862e-13
two O 0 2.228021776405284e-13
Spanish O 0 8.0986377326564e-11
kindreds O 0 1.1870898042332101e-08
with O 0 9.543360025843217e-12
familial B-Disease 1 0.9999985694885254
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 5.501719613221212e-08

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 4.08806855034527e-09
FNDI B-Disease 1 1.0
) O 0 3.0609515573251644e-13
is O 0 7.996273931084978e-15
an O 0 1.0318030203024589e-14
autosomal B-Disease 1 0.9999843835830688
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 3.027456685344987e-08
by O 0 3.794493799030851e-12
deficiency O 0 1.826058178266976e-05
in O 0 2.1087680213138782e-10
the O 0 1.630407986397131e-08
antidiuretic O 0 1.0443898190715117e-06
hormone O 0 4.254163243899711e-09
arginine O 0 1.6643281197659121e-09
vasopressin O 0 2.444725810679671e-10
( O 0 4.899416376075161e-13
AVP O 0 3.070661780402162e-11
) O 0 2.4128792293722813e-16
encoded O 0 7.03263186380631e-16
by O 0 7.626406152644663e-14
the O 0 1.869683852184778e-10
AVP O 0 2.8380671324157447e-07
- O 0 4.1800842787154124e-09
neurophysin O 0 5.959349209661013e-07
II O 0 5.3762163588544354e-05
( O 0 2.5926876201509685e-09
AVP O 0 1.240571236849064e-06
- O 0 2.0279293799774223e-09
NPII O 0 3.708618123710039e-07
) O 0 3.075712644642903e-12
gene O 0 1.3496030681903193e-11
on O 0 2.1285487261657465e-10
chromosome O 0 6.93607615787073e-09
20p13 O 0 9.904463382781614e-08
. O 0 2.21999325589195e-08

In O 0 6.753053116703711e-10
this O 0 3.826209748342135e-12
study O 0 1.845419650425839e-12
, O 0 5.712875918856275e-13
we O 0 9.116709123735411e-13
analyzed O 0 1.9315723066154478e-12
two O 0 7.479600706156164e-13
families O 0 6.091095916494968e-14
with O 0 1.0806513019503972e-12
FNDI B-Disease 1 1.0
using O 0 7.985266961552107e-12
direct O 0 1.5432101777013152e-11
automated O 0 8.829070252680538e-10
fluorescent O 0 3.40294077638692e-11
, O 0 3.7439951312834285e-13
solid O 0 5.4415461719914404e-11
phase O 0 1.2654073622275774e-10
, O 0 2.717242663513586e-13
single O 0 2.728055845460653e-12
- O 0 2.794236413430906e-12
stranded O 0 9.031440525997247e-12
DNA O 0 1.3879622277890302e-12
sequencing O 0 6.751548647411509e-13
of O 0 5.4781512659474174e-11
PCR O 0 1.3088109263037495e-08
- O 0 9.561197344964967e-08
amplified O 0 4.30529354389364e-07
AVP O 0 1.8752909454633482e-05
- O 0 6.331075041998702e-08
NPII O 0 7.94445259089116e-06
DNA O 0 2.5051923557839473e-07
. O 0 8.771752213476702e-09

In O 0 9.767746611544226e-10
one O 0 3.3042502761704284e-11
of O 0 8.938326190310875e-10
the O 0 2.3933605097781196e-10
families O 0 1.0322606484869379e-12
, O 0 5.162432981098419e-13
affected O 0 5.253941270759455e-13
individuals O 0 1.9711703515105927e-14
presented O 0 1.2369592329586343e-11
a O 0 3.1429930272969253e-12
novel O 0 5.6289881610049886e-12
nonsense O 0 1.4205150944412992e-10
mutation O 0 6.936512453835364e-13
in O 0 5.712004220309597e-13
exon O 0 1.2786421921262558e-10
3 O 0 8.48532494268639e-11
of O 0 3.653532337777321e-11
the O 0 1.0231718250430788e-11
gene O 0 1.233902303249268e-12
, O 0 1.0237192766670428e-13
consisting O 0 5.28052428172554e-13
in O 0 3.93007935223233e-12
a O 0 2.438703960994104e-10
G O 0 2.6475595049646472e-08
to O 0 1.4734663489335276e-10
T O 0 1.6585646633870965e-08
transition O 0 1.3638057350107147e-09
at O 0 2.7618118902950073e-10
nucleotide O 0 2.4410773402649966e-10
2101 O 0 1.5679002984825274e-08
, O 0 1.6641596683585752e-13
which O 0 1.0068137695892678e-14
produces O 0 2.1602626642820005e-14
a O 0 1.2641679424194724e-13
stop O 0 1.6698837408332667e-12
signal O 0 5.642750502965477e-11
in O 0 2.0894293240036887e-11
codon O 0 9.285741620068677e-10
82 O 0 1.0075655865193767e-09
( O 0 3.144451712899787e-11
Glu O 0 2.1263316796193976e-07
) O 0 1.3162014013412549e-11
of O 0 1.7363673832093696e-09
NPII O 0 2.7714149837265722e-05
. O 0 5.523178714383903e-08

The O 0 1.5894781313363637e-07
premature O 0 4.560372346418262e-08
termination O 0 1.7821270015261348e-09
eliminates O 0 3.3244131891763118e-09
part O 0 4.4975228402632794e-11
of O 0 2.2114174935694564e-09
the O 0 7.387679357151455e-10
C O 0 3.207319565490252e-08
- O 0 6.505576632953591e-11
terminal O 0 6.266383939523834e-11
domain O 0 7.956608462367232e-12
of O 0 3.7086965443133835e-11
NPII O 0 1.0494733260202338e-07
, O 0 2.2815334690950984e-12
including O 0 3.685382294477124e-12
a O 0 1.3412527165301835e-11
cysteine O 0 3.268265866274156e-11
residue O 0 1.4536920556196264e-09
in O 0 6.9432927289614366e-12
position O 0 1.0129062866237604e-10
85 O 0 4.652734864052377e-10
, O 0 2.4196634279549656e-12
which O 0 3.027183538562017e-13
could O 0 4.515775774149855e-13
be O 0 2.2779797796343426e-13
involved O 0 3.6829138913910264e-13
in O 0 3.922021561686417e-12
the O 0 4.950940768466694e-10
correct O 0 8.06296540645235e-09
folding O 0 2.7664224688805916e-08
of O 0 2.0644597142904786e-08
the O 0 5.621553356149889e-08
prohormone O 0 9.358324314234778e-05
. O 0 2.8579322020050313e-07

In O 0 6.382135930849131e-10
the O 0 7.348218145075691e-10
second O 0 1.2355032552591183e-09
family O 0 2.2500990654039654e-11
, O 0 6.400635230163765e-12
a O 0 2.1228876295742438e-11
G279A O 0 1.2181781139375403e-09
substitution O 0 1.4824003136126862e-09
at O 0 7.713935601394439e-10
position O 0 7.359856474264959e-11
- O 0 7.836854429288387e-12
1 O 0 8.179704830135748e-11
of O 0 3.0499169162423456e-11
the O 0 8.917167351740751e-12
signal O 0 3.5523292640782245e-10
peptide O 0 2.45633947210111e-11
was O 0 2.1390519563957433e-11
observed O 0 4.314726093773702e-12
in O 0 8.823770165054812e-13
all O 0 3.825042279442803e-12
affected O 0 1.5538516653923473e-11
individuals O 0 1.4285997515170457e-12
. O 0 4.0083332208951106e-09

This O 0 1.8775027366135788e-10
missense O 0 1.6042638151247957e-07
mutation O 0 8.672365048312258e-10
, O 0 1.6551742615389387e-11
which O 0 7.328521123284304e-11
replaces O 0 3.5116306662530405e-07
Ala O 0 1.1421448675719148e-07
with O 0 2.107637155079889e-11
Thr O 0 1.5105543980098446e-06
, O 0 9.446146989611215e-12
is O 0 1.7527280083036445e-13
frequent O 0 9.500534907391778e-12
among O 0 3.9727460904304124e-11
FNDI B-Disease 1 1.0
patients O 0 5.906751425754919e-07
and O 0 4.802743272525056e-11
is O 0 8.082584948554405e-12
thought O 0 8.323977791768744e-12
to O 0 3.7254460584154603e-13
reduce O 0 1.1166052804600923e-10
the O 0 7.026629278428231e-11
efficiency O 0 2.128034193304984e-09
of O 0 1.9394745531808866e-10
cleavage O 0 2.723716044372715e-11
by O 0 7.049419641774746e-12
signal O 0 3.26154534491252e-08
peptidases O 0 4.875332137999067e-07
. O 0 9.156611580074525e-10
. O 0 5.7835927158578215e-09

Genetic O 0 8.429985598468193e-09
heterogeneity O 0 2.7812891545409002e-08
of O 0 2.3546137128960254e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 7.036786153769015e-10
due O 0 1.0587555152596906e-06
to O 0 1.9764413716760743e-10
TWIST O 0 2.998962372657843e-06
and O 0 2.085585038003046e-09
FGFR O 0 0.04225970804691315
mutations O 0 3.3409293109798455e-08
. O 0 4.983134793690169e-09

Thirty O 0 7.116561846487457e-07
- O 0 4.220479254968268e-08
two O 0 5.427138946578758e-11
unrelated O 0 6.467227309236989e-10
patients O 0 7.549516567451064e-13
with O 0 7.735545331458843e-15
features O 0 6.68130717418336e-10
of O 0 1.1406573321437463e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.415537115971425e-11
a O 0 6.463105745035946e-11
common O 0 4.803676034725868e-08
autosomal B-Disease 0 0.0014814091846346855
dominant I-Disease 0 0.0002605098707135767
condition I-Disease 1 0.9999103546142578
of O 0 0.26653847098350525
craniosynostosis B-Disease 1 1.0
and O 0 1.2650062330976652e-07
limb B-Disease 1 0.9999145269393921
anomalies I-Disease 0 0.30137452483177185
, O 0 1.3647052932164172e-10
were O 0 6.178347417007402e-11
screened O 0 1.6963506987988097e-10
for O 0 7.916584054967757e-12
mutations O 0 3.6317854973377806e-11
in O 0 1.4171917805949619e-10
TWIST O 0 2.6265109909218154e-07
, O 0 2.4492483041704816e-10
FGFR2 O 0 8.993848314275965e-05
, O 0 4.859850299965274e-10
and O 0 1.5304167932939094e-09
FGFR3 O 0 0.00016670154582243413
. O 0 1.0823164586781786e-07

Nine O 0 1.1996220017351789e-08
novel O 0 1.870543442361594e-10
and O 0 3.4296173540004915e-11
three O 0 6.875375269110862e-11
recurrent O 0 2.6078066639456665e-06
TWIST O 0 3.3682617868180387e-06
mutations O 0 1.86195503459885e-09
were O 0 5.41153344357781e-10
found O 0 1.9242116580664437e-11
in O 0 2.0946364434615283e-11
12 O 0 2.4451619395904345e-08
families O 0 8.792296057880122e-11
. O 0 7.116804034978941e-09

Seven O 0 5.9260031548546976e-08
families O 0 3.607952131501335e-11
were O 0 1.7184431655437038e-10
found O 0 5.019893355162619e-12
to O 0 2.089699073504203e-12
have O 0 1.1453255878424162e-11
the O 0 3.0926930461028235e-10
FGFR3 O 0 1.346616591035854e-05
P250R O 0 8.799153761174239e-08
mutation O 0 9.312021292950945e-11
, O 0 3.7033134263168843e-13
and O 0 5.878055204036614e-13
one O 0 1.172027210526172e-12
individual O 0 9.611272281523364e-13
was O 0 8.51685055813789e-10
found O 0 8.095499097471315e-12
to O 0 1.1258985280551692e-12
have O 0 2.9615986312653275e-12
an O 0 1.3988213799082105e-12
FGFR2 O 0 1.5811040157132084e-06
VV269 O 0 2.1394882310232788e-07
- O 0 1.4584419005814198e-08
270 O 0 3.4104101764853567e-09
deletion O 0 9.392372213312683e-09
. O 0 2.4678847854175956e-09

To O 0 9.433116787693763e-11
date O 0 2.0490737995260133e-08
, O 0 8.234739279355807e-12
our O 0 4.301775515663797e-12
detection O 0 8.575429949475577e-11
rate O 0 2.8464702817032617e-11
for O 0 1.3658132784477583e-12
TWIST O 0 3.151058969308451e-09
or O 0 1.027611884474311e-10
FGFR O 0 6.698602419419331e-07
mutations O 0 8.651721700170256e-12
is O 0 1.221665862005325e-13
68 O 0 4.741848580458452e-11
% O 0 9.466560564955206e-13
in O 0 1.0066996064886369e-12
our O 0 2.99444385953862e-10
Saethre B-Disease 1 0.9998596906661987
- I-Disease 1 0.9999985694885254
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.930698072058703e-10
, O 0 2.8732173433000663e-13
including O 0 2.8236174249435253e-12
our O 0 5.480986220440798e-10
five O 0 1.5430018374118504e-10
patients O 0 2.501668663890122e-11
elsewhere O 0 2.5218136606719455e-11
reported O 0 3.506524584584447e-11
with O 0 4.2343257372623455e-11
TWIST O 0 3.4361888538114727e-05
mutations O 0 1.5512399897943396e-07
. O 0 2.085769068571608e-08

More O 0 3.819942417937483e-10
than O 0 5.686486351241804e-11
35 O 0 1.1671412725178243e-09
different O 0 6.572636965934686e-12
TWIST O 0 8.741205093087956e-09
mutations O 0 2.830175330204021e-11
are O 0 3.572245309887284e-13
now O 0 2.3832986365684983e-13
known O 0 2.472855904420146e-13
in O 0 1.5222804570710902e-12
the O 0 1.7615811587212704e-11
literature O 0 1.0019843288411323e-10
. O 0 7.697635306946893e-10

The O 0 1.2160846551978466e-08
most O 0 1.3752349953266574e-11
common O 0 3.535278840505196e-12
phenotypic O 0 2.2574639380046335e-10
features O 0 2.3161909890045962e-11
, O 0 2.5286698191080703e-13
present O 0 5.100771150942651e-13
in O 0 1.3804114101789722e-12
more O 0 2.676374916230507e-14
than O 0 1.1139020614095788e-13
a O 0 4.62496577494087e-12
third O 0 4.360314886930894e-10
of O 0 1.7778635452714298e-08
our O 0 6.375885597265096e-09
patients O 0 7.256218629431155e-12
with O 0 9.519249537931485e-13
TWIST O 0 3.4862633668808485e-08
mutations O 0 3.9453048467086305e-11
, O 0 2.4930979589804503e-12
are O 0 1.360659740261283e-12
coronal B-Disease 0 3.903875551714009e-07
synostosis I-Disease 0 8.870059104992833e-07
, O 0 1.0680888812286682e-10
brachycephaly B-Disease 0 4.64410504719126e-06
, O 0 1.3436814993994517e-09
low B-Disease 0 0.004832174628973007
frontal I-Disease 1 0.9999998807907104
hairline I-Disease 1 1.0
, O 0 2.428698486767189e-08
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.9999881982803345
, O 0 8.581263699625197e-09
ptosis B-Disease 1 0.999987006187439
, O 0 9.113818588701861e-10
hypertelorism B-Disease 0 0.001024508965201676
, O 0 1.883511346889577e-09
broad B-Disease 0 2.779492933768779e-05
great I-Disease 0 0.0006160375778563321
toes I-Disease 0 0.0005808131536468863
, O 0 6.816150976973745e-10
and O 0 7.953676828265088e-09
clinodactyly B-Disease 0 0.00038364800275303423
. O 0 1.0113747066498036e-06

Significant O 0 1.7048311207190636e-08
intra O 0 1.2099902733098133e-06
- O 0 1.5698692124033187e-08
and O 0 7.07292488466571e-11
interfamilial O 0 4.8802906604805685e-08
phenotypic O 0 3.53778197847987e-08
variability O 0 2.3813995220223205e-09
is O 0 3.823129421549887e-13
present O 0 7.846976649190929e-13
for O 0 2.6439761838248366e-12
either O 0 3.243124380158946e-10
TWIST O 0 7.593320816567939e-08
mutations O 0 6.531864493730666e-10
or O 0 3.1215960372144025e-10
FGFR O 0 0.00010135719639947638
mutations O 0 4.6843329215562335e-08
. O 0 9.2716581079344e-09

The O 0 1.4060189679199198e-09
overlap O 0 9.94505450213623e-11
in O 0 7.654423102299024e-12
clinical O 0 5.805421032789582e-09
features O 0 7.484164954441042e-10
and O 0 1.8732236248264478e-11
the O 0 1.936597583684918e-11
presence O 0 2.9197124318952605e-12
, O 0 1.865591421580312e-13
in O 0 6.130775141027778e-13
the O 0 2.2144191862139007e-12
same O 0 7.563900135572343e-13
genes O 0 8.695785248553217e-14
, O 0 2.7007945372866694e-14
of O 0 5.1995126953974236e-12
mutations O 0 3.0427087715709233e-13
for O 0 3.6556475620057316e-13
more O 0 3.83672924702573e-14
than O 0 5.752786485027639e-13
one O 0 8.725333823511594e-12
craniosynostotic B-Disease 0 1.9123253878206015e-06
condition I-Disease 0 0.3827499449253082
- O 0 1.5903621752855202e-09
such O 0 2.489052297605099e-10
as O 0 1.300637098022861e-10
Saethre B-Disease 0 5.346674242900917e-06
- I-Disease 0 3.173195395334005e-08
Chotzen I-Disease 0 5.166165237824316e-07
, I-Disease 0 5.946487746655293e-11
Crouzon I-Disease 0 1.8743172347512882e-07
, I-Disease 0 5.855056023351679e-11
and I-Disease 0 9.688733842994068e-11
Pfeiffer I-Disease 0 4.2044987935696554e-07
syndromes I-Disease 0 9.541514373268e-06
- O 0 8.697503517396399e-08
support O 0 6.23290663526177e-09
the O 0 1.4079224008867186e-08
hypothesis O 0 2.5420312521617916e-09
that O 0 1.860131189704295e-12
TWIST O 0 5.031259409093991e-09
and O 0 1.584148263955587e-11
FGFRs O 0 5.190328167259395e-08
are O 0 1.2415536264007154e-12
components O 0 1.2441743468816213e-10
of O 0 1.8580136318391283e-09
the O 0 6.067983615576367e-11
same O 0 4.7227018303008794e-12
molecular O 0 4.85680835826674e-11
pathway O 0 1.5585526575920272e-12
involved O 0 9.34071342408721e-15
in O 0 9.179671284990486e-15
the O 0 4.168912665167973e-13
modulation O 0 4.535997619181664e-11
of O 0 2.888101979792168e-09
craniofacial O 1 1.0
and O 0 1.6728128571230627e-07
limb O 0 0.07137613743543625
development O 0 2.945075738836067e-09
in O 0 7.747993913120865e-11
humans O 0 2.0338548900600273e-10
. O 0 7.760891235220058e-11
. O 0 2.8902951143550126e-09

Mutation O 0 1.6084246157177517e-09
analysis O 0 3.12400660895662e-11
of O 0 5.353263388130358e-10
UBE3A O 1 0.9632547497749329
in O 0 1.15801876745536e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0002730892738327384
. O 0 7.531226486889864e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.00011136705143144354
AS B-Disease 1 1.0
) O 0 3.679587884386493e-12
is O 0 3.1552443492156856e-13
caused O 0 6.854578536719114e-12
by O 0 1.7002747950897734e-12
chromosome O 0 2.8593258871723037e-09
15q11 O 0 1.5414091336651836e-08
- O 0 6.92552404313318e-10
q13 O 0 6.451051359768201e-10
deletions O 0 2.024974112002642e-11
of O 0 1.3770197655749161e-11
maternal O 0 3.6101458194409686e-12
origin O 0 1.7163832475523139e-13
, O 0 2.0740518203170473e-14
by O 0 2.763799660052829e-13
paternal O 0 4.7138000169866245e-09
uniparental B-Disease 0 0.0005053587956354022
disomy I-Disease 0 0.013529316522181034
( O 0 4.32947437900566e-08
UPD B-Disease 1 1.0
) O 0 8.293787531754582e-12
15 O 0 3.8231112720055194e-11
, O 0 1.3898078651472523e-13
by O 0 1.1564873407879372e-12
imprinting O 0 5.5801843700464815e-05
defects O 1 0.978540301322937
, O 0 3.3423372576557586e-12
and O 0 1.2307879325088034e-12
by O 0 2.268918126296926e-12
mutations O 0 1.947562076887177e-11
in O 0 2.5134056294562335e-11
the O 0 1.6967819371771498e-09
UBE3A O 0 2.2052321583032608e-05
gene O 0 7.332010110161491e-09
. O 0 3.601554610099811e-09

UBE3A O 0 0.001020575175061822
encodes O 0 2.69452549161997e-08
a O 0 4.564338240697907e-09
ubiquitin O 0 7.826424841539392e-09
- O 0 3.014525296052284e-09
protein O 0 5.53090073740492e-10
ligase O 0 2.1508590047902842e-11
and O 0 2.9548731083489654e-12
shows O 0 5.627963095555799e-10
brain O 0 8.965994879872596e-08
- O 0 2.634747531260473e-09
specific O 0 5.888163290279635e-10
imprinting O 0 3.1012580166134285e-06
. O 0 1.673011418290571e-08

Here O 0 2.6524775265102107e-08
we O 0 1.305204833101925e-10
describe O 0 1.683021083609404e-10
UBE3A O 0 1.3178221252019284e-06
coding O 0 3.3810589883387365e-08
- O 0 1.7451559086723023e-09
region O 0 3.3287134160175924e-10
mutations O 0 6.54481547082697e-12
detected O 0 8.418516751762528e-12
by O 0 2.0971737801217527e-12
SSCP O 0 2.8168730636934924e-07
analysis O 0 1.571598406968633e-11
in O 0 4.4728679093886115e-11
13 O 0 1.973580410208342e-08
AS B-Disease 1 0.9999998807907104
individuals O 0 7.29117558429665e-13
or O 0 1.2826424818090931e-11
families O 0 1.8816101454710576e-11
. O 0 4.303538414518471e-09

Two O 0 2.5278021897889857e-09
identical O 0 6.096783966569319e-09
de O 0 9.077114668798458e-07
novo O 0 1.0772834002636955e-06
5 O 0 1.2685048034200008e-07
- O 0 3.5011063492795813e-10
bp O 0 8.613164348414415e-11
duplications O 0 3.985392016403466e-10
in O 0 1.2078218980526856e-10
exon O 0 5.326015184436983e-08
16 O 0 1.048150632954048e-08
were O 0 3.3772802332521223e-09
found O 0 8.036782905840312e-10
. O 0 6.732248092333748e-09

Among O 0 2.334835658146517e-09
the O 0 1.3041080437758978e-09
other O 0 1.3742333659916284e-11
11 O 0 2.0603792005857713e-09
unique O 0 2.3249070724151721e-10
mutations O 0 6.50974690818984e-11
, O 0 1.715435953009159e-11
8 O 0 2.6164599375988473e-08
were O 0 5.865520846803918e-10
small O 0 1.544287787924592e-11
deletions O 0 1.0187907462100299e-10
or O 0 1.5436723080353154e-11
insertions O 0 6.308058519977067e-10
predicted O 0 3.4691149952692513e-09
to O 0 6.959707549852867e-12
cause O 0 5.915644418763577e-09
frameshifts O 0 5.673206828760158e-07
, O 0 2.4905896789384485e-11
1 O 0 3.5738474402080556e-09
was O 0 8.545762014700031e-11
a O 0 1.0194253210679682e-12
mutation O 0 1.2606669180792451e-13
to O 0 1.596521749709385e-14
a O 0 5.181887362780413e-13
stop O 0 1.0768679351014221e-11
codon O 0 1.7698965557033652e-11
, O 0 1.1143992358682991e-13
1 O 0 9.167525245878938e-12
was O 0 2.4472938866398897e-12
a O 0 4.712208271154261e-13
missense O 0 1.1051994042166058e-10
mutation O 0 1.945266864256112e-12
, O 0 7.222105807272103e-14
and O 0 6.598370396078412e-13
1 O 0 1.6990489015711319e-09
was O 0 5.290330951090993e-10
predicted O 0 1.624812090428307e-10
to O 0 9.478159359796456e-13
cause O 0 5.974273159514709e-11
insertion O 0 8.677800665546354e-12
of O 0 9.459264482813978e-10
an O 0 1.0128477917481504e-11
isoleucine O 0 1.049035063260817e-07
in O 0 2.7702198174273107e-11
the O 0 1.8626858389048095e-10
hect O 0 8.561726438927053e-09
domain O 0 6.228256244078523e-10
of O 0 4.997012137408774e-09
the O 0 1.111682079724119e-09
UBE3A O 0 7.817683354005567e-07
protein O 0 9.701715125709498e-11
, O 0 2.5507200518415374e-13
which O 0 2.6043332394072236e-14
functions O 0 3.3317333267279814e-12
in O 0 2.76812288368955e-11
E2 O 0 2.930189779704051e-08
binding O 0 7.242726557388224e-11
and O 0 6.173255483188367e-12
ubiquitin O 0 2.0432137926018612e-10
transfer O 0 2.0223360763793607e-09
. O 0 2.1976884756469417e-09

Eight O 0 1.5271867326305255e-08
of O 0 4.276642151523902e-09
the O 0 5.864712881997747e-11
cases O 0 9.912174379900218e-12
were O 0 3.67714088345128e-11
familial O 0 2.757959860488768e-09
, O 0 1.0545302825404335e-10
and O 0 3.394418079949446e-10
five O 0 3.4206706356343375e-09
were O 0 4.287954435966412e-09
sporadic O 0 6.871450023027137e-05
. O 0 4.422383881319547e-07

In O 0 1.1919347453481777e-10
two O 0 1.2146804395651856e-11
familial O 0 1.6244660061559557e-09
cases O 0 4.243040988005653e-11
and O 0 9.910132610368994e-12
one O 0 3.432220219840021e-12
sporadic O 0 1.8726019845871633e-07
case O 0 2.93821800223526e-10
, O 0 5.777354723096595e-12
mosaicism O 0 5.704223582370105e-08
for O 0 1.5434374611711377e-10
UBE3A O 0 4.911620180791942e-06
mutations O 0 8.981450999590024e-12
was O 0 4.592686907861632e-12
detected O 0 3.5059458049387093e-13
in O 0 4.876612351781273e-13
the O 0 6.938990181060145e-12
mother O 0 2.2857063464165606e-12
of O 0 6.03926242348507e-09
three O 0 2.4792470298962144e-08
AS B-Disease 1 1.0
sons O 0 1.438826502386803e-09
, O 0 1.4951050380379582e-12
in O 0 6.383420701749909e-12
the O 0 8.944767843077628e-11
maternal O 0 2.3927351766594995e-10
grandfather O 0 7.504032950578221e-10
of O 0 2.1940672922937665e-07
two O 0 2.1620614187867204e-09
AS B-Disease 1 1.0
first O 0 1.4528216407683203e-09
cousins O 0 5.847625716981497e-10
, O 0 6.278032781137366e-12
and O 0 4.479251605044032e-12
in O 0 4.295063263382026e-11
the O 0 1.7143647612627433e-09
mother O 0 3.061832176687318e-10
of O 0 2.1055433307992644e-07
an O 0 1.080176836865121e-09
AS B-Disease 1 1.0
daughter O 0 2.999672119585739e-07
. O 0 4.4466079884841747e-07

The O 0 3.3919328457088227e-10
frequencies O 0 4.181752600446176e-12
with O 0 3.4314261501688925e-13
which O 0 4.3856311269206694e-13
we O 0 2.2332634873334367e-13
detected O 0 4.0498325179494365e-12
mutations O 0 4.0512599243196223e-13
were O 0 3.411003467526652e-12
5 O 0 6.147455461347207e-11
( O 0 1.231646891679955e-13
14 O 0 2.018857823971043e-11
% O 0 6.600107287958734e-13
) O 0 2.673516349440113e-15
of O 0 8.672765739077548e-13
35 O 0 1.5726411058819556e-12
in O 0 9.475334064460231e-14
sporadic O 0 2.4958266009456054e-10
cases O 0 2.2773900820727278e-12
and O 0 1.312733342168082e-12
8 O 0 6.25569929191272e-10
( O 0 8.730435672359496e-14
80 O 0 1.1545219641417859e-11
% O 0 8.689522625754398e-13
) O 0 1.5827142656361926e-14
of O 0 6.9219773142503715e-12
10 O 0 1.9884607849185443e-11
in O 0 7.690569535367953e-12
familial O 0 6.062876423129637e-09
cases O 0 1.0139075690140942e-10
. O 0 1.6170859096220624e-10
. O 0 3.819791150050378e-09

The O 0 1.3943645171821117e-06
hemochromatosis B-Disease 1 1.0
845 O 0 3.813147770870273e-07
G O 0 2.7979359629171086e-07
- O 0 2.0070154427287434e-09
- O 0 2.726664449781424e-10
> O 0 1.161365337232212e-09
A O 0 1.823145280577254e-11
and O 0 7.475589564693783e-14
187 O 0 1.118680452091847e-12
C O 0 1.0891840207527537e-10
- O 0 8.850815913508114e-11
- O 0 1.9958523722607424e-10
> O 0 2.7808531033457484e-09
G O 0 2.0062920214058977e-09
mutations O 0 5.666324180697568e-12
: O 0 1.5753655771924037e-14
prevalence O 0 7.469001805926467e-11
in O 0 5.601566844919137e-13
non O 0 8.644839510907332e-09
- O 0 4.4324788284200167e-10
Caucasian O 0 1.125178838989882e-09
populations O 0 3.695938000092269e-10
. O 0 4.886451798746805e-10

Hemochromatosis B-Disease 1 0.961100697517395
, O 0 1.8210827290587872e-09
the O 0 9.066338435559373e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999877214431763
, O 0 5.6012094268309554e-11
leads O 0 6.308961686407599e-10
, O 0 2.570800343437707e-12
if O 0 2.102221001443194e-11
untreated O 0 1.839154606386728e-08
, O 0 3.731861011619514e-13
to O 0 4.586506088116726e-12
progressive O 1 0.8715581893920898
iron B-Disease 1 0.9993595480918884
overload I-Disease 0 0.006526996847242117
and O 0 1.2203856591952444e-08
premature B-Disease 0 4.6531212660738674e-07
death I-Disease 0 1.3086253147776006e-07
. O 0 4.977359857605279e-09

The O 0 1.72680563537142e-06
hemochromatosis B-Disease 1 1.0
gene O 0 1.0682570383835355e-08
, O 0 6.041560307590288e-11
HFE O 0 7.317689323826926e-06
, O 0 2.1474813247102098e-11
recently O 0 5.6961799860255624e-11
has O 0 3.2343043716333286e-13
been O 0 2.421661504138639e-13
identified O 0 1.712472394790887e-13
, O 0 5.1006711332922394e-14
and O 0 3.0807133103230577e-13
characterization O 0 1.3102474834270073e-11
of O 0 8.382122218542065e-10
this O 0 3.904868615955959e-12
gene O 0 2.9546645078509792e-12
has O 0 6.730100282409043e-14
shown O 0 1.1132117634388844e-13
that O 0 4.30198208328271e-15
it O 0 1.983222190394011e-15
contains O 0 5.998607372544734e-14
two O 0 3.9055872658134635e-14
mutations O 0 8.130260652000273e-14
that O 0 3.778240605578284e-14
result O 0 1.5927708804652774e-11
in O 0 3.1737473760173884e-11
amino O 0 1.6358574217445465e-10
acid O 0 4.115342181615356e-12
substitutions O 0 1.6024487292654044e-11
- O 0 2.4298393158650455e-11
cDNA O 0 1.2386550118925754e-10
nucleotides O 0 2.2658992737678574e-12
845 O 0 7.04639515139438e-12
G O 0 1.9243558135872973e-10
- O 0 1.9396002859384254e-10
- O 0 1.0830603774936165e-10
> O 0 1.6746284914326282e-10
A O 0 1.4687490806908343e-11
( O 0 2.2817257066106095e-15
C282Y O 0 7.13034937083884e-13
) O 0 1.5174658777531835e-15
and O 0 1.5015451311798864e-14
187 O 0 7.187068323290247e-13
C O 0 6.717106731946032e-11
- O 0 1.732918808450279e-10
- O 0 2.8861399381518993e-10
> O 0 1.233925406296521e-09
G O 0 3.774749401941335e-09
( O 0 1.2544766657754391e-12
H63D O 0 2.8838098131700463e-08
) O 0 3.308272059077133e-12
. O 0 4.890831489801073e-11

Although O 0 3.5668492159857124e-07
hemochromatosis B-Disease 1 1.0
is O 0 3.041087520694319e-11
common O 0 1.4301155745743976e-12
in O 0 2.31784686929859e-12
Caucasians O 0 2.0950021717425216e-09
, O 0 4.557902232721345e-12
affecting O 0 1.0307153741617725e-10
> O 0 5.28325472259894e-09
= O 0 8.677759621988912e-10
1 O 0 9.897713759698945e-10
/ O 0 8.970258563723021e-11
300 O 0 5.805918354591377e-13
individuals O 0 9.348412953577752e-15
of O 0 1.748902932197094e-11
northern O 0 1.1995064663761212e-10
European O 0 1.3949853425176961e-11
origin O 0 1.778273817261422e-12
, O 0 3.339627294325631e-13
it O 0 1.0270166065241143e-13
has O 0 9.327045022823957e-14
not O 0 1.2060468455084988e-14
been O 0 4.7765258545315326e-14
recognized O 0 4.4656520235136776e-13
in O 0 1.0629540867293508e-12
other O 0 2.5152074433626437e-12
populations O 0 9.624380459261062e-11
. O 0 8.352502023356578e-10

The O 0 5.409644954212922e-10
present O 0 2.720605858652636e-11
study O 0 1.3688332151789995e-12
used O 0 2.8661345215577616e-13
PCR O 0 2.471119697755597e-10
and O 0 7.146773624289171e-12
restriction O 0 2.9491229458500356e-09
- O 0 9.61320745229699e-11
enzyme O 0 6.794787714252404e-13
digestion O 0 2.541814198356307e-12
to O 0 9.084673998857075e-15
analyze O 0 1.1138531367865454e-13
the O 0 1.093437067777557e-13
frequency O 0 2.9833013229924044e-12
of O 0 2.6091798860372606e-11
the O 0 2.3415856059694207e-11
845 O 0 5.7523208418786e-11
G O 0 7.968948834147227e-10
- O 0 9.550794183299516e-11
- O 0 3.439581258701807e-11
> O 0 2.4107427165631634e-10
A O 0 8.274194697455162e-12
and O 0 3.2144564923253585e-14
187 O 0 8.266555842628698e-13
C O 0 2.972120119459909e-11
- O 0 1.436403773702466e-11
- O 0 2.0481486298629115e-11
> O 0 3.877471399515997e-10
G O 0 3.24805821128038e-10
mutations O 0 5.612774784877206e-13
in O 0 5.165132102406822e-13
HLA O 0 5.651474774270859e-11
- O 0 2.2183040994383507e-12
typed O 0 9.260947043954193e-13
samples O 0 3.9972316906097816e-13
from O 0 9.976201722355915e-13
non O 0 6.407558483800813e-09
- O 0 9.729994587814872e-11
Caucasian O 0 6.07706385213902e-11
populations O 0 4.767393077531601e-12
, O 0 7.305844839690379e-14
comprising O 0 3.8279908756710945e-12
Australian O 0 6.929960078005948e-11
Aboriginal O 0 1.0569709690821938e-10
, O 0 1.92186327616084e-12
Chinese O 0 3.9591906142444344e-11
, O 0 6.341021024230953e-12
and O 0 8.475814494701694e-11
Pacific O 0 4.187906910146921e-08
Islanders O 0 5.112287340125476e-07
. O 0 2.8633005300093828e-08

Results O 0 2.4746535931541302e-09
showed O 0 1.0844541931120943e-09
that O 0 7.222000233085557e-13
the O 0 1.3443166024806885e-10
845 O 0 1.3871834791956417e-09
G O 0 1.0631087121737437e-07
- O 0 1.2648802893977518e-08
- O 0 2.3064856691235036e-09
> O 0 3.3956113476563132e-09
A O 0 4.038102491277229e-11
mutation O 0 3.594430796841769e-13
was O 0 1.0740647466474934e-13
present O 0 5.2204122846940225e-15
in O 0 9.506139805718922e-15
these O 0 6.4108637289842646e-15
populations O 0 2.0328628103777335e-13
( O 0 1.841788016993277e-15
allele O 0 4.076099063853901e-14
frequency O 0 5.685138557837144e-12
0 O 0 6.051362883008338e-11
. O 0 4.867298648543808e-14
32 O 0 3.228770983215723e-12
% O 0 4.4432556592366446e-13
) O 0 1.178913500295923e-14
, O 0 3.7264387810296423e-14
and O 0 2.0822022762673892e-13
, O 0 7.92059357012688e-14
furthermore O 0 2.434583784571842e-12
, O 0 8.230790587938561e-14
it O 0 7.982334818091782e-14
was O 0 6.008463865336822e-11
always O 0 1.43867892859334e-12
seen O 0 2.0861258684043427e-13
in O 0 1.6020491479099876e-14
conjunction O 0 1.1444710196900632e-12
with O 0 1.2321760365502366e-12
HLA O 0 1.9306407139652038e-08
haplotypes O 0 2.4557317290785363e-10
common O 0 5.75949747963489e-12
in O 0 2.3038749727422037e-12
Caucasians O 0 3.225924249949941e-10
, O 0 5.895211077112938e-13
suggesting O 0 1.4793060873485864e-11
that O 0 4.5087037402191665e-12
845 O 0 1.5865113667246078e-09
G O 0 3.955950433010003e-06
- O 0 2.8902747999381972e-06
- O 0 4.0704406956137973e-07
> O 0 1.1316037671349477e-06
A O 0 2.750007332963378e-09
may O 0 2.164554343056513e-12
have O 0 1.664047724484266e-14
been O 0 8.298996730170087e-15
introduced O 0 3.2233283154149e-14
into O 0 2.6033485636060404e-15
these O 0 2.5570596953462506e-15
populations O 0 3.721509388089801e-14
by O 0 3.024159427652412e-13
Caucasian O 0 1.796162663048051e-09
admixture O 0 3.006281446005232e-08
. O 0 2.4635124162841748e-08

187 O 0 1.640489699639147e-08
C O 0 1.6400955260564842e-08
- O 0 1.3257949182943207e-09
- O 0 3.6302638672935927e-10
> O 0 1.0875176315039425e-09
G O 0 6.475645575321209e-10
was O 0 3.42849728642014e-12
present O 0 1.026194239176284e-13
at O 0 2.783256210139168e-13
an O 0 7.265953441874611e-16
allele O 0 4.507718593467665e-14
frequency O 0 7.673250923545538e-12
of O 0 7.288753489653743e-10
2 O 0 8.572531129402705e-08
. O 0 2.354513028990368e-09

68 O 0 1.4242351653592777e-07
% O 0 1.6406757896714197e-10
in O 0 6.086805105082194e-12
the O 0 2.7597884047492194e-11
two O 0 1.1168128054295234e-12
populations O 0 1.5778059197710248e-12
analyzed O 0 2.053107033342383e-12
( O 0 7.980557404155264e-13
Australian O 0 1.8583565242202837e-10
Aboriginal O 0 3.9984118793690016e-10
and O 0 3.8416415881759036e-11
Chinese O 0 1.6069312547273285e-09
) O 0 2.7876848399110976e-11
. O 0 2.3884549893438134e-09

In O 0 5.968828209468313e-11
the O 0 6.290454268587098e-11
Australian O 0 2.0432994185526354e-10
Aboriginal O 0 1.1894502049969446e-10
samples O 0 8.356541153498043e-12
, O 0 2.8598887581027244e-12
187 O 0 4.406883538643491e-11
C O 0 2.0723092131191834e-09
- O 0 2.590379244438168e-09
- O 0 4.668436304200441e-09
> O 0 6.795906415391073e-08
G O 0 1.3498244300080842e-07
was O 0 6.061762758413636e-10
found O 0 4.4672192377540054e-13
to O 0 7.083170719878948e-15
be O 0 1.629725271835164e-14
associated O 0 1.7739637341550318e-13
with O 0 1.0474604582137725e-13
HLA O 0 6.211153369406475e-09
haplotypes O 0 2.8204122370922846e-10
common O 0 4.5389291283837174e-12
in O 0 1.3527465822851803e-12
Caucasians O 0 1.2256354264827962e-10
, O 0 9.903547166373317e-14
suggesting O 0 2.6710469773483236e-13
that O 0 1.3268690650608626e-14
it O 0 3.8775596232151766e-14
was O 0 6.272216253322416e-12
introduced O 0 1.7309350567457082e-12
by O 0 3.9003780131878496e-13
recent O 0 2.3569460619321525e-11
admixture O 0 2.3747319666256317e-09
. O 0 4.264163244727115e-09

In O 0 1.1115950382389883e-09
the O 0 2.8321420209032055e-10
Chinese O 0 2.0701896794039776e-11
samples O 0 1.6439946192575716e-12
analyzed O 0 5.445561970102153e-12
, O 0 1.3924593899802828e-12
187 O 0 1.1129857452329972e-11
C O 0 3.5318989399790723e-10
- O 0 2.3608928700902254e-10
- O 0 2.1864154930995028e-10
> O 0 1.0855220056171788e-09
G O 0 9.828559077718069e-10
was O 0 5.715145370843722e-12
present O 0 3.0636265551352293e-13
in O 0 7.215418583797484e-13
association O 0 2.190269883864393e-12
with O 0 1.3782526247401502e-14
a O 0 1.4406450208129251e-12
wide O 0 1.0288173958594715e-11
variety O 0 5.5345992545918765e-12
of O 0 7.649814809385092e-11
HLA O 0 2.5907647138723178e-09
haplotypes O 0 6.693650494993264e-11
, O 0 2.6185902946875006e-13
showing O 0 5.204615211029662e-11
this O 0 6.006383541576343e-13
mutation O 0 5.356012942187016e-13
to O 0 1.889699673325064e-14
be O 0 1.3906696703491067e-13
widespread O 0 6.468868218867385e-10
and O 0 1.0500299414684111e-11
likely O 0 2.269480827224446e-12
to O 0 1.4266794126291393e-13
predate O 0 3.3115141184758556e-10
the O 0 2.186264190517928e-11
more O 0 1.9664586799195138e-13
genetically O 0 1.3380943922336463e-11
restricted O 0 5.424393573205677e-12
845 O 0 6.035306282514696e-11
G O 0 3.260307579466826e-08
- O 0 5.876713515817755e-08
- O 0 1.9215226743085623e-08
> O 0 4.0568604475765824e-08
A O 0 2.4994342151529736e-09
mutation O 0 8.621617864079667e-10
. O 0 1.5693528421234504e-10

Genotype O 0 1.1183816468474106e-06
- O 0 4.238081174889885e-08
phenotype O 0 5.363097965727093e-09
correlations O 0 4.8439905420138984e-09
in O 0 9.383342991498012e-10
attenuated B-Disease 1 0.9998797178268433
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.00042393687181174755

Germ O 0 4.828426972380839e-05
- O 0 1.3692621791960846e-07
line O 0 1.231419677338863e-08
mutations O 0 2.017315481328552e-10
of O 0 9.692121549775834e-10
the O 0 1.9438593790166436e-10
tumor B-Disease 0 5.707140005029032e-08
suppressor O 0 3.1279890322366555e-07
APC O 0 1.7729457901793921e-09
are O 0 5.311342728478441e-13
implicated O 0 2.7305300381863518e-11
in O 0 2.7829316628924516e-10
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.0072203390300273895
AAPC B-Disease 1 1.0
) O 0 1.214561654375168e-12
, O 0 8.912022595591873e-14
a O 0 1.2397503813474375e-12
variant O 0 4.0070027296224e-09
of O 0 5.670480618391593e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.367751221754588e-06
FAP B-Disease 0 2.2938900656299666e-05
) O 0 1.7516345318657756e-10
. O 0 1.324465426222332e-09

AAPC B-Disease 1 1.0
is O 0 3.987595323384774e-11
recognized O 0 5.352339231545766e-12
by O 0 1.8240060341030012e-13
the O 0 2.6844145396137664e-12
occurrence O 0 3.0003208251194735e-10
of O 0 5.351571630285434e-09
< O 0 1.779346945340876e-07
100 O 0 7.426829151668812e-10
colonic B-Disease 0 1.5933316035443568e-06
adenomas I-Disease 0 4.470188628147298e-07
and O 0 4.405509431652105e-13
a O 0 1.9133109538990029e-13
later O 0 2.1067798113699743e-12
onset O 0 0.2257682979106903
of O 1 0.9999936819076538
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.8380366673120818e-11
age O 0 3.827600458805591e-10
> O 0 5.277413617221782e-09
40 O 0 6.585627876365407e-11
years O 0 1.3786097263768227e-11
) O 0 2.594613109432875e-12
. O 0 1.9164804465621188e-10

The O 0 1.3419654276702886e-09
aim O 0 2.466492121655506e-09
of O 0 2.842056034957352e-10
this O 0 3.460833507794303e-13
study O 0 3.612561909772244e-13
was O 0 7.185400278247878e-12
to O 0 5.436105125072865e-13
assess O 0 9.249750965167891e-10
genotype O 0 5.35561781589422e-08
- O 0 2.1589716681091886e-08
phenotype O 0 4.130218389519769e-09
correlations O 0 7.832039017330317e-09
in O 0 5.871915398358851e-09
AAPC B-Disease 1 1.0
families O 0 3.245754220948527e-10
. O 0 4.757172433755841e-09

By O 0 1.5238099670966676e-10
protein O 0 4.234699535476949e-10
- O 0 7.820775971278948e-11
truncation O 0 8.124995787284206e-09
test O 0 3.328721520645672e-09
( O 0 8.986620583968652e-13
PTT O 0 1.855572501208158e-10
) O 0 1.2745173467228633e-14
assay O 0 1.277339236986641e-12
, O 0 2.990054425301529e-14
the O 0 1.6295458363756177e-13
entire O 0 3.265415010871714e-13
coding O 0 3.737704156597799e-12
region O 0 4.933966863546191e-12
of O 0 3.985086219349121e-11
the O 0 2.333285509248384e-10
APC B-Disease 0 1.2928418335889091e-09
gene O 0 3.9403320016562215e-12
was O 0 5.0598050055361554e-12
screened O 0 3.647558297070752e-11
in O 0 7.585311502175673e-13
affected O 0 2.724670532597284e-12
individuals O 0 1.6952677326168009e-13
from O 0 1.256551807049533e-10
11 O 0 6.32814917480573e-05
AAPC B-Disease 1 1.0
kindreds O 0 7.668139733141288e-05
, O 0 6.924199408286924e-11
and O 0 1.2800763921072544e-11
their O 0 1.747835730314673e-11
phenotypic O 0 2.8920611683247444e-08
differences O 0 8.115326188828931e-10
were O 0 1.3073231386329098e-09
examined O 0 7.868033335967084e-09
. O 0 1.3909756013674723e-08

Five O 0 7.708703009257079e-09
novel O 0 1.4712711049469362e-09
germ O 0 3.9947904042492155e-06
- O 0 1.977801531438672e-07
line O 0 5.1951417390228016e-08
APC B-Disease 0 6.512300032568419e-09
mutations O 0 3.857457062106384e-11
were O 0 3.949129565028464e-11
identified O 0 3.4240353607994933e-11
in O 0 3.247903335168445e-10
seven O 0 4.54055744114612e-08
kindreds O 0 0.00031045149080455303
. O 0 4.258135390955431e-07

Mutations O 0 3.438286100276855e-09
were O 0 2.438201585075461e-10
located O 0 1.020613107916013e-10
in O 0 5.362844283235413e-12
three O 0 1.6003831289704284e-12
different O 0 5.926154884742033e-14
regions O 0 2.3117388558979712e-10
of O 0 2.3458717635094217e-08
the O 0 3.229270362226089e-08
APC B-Disease 0 1.1407771616234186e-08
gene O 0 1.636256061199326e-11
( O 0 8.627658049792375e-13
1 O 0 4.1034875497558687e-10
) O 0 1.1770761503080568e-13
at O 0 2.7810623595692086e-11
the O 0 2.8103797067302594e-11
5 O 0 8.737012502368913e-11
end O 0 4.863389899134596e-11
spanning O 0 1.6046028394889333e-10
exons O 0 8.321910272002242e-09
4 O 0 3.1558347046711788e-09
and O 0 2.741070564971082e-11
5 O 0 4.973646494654815e-10
, O 0 1.3007003243567516e-12
( O 0 4.054697929408574e-14
2 O 0 6.752557280692573e-12
) O 0 4.574425572085846e-15
within O 0 1.1236158488012182e-12
exon O 0 2.9568590631523506e-11
9 O 0 7.218013686749458e-11
, O 0 1.6027894885872057e-13
and O 0 2.6078041093745286e-13
( O 0 5.687866220767737e-14
3 O 0 2.6200815822496892e-11
) O 0 4.3013115720016634e-14
at O 0 2.1613457551472592e-11
the O 0 3.984592170103163e-11
3 O 0 3.399744097354329e-10
distal O 0 1.9950556831571653e-11
end O 0 1.0114410003980723e-10
of O 0 1.3809578480739049e-10
the O 0 2.035104446074243e-10
gene O 0 3.918496638277702e-10
. O 0 6.23092966112182e-10

Variability O 0 3.507812484926376e-09
in O 0 7.56722288997036e-12
the O 0 2.4985725294301986e-12
number O 0 6.342354419430762e-11
of O 0 3.438306521275081e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 4.946443254993937e-07
most O 0 9.250160316540135e-13
apparent O 0 1.8018843361833348e-11
in O 0 5.234137233876834e-13
individuals O 0 6.6631677389170085e-15
with O 0 4.4323343552279265e-14
mutations O 0 3.2938786247160845e-12
in O 0 1.0417750863356279e-11
region O 0 1.8337210638819101e-09
1 O 0 3.7120503293408547e-07
, O 0 4.024577546224428e-11
and O 0 1.2924472603259574e-09
upper O 1 0.9999957084655762
- O 0 1.595474714122247e-05
gastrointestinal O 1 0.7965131998062134
manifestations O 0 0.0017722937045618892
were O 0 1.7879719926838789e-10
more O 0 1.491745908657055e-13
severe O 0 4.831527533610824e-08
in O 0 4.157333921561701e-10
them O 0 3.05148933898991e-10
. O 0 1.5408771147917832e-08

In O 0 1.919300829378301e-10
individuals O 0 4.419884597206547e-13
with O 0 4.0124015763566556e-13
mutations O 0 8.453110607320458e-12
in O 0 2.723767739132299e-11
either O 0 1.9060726608177703e-10
region O 0 6.655744400063668e-09
2 O 0 4.1431288622106877e-08
or O 0 1.104476059221593e-11
region O 0 5.522541313141005e-10
3 O 0 3.2581985998092478e-09
, O 0 6.424531046045345e-13
the O 0 4.7551515676425016e-12
average O 0 1.868049335010391e-12
number O 0 6.647389583225305e-11
of O 0 3.5441016787984836e-09
adenomas B-Disease 0 1.1373224879207555e-05
tended O 0 1.009238387306155e-10
to O 0 1.4059953288431126e-12
be O 0 6.74003691400471e-12
lower O 0 2.6771257433111373e-10
than O 0 8.644784378359499e-14
those O 0 5.932906753771186e-14
in O 0 1.7247614198401956e-13
individuals O 0 6.744771740088435e-15
with O 0 1.0849934706648294e-14
mutations O 0 5.456920654819779e-14
in O 0 2.229496968986222e-13
region O 0 1.7532747823012507e-11
1 O 0 1.7772719407282977e-10
, O 0 5.753727436988085e-14
although O 0 7.600590079190339e-13
age O 0 8.275962380677182e-12
at O 0 1.5743775727550258e-10
diagnosis O 0 5.636538347175701e-09
was O 0 5.50422263323469e-10
similar O 0 1.771106317161042e-10
. O 0 1.8455562633690192e-09

In O 0 1.654283643404142e-08
all O 0 1.1024555135463743e-07
AAPC B-Disease 1 1.0
kindreds O 0 2.3443544705514796e-06
, O 0 1.2290572205808648e-11
a O 0 9.157789977731756e-12
predominance O 0 2.365614726329568e-08
of O 0 1.0160689498661668e-06
right O 1 0.9999992847442627
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 1.3435942491923925e-05
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9999099969863892
sparing O 0 3.498386647038387e-08
was O 0 5.449819706626613e-09
observed O 0 2.8103610549834457e-09
. O 0 8.245970017917159e-10

No O 0 3.4289926134078996e-06
desmoid B-Disease 1 0.9990670084953308
tumors I-Disease 1 1.0
were O 0 1.575003771847605e-08
found O 0 1.442223857700542e-11
in O 0 1.5983887824422283e-11
these O 0 1.341151079081726e-10
kindreds O 0 6.446134193538455e-06
. O 0 6.962947196598179e-08

Our O 0 1.742442634622421e-08
data O 0 3.7865593993657853e-10
suggest O 0 5.0207192570095316e-11
that O 0 9.79274712535616e-13
, O 0 4.168072137433754e-12
in O 0 4.1491193814024996e-10
AAPC B-Disease 1 1.0
families O 0 1.526513832873777e-12
, O 0 2.987057758259415e-13
the O 0 4.669853913286115e-12
location O 0 1.088897971790459e-09
of O 0 1.4852114205154976e-08
the O 0 4.910149797865415e-08
APC B-Disease 0 2.1804774519296188e-07
mutation O 0 1.1896822416090913e-09
may O 0 4.107034712319546e-10
partially O 0 3.2951341655262922e-09
predict O 0 1.8574811133653668e-10
specific O 0 7.291962172972788e-11
phenotypic O 0 2.497761215636274e-07
expression O 0 3.9131901274913616e-08
. O 0 4.5724850572526066e-09

This O 0 3.049999697246619e-10
should O 0 1.033226455782188e-11
help O 0 2.463868139460784e-13
in O 0 1.4094645589546317e-12
the O 0 3.070251691772441e-11
design O 0 1.0657537963254526e-08
of O 0 2.144012967164599e-09
tailored O 0 1.3732861514625938e-09
clinical O 0 0.0003951483522541821
- O 0 2.9804066770111604e-08
management O 0 5.505209621503582e-10
protocols O 0 7.121145895183645e-10
in O 0 1.0011159653003365e-12
this O 0 6.621742406785411e-14
subset O 0 1.5070520387183706e-09
of O 0 1.239052638268845e-09
FAP B-Disease 0 6.61413707803149e-07
patients O 0 1.5151155330350718e-10
. O 0 5.732288602122715e-11
. O 0 2.406710386537725e-09

Wilms B-Disease 1 0.9999656677246094
' I-Disease 0 5.394871550379321e-06
tumor I-Disease 0 3.419543759264343e-08
1 O 0 1.9248716398578836e-08
and O 0 7.008947588982295e-11
Dax O 0 4.712894678959856e-06
- O 0 3.998093855983598e-09
1 O 0 4.352838534060766e-09
modulate O 0 1.6547870018701616e-10
the O 0 6.798801105434293e-11
orphan O 0 7.364842069534916e-11
nuclear O 0 7.316206529495162e-10
receptor O 0 7.991681101604531e-12
SF O 0 3.50464546272633e-07
- O 0 9.055886596165408e-11
1 O 0 9.692541214079142e-11
in O 0 4.728333067964552e-13
sex O 0 6.605636176937324e-13
- O 0 2.532569965373044e-13
specific O 0 1.213177128200904e-12
gene O 0 3.122041167258338e-11
expression O 0 1.7283117159649919e-09
. O 0 6.080185799284266e-10

Products O 0 1.9474834189736612e-08
of O 0 3.0177254473073845e-08
steroidogenic O 0 1.7767080180419725e-06
factor O 0 2.772744256418491e-09
1 O 0 2.808337029591712e-08
( O 0 1.5065216435461437e-11
SF O 0 1.5005988643679302e-05
- O 0 9.841732762083666e-09
1 O 0 4.9586548200863945e-09
) O 0 1.1759189542243087e-12
and O 0 2.228389694991506e-11
Wilms B-Disease 0 3.3862979762488976e-06
tumor I-Disease 0 5.6294826578096036e-08
1 O 0 1.99916510013054e-08
( O 0 1.3642433537019993e-12
WT1 O 0 3.366514400582332e-09
) O 0 3.777678514514486e-14
genes O 0 9.245040713881658e-14
are O 0 5.937522659817248e-15
essential O 0 1.5027041026446919e-12
for O 0 7.739064922761274e-13
mammalian O 0 2.5760218402837154e-09
gonadogenesis O 0 1.8007214608317668e-09
prior O 0 2.2801566190722156e-10
to O 0 6.533028892169446e-12
sexual O 0 3.93247309715683e-11
differentiation O 0 2.876337390489425e-09
. O 0 9.34399779772832e-10

In O 0 3.0713073750909814e-10
males O 0 4.81676807814746e-12
, O 0 4.555434154895899e-12
SF O 0 0.0001377496955683455
- O 0 3.3765218176995404e-08
1 O 0 5.298260941088984e-09
participates O 0 1.1356556970862353e-12
in O 0 7.427266673866104e-14
sexual O 0 7.857156223388395e-14
development O 0 1.0521700291631422e-13
by O 0 7.322861562194128e-15
regulating O 0 3.944625875940133e-12
expression O 0 3.070954601724907e-11
of O 0 1.2892557854637943e-10
the O 0 3.257351610663761e-10
polypeptide O 0 6.655835704805213e-08
hormone O 0 3.8157771387048456e-10
Mullerian O 0 2.287934064426622e-09
inhibiting O 0 2.308513519233557e-10
substance O 0 3.5230446338019306e-10
( O 0 6.98536150797735e-12
MIS O 0 9.937158438333427e-07
) O 0 1.5861013891171893e-11
. O 0 5.827138771508089e-10

Here O 0 3.098127976386422e-08
, O 0 9.336706408014095e-11
we O 0 6.6700694446863995e-12
show O 0 8.608139201449205e-11
that O 0 1.6745859907074667e-11
WT1 O 0 6.603910151170567e-06
- O 0 2.4800320019835453e-08
KTS O 0 1.940569973157835e-06
isoforms O 0 2.0751136364793865e-09
associate O 0 2.3443127994404733e-10
and O 0 1.8926774210392683e-12
synergize O 0 1.834070784134667e-09
with O 0 1.917689965158509e-11
SF O 0 0.0021259868517518044
- O 0 2.2734885973818564e-08
1 O 0 4.196124336885987e-09
to O 0 6.164783527412565e-12
promote O 0 2.01687400114281e-09
MIS O 0 1.186028566735331e-05
expression O 0 7.66972174659486e-09
. O 0 6.294381682536709e-10

In O 0 3.6998032415525017e-10
contrast O 0 6.288825571409973e-10
, O 0 1.5647318163392043e-10
WT1 O 0 1.6319549104082398e-05
missense O 0 8.184991173720846e-08
mutations O 0 4.385861118727519e-11
, O 0 3.2446969915576884e-13
associated O 0 4.616505094867662e-12
with O 0 3.94995668118181e-12
male B-Disease 0 2.2348606298905338e-10
pseudohermaphroditism I-Disease 1 1.0
in O 0 8.496670034219278e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.219098942963683e-08
fail O 0 2.5917998414115573e-07
to O 0 7.971251263227952e-12
synergize O 0 2.28558008075197e-08
with O 0 1.772147151246628e-10
SF O 1 0.9999990463256836
- O 0 3.5235602808825206e-06
1 O 0 7.208440706563124e-07
. O 0 2.9899824838253153e-09

Additionally O 0 1.2791654846466827e-08
, O 0 3.3219756806479595e-11
the O 0 5.0607535523328195e-11
X O 0 7.03312821315194e-07
- O 0 1.1098118868346774e-08
linked O 0 2.7908333422033138e-08
, O 0 5.596208826202931e-12
candidate O 0 1.5394734098617135e-11
dosage O 0 8.991915545486506e-10
- O 0 1.5855145321652664e-11
sensitive O 0 1.2740460075821858e-10
sex O 0 7.596652473740306e-12
- O 0 1.360068828393235e-11
reversal O 0 3.912417334550611e-10
gene O 0 2.997813802751992e-11
, O 0 2.6168839230983343e-12
Dax O 0 2.8236661364644533e-06
- O 0 8.270278684108234e-09
1 O 0 1.1173306724288068e-08
, O 0 2.0559675923542686e-12
antagonizes O 0 9.308469967050925e-11
synergy O 0 1.2864401384427016e-11
between O 0 9.494738328896801e-12
SF O 0 5.3408134590426926e-06
- O 0 3.94484056531752e-10
1 O 0 1.5637710570892693e-10
and O 0 2.4604459095134423e-12
WT1 O 0 3.0521214000600594e-08
, O 0 1.1819046175781667e-12
most O 0 4.152382647795716e-13
likely O 0 7.926789785542634e-14
through O 0 7.768250967618226e-15
a O 0 8.004059519122961e-14
direct O 0 2.1330810381914311e-13
interaction O 0 2.083379259040785e-12
with O 0 3.285990837070818e-12
SF O 0 0.058260731399059296
- O 0 2.8667551532635116e-07
1 O 0 1.4881639742725383e-07
. O 0 2.3146959904352116e-09

We O 0 1.615213385264269e-08
propose O 0 8.226996861537827e-09
that O 0 4.082781335235097e-11
WT1 O 0 1.6776469919932424e-06
and O 0 1.1691264623081565e-09
Dax O 0 9.10216331249103e-05
- O 0 1.862342990932575e-08
1 O 0 7.776635335687843e-09
functionally O 0 1.0172858389001505e-10
oppose O 0 7.314469342711849e-12
each O 0 5.4950614472918085e-15
other O 0 4.019091713624613e-15
in O 0 2.0350004504860603e-13
testis O 0 3.1114608112225994e-10
development O 0 2.17127769756853e-12
by O 0 4.2734205388771096e-13
modulating O 0 4.3918238490370243e-10
SF O 0 0.00010131265298696235
- O 0 1.4883138277355101e-08
1 O 0 4.380625995281662e-08
- O 0 2.203084659146981e-10
mediated O 0 7.602403151452108e-09
transactivation O 0 2.2656668363651988e-07
. O 0 1.0843170805685531e-10
. O 0 4.562586419787351e-10

A O 0 1.3350016203617088e-08
mouse O 0 9.823385438423315e-10
model O 0 4.658113825217747e-11
for O 0 5.73918357282821e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9992423057556152
centre O 0 0.000852556899189949
mutations O 0 1.2621256928468938e-08
. O 0 2.3310091634698438e-09

Imprinting O 0 2.0790116650459822e-07
in O 0 1.593219112194788e-09
the O 0 1.8349211039492275e-09
15q11 O 0 4.386980734238932e-08
- O 0 2.576606705773088e-09
q13 O 0 4.665988040386537e-09
region O 0 1.4334158859874435e-10
involves O 0 5.050664313860365e-12
an O 0 7.895132437358773e-14
imprinting O 0 9.603999373553052e-09
centre O 0 2.0538853107154864e-07
( O 0 4.182167633037803e-12
IC O 0 1.0983560727595432e-08
) O 0 1.4470609226938796e-13
, O 0 4.301574152215312e-14
mapping O 0 1.602615934924445e-12
in O 0 1.6122645753180453e-12
part O 0 3.1264014814513796e-12
to O 0 1.9356883717430717e-12
the O 0 5.258377760997135e-11
promoter O 0 6.138439534453255e-09
and O 0 5.571949152072264e-11
first O 0 4.3619621803436814e-10
exon O 0 4.065598346869592e-08
of O 0 9.18425246965171e-09
SNRPN O 0 5.93713739363011e-05
. O 0 1.6975636185634357e-07

Deletion O 0 1.0444725973002278e-08
of O 0 1.0563632635296472e-08
this O 0 1.1837919533519425e-10
IC O 0 4.771733301822678e-07
abolishes O 0 2.507089291725606e-08
local O 0 7.3036160452844e-10
paternally O 0 2.3396926757124348e-11
derived O 0 1.4498339391566008e-14
gene O 0 3.7006002103802393e-14
expression O 0 2.4078257291650085e-13
and O 0 8.985412748867185e-15
results O 0 5.225441607192849e-12
in O 0 1.2267655780107134e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9996870756149292
PWS B-Disease 1 1.0
) O 0 2.151969269448273e-09
. O 0 5.714762441044741e-09

We O 0 2.4664166264898313e-09
have O 0 9.633521411145374e-12
created O 0 1.6113922696181504e-11
two O 0 5.599497428232514e-12
deletion O 0 1.996739579235296e-10
mutations O 0 1.4423889166392811e-11
in O 0 3.898954076264616e-11
mice O 0 4.82195672280028e-10
to O 0 1.6787370105131316e-11
understand O 0 6.669278462823058e-09
PWS B-Disease 1 1.0
and O 0 7.904159549099177e-10
the O 0 5.910397171682291e-10
mechanism O 0 2.4205994986203905e-09
of O 0 5.285711868197041e-10
this O 0 6.691404375036569e-11
IC O 0 2.6897096176980995e-06
. O 0 2.0165325409493562e-08

Mice O 0 1.0569442565611098e-05
harbouring O 0 3.2731077226344496e-06
an O 0 1.0139075690140942e-10
intragenic O 0 7.407948032778222e-07
deletion O 0 4.44348735584299e-08
in O 0 1.6716900086422015e-09
Snrpn O 0 7.560538961115526e-06
are O 0 2.2540821986716253e-10
phenotypically O 0 2.597534987103245e-08
normal O 0 4.680276166624253e-09
, O 0 2.1540850700385583e-12
suggesting O 0 1.1476500305640513e-11
that O 0 5.244730431203104e-13
mutations O 0 1.5755844545717324e-11
of O 0 5.055018625910179e-09
SNRPN O 0 6.53021561447531e-05
are O 0 1.2100301663431345e-11
not O 0 1.2453293604663962e-12
sufficient O 0 4.6514747609194274e-10
to O 0 1.120291498457604e-10
induce O 0 1.9324557797517627e-05
PWS B-Disease 1 1.0
. O 0 1.775902092049364e-07

Mice O 0 3.7628691273994264e-08
with O 0 5.897081434280693e-12
a O 0 3.2229705015929255e-11
larger O 0 5.3694557480832295e-12
deletion O 0 4.13819464806231e-11
involving O 0 2.8375355450721562e-12
both O 0 1.838352213512362e-11
Snrpn O 0 1.6872098740350339e-07
and O 0 7.501371190876682e-10
the O 0 1.8467051887682828e-08
putative O 0 2.189922633988317e-05
PWS O 1 1.0
- O 0 5.672575298376614e-06
IC O 0 5.1180239097448066e-05
lack O 0 2.2417667366880778e-07
expression O 0 1.7137632424280014e-09
of O 0 1.3292486000793247e-09
the O 0 3.646808688362313e-10
imprinted O 0 5.492015731078936e-10
genes O 0 2.842965099447703e-11
Zfp127 O 0 1.1517744091804616e-08
( O 0 5.602811964378063e-11
mouse O 0 6.094946769508169e-09
homologue O 0 4.485989535396584e-08
of O 0 4.122584496002446e-09
ZNF127 O 0 2.689924940568744e-06
) O 0 7.37195374189703e-11
, O 0 8.630365866402201e-11
Ndn O 0 2.3016891645966098e-06
and O 0 5.328265606507898e-10
Ipw O 0 1.560704276926117e-07
, O 0 1.0071596334704225e-10
and O 0 2.088831538293867e-11
manifest O 0 6.775980887496758e-10
several O 0 1.440002804498075e-11
phenotypes O 0 1.1495264740091216e-09
common O 0 5.980568817953724e-10
to O 0 5.701545013891973e-09
PWS B-Disease 1 1.0
infants O 0 0.07485444098711014
. O 0 3.0384597948796e-08

These O 0 9.030751840777285e-12
data O 0 1.1977500588566947e-11
demonstrate O 0 1.1602727459369966e-11
that O 0 9.808201072072226e-14
both O 0 4.988488463454621e-13
the O 0 7.871204556197942e-12
position O 0 3.1655376236949806e-11
of O 0 2.828945966371066e-10
the O 0 1.3322480618693788e-10
IC O 0 3.250348612482412e-08
and O 0 1.1486705683849685e-11
its O 0 6.032575480818814e-12
role O 0 3.0541764863695198e-12
in O 0 6.3035666096611376e-12
the O 0 9.723347994816667e-12
coordinate O 0 6.4966951089651115e-12
expression O 0 1.8017512481982578e-10
of O 0 4.103761497287195e-10
genes O 0 7.23087605417061e-13
is O 0 5.990557849040387e-14
conserved O 0 2.037479343228177e-12
between O 0 1.40843261532686e-12
mouse O 0 1.0033885944338294e-09
and O 0 5.043377174218655e-12
human O 0 3.6653981932976976e-11
, O 0 2.9296403085583844e-13
and O 0 2.64079963408978e-13
indicate O 0 2.636553302071132e-12
that O 0 4.255112158891433e-13
the O 0 5.0425909975393424e-11
mouse O 0 1.727196996537117e-10
is O 0 1.936964992696119e-13
a O 0 1.709848354482929e-13
suitable O 0 2.700277067918533e-12
model O 0 5.406583384118258e-13
system O 0 2.357097590027779e-12
in O 0 4.861752818906273e-13
which O 0 6.847606113863022e-14
to O 0 7.612483641497234e-14
investigate O 0 1.3485164590890109e-12
the O 0 2.874413597767078e-12
molecular O 0 3.856941849234019e-11
mechanisms O 0 7.878748348177922e-11
of O 0 1.6291060514483924e-11
imprinting O 0 1.6072308761660992e-10
in O 0 1.6390915317729404e-12
this O 0 9.208085005206132e-14
region O 0 8.719776636856302e-12
of O 0 6.076623926265512e-11
the O 0 4.160576050349363e-11
genome O 0 1.739226956898321e-10
. O 0 1.117721748489231e-10
. O 0 5.498873356657441e-09

Mutations O 0 5.441237460601656e-10
of O 0 3.722938846095758e-09
the O 0 3.202010601111027e-10
ATM O 0 7.480601027509692e-09
gene O 0 1.4690375652048893e-11
detected O 0 1.3555676546539441e-11
in O 0 1.690168317802776e-11
Japanese O 1 0.9999959468841553
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999922513961792
: O 0 1.7161747283694906e-12
possible O 0 9.893625849133336e-12
preponderance O 0 1.668047211467183e-08
of O 0 1.3559000588969639e-09
the O 0 4.4401766985391333e-11
two O 0 5.442207882261352e-12
founder O 0 1.8133325951907864e-09
mutations O 0 8.035445225873517e-11
4612del165 O 0 5.686209725297431e-09
and O 0 9.494529606968172e-10
7883del5 O 0 6.082059371692594e-07
. O 0 1.1506912755976373e-07

The O 0 9.503814624167717e-08
ATM O 0 0.0009679860668256879
( O 0 7.1609624683333095e-06
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 2.158741935209818e-11
mutated O 0 4.997671547435356e-12
) O 0 1.1720438089838064e-14
gene O 0 2.3805772891155597e-13
on O 0 1.13921415703655e-11
human O 0 1.653461048634064e-11
chromosome O 0 1.5789011209577097e-09
11q22 O 0 6.184840373180123e-08
. O 0 7.410277280683886e-09

3 O 0 7.468213993888639e-07
has O 0 4.409186904474893e-11
recently O 0 1.3883388362556648e-11
been O 0 5.854379481196048e-13
identified O 0 4.0089061085525624e-13
as O 0 2.2747233784092824e-13
the O 0 1.6395042875400057e-12
gene O 0 2.185949311101984e-13
responsible O 0 2.8880462474636936e-13
for O 0 1.2539418999945196e-14
the O 0 7.077843628029712e-13
human O 0 1.46539536061141e-09
recessive B-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.659765959873056e-11
. O 0 3.4802472015371677e-10

In O 0 1.027465446057363e-09
order O 0 6.895678472673694e-11
to O 0 3.699854008235026e-13
define O 0 1.1957140139129407e-11
the O 0 2.698315529348072e-12
types O 0 2.841945775933219e-11
of O 0 1.7960838372133026e-09
disease O 0 1.2464183782867622e-05
- O 0 1.2929841919362417e-10
causing O 0 1.3689337163835802e-10
ATM O 0 3.1520748233759832e-09
mutations O 0 1.6651258280195314e-12
in O 0 2.082977887396531e-12
Japanese O 1 0.6368982195854187
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.308065726377208e-08
as O 0 1.1152845140471879e-12
well O 0 5.048020581730449e-14
as O 0 2.1817993239988884e-14
to O 0 1.1896564191659492e-14
look O 0 1.6409604862541345e-14
for O 0 9.228580661430844e-15
possible O 0 1.9818714811631333e-12
mutational O 0 5.668188696184018e-10
hotspots O 0 1.3752469163463843e-09
, O 0 9.802109211115573e-13
reverse O 0 4.379951262789561e-11
- O 0 1.5077110566974472e-12
transcribed O 0 1.3163539269028801e-12
RNA O 0 5.385207254085533e-13
derived O 0 2.1111853635598496e-15
from O 0 8.066494656478254e-15
ten O 0 6.1082042202009745e-12
patients O 0 3.609627787642955e-13
belonging O 0 1.4110918379953152e-12
to O 0 5.934516658472055e-13
eight O 0 3.188201092019227e-10
unrelated O 0 1.8716836081011934e-08
Japanese O 1 0.999995231628418
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 5.993558080397143e-12
was O 0 1.4322346260364771e-11
analyzed O 0 6.406519195353844e-13
for O 0 1.3489968690716392e-13
mutations O 0 5.93727676615266e-14
by O 0 1.663629764546773e-13
the O 0 4.66314270183843e-12
restriction O 0 1.3181063185374597e-10
endonuclease O 0 2.87256940456615e-10
fingerprinting O 0 6.905909732957127e-10
method O 0 5.434641625612358e-10
. O 0 7.421532832729838e-10

As O 0 6.475077141132601e-10
has O 0 3.86892037504416e-12
been O 0 2.309267414877386e-13
reported O 0 2.1998607091771455e-13
by O 0 7.831276317531166e-13
others O 0 4.515226734169708e-12
, O 0 6.580913114798137e-13
mutations O 0 2.0398823689232737e-12
that O 0 7.030656981078798e-13
lead O 0 1.3647781516024082e-10
to O 0 1.9221207958608488e-11
exon O 0 2.8724301159854804e-08
skipping O 0 3.2533422622549324e-09
or O 0 5.207405687213118e-11
premature O 0 6.363317511803857e-11
protein O 0 5.158697774509946e-11
truncation O 0 8.228726500192352e-08
were O 0 1.0388097049229827e-09
also O 0 3.459279737660914e-11
predominant O 0 1.5325989366488102e-09
in O 0 1.695639045840025e-10
our O 0 2.6606949976581973e-09
mutants O 0 3.150123362161139e-08
. O 0 5.6779088097869135e-09

Six O 0 1.8896177955696203e-09
different O 0 1.0666117511784479e-12
mutations O 0 3.002987442046745e-11
were O 0 1.2586932364444525e-11
identified O 0 4.0730955934431545e-12
on O 0 7.621157038784077e-10
12 O 0 1.6844799999304882e-09
of O 0 2.558989686818336e-09
the O 0 1.371961433349611e-09
16 O 0 1.1305854918930436e-08
alleles O 0 1.7922707762352275e-10
examined O 0 7.819083158722151e-09
. O 0 1.0362751545756055e-08

Four O 0 2.0046865500944477e-08
were O 0 1.4326787534102436e-09
deletions O 0 1.1323783022376688e-09
involving O 0 1.2272517724287724e-10
a O 0 5.988033402459791e-10
loss O 0 1.2752531475257456e-08
of O 0 3.6479295317803917e-07
a O 0 6.286621889728394e-09
single O 0 3.647234958492618e-09
exon O 0 9.076373430616513e-08
exon O 0 4.750175364165443e-08
7 O 0 3.6356723853714357e-08
, O 0 4.8529839868916014e-11
exon O 0 5.417402082485978e-09
16 O 0 2.1913264536266297e-09
, O 0 4.7990712098711086e-11
exon O 0 1.2333190468893918e-08
33 O 0 3.1399118860520048e-09
or O 0 8.693630260125929e-10
exon O 0 2.1797995941597037e-07
35 O 0 3.360209888114696e-08
. O 0 1.4640884948846633e-08

The O 0 1.2532672144516255e-07
others O 0 4.544783660520579e-09
were O 0 2.5387061897141905e-10
minute O 0 2.2525532550332628e-09
deletions O 0 3.727726183289093e-10
, O 0 4.959914857299852e-12
4649delA O 0 9.419529600762644e-10
in O 0 3.534500470081525e-10
exon O 0 1.5132195940736892e-08
33 O 0 4.968934153026794e-10
and O 0 6.884675555346442e-12
7883del5 O 0 3.5134506415346323e-09
in O 0 1.4297795170037375e-09
exon O 0 2.65975330648871e-07
55 O 0 4.1944783646385986e-08
. O 0 1.4968657424674348e-08

The O 0 6.022559784213399e-09
mutations O 0 8.590293754107137e-11
4612del165 O 0 2.2379702258046308e-10
and O 0 1.0458286146819429e-11
7883del5 O 0 8.308045362781513e-10
were O 0 5.5099758089482975e-11
found O 0 8.541923678800911e-13
in O 0 1.412779669727332e-13
more O 0 3.908446764340099e-15
than O 0 3.0804653668387375e-14
two O 0 2.0483144531641823e-13
unrelated O 0 2.529288410657582e-12
families O 0 9.054434922640096e-15
; O 0 7.582020609769001e-15
44 O 0 2.9766169997585967e-12
% O 0 5.612327876741707e-12
( O 0 1.9260602227705315e-13
7 O 0 3.5269058784592744e-09
of O 0 7.100330545739553e-09
16 O 0 1.136875482643518e-09
) O 0 5.4237569432425206e-14
of O 0 6.116201729106097e-12
the O 0 1.6919736011561382e-12
mutant O 0 1.1674539807104978e-11
alleles O 0 2.714844137257505e-13
had O 0 1.1796165173133533e-12
one O 0 1.4695573046213245e-13
of O 0 3.4143639304762274e-11
the O 0 1.0724123672423147e-10
two O 0 7.741966789875931e-11
mutations O 0 4.181376134226866e-09
. O 0 1.4175716600561827e-08

The O 0 1.0649104709159474e-08
4612del165 O 0 5.313349760172059e-09
mutations O 0 6.064925471560567e-12
in O 0 1.665316322341237e-12
three O 0 4.785593037300029e-13
different O 0 4.123139885612616e-14
families O 0 1.396932970774284e-13
were O 0 7.049083539101275e-12
all O 0 4.808057164212842e-12
ascribed O 0 9.559596864106013e-11
to O 0 3.819793006204497e-12
the O 0 4.424775268407899e-10
same O 0 3.802060888347114e-10
T O 0 3.2323992371630084e-09
- O 0 4.090373179055362e-11
- O 0 1.7981113126230852e-11
> O 0 9.510583293126373e-11
A O 0 1.134331430868718e-11
substitution O 0 4.507534102915489e-12
at O 0 3.250757302231122e-12
the O 0 1.0601922985353784e-12
splice O 0 1.0153396873269216e-10
donor O 0 1.3478948859835249e-11
site O 0 1.730207366268388e-10
in O 0 6.48713929796152e-11
intron O 0 8.652289125166135e-07
33 O 0 2.0945202550137765e-07
. O 0 5.6143740323477687e-08

Microsatellite O 0 9.575464900990482e-07
genotyping O 0 1.634381590065459e-07
around O 0 1.7799757501268942e-10
the O 0 6.312307343492307e-10
ATM O 0 8.800496686944825e-08
locus O 0 1.7753145620247324e-09
also O 0 8.73579160398652e-12
indicated O 0 9.292783556547057e-12
that O 0 5.663951770161317e-14
a O 0 1.3096922634944774e-12
common O 0 1.1264570005942165e-12
haplotype O 0 2.3910687665940067e-11
was O 0 5.875416125844524e-11
shared O 0 4.774078810228233e-13
by O 0 9.834989674875269e-14
the O 0 1.622252787832068e-12
mutant O 0 1.7944453215013034e-11
alleles O 0 1.1146330847243771e-13
in O 0 3.806314530056809e-13
both O 0 1.844386102178852e-11
mutations O 0 1.1036306313272348e-09
. O 0 3.962677741498055e-09

This O 0 1.7650101380439764e-09
suggests O 0 3.499624479097463e-10
that O 0 1.3576991093888768e-12
these O 0 5.2939800980478235e-12
two O 0 5.6281750093756244e-11
founder O 0 7.138095980963044e-08
mutations O 0 5.164154659453857e-10
may O 0 3.8305508764935325e-10
be O 0 2.283319540385964e-11
predominant O 0 4.150150001436259e-09
among O 0 1.7219102879661996e-11
Japanese O 0 5.7297615541074265e-08
ATM O 0 7.597071203235828e-07
mutant O 0 2.2703734714468737e-07
alleles O 0 2.404764609664767e-09
. O 0 1.875191779632246e-09

W474C O 0 2.1864068457944086e-06
amino O 0 9.797347644280308e-08
acid O 0 1.491862050562176e-10
substitution O 0 1.47552994128608e-11
affects O 0 8.583254549818231e-14
early O 0 8.569926994612953e-13
processing O 0 1.6411037459529432e-11
of O 0 4.982160864419605e-11
the O 0 1.8808279586557397e-11
alpha O 0 2.924591124831011e-11
- O 0 5.757067457305698e-13
subunit O 0 1.0226820258696367e-11
of O 0 3.0840677234245106e-11
beta O 0 4.385983132237925e-09
- O 0 2.7450797190908816e-10
hexosaminidase O 0 2.9590847550053923e-09
A O 0 1.0622822760320005e-10
and O 0 1.0961223655082605e-13
is O 0 1.7972683888020646e-14
associated O 0 1.3282504436606946e-12
with O 0 1.2028507530292831e-11
subacute O 1 0.9947732090950012
G B-Disease 0 0.019279219210147858
( I-Disease 0 2.759926731599194e-10
M2 I-Disease 0 5.167027552488435e-07
) I-Disease 0 1.574364770495773e-11
gangliosidosis I-Disease 0 9.633705388978342e-08
. O 0 7.961417303192775e-09

Mutations O 0 1.3038362056683184e-10
in O 0 7.751423114488176e-11
the O 0 3.6945285719625076e-10
HEXA O 0 5.896305879105057e-07
gene O 0 9.324956605494261e-12
, O 0 2.706360255257806e-13
encoding O 0 4.1625245459676885e-13
the O 0 3.392927605538887e-11
alpha O 0 5.147630585677909e-11
- O 0 1.5546721895964843e-12
subunit O 0 7.844914821919513e-12
of O 0 1.3304958523807642e-10
beta O 0 4.0887857544191775e-09
- O 0 2.9348237728932247e-10
hexosaminidase O 0 1.5685163390344314e-08
A O 0 1.0993657095781373e-09
( O 0 3.8668230401515957e-13
Hex O 0 5.360937249676567e-10
A O 0 5.6357158523256956e-11
) O 0 1.4997961775503957e-14
, O 0 1.5900063722791048e-14
that O 0 9.056960774888809e-14
abolish O 0 2.1423125495800832e-09
Hex O 0 1.11816218506533e-08
A O 0 3.2734578936377545e-10
enzyme O 0 3.3134564970255242e-12
activity O 0 4.595177363619918e-11
cause O 0 2.518818973840098e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 4.4867040638330025e-10
TSD B-Disease 0 0.00015668086416553706
) O 0 8.936573269585635e-13
, O 0 1.0368424868678616e-12
the O 0 3.4638766854833136e-10
fatal O 0 4.695104144047946e-05
infantile B-Disease 0 0.00012802565470337868
form I-Disease 0 3.951243332522836e-09
of I-Disease 0 6.159953045425937e-07
G I-Disease 0 1.662199338170467e-06
( I-Disease 0 7.425971296215472e-12
M2 I-Disease 0 5.568586480819704e-09
) I-Disease 0 3.173320438885907e-13
gangliosidosis I-Disease 0 2.4361019868024414e-09
, I-Disease 0 1.1254481721567622e-11
Type I-Disease 0 2.0084285345944863e-09
1 I-Disease 0 2.7962101967204944e-07
. O 0 3.5483900262534007e-09

Less O 0 4.5670964232691347e-10
severe O 0 2.1322603060980327e-06
, O 0 1.0785087406484095e-10
subacute O 1 0.9999964237213135
( O 0 2.009344246545197e-09
juvenile O 1 0.9999992847442627
- O 0 4.275706189105222e-08
onset O 1 0.999997615814209
) O 0 9.17310411657768e-12
and O 0 1.5601543668086748e-10
chronic O 1 1.0
( O 0 5.4605521493389375e-11
adult O 0 8.540541216461861e-07
- O 0 1.2374330893294427e-08
onset O 1 0.9998871088027954
) O 0 3.025613342765715e-13
variants O 0 2.4016177935237693e-11
are O 0 1.9046077920099186e-14
characterized O 0 3.295427421072007e-14
by O 0 5.3672157999474016e-15
a O 0 3.055946609046428e-13
broad O 0 1.1820383213900776e-11
spectrum O 0 7.748197049239902e-12
of O 0 3.804857470757206e-12
clinical O 0 2.1277661854668395e-09
manifestations O 0 1.6906511746128672e-08
and O 0 2.587437425774497e-12
are O 0 7.116647156020332e-15
associated O 0 4.864588820738952e-14
with O 0 3.0857813456157054e-14
residual O 0 1.3573946944234194e-06
levels O 0 3.173558980051894e-07
of O 0 1.140656848974686e-07
Hex O 0 1.1049664863094222e-05
A O 0 3.1033980008032813e-07
enzyme O 0 3.7977410105582976e-10
activity O 0 2.695274670116987e-09
. O 0 1.6902343968894229e-09

We O 0 9.438322345900474e-10
identified O 0 2.1696074103960683e-10
a O 0 3.043152882464817e-11
1422 O 0 6.776824434950868e-09
G O 0 2.5164888839412924e-08
- O 0 1.0293484953294296e-09
- O 0 1.8244609989448435e-10
> O 0 1.1174153824455857e-09
C O 0 5.577129869038799e-10
( O 0 2.587391835073144e-13
amino O 0 8.269902991575595e-12
acid O 0 1.4767390598118685e-13
W474C O 0 8.565351661445064e-13
) O 0 7.967219033398041e-17
substitution O 0 6.1084047806622254e-15
in O 0 2.9424728153576397e-15
the O 0 1.5334869130274355e-14
first O 0 6.95606427818761e-14
position O 0 1.5725571886338052e-12
of O 0 1.973701584112586e-11
exon O 0 1.1640598485129772e-09
13 O 0 2.5789997915026674e-10
of O 0 5.262915658832412e-10
HEXA O 0 6.72100723022595e-05
of O 0 1.5702525502092612e-08
a O 0 8.23141887984491e-10
non O 0 4.025827138320892e-08
- O 0 1.69634417623854e-10
Jewish O 0 1.6941550939897354e-10
proband O 0 1.3582429119196604e-06
who O 0 3.391454339585209e-10
manifested O 0 2.311096425344772e-09
a O 0 7.740641461140285e-10
subacute O 0 0.012064266949892044
variant O 0 3.4711601983872242e-06
of O 0 0.2122698277235031
G B-Disease 1 0.9996665716171265
( I-Disease 0 1.5527896746192482e-09
M2 I-Disease 0 1.2883620001957752e-06
) I-Disease 0 2.1521394041879027e-11
gangliosidosis I-Disease 0 3.3757368100850726e-07
. O 0 1.5336055980696983e-08

On O 0 1.0316648513253313e-07
the O 0 4.590932967118988e-09
second O 0 8.241571869405107e-09
maternally O 0 4.678660570078819e-09
inherited O 0 1.4741586840116838e-09
allele O 0 5.520453191798502e-11
, O 0 9.036328543071681e-13
we O 0 4.2686633307947863e-13
identified O 0 2.0631799220460767e-12
the O 0 8.78788274788489e-12
common O 0 3.220437605477855e-08
infantile O 1 1.0
disease O 1 1.0
- O 0 6.511271521958406e-08
causing O 0 4.2012598555629665e-07
4 O 0 6.560983820236288e-06
- O 0 1.0211237411184015e-09
bp O 0 9.903297626401297e-11
insertion O 0 2.2409804914524933e-11
, O 0 1.6644852163238966e-11
+ O 0 2.3122151415755354e-10
TATC O 0 2.009936110880517e-07
1278 O 0 4.322362201492069e-08
, O 0 7.030607433039515e-12
in O 0 4.3687872763875646e-11
exon O 0 2.7338121100228818e-08
11 O 0 1.602170129899605e-08
. O 0 7.42939754161398e-09

Pulse O 0 0.0007863329956308007
- O 0 6.493536375273834e-07
chase O 0 2.9502256193580934e-09
analysis O 0 4.253669898951484e-12
using O 0 3.857006294211152e-12
proband O 0 3.4214340249860697e-09
fibroblasts O 0 1.5880341486251837e-09
revealed O 0 8.722209760003707e-11
that O 0 3.560083543067971e-13
the O 0 4.524123263516255e-12
W474C O 0 1.2108758440376732e-10
- O 0 8.206861405735122e-12
containing O 0 2.267656028231979e-11
alpha O 0 6.104434319142982e-11
- O 0 3.3061650205751247e-12
subunit O 0 1.4271570036861192e-11
precursor O 0 1.4438375495195999e-10
was O 0 1.8904894316662535e-10
normally O 0 2.0191801789609665e-12
synthesized O 0 1.364392279712412e-11
, O 0 1.269888816497755e-12
but O 0 8.015888842451135e-13
not O 0 5.997306058887208e-13
phosphorylated O 0 4.2014378087706916e-11
or O 0 9.156703173474057e-13
secreted O 0 1.2403175275038647e-13
, O 0 2.2531974929514836e-13
and O 0 3.1488793777317836e-12
the O 0 3.2459648857674495e-10
mature O 0 5.590773399788418e-10
lysosomal O 0 2.2324257997752284e-08
alpha O 0 5.826116811213922e-10
- O 0 3.515632229778021e-11
subunit O 0 9.964155195385516e-11
was O 0 1.4899198541584724e-10
not O 0 6.684231293463405e-12
detected O 0 1.353192446984508e-09
. O 0 1.452932441026178e-09

When O 0 1.522299369893787e-10
the O 0 1.3318517122495876e-10
W474C O 0 6.71101452187628e-10
- O 0 6.6135946545642366e-12
containing O 0 7.0797235261765845e-12
alpha O 0 5.201141947686061e-11
- O 0 1.5298482966552562e-12
subunit O 0 3.154327146703828e-11
was O 0 2.852198338620937e-11
transiently O 0 2.1903097391362536e-10
co O 0 7.27770621544721e-11
- O 0 1.0675704027393595e-12
expressed O 0 9.828318714433237e-13
with O 0 2.120169037350076e-14
the O 0 5.410619435125552e-12
beta O 0 1.4745057605458634e-11
- O 0 2.49626572667791e-13
subunit O 0 2.756891936961381e-13
to O 0 1.9422099562307893e-14
produce O 0 1.3503593859418017e-12
Hex O 0 8.166022857913902e-10
A O 0 1.9582535593087869e-10
( O 0 4.183790493954634e-14
alphabeta O 0 3.1463113364660344e-11
) O 0 3.681577883263981e-14
in O 0 2.3128565035390736e-12
COS O 0 8.607593571241523e-08
- O 0 3.6567829320155454e-10
7 O 0 6.018835985166504e-10
cells O 0 1.4953532119152402e-12
, O 0 8.564465326169057e-14
the O 0 1.5573787918998772e-12
mature O 0 3.34855212134888e-12
alpha O 0 2.088324521989926e-12
- O 0 6.565550918690918e-14
subunit O 0 3.0591653342459946e-13
was O 0 9.978865607093712e-13
present O 0 1.518842831452899e-13
, O 0 2.501221038825937e-14
but O 0 2.7152364490373553e-14
its O 0 2.936599802303569e-13
level O 0 1.6636926558621923e-10
was O 0 2.8989382075406134e-11
much O 0 1.3832263242793963e-12
lower O 0 1.692613584014513e-11
than O 0 7.94122271874408e-15
that O 0 1.2861266108913413e-14
from O 0 1.4753258022800336e-13
normal O 0 8.189555283921734e-11
alpha O 0 4.2341800204903635e-11
- O 0 6.428232512262211e-13
subunit O 0 5.177322871634249e-13
transfections O 0 1.4153541186279206e-11
, O 0 1.0422550002957623e-13
although O 0 4.127784811007451e-13
higher O 0 2.233511769630936e-12
than O 0 5.652648962513156e-15
in O 0 2.0240840253871184e-13
those O 0 1.4083914969594685e-13
cells O 0 5.519499787776105e-13
transfected O 0 2.3771810908623792e-11
with O 0 2.614945037577015e-14
an O 0 1.8027385953380687e-13
alpha O 0 1.0527457378062266e-10
- O 0 8.51661362960554e-12
subunit O 0 8.006209584188184e-11
associated O 0 1.3712020408007675e-10
with O 0 3.3902575191646633e-10
infantile O 1 0.9978310465812683
TSD B-Disease 0 0.06930962949991226
. O 0 2.8059277568104335e-08

Furthermore O 0 1.3121245201475062e-09
, O 0 3.9038338534025385e-12
the O 0 1.631070278840241e-12
precursor O 0 7.718078780249993e-12
level O 0 3.422150340881558e-10
of O 0 3.631896519640243e-11
the O 0 2.5907770720423606e-11
W474C O 0 6.703977928346205e-10
alpha O 0 1.7489505677037442e-10
- O 0 8.822798394647613e-12
subunit O 0 3.0956660845848916e-11
was O 0 8.051907751660536e-11
found O 0 7.149824352362111e-13
to O 0 4.69319000979615e-14
accumulate O 0 2.505547005494154e-14
in O 0 2.1997306049164472e-13
comparison O 0 3.8836162476012237e-13
to O 0 3.3574529332940084e-13
the O 0 4.112339288542266e-11
normal O 0 1.5367174199809597e-09
alpha O 0 3.0496855041306503e-10
- O 0 6.777615361303058e-12
subunit O 0 4.205390202738357e-11
precursor O 0 4.373541806490522e-10
levels O 0 3.848817708984598e-09
. O 0 2.330652337789729e-10

We O 0 5.886501286411772e-10
conclude O 0 3.547460936115243e-10
that O 0 3.9374677563569493e-13
the O 0 1.3936663455227372e-11
1422 O 0 7.203277530010155e-09
G O 0 1.8905043930317333e-07
- O 0 1.839308971796072e-08
- O 0 3.0078917134801486e-09
> O 0 5.228878663388059e-09
C O 0 1.3156078448872677e-09
mutation O 0 5.131668527613709e-12
is O 0 8.732046559618584e-15
the O 0 6.136177042826915e-14
cause O 0 7.499274638778086e-12
of O 0 9.409437673468801e-10
Hex B-Disease 0 0.1528829038143158
A I-Disease 1 0.9944685697555542
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.082133602840599e-10
the O 0 2.3539605820133147e-09
proband O 0 5.168476491235197e-07
. O 0 1.2902904522604786e-08

The O 0 4.056177616007517e-09
resulting O 0 7.667317891701941e-10
W474C O 0 4.410857012970837e-09
substitution O 0 1.041418506986247e-09
clearly O 0 6.635175048286257e-12
interferes O 0 5.296805203648669e-13
with O 0 7.82019712658108e-14
alpha O 0 2.90795391238996e-11
- O 0 6.469006645463959e-13
subunit O 0 5.7248771695439515e-12
processing O 0 3.7871279029433325e-11
, O 0 2.0418547766205136e-13
but O 0 5.333867435187642e-14
because O 0 7.730032163411754e-14
the O 0 5.227781640741724e-13
base O 0 8.03478204108865e-12
substitution O 0 2.8903032744942436e-11
falls O 0 8.134461160214101e-11
at O 0 2.837504536890023e-11
the O 0 4.489224530307423e-12
first O 0 2.5566831637902077e-12
position O 0 1.8765995701830462e-11
of O 0 2.1440689501606158e-10
exon O 0 1.0548774298513308e-08
13 O 0 6.393247597991092e-10
, O 0 1.3237265450438684e-11
aberrant O 0 1.0183347498582407e-09
splicing O 0 2.0780761555982963e-09
may O 0 1.1626902218786483e-10
also O 0 7.876456648361896e-13
contribute O 0 7.340134766274306e-14
to O 0 2.6243915894619274e-12
Hex B-Disease 0 7.460934739356162e-06
A I-Disease 0 2.2931139938009437e-06
deficiency I-Disease 0 1.422713467036374e-07
in O 0 2.6488131132929027e-11
this O 0 6.527947019746572e-12
proband O 0 7.06344422951588e-08
. O 0 4.231421324440987e-10
. O 0 1.3126502107496663e-09

Two O 0 2.4959742606078805e-10
frequent O 0 8.580636756683191e-10
missense O 0 5.908847811042506e-07
mutations O 0 7.979052085715921e-09
in O 0 4.2625472929103125e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 3.8991373003227636e-05

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.7332173474216006e-09
an O 0 7.690228898127316e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 9.101445291870291e-11
by O 0 1.6516294379720418e-15
early O 0 2.3122283254739529e-10
childhood O 1 0.9999998807907104
deafness B-Disease 1 1.0
and O 0 0.0003793344949372113
goiter B-Disease 1 1.0
. O 0 1.41710063417122e-06

A O 0 3.761374767208281e-09
century O 0 3.0951008422874793e-10
after O 0 3.1025032803250197e-12
its O 0 3.715908060853562e-13
recognition O 0 1.090322537117272e-11
as O 0 2.4357370287386715e-11
a O 0 1.1518089815254484e-09
syndrome O 0 7.525081002768275e-08
by O 0 6.117461572030525e-12
Vaughan O 0 1.4226586131371732e-08
Pendred O 0 1.5942845266181394e-06
, O 0 6.113778927563374e-11
the O 0 1.0366127956018545e-09
disease O 0 2.305025873283739e-06
gene O 0 1.0518184934138475e-10
( O 0 3.4661995496065856e-12
PDS O 0 2.981689419812028e-07
) O 0 7.740925413689259e-13
was O 0 1.0130145333686613e-10
mapped O 0 8.841975068785146e-11
to O 0 2.3625811376715156e-11
chromosome O 0 3.1924884069667314e-08
7q22 O 0 1.457951839256566e-06
- O 0 6.070874292163353e-07
q31 O 0 6.323924139906012e-07
. O 0 8.874287971138983e-09

1 O 0 3.0711791509929753e-07
and O 0 4.155088426105458e-11
, O 0 1.0161449806589395e-11
recently O 0 6.578070033125272e-11
, O 0 1.1947695437164452e-12
found O 0 3.115874799928392e-13
to O 0 2.2694103811882888e-13
encode O 0 1.8098926871101817e-11
a O 0 4.579954471228831e-10
putative O 0 3.116691260629523e-08
sulfate O 0 2.5687027616072555e-08
transporter O 0 1.4797124947563134e-07
. O 0 8.893739966708836e-09

We O 0 3.3228012008557073e-10
performed O 0 6.27497151461931e-11
mutation O 0 1.115886571513569e-12
analysis O 0 1.0364801329492898e-13
of O 0 4.5832903444731343e-11
the O 0 3.7349853765356045e-10
PDS B-Disease 0 8.472728723063483e-07
gene O 0 1.7375713715073182e-11
in O 0 7.790757622361255e-12
patients O 0 5.5804549349558474e-12
from O 0 5.706845152692042e-12
14 O 0 4.478686310704916e-09
Pendred B-Disease 0 4.568573430674405e-08
families O 0 5.717301632124361e-13
originating O 0 6.287739426347194e-12
from O 0 2.040349226378746e-12
seven O 0 1.4447236809655983e-11
countries O 0 1.6219495364844239e-12
and O 0 6.921845908947066e-12
identified O 0 2.872246052110228e-10
all O 0 1.1968515067906083e-09
mutations O 0 2.2996648141315745e-08
. O 0 1.988152753540362e-08

The O 0 5.5709983293183996e-09
mutations O 0 3.537709014622692e-11
include O 0 1.9490485614337416e-11
three O 0 1.3300486580158921e-11
single O 0 7.911667154747448e-11
base O 0 5.617517562228613e-10
deletions O 0 3.8152606074426387e-10
, O 0 2.1329989163820784e-10
one O 0 2.177609065290298e-10
splice O 0 6.042651534698962e-08
site O 0 2.0673507350466025e-09
mutation O 0 1.2376726032936602e-10
and O 0 1.095174645415753e-11
10 O 0 1.270348604087701e-09
missense O 0 3.311328384825174e-07
mutations O 0 8.468550305451572e-09
. O 0 1.9823101382598907e-08

One O 0 2.192940273815225e-09
missense O 0 5.4136240379421e-08
mutation O 0 2.9896370101756276e-11
( O 0 4.3961164461307767e-13
L236P O 0 4.4887728950504524e-11
) O 0 2.154650969362487e-13
was O 0 1.1688020343236794e-11
found O 0 1.7030718198543515e-13
in O 0 3.0054009682398825e-14
a O 0 4.6265488456379705e-14
homozygous O 0 1.038435721960329e-12
state O 0 8.056196768718715e-14
in O 0 3.4947828593707986e-13
two O 0 8.120563141193748e-13
consanguineous O 0 4.263293273965019e-09
families O 0 1.3447350058568702e-13
and O 0 3.1710574379013867e-13
in O 0 1.2625925695577966e-12
a O 0 2.338361925965926e-12
heterozygous O 0 2.660822734021351e-12
state O 0 1.7674219292967974e-13
in O 0 5.841552285293372e-13
five O 0 1.728810128907854e-12
additional O 0 2.4770168555177108e-11
non O 0 1.3293046094986494e-06
- O 0 1.630663746254868e-07
consanguineous O 0 1.157868518930627e-05
families O 0 7.440979499229172e-10
. O 0 1.00557704385551e-08

Another O 0 3.505244539070418e-09
missense O 0 1.2359002710127243e-07
mutation O 0 4.300186248751281e-11
( O 0 9.786156260349621e-13
T416P O 0 1.4445866725054657e-10
) O 0 2.6382219434246956e-13
was O 0 9.403471924740447e-12
found O 0 1.334069166985044e-13
in O 0 8.794278917286305e-14
a O 0 8.974009821924658e-14
homozygous O 0 2.732226988058639e-12
state O 0 6.184518500616798e-13
in O 0 6.0535300730468755e-12
one O 0 2.3482396582785725e-12
family O 0 4.088699593739892e-13
and O 0 1.7996808741611164e-13
in O 0 2.057921541509522e-12
a O 0 1.9716838838695905e-12
heterozygous O 0 2.5881185215792524e-12
state O 0 3.092475819692353e-13
in O 0 6.494688467584275e-12
four O 0 1.0206248346467106e-10
families O 0 1.240212186420786e-11
. O 0 2.5333382058789766e-09

Pendred B-Disease 0 0.001416767481714487
patients O 0 1.3554456224085243e-08
in O 0 3.6091651889336163e-10
three O 0 7.731286721934794e-10
non O 0 6.067464255465893e-06
- O 0 4.6511157592021846e-08
consanguineous O 0 6.897069397382438e-06
families O 0 2.529907533466158e-11
were O 0 2.5048725246779036e-11
shown O 0 5.683902133679641e-12
to O 0 3.483657372987947e-12
be O 0 8.248620536610574e-12
compound O 0 3.8541933533586814e-10
heterozygotes O 0 3.325895669981094e-10
for O 0 1.1526913104575875e-11
L236P O 0 5.715917517079561e-09
and O 0 3.680476201584071e-10
T416P O 0 1.1314920556060315e-07
. O 0 5.245020417987689e-09

In O 0 3.4439681662057353e-10
total O 0 1.2149433681329924e-09
, O 0 2.3868131429627404e-11
one O 0 4.196005955886539e-12
or O 0 2.0624994767626248e-12
both O 0 7.465878609780319e-12
of O 0 2.0340267248286636e-09
these O 0 5.1228474587383666e-12
mutations O 0 3.814056275669442e-12
were O 0 2.9198460056029107e-12
found O 0 1.8408556200655984e-13
in O 0 2.0487569973859365e-12
nine O 0 2.575971380647246e-10
of O 0 1.4948906557066266e-09
the O 0 1.673036265081862e-09
14 O 0 1.2868863308312939e-08
families O 0 2.2010337996647422e-11
analyzed O 0 3.2871305677417695e-09
. O 0 1.1768860552763272e-08

The O 0 9.616641927223668e-10
identification O 0 7.421872560975373e-10
of O 0 3.883639188018151e-09
two O 0 1.334832244737072e-10
frequent O 0 2.2005197664043408e-09
PDS B-Disease 0 9.171612873615231e-06
mutations O 0 6.266455410131044e-11
will O 0 1.92189992219427e-12
facilitate O 0 9.02914982364722e-12
the O 0 7.282020472731965e-12
molecular O 0 1.0923141502416911e-08
diagnosis O 0 1.2478611097321846e-05
of O 0 3.7261345369188348e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.3452533494273666e-05

Insertional O 0 9.708454626888852e-07
mutation O 0 2.413572397497177e-10
by O 0 1.5228235339392882e-12
transposable O 0 3.378448099056186e-08
element O 0 7.72966934903252e-09
, O 0 1.6397591617867135e-10
L1 O 0 1.4635405420904135e-07
, O 0 2.4509469974398623e-12
in O 0 2.2571441243846024e-11
the O 0 7.560237769155265e-09
DMD B-Disease 1 1.0
gene O 0 5.592415974753351e-10
results O 0 2.316274776148486e-11
in O 0 1.8279678118404696e-11
X B-Disease 1 0.9999997615814209
- I-Disease 1 0.999982476234436
linked I-Disease 1 0.9999892711639404
dilated I-Disease 0 0.47723954916000366
cardiomyopathy I-Disease 1 1.0
. O 0 3.5243195384282444e-07

X B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
linked I-Disease 1 0.9999953508377075
dilated I-Disease 1 0.9999614953994751
cardiomyopathy I-Disease 1 1.0
( O 0 2.13622053379936e-09
XLDCM B-Disease 0 0.0001791153772501275
) O 0 7.979796294230179e-13
is O 0 6.396260203347243e-14
a O 0 3.0222048821859637e-13
clinical O 0 8.813930918449842e-09
phenotype O 0 8.91091977983649e-10
of O 0 2.418619748922879e-09
dystrophinopathy B-Disease 0 3.722621499946399e-07
which O 0 8.83589588215189e-13
is O 0 2.7600683782762203e-14
characterized O 0 4.058421350719432e-13
by O 0 1.1250306513211489e-13
preferential O 0 2.985674152355955e-09
myocardial B-Disease 0 0.09518654644489288
involvement I-Disease 0 1.1764472729325348e-10
without O 0 1.8408143932779897e-12
any O 0 5.555516441844988e-13
overt O 0 2.097224061081704e-10
clinical O 0 1.3895529264118522e-05
signs O 0 0.0018270800355821848
of O 0 0.0005866826977580786
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.0001137835715780966

To O 0 1.1010727919702479e-11
date O 0 1.8087349396012087e-09
, O 0 8.853643729614391e-13
several O 0 3.343579211244341e-13
mutations O 0 3.487486775061166e-12
in O 0 5.6071492934850475e-12
the O 0 2.476242002558138e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 2.843837343391442e-08
, O 0 1.1305132524563888e-10
DMD O 1 1.0
, O 0 2.826333134545167e-12
have O 0 5.99988876398734e-14
been O 0 1.8609418883262438e-14
identified O 0 7.071375955495021e-14
in O 0 7.267378430812765e-13
patients O 0 6.496940030235876e-13
with O 0 4.941517572736032e-13
XLDCM B-Disease 1 0.9898080229759216
, O 0 4.5936528886292294e-11
but O 0 1.0097032801872907e-12
a O 0 3.8675752054087575e-13
pathogenic O 0 1.8241322081308242e-12
correlation O 0 1.3403800638855934e-12
of O 0 1.6827634771732214e-11
these O 0 7.729005152903867e-13
cardiospecific O 0 3.703568340895913e-09
mutations O 0 5.38907599101357e-11
in O 0 2.3882168465050313e-10
DMD O 1 1.0
with O 0 1.2004219840378028e-10
the O 0 1.2795461579173661e-08
XLDCM B-Disease 0 0.001815142692066729
phenotype O 0 1.4171229523185502e-08
has O 0 2.524094822042855e-11
remained O 0 4.864840197349452e-10
to O 0 3.670755539808557e-12
be O 0 6.523979273476144e-11
elucidated O 0 4.327340548115899e-07
. O 0 9.418024582430462e-09

We O 0 1.6375752975861246e-09
report O 0 1.1796148259579642e-11
here O 0 1.4586253212212075e-12
the O 0 6.629479409013539e-13
identification O 0 7.646222197066344e-12
of O 0 4.317123741826023e-11
a O 0 7.32966378563793e-12
unique O 0 7.271236997924424e-12
de O 0 2.311661617682148e-08
novo O 0 9.437611225848741e-08
L1 O 0 2.0754510998699516e-08
insertion O 0 9.177461741949333e-12
in O 0 1.6060808932794046e-11
the O 0 3.5196598413556046e-10
muscle O 0 7.819187963775676e-09
exon O 0 2.4891214422950725e-08
1 O 0 8.571072740437558e-09
in O 0 1.6727609575273306e-10
DMD O 1 1.0
in O 0 2.0455065419255902e-10
three O 0 1.346061179186009e-10
XLDCM B-Disease 0 1.1689837265294045e-05
patients O 0 8.768314546658829e-11
from O 0 5.2593584869142784e-12
two O 0 1.6336553637641416e-11
unrelated O 0 8.456828015646067e-10
Japanese O 0 4.873440389019379e-07
families O 0 6.365019622478485e-10
. O 0 3.068084453161646e-08

The O 0 4.993582436441102e-09
insertion O 0 4.874815551225709e-10
was O 0 3.5283322930013128e-09
a O 0 1.2950401861999694e-10
5 O 0 6.191845924874428e-10
- O 0 8.966678961830343e-12
truncated O 0 7.666126414229701e-12
form O 0 5.836896721164719e-13
of O 0 3.45303022286636e-11
human O 0 2.9273590496092794e-11
L1 O 0 5.250302970161158e-10
inversely O 0 1.051474445706857e-12
integrated O 0 6.293705834270469e-11
in O 0 2.954270075100629e-12
the O 0 5.274318828907276e-11
5 O 0 1.6927703683222717e-09
- O 0 8.412758684128718e-11
untranslated O 0 8.206376378439018e-08
region O 0 1.515471081958708e-10
in O 0 1.9775301188240668e-11
the O 0 1.1339123390241568e-10
muscle O 0 1.6215095932636814e-09
exon O 0 4.466580882933613e-09
1 O 0 9.96163262989569e-10
, O 0 6.748816322411574e-14
which O 0 2.4532642356380613e-14
affected O 0 5.14281441054993e-14
the O 0 7.208031372295254e-13
transcription O 0 4.908754392546344e-12
or O 0 4.1213806998251223e-13
the O 0 9.285377154666374e-12
stability O 0 2.6233344385673263e-09
of O 0 5.928958990430999e-10
the O 0 1.5179850432200936e-10
muscle O 0 6.846297834206538e-11
form O 0 4.751544990799772e-11
of O 0 5.320202056680046e-10
dystrophin O 0 3.135459447634048e-09
transcripts O 0 9.174981607795729e-11
but O 0 3.3597910152789734e-13
not O 0 5.529549325475509e-14
that O 0 4.810702956326886e-14
of O 0 1.1468103550127395e-10
the O 0 2.617765171297748e-10
brain O 0 3.2644578595864004e-08
or O 0 2.7786245526684183e-10
Purkinje O 0 0.0001564145932206884
cell O 0 1.7225755073013715e-05
form O 0 2.085760009151727e-09
, O 0 2.8535042384536524e-11
probably O 0 6.0326678548439094e-12
due O 0 8.411719654155547e-10
to O 0 8.795675234159195e-13
its O 0 5.210493061319488e-12
unique O 0 3.1841504259666475e-12
site O 0 5.018698998049409e-11
of O 0 1.419193512708361e-10
integration O 0 5.406491254689172e-09
. O 0 5.41372457973921e-09

We O 0 2.3414004068911254e-09
speculate O 0 1.2415050931746663e-10
that O 0 6.39940777777924e-14
this O 0 3.627529388526042e-14
insertion O 0 2.4373610226467723e-13
of O 0 3.6902446376441134e-11
an O 0 1.8061053954493422e-12
L1 O 0 4.084516547209205e-08
sequence O 0 2.0177848281122124e-10
in O 0 4.996630664777513e-09
DMD O 1 1.0
is O 0 5.904027960967895e-11
responsible O 0 1.016021034666581e-11
for O 0 6.547521314188842e-13
some O 0 2.2468031395887073e-13
of O 0 4.191840971556893e-11
the O 0 3.3042926034232423e-12
population O 0 6.715431027015314e-14
of O 0 7.737682022890269e-12
Japanese O 0 1.9359616132419433e-08
patients O 0 3.370931311863501e-11
with O 0 2.2469897470456246e-11
XLDCM B-Disease 1 0.5806152820587158
. O 0 4.62359706077109e-09
. O 0 1.1792049114944803e-08

Severe O 0 1.8276297851116396e-05
early O 0 1.421729120920645e-05
- O 0 0.12510599195957184
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 8.394702710745605e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9994682669639587
red O 1 0.9999620914459229
hair O 0 0.0482475571334362
pigmentation O 0 0.24101221561431885
caused O 0 9.360291386428798e-08
by O 0 1.3670342635663246e-10
POMC O 0 6.105046486482024e-05
mutations O 0 5.1280410473530935e-11
in O 0 4.111107981819018e-11
humans O 0 3.020924344010467e-10
. O 0 4.666234620920306e-10

Sequential O 0 1.0016681706304098e-08
cleavage O 0 3.3512539410196496e-09
of O 0 4.851850476939035e-09
the O 0 4.668576081279241e-10
precursor O 0 4.617724813638091e-10
protein O 0 1.5917664408782173e-10
pre O 0 1.2180572639408638e-07
- O 0 1.5996691971054133e-08
pro O 0 2.58122781815473e-07
- O 0 1.181660769233872e-09
opiomelanocortin O 0 4.9076220420829486e-08
( O 0 1.2803228963131907e-11
POMC O 0 2.9749262608902427e-08
) O 0 3.11464890608449e-14
generates O 0 1.1275913335646523e-13
the O 0 6.263512711962571e-12
melanocortin O 0 2.7218504783377284e-08
peptides O 0 8.427389341925107e-11
adrenocorticotrophin O 0 3.503185741493553e-09
( O 0 1.034454900211701e-11
ACTH O 0 7.435748461404046e-09
) O 0 2.4044847601704944e-13
, O 0 7.047171006469011e-13
melanocyte O 0 2.1020959195539035e-08
- O 0 2.0722381588456074e-09
stimulating O 0 1.7280677999664817e-09
hormones O 0 7.581804628564726e-11
( O 0 1.7556722948283005e-13
MSH O 0 3.00406721720492e-09
) O 0 9.837723558415827e-15
alpha O 0 1.5919370314164405e-13
, O 0 1.7062044060383468e-15
beta O 0 4.357521017194638e-14
and O 0 3.081756583863532e-15
gamma O 0 7.830272075268901e-14
as O 0 1.8007271631388828e-14
well O 0 1.3967058304191482e-14
as O 0 3.029423161437193e-14
the O 0 2.0353769396904559e-13
opioid O 0 3.115157437560967e-12
- O 0 2.4829603976171677e-13
receptor O 0 4.144127667979683e-14
ligand O 0 2.5919667887702724e-12
beta O 0 3.8304195926208706e-10
- O 0 3.9813047303383087e-10
endorphin O 0 3.8076311881241054e-08
. O 0 3.7618391734994816e-10

While O 0 1.0057875643454395e-09
a O 0 2.7789041900927458e-11
few O 0 3.240771583382096e-12
cases O 0 1.365557948836138e-12
of O 0 1.473427824194573e-09
isolated O 1 0.6197202801704407
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999973773956299
have O 0 8.903440484875347e-11
been O 0 1.533433623135405e-11
reported O 0 1.1353016443615971e-10
( O 0 1.0614458617608236e-10
OMIM O 1 0.5791167616844177
201400 O 0 5.059207524027443e-07
) O 0 3.589807704568182e-12
, O 0 9.074672437103803e-13
an O 0 2.2738354168300168e-12
inherited O 0 1.6411977412644774e-05
POMC O 1 0.9999992847442627
defect O 0 0.13048794865608215
has O 0 1.0294735897087293e-10
not O 0 3.828691703955389e-12
been O 0 6.194580005197681e-12
described O 0 1.5813649001383823e-11
so O 0 4.489164682347502e-12
far O 0 5.479070669389685e-11
. O 0 7.36512628662922e-10

Recent O 0 2.704066658087978e-11
studies O 0 1.3629246385996052e-12
in O 0 3.5890187306472643e-13
animal O 0 4.864222306194543e-12
models O 0 5.274967745591552e-13
elucidated O 0 1.0264306765650488e-10
a O 0 1.8371667034888794e-12
central O 0 7.953684239003778e-11
role O 0 6.745580222872194e-12
of O 0 1.2164181883989045e-09
alpha O 0 3.6694729477204646e-09
- O 0 5.786006118668752e-10
MSH O 0 1.246427814294293e-07
in O 0 4.536964554047174e-12
the O 0 1.040883351732802e-11
regulation O 0 2.3290169792744564e-10
of O 0 4.9252813633104964e-11
food O 0 2.2339177382924014e-11
intake O 0 3.1314008460889275e-13
by O 0 6.4234709673711976e-15
activation O 0 4.712012897922779e-12
of O 0 1.8047228989015451e-10
the O 0 8.393540723572457e-11
brain O 0 6.703878785430106e-09
melanocortin O 0 4.511388169703423e-07
- O 0 2.5202809283975114e-10
4 O 0 5.029983540794092e-09
- O 0 2.243893265641006e-11
receptor O 0 6.8358170686455555e-12
( O 0 4.650040118583942e-13
MC4 O 0 3.547766596057045e-07
- O 0 2.7739649466340666e-10
R O 0 5.881563569509751e-10
; O 0 1.2432685902920987e-13
refs O 0 2.4926619796028504e-11
3 O 0 1.277359294726832e-11
- O 0 1.4286262331551086e-13
5 O 0 1.155441709107738e-13
) O 0 3.7256800433262054e-17
and O 0 1.1022760688697881e-16
the O 0 3.6402947679642274e-15
linkage O 0 1.2585779640694739e-11
of O 0 9.462900081580461e-12
human O 0 1.177383968098411e-09
obesity B-Disease 1 1.0
to O 0 3.553475872927758e-13
chromosome O 0 4.588836255425832e-11
2 O 0 3.7017514054049627e-10
in O 0 1.7025854467597745e-12
close O 0 6.428039957956377e-12
proximity O 0 2.496345907765374e-10
to O 0 3.6780301027050655e-12
the O 0 2.4815344223938496e-10
POMC O 0 1.6637440580780094e-07
locus O 0 7.727066902996071e-11
, O 0 9.21288436164791e-13
led O 0 2.9030976841232237e-12
to O 0 1.2956510051041065e-13
the O 0 6.081165519061793e-12
proposal O 0 2.311546787314711e-12
of O 0 8.20057129841123e-12
an O 0 4.2145320978785594e-13
association O 0 9.781836451949744e-11
of O 0 1.2897360956998227e-09
POMC O 0 0.00013269313785713166
with O 0 1.0080514201149526e-10
human O 0 6.400161510100588e-06
obesity B-Disease 1 1.0
. O 0 2.145576694090323e-08

The O 0 9.47257050576411e-10
dual O 0 5.824852600255781e-09
role O 0 1.5275522513569229e-10
of O 0 1.1677185440817084e-08
alpha O 0 4.457612590158533e-08
- O 0 4.064355962896116e-09
MSH O 0 3.4180251873294765e-07
in O 0 4.952446439054903e-12
regulating O 0 4.954319940408958e-11
food O 0 2.5731822228536316e-10
intake O 0 1.031439031407011e-10
and O 0 5.798638912785092e-12
influencing O 0 3.5966738476389537e-09
hair O 0 4.669026338888216e-07
pigmentation O 0 5.242043243924854e-08
predicts O 0 1.3928698472387424e-10
that O 0 4.6166412706605264e-14
the O 0 3.78952294891044e-13
phenotype O 0 2.383754435161811e-12
associated O 0 2.2878948085017226e-13
with O 0 1.365473896062716e-13
a O 0 3.1610002809712157e-11
defect O 0 3.032461748375681e-08
in O 0 1.6102377764504183e-10
POMC O 0 7.577970336569706e-06
function O 0 3.1072205919358e-10
would O 0 1.3587742042631135e-12
include O 0 2.3195961817989996e-10
obesity B-Disease 1 1.0
, O 0 6.640008096310546e-13
alteration O 0 3.765071365791073e-09
in O 0 4.525146091172161e-10
pigmentation O 1 0.990481972694397
and O 0 3.116739151209913e-07
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999951124191284
. O 0 2.1721049847656104e-07

The O 0 9.847341830848677e-10
observation O 0 7.609051522194932e-08
of O 0 6.804152352657411e-09
these O 0 1.3869208559391666e-10
symptoms O 0 8.012069656615495e-07
in O 0 1.00626729171438e-09
two O 0 2.7617380604638697e-10
probands O 0 1.0591352292976808e-06
prompted O 0 3.3767908469428676e-09
us O 0 1.126178230531627e-11
to O 0 3.2720501655369993e-12
search O 0 1.1595100574135486e-10
for O 0 4.922463825440815e-11
mutations O 0 6.548305231390827e-10
within O 0 4.473606374233441e-09
their O 0 8.851837485224223e-09
POMC O 0 2.163833960366901e-05
genes O 0 3.976039941733234e-09
. O 0 4.567028977220389e-09

Patient O 0 1.2004549034827505e-06
1 O 0 4.363915650174022e-06
was O 0 1.0998717492327614e-08
found O 0 3.4028285831461114e-12
to O 0 2.7596485209849253e-13
be O 0 4.835377974757304e-13
a O 0 2.0202435644517402e-12
compound O 0 8.620758273902851e-11
heterozygote O 0 9.623114111123598e-11
for O 0 4.2877656178212653e-13
two O 0 3.9866937875943087e-13
mutations O 0 1.2913218671445348e-12
in O 0 1.6045406323050848e-11
exon O 0 6.469624391769457e-09
3 O 0 6.8403265274241676e-09
( O 0 1.882722059851072e-12
G7013T O 0 3.5742001025518277e-10
, O 0 1.1665230413571148e-12
C7133delta O 0 1.384177772401074e-10
) O 0 1.6006869495242132e-14
which O 0 1.0387180278772536e-14
interfere O 0 3.1403712638135295e-14
with O 0 8.666506538291836e-15
appropriate O 0 3.284781301127193e-12
synthesis O 0 7.325194617546771e-11
of O 0 6.527207108142363e-10
ACTH O 0 2.8646451255553984e-07
and O 0 5.120566748395561e-10
alpha O 0 4.568216525058233e-07
- O 0 2.8523450623652025e-07
MSH O 0 4.7640103730373085e-05
. O 0 8.460800948739688e-09

Patient O 0 8.319533861822492e-08
2 O 0 1.9408604501336413e-08
was O 0 5.895216953488713e-11
homozygous O 0 1.8300643986335352e-11
for O 0 1.1920517741306758e-12
a O 0 5.07605416033563e-12
mutation O 0 2.594469561065238e-12
in O 0 1.1513422160103204e-11
exon O 0 2.5244824009007516e-09
2 O 0 1.1726192239436273e-09
( O 0 5.269014933563521e-13
C3804A O 0 1.348975792181406e-10
) O 0 3.672658423041486e-13
which O 0 1.788225925843101e-12
abolishes O 0 2.927938425045795e-08
POMC O 0 1.254116455129406e-06
translation O 0 1.4266957615305387e-09
. O 0 2.390259545848039e-09

These O 0 2.2787176312544233e-10
findings O 0 6.86206126643274e-12
represent O 0 5.512913801679342e-13
the O 0 1.7071639241139636e-12
first O 0 6.927878409834776e-13
examples O 0 1.120793215181326e-11
of O 0 7.062979645588996e-10
a O 0 2.053760272957561e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 4.328266633990552e-09
the O 0 2.63826627211472e-10
POMC O 0 1.1390622489670932e-07
gene O 0 9.108486534459281e-13
and O 0 1.7919388574979406e-14
define O 0 6.777198160307085e-13
a O 0 4.2710819147910584e-13
new O 0 5.4461563731011964e-11
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 0 3.153051875415258e-05
resulting O 0 4.4233001051004195e-13
in O 0 2.479220713273722e-14
early O 0 5.3763947960305813e-08
- O 1 0.719118058681488
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 2.5603245035199507e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9925457835197449
red O 0 0.06320767849683762
hair O 0 1.7213633327628486e-06
pigmentation O 0 8.068912393355276e-06
. O 0 2.857296621527894e-10
. O 0 1.3655261366096738e-09

A O 0 8.286811237212532e-09
European O 0 7.508585975202209e-10
multicenter O 0 1.7937841434445545e-08
study O 0 3.5039839085815316e-11
of O 0 9.66224718013109e-08
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 7.190206208207428e-10
classification O 0 2.4315616187209343e-09
of O 0 4.1098713321474634e-10
105 O 0 3.3668851040502545e-10
mutations O 0 1.6185315891356633e-12
and O 0 1.4174004038611937e-13
a O 0 4.4984277262384575e-13
general O 0 5.549439813928858e-12
system O 0 5.509910236400906e-12
for O 0 1.8094282582675758e-13
genotype O 0 9.591188086799374e-12
- O 0 7.839974871561017e-13
based O 0 4.709763937356393e-13
prediction O 0 3.586398289456838e-09
of O 0 2.448824476530831e-09
metabolic O 0 0.1782223880290985
phenotype O 0 1.959757511826865e-08
. O 0 6.754109493911642e-10

Phenylketonuria B-Disease 1 0.6848235726356506
( O 0 2.748807759189731e-08
PKU B-Disease 0 8.523165888618678e-05
) O 0 1.4481225246720797e-11
and O 0 2.638939414212338e-11
mild B-Disease 1 0.9999709129333496
hyperphenylalaninemia I-Disease 1 1.0
( O 0 1.9147087186865974e-06
MHP B-Disease 1 1.0
) O 0 5.92845564306721e-12
are O 0 9.347037033258232e-12
allelic B-Disease 1 0.9927400946617126
disorders I-Disease 1 0.9999780654907227
caused O 0 3.588565555823209e-10
by O 0 3.403073450206767e-13
mutations O 0 1.3527232719384719e-12
in O 0 3.735558737338884e-12
the O 0 5.8126500140920356e-11
gene O 0 1.823730333416762e-10
encoding O 0 5.558216664702798e-10
phenylalanine O 0 3.7863867419218877e-07
hydroxylase O 0 4.482509666559054e-06
( O 0 3.477168553089882e-10
PAH O 0 1.7361267055093776e-06
) O 0 2.38460137053087e-11
. O 0 3.030943551696197e-10

Previous O 0 3.5725680191944775e-08
studies O 0 1.3060240389162203e-10
have O 0 1.395117745287e-12
suggested O 0 1.2977762310975582e-12
that O 0 4.715415476705745e-14
the O 0 8.567186023100692e-12
highly O 0 2.8148228192748093e-10
variable O 0 1.5765998284678062e-08
metabolic O 1 0.9953036308288574
phenotypes O 0 7.194793738563021e-07
of O 0 5.0792521506082267e-05
PAH B-Disease 1 1.0
deficiency I-Disease 0 0.03922944515943527
correlate O 0 2.7367845767400922e-09
with O 0 6.127020002466566e-10
PAH O 1 0.9972535967826843
genotypes O 0 3.3822313980635954e-06
. O 0 8.796649630937736e-09

We O 0 1.1479796002689113e-09
identified O 0 6.22689885765304e-11
both O 0 5.829645793875571e-12
causative O 0 7.53009876675037e-10
mutations O 0 2.257376750802731e-11
in O 0 1.4254486480069772e-11
686 O 0 6.229982751904117e-09
patients O 0 1.950585526433457e-10
from O 0 7.636169474523058e-11
seven O 0 4.7504262745690085e-09
European O 0 1.6620090548258304e-07
centers O 0 1.1150616785471357e-07
. O 0 2.9417538627285467e-08

On O 0 4.1987586740788174e-09
the O 0 1.880982175572754e-11
basis O 0 4.026512456789533e-11
of O 0 8.424014263930246e-11
the O 0 1.461514069489578e-11
phenotypic O 0 4.6145047782886195e-09
characteristics O 0 2.350545313944963e-10
of O 0 7.120778966474006e-10
297 O 0 1.3730715453519338e-09
functionally O 0 2.9384226607476194e-08
hemizygous O 0 1.2586586990437354e-06
patients O 0 1.5229964511753735e-10
, O 0 4.467460255896949e-12
105 O 0 1.8187397143876183e-09
of O 0 2.4534589471159052e-08
the O 0 1.788740378039222e-09
mutations O 0 3.2175838382553223e-11
were O 0 4.6010886073366564e-11
assigned O 0 5.7954101587154305e-12
to O 0 8.635889854786971e-13
one O 0 8.97629540141942e-12
of O 0 4.954114340982585e-10
four O 0 8.308405352597248e-11
arbitrary O 0 1.8371492771507292e-08
phenotype O 0 1.0421542739891265e-08
categories O 0 5.306381556380302e-09
. O 0 2.4334128045921943e-09

We O 0 1.386413761572669e-09
proposed O 0 1.298099266966446e-10
and O 0 1.7838790340729549e-12
tested O 0 1.3277445982950997e-11
a O 0 1.9233447300093243e-12
simple O 0 4.786232174480709e-13
model O 0 5.901779309399127e-14
for O 0 7.730559695531304e-15
correlation O 0 3.7709494814935907e-13
between O 0 1.3699511360390493e-12
genotype O 0 2.1292592689015066e-10
and O 0 1.1458914546402799e-11
phenotypic O 0 8.701153575429998e-08
outcome O 0 4.842146239525391e-08
. O 0 5.52876233683719e-09

The O 0 1.5857753998815838e-10
observed O 0 9.794942634755444e-11
phenotype O 0 9.878584061873141e-11
matched O 0 2.442916008371654e-11
the O 0 8.195598713567342e-12
predicted O 0 1.3046247415715584e-10
phenotype O 0 6.928423546687101e-12
in O 0 1.4670311135594333e-13
79 O 0 2.4029648063028652e-11
% O 0 1.392353029747162e-12
of O 0 2.678145726020542e-11
the O 0 1.3039524321412088e-11
cases O 0 6.619270561357415e-13
, O 0 1.5471399660536844e-13
and O 0 1.257991107117551e-13
in O 0 6.610892389069534e-13
only O 0 7.008712729107691e-13
5 O 0 7.535756046950226e-11
of O 0 1.0075842243884026e-10
184 O 0 5.290893417830844e-11
patients O 0 4.746271084488107e-12
was O 0 6.259120999274614e-11
the O 0 1.805086982664683e-11
observed O 0 1.193239777819155e-11
phenotype O 0 1.8660194917030637e-12
more O 0 9.641337275529023e-15
than O 0 1.1629767786812406e-13
one O 0 4.3536352366084496e-13
category O 0 2.6729879420983593e-10
away O 0 7.536848922740091e-11
from O 0 4.477953164522264e-12
that O 0 2.966488816744106e-12
expected O 0 9.925029686996822e-10
. O 0 1.991529607892062e-09

Among O 0 4.703191169852516e-10
the O 0 2.9286503777647965e-10
seven O 0 1.9188716587903443e-11
contributing O 0 5.350053299685298e-12
centers O 0 3.286368399635364e-11
, O 0 3.600661164625957e-13
the O 0 1.7880486587878996e-12
proportion O 0 6.2765001529463404e-12
of O 0 1.9179652310796769e-10
patients O 0 1.1997386591133807e-12
for O 0 8.267817311856385e-13
whom O 0 3.2902053477557036e-12
the O 0 6.476108711794826e-12
observed O 0 2.2241179384319132e-11
phenotype O 0 1.2694559813064554e-11
did O 0 3.5824872257096685e-13
not O 0 9.266648863179294e-14
match O 0 2.8041163835368366e-10
the O 0 4.770285295246923e-12
predicted O 0 5.858417917448122e-11
phenotype O 0 1.4497247803266222e-12
was O 0 1.7026243696177668e-12
4 O 0 2.0170564871135888e-11
% O 0 6.74694024607736e-13
- O 0 1.4818242119463143e-12
23 O 0 3.482250598985104e-11
% O 0 1.7242271846407142e-11
( O 0 2.675882519037609e-12
P O 0 4.009764964507667e-08
< O 0 7.499840193325724e-10
. O 0 1.0246301420172022e-12
0001 O 0 1.592141529727087e-08
) O 0 1.37787942202359e-14
, O 0 4.444268371828382e-15
suggesting O 0 2.8303976932933343e-14
that O 0 3.9055386884739385e-16
differences O 0 1.4354377671850667e-14
in O 0 1.8329017096403374e-14
methods O 0 2.609555637984179e-13
used O 0 1.1787740786728049e-14
for O 0 2.6859802359710527e-13
mutation O 0 9.42304220763468e-12
detection O 0 4.218044802328791e-10
or O 0 8.589437321127047e-12
phenotype O 0 5.171093553357764e-10
classification O 0 3.4316149921664874e-10
may O 0 1.0645325766722724e-12
account O 0 9.25940080224964e-15
for O 0 7.120503697029181e-15
a O 0 6.799970336162156e-14
considerable O 0 1.1497506505891986e-12
proportion O 0 1.2326068984935823e-11
of O 0 1.3902633211326787e-10
genotype O 0 3.785140378909091e-08
- O 0 2.2610066707784426e-07
phenotype O 0 5.8382919831956315e-08
inconsistencies O 0 5.747471121253511e-08
. O 0 2.1996774179910972e-08

Our O 0 8.863969114258907e-09
data O 0 2.8641988780719885e-10
indicate O 0 2.946252616875533e-11
that O 0 4.6705660172730035e-12
the O 0 1.6808084923880529e-09
PAH O 0 4.384560725156916e-06
- O 0 1.3813405974616444e-09
mutation O 0 8.101847318031652e-12
genotype O 0 3.0362984262261028e-12
is O 0 1.6200001477545585e-14
the O 0 2.056389997520669e-13
main O 0 7.507379440330197e-11
determinant O 0 6.188614065649745e-09
of O 0 2.393941489486906e-09
metabolic O 1 0.9705365896224976
phenotype O 0 4.757623739415351e-10
in O 0 2.7403585043522805e-12
most O 0 4.120235402860217e-12
patients O 0 1.4515089130640035e-09
with O 0 6.28839984528895e-08
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.3411597592494218e-06

In O 0 1.7196202795055626e-10
the O 0 4.975997391909459e-11
present O 0 4.3860431779563225e-12
study O 0 8.874100456204848e-13
, O 0 2.0230419715740883e-13
the O 0 5.66612945798739e-12
classification O 0 1.1500133068054197e-09
of O 0 4.76887374034618e-09
105 O 0 1.4562006356300117e-07
PAH O 0 4.028127023048e-06
mutations O 0 5.822245029846185e-12
may O 0 1.4585187712527065e-13
allow O 0 3.0065248115542995e-14
the O 0 4.5310988034535926e-13
prediction O 0 9.941602402419036e-11
of O 0 4.612581844254393e-11
the O 0 1.6807683717035005e-11
biochemical O 0 1.0599230382268843e-09
phenotype O 0 2.7608848540694453e-10
in O 0 1.499641209823377e-11
> O 0 1.9983101839926576e-09
10 O 0 9.834329184332802e-11
, O 0 1.2482876060940229e-12
000 O 0 1.456599424409788e-11
genotypes O 0 1.1064459071175037e-10
, O 0 1.7522343168444032e-12
which O 0 2.5341932870757977e-13
may O 0 9.140632044671304e-13
be O 0 8.024941252965032e-14
useful O 0 4.458959650078739e-14
for O 0 3.217936442485858e-13
the O 0 2.4319581071186036e-11
management O 0 2.7307606176307786e-10
of O 0 5.315840545527806e-10
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.4167391704233978e-08
newborns O 0 3.327789599438802e-08
. O 0 1.53325085960887e-09

Somatic O 0 3.065736393637053e-07
instability O 0 1.3843499857557617e-07
of O 0 1.1716377201764772e-07
the O 0 9.665118483326296e-09
CTG O 0 3.5290452160552377e-06
repeat O 0 8.77297345880379e-09
in O 0 9.360136277170028e-11
mice O 0 2.3604798116139136e-09
transgenic O 0 2.823901557036379e-09
for O 0 1.6015504894495436e-11
the O 0 1.0246739293506835e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 8.985217618828756e-07
is O 0 6.5697668659436825e-12
age O 0 6.815883794863975e-12
dependent O 0 1.6897934874277043e-12
but O 0 2.5189543512030635e-14
not O 0 7.282107418969935e-15
correlated O 0 4.2276047978106676e-14
to O 0 1.4198729438562058e-14
the O 0 2.953554284826354e-12
relative O 0 2.669116039299979e-10
intertissue O 0 1.055155074425329e-08
transcription O 0 2.004544086275928e-09
levels O 0 8.347759816729194e-09
and O 0 3.220223740441064e-11
proliferative O 0 1.2374975085549522e-05
capacities O 0 3.693902215218259e-07
. O 0 1.7418877007457922e-08

A O 0 3.9671115814599034e-07
( O 0 3.5220235061750316e-10
CTG O 0 4.0378938592766644e-07
) O 0 2.8950687333550995e-12
nexpansion O 0 3.1265912081579472e-09
in O 0 2.7093221763307973e-11
the O 0 2.5509525047873183e-10
3 O 0 1.1663318311150306e-08
- O 0 9.036480452806472e-10
untranslated O 0 1.7978761945869337e-07
region O 0 1.273074978769273e-09
( O 0 6.390949401635648e-12
UTR O 0 1.7792909545732982e-07
) O 0 1.2222398657404931e-12
of O 0 3.6485481302861444e-10
the O 0 3.2505280245231916e-08
DM O 1 1.0
protein O 0 1.1901413188297738e-08
kinase O 0 2.500721629772329e-09
gene O 0 9.960943875286787e-11
( O 0 4.189198629916263e-13
DMPK O 0 4.2719867643370435e-09
) O 0 2.6820063300770323e-14
is O 0 4.458804304236213e-15
responsible O 0 7.224424509143235e-13
for O 0 1.0455892228422581e-11
causing O 1 0.9999964237213135
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.06456419080495834
DM B-Disease 1 1.0
) O 0 2.366257467745214e-10
. O 0 4.4067344218134963e-10

Major O 0 7.033840176973172e-08
instability O 0 1.556308961880859e-05
, O 0 3.1434577163480526e-10
with O 0 3.4869147499949626e-12
very O 0 1.3415385339068941e-12
large O 0 5.570774419018376e-13
expansions O 0 1.6326088050910847e-11
between O 0 6.457828629485851e-12
generations O 0 2.964132064797731e-11
and O 0 1.9396131836074693e-12
high O 0 2.60706706223246e-10
levels O 0 1.6009037151487604e-10
of O 0 4.97143437527825e-11
somatic O 0 6.14668804743701e-09
mosaicism O 0 8.652150995658303e-08
, O 0 8.419331312854716e-13
is O 0 8.480684280916598e-14
observed O 0 6.427770208455863e-12
in O 0 6.728673174194455e-11
patients O 0 7.248839306583932e-10
. O 0 3.1083424723021835e-09

There O 0 4.109842244304218e-09
is O 0 9.945750820139487e-12
a O 0 1.923190556460397e-12
good O 0 6.733569864886269e-13
correlation O 0 7.980496688833605e-13
between O 0 3.048781062678363e-12
repeat O 0 1.2493035772553895e-10
size O 0 3.341151791000363e-12
( O 0 1.4086306990637731e-13
at O 0 2.1247548859237853e-11
least O 0 5.332659769492765e-13
in O 0 5.495150775386426e-13
leucocytes O 0 2.9870050877178755e-10
) O 0 3.9782450744025796e-14
, O 0 1.0059652966860032e-14
clinical O 0 1.278186168018891e-10
severity O 0 3.136147341820106e-09
and O 0 2.410069106090207e-12
age O 0 1.05654159032742e-10
of O 0 4.092749694706299e-09
onset O 0 0.1388368457555771
. O 0 5.9539306818123805e-08

The O 0 4.205348886898719e-07
trinucleotide O 0 0.00015556289872620255
repeat O 0 5.55544488634041e-07
instability O 0 6.438580726353393e-07
mechanisms O 0 4.4588542635892736e-08
involved O 0 1.2343580324536418e-10
in O 0 4.520041674282993e-09
DM B-Disease 1 1.0
and O 0 7.30312865737659e-10
other O 0 8.025320685778325e-11
human O 0 2.2658130546915345e-05
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 2.1048208315166406e-11
unknown O 0 3.6681293558160633e-09
. O 0 1.4492016475742275e-09

We O 0 2.3163465590059218e-10
studied O 0 3.7053118906449356e-10
somatic O 0 2.3492374712219544e-09
instability O 0 1.7545001562702112e-10
by O 0 2.2386810287489123e-12
measuring O 0 1.195075149951208e-08
the O 0 4.577107581837936e-10
CTG O 0 3.5015648336411687e-07
repeat O 0 3.6640528389142446e-09
length O 0 1.5755752605373097e-11
at O 0 1.355289214188815e-10
several O 0 2.028641794479813e-12
ages O 0 1.2385598623099181e-11
in O 0 5.553407668619503e-13
various O 0 4.447429837600714e-12
tissues O 0 2.836627981117612e-11
of O 0 9.224486174908009e-10
transgenic O 0 4.058927629557729e-07
mice O 0 7.206860108688318e-10
carrying O 0 9.02913247641246e-12
a O 0 2.21000249350789e-11
( O 0 1.3370382058452979e-11
CTG O 0 1.5405105102672678e-07
) O 0 3.7918604887943186e-12
55expansion O 0 3.843169338324515e-09
surrounded O 0 3.58461843541491e-10
by O 0 2.5328608568159217e-12
45 O 0 9.474680762178167e-11
kb O 0 1.455011044981802e-07
of O 0 2.5061426711658896e-08
the O 0 8.228252745823283e-09
human O 0 9.307310477879582e-08
DM B-Disease 1 1.0
region O 0 3.988892327555504e-09
, O 0 1.1694754539770535e-11
using O 0 4.2653547360771427e-11
small O 0 5.55349322084453e-09
- O 0 8.377016058602749e-08
pool O 0 1.93609338339229e-07
PCR O 0 5.447255375656823e-07
. O 0 2.8212111757852654e-08

These O 0 5.207100306492407e-10
mice O 0 1.4320066243911356e-09
have O 0 2.531478444835894e-13
been O 0 3.023097180573919e-14
shown O 0 4.6723167462835516e-14
to O 0 1.3302571968498798e-14
reproduce O 0 3.140182775265843e-12
the O 0 8.007362134465623e-13
intergenerational O 0 1.4972233522425604e-11
and O 0 2.672081306220875e-13
somatic O 0 2.5029250894093025e-10
instability O 0 1.7320077594362715e-09
of O 0 2.0826036450927177e-09
the O 0 1.416489814332067e-09
55 O 0 1.1789171416864974e-08
CTG O 0 2.575724465714302e-06
repeat O 0 1.5910181616618502e-08
suggesting O 0 9.627722230565183e-11
that O 0 2.866615365221259e-13
surrounding O 0 2.670595298723266e-12
sequences O 0 2.949422390347012e-12
and O 0 4.250174431147391e-12
the O 0 4.910648623845937e-11
chromatin O 0 1.7532256202379415e-10
environment O 0 1.5426546151608989e-10
are O 0 4.8293102372989893e-14
involved O 0 1.195909013094673e-13
in O 0 3.495478212434122e-12
instability O 0 2.1149734408254517e-08
mechanisms O 0 6.07432639299077e-07
. O 0 5.4554490702685143e-08

As O 0 3.649813090644827e-11
observed O 0 1.4983660145961863e-11
in O 0 1.9441392939967272e-12
some O 0 2.407233212677745e-13
of O 0 6.302896399246194e-11
the O 0 6.663740392820472e-11
tissues O 0 2.90386464874004e-10
of O 0 9.423919209439191e-07
DM B-Disease 1 1.0
patients O 0 3.2231397550930296e-09
, O 0 6.470993445945039e-13
there O 0 7.722834524659383e-12
is O 0 1.5590521495328913e-12
a O 0 1.879127279127979e-12
tendency O 0 5.715843597042802e-12
for O 0 1.229994730199413e-12
repeat O 0 5.263176561243199e-10
length O 0 3.72594533351589e-12
and O 0 5.625811014958737e-12
somatic O 0 1.4283786375912655e-09
mosaicism O 0 2.6362856342387886e-09
to O 0 3.7197777139324345e-14
increase O 0 2.871260087328187e-14
with O 0 2.0224622622249874e-14
the O 0 5.6005655842128466e-12
age O 0 6.779144606783305e-11
of O 0 1.419307893435473e-09
the O 0 1.1748154671309408e-09
mouse O 0 4.164408906603967e-08
. O 0 6.86895962331846e-09

Furthermore O 0 7.723169659357154e-09
, O 0 2.736129205149762e-11
we O 0 3.390983240730838e-13
observed O 0 4.74147305619399e-13
no O 0 6.305820801503007e-14
correlation O 0 2.0182781227534585e-13
between O 0 2.639158152000637e-13
the O 0 3.2398275034983826e-11
somatic O 0 2.198368775907511e-08
mutation O 0 8.018347652516411e-10
rate O 0 4.904613382095135e-10
and O 0 2.1245188767948786e-12
tissue O 0 6.930836460306011e-10
proliferation O 0 1.4088659554545302e-06
capacity O 0 2.143764632478451e-08
. O 0 1.5585015500363397e-09

The O 0 2.855664682499537e-08
somatic O 0 6.460784902628802e-07
mutation O 0 8.648693983204225e-10
rates O 0 1.0750132034553772e-10
in O 0 5.955426039469525e-13
different O 0 2.2105651727513664e-13
tissues O 0 1.1689028911465726e-10
were O 0 4.1191397515127903e-10
also O 0 7.16637556588684e-12
not O 0 2.247690423541615e-13
correlated O 0 3.4506386463462047e-12
to O 0 7.892020912649012e-13
the O 0 1.0324487792479076e-10
relative O 0 7.053236217302583e-09
inter O 0 7.463614224434423e-07
- O 0 5.484947218636904e-11
tissue O 0 8.563656728188818e-12
difference O 0 2.756819512256259e-12
in O 0 2.42569256781594e-13
transcriptional O 0 4.9016835729220887e-11
levels O 0 7.000249685473747e-11
of O 0 2.4773665757704677e-11
the O 0 1.3878304755410298e-11
three O 0 1.436405898738724e-12
genes O 0 9.09345407133777e-13
( O 0 8.20150479648174e-13
DMAHP O 0 2.465953059527237e-07
, O 0 1.0383516269030224e-10
DMPK O 0 1.1299505331408e-06
and O 0 8.46870351622897e-11
59 O 0 6.443611755280187e-10
) O 0 4.767645154536704e-13
surrounding O 0 2.586032603335564e-11
the O 0 2.200506166172289e-10
repeat O 0 1.0057804367136214e-08
. O 0 7.348176511712268e-10
. O 0 5.572422079325179e-09

A O 0 2.7672759639330025e-09
novel O 0 1.6498610810877778e-10
missense O 0 1.8441568272464792e-08
mutation O 0 3.8764491616660735e-11
in O 0 5.719616620603052e-12
patients O 0 2.231595550711285e-12
from O 0 1.155808088126875e-12
a O 0 3.8784385425483237e-11
retinoblastoma B-Disease 0 4.3403599647717783e-07
pedigree O 0 8.169792620194016e-10
showing O 0 4.0551467739291525e-10
only O 0 6.3284065487945185e-12
mild O 0 5.0054186573333936e-08
expression O 0 3.932656866822981e-09
of O 0 1.2950234218322976e-09
the O 0 1.986354275507196e-10
tumor B-Disease 0 4.0390712996440925e-08
phenotype O 0 1.09130149361647e-09
. O 0 3.3925540154911005e-10

We O 0 9.144638934976967e-10
have O 0 3.658870352963445e-13
used O 0 5.434567794154917e-14
single O 0 3.4238705620692755e-12
strand O 0 1.78943127676634e-11
conformation O 0 1.7260985392744677e-12
polymorphism O 0 2.0763180671318215e-12
analysis O 0 4.96496425786766e-14
to O 0 6.642864359171323e-15
study O 0 1.5144191849452045e-14
the O 0 6.534770554539326e-13
27 O 0 2.736088855481711e-10
exons O 0 7.311718341895812e-09
of O 0 2.136481214165542e-09
the O 0 1.904859825430094e-09
RB1 O 0 1.3156316924778366e-07
gene O 0 6.335444321936556e-13
in O 0 2.5631366061713845e-13
individuals O 0 1.1164241528320053e-14
from O 0 1.8888079034856675e-12
a O 0 2.4680519780662102e-11
family O 0 2.0178021579997374e-12
showing O 0 4.0288825609025025e-09
mild O 0 3.5485145417624153e-06
expression O 0 6.98806630339277e-08
of O 0 4.20265457989899e-08
the O 0 2.464441761773628e-09
retinoblastoma B-Disease 0 2.7494006644701585e-06
phenotype O 0 5.981532780197085e-08
. O 0 2.5273827475302824e-09

In O 0 5.061499552816429e-10
this O 0 1.3766889538080473e-11
family O 0 2.8626448000251825e-12
affected O 0 8.813375376726107e-13
individuals O 0 2.6326309161090952e-14
developed O 0 2.664543030661548e-10
unilateral B-Disease 1 0.9999961853027344
tumors I-Disease 1 1.0
and O 0 8.387299882395283e-11
, O 0 2.337782094644081e-12
as O 0 1.004346345673257e-12
a O 0 9.466813184061396e-13
result O 0 1.3117203503942854e-11
of O 0 5.275596626219681e-11
linkage O 0 6.227947602077677e-10
analysis O 0 6.2433556588525896e-12
, O 0 1.5843952668945227e-12
unaffected O 0 1.7281074349284609e-09
mutation O 0 2.959917380640498e-11
carriers O 0 7.504393699335477e-13
were O 0 1.2549248099014143e-11
also O 0 2.338397704637618e-12
identified O 0 5.937791924814917e-12
within O 0 1.8576830351779705e-10
the O 0 4.453038382479235e-09
pedigree O 0 2.4639359708089614e-07
. O 0 4.218113502929555e-08

A O 0 2.8998496048870948e-08
single O 0 9.455962679538743e-10
band O 0 5.268690483895e-10
shift O 0 1.97673918900243e-10
using O 0 5.264336275928594e-12
SSCP O 0 8.19781487138016e-09
was O 0 4.300957159864005e-11
identified O 0 1.422509137392891e-12
in O 0 1.6162456572751949e-12
exon O 0 2.9357755115810846e-10
21 O 0 5.3462404642212746e-11
which O 0 1.0391822358136668e-13
resulted O 0 3.6549105755789846e-12
in O 0 1.1226261890581735e-12
a O 0 2.1497189445218723e-11
missense O 0 8.102323256764521e-09
mutation O 0 9.775606713002816e-11
converting O 0 3.0919913851512604e-10
a O 0 1.7563986376423202e-10
cys O 0 3.341947603985318e-06
- O 0 5.702069927338016e-08
- O 0 8.73313865668024e-09
> O 0 1.546028904897412e-08
arg O 0 1.723907594453067e-08
at O 0 1.1121246978884614e-10
nucleotide O 0 2.0394019806246888e-10
position O 0 1.5196768843317443e-10
28 O 0 4.3388609372030373e-10
in O 0 4.098033717925276e-11
the O 0 1.8710117899445322e-09
exon O 0 3.2281070616591023e-07
. O 0 5.286802995385642e-09

The O 0 5.910651168505865e-08
mutation O 0 4.655666518971202e-09
destroyed O 0 2.9096568709974235e-07
an O 0 9.984702648013766e-11
NdeI O 0 3.198088279532385e-06
restriction O 0 6.921171689100447e-07
enzyme O 0 2.5891837562852515e-09
site O 0 5.978153971852862e-09
. O 0 2.8344240288191713e-09

Analysis O 0 2.1572366115663044e-10
of O 0 2.5913788448406194e-08
all O 0 4.75142092337677e-10
family O 0 1.0711526284012951e-11
members O 0 6.185792438169468e-13
demonstrated O 0 6.2827768161632935e-12
that O 0 1.0827241338738636e-13
the O 0 2.1205240688382254e-11
missense O 0 7.265510930665187e-07
mutation O 0 7.688399250582734e-08
co O 0 2.314972562089679e-06
- O 0 1.6161183111762512e-06
segregated O 0 9.187234439878011e-08
with O 0 3.5784528552157413e-12
patients O 0 3.474463494690383e-10
with O 0 2.8544530628060727e-10
tumors B-Disease 1 1.0
or O 0 1.3674633869698027e-08
who O 0 1.397748694564882e-09
, O 0 1.3011923136185821e-11
as O 0 8.944865681481673e-12
a O 0 2.4322815896787864e-12
result O 0 6.834069768424378e-12
of O 0 2.3517278402440667e-11
linkage O 0 4.147821530686713e-10
analysis O 0 1.504367377197502e-12
had O 0 9.411079554544344e-12
been O 0 2.762493792746179e-12
predicted O 0 2.7656477802340262e-11
to O 0 2.3466355269542716e-13
carry O 0 3.388909378815308e-12
the O 0 2.30727201233627e-10
predisposing O 0 1.3020860478718532e-07
mutation O 0 8.610413715359755e-09
. O 0 2.471917559532244e-09

These O 0 1.107644791858986e-11
observations O 0 1.6175387418382314e-11
point O 0 1.4530093794817844e-10
to O 0 2.0611257926100857e-13
another O 0 6.155262931295535e-13
region O 0 4.007357987112492e-11
of O 0 4.040107970393336e-10
the O 0 3.940233028743023e-09
RB1 O 0 5.999208383400401e-07
gene O 0 5.764982241585059e-12
where O 0 9.639311918108184e-12
mutations O 0 9.582388051446178e-13
only O 0 2.3377542848583566e-13
modify O 0 8.686937345674106e-13
the O 0 1.06062923201089e-12
function O 0 2.4706139911678804e-11
of O 0 5.201104547047919e-10
the O 0 9.236471310014593e-11
gene O 0 1.2170713221959506e-11
and O 0 2.929597103101811e-12
raise O 0 3.2692245178350676e-12
important O 0 2.92359105674711e-12
questions O 0 3.6257119268717775e-13
for O 0 5.564381420908315e-13
genetic O 0 1.501571089690401e-10
counseling O 0 8.736825499178202e-12
in O 0 3.4412462029259627e-12
families O 0 5.770784647666713e-14
with O 0 2.560839994919517e-13
these O 0 1.3891546767064167e-11
distinctive O 0 1.1262116794696908e-09
phenotypes O 0 3.987599139776421e-09
. O 0 4.1712577836250375e-10
. O 0 1.1849316194911808e-08

Maternal B-Disease 0 8.223955205721722e-07
disomy I-Disease 0 0.0001874251465778798
and O 0 1.0871078302443493e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.6916139125823975
with O 0 9.287361678322892e-12
gamete O 0 1.905580404581997e-08
complementation O 0 0.00043657131027430296
in O 0 2.301960878858811e-11
a O 0 4.78019533678431e-12
case O 0 4.229956229034881e-12
of O 0 1.86400797574926e-10
familial O 0 2.5347315357748812e-08
translocation O 0 5.05462651290145e-07
( O 0 2.079323171977343e-11
3 O 0 5.503952404950496e-09
; O 0 7.424721102690379e-13
15 O 0 6.816342629223371e-11
) O 0 4.619124771261876e-14
( O 0 1.797882148875645e-14
p25 O 0 6.037298438954508e-11
; O 0 7.21491890212124e-14
q11 O 0 6.27236249051144e-11
. O 0 2.134616485308105e-12
2 O 0 1.2582666852889446e-10
) O 0 1.0605523620768609e-12
. O 0 5.0248961241949885e-11

Maternal B-Disease 0 0.0001329993101535365
uniparental I-Disease 1 0.9911025762557983
disomy I-Disease 1 0.9298190474510193
( I-Disease 0 1.4086094779486302e-06
UPD I-Disease 1 1.0
) I-Disease 0 6.370308794356738e-12
for I-Disease 0 7.681479584353834e-12
chromosome I-Disease 0 4.22487511642089e-09
15 I-Disease 0 2.575697655160525e-09
is O 0 9.785372382178914e-13
responsible O 0 4.737786985647974e-12
for O 0 1.2050081798272577e-13
an O 0 1.8245443743629582e-14
estimated O 0 4.314279510898855e-13
30 O 0 1.4529967940629662e-12
% O 0 2.823249717776727e-13
of O 0 1.4952020741323957e-12
cases O 0 2.4146151657994386e-12
of O 0 2.427349272693391e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997289776802063
PWS B-Disease 1 1.0
) O 0 2.3813495619862124e-09
. O 0 7.278351699113728e-09

We O 0 1.4482539612004075e-09
report O 0 9.386698883451228e-12
on O 0 2.5113832888279397e-11
an O 0 8.012689768415945e-14
unusual O 0 6.193587743369422e-12
case O 0 8.152148227302813e-12
of O 0 5.816900849886508e-10
maternal B-Disease 0 3.759402122938127e-09
disomy I-Disease 0 7.713308605161728e-07
15 I-Disease 0 5.409991032934158e-08
in O 0 3.875028298239158e-08
PWS B-Disease 1 1.0
that O 0 1.491428855415755e-11
is O 0 8.883991090523347e-13
most O 0 8.517596621505225e-14
consistent O 0 5.430470309542024e-12
with O 0 1.140931018281735e-13
adjacent O 0 2.322931402787276e-09
- O 0 2.400043774830607e-10
1 O 0 3.996630137947932e-09
segregation O 0 4.982558010624416e-08
of O 0 4.045158374932356e-10
a O 0 7.142852975761116e-11
paternal O 0 1.7743251312651864e-10
t O 0 1.9828490238626983e-10
( O 0 1.498275787291392e-13
3 O 0 7.627697778955778e-11
; O 0 5.121953005498593e-14
15 O 0 2.710147644496841e-12
) O 0 1.928491791781885e-15
( O 0 1.6374578356106485e-15
p25 O 0 3.2455095468758577e-12
; O 0 5.724300750070818e-15
q11 O 0 2.0771260145907577e-12
. O 0 3.479656070660281e-14
2 O 0 4.3510038779358273e-13
) O 0 2.4226185200789297e-16
with O 0 9.61907132044455e-16
simultaneous O 0 1.0448999304690787e-10
maternal O 0 1.3575355284345392e-09
meiotic O 0 4.7809983527713484e-08
nondisjunction O 0 1.6849080353154022e-08
for O 0 2.7773477961900994e-10
chromosome O 0 9.811635237610972e-08
15 O 0 1.2804305526969983e-07
. O 0 1.4540588288980416e-08

The O 0 8.385580230196865e-09
patient O 0 1.4975626072555315e-08
( O 0 7.222034775766772e-11
J O 0 8.276087442027347e-07
. O 0 1.2778881251784835e-11
B O 0 3.8194616913678203e-10
. O 0 5.917604595359269e-14
) O 0 3.398075955817967e-15
, O 0 2.253286533054899e-14
a O 0 5.985055658540295e-13
17 O 0 3.468681245011318e-11
- O 0 2.6620919010844624e-12
year O 0 4.142899565073854e-12
- O 0 4.508258696911405e-11
old O 0 3.637527501432203e-10
white O 0 8.673299925487932e-12
male O 0 4.989915815614698e-13
with O 0 7.961826727423404e-13
PWS B-Disease 1 1.0
, O 0 4.467275160902062e-11
was O 0 1.241640790183851e-09
found O 0 2.289900734309125e-11
to O 0 2.7404680087717015e-12
have O 0 7.409899083210547e-12
47 O 0 1.0309000875174945e-10
chromosomes O 0 1.406478926380128e-11
with O 0 2.2045830872646777e-12
a O 0 2.1208246270276732e-10
supernumerary O 0 1.251534627044748e-06
, O 0 1.1192786281144507e-11
paternal O 0 7.835258830635183e-11
der O 0 1.0461911870152107e-06
( O 0 5.726337915130941e-13
15 O 0 6.769863315769786e-12
) O 0 2.9826937513415365e-15
consisting O 0 4.010242252204879e-14
of O 0 5.6533288467219833e-11
the O 0 2.888774108811276e-09
short O 0 4.924197050115708e-09
arm O 0 1.7282532738249756e-08
and O 0 7.146290781356868e-10
the O 0 6.073758385127803e-08
proximal O 0 2.9912441732449224e-06
long O 0 5.643662959187168e-08
arm O 0 2.1784668291502385e-08
of O 0 2.2275600031207432e-08
chromosome O 0 2.558684286668722e-07
15 O 0 5.428714757726993e-07
, O 0 1.2091841417039007e-10
and O 0 3.9527564554830974e-10
distal O 0 1.1144110345640001e-07
chromosome O 0 2.4560476958868094e-05
arm O 0 5.604834950645454e-05
3p O 0 0.00017425116675440222
. O 0 4.146133960603038e-07

The O 0 2.0128377400396857e-06
t O 0 3.6557896265776435e-08
( O 0 1.0855706090995287e-11
3 O 0 3.3604435900613794e-10
; O 0 1.4538445046365783e-13
15 O 0 6.322133355024517e-12
) O 0 8.672525554415025e-15
was O 0 7.472542550013284e-13
present O 0 1.665321797562208e-13
in O 0 2.338744432492379e-13
the O 0 7.528507439853727e-13
balanced O 0 6.492554432448172e-13
state O 0 2.3805351068747864e-14
in O 0 1.1400304528522143e-13
the O 0 1.2559952210222658e-11
patients O 0 3.872035504726146e-12
father O 0 1.1261524698880088e-11
and O 0 1.4306900109062326e-10
a O 0 1.3042646962446725e-09
sister O 0 5.19432923340446e-08
. O 0 2.021179028588449e-07

Fluorescent O 0 2.136330445878798e-09
in O 0 8.129105895371413e-12
situ O 0 2.0024146230035456e-10
hybridization O 0 2.8647093378020294e-12
analysis O 0 8.716148462706297e-13
demonstrated O 0 5.788251822291812e-12
that O 0 1.2193146340690186e-13
the O 0 2.0604057349160598e-10
PWS B-Disease 1 1.0
critical O 0 3.2428520979621567e-10
region O 0 3.809826412681794e-11
resided O 0 2.5515314860946603e-10
on O 0 2.2405285959870014e-10
the O 0 1.645764947932893e-11
derivative O 0 2.4302424656008625e-11
chromosome O 0 8.672840917656188e-11
3 O 0 6.606767910533051e-10
and O 0 3.73622682271757e-13
that O 0 2.1559570264045175e-14
there O 0 6.620912043446558e-13
was O 0 4.1110847365244396e-11
no O 0 4.310514618854899e-12
deletion O 0 2.0316437768230777e-11
of O 0 2.6863430924173315e-10
the O 0 1.5162870958818075e-09
PWS B-Disease 1 1.0
region O 0 1.0069757250263933e-09
on O 0 7.855373573839586e-10
the O 0 5.877534570153387e-11
normal O 0 1.0043765819034434e-09
pair O 0 9.299525732808789e-11
of O 0 1.7071723201755873e-10
15s O 0 2.6729383151291586e-09
present O 0 4.991691435196621e-11
in O 0 9.927660915565184e-10
J O 0 0.00013942665827926248
. O 0 7.719314965015656e-08

B O 0 0.0005316999158822
. O 0 2.358173105676542e-07

Methylation O 0 8.600959944260467e-09
analysis O 0 1.0565959912556266e-10
at O 0 4.683738397126547e-10
exon O 0 1.1346701356274025e-09
alpha O 0 6.487820003453493e-11
of O 0 5.6455062846794135e-11
the O 0 2.6225315322148113e-11
small O 0 8.960950904912668e-12
nuclear O 0 2.3767313450662186e-08
ribonucleoprotein O 0 2.0230855213299037e-08
- O 0 9.294565672668398e-10
associated O 0 2.280527544584743e-09
polypeptide O 0 1.1820235812365354e-07
N O 0 2.4733532200116315e-07
( O 0 3.132501636554652e-12
SNRPN O 0 1.7582605593702283e-08
) O 0 1.673511454197349e-13
gene O 0 1.7365833163834887e-12
showed O 0 1.2653995039302313e-11
a O 0 4.979476574996922e-13
pattern O 0 1.067302236174017e-11
characteristic O 0 4.955475474410775e-10
of O 0 6.456443157887293e-10
only O 0 4.629660804028601e-12
the O 0 2.134894691585565e-11
maternal O 0 4.907933087716643e-11
chromosome O 0 1.6440661054772931e-09
15 O 0 7.205421148626101e-09
in O 0 5.068892416915105e-09
J O 0 0.0031001551542431116
. O 0 8.29703097338097e-08

B O 0 0.0005121129215694964
. O 0 3.082426189848775e-07

Maternal B-Disease 0 2.468315187797998e-07
disomy I-Disease 0 6.23223115781002e-07
was O 0 1.977034314037951e-09
confirmed O 0 3.574443518949977e-11
by O 0 1.1988831151790724e-12
polymerase O 0 1.1591291294854589e-11
chain O 0 1.0966259150757551e-10
reaction O 0 3.974030577270221e-13
analysis O 0 1.1615114794451264e-13
of O 0 8.5225125567856e-12
microsatellite O 0 1.527757031993815e-09
repeats O 0 5.339558240002873e-10
at O 0 3.246554580726979e-09
the O 0 9.507414855391971e-10
gamma O 0 6.2078604479154365e-09
- O 0 3.5403318054960664e-09
aminobutyric O 0 8.572907717052658e-08
acid O 0 7.065809048967253e-10
receptor O 0 1.6419711076909316e-11
beta3 O 0 1.2594508769225854e-09
subunit O 0 1.2338212396212356e-10
( O 0 9.930715104411458e-13
GABRB3 O 0 1.8379482824570914e-08
) O 0 3.414967744350128e-12
locus O 0 1.4667124181855229e-09
. O 0 1.2576674146558275e-09

A O 0 1.4368082474902621e-06
niece O 0 2.425315130949457e-07
( O 0 1.9946534701720253e-10
B O 0 3.960208516673447e-08
. O 0 6.159987884363227e-12
B O 0 2.1582366449557355e-10
. O 0 6.14036816184993e-14
) O 0 7.907242086240842e-16
with O 0 5.011734706709611e-15
45 O 0 1.5599444479208469e-12
chromosomes O 0 2.1030449788312505e-13
and O 0 2.6652809191445026e-13
the O 0 3.158094011995738e-12
derivative O 0 1.1395923267543129e-11
3 O 0 4.676166398542847e-11
but O 0 9.941208284087316e-14
without O 0 7.069168384346569e-13
the O 0 1.8187924040111159e-12
der O 0 3.77787534588947e-09
( O 0 1.7731509891014824e-14
15 O 0 6.242185587868043e-13
) O 0 3.751912111072189e-15
demonstrated O 0 9.54579514392262e-13
a O 0 1.9552310887970686e-13
phenotype O 0 2.4402743280943495e-12
consistent O 0 8.08523278710005e-13
with O 0 2.4709482083460103e-15
that O 0 1.2229474397951797e-14
reported O 0 1.160006552619608e-12
for O 0 2.596484442382585e-12
haploinsufficiency O 0 2.723876662003022e-07
of O 0 2.588398615444021e-07
distal O 0 1.0559406149468487e-07
3 O 0 1.051685740094399e-05
p O 0 1.5162672752921935e-05
. O 0 5.0402618967382296e-08

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 4.075930704061648e-09
with O 0 4.40162272949407e-12
unbalanced O 0 1.2942586558040148e-08
segregation O 0 2.54994375836759e-07
of O 0 1.0623476542903632e-09
non O 0 1.0112552928376317e-07
- O 0 5.713288175890341e-10
Robertsonian O 0 5.707422801037865e-08
translocations O 0 1.922333154880107e-07
has O 0 1.218895036986245e-11
been O 0 8.259053705696184e-13
reported O 0 1.1838900085964221e-12
previously O 0 1.7420995757078117e-09
but O 0 2.72093268055551e-11
has O 0 9.406378453924447e-12
not O 0 4.88536348961649e-13
, O 0 4.5029943857889665e-13
to O 0 4.811494627200708e-13
our O 0 1.0006430579967418e-11
knowledge O 0 1.4131746120527033e-11
, O 0 2.6693052065582257e-13
been O 0 1.1569015873329896e-13
observed O 0 8.207013627720139e-13
in O 0 4.283923747423063e-13
a O 0 1.5809999143190367e-11
case O 0 1.248293690636615e-10
of O 0 9.195983352583426e-08
PWS B-Disease 1 1.0
. O 0 8.543196940991038e-07

Furthermore O 0 5.3264521682194754e-08
, O 0 7.567620974313627e-10
our O 0 3.1816041468069045e-10
findings O 0 4.820627837881508e-12
are O 0 1.760716003334703e-13
best O 0 2.719093396622019e-13
interpreted O 0 5.792688919682709e-13
as O 0 2.497494669840422e-13
true O 0 1.2837586028935366e-11
gamete O 0 2.2894401929818287e-09
complementation O 0 2.609378725537681e-06
resulting O 0 5.68542657397586e-10
in O 0 2.117603037365967e-10
maternal B-Disease 0 2.199850996476016e-06
UPD I-Disease 1 1.0
15 I-Disease 0 2.0650188162107952e-05
and O 0 2.5225906483683502e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999574422836304
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 1.1034711860702373e-05
2 I-Disease 0 4.327824353822507e-05
and O 0 6.820572995280827e-10
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 8.176553878413984e-11
a O 0 1.167462914536399e-11
case O 0 3.2733423176861676e-12
for O 0 1.4299710504248053e-12
" O 0 1.7513807071267706e-10
lumping O 0 2.412390731620917e-09
" O 0 4.208491777291101e-09
. O 0 9.433553938009709e-10

Recent O 0 2.425178113885096e-10
studies O 0 1.2129463232424254e-11
demonstrated O 0 2.3133476037551226e-11
the O 0 3.556108315802553e-12
existence O 0 9.755113383747016e-12
of O 0 2.8769284177165844e-10
a O 0 4.3862712073572396e-11
genetically O 0 1.5635623351606398e-10
distinct O 0 1.0584834224391937e-11
, O 0 1.7189100620304543e-12
usually O 0 1.218152965651309e-12
lethal O 0 2.6864850621866054e-11
form O 0 1.885147420110922e-12
of O 0 9.392362582127944e-11
the O 0 2.5061591690800356e-10
Schwartz B-Disease 1 0.9994103908538818
- I-Disease 1 0.9999998807907104
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.563662420713598e-10
SJS B-Disease 0 0.0006291865720413625
) O 0 4.782842177863955e-11
of O 0 4.352949360963976e-07
myotonia B-Disease 1 1.0
and O 1 0.9999237060546875
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.9777590171420343e-08
which O 0 2.3486360078983637e-10
we O 0 1.9749377133670976e-10
called O 0 5.753522547280454e-09
SJS B-Disease 0 0.0003949353995267302
type I-Disease 0 1.4865399862173945e-06
2 I-Disease 0 4.026897840958554e-06
. O 0 4.965743816143231e-09

This O 0 1.0766718627763794e-09
disorder O 0 1.6776821212260984e-06
is O 0 1.331509989072055e-12
reminiscent O 0 1.7367836335768772e-10
of O 0 1.3065148962709827e-10
another O 0 6.283879666613146e-12
rare O 0 9.232793973801279e-10
condition O 0 1.1707319202969302e-07
, O 0 7.1286396924330475e-12
the O 0 1.0050741350298154e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.066592034808082e-09
SWS B-Disease 1 0.9999995231628418
) O 0 3.753621545532493e-12
, O 0 8.188625558874785e-13
which O 0 9.618644856296266e-13
comprises O 0 5.3745303346675044e-11
campomelia B-Disease 0 1.4823804406205454e-07
at O 0 5.8674515912571223e-08
birth O 0 3.290771246611257e-07
with O 0 1.9615815638474032e-09
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 3.4910441204516474e-10
contractures B-Disease 0 5.653167318087071e-05
, O 0 1.9659395639193278e-11
and O 0 2.2128455318126683e-11
early B-Disease 0 2.1028762375863153e-07
death I-Disease 0 4.580453207836399e-07
. O 0 1.1168704183717182e-08

To O 0 1.6222170828861238e-10
test O 0 2.8328769885455074e-10
for O 0 1.5901232153919809e-12
possible O 0 2.1194485402831198e-11
nosologic O 0 2.63120192300903e-09
identity O 0 4.7764765233326845e-12
between O 0 2.577700032591057e-11
these O 0 5.093106145159787e-11
disorders O 0 1.2526975297078025e-06
, O 0 7.238175445296868e-13
we O 0 2.2583734741229294e-13
reviewed O 0 6.13625036199883e-13
the O 0 5.285048115290236e-13
literature O 0 3.1364098601258106e-13
and O 0 1.0249873188704003e-13
obtained O 0 2.514655801297283e-12
a O 0 2.502354660288697e-12
follow O 0 1.3307635158762987e-12
- O 0 1.2078712596091945e-12
up O 0 1.2971452254331717e-12
of O 0 3.343486945639462e-11
the O 0 5.418799089995652e-12
only O 0 4.792498863037675e-13
two O 0 8.704137128938416e-13
surviving O 0 2.8511188965296697e-09
patients O 0 2.7179813955058307e-11
, O 0 1.3068774578142706e-12
one O 0 7.794350017839569e-13
with O 0 6.2993837576796885e-12
SJS B-Disease 1 0.7047698497772217
type I-Disease 0 2.488251448085066e-05
2 I-Disease 0 5.655614131683251e-06
at O 0 1.3069392235109945e-09
age O 0 2.1635771299544082e-11
10 O 0 4.558198003073999e-12
years O 0 8.014375838319432e-13
and O 0 5.09326576140362e-13
another O 0 3.875838723316899e-13
with O 0 1.50003804950255e-12
SWS B-Disease 0 0.037641916424036026
at O 0 4.185269908418832e-09
age O 0 1.2207086452775684e-09
7 O 0 8.74381029802862e-08
years O 0 1.8142078950234009e-09
. O 0 3.3841540680867865e-09

Patients O 0 7.596500095630176e-10
reported O 0 3.420334154791149e-11
as O 0 1.857395313942245e-11
having O 0 3.228004530342332e-10
either O 0 6.601430069252956e-09
neonatal O 1 1.0
SJS B-Disease 1 0.9999998807907104
or O 0 3.3281960298836566e-08
SWS B-Disease 1 0.9999918937683105
presented O 0 4.1010542184416465e-10
a O 0 8.578136573463013e-13
combination O 0 3.410411493140475e-12
of O 0 4.074937002412904e-12
a O 0 9.888188358397887e-13
severe O 0 2.6238251571442106e-09
, O 0 3.6928180782366815e-13
prenatal O 1 0.9983226656913757
- O 0 0.02343548834323883
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.237094872071423e-13
with O 0 5.632843583930347e-12
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999996423721313
contractures I-Disease 1 1.0
, O 0 1.962091999985205e-07
respiratory O 1 1.0
and O 0 2.758045525297348e-08
feeding O 0 2.4434323009359105e-08
difficulties O 0 3.7215494330666843e-07
, O 0 1.14674858150976e-11
tendency O 0 4.3531997451218274e-11
to O 0 5.076467675044216e-13
hyperthermia B-Disease 1 0.7989209890365601
, O 0 1.5536908782101677e-12
and O 0 3.121942537386707e-13
frequent O 0 6.04397738454554e-12
death O 0 1.4619050414665935e-10
in O 0 8.835799279738321e-12
infancy O 0 1.1184425607879689e-10
) O 0 1.0743920062969946e-14
with O 0 2.0079713919699503e-14
a O 0 5.265320297820342e-12
distinct O 0 4.911119289019439e-10
campomelic B-Disease 1 0.9999568462371826
- I-Disease 1 0.9999997615814209
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 7.919241397758015e-06

The O 0 3.089664302180495e-09
similarity O 0 5.05063324496291e-09
of O 0 6.429609555880234e-08
the O 0 2.923004283061914e-09
clinical O 0 6.247631745281979e-07
and O 0 3.2609448474829605e-10
radiographic O 0 2.823052454914432e-06
findings O 0 9.74207048365372e-10
is O 0 6.0614560246086135e-12
so O 0 2.1033337831849463e-13
extensive O 0 3.4112476732239827e-10
that O 0 8.666420879543946e-12
these O 0 4.5327480657775254e-10
disorders O 0 0.003789898008108139
appear O 0 3.151476996032798e-11
to O 0 7.562631076929449e-13
be O 0 2.364888233158391e-12
a O 0 5.439219387393113e-12
single O 0 2.6052613191773766e-11
entity O 0 7.815773805930348e-09
. O 0 3.279310334391994e-08

The O 0 9.130668843226886e-08
follow O 0 1.2301185625673838e-09
- O 0 5.4744431210451694e-11
up O 0 4.002925161478155e-12
observation O 0 1.4731130759670918e-09
of O 0 2.4302065915193793e-10
an O 0 2.787182377256281e-13
identical O 0 9.526264325987466e-12
and O 0 4.635879354009109e-13
unique O 0 1.0453101058349734e-11
pattern O 0 3.9639264315383116e-08
of O 0 0.050061486661434174
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 4.1294015318271704e-08
the O 0 1.0089433288840155e-07
two O 0 1.372128966004027e-09
patients O 0 2.8287625020162466e-10
( O 0 1.2453910515700106e-12
one O 0 2.1126158114559423e-11
with O 0 4.1367129166580696e-10
SJS B-Disease 1 0.9999923706054688
type I-Disease 0 0.32000648975372314
2 I-Disease 0 0.00010857961024157703
, O 0 1.905118424128105e-12
one O 0 2.689230403033621e-13
with O 0 1.1062612414666773e-12
SWS B-Disease 0 1.8864675439544953e-05
) O 0 4.2560372543951064e-13
surviving O 0 5.427307492311684e-10
beyond O 0 1.1523584309003354e-09
infancy O 0 1.8363355280826e-09
adds O 0 6.9525032432571354e-12
to O 0 3.230654133969113e-13
the O 0 1.1039579840554925e-11
evidence O 0 1.9928272573799255e-11
in O 0 3.742540565648822e-12
favor O 0 3.3577446378885156e-11
of O 0 6.273583041949138e-11
identity O 0 2.2282717337951397e-10
. O 0 4.3217336376244475e-09

The O 0 1.3954989697140263e-07
hypothesis O 0 6.900977922441598e-08
that O 0 2.669350296358175e-10
SWS B-Disease 1 0.9995699524879456
and O 0 5.446933926123165e-08
SJS B-Disease 1 0.9999006986618042
type I-Disease 0 0.00523894838988781
2 I-Disease 0 0.18029862642288208
are O 0 7.493130421698524e-11
the O 0 1.2067948029770292e-10
same O 0 3.9191616618694525e-10
disorder O 0 1.7974212340732265e-08
should O 0 5.109983074701174e-13
be O 0 3.578804326455007e-14
testable O 0 2.290712107846926e-12
by O 0 1.5406285866189154e-14
molecular O 0 4.477082333337323e-12
methods O 0 2.869255007198479e-11
. O 0 2.934710460755774e-11
. O 0 8.218241087654121e-10

A O 0 7.54801998681387e-09
mouse O 0 3.968696205003397e-10
model O 0 1.664898080511179e-11
of O 0 1.9466382672472804e-10
severe O 1 0.9987174272537231
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.551116943359375
defects O 1 0.9999998807907104
in O 0 3.13151460318295e-09
hemostasis O 1 0.9999969005584717
and O 0 1.5363232819254335e-07
thrombosis B-Disease 0 0.24201110005378723
. O 0 6.717320388816006e-07

von B-Disease 0 0.002906236331909895
Willebrand I-Disease 0 0.0024841995909810066
factor I-Disease 0 6.111573043199314e-07
( I-Disease 0 2.0014228052644967e-09
vWf I-Disease 0 3.2219666081800824e-06
) I-Disease 0 1.2517760161756541e-08
deficiency I-Disease 1 0.9999998807907104
causes O 0 0.0008492901688441634
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 4.420764696533297e-07
humans O 0 1.0023518681734345e-09
. O 0 1.2829416695669948e-10

We O 0 1.0135252637155645e-09
generated O 0 1.7675551994278393e-11
a O 0 1.4617147769957484e-11
mouse O 0 4.1942078282675155e-11
model O 0 2.726812699249681e-12
for O 0 2.9974679964690776e-13
this O 0 4.076132064257526e-13
disease O 0 1.7493666237822225e-11
by O 0 5.964881231090499e-14
using O 0 1.0232395443107722e-12
gene O 0 2.5044138637908553e-11
targeting O 0 5.412658654613267e-10
. O 0 9.663878586252395e-10

vWf B-Disease 0 0.00038787454832345247
- I-Disease 0 0.0415613166987896
deficient I-Disease 0 1.5106109458429273e-05
mice O 0 2.8530298123996545e-08
appeared O 0 2.1870619204555908e-10
normal O 0 2.0830279168215782e-10
at O 0 7.765481313537492e-11
birth O 0 2.1053670959392257e-11
; O 0 1.3625289319117023e-13
they O 0 1.3180748810112664e-12
were O 0 9.198053776970916e-12
viable O 0 2.811894495025058e-09
and O 0 1.0479416640007955e-10
fertile O 0 9.632746156285066e-09
. O 0 4.8856900747296095e-09

Neither O 0 8.65682011408353e-07
vWf O 0 2.8756480787706096e-06
nor O 0 1.3282385680213338e-07
vWf O 0 2.4988545987980615e-07
propolypeptide O 0 8.085251010925276e-07
( O 0 1.92647919838862e-09
von B-Disease 0 0.00013329832290764898
Willebrand I-Disease 0 0.0003717910440173
antigen O 0 7.679889222345082e-07
II O 0 0.0001509041612735018
) O 0 3.569264024963492e-12
were O 0 4.602956037158545e-12
detectable O 0 5.804000613451876e-10
in O 0 1.5682260177951601e-12
plasma O 0 3.292016659273145e-10
, O 0 1.0030159211874001e-12
platelets O 0 8.557914099593944e-11
, O 0 7.284396176532315e-12
or O 0 3.1419322438913655e-12
endothelial O 0 8.463338536934817e-12
cells O 0 4.0881696899280895e-13
of O 0 3.59333569843745e-12
the O 0 5.395748518127741e-12
homozygous O 0 8.616454771903648e-10
mutant O 0 4.831923305914643e-08
mice O 0 4.528500952005743e-08
. O 0 8.083101965539186e-10

The O 0 2.8421656139698825e-09
mutant O 0 1.0421228324730691e-07
mice O 0 1.8814695579294494e-08
exhibited O 0 3.913442014891189e-09
defects O 0 2.9254460969241336e-06
in O 0 3.293408948334964e-11
hemostasis O 0 5.344526243789005e-07
with O 0 2.2131536187020018e-11
a O 0 1.949794325994958e-09
highly O 0 2.931671261308111e-08
prolonged O 0 0.004587505478411913
bleeding O 0 4.2606516217347234e-06
time O 0 5.553257298451797e-10
and O 0 8.476347401753515e-11
spontaneous O 0 2.960385927508469e-07
bleeding O 0 1.1245062125908589e-07
events O 0 1.0011240968166302e-11
in O 0 9.629989947829154e-13
approximately O 0 1.0009327351331865e-12
10 O 0 1.4104602034936686e-11
% O 0 1.9269441944858023e-11
of O 0 2.871634263712508e-09
neonates O 0 2.745421170402551e-07
. O 0 3.248408475542419e-08

As O 0 1.6376110537064115e-11
in O 0 1.923895071032078e-12
the O 0 1.3035422567753141e-11
human O 0 3.587997399190357e-10
disease O 0 5.1674873269291766e-09
, O 0 2.578986015629864e-13
the O 0 6.420075408797299e-12
factor O 0 1.0743157231873912e-11
VIII O 0 1.8152937486526355e-10
level O 0 1.278018579853324e-09
in O 0 1.9155467143039395e-12
these O 0 8.527598657596946e-13
mice O 0 1.34729993828131e-09
was O 0 2.7747798503341414e-10
reduced O 0 3.165400164206744e-10
strongly O 0 1.0308833864672295e-12
as O 0 1.704488601043247e-13
a O 0 8.509173183776642e-13
result O 0 8.031289175369771e-12
of O 0 7.462352263898353e-11
the O 0 2.6957550774975303e-11
lack O 0 1.4373151557833808e-09
of O 0 1.3836762291496996e-10
protection O 0 3.092115175018506e-10
provided O 0 3.2154717256871468e-12
by O 0 4.384865734397003e-11
vWf O 0 1.2412594685429212e-07
. O 0 1.7091288384563086e-08

Defective O 0 8.297527529066429e-05
thrombosis B-Disease 0 1.5111487172703164e-08
in O 0 4.282702664726301e-11
mutant O 0 4.3391117365843e-09
mice O 0 7.117357259112111e-10
was O 0 1.3060408657339373e-11
also O 0 6.109433163363487e-14
evident O 0 2.0764397417206287e-13
in O 0 6.63701305557169e-15
an O 0 5.163468906628076e-16
in O 0 3.764185618477904e-14
vivo O 0 5.278012055187631e-11
model O 0 5.025298580041415e-11
of O 0 2.622150319098182e-08
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 1.0290132195223123e-06

In O 0 1.5068041259169718e-10
this O 0 1.842486449868397e-12
model O 0 1.0175608619600318e-11
, O 0 3.3666825837580516e-12
the O 0 2.1203026834282213e-10
exteriorized O 0 1.4760057354124e-07
mesentery O 0 3.255262583934382e-07
was O 0 6.8147247844763115e-09
superfused O 0 7.422176651061818e-08
with O 0 1.6688347925786218e-10
ferric O 0 4.3310112118888355e-07
chloride O 0 2.3849677788234658e-09
and O 0 2.4713320279090567e-10
the O 0 8.7410673144106e-10
accumulation O 0 7.74104425005362e-09
of O 0 6.489177621915587e-07
fluorescently O 0 9.764846709003905e-07
labeled O 0 3.888679156460739e-09
platelets O 0 1.9355793356989892e-10
was O 0 6.61445620497858e-11
observed O 0 3.887657556989055e-12
by O 0 7.912840521706599e-12
intravital O 0 1.1798015719932664e-07
microscopy O 0 9.857400229407176e-09
. O 0 1.643766012193737e-08

We O 0 4.135547460037969e-09
conclude O 0 3.499178946597681e-09
that O 0 1.801275166350702e-12
these O 0 2.486838642998257e-12
mice O 0 1.7071275504321193e-09
very O 0 1.2552306199661856e-12
closely O 0 1.0670539105084309e-11
mimic O 0 1.647243408342547e-08
severe O 0 0.06240998953580856
human O 0 0.003788901027292013
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 4.735176844405942e-05
will O 0 1.6189902196650507e-10
be O 0 8.880974840079492e-13
very O 0 1.558774065228176e-14
useful O 0 1.866709098494873e-13
for O 0 2.264472517918975e-13
investigating O 0 2.5349004579428014e-12
the O 0 4.628354557251191e-12
role O 0 2.2696538658911747e-12
of O 0 1.4594192174199883e-11
vWf O 0 4.729988622997894e-11
in O 0 2.967535722361858e-12
normal O 0 9.856681026931824e-10
physiology O 0 1.2710805741278364e-09
and O 0 1.4838436469127858e-12
in O 0 2.1667695415672483e-11
disease O 0 1.9616692270574276e-07
models O 0 2.637813578676429e-10
. O 0 6.836198274129401e-11
. O 0 4.3772829805277524e-09

Oral O 0 1.1946236782023334e-06
contraceptives O 0 7.788276690234852e-08
and O 0 3.1309009204671945e-12
the O 0 2.2891933140756215e-11
risk O 0 4.192558478166575e-08
of O 0 2.457031405356247e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0015831519849598408

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999998807907104
Clinical O 1 0.9999969005584717
Study O 0 1.5720392809726036e-07
Group O 0 2.441899482619192e-08
. O 0 9.631735409243447e-09

BACKGROUND O 0 3.9261872188944835e-06
Women O 0 2.2928027532120865e-11
with O 0 5.538440257628341e-13
mutations O 0 6.019243263544194e-12
in O 0 3.0512026932827396e-11
either O 0 2.0829006575073805e-10
the O 0 4.394096642101886e-09
BRCA1 O 0 1.2517036296344486e-09
or O 0 1.541789092229795e-11
the O 0 9.05932939776477e-10
BRCA2 O 0 1.7636160587475302e-10
gene O 0 2.450124521671815e-12
have O 0 2.469875229360076e-14
a O 0 8.112106364248362e-14
high O 0 1.3270483670280164e-11
lifetime O 0 2.716681879455507e-10
risk O 0 4.857126327806327e-07
of O 0 0.004066814668476582
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00010313496022718027

Oral O 0 4.878096660831943e-05
contraceptives O 0 0.00044581765541806817
protect O 0 1.509765041873834e-07
against O 1 0.9999998807907104
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 6.52876906315214e-07
general O 0 1.5520168972216197e-07
, O 0 8.238352708356267e-12
but O 0 1.0798662311573004e-12
it O 0 4.054405736923089e-13
is O 0 2.338766658636915e-13
not O 0 6.99510097740795e-14
known O 0 1.6518966099512977e-12
whether O 0 1.889860230114282e-12
they O 0 6.475734662045318e-13
also O 0 1.623623246483144e-13
protect O 0 2.0776796624301375e-13
against O 0 1.1801931827648549e-11
hereditary B-Disease 0 2.6100658487848705e-06
forms I-Disease 0 2.9740977680603464e-08
of I-Disease 0 0.0042517599649727345
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.7691384073259542e-06

METHODS O 0 2.248802388749027e-08
We O 0 5.744645731331488e-11
enrolled O 0 3.830256598003068e-11
207 O 0 1.1464604959821045e-10
women O 0 5.734414679214872e-13
with O 0 7.353556652489601e-11
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 5.6834772443892234e-09
161 O 0 4.535947728534495e-10
of O 0 7.778493227306171e-08
their O 0 7.324391759766513e-09
sisters O 0 9.680707790948873e-09
as O 0 2.1545544862111576e-11
controls O 0 2.0206252671073344e-08
in O 0 8.029393122610529e-11
a O 0 2.726243397699335e-10
case O 0 3.9084047109838593e-10
- O 0 7.617756980771162e-10
control O 0 2.5131264180799917e-08
study O 0 2.7245433686928777e-10
. O 0 5.544399384049825e-10

All O 0 3.8354071030255454e-09
the O 0 1.1129974719636948e-09
patients O 0 2.3406568350203827e-11
carried O 0 1.1592130901016962e-11
a O 0 4.9655561780437285e-12
pathogenic O 0 1.7289042419932343e-10
mutation O 0 1.106415913748604e-11
in O 0 2.5758816954435382e-11
either O 0 1.4652772051260143e-10
BRCA1 O 0 1.034143742861815e-10
( O 0 6.32266049412078e-13
179 O 0 4.718076623833056e-11
women O 0 3.298285472866369e-12
) O 0 7.536006866280809e-13
or O 0 4.196712422022131e-11
BRCA2 O 0 1.180032294101352e-09
( O 0 7.742022301027163e-12
28 O 0 8.332953171930058e-08
women O 0 4.389660857029298e-11
) O 0 5.7166502434591315e-12
. O 0 1.0518310666896014e-09

The O 0 9.346572227286742e-08
control O 0 1.3437125971904607e-06
women O 0 6.428972371824715e-12
were O 0 2.2656760148564992e-11
enrolled O 0 7.088888503981039e-11
regardless O 0 1.2898117296433753e-10
of O 0 1.5065778624645532e-09
whether O 0 2.3245599889420987e-11
or O 0 2.0467348302299904e-11
not O 0 8.894473699228023e-12
they O 0 8.468731792221629e-12
had O 0 2.208351973509437e-10
either O 0 8.348297608762323e-10
mutation O 0 1.2979768371224054e-08
. O 0 3.852093310996452e-09

Lifetime O 0 6.008642028376698e-09
histories O 0 2.705214718901061e-09
of O 0 2.76696070500293e-08
oral O 0 4.157126568316016e-06
- O 0 2.5959103311379295e-08
contraceptive O 0 1.4247114599186261e-08
use O 0 5.2927076783781946e-12
were O 0 2.918241006916872e-13
obtained O 0 1.108569345261573e-13
by O 0 5.983021288688897e-14
interview O 0 1.587926665158612e-11
or O 0 9.499800441735082e-14
by O 0 1.5382941638162825e-14
written O 0 1.9722911455063996e-14
questionnaire O 0 6.790308443091063e-16
and O 0 4.169114801110506e-15
were O 0 2.3734761036989585e-14
compared O 0 1.8327863437529214e-14
between O 0 2.927372428664088e-13
patients O 0 2.6037995544403447e-12
and O 0 1.4749496112312355e-12
control O 0 2.9352411274885526e-06
women O 0 1.338047240281165e-13
, O 0 1.94410392190085e-14
after O 0 1.5188580644934224e-12
adjustment O 0 1.1128249710612437e-10
for O 0 3.798431025010124e-13
year O 0 1.0773522915799583e-12
of O 0 1.2554569883693745e-10
birth O 0 1.0378453652037933e-09
and O 0 2.0861092020485472e-10
parity O 0 2.845639528459287e-07
. O 0 4.468267977841833e-09

RESULTS O 0 4.278477572228212e-09
The O 0 3.120308872395228e-11
adjusted O 0 5.312069673024666e-10
odds O 0 6.808644315015044e-09
ratio O 0 3.822653860119374e-10
for O 0 9.592231009492025e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.2591417686280693e-08
with O 0 3.119543740080083e-13
any O 0 1.2016308954809762e-11
past O 0 9.896116912044839e-12
use O 0 1.4271727246176202e-12
of O 0 1.570904101244608e-10
oral O 0 4.0237082998828555e-08
contraceptives O 0 4.694171451546936e-08
was O 0 3.338602505564836e-09
0 O 0 3.754774624553647e-08
. O 0 2.410118771223324e-09

5 O 0 1.7474116376092752e-08
( O 0 8.235493884067857e-12
95 O 0 7.762582798775952e-10
percent O 0 2.531182763387818e-10
confidence O 0 2.8897273463002193e-09
interval O 0 6.643821937046823e-09
, O 0 1.4638741607786443e-11
0 O 0 1.457700626872338e-10
. O 0 3.0522180377752506e-13
3 O 0 5.3956348937400644e-12
to O 0 7.364015674376015e-14
0 O 0 2.340906808673271e-11
. O 0 4.027690995393046e-13
8 O 0 1.3384984787201404e-10
) O 0 6.023144765061883e-13
. O 0 4.381622148441622e-11

The O 0 1.1638761954202437e-08
risk O 0 1.3788082897647769e-09
decreased O 0 7.922353745248856e-12
with O 0 3.796543971128913e-15
increasing O 0 3.579147340917327e-13
duration O 0 1.3680170711516393e-11
of O 0 1.3689122752014171e-11
use O 0 8.473461190518228e-13
( O 0 1.8029310412236849e-13
P O 0 1.0465999178421725e-09
for O 0 5.408594579148218e-13
trend O 0 3.701412787382452e-10
, O 0 3.421335751600113e-13
< O 0 3.067881018670171e-11
0 O 0 1.1630755386571323e-11
. O 0 3.0941029361027106e-14
001 O 0 7.54276632472517e-13
) O 0 1.1680969477930006e-16
; O 0 2.991989699709636e-17
use O 0 3.6840324259264465e-16
for O 0 1.5045036478580562e-14
six O 0 3.881512895386602e-13
or O 0 1.2717102795356625e-14
more O 0 3.9609934061350855e-16
years O 0 5.320678454572535e-14
was O 0 2.6717517087604392e-12
associated O 0 7.213047975747344e-14
with O 0 4.0775590098417885e-15
a O 0 4.129548807942085e-13
60 O 0 7.522594201204991e-13
percent O 0 2.6926549098055252e-12
reduction O 0 1.123236170741393e-09
in O 0 1.228211976567195e-10
risk O 0 1.8403657975341048e-07
. O 0 5.0147046515292004e-09

Oral O 0 3.851959991152398e-05
- O 0 8.973625398311924e-08
contraceptive O 0 6.178732547823529e-08
use O 0 4.1857049076776676e-11
protected O 0 3.388568075024523e-07
against O 0 6.991056579863653e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 1.3457062721100588e-11
for O 0 4.15429165677092e-13
carriers O 0 5.30254347917182e-14
of O 0 6.051913744448134e-12
the O 0 4.780069742804649e-11
BRCA1 O 0 5.742191791502371e-11
mutation O 0 7.187370273595284e-13
( O 0 2.265473643099994e-14
odds O 0 4.048675977808003e-11
ratio O 0 3.2533234461430693e-13
, O 0 5.786943325794894e-14
0 O 0 5.803153096950453e-12
. O 0 1.4000210326714068e-14
5 O 0 4.3383249466802387e-13
; O 0 7.803620310638487e-16
95 O 0 1.403784749033632e-12
percent O 0 8.544074735911122e-13
confidence O 0 2.7603726596159284e-11
interval O 0 3.560549077796793e-11
, O 0 2.160758280200098e-13
0 O 0 3.290814018855337e-12
. O 0 1.6374088771062972e-14
3 O 0 3.7432310398023694e-13
to O 0 3.39863330349726e-15
0 O 0 7.350183287534173e-13
. O 0 5.9113514593294586e-15
9 O 0 8.377825885287626e-13
) O 0 1.6577136226926103e-16
and O 0 3.4769588107067797e-16
for O 0 1.3594280586412522e-15
carriers O 0 1.2978442105737731e-14
of O 0 4.913257301009111e-13
the O 0 1.735378854506031e-11
BRCA2 O 0 3.28026911189383e-11
mutation O 0 6.586425198643053e-13
( O 0 5.362552375352998e-14
odds O 0 1.6725057450095449e-10
ratio O 0 1.2648704783221887e-12
, O 0 1.3898634305085922e-13
0 O 0 1.3808519432056965e-11
. O 0 1.0828192048518634e-13
4 O 0 9.656480476349927e-12
; O 0 6.839471294140887e-15
95 O 0 1.2619961499427124e-11
percent O 0 6.819785187961447e-12
confidence O 0 1.905669094748319e-10
interval O 0 9.422619351440176e-10
, O 0 2.0688466131207894e-12
0 O 0 2.1958259863175122e-11
. O 0 1.2087165578329728e-13
2 O 0 4.9156685666407185e-12
to O 0 1.5658461127113915e-13
1 O 0 3.581185695211708e-11
. O 0 3.9007504366340984e-13
1 O 0 6.434986571379753e-11
) O 0 3.791626843226148e-13
. O 0 4.2916076942178805e-11

CONCLUSIONS O 0 3.5714990076485265e-07
Oral O 0 3.8104503801150713e-06
- O 0 2.8588639011672967e-08
contraceptive O 0 1.6010703873803322e-08
use O 0 2.4052931955204082e-12
may O 0 4.4506691626415573e-13
reduce O 0 2.791801945872807e-12
the O 0 1.3648445438066426e-12
risk O 0 1.0929142923998825e-08
of O 0 4.734869798994623e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 7.911104660252022e-08
women O 0 3.345523321264879e-14
with O 0 1.551758599545837e-14
pathogenic O 0 1.3461408376880257e-10
mutations O 0 5.869857117729582e-12
in O 0 4.353149785085719e-11
the O 0 2.919855912608682e-09
BRCA1 O 0 9.431201597465133e-09
or O 0 2.6580877499071676e-09
BRCA2 O 0 1.7702880938941234e-07
gene O 0 6.099223242017615e-07

A O 0 2.2507897767809482e-07
Japanese O 0 1.1437908398193031e-07
family O 0 1.0866048338886714e-10
with O 0 1.7448588407464882e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.950478667467337e-09
a O 0 5.345471176809724e-09
codon O 0 2.880478611189119e-08
291 O 0 3.2799829519092327e-10
deletion O 0 5.112076872926252e-10
: O 0 1.5486376287246473e-12
a O 0 2.531185113938128e-12
clinical O 0 1.8840398130492986e-09
, O 0 7.551662203550413e-13
biochemical O 0 7.256986678250144e-10
, O 0 3.4954313749002708e-12
pathological O 0 2.2306005121208727e-05
, O 0 6.06918421769409e-12
and O 0 1.0288527842183814e-11
genetic O 0 2.846909197273817e-08
report O 0 3.6025488148183626e-10
. O 0 2.9877136320521913e-09

We O 0 4.804871500674324e-10
report O 0 1.2061750903624713e-11
a O 0 5.646752596760729e-12
Japanese O 0 2.302533941289653e-09
family O 0 1.9301369530433377e-11
with O 0 6.029499122206516e-10
adrenoleukodystrophy B-Disease 1 1.0
( O 0 7.617283699801192e-05
ALD B-Disease 1 1.0
) O 0 1.108899755873638e-12
with O 0 3.4323818743839385e-13
a O 0 5.460302349158397e-11
three O 0 4.9289562015220056e-11
base O 0 3.9779211036261586e-09
pair O 0 2.243386143518933e-09
deletion O 0 6.263447538401579e-10
( O 0 8.42192201394587e-12
delGAG O 0 2.8534854479289606e-09
291 O 0 5.373392703011959e-11
) O 0 1.7762795899954609e-13
in O 0 1.2877019762991271e-11
the O 0 1.6925644885645852e-08
ALD B-Disease 1 1.0
gene O 0 2.623393982048583e-07
. O 0 1.9585767674357157e-08

A O 0 2.5367677736198857e-08
variety O 0 8.957201647064039e-10
of O 0 9.291339919670349e-10
phenotypes O 0 4.748059723169717e-10
were O 0 1.264313913978965e-11
observed O 0 1.358466551054649e-11
within O 0 1.2092463141932797e-10
this O 0 2.6933396485295802e-11
family O 0 4.1834480324354217e-10
. O 0 1.4538785286788425e-08

While O 0 4.2336192329628375e-09
the O 0 3.0807079109962388e-09
proband O 0 9.137949632531672e-07
( O 0 4.047396306994244e-10
patient O 0 7.5608435068375e-09
1 O 0 1.809916128081568e-08
) O 0 1.1569720604742012e-13
was O 0 4.280691686536775e-12
classified O 0 4.622652629605872e-13
as O 0 2.0530118946017473e-13
having O 0 1.180530282904324e-12
a O 0 6.111324554053388e-13
rare O 0 1.305074711493992e-11
intermediate O 0 3.4926672665136493e-11
type O 0 9.114609240967741e-12
of O 0 8.13287909240401e-11
adult O 0 1.027457563473888e-09
cerebral O 0 2.125901410465758e-08
and O 0 9.362707137361426e-11
cerebello O 1 0.9997596144676208
- O 0 1.9096583855571225e-05
brain O 0 3.248946541134501e-06
stem O 0 8.393157002739571e-11
forms O 0 1.824338423384031e-11
, O 0 5.241430119790058e-13
his O 0 2.504224050348114e-10
younger O 0 3.8781666766851686e-10
brother O 0 4.852146684442005e-09
( O 0 1.5847103143618035e-11
patient O 0 3.904762735373879e-09
2 O 0 4.625557181725526e-08
) O 0 3.73174689934086e-13
and O 0 1.2044900667140812e-11
nephew O 0 6.611435399150878e-09
( O 0 7.178016861453251e-12
patient O 0 7.796209011701194e-09
3 O 0 5.344005771235061e-08
) O 0 1.5584575730615002e-12
had O 0 2.063418186315502e-10
a O 0 8.998658485026567e-10
childhood O 1 0.9506354928016663
ALD B-Disease 1 1.0
type O 0 1.8289270883542486e-05
. O 0 4.2696349566995195e-08

Another O 0 6.868804121040739e-07
nephew O 0 8.73497538123047e-06
( O 0 2.700801582378176e-09
patient O 0 1.1718154269146908e-07
4 O 0 1.5740299659228185e-06
) O 0 7.000794041700509e-12
of O 0 4.650031026898205e-09
patient O 0 1.4546920112934458e-07
1 O 0 2.3215231976791983e-06
was O 0 2.969108514605523e-09
classified O 0 2.2618330819401677e-11
as O 0 4.475152887151168e-12
having O 0 2.279185867815059e-11
an O 0 2.5653387834140284e-12
adolescent O 0 7.791883582797254e-09
form O 0 2.087610750933777e-09
. O 0 6.5267369286914345e-09

The O 0 3.972575601807193e-09
tau O 0 9.077421592174062e-10
level O 0 3.2478475464614576e-10
in O 0 3.205502703551577e-12
the O 0 3.446516336214067e-11
cerebrospinal O 0 1.1271164002124578e-09
fluid O 0 6.490601459074874e-12
( O 0 3.862049135355816e-12
CSF O 0 4.5636916468083655e-10
) O 0 1.249041966860584e-13
in O 0 4.1964383357129265e-12
patient O 0 1.6636363397992682e-09
1 O 0 5.243202849669615e-08
was O 0 4.5496031941816284e-10
as O 0 8.006078981194487e-13
high O 0 5.105581755981969e-12
as O 0 9.244683604791096e-15
that O 0 4.214640280926583e-15
of O 0 4.872997404897772e-12
patients O 0 1.2388480866154516e-11
with O 0 6.611857589211567e-11
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.9999654293060303
( O 0 2.0211764120009468e-12
AD B-Disease 0 6.909766508966797e-11
) O 0 3.1970643580431224e-12
. O 0 3.83577114515532e-10

His O 0 1.1018475909452263e-08
brain O 0 3.856679142710817e-10
magnetic O 0 2.7971493177236795e-11
resonance O 0 2.6989757651030288e-11
image O 0 2.983445088200476e-11
( O 0 1.8403852118480113e-13
MRI O 0 3.7390343599064124e-10
) O 0 3.833819654970594e-13
showed O 0 3.635322043393785e-10
abnormalities B-Disease 0 1.0350173340611946e-07
in I-Disease 0 2.183920795942318e-12
the I-Disease 0 1.632720868227633e-11
bilateral I-Disease 0 2.0559274283016293e-09
cerebellar I-Disease 0 3.455583282629959e-05
hemispheres I-Disease 0 1.3116397745704944e-08
and O 0 1.0157658048015605e-10
brain O 0 2.4915772556255433e-08
stem O 0 5.252203186256743e-11
, O 0 2.781314132997703e-13
but O 0 4.587151513670007e-13
not O 0 3.9691522095951226e-13
in O 0 1.805851475300546e-11
the O 0 7.640165722300196e-10
cerebral O 0 7.312805916370735e-09
white O 0 3.459502215946708e-12
matter O 0 1.3310319101240975e-13
, O 0 5.900267186181689e-15
where O 0 3.680524513090776e-14
marked O 0 1.4531242962384505e-12
reductions O 0 6.140928043851801e-11
of O 0 5.093854157922628e-11
the O 0 8.11513634069172e-11
cerebral O 0 8.386148026007234e-11
blood O 0 4.409737549074255e-13
flow O 0 7.021477583385449e-13
and O 0 1.0957383004411847e-12
oxygen O 0 6.466410046312987e-11
metabolism O 0 2.1288624196813544e-09
were O 0 8.469329404459103e-12
clearly O 0 4.528230275555739e-13
demonstrated O 0 1.0844064090697464e-13
by O 0 2.8451850250799104e-14
positron O 0 1.3458236261532086e-12
emission O 0 6.572076216571077e-11
tomography O 0 1.421127521217258e-10
( O 0 6.441221254288587e-12
PET O 0 5.89119952820738e-09
) O 0 5.921878439008044e-12
. O 0 2.8537888718815907e-10

In O 0 1.3934710052510013e-09
patients O 0 8.271457963004991e-10
2 O 0 4.586819368768147e-09
and O 0 1.2734379523093864e-11
3 O 0 1.9550112639876716e-09
, O 0 3.5407701076684006e-13
the O 0 2.1360461142927445e-12
autopsy O 0 1.7175592059714972e-09
findings O 0 3.310954808932731e-12
showed O 0 4.030661915344069e-11
massive O 0 5.701370486832502e-09
demyelination B-Disease 1 1.0
of I-Disease 0 8.098137914203107e-05
the I-Disease 0 2.0489942187396082e-07
cerebral I-Disease 0 2.719578446885862e-07
white I-Disease 0 1.2204141343341579e-11
matter I-Disease 0 3.3483974056988663e-13
with O 0 9.348845618007209e-14
sparing O 0 1.8683291025389792e-10
of O 0 1.1037284508574885e-07
the O 0 1.4630060718445748e-07
U O 1 0.9983194470405579
- O 0 2.9599839024285757e-08
fibers O 0 6.261882679048369e-10
, O 0 8.834211031975847e-13
compatible O 0 3.1132599276340045e-10
with O 0 2.4341276607178775e-13
the O 0 1.0070419324825775e-11
findings O 0 3.474049390175815e-12
of O 0 5.157480553741323e-10
childhood O 0 0.01616353914141655
ALD B-Disease 1 1.0
. O 0 4.868446694672457e-07

Oleic O 0 0.00011144651216454804
and O 0 7.676061386518995e-08
erucic O 0 8.744343358557671e-05
acids O 0 5.651577428267274e-09
( O 0 2.3654847178256055e-11
Lorenzos O 0 4.45730634623942e-08
Oil O 0 8.040784704732573e-10
) O 0 6.994090094407379e-13
were O 0 9.87108225020128e-12
administered O 0 5.350892298694454e-11
to O 0 5.774302910821483e-12
patients O 0 4.231863123815849e-11
1 O 0 2.8317763689500453e-09
and O 0 5.902414841607584e-12
4 O 0 2.0008275036786927e-09
, O 0 2.324624325499014e-13
but O 0 7.36904569482999e-14
sufficient O 0 6.255489615886178e-12
effectiveness O 0 3.056497416276116e-11
was O 0 2.2206632366295054e-11
not O 0 1.2423731748228972e-12
obtained O 0 8.927995842622494e-11
. O 0 7.761635223424435e-10

The O 0 8.330426481961695e-08
findings O 0 6.416360776029251e-10
in O 0 9.657958460751459e-11
this O 0 8.406162051166621e-12
family O 0 4.566473501416146e-12
suggest O 0 2.718566040685322e-12
that O 0 1.102376653502879e-13
delGAG291 O 0 3.8215236530803054e-10
is O 0 4.764936275408749e-13
part O 0 1.000299127383586e-12
of O 0 6.915132355622688e-11
the O 0 1.0931008875836312e-10
cause O 0 5.890477550174467e-10
of O 0 2.285814426628008e-09
Japanese O 0 3.2018604088079883e-06
ALD B-Disease 1 1.0
with O 0 5.953989384854808e-11
phenotypic O 0 7.413361799990525e-07
variations O 0 1.1396510757322176e-07
. O 0 3.3572373325796434e-08

Moreover O 0 2.0227990393806294e-09
, O 0 3.0821903189426347e-12
although O 0 1.7093699502743198e-12
the O 0 2.09981164400741e-12
scale O 0 1.1062102345249514e-09
of O 0 4.0353101415924186e-10
the O 0 3.888986702116348e-11
study O 0 2.3299108952920533e-13
is O 0 1.3479596772277263e-14
limited O 0 1.631306038602648e-13
, O 0 7.883967187861246e-14
there O 0 2.485401858279279e-12
is O 0 8.198752549266886e-13
a O 0 4.05773461706338e-12
possibility O 0 3.382293889409027e-10
that O 0 2.5284507126910327e-11
PET O 0 9.07111186165821e-08
can O 0 2.579548120246189e-12
detect O 0 1.4332436626407485e-10
an O 0 4.695881270638802e-12
insidious B-Disease 0 8.364705905705705e-08
lesion I-Disease 0 9.806518391997088e-06
which O 0 9.826636900023278e-12
is O 0 2.43345925007854e-13
undetectable O 0 5.61968700740767e-12
by O 0 2.3020188796092807e-14
computed O 0 7.1060505570097465e-12
tomogram O 0 3.0572120390814916e-09
( O 0 4.204672363321976e-13
CT O 0 1.170130436989325e-09
) O 0 2.6393883755557006e-14
or O 0 1.2830541682817657e-14
MRI O 0 3.6076955225311513e-12
analysis O 0 6.206211082158616e-14
, O 0 1.5021926031647675e-14
and O 0 1.0746625486203476e-14
that O 0 7.613873283750499e-15
the O 0 6.853712476023732e-13
higher O 0 1.0419480382661828e-11
level O 0 3.134285886385868e-10
of O 0 4.361460498314429e-11
tau O 0 2.7519037396062096e-11
reflects O 0 1.2194031320713478e-13
the O 0 7.948105877880057e-14
process O 0 8.295523556273166e-13
of O 0 1.2590869319373255e-11
neuronal B-Disease 0 9.958069568938299e-08
degeneration I-Disease 1 0.9899715185165405
in O 0 1.3257146491696403e-08
ALD B-Disease 1 1.0
. O 0 1.1503050245664781e-07

Lorenzos O 0 1.1140598871861584e-05
Oil O 0 3.353826016905259e-08
should O 0 4.0493167846600286e-11
be O 0 1.6320279817242517e-13
given O 0 5.848037440588094e-14
in O 0 2.756907657892882e-13
the O 0 4.215499043586091e-12
early O 0 3.556329120080193e-10
stage O 0 7.167370696947728e-09
. O 0 1.0001818123717143e-10
. O 0 2.043713642763123e-09

Nonsense O 0 8.316382604789396e-07
mutation O 0 1.6532797353363549e-09
in O 0 1.8770730803030489e-10
exon O 0 1.8352439568047885e-08
4 O 0 7.86081866266386e-09
of O 0 2.0498973629656803e-09
human O 0 2.076541993911718e-10
complement O 0 7.469703744433787e-10
C9 O 0 7.612636920839577e-08
gene O 0 7.78496451331323e-12
is O 0 1.1795146565192483e-13
the O 0 1.993069338040998e-12
major O 0 2.176911290119321e-10
cause O 0 1.802955340579615e-09
of O 0 1.3291148626137783e-08
Japanese O 0 4.18923627876211e-06
complement B-Disease 0 3.9668913814239204e-05
C9 I-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9997988343238831
. O 0 8.402010820418582e-08

Deficiency B-Disease 0 0.0034780653659254313
of I-Disease 0 9.473088721279055e-05
the I-Disease 0 3.256144225360913e-07
ninth I-Disease 0 2.1056569039501483e-06
component I-Disease 0 3.7980495193323804e-08
of I-Disease 0 1.9445867849299248e-07
human I-Disease 0 1.480894784577913e-08
complement I-Disease 0 1.0701816099967232e-09
( O 0 6.526381518545676e-11
C9 O 0 2.3702222051724675e-07
) O 0 4.012623837802015e-13
is O 0 1.048599886934419e-13
the O 0 1.4135081993771337e-12
most O 0 1.174847328797024e-12
common O 0 5.932174751421826e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.7626463722517656e-08
Japan O 0 2.912132231358555e-06
but O 0 7.346304987942975e-12
is O 0 7.305709314418818e-13
rare O 0 7.843179231081798e-12
in O 0 2.011799364251554e-12
other O 0 1.0442454193015926e-12
countries O 0 2.638133982102442e-11
. O 0 1.4999345099298012e-09

We O 0 2.6746030737379023e-11
studied O 0 5.842669664052336e-12
the O 0 3.705531975012333e-13
molecular O 0 1.5909848308584551e-12
basis O 0 2.079981673008824e-11
of O 0 1.715797504076022e-09
C9 B-Disease 0 0.0018012345535680652
deficiency I-Disease 0 8.665016082431976e-08
in O 0 7.38014094281425e-11
four O 0 2.1042519116054592e-10
Japanese O 0 4.590804110193858e-07
C9 B-Disease 1 0.9999970197677612
- I-Disease 0 0.004450664855539799
deficient I-Disease 0 2.4983139155665413e-05
patients O 0 5.249661816364437e-10
who O 0 8.220318523100012e-12
had O 0 4.413026055694047e-10
suffered O 0 0.006006564013659954
from O 0 4.259747754531418e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.5409622022843905e-08

Direct O 0 4.156406330224627e-10
sequencing O 0 1.6058641916227856e-10
of O 0 2.129479703683046e-09
amplified O 0 3.049512864450321e-09
C9 O 0 1.008379655331737e-07
cDNA O 0 3.050629748813094e-09
and O 0 1.0417115087202333e-11
DNA O 0 5.660126534134946e-11
revealed O 0 1.500748483818093e-11
a O 0 1.1692055310041916e-11
nonsense O 0 3.567361961387405e-10
substitution O 0 2.522329844989457e-10
( O 0 3.274728795424342e-12
CGA O 0 4.839890266339353e-09
- O 0 1.301118379704036e-10
- O 0 1.1329308324814491e-10
> O 0 6.654573558861898e-10
TGA O 0 1.2775537960862948e-08
) O 0 4.3276119450139094e-14
at O 0 3.1877723117440526e-12
codon O 0 7.0703044113828994e-12
95 O 0 1.9103373397055812e-11
in O 0 2.5966132456006763e-12
exon O 0 2.5495175415279903e-10
4 O 0 1.8555477987458602e-10
in O 0 5.624223309297349e-12
the O 0 2.666470100276541e-10
four O 0 1.2773655466702394e-09
C9 B-Disease 0 6.12224466749467e-05
- I-Disease 0 1.8524171707667847e-07
deficient I-Disease 0 1.9358250114009934e-08
individuals O 0 1.4872729783843575e-11
. O 0 3.027201378458244e-09

An O 0 1.2751587979975554e-11
allele O 0 5.7055745544820624e-11
- O 0 5.497263408371644e-11
specific O 0 5.651021664498934e-11
polymerase O 0 1.8029414627918072e-09
chain O 0 1.0176981959375553e-06
reaction O 0 7.919431221914408e-10
system O 0 5.286295845507993e-10
designed O 0 4.255619814874656e-11
to O 0 2.674299312815237e-13
detect O 0 1.3523157203418346e-12
exclusively O 0 2.3260579660316916e-12
only O 0 4.562727691330426e-13
one O 0 1.3612819638880724e-13
of O 0 1.0755726170819102e-11
the O 0 4.110094643100526e-12
normal O 0 7.134897273691765e-12
and O 0 3.398427643897667e-14
mutant O 0 2.241774474387448e-12
alleles O 0 6.365416176199335e-15
indicated O 0 3.5233734739471487e-14
that O 0 2.3603602220271993e-15
all O 0 2.9053617693099165e-13
the O 0 6.1699122373692905e-12
four O 0 2.037059756987425e-12
patients O 0 1.1858466682571067e-13
were O 0 2.6173418358858835e-13
homozygous O 0 3.5640938984837778e-12
for O 0 9.696932926767099e-13
the O 0 2.8402226751045312e-11
mutation O 0 3.2904312954884496e-12
in O 0 6.195478158277368e-12
exon O 0 3.034108964072857e-09
4 O 0 4.369641981583072e-09
and O 0 2.7080603384743718e-12
that O 0 2.1448756670500863e-13
the O 0 5.821614718071189e-11
parents O 0 5.108757600985614e-12
of O 0 4.237915296467776e-10
patient O 0 4.2522163568037286e-09
2 O 0 1.6234392319347535e-07
were O 0 2.684408251241166e-09
heterozygous O 0 1.157930995532297e-08
. O 0 5.86347681519328e-09

The O 0 1.570078822510368e-08
common O 0 1.78334091938126e-09
mutation O 0 2.1081486556440154e-10
at O 0 6.878185243586188e-10
codon O 0 8.004870100108974e-10
95 O 0 1.8888683950279983e-09
in O 0 3.2863703425256574e-10
exon O 0 3.025765593633878e-08
4 O 0 1.8055612116540942e-08
might O 0 7.101849924112669e-12
be O 0 2.1763806848287132e-13
responsible O 0 3.042745309184136e-12
for O 0 9.180136035027986e-13
most O 0 1.2926186163109143e-11
Japanese O 0 6.025733796377608e-07
C9 B-Disease 1 0.9998793601989746
deficiency I-Disease 0 0.0002905705478042364
. O 0 6.436057797820638e-10
. O 0 5.545448988897306e-09

BRCA1 O 0 4.380749096810632e-09
required O 0 5.465532887383162e-11
for O 0 1.0063814365190993e-11
transcription O 0 1.3587070135656631e-08
- O 0 2.2925176423882476e-08
coupled O 0 2.003341137424286e-08
repair O 0 1.416237296325562e-07
of O 0 1.3620989136597927e-07
oxidative O 0 0.0002502523420844227
DNA O 0 2.0335995998266299e-07
damage O 0 2.5232955067622242e-06
. O 0 4.800046582431605e-09

The O 0 4.119042387173977e-07
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9993224143981934
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999758005142212
gene O 0 4.577799472826882e-09
BRCA1 O 0 4.1756517688007477e-10
encodes O 0 1.2992529795086138e-11
a O 0 1.4815035309645452e-10
zinc O 0 1.2854194153533172e-08
finger O 0 2.339183566846259e-07
protein O 0 6.934518381740418e-08
of O 0 4.208710890907241e-07
unknown O 0 5.425769700195815e-07
function O 0 1.8851764593819098e-08
. O 0 1.2666975246489187e-09

Association O 0 4.0683286073317504e-08
of O 0 1.1646934083842098e-08
the O 0 1.4118020086328897e-09
BRCA1 O 0 7.510186222914328e-11
protein O 0 3.5302791506069964e-12
with O 0 1.8758711489534619e-13
the O 0 1.2306225483094124e-10
DNA O 0 2.1003154770937726e-09
repair O 0 8.93836382687141e-09
protein O 0 8.144774299445601e-10
Rad51 O 0 4.684777454855293e-09
and O 0 2.235284657023384e-12
changes O 0 1.1522072358716162e-12
in O 0 8.646334109839796e-14
the O 0 5.70083463400338e-14
phosphorylation O 0 8.10147305144171e-13
and O 0 1.4748784333586118e-13
cellular O 0 2.733615070416029e-11
localization O 0 3.110192769995024e-09
of O 0 1.3862941350417657e-10
the O 0 2.7530273200015998e-11
protein O 0 5.069738379104294e-11
after O 0 1.735471662211996e-11
exposure O 0 1.0965924696071383e-10
to O 0 1.3773455466437046e-11
DNA O 0 9.763355457437228e-09
- O 0 1.8704480186926276e-09
damaging O 0 7.717412486840658e-09
agents O 0 1.2369239313358982e-11
are O 0 2.0446257263228435e-13
consistent O 0 1.445076523720612e-11
with O 0 1.4689658723362337e-13
a O 0 6.1150117088015765e-12
role O 0 1.1895629446756484e-11
for O 0 3.882501958818452e-11
BRCA1 O 0 5.758570287284215e-10
in O 0 2.6613025672084234e-10
DNA O 0 1.7013074682381557e-07
repair O 0 1.0207151717622764e-05
. O 0 2.5956833837881277e-07

Here O 0 1.1980031189295914e-08
, O 0 1.4413904965426827e-11
it O 0 2.68749703481036e-13
is O 0 6.923264451964492e-14
shown O 0 7.446874605680776e-13
that O 0 4.682677314481187e-13
mouse O 0 9.894202124272056e-10
embryonic O 0 5.353651411077465e-10
stem O 0 1.6341041367273768e-11
cells O 0 6.112516742762253e-12
deficient B-Disease 0 2.4783071428391423e-11
in I-Disease 0 1.3203879829781773e-11
BRCA1 I-Disease 0 1.2333413457188414e-10
are O 0 3.985158286267526e-13
defective O 0 1.2083925873818124e-11
in O 0 5.282410359824796e-12
the O 0 3.063781867096438e-11
ability O 0 6.073836095535357e-13
to O 0 2.453934679156472e-13
carry O 0 7.789995319813781e-13
out O 0 3.1245297148208007e-12
transcription O 0 1.5308313505713045e-09
- O 0 4.51599158068916e-09
coupled O 0 4.617859428179827e-09
repair O 0 1.488032719265675e-08
of O 0 4.341048853717666e-09
oxidative O 0 2.0035976433518954e-07
DNA O 0 3.119972502574342e-09
damage O 0 3.6201171838001756e-08
, O 0 3.14411430918371e-12
and O 0 1.027911263051795e-11
are O 0 4.368418821121267e-12
hypersensitive O 0 1.2631967694076707e-09
to O 0 2.3806023125017006e-11
ionizing O 0 2.893196153763711e-07
radiation O 0 4.354016311935993e-07
and O 0 8.534082468480975e-11
hydrogen O 0 1.8206962326683396e-10
peroxide O 0 2.1784076764674865e-09
. O 0 5.5622284556022805e-09

These O 0 1.0542774431243629e-09
results O 0 2.2981156977408546e-09
suggest O 0 1.3156573053230147e-10
that O 0 7.670323577679827e-12
BRCA1 O 0 1.270949040454994e-10
participates O 0 6.947024878099783e-13
, O 0 1.4983587287575872e-13
directly O 0 5.400015626170519e-14
or O 0 4.8280854276572596e-14
indirectly O 0 1.6207488909986134e-13
, O 0 6.367289643672072e-14
in O 0 5.1848560167488955e-12
transcription O 0 1.2193503096114e-08
- O 0 2.2673047439525362e-08
coupled O 0 1.0536266970007091e-08
repair O 0 8.855692357201406e-08
of O 0 4.729661995384049e-08
oxidative O 0 2.275507313242997e-06
DNA O 0 1.585994979791394e-08
damage O 0 9.455575167294228e-08
. O 0 1.197714011302864e-10
. O 0 1.5383098128651795e-09

Truncation O 0 3.7018722309767327e-07
mutations O 0 4.6333054060099244e-10
in O 0 1.8788630373745008e-11
the O 0 1.7741010049920902e-11
transactivation O 0 4.139385012535968e-08
region O 0 6.371068117516643e-10
of O 0 3.573111140298124e-09
PAX6 O 0 5.3632556955562904e-05
result O 0 2.7453639361851856e-09
in O 0 3.3157296353003574e-10
dominant O 0 2.75269087524066e-07
- O 0 6.534085716936033e-09
negative O 0 1.8187397143876183e-09
mutants O 0 2.1195029376031016e-07
. O 0 4.545892995366785e-09

PAX6 O 0 0.0018770938040688634
is O 0 1.5115659834918915e-09
a O 0 7.393723133741759e-11
transcription O 0 9.11589970176152e-11
factor O 0 9.582959425991078e-12
with O 0 3.731447930591797e-13
two O 0 9.539028421323703e-12
DNA O 0 1.0612657280750781e-10
- O 0 5.0577016533215335e-12
binding O 0 1.5621547458377627e-11
domains O 0 7.401536848694601e-12
( O 0 9.748072574838895e-14
paired O 0 4.658058227330342e-12
box O 0 2.1847564035670786e-10
and O 0 4.040435087199201e-12
homeobox O 0 3.3026895107646226e-10
) O 0 8.585023154612098e-14
and O 0 1.4568097162631632e-12
a O 0 8.180797012036223e-11
proline O 0 2.0272301171075924e-08
- O 0 3.7486547199705456e-09
serine O 0 2.627154742640414e-07
- O 0 8.129475759233173e-09
threonine O 0 3.2814759265420435e-07
( O 0 1.4004826812130666e-11
PST O 0 5.169302312424406e-06
) O 0 1.7997538138622704e-12
- O 0 1.6832835472713192e-11
rich O 0 3.3342699261307285e-12
transactivation O 0 4.07870892615847e-08
domain O 0 1.497060075905665e-08
. O 0 2.5581112783612525e-09

PAX6 O 0 0.03197610750794411
regulates O 0 9.330630490467229e-08
eye O 0 6.713477773701015e-07
development O 0 8.033242404614782e-10
in O 0 8.409080723414952e-12
animals O 0 1.0598147359708321e-11
ranging O 0 1.2947315441991236e-10
from O 0 1.4257530919770112e-11
jellyfish O 0 1.290440410778304e-12
to O 0 5.139688587924018e-13
Drosophila O 0 2.2323556891912233e-10
to O 0 9.941294315529703e-12
humans O 0 2.481486960359547e-10
. O 0 9.566916148173732e-10

Heterozygous O 0 1.868651722247705e-08
mutations O 0 4.664168010148906e-11
in O 0 1.2156375732430558e-11
the O 0 1.4175891016598996e-10
human O 0 6.686941556033332e-10
PAX6 O 0 3.600232048484031e-06
gene O 0 1.3063529424872655e-10
result O 0 1.600170169979709e-11
in O 0 4.520549787365852e-13
various O 0 9.154991218243702e-13
phenotypes O 0 6.607647068390676e-11
, O 0 9.255807925656612e-13
including O 0 1.2168770158194064e-10
aniridia B-Disease 1 1.0
, O 0 1.0856343379828104e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 3.321865227334797e-09
autosomal B-Disease 0 2.597216189315077e-05
dominant I-Disease 0 1.1464329645605176e-06
keratitis I-Disease 1 0.9999996423721313
, O 0 8.19141865449069e-10
and O 0 5.90364024333212e-09
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.00014428654685616493

It O 0 5.991537821437021e-11
is O 0 3.447185245586404e-12
believed O 0 3.246035818610382e-12
that O 0 3.6735954447690566e-14
the O 0 1.827677549234852e-12
mutated O 0 4.7764765233326845e-12
allele O 0 1.461040143035941e-11
of O 0 1.0028069485912283e-09
PAX6 O 0 3.093403847742593e-06
produces O 0 2.6276585074480607e-11
an O 0 4.177612845501083e-13
inactive O 0 4.886703264261882e-10
protein O 0 4.3909129665564706e-09
and O 0 2.9248767297040956e-10
aniridia B-Disease 1 1.0
is O 0 1.4880341403511466e-10
caused O 0 2.8929353357298737e-10
due O 0 1.4343246590442504e-09
to O 0 1.3874282799031246e-11
genetic O 0 1.1418900669468712e-07
haploinsufficiency O 0 3.777967776841251e-06
. O 0 2.8791712125553204e-08

However O 0 9.06389241439598e-10
, O 0 8.535543799537137e-12
several O 0 2.8010666702771303e-12
truncation O 0 2.0895678076726654e-08
mutations O 0 8.822382407958074e-11
have O 0 1.0421442354913157e-12
been O 0 5.04409610867923e-13
found O 0 1.278851783720553e-14
to O 0 1.1153471504395714e-14
occur O 0 4.992962423719383e-13
in O 0 3.051218566002545e-12
the O 0 1.78516076920765e-10
C O 0 3.7831988208836265e-08
- O 0 1.4327489195054e-10
terminal O 0 5.155730287143001e-10
half O 0 1.6969280798237452e-12
of O 0 8.072770750489067e-12
PAX6 O 0 4.194734160023472e-08
in O 0 3.660770905161703e-12
patients O 0 6.470696916650864e-13
with O 0 4.253651467514552e-13
Aniridia B-Disease 1 1.0
resulting O 0 2.61755561670185e-10
in O 0 5.004768734856446e-12
mutant O 0 3.0720573307441157e-10
proteins O 0 4.805829345588819e-12
that O 0 6.488357485838481e-13
retain O 0 3.258719127874343e-10
the O 0 2.845169100318401e-10
DNA O 0 2.168234064514607e-10
- O 0 6.0140330215840976e-12
binding O 0 7.565737099313186e-12
domains O 0 6.179793655969323e-12
but O 0 1.1555215334926872e-12
have O 0 1.4054805496516165e-12
lost O 0 2.4582436086717507e-10
most O 0 6.366102306767929e-13
of O 0 2.1855398046888297e-10
the O 0 3.279269911171667e-10
transactivation O 0 1.2827624118472158e-07
domain O 0 1.910019697959342e-08
. O 0 5.184883189457423e-09

It O 0 1.342855826536038e-10
is O 0 3.5274116527012067e-12
not O 0 2.8593636789905896e-13
clear O 0 1.244593837712582e-11
whether O 0 6.078471601923818e-13
such O 0 1.318012712858696e-11
mutants O 0 4.164527922512207e-08
really O 0 7.330953899487014e-11
behave O 0 2.963868571143752e-13
as O 0 1.4753828584193607e-12
loss O 0 1.2142617467070238e-10
- O 0 4.1325626948252037e-11
of O 0 5.627579735545396e-09
- O 0 2.6865273894394193e-10
function O 0 5.911783840240048e-10
mutants O 0 6.946266895013764e-10
as O 0 1.0567964689109366e-12
predicted O 0 1.4317327878821118e-10
by O 0 1.5036281247882144e-11
haploinsufficiency O 0 5.662472517542483e-07
. O 0 3.173268225964421e-08

Contrary O 0 7.181081951301849e-09
to O 0 2.150964736186145e-12
this O 0 3.7671105926513626e-13
theory O 0 2.2845185465580897e-10
, O 0 7.514821013729356e-13
our O 0 1.9965888751333205e-12
data O 0 3.7353948059704045e-12
showed O 0 6.0396819490105e-11
that O 0 1.3754329706433532e-13
these O 0 1.5932918775562327e-13
mutants O 0 3.5766006822868235e-10
are O 0 1.0890646023886674e-12
dominant O 0 1.588839337873793e-10
- O 0 1.183773218338402e-11
negative O 0 2.8562037717588806e-12
in O 0 1.90334618725696e-12
transient O 0 4.4333411941543943e-10
transfection O 0 3.0102504933182672e-09
assays O 0 8.005568430391463e-11
when O 0 5.5778372372305984e-12
they O 0 1.4494261910483197e-12
are O 0 2.5120083422223993e-13
coexpressed O 0 2.138417887209698e-09
with O 0 2.8648913102946594e-11
wild O 0 2.035631041508168e-05
- O 0 2.6995778057425923e-07
type O 0 4.924772269987443e-07
PAX6 O 0 0.011191963218152523
. O 0 1.1775252772849853e-07

We O 0 1.5235317452066965e-09
found O 0 1.7253611733769603e-12
that O 0 5.442181603911196e-14
the O 0 8.890606133238332e-12
dominant O 0 1.879080002709088e-09
- O 0 3.3298037938056524e-11
negative O 0 1.005821034100185e-11
effects O 0 8.561938713569361e-09
result O 0 8.660212130751077e-11
from O 0 5.407192163638108e-13
the O 0 6.249550790066172e-12
enhanced O 0 1.68235269465411e-11
DNA O 0 2.5858353652763455e-11
binding O 0 6.73015853117076e-12
ability O 0 1.778423003480356e-12
of O 0 1.4775414225454142e-10
these O 0 1.0315605140920336e-11
mutants O 0 9.236533315970519e-09
. O 0 3.712302687475244e-09

Kinetic O 0 1.6179723116849232e-09
studies O 0 2.945140312182737e-11
of O 0 5.027081875774719e-11
binding O 0 4.2535749228411746e-11
and O 0 2.3273980399168837e-12
dissociation O 0 1.116117094579483e-11
revealed O 0 1.7313906384985867e-12
that O 0 8.020683726558953e-15
various O 0 2.7085237806930007e-13
truncation O 0 6.0792726408465114e-09
mutants O 0 6.004162944606151e-09
have O 0 1.753652778546666e-11
3 O 0 1.8659012113175777e-09
- O 0 7.485245756555514e-11
5 O 0 6.843873245898635e-10
- O 0 3.455665961715759e-11
fold O 0 3.7480647058218963e-11
higher O 0 3.18235346928597e-12
affinity O 0 4.949061044876371e-14
to O 0 1.596394593123343e-13
various O 0 3.120217842780826e-12
DNA O 0 1.667192425780506e-11
- O 0 8.462425638705584e-14
binding O 0 1.9984014443252818e-13
sites O 0 7.452525873979585e-14
when O 0 4.85022585245895e-15
compared O 0 2.4708459291176293e-14
with O 0 1.0552525345241311e-14
the O 0 1.592355552970659e-10
wild O 0 1.7515769457077113e-07
- O 0 1.882374078832072e-08
type O 0 7.063255225148168e-08
PAX6 O 0 0.00030323551618494093
. O 0 5.3513190323428717e-08

These O 0 7.164356607969324e-11
results O 0 5.358695431834093e-11
provide O 0 5.543896505061374e-12
a O 0 2.0999196305437895e-12
new O 0 4.517139266801973e-12
insight O 0 7.551766503799406e-12
into O 0 1.886675494652823e-13
the O 0 1.5095440088902512e-12
role O 0 1.343494868306927e-12
of O 0 3.383066396467349e-11
mutant O 0 1.1468071825504467e-08
PAX6 O 0 6.935629244253505e-06
in O 0 9.023115032924522e-10
causing O 0 6.061710422500255e-08
aniridia B-Disease 1 1.0
. O 0 5.017565030129845e-09
. O 0 1.3805090404162002e-08

Reversal O 0 3.511764035124543e-08
of O 0 1.3688778111031752e-08
severe O 1 0.9999986886978149
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 3.549188498652711e-09
excellent O 0 9.471703421581879e-10
neuropsychologic O 0 5.842469974481901e-08
outcome O 0 1.523834058936302e-09
in O 0 2.0866254904494674e-11
very B-Disease 0 6.5293044408665235e-12
- I-Disease 0 5.294469862526796e-10
long I-Disease 0 1.5867573921468647e-08
- I-Disease 0 3.2334326078853337e-06
chain I-Disease 1 1.0
acyl I-Disease 1 1.0
- I-Disease 1 1.0
coenzyme I-Disease 1 1.0
A I-Disease 1 0.9958133101463318
dehydrogenase I-Disease 1 0.9999955892562866
deficiency I-Disease 1 0.9999943971633911
. O 0 8.517406335784017e-09

Very B-Disease 0 6.664408136458633e-09
- I-Disease 0 8.906437365396869e-09
long I-Disease 0 1.299408580734962e-08
- I-Disease 0 1.3004702736907348e-07
chain I-Disease 1 0.8827654123306274
acyl I-Disease 1 0.9965164661407471
- I-Disease 0 0.0008501087431795895
coenzyme I-Disease 0 0.003936986904591322
A I-Disease 0 2.28829328818847e-08
dehydrogenase I-Disease 0 6.90824120130884e-10
( I-Disease 0 2.287759554280705e-13
VLCAD I-Disease 0 6.39197367036104e-07
) I-Disease 0 1.4653819607399199e-12
deficiency I-Disease 0 9.596014649559947e-09
is O 0 8.84686949891543e-14
a O 0 1.9236454876919717e-12
disorder O 0 3.920043582184007e-06
of O 0 2.2832061574717954e-07
fatty O 0 1.2049123476742807e-08
acid O 0 2.699047756127282e-11
beta O 0 2.4939744713847745e-11
oxidation O 0 2.6374613604218666e-10
that O 0 7.518975269878506e-14
reportedly O 0 1.5168662766823493e-12
has O 0 6.168184977947645e-15
high O 0 1.6383038588946297e-12
rates O 0 6.106433501212871e-12
of O 0 1.839628059260856e-12
morbidity O 0 1.8038716120827303e-07
and O 0 2.2225318807578276e-11
mortality O 0 2.973508799186675e-07
. O 0 1.9805594941857407e-09

We O 0 1.7515811023827155e-10
describe O 0 5.110424236565159e-12
the O 0 3.0859373216507446e-12
outcome O 0 8.010241775435745e-11
of O 0 2.610535398961389e-10
a O 0 3.5461671793468597e-11
5 O 0 4.340831305515991e-10
- O 0 8.333493617396215e-12
year O 0 1.3167337012398583e-11
- O 0 1.5542438169813266e-10
old O 0 1.3169284551750593e-09
girl O 0 1.4976724027615518e-10
with O 0 1.101136404280112e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.6974130989666492e-09
was O 0 7.234966792335484e-11
first O 0 3.2184168524684864e-12
seen O 0 1.1243496585155999e-11
at O 0 1.0733081957925439e-11
5 O 0 7.202510723253175e-12
months O 0 1.6540269859050688e-13
of O 0 4.54085987561248e-12
age O 0 1.1775175452755082e-11
with O 0 2.6129088042531334e-12
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 5.442675998779123e-08
hepatomegaly B-Disease 1 1.0
, O 0 5.8667801567935385e-06
encephalopathy B-Disease 1 1.0
, O 0 2.713650104624321e-08
and O 0 2.6192369659838732e-06
hypotonia B-Disease 1 1.0
. O 0 4.638619793695398e-05

Biochemical O 0 2.4789144958958786e-07
studies O 0 1.1899824237104895e-08
indicated O 0 0.16447299718856812
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.0001112305762944743
by O 0 5.94703244982675e-11
a O 0 6.843559607894178e-10
stable O 0 1.9704101816842012e-07
yet O 0 1.0730758503996185e-09
inactive O 0 1.3727447623068656e-08
enzyme O 0 1.4435957984559877e-09
. O 0 2.064364013065756e-09

Molecular O 0 1.3750377725330054e-08
genetic O 0 2.4666848563725807e-09
analysis O 0 4.533281736107675e-11
of O 0 1.1948129596817125e-08
her O 0 2.5050850283037107e-09
VLCAD O 0 0.06578521430492401
gene O 0 4.732546798891235e-09
revealed O 0 4.2134373767765965e-10
a O 0 3.4977607615838124e-11
T1372C O 0 7.949183533639825e-10
( O 0 1.5434329161956306e-12
F458L O 0 3.9195879875109085e-10
) O 0 1.311101943159143e-12
missense O 0 1.8610389895812318e-09
mutation O 0 1.4209269871834351e-10
and O 0 3.749358809534975e-11
a O 0 1.112751224496833e-09
1668 O 0 4.055842964589829e-06
ACAG O 0 0.00028243500855751336
1669 O 0 6.369437869579997e-06
splice O 0 2.7811756808659993e-06
site O 0 7.935587831298108e-08
mutation O 0 3.026786998816533e-08
. O 0 8.55462545246155e-09

After O 0 2.2063731397459208e-10
initial O 0 4.1114470161751626e-10
treatment O 0 5.207822714736743e-11
with O 0 1.3932456533957693e-12
intravenous O 0 1.4211926080420767e-10
glucose O 0 4.4092441697785034e-08
and O 0 1.3103318343560266e-12
carnitine O 0 1.2795618731242797e-10
, O 0 6.894773651750646e-14
the O 0 1.5068543201407492e-12
patient O 0 3.0632323066992484e-11
has O 0 2.2031736244404465e-13
thrived O 0 1.1104200024758537e-11
on O 0 1.1109835273970248e-11
a O 0 7.558929177031715e-12
low O 0 3.5882594673353196e-09
- O 0 4.4261255771615993e-10
fat O 0 1.99596361660781e-09
diet O 0 2.8123917084066363e-10
supplemented O 0 6.007369623452219e-13
with O 0 2.0153190639742025e-14
medium O 0 4.547364984563984e-10
- O 0 1.5879486614522875e-10
chain O 0 2.3136765836540008e-09
triglyceride O 0 4.208660531190844e-09
oil O 0 5.820893073105182e-11
and O 0 2.678241526124503e-12
carnitine O 0 9.308155357601322e-10
and O 0 2.2093282064927777e-11
avoidance O 0 6.414164488433016e-08
of O 0 4.304589129588976e-09
fasting O 0 6.284766129738273e-08
. O 0 3.79425335594874e-09

Her O 0 1.1630212611635216e-05
ventricular O 1 0.9999942779541016
hypertrophy O 0 0.29196596145629883
resolved O 0 1.6606544761543773e-07
significantly O 0 3.3296261581217124e-11
over O 0 8.214221837443691e-12
1 O 0 3.564886164042491e-10
year O 0 2.039197586831132e-12
, O 0 1.1667588553296304e-12
and O 0 9.930491325083057e-12
cognitively O 0 1.6740010266858008e-08
, O 0 1.7286090094048578e-12
she O 0 1.5961518131518693e-12
is O 0 1.0225093748051847e-13
in O 0 4.180330669296961e-13
the O 0 2.3876142382639465e-11
superior O 0 5.26034660275343e-10
range O 0 1.4492175515190553e-10
for O 0 3.3452473430228835e-11
age O 0 6.810189745465323e-09
. O 0 1.1035511171542112e-08

Clinical O 0 2.648757231327181e-07
recognition O 0 1.216825324945603e-07
of O 1 0.9990065693855286
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 2.0199770744966372e-09
important O 0 2.4316057847806327e-11
because O 0 3.376655237970899e-13
it O 0 5.528473932445675e-14
is O 0 5.224658799671787e-14
one O 0 4.7818862178349367e-14
of O 0 3.3983808822579675e-11
the O 0 4.067368317151043e-11
few O 0 3.4715078034430746e-11
directly O 0 3.2375296887821037e-11
treatable O 1 0.9978736639022827
causes O 0 5.783578616025409e-10
of O 0 1.0825414875625938e-07
cardiomyopathy B-Disease 1 1.0
in O 0 1.1363020036014859e-07
children O 0 1.7864074108864259e-10
. O 0 2.7237276323255344e-10
. O 0 1.1877510530666768e-08

Cloning O 0 9.553427382513746e-09
of O 0 1.335647925593264e-09
a O 0 7.298652134057892e-12
novel O 0 9.881762942642869e-12
member O 0 1.6541644790035726e-11
of O 0 5.473193009919441e-10
the O 0 1.0919677384535476e-09
low O 0 3.1283523327374496e-08
- O 0 4.150464694152589e-10
density O 0 3.6600067421233007e-10
lipoprotein O 0 2.1763473512237397e-07
receptor O 0 1.6713456174599628e-09
family O 0 1.6742612851672334e-10
. O 0 5.346919351723045e-09

A O 0 2.8617974656697243e-09
gene O 0 2.810935728972397e-12
encoding O 0 7.418181737287033e-13
a O 0 2.582413232907199e-12
novel O 0 2.3575653148449893e-12
transmembrane O 0 6.748517716870239e-11
protein O 0 1.3268205978356207e-11
was O 0 1.037814625903799e-11
identified O 0 1.0521961177779177e-13
by O 0 1.3308738368354809e-14
DNA O 0 4.838145400802574e-13
sequence O 0 2.188488851403124e-14
analysis O 0 6.65950855658487e-15
within O 0 2.420959483231955e-13
the O 0 5.7401414350899405e-12
insulin B-Disease 1 0.9999984502792358
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 6.308455979819882e-10
IDDM B-Disease 0 2.262161387989181e-06
) O 0 6.838486482814432e-13
locus O 0 9.032995185176418e-11
IDDM4 O 0 2.8222983061709783e-08
on O 0 1.0687333240610997e-09
chromosome O 0 3.0958227092980906e-09
11q13 O 0 3.537296322519978e-08
. O 0 4.5049111108141915e-09

Based O 0 2.687526867717338e-10
on O 0 1.5373271544660838e-09
its O 0 5.085466422971585e-11
chromosomal O 0 3.746926680037177e-08
position O 0 1.7636707649870687e-09
, O 0 3.2515260015714142e-12
this O 0 4.272369133820342e-13
gene O 0 5.308256438574244e-12
is O 0 9.899505125149019e-14
a O 0 1.1408788410521842e-13
candidate O 0 1.8975779606487941e-13
for O 0 1.1860728599353415e-13
conferring O 0 2.047428004914309e-09
susceptibility O 0 8.466598160339345e-07
to O 0 7.417004233012392e-10
diabetes B-Disease 1 1.0
. O 0 2.963050960147484e-08

The O 0 1.7888845960101207e-08
gene O 0 1.2180920716531318e-09
, O 0 2.1007659153915448e-11
termed O 0 1.6831439575426543e-09
low O 0 2.7081212827795298e-09
- O 0 2.95183252840836e-11
density O 0 2.8169000118594134e-11
lipoprotein O 0 1.0382843196321545e-10
receptor O 0 1.856845189759926e-12
related O 0 3.701726425386909e-12
protein O 0 2.210230089227938e-11
5 O 0 3.143721671872157e-10
( O 0 7.731359633446691e-14
LRP5 O 0 1.4302758977180474e-09
) O 0 1.4672264054757522e-14
, O 0 1.0437863342204444e-14
encodes O 0 4.244264580630444e-14
a O 0 9.104249472369208e-13
protein O 0 1.0463892773093786e-11
of O 0 9.302901227137284e-10
1615 O 0 4.2578264469739224e-08
amino O 0 6.742113534130567e-10
acids O 0 9.049298853661125e-13
that O 0 1.705339733629966e-14
contains O 0 6.81112135550617e-14
conserved O 0 1.1563174463075088e-12
modules O 0 6.100752715509916e-12
which O 0 7.134536153053164e-14
are O 0 1.5375519935478983e-14
characteristic O 0 4.419644858422167e-11
of O 0 5.134395686390292e-10
the O 0 2.4631716111223056e-10
low O 0 6.095028037833572e-09
- O 0 3.9867584927799626e-11
density O 0 1.4478713367127583e-11
lipoprotein O 0 5.6996634079098385e-09
( O 0 1.2208145085124134e-11
LDL O 0 2.8000682661399878e-08
) O 0 3.557017310903965e-12
receptor O 0 5.959272658673243e-11
family O 0 4.1808136813648034e-11
. O 0 8.605975931885723e-10

These O 0 3.26303394027061e-11
modules O 0 4.2269684974449717e-10
include O 0 1.6542874708980193e-11
a O 0 5.747481050116798e-12
putative O 0 3.584014682256331e-11
signal O 0 5.891148679992853e-11
peptide O 0 2.191766082862423e-12
for O 0 4.3811498482912437e-13
protein O 0 7.1250514169229895e-12
export O 0 1.0849832837722673e-10
, O 0 2.420839407841352e-13
four O 0 1.9607408145022598e-12
epidermal O 0 3.59763940860347e-10
growth O 0 1.6672814170948236e-11
factor O 0 7.96556288810979e-13
( O 0 1.0893860141227008e-13
EGF O 0 7.054978129472644e-11
) O 0 2.0058200976905138e-14
repeats O 0 1.6911347539352861e-12
with O 0 1.3010916671309103e-13
associated O 0 2.1381302978129568e-11
spacer O 0 4.433958478156086e-10
domains O 0 1.6795001500646833e-10
, O 0 3.0975326470450426e-11
three O 0 1.2503428847843168e-10
LDL O 0 1.2271383909023825e-08
- O 0 6.502751670467433e-10
receptor O 0 8.31843881970995e-12
( O 0 2.541880822579806e-13
LDLR O 0 1.5107366024835756e-08
) O 0 8.922261529858283e-14
repeats O 0 7.097056883148545e-12
, O 0 4.4950311918826036e-13
a O 0 2.124369040054641e-12
single O 0 1.1423366592933082e-11
transmembrane O 0 3.398627212991556e-11
spanning O 0 2.6540536435248896e-10
domain O 0 7.146018221604322e-10
, O 0 1.582064861060939e-11
and O 0 2.479039890035395e-11
a O 0 2.9467431272856004e-10
cytoplasmic O 0 1.3158493850085051e-08
domain O 0 9.566957004381038e-09
. O 0 3.57093110636697e-09

The O 0 2.0251626153822144e-08
encoded O 0 4.64233707031525e-10
protein O 0 1.023309437186981e-09
has O 0 1.8468423405165746e-12
a O 0 7.945958344426907e-13
unique O 0 4.566342963474579e-12
organization O 0 2.0614739082436273e-11
of O 0 3.4953500094303536e-09
EGF O 0 1.8526291967191355e-07
and O 0 1.559987833354981e-10
LDLR O 0 2.9432744668156374e-06
repeats O 0 6.949079978113559e-09
; O 0 1.3520300330693846e-11
therefore O 0 5.961455634695412e-11
, O 0 9.747338353127688e-12
LRP5 O 0 2.960305437227362e-06
likely O 0 3.2324823373564016e-11
represents O 0 1.065215081939852e-12
a O 0 8.2661774560705e-13
new O 0 3.2614392957153182e-12
category O 0 6.182641065777261e-10
of O 0 1.9889483393598084e-09
the O 0 1.4606633236269317e-08
LDLR O 0 0.0004720280412584543
family O 0 7.011575320348129e-09
. O 0 1.9470078882477537e-08

Both O 0 7.640460708557839e-09
human O 0 2.2128782362074162e-08
and O 0 9.037824377777781e-10
mouse O 0 3.735228233381349e-07
LRP5 O 0 0.00022003894264344126
cDNAs O 0 2.268915295644547e-06
have O 0 5.675328540455382e-10
been O 0 6.258106532985863e-11
isolated O 0 8.191731182272122e-10
and O 0 2.593718816112922e-11
the O 0 2.5480301202307487e-10
encoded O 0 3.1314756343547856e-11
mature O 0 7.613715213850014e-11
proteins O 0 9.858978867668955e-13
are O 0 4.9966751385337876e-14
95 O 0 4.614764126387172e-11
% O 0 2.9721353416584106e-12
identical O 0 1.3682805756476402e-11
, O 0 2.575073401039907e-13
indicating O 0 9.619805819982563e-12
a O 0 9.709109601366284e-13
high O 0 1.1407362901505458e-11
degree O 0 3.087229916154399e-10
of O 0 6.445181888192764e-11
evolutionary O 0 3.602672327129852e-10
conservation O 0 3.7943381769878215e-10
. O 0 1.0608583456139797e-11
. O 0 6.535154639664142e-10

The O 0 1.4691832461721788e-07
APC B-Disease 0 5.3934751775841505e-08
variants O 0 8.550543051377701e-10
I1307K O 0 6.359367699104723e-09
and O 0 2.7686988118835743e-11
E1317Q O 0 4.265521713620046e-09
are O 0 1.7424093851775568e-12
associated O 0 7.80700892821784e-10
with O 0 2.6840671125683002e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 3.1452870863368787e-10
but O 0 1.8048243021623334e-12
not O 0 9.19296214672849e-13
always O 0 4.010659426095797e-12
with O 0 1.4837183402467008e-13
a O 0 4.708637299510876e-11
family O 0 5.367858935123593e-12
history O 0 1.1730594273728912e-10
. O 0 1.5430851041386973e-09

Classical O 1 0.9967831373214722
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.032750464626588e-05
FAP B-Disease 0 1.963650902325753e-06
) O 0 1.5448643883239632e-12
is O 0 1.8615392159606475e-13
a O 0 8.700140434469983e-12
high O 0 0.0006056936690583825
- O 1 0.9999932050704956
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999947547912598
that O 0 5.732785665450713e-13
predisposes O 0 1.4396890797574446e-12
to O 0 3.8303097537250794e-14
hundreds O 0 1.9294063417253648e-13
or O 0 7.587898001983409e-14
thousands O 0 1.0716751921643897e-12
of O 0 3.3864034776343033e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.4554296135902405
carcinoma I-Disease 1 1.0
and O 0 7.875713275984353e-11
that O 0 2.3440543126321267e-13
results O 0 6.776943155956117e-12
from O 0 1.261129221885593e-12
truncating O 0 6.322971590755344e-10
mutations O 0 1.7649568872374344e-12
in O 0 4.382038135131161e-12
the O 0 6.228969007260332e-10
APC B-Disease 0 1.8181093963676176e-08
gene O 0 3.726093211753323e-09
. O 0 5.0139106200219885e-09

A O 0 1.1377263575695906e-08
variant O 0 7.248939226656148e-09
of O 0 2.494119577534093e-09
FAP B-Disease 0 3.240469368392951e-07
is O 0 1.185622156008037e-10
attenuated B-Disease 0 0.015392852015793324
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 1.2943567329060102e-09
which O 0 5.333219217813767e-13
results O 0 6.086933040938547e-12
from O 0 2.8650209375064017e-12
germ O 0 6.603737574550905e-07
- O 0 1.3984046143278306e-09
line O 0 3.173894203012395e-10
mutations O 0 5.646437093928536e-13
in O 0 6.47627838943482e-13
the O 0 1.1650472253599276e-11
5 O 0 1.2671971805211513e-10
and O 0 1.2552042738533942e-12
3 O 0 2.9869254292158587e-10
regions O 0 3.1503122333020883e-10
of O 0 1.6601590102638397e-09
the O 0 7.557296122229218e-09
APC B-Disease 0 6.370575533765077e-08
gene O 0 2.933112863701126e-09
. O 0 2.325218462218004e-09

Attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.0074477242305874825
have O 0 2.1497845170692642e-11
" O 0 1.1435121599623344e-10
multiple O 0 2.7497883081650798e-08
" O 1 0.9999861717224121
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 8.681977359259463e-11
typically O 0 3.458717036733394e-12
fewer O 0 1.5542303772111965e-12
than O 0 1.0444560662311794e-13
100 O 0 8.891216755901876e-12
) O 0 2.127984102134623e-14
without O 0 1.029441072317172e-12
the O 0 5.936512132570515e-12
florid O 0 1.0625138546771495e-09
phenotype O 0 5.160233351730881e-11
of O 0 5.672035757742222e-11
classical O 0 5.3868852489813435e-08
FAP B-Disease 0 8.310460088978289e-07
. O 0 4.80414996673062e-09

Another O 0 3.734097031582451e-09
group O 0 6.252812156937182e-10
of O 0 4.6731578606795665e-09
patients O 0 1.8476474517026276e-10
with O 0 1.2538069540934949e-12
multiple O 0 1.9826845942816362e-08
adenomas B-Disease 1 0.9999793767929077
has O 0 1.627708384743798e-11
no O 0 2.7430736501687925e-11
mutations O 0 2.48923039299076e-12
in O 0 9.883704965574225e-12
the O 0 5.423768101309179e-10
APC B-Disease 0 1.5555970955816179e-09
gene O 0 7.130952078826525e-12
, O 0 6.193064724241415e-13
and O 0 3.3313395444989347e-12
their O 0 1.0746785406023918e-11
phenotype O 0 7.99314850419286e-11
probably O 0 1.7560216518733296e-12
results O 0 7.405655949588308e-13
from O 0 3.800619487095286e-13
variation O 0 9.449507842873572e-10
at O 0 1.2476659705384918e-09
a O 0 2.6421677346011307e-11
locus O 0 7.223880521545212e-11
, O 0 1.308054576112938e-12
or O 0 4.248365168772056e-13
loci O 0 6.04886713634345e-12
, O 0 6.528864905305798e-13
elsewhere O 0 3.2375896668462856e-12
in O 0 1.6482395960235041e-12
the O 0 6.56300638834928e-11
genome O 0 5.879521869367466e-10
. O 0 1.8441417282133443e-09

Recently O 0 5.046848716716568e-09
, O 0 1.0336600499150084e-11
however O 0 7.908977292525599e-12
, O 0 6.084654806913503e-13
a O 0 3.77827326716873e-12
missense O 0 2.209001870312477e-09
variant O 0 1.6347790898763037e-09
of O 0 6.994213919142567e-08
APC B-Disease 0 1.0418103713050186e-08
( O 0 1.5592039378370393e-12
I1307K O 0 9.215851415333987e-10
) O 0 5.526747679299171e-13
was O 0 1.0649434459275575e-11
described O 0 8.396446515498979e-13
that O 0 5.12506813856871e-15
confers O 0 2.3347476296037284e-12
an O 0 7.677656452865524e-16
increased O 0 4.173465826401435e-12
risk O 0 8.698030740106333e-09
of O 0 0.0072572785429656506
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 3.8628315823796555e-11
including O 0 6.678666647497167e-11
multiple O 0 8.368296278149501e-08
adenomas B-Disease 1 0.9999933242797852
, O 0 1.8994601724831028e-10
in O 0 2.3592074072098512e-08
Ashkenazim O 0 0.00011051102046621963
. O 0 7.786108113805312e-08

We O 0 6.844473876554957e-10
have O 0 5.646470162094797e-13
studied O 0 4.465688235866239e-12
a O 0 1.5299942302676728e-12
set O 0 5.331861688273598e-11
of O 0 9.501585282456482e-12
164 O 0 1.6633054655823543e-10
patients O 0 2.3974333802911918e-12
with O 0 3.2874579794506253e-12
multiple O 1 0.9999978542327881
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 2.994127257238688e-08
/ I-Disease 1 0.997730553150177
or I-Disease 0 2.781295052045607e-06
carcinoma I-Disease 1 1.0
and O 0 9.716536464310366e-10
analyzed O 0 1.8402405987938408e-10
codons O 0 4.603153413995642e-10
1263 O 0 8.277254437416559e-09
- O 0 9.204432771525717e-10
1377 O 0 5.743651665390814e-10
( O 0 1.3340825839869286e-12
exon O 0 2.4756438565809447e-10
15G O 0 3.0859537147875926e-09
) O 0 1.0554060338348326e-13
of O 0 1.7596032270139617e-11
the O 0 9.302843217984247e-11
APC B-Disease 0 1.1274770006508561e-10
gene O 0 6.148070334083267e-13
for O 0 2.3056333318255406e-12
germ O 0 1.5168917855135078e-07
- O 0 1.4019867933257046e-08
line O 0 3.6831604433018583e-09
variants O 0 4.541845566308211e-09
. O 0 2.896895834325619e-09

Three O 0 8.928226158388952e-09
patients O 0 2.9974595722181974e-11
with O 0 8.930013304341011e-13
the O 0 2.115487646170422e-10
I1307K O 0 2.913058461118112e-09
allele O 0 2.5163940375882987e-11
were O 0 7.890249217878953e-12
detected O 0 4.63524531257864e-12
, O 0 1.9922476483195256e-13
each O 0 8.424836349385512e-14
of O 0 4.832748090599637e-10
Ashkenazi O 0 6.429251797612778e-09
descent O 0 2.8025047171809092e-08
. O 0 3.1588538007554234e-08

Four O 0 6.032851729287358e-08
patients O 0 2.3244826063972823e-09
had O 0 3.188730113290461e-10
a O 0 2.3562099493723565e-10
germ O 0 1.2251047110112268e-06
- O 0 7.753486741535198e-09
line O 0 2.654834796445016e-09
E1317Q O 0 7.571046012344596e-09
missense O 0 1.179324193856246e-08
variant O 0 1.974362451306888e-09
of O 0 1.0075506651219257e-08
APC O 0 8.790724814744522e-10
that O 0 3.255247633948688e-13
was O 0 4.111241208581973e-11
not O 0 1.5125780402497346e-13
present O 0 8.728958853475299e-13
in O 0 8.995915991294456e-13
controls O 0 8.166878839865888e-10
; O 0 2.2697134156954984e-13
one O 0 4.908564874006593e-13
of O 0 1.1148262174520696e-10
these O 0 5.819366798338887e-13
individuals O 0 1.8831736571609664e-13
had O 0 5.901247546180599e-11
an O 0 1.6524314468829848e-13
unusually O 0 1.127149675678174e-11
large O 0 3.185049663248507e-12
number O 0 9.565086916962784e-11
of O 0 3.196180387021741e-08
metaplastic B-Disease 0 0.00020717074221465737
polyps I-Disease 0 5.5068001529434696e-05
of I-Disease 0 3.214525179373595e-07
the I-Disease 0 3.7228126359423186e-08
colorectum I-Disease 0 1.0368523362558335e-05
. O 0 1.7703996491036378e-07

There O 0 2.2119024389866127e-09
is O 0 3.719129171297908e-12
increasing O 0 2.8197854207850925e-12
evidence O 0 3.870160268648615e-12
that O 0 1.1688826820246533e-14
there O 0 8.450425553535243e-14
exist O 0 2.8701184224405596e-12
germ O 0 2.4908488605035473e-09
- O 0 6.614379877145637e-11
line O 0 3.1949321660507124e-11
variants O 0 6.768288186853599e-12
of O 0 1.8545959212801222e-10
the O 0 3.218174615682301e-10
APC B-Disease 0 1.428313245455115e-09
gene O 0 2.5390716005407876e-12
that O 0 2.374947738741518e-14
predispose O 0 1.9145777086122806e-13
to O 0 4.589947450844281e-15
the O 0 5.820151760711767e-14
development O 0 1.3635772198872242e-12
of O 0 3.0070109596769257e-11
multiple O 1 0.9971828460693359
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9991266131401062
carcinoma I-Disease 1 1.0
, O 0 6.539178920572652e-11
but O 0 1.3325871439304193e-12
without O 0 1.5743286882474727e-11
the O 0 1.5591123878055946e-11
florid O 0 5.57436485859597e-10
phenotype O 0 3.379672193146166e-12
of O 0 5.386689358455321e-12
classical O 0 6.284512021892397e-09
FAP B-Disease 0 5.893177057458843e-09
, O 0 1.1089246247609694e-13
and O 0 3.0137818510331954e-14
possibly O 0 1.1459902613723903e-14
with O 0 7.80397765266311e-16
importance O 0 3.617750890527738e-11
for O 0 2.255328809042112e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 1.4769153722227202e-07
in O 0 5.461380046117847e-13
the O 0 9.022860583685066e-13
general O 0 9.521214545948897e-12
population O 0 1.9926084165924202e-13
. O 0 3.7227629832992104e-12
. O 0 6.833894561353304e-10

Genomic O 0 1.3014772370922856e-08
structure O 0 9.934140177136896e-10
of O 0 3.6340741527141063e-10
the O 0 4.219090909973744e-10
human O 0 0.08829762041568756
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 4.535909465630539e-05
CLD B-Disease 1 0.9999998807907104
) O 0 3.890398558858976e-10
gene O 0 6.236937633019579e-09
. O 0 9.319119698147915e-09

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.02536119520664215
CLD B-Disease 1 1.0
) O 0 5.23709591318533e-12
is O 0 2.7078420885770504e-13
caused O 0 2.5013001652557376e-12
by O 0 1.1337246652544028e-13
mutations O 0 5.656278397048187e-13
in O 0 1.3607479943181233e-12
a O 0 3.1132269071726393e-12
gene O 0 1.3237461257351035e-12
which O 0 1.3088374785016899e-13
encodes O 0 7.033057946789767e-13
an O 0 2.480730735849451e-13
intestinal O 0 8.336241990036797e-07
anion O 0 1.5665760244587545e-08
transporter O 0 5.769944166900132e-08
. O 0 1.128536042394046e-09

We O 0 2.305355462084435e-09
report O 0 2.716882621656147e-11
here O 0 3.9633743335876215e-12
the O 0 1.1728635640820273e-12
complete O 0 1.3732881498640381e-10
genomic O 0 4.477524573331948e-09
organization O 0 5.671238478832663e-10
of O 0 1.436534113885557e-09
the O 0 5.506196609772473e-10
human O 0 2.157789280587963e-09
CLD B-Disease 0 1.557651671646454e-06
gene O 0 8.166298193224009e-11
which O 0 2.3725958264025904e-12
spans O 0 1.7170268679089773e-11
approximately O 0 2.643930647333592e-12
39kb O 0 1.2456311537789588e-08
, O 0 6.381353778728283e-11
and O 0 1.878405347932599e-10
comprises O 0 1.3469819926115179e-08
21 O 0 6.087235533414059e-07
exons O 0 2.2469290342996828e-05
. O 0 1.6571013361499354e-07

All O 0 7.965153869804453e-09
exon O 0 1.4121991398496903e-07
/ O 0 9.837640924104107e-09
intron O 0 8.78615313837372e-09
boundaries O 0 9.159930591806642e-10
conform O 0 1.0763017560533328e-10
to O 0 6.965046161350186e-12
the O 0 4.0054495831221004e-10
GT O 0 1.2454432862796239e-06
/ O 0 1.841629853061022e-07
AG O 0 2.482198169673211e-06
rule O 0 4.065008951670279e-08
. O 0 8.215268465505687e-09

An O 0 3.6511063269961674e-12
analysis O 0 3.4812994501032257e-12
of O 0 1.6014419790266743e-09
the O 0 1.1089522633511706e-09
putative O 0 1.4288334959644544e-09
promoter O 0 1.0092066737854566e-08
region O 0 5.988468054773932e-10
sequence O 0 1.2187584275125118e-10
shows O 0 1.7838341914711009e-09
a O 0 4.081368132347052e-09
putative O 0 1.556335860186664e-07
TATA O 0 9.27429209696129e-06
box O 0 4.834993561075862e-08
and O 0 3.6706034045597136e-11
predicts O 0 6.898681625955305e-10
multiple O 0 5.760939988941338e-11
transcription O 0 1.6296921589997737e-09
factor O 0 3.7774916528121594e-10
binding O 0 1.6565680771574165e-10
sites O 0 9.662201039262186e-10
. O 0 1.7902559434901377e-09

The O 0 5.128858227010369e-09
genomic O 0 1.503997459906259e-08
structure O 0 1.0093895497220728e-08
was O 0 7.639641141921061e-10
determined O 0 2.54390102732982e-11
using O 0 9.85798248587244e-13
DNA O 0 8.012607070895239e-12
from O 0 2.446844810100046e-13
several O 0 2.790096983746465e-13
sources O 0 9.920037881416821e-13
including O 0 6.079839865065495e-13
multiple O 0 3.8412897862549755e-11
large O 0 3.0873668066533355e-09
- O 0 4.928180974417273e-09
insert O 0 2.0315606974463662e-09
libaries O 0 1.7038786381817772e-08
and O 0 4.111733089423586e-12
genomic O 0 5.208036224502166e-09
DNA O 0 8.290285125056585e-10
from O 0 3.001945220182378e-11
Finnish O 0 1.7338654288323596e-05
CLD B-Disease 1 0.9999980926513672
patients O 0 2.017332789705506e-08
and O 0 1.4374084145174493e-09
controls O 0 1.221842467202805e-05
. O 0 1.0003701333971549e-07

Exon O 0 8.570860927648027e-07
- O 0 9.698167824367943e-10
specific O 0 3.141562010533505e-11
primers O 0 1.7112571082389394e-10
developed O 0 7.1193727996243794e-12
in O 0 4.416084197541442e-13
this O 0 5.3578699772205765e-14
study O 0 3.201393550212803e-14
will O 0 1.5373468421680733e-14
facilitate O 0 7.125237899696657e-13
mutation O 0 3.0133808317546473e-13
screening O 0 6.627329978206586e-13
studies O 0 6.004033126791666e-14
of O 0 4.056357246623454e-12
patients O 0 1.3602029658860149e-12
with O 0 2.9106255708573336e-13
the O 0 8.458542311018391e-09
disease O 0 0.019233807921409607
. O 0 8.380688143461157e-09

Genomic O 0 6.986531353447845e-09
sequencing O 0 1.021832951586532e-09
of O 0 8.851837485224223e-09
a O 0 1.9426604325190056e-08
BAC O 0 3.530662434059195e-05
clone O 0 1.1775123311963398e-06
H O 1 1.0
_ O 0 7.886295783077202e-11
RG364P16 O 0 3.91223831108789e-10
revealed O 0 1.936564450466527e-11
the O 0 1.3592227387018707e-12
presence O 0 4.718180056720311e-13
of O 0 5.246596213037691e-11
another O 0 1.4174289346413627e-11
, O 0 2.661452221802696e-12
highly O 0 1.0817055584588786e-11
homologous O 0 8.318248000127593e-12
gene O 0 3.3908317126352117e-11
3 O 0 8.656487970881699e-09
of O 0 1.4849592666621447e-08
the O 0 2.8819403752322614e-08
CLD B-Disease 0 2.0744850189657882e-05
gene O 0 1.4146478433119114e-10
, O 0 1.4838209870873809e-12
with O 0 4.850600715360087e-13
a O 0 9.191703821687103e-12
similar O 0 3.676669212138162e-12
genomic O 0 1.4563507066966963e-09
structure O 0 3.437184536991822e-09
, O 0 2.0821400159576342e-12
recently O 0 1.3336404897090759e-11
identified O 0 2.285771615387344e-12
as O 0 3.9950920176223814e-12
the O 0 1.2879250554931332e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 2.6215353443603817e-08
( O 0 4.5592432607044486e-11
PDS B-Disease 0 1.0784521009554737e-06
) O 0 3.795044140053605e-12
. O 0 5.0221556080476404e-11
. O 0 1.6904601052303292e-09

The O 0 9.78443992494249e-09
APCI1307K O 0 1.961073576239869e-05
allele O 0 1.3429620970839551e-08
and O 0 3.676406401531551e-10
cancer B-Disease 0 1.4308873232948827e-06
risk O 0 1.2804788340758932e-08
in O 0 6.525933265999484e-11
a O 0 4.5954753891130906e-11
community O 0 3.105258064572958e-11
- O 0 6.570230470792637e-12
based O 0 2.768137498734835e-12
study O 0 5.454605517263289e-12
of O 0 8.888135366591499e-11
Ashkenazi O 0 1.8298174087050256e-10
Jews O 0 2.06899081200973e-10
. O 0 2.150221556362908e-09

Mutations O 0 4.7608756936767804e-09
in O 0 7.869110918434785e-10
APC O 0 2.8140958008293637e-08
are O 0 3.2078265824880825e-12
classically O 0 2.3914541458225358e-09
associated O 0 5.354121590528393e-10
with O 0 1.0803607786158409e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.0140952276269672e-06
FAP B-Disease 0 3.0882276860211277e-06
) O 0 3.7099167596484073e-13
, O 0 8.348726034503387e-14
a O 0 7.272235331284849e-12
highly O 0 3.6410372672435187e-07
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 6.863697876724473e-08
by O 0 9.217120339535811e-13
multiple O 0 4.0354483643589845e-10
intestinal O 1 0.9997811913490295
polyps B-Disease 0 2.0257853975635953e-05
and O 0 8.544567831059169e-12
, O 0 1.355788718055903e-13
without O 0 6.783434924884091e-12
surgical O 0 6.714130904583726e-07
intervention O 0 3.5400613551672677e-09
, O 0 3.599567475684462e-14
the O 0 2.763356763465369e-13
development O 0 7.341671715010989e-11
of O 0 2.5901519506987825e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 8.541777951620588e-09
CRC B-Disease 1 0.9963043928146362
) O 0 6.15587997243594e-11
. O 0 1.5497569894051821e-09

APC B-Disease 0 2.7115988814330194e-06
is O 0 3.1664204591663747e-10
a O 0 3.420166649892309e-10
tumour O 1 1.0
- O 0 3.064117848339265e-09
suppressor O 0 1.6792062185189138e-09
gene O 0 5.800209704892589e-12
, O 0 6.301564630349643e-14
and O 0 9.549473841893863e-13
somatic O 0 2.6480171300136135e-07
loss O 0 1.4643623202914569e-08
occurs O 0 2.4339188442468185e-09
in O 0 1.0312394493894317e-08
tumours B-Disease 1 1.0
. O 0 2.1634531321979011e-07

The O 0 3.621982500590093e-07
germline O 0 1.3449765674522496e-06
T O 0 6.68082567045758e-09
- O 0 6.360474646971426e-12
to O 0 2.020070308944577e-12
- O 0 9.836725184397821e-12
A O 0 1.6842405942130156e-11
transversion O 0 2.2268271948622242e-10
responsible O 0 1.3963323552967921e-11
for O 0 9.774160647513241e-13
the O 0 6.56343243643498e-11
APC O 0 7.185969597145458e-10
I1307K O 0 4.378850615438523e-10
allele O 0 1.3253433940596526e-11
converts O 0 1.7471026361737252e-11
the O 0 1.1041438596759434e-10
wild O 0 4.653482932326369e-09
- O 0 1.2219373950184131e-11
type O 0 7.778879103359504e-12
sequence O 0 1.4567437534029892e-11
to O 0 3.4573518093578004e-12
a O 0 1.6627535459612375e-10
homopolymer O 0 2.7508774564921623e-06
tract O 0 1.7517151036372525e-06
( O 0 2.13235106655274e-11
A8 O 0 7.205104957108688e-09
) O 0 9.09615129529237e-15
that O 0 1.16845027170508e-14
is O 0 4.4181905313120384e-13
genetically O 0 2.94505198006334e-10
unstable O 0 7.759089482028969e-10
and O 0 3.8074601804716224e-10
prone O 0 6.781106520747926e-08
to O 0 3.358912037398909e-10
somatic O 0 0.0005977496621198952
mutation O 0 2.462411714532209e-07
. O 0 6.669087948552033e-09

The O 0 1.7243120709053983e-08
I1307K O 0 1.7594649293073417e-08
allele O 0 3.499484313440604e-10
was O 0 1.053774845161115e-09
found O 0 1.0271077391377226e-11
in O 0 3.5511486112804747e-11
6 O 0 1.7281007558267447e-07
. O 0 2.0734647776521342e-08

1 O 0 1.6036138106301223e-07
% O 0 2.9001451240517895e-10
of O 0 3.0674567330635227e-09
unselected O 0 3.2517611998628126e-06
Ashkenazi O 0 6.221017478935664e-09
Jews O 0 2.6414886944436944e-10
and O 0 2.2937781882226282e-11
higher O 0 3.4808381177420245e-10
proportions O 0 1.292642104466779e-09
of O 0 2.1243545234028716e-06
Ashkenazim O 0 6.525938806589693e-05
with O 0 5.825427917827142e-10
family O 0 5.197475227980419e-10
or O 0 3.92303377283465e-11
personal O 0 1.872575650097019e-09
histories O 0 6.693685605796418e-08
of O 1 0.9999858140945435
CRC B-Disease 1 1.0
( O 0 2.502123230829767e-10
ref O 0 2.9882905039357865e-08
. O 0 6.331053736818859e-11
2 O 0 5.0154507214017485e-09
) O 0 6.362294371897725e-12
. O 0 3.547684368498949e-10

To O 0 3.8547210562400736e-11
evaluate O 0 8.695301423333746e-11
the O 0 1.0258918714534104e-11
role O 0 2.520985156739819e-12
of O 0 5.366479136070801e-11
I1307K O 0 5.254853885361399e-09
in O 0 1.8272992841072977e-10
cancer B-Disease 0 8.636714454723915e-09
, O 0 2.3623018471918833e-11
we O 0 3.584630162145608e-11
genotyped O 0 1.0984297915683783e-07
5 O 0 1.5466946479136823e-07
, O 0 5.609958053653941e-10
081 O 0 4.311782959121047e-06
Ashkenazi O 0 3.084341670955837e-09
volunteers O 0 2.698646341114941e-11
in O 0 1.1541961830729974e-11
a O 0 3.697191164331315e-11
community O 0 5.859490670445666e-11
survey O 0 1.833318719057786e-09
. O 0 1.641159563803285e-08

Risk O 0 1.3223053763056214e-08
of O 0 2.457466674599118e-09
developing O 0 9.387802492710762e-06
colorectal B-Disease 1 1.0
, I-Disease 0 2.3954088490540926e-08
breast I-Disease 0 0.00011613951937761158
and I-Disease 0 1.6027630778125967e-08
other I-Disease 0 3.504183254676718e-08
cancers I-Disease 1 0.9999994039535522
were O 0 3.494943445758736e-09
compared O 0 3.717996396868095e-11
between O 0 8.028908093926646e-10
genotyped O 0 0.015138587914407253
I1307K O 0 6.61527224110614e-07
carriers O 0 1.2226205291232528e-11
and O 0 8.627411393798134e-13
non O 0 7.61743723654007e-10
- O 0 2.4462673640229804e-12
carriers O 0 5.571622129591988e-14
and O 0 2.0175381208894193e-14
their O 0 9.65726251137694e-14
first O 0 2.3684090712933203e-12
- O 0 6.0366963164359966e-12
degree O 0 2.479974003932739e-09
relatives O 0 3.3663841159103924e-10
. O 0 8.814128871215132e-10

Sperm O 0 5.498849708907017e-10
DNA O 0 1.108334257704513e-10
analysis O 0 1.6921091264276988e-12
in O 0 1.1425893217675842e-11
a O 0 2.0633288411175954e-09
Friedreich B-Disease 1 0.9999992847442627
ataxia I-Disease 1 1.0
premutation O 1 0.99979168176651
carrier O 0 2.781268904072931e-07
suggests O 0 2.5672663994669165e-09
both O 0 5.320300797140298e-11
meiotic O 0 2.3541443283647823e-07
and O 0 5.200447711350975e-11
mitotic O 0 2.012443323096136e-09
expansion O 0 7.839358606709368e-10
in O 0 7.285595043926563e-11
the O 0 1.2316422326463794e-09
FRDA B-Disease 0 9.118571142607834e-06
gene O 0 2.5637445943971215e-08
. O 0 9.198206640803619e-09

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 1.1068691492255311e-05
usually O 0 3.5027294953415833e-10
caused O 0 2.8905733709394532e-11
by O 0 8.330464681786942e-14
an O 0 2.8161060451874914e-14
expansion O 0 1.5114498541635157e-10
of O 0 4.8302624122698035e-09
a O 0 8.899102788006985e-09
GAA O 0 5.664946343131305e-07
trinucleotide O 0 1.5406675402118708e-07
repeat O 0 2.4175219603961295e-09
in O 0 1.3960987921279866e-10
intron O 0 4.418403776185187e-08
1 O 0 5.3465750937675693e-08
of O 0 1.3027488421357702e-08
the O 0 1.653116576960656e-08
FRDA B-Disease 0 3.158625986543484e-05
gene O 0 2.8701023779831303e-08
. O 0 6.941118790848577e-09

Occasionally O 0 2.62147530349921e-08
, O 0 1.0676224487804475e-10
a O 0 4.239206555234354e-11
fully O 0 1.662347620667859e-10
expanded O 0 7.205414043198743e-11
allele O 0 5.438557937331723e-11
has O 0 1.4329005646948612e-12
been O 0 1.0645041705753533e-12
found O 0 2.9090103806708734e-13
to O 0 1.2625149406822467e-13
arise O 0 1.1392898343481894e-12
from O 0 8.205918041424842e-13
a O 0 1.6957480558632554e-11
premutation O 0 1.1059532845081321e-08
of O 0 9.917560106487144e-09
100 O 0 2.9313456106905278e-09
or O 0 4.237217868241494e-11
less O 0 1.9667879824769585e-10
triplet O 0 2.4085397853923496e-07
repeats O 0 4.3052403952970053e-07
. O 0 5.537038916259007e-08

We O 0 9.877651585554759e-09
have O 0 1.3046316631182275e-11
examined O 0 4.329996777796552e-11
the O 0 3.16109673159648e-11
sperm O 0 5.840641772308919e-12
DNA O 0 1.3824311140275825e-10
of O 0 9.260377464848091e-10
a O 0 1.5091691230040283e-09
premutation O 0 8.698247029315098e-07
carrier O 0 9.940649192685669e-08
. O 0 5.418779380761407e-08

This O 0 5.074287656725573e-10
mans O 0 3.131188464067236e-07
leucocyte O 0 1.9732000922090265e-08
DNA O 0 6.223174198183301e-10
showed O 0 1.1677352140804231e-10
one O 0 6.003234476366359e-13
normal O 0 7.429513601553417e-12
allele O 0 9.013898568527301e-13
and O 0 4.78608634928851e-13
one O 0 1.343255883043057e-13
allele O 0 1.6133781593694052e-12
of O 0 4.659250762983902e-11
approximately O 0 1.2168811097668097e-11
100 O 0 5.661025537229136e-10
repeats O 0 1.2176863073420918e-08
. O 0 2.530799214639501e-08

His O 0 6.14230488693579e-09
sperm O 0 3.568068063231067e-11
showed O 0 2.3576113283851896e-11
an O 0 3.403350938200288e-14
expanded O 0 2.5593667810075438e-12
allele O 0 1.0174211299840419e-11
in O 0 2.1175049561006354e-11
a O 0 2.8871255386420103e-10
tight O 0 1.17274288058411e-08
range O 0 6.509278671629204e-10
centering O 0 2.93758906089181e-11
on O 0 2.0667505207239145e-10
a O 0 5.7425284145928845e-12
size O 0 2.6767503144564664e-12
of O 0 9.836880615621268e-11
approximately O 0 1.4299533779293938e-10
320 O 0 5.778263978406528e-10
trinucleotide O 0 7.208846000139602e-07
repeats O 0 2.603845246085257e-07
. O 0 1.0724998134037378e-07

His O 0 2.07292970344497e-07
affected O 0 2.509203689271544e-08
son O 0 3.397258296899963e-08
has O 0 2.1937089644818997e-10
repeat O 0 4.6136072739955125e-09
sizes O 0 1.7397553397913157e-09
of O 0 3.636698764353241e-08
1040 O 0 2.9578787419382024e-08
and O 0 5.415932147201374e-10
540 O 0 1.0314361809093953e-08
. O 0 7.205421148626101e-09

These O 0 3.69592204063629e-11
data O 0 4.2363126895317293e-11
suggest O 0 7.610309409565585e-13
that O 0 4.415473063269998e-15
expansion O 0 7.540709051102878e-13
occurs O 0 1.3268489056767179e-14
in O 0 2.764683860805809e-14
two O 0 6.067742879325988e-14
stages O 0 3.3154956557979176e-10
, O 0 3.3754187053931795e-13
the O 0 2.038466617726442e-12
first O 0 1.814436947043807e-12
during O 0 1.990448170868797e-12
meiosis O 0 2.1051489544621216e-12
followed O 0 4.271132492822405e-12
by O 0 2.144385797403503e-12
a O 0 9.760887237364457e-11
second O 0 4.999364255908745e-10
mitotic O 0 3.118641345167816e-08
expansion O 0 6.127621787754833e-08
. O 0 1.720379749770018e-08

We O 0 7.547584224276704e-10
also O 0 2.5202351056768935e-12
show O 0 9.019419325989597e-13
that O 0 2.223919392553824e-14
in O 0 2.6383176242664175e-13
all O 0 2.0324759670425907e-12
informative O 0 1.1187449404370664e-11
carrier O 0 3.747426414318911e-12
father O 0 5.829156601855345e-12
to O 0 1.5018044316819634e-12
affected O 0 6.354266071650905e-12
child O 0 3.2200008718424877e-12
transmissions O 0 1.1198685728741609e-10
, O 0 1.4005479718678937e-13
with O 0 2.6543014070316492e-14
the O 0 5.845846810098587e-12
notable O 0 8.797860877318708e-12
exception O 0 1.7146966138636976e-11
of O 0 9.24380738620556e-10
the O 0 2.1034976538381045e-10
premutation O 0 7.732854356845564e-09
carrier O 0 1.0766836033848648e-10
, O 0 8.186849635716253e-12
the O 0 2.60556940606671e-11
expansion O 0 2.2381368980362026e-10
size O 0 2.390038167376929e-11
decreases O 0 9.945414630729843e-11
. O 0 6.249076950348709e-11
. O 0 3.3764300244598644e-09

The O 0 2.3473175403410096e-08
R496H O 0 1.3471378679241752e-07
mutation O 0 1.638496893718866e-09
of O 0 4.072752357586751e-09
arylsulfatase O 0 8.224002385759377e-07
A O 0 4.0039946469505594e-08
does O 0 1.0016628151920948e-11
not O 0 5.477095860184633e-11
cause O 0 8.735140113458328e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 9.98465566226514e-07

Deficiency B-Disease 0 0.04629899561405182
of I-Disease 0 1.1999160960840527e-05
arylsulfatase I-Disease 0 0.3332451581954956
A I-Disease 0 1.9956349206040613e-05
( O 0 7.148989733529731e-10
ARSA O 0 0.00015474479005206376
) O 0 4.8371907174216133e-11
enzyme O 0 6.721451173419268e-11
activity O 0 1.623090883917655e-09
causes O 0 5.27638974290312e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 3.832119261915068e-07
MLD B-Disease 1 1.0
) O 0 4.1947140205778055e-10
. O 0 9.353929852906617e-10

A O 0 2.1130450722495198e-09
number O 0 9.542091422565235e-11
of O 0 7.428532455833192e-09
ARSA O 0 7.335900590987876e-05
gene O 0 3.995271335988093e-10
mutations O 0 1.653833146819661e-11
responsible O 0 3.1951455370382575e-11
for O 0 1.8601367668402702e-10
MLD B-Disease 1 1.0
have O 0 9.832608061088877e-10
been O 0 8.805285667268237e-11
identified O 0 7.971685533902928e-10
. O 0 4.821168353430494e-09

Recently O 0 1.2029398810398106e-08
, O 0 3.478400553702521e-11
the O 0 6.697366966568197e-11
R496H O 0 4.858119684314488e-09
mutation O 0 3.7127115271040623e-10
of O 0 6.098319182967771e-09
ARSA O 0 3.639896385720931e-05
was O 0 7.63355689770151e-09
proposed O 0 2.5850561274909367e-11
to O 0 4.845755415851249e-13
be O 0 7.34079680722588e-13
a O 0 3.901749583146152e-12
cause O 0 2.1154554497027078e-10
of O 0 8.511012339340596e-08
MLD B-Disease 1 1.0
( O 0 9.825104618776948e-11
Draghia O 0 2.2674306876524497e-07
et O 0 1.4739056553025875e-07
al O 0 1.3420755617943314e-09
. O 0 6.2084309047916175e-12
, O 0 1.7284837840539358e-12
1997 O 0 1.3304018997573053e-10
) O 0 6.1197258198475435e-12
. O 0 3.8969485971485085e-10

We O 0 3.0158595620832784e-09
have O 0 9.806565282044488e-12
investigated O 0 8.938458306850805e-11
the O 0 1.906886280822473e-11
R496H O 0 1.2728370579750958e-09
mutation O 0 5.037781823646892e-12
and O 0 3.2307774619662333e-13
found O 0 8.916885919961828e-14
this O 0 1.3437293405792541e-14
mutation O 0 7.295237547735867e-13
at O 0 9.649814801393486e-12
a O 0 2.973846483737136e-13
relatively O 0 1.6329807243833233e-13
high O 0 8.712469764735054e-14
frequency O 0 3.8209110761423457e-14
in O 0 1.0219044238742557e-14
an O 0 1.2286095374102195e-15
African O 0 1.0135946579671942e-13
American O 0 4.887168686233678e-14
population O 0 5.381631284270133e-14
( O 0 2.1162581168260135e-14
f O 0 3.145401161752659e-10
= O 0 1.8696123815775678e-10
0 O 0 1.4576867490845302e-10
. O 0 3.972045132041857e-13
09 O 0 9.56500850746167e-12
, O 0 5.2373097449587985e-14
n O 0 3.1986134661071697e-12
= O 0 1.766904678124348e-11
61 O 0 4.837374945054762e-11
subjects O 0 5.733228822246694e-11
) O 0 4.951388691415426e-12
. O 0 1.6953026482635636e-10

The O 0 1.525770926491532e-06
ARSA O 0 0.0005618641735054553
enzyme O 0 6.506830491082027e-11
activity O 0 1.2781367977887648e-11
in O 0 5.856099567942696e-13
subjects O 0 5.407834336584871e-12
with O 0 2.531208207444402e-13
and O 0 8.815162141906363e-12
without O 0 5.003606903808411e-11
the O 0 4.447584661670945e-11
R496H O 0 2.6677380304818143e-09
mutation O 0 4.221294494510808e-11
was O 0 6.125684681723698e-11
determined O 0 7.346855068757208e-11
and O 0 9.067376190163845e-12
found O 0 6.893229476806484e-12
to O 0 1.6721593727730966e-12
be O 0 3.0674539297503856e-11
normal O 0 6.546460706857715e-09
. O 0 2.3378661229145337e-09

It O 0 8.827515801668184e-11
is O 0 2.176290614733234e-12
therefore O 0 1.4807053153043093e-12
concluded O 0 2.197333027337267e-12
that O 0 2.0901117344035783e-14
the O 0 3.597971746926998e-12
R496H O 0 9.346083906791591e-10
mutation O 0 4.285668694925526e-11
of O 0 6.70218824883051e-10
ARSA O 0 2.6692873689171392e-06
does O 0 1.9649863333692785e-12
not O 0 2.876177757332038e-13
negatively O 0 1.898666702917877e-14
influence O 0 1.4754891102322643e-13
the O 0 3.809098002294231e-12
activity O 0 3.728122324742067e-11
of O 0 7.207066610170898e-10
ARSA O 0 2.8513262805063277e-05
and O 0 2.074657529105295e-10
is O 0 5.581881311333969e-12
not O 0 4.158797004688575e-12
a O 0 1.2142664651548785e-10
cause O 0 6.275171671177304e-08
of O 0 1.7068154193111695e-05
MLD B-Disease 1 1.0

Down O 0 1.949986881299992e-06
- O 0 1.803678628675698e-08
regulation O 0 3.090738687205885e-08
of O 0 6.977288968812445e-09
transmembrane O 0 1.035147192851582e-06
carbonic O 0 5.940103164903121e-07
anhydrases O 0 8.28143038233975e-06
in O 0 3.7990278656252485e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.0048500425182282925
lines O 0 4.552901944343546e-10
by O 0 1.4173396831185237e-11
wild O 0 1.0443875908094924e-05
- O 0 3.8318848538665407e-08
type O 0 3.749429424715345e-07
von B-Disease 1 0.9999932050704956
Hippel I-Disease 1 0.9999998807907104
- I-Disease 0 0.03677147626876831
Lindau I-Disease 0 0.002704164246097207
transgenes O 0 4.3400661525083706e-05
. O 0 3.680942839423551e-08

To O 0 9.449184767973406e-10
discover O 0 8.47882597465599e-10
genes O 0 4.1472974360301507e-11
involved O 0 1.9552704941250276e-11
in O 0 6.33703700625432e-10
von B-Disease 1 0.9999915361404419
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999983310699463
Lindau I-Disease 1 0.9999994039535522
( O 0 3.4466404486011015e-07
VHL B-Disease 0 0.4416009485721588
) O 0 5.72656193298382e-11
- O 0 1.0870427891163104e-09
mediated O 0 1.0340781386730669e-07
carcinogenesis O 0 7.773125980747864e-05
, O 0 8.494182440754727e-11
we O 0 1.0637300068561117e-10
used O 0 1.3126252307316122e-09
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.0029846744146198034
lines O 0 1.3074005211777262e-09
stably O 0 2.6803370190009446e-08
transfected O 0 1.5495441596513615e-09
with O 0 1.639698142888446e-12
wild O 0 1.6986646187433507e-06
- O 0 5.455813578691959e-08
type O 0 6.895596129652404e-07
VHL O 0 0.07556416839361191
- O 0 1.2713144315057434e-07
expressing O 0 3.986382779430642e-09
transgenes O 0 9.34062597934826e-07
. O 0 6.024087895184493e-09

Large O 0 4.468576975114047e-08
- O 0 1.4323371377855665e-09
scale O 0 8.731840139830638e-09
RNA O 0 3.8714781380733143e-10
differential O 0 1.0262349303680196e-10
display O 0 1.8562520964771068e-10
technology O 0 1.1761040752400476e-10
applied O 0 4.159100494560697e-11
to O 0 7.473254870840607e-13
these O 0 3.4381609430138294e-13
cell O 0 7.449297428907542e-11
lines O 0 1.986041539558947e-12
identified O 0 3.350697269557251e-13
several O 0 2.153960603629157e-13
differentially O 0 7.40164960572054e-12
expressed O 0 4.0596988119291633e-13
genes O 0 1.2219035733316425e-13
, O 0 6.461641660106265e-14
including O 0 1.4960120815754596e-12
an O 0 5.086453393893242e-12
alpha O 0 8.631313441753719e-09
carbonic O 0 3.8414253999974335e-09
anhydrase O 0 1.3974909229830246e-08
gene O 0 1.355992401697037e-10
, O 0 2.856619281399464e-11
termed O 0 3.511147639301271e-08
CA12 O 0 4.118194920010865e-05
. O 0 1.174104085066574e-07

The O 0 6.7250613966507444e-09
deduced O 0 1.7591378353998266e-10
protein O 0 1.2779198706180939e-11
sequence O 0 3.503354290695926e-12
was O 0 6.90138918235661e-11
classified O 0 3.753521365251755e-12
as O 0 7.976543904553157e-12
a O 0 7.282899283644895e-11
one O 0 1.0064970384915384e-10
- O 0 1.0835139896414603e-08
pass O 0 4.9661035284032096e-09
transmembrane O 0 3.4960585537646693e-08
CA O 0 9.738121775626496e-08
possessing O 0 1.60101754076436e-09
an O 0 1.5822822219124788e-11
apparently O 0 1.7540426888729144e-09
intact O 0 9.989812310706725e-10
catalytic O 0 1.2187678644082212e-10
domain O 0 2.376458141384319e-09
in O 0 2.660175968394185e-10
the O 0 1.7016628106603093e-09
extracellular O 0 6.685583286980545e-08
CA O 0 1.3385911188379396e-05
module O 0 2.482567651895806e-06
. O 0 2.4820904442890424e-08

Reintroduced O 0 2.1885430214751977e-06
wild O 0 1.1870977687067352e-05
- O 0 1.6961945448201732e-07
type O 0 1.5402136455122672e-07
VHL B-Disease 0 4.555234045255929e-05
strongly O 0 6.586359790894392e-10
inhibited O 0 6.153297316124906e-11
the O 0 2.1299000757535325e-11
overexpression O 0 1.135878391345102e-09
of O 0 1.7622652226378932e-09
the O 0 1.0066512068362954e-09
CA12 O 0 3.1559059721075755e-07
gene O 0 8.874798465563494e-12
in O 0 1.3945059300010665e-12
the O 0 2.793408004908571e-10
parental O 0 0.13426735997200012
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9945789575576782
lines O 0 1.1537548516571405e-07
. O 0 4.586119484173423e-09

Similar O 0 4.1384018434342806e-10
results O 0 1.231552360092536e-10
were O 0 5.768776949188759e-12
obtained O 0 1.53033282660614e-12
with O 0 3.180217807846608e-12
CA9 O 0 4.013501893496141e-06
, O 0 4.149322899160701e-11
encoding O 0 2.4979365798039055e-10
another O 0 3.296527772977953e-10
transmembrane O 0 4.160709465850232e-08
CA O 0 2.8560143050526676e-07
with O 0 9.942622246350563e-12
an O 0 3.0122977029423126e-11
intact O 0 4.267737452323672e-08
catalytic O 0 5.56012791363969e-09
domain O 0 1.0238413494789711e-07
. O 0 8.76986216979958e-09

Although O 0 4.3430839480329553e-10
both O 0 1.0020105405128543e-11
domains O 0 1.7664708584774758e-10
of O 0 2.7303363125952274e-08
the O 0 2.8411861308086372e-08
VHL B-Disease 0 9.191035701405781e-07
protein O 0 1.628122220376227e-10
contribute O 0 1.2388616608266512e-12
to O 0 1.04559080577743e-12
regulation O 0 1.4863243968932238e-09
of O 0 1.8227681586324707e-09
CA12 O 0 4.771619387611281e-06
expression O 0 3.1391216293030766e-09
, O 0 5.058859147560879e-12
the O 0 1.5770214994992315e-11
elongin O 0 2.2361492657552162e-09
binding O 0 3.1616892437469346e-10
domain O 0 2.539408683333022e-10
alone O 0 1.903397925384631e-11
could O 0 1.0335693238772148e-11
effectively O 0 2.124439929529487e-10
regulate O 0 5.321331375540694e-09
CA9 O 0 5.789439092040993e-05
expression O 0 3.653705249462291e-08
. O 0 6.756483816872105e-09

We O 0 4.152954957703514e-08
mapped O 0 4.5949562377245456e-08
CA12 O 0 1.410315599059686e-05
and O 0 7.831322257345619e-09
CA9 O 0 1.0032524187408853e-05
loci O 0 4.223873750763829e-10
to O 0 3.0248144267108756e-11
chromosome O 0 4.3888870315811346e-09
bands O 0 2.059174164514843e-08
15q22 O 0 1.0674874317828653e-07
and O 0 1.165288310289725e-09
17q21 O 0 4.05628099997557e-07
. O 0 2.0501214947898916e-08

2 O 0 2.7661586798899407e-08
respectively O 0 4.974851086636534e-10
, O 0 7.476922726790125e-12
regions O 0 5.175237460797177e-10
prone O 0 1.6081508347198792e-10
to O 0 2.598519544070449e-13
amplification O 0 7.409223928833697e-11
in O 0 2.140349876500469e-11
some O 0 3.022749758829768e-11
human O 0 1.473602839752175e-08
cancers B-Disease 0 1.14954418677371e-05
. O 0 6.326340340478964e-09

Additional O 0 2.279035016261588e-10
experiments O 0 2.5752162624570474e-09
are O 0 4.7930314231448e-12
needed O 0 4.449058742944656e-12
to O 0 1.8154607591552852e-13
define O 0 8.532597371713191e-12
the O 0 1.7268370761103213e-11
role O 0 3.4051029357273777e-11
of O 0 1.1641026809172672e-08
CA O 0 2.539668457757216e-07
IX O 0 3.1981684855963977e-08
and O 0 2.1614789125212752e-10
CA O 0 9.191087002591303e-09
XII O 0 1.5207040071629763e-09
enzymes O 0 2.8166997814021988e-12
in O 0 1.3555153093730565e-12
the O 0 1.374511181956306e-11
regulation O 0 2.372572360798131e-09
of O 0 2.84290174734636e-10
pH O 0 1.4175161044960305e-10
in O 0 4.9625642137285375e-12
the O 0 4.07725415929594e-12
extracellular O 0 8.212278947150597e-12
microenvironment O 0 6.528896867585843e-11
and O 0 3.482247313852521e-13
its O 0 7.526439866310797e-13
potential O 0 3.314259457154467e-12
impact O 0 1.7571223642764977e-10
on O 0 5.5038684720898345e-09
cancer B-Disease 0 2.504392000446387e-07
cell O 0 1.5158389032876585e-06
growth O 0 8.878897261865859e-08
. O 0 2.9568394399603903e-09

A O 0 2.5083760846200676e-08
gene O 0 1.287992490439649e-10
encoding O 0 1.15182821613935e-10
a O 0 2.043529373496611e-10
transmembrane O 0 1.901969914896995e-09
protein O 0 6.42595976430016e-11
is O 0 3.5769615215749603e-14
mutated O 0 1.5764725137291935e-13
in O 0 8.621599392527254e-14
patients O 0 7.298668613930914e-11
with O 0 6.980746536378035e-10
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.00011700610775733367
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 2.8685761321867176e-07
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 1.9748086846349544e-11
. O 0 1.2943955629562964e-10

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.5434959499980323e-06
WFS B-Disease 1 0.5433840155601501
; O 0 5.548111969844172e-10
OMIM O 0 4.515012915362604e-05
222300 O 0 2.4381656693606146e-09
) O 0 8.524861453687235e-14
is O 0 1.941606360552576e-14
an O 0 3.782893594726777e-13
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
defined O 0 8.04563967532479e-12
by O 0 5.777213627736373e-15
young O 0 5.810923167344842e-14
- O 0 1.0245133734432255e-11
onset O 1 0.9999734163284302
non O 1 0.999990701675415
- O 0 9.909751952363877e-07
immune O 0 0.009705671109259129
insulin B-Disease 1 1.0
- I-Disease 1 0.9999938011169434
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.6538578506697377e-08
progressive O 1 0.9999309778213501
optic B-Disease 1 0.9999986886978149
atrophy I-Disease 1 0.9776530265808105
. O 0 2.654582864636268e-08

Linkage O 0 1.1197783322813848e-07
to O 0 1.3058347458905217e-10
markers O 0 1.4650041180175322e-09
on O 0 8.148258068274572e-09
chromosome O 0 2.5364194300436793e-08
4p O 0 1.3425443512460333e-06
was O 0 1.3087003702949573e-09
confirmed O 0 1.733229670897174e-10
in O 0 1.211864775196858e-10
five O 0 9.744877127459972e-10
families O 0 8.475054685819217e-11
. O 0 9.779476783933205e-09

On O 0 2.6673818709355146e-09
the O 0 1.153469854353606e-11
basis O 0 6.334206770208795e-11
of O 0 3.5114391949697676e-10
meiotic O 0 6.4467303673154674e-06
recombinants O 0 4.9072761612478644e-05
and O 0 2.7205061314816703e-08
disease O 0 0.00023625178437214345
- O 0 8.145950580740191e-11
associated O 0 3.529284503533958e-11
haplotypes O 0 9.475064066677419e-10
, O 0 9.138318574075655e-12
the O 0 2.227703355117683e-09
WFS B-Disease 0 7.156763604143634e-05
gene O 0 3.941320880773702e-10
was O 0 3.247153657071067e-10
localized O 0 3.2444684716637084e-09
to O 0 3.683697791245777e-11
a O 0 1.3543647314762097e-09
BAC O 0 3.0493886242766166e-06
/ O 0 8.705930198971146e-09
P1 O 0 2.5624295574289135e-08
contig O 0 5.569365058022413e-08
of O 0 2.0750303697525396e-09
less O 0 3.2864187066161676e-11
than O 0 1.1826014343144231e-12
250 O 0 1.0822591434145323e-10
kb O 0 1.635257603993523e-06
. O 0 2.9267939183341696e-08

Mutations O 0 1.4568556083727202e-10
in O 0 1.624709047853834e-11
a O 0 6.5139673169345436e-12
novel O 0 1.4002530038248473e-11
gene O 0 9.402825740245646e-12
( O 0 3.0650295127464255e-13
WFS1 O 0 5.358312904490958e-09
) O 0 3.4503405991689884e-13
encoding O 0 5.394174256573292e-12
a O 0 3.638122442195524e-11
putative O 0 1.0870759847847467e-09
transmembrane O 0 1.1327023763385569e-09
protein O 0 8.771011694719277e-10
were O 0 6.145274566993209e-11
found O 0 4.334189528543836e-13
in O 0 1.0887343544069283e-12
all O 0 1.4300099299147107e-11
affected O 0 6.8177173975780825e-12
individuals O 0 1.190828441714406e-13
in O 0 1.6506448985431632e-10
six O 0 8.796151007572917e-08
WFS B-Disease 0 0.00472595077008009
families O 0 5.991866291327197e-12
, O 0 1.8520313321140902e-12
and O 0 1.0695554684969633e-12
these O 0 1.04425734552549e-12
mutations O 0 1.0989558221763396e-11
were O 0 2.469284325623544e-12
associated O 0 4.635475163439207e-12
with O 0 4.4663695485114285e-12
the O 0 3.254995206702915e-08
disease O 0 0.05821877717971802
phenotype O 0 5.118287305094782e-08
. O 0 2.703295809425299e-09

WFS1 O 0 0.0007870818371884525
appears O 0 1.7457651990682166e-09
to O 0 2.6834723679258765e-12
function O 0 9.331792977240738e-11
in O 0 2.5695221991806072e-11
survival O 0 5.882718596694758e-07
of O 0 1.0793700155886654e-08
islet O 0 4.35322284886297e-08
beta O 0 1.0514865422805997e-08
- O 0 7.904852883378055e-10
cells O 0 3.107426468917929e-11
and O 0 4.7582181250671596e-12
neurons O 0 6.080032310951111e-11
. O 0 1.7876573485398062e-11
. O 0 6.835967347740279e-10

Stable O 0 1.3536526566326756e-08
interaction O 0 1.2467534817039994e-11
between O 0 8.819702780604732e-12
the O 0 1.1412156636358972e-10
products O 0 6.07627892446061e-10
of O 0 2.7806725810819444e-09
the O 0 5.72835956447193e-09
BRCA1 O 0 2.228884854460489e-09
and O 0 8.764100556390986e-11
BRCA2 O 0 5.131497449184508e-10
tumor B-Disease 0 1.369785951332858e-09
suppressor O 0 2.9573639093172233e-09
genes O 0 8.886029065346968e-12
in O 0 3.656516062156001e-11
mitotic O 0 9.035436931981167e-08
and O 0 2.8895785764149196e-09
meiotic O 0 5.131971192895435e-05
cells O 0 1.481249967127951e-07
. O 0 1.9945261442444462e-08

BRCA1 O 0 5.660102146975987e-07
and O 0 3.6439717909786395e-10
BRCA2 O 0 4.6115437857263686e-11
account O 0 6.283093891088637e-14
for O 0 8.84290538472228e-14
most O 0 2.0120811958300282e-14
cases O 0 1.4008972035520467e-14
of O 0 1.2701867552547541e-12
familial O 0 9.274235268641462e-10
, O 0 8.034746912938262e-13
early O 0 8.954933683469335e-09
onset O 1 0.9999998807907104
breast B-Disease 0 0.4329642653465271
and I-Disease 0 2.0978666270821122e-07
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.5074781003932003e-05
encode O 0 3.751204208368719e-11
products O 0 1.0036258490941918e-09
that O 0 3.70102575973294e-13
each O 0 2.2769880395783794e-14
interact O 0 2.977204935491681e-14
with O 0 8.85443736560465e-13
hRAD51 O 0 4.095164740647306e-08
. O 0 4.496738537085321e-09

Results O 0 4.446605306185347e-09
presented O 0 1.5125235508506307e-09
here O 0 1.3419032551809096e-10
show O 0 8.778371779483152e-11
that O 0 4.095960983580005e-12
BRCA1 O 0 8.154157904449733e-11
and O 0 3.034561534345781e-12
BRCA2 O 0 2.511972574392729e-11
coexist O 0 5.871503370308284e-12
in O 0 1.7994379857694254e-12
a O 0 4.617702487746955e-12
biochemical O 0 2.5677608928020845e-09
complex O 0 9.581365922883833e-09
and O 0 2.776589028141707e-11
colocalize O 0 5.942063907582451e-08
in O 0 1.3689868127997329e-09
subnuclear O 0 9.168326187136699e-07
foci O 0 1.0323473134121741e-06
in O 0 2.885292560428354e-10
somatic O 0 1.5124714813907758e-09
cells O 0 4.123915185033633e-12
and O 0 3.295906841720153e-13
on O 0 7.195209705823657e-11
the O 0 4.2597106397757045e-12
axial O 0 1.0416082059372389e-11
elements O 0 1.8611197305506977e-10
of O 0 1.6015886394882273e-09
developing O 0 4.51086945574275e-09
synaptonemal O 0 9.288996807299554e-07
complexes O 0 3.1323889970735763e-07
. O 0 4.7835339245239084e-08

Like O 0 4.674933862247599e-08
BRCA1 O 0 7.997308415497173e-08
and O 0 3.1426561353242732e-09
RAD51 O 0 2.5996223484980874e-05
, O 0 1.9827517405701656e-09
BRCA2 O 0 1.5382716211931324e-09
relocates O 0 4.7093287602884004e-11
to O 0 8.62521078864864e-12
PCNA O 0 2.4244267038397993e-08
+ O 0 4.8206829153518704e-12
replication O 0 1.424448406450729e-11
sites O 0 1.1877757891826102e-12
following O 0 1.2147059400002824e-11
exposure O 0 3.0506164261367985e-10
of O 0 8.35805202825668e-09
S O 0 2.378912888900686e-08
phase O 0 3.6934524327847384e-09
cells O 0 2.2950780165231777e-11
to O 0 9.780077789289798e-12
hydroxyurea O 0 6.507494987317841e-09
or O 0 4.47163972516762e-11
UV O 0 1.1742613423848525e-06
irradiation O 0 2.0359529173674673e-08
. O 0 7.040478200437406e-10

Thus O 0 7.293499582061713e-09
, O 0 1.323595955060597e-10
BRCA1 O 0 4.705300038487792e-10
and O 0 5.99584487961935e-12
BRCA2 O 0 1.8023036188474784e-11
participate O 0 5.248542486041563e-13
, O 0 7.641345103328798e-14
together O 0 2.311284403612706e-14
, O 0 1.0021567316232868e-13
in O 0 1.5277633758775666e-12
a O 0 1.393833746338169e-11
pathway O 0 2.5238540424243894e-11
( O 0 5.782596352709585e-14
s O 0 1.2495406185447644e-12
) O 0 1.912557407978137e-15
associated O 0 8.523105723794167e-14
with O 0 1.9349996729705818e-14
the O 0 4.321578685184679e-12
activation O 0 6.931463649578751e-12
of O 0 1.1041100672626314e-10
double O 0 3.9426140130416343e-10
- O 0 4.990228230639104e-10
strand O 0 2.868420834190033e-09
break O 0 8.222510672339922e-09
repair O 0 1.685104145110472e-08
and O 0 2.2730441140428326e-10
/ O 0 6.857361345424806e-09
or O 0 5.621609081019052e-11
homologous O 0 4.562708266764304e-10
recombination O 0 2.179134872548616e-09
. O 0 1.434856322646283e-08

Dysfunction O 0 0.00554285291582346
of O 0 1.6496303487656405e-06
this O 0 1.2834655560567398e-10
pathway O 0 1.1276710676355606e-09
may O 0 6.884793950223678e-12
be O 0 7.185365583778358e-14
a O 0 5.6749272842786594e-14
general O 0 9.26746743581952e-13
phenomenon O 0 2.9040613230141288e-12
in O 0 7.745617569641233e-14
the O 0 2.6610040126245904e-13
majority O 0 8.264407631549189e-14
of O 0 4.279203402214604e-13
cases O 0 1.8980593464133777e-13
of O 0 1.8815285440787477e-10
hereditary B-Disease 1 0.9999988079071045
breast I-Disease 1 0.9656636118888855
and I-Disease 0 1.1503778978294577e-06
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9984867572784424
. O 0 2.747094640653813e-07

A O 0 6.056172452417741e-09
novel O 0 1.7710252708802443e-10
Arg362Ser O 0 9.805831702180967e-09
mutation O 0 1.5742265130347377e-11
in O 0 5.449915692345986e-12
the O 0 5.308016526317516e-11
sterol O 0 1.1206009276065743e-07
27 O 0 2.512147148081567e-07
- O 0 2.9155651226631107e-09
hydroxylase O 0 2.5263430458721814e-08
gene O 0 4.54183253506546e-11
( O 0 2.57815985357443e-13
CYP27 O 0 2.75240008562605e-09
) O 0 1.9647030855517167e-14
: O 0 2.560310184281339e-15
its O 0 4.224284089844252e-14
effects O 0 1.0112764792236106e-11
on O 0 6.60138541053179e-11
pre O 0 1.0423406582305006e-09
- O 0 4.262067261617819e-12
mRNA O 0 7.901077361816e-12
splicing O 0 5.968304322978568e-11
and O 0 1.083150279537759e-12
enzyme O 0 1.2576222615384713e-12
activity O 0 1.2991246967075654e-10
. O 0 6.295066135031391e-10

A O 0 5.3693005597210686e-09
novel O 0 6.987296852223324e-11
C O 0 5.017447568533839e-10
to O 0 1.6911154551366159e-12
A O 0 6.657693146783217e-11
mutation O 0 2.4923136471288743e-12
in O 0 8.650561278585045e-13
the O 0 1.4454292797394519e-11
sterol O 0 6.75640876579564e-08
27 O 0 1.0320918875095231e-07
- O 0 1.687251671711465e-09
hydroxylase O 0 1.0665224259298611e-08
gene O 0 1.2289916480334728e-11
( O 0 1.212954297549404e-13
CYP27 O 0 8.996221545487515e-10
) O 0 3.399348199304743e-14
was O 0 1.1085614847958225e-12
identified O 0 6.225844628249613e-14
by O 0 6.582177159005984e-14
sequencing O 0 1.781717481885714e-11
amplified O 0 4.154631083608251e-10
CYP27 O 0 2.4844547397151473e-07
gene O 0 9.492225755414196e-11
products O 0 6.533867197289212e-11
from O 0 1.3564127035112228e-12
a O 0 1.3433469614465565e-11
patient O 0 1.886890643731931e-10
with O 0 8.841975068785146e-11
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 6.186843926059282e-09
CTX B-Disease 0 1.0975479199260008e-05
) O 0 5.416652196221783e-11
. O 0 1.1209804195999595e-09

The O 0 9.609679274547034e-09
mutation O 0 4.41212538726532e-10
changed O 0 9.06084512974914e-11
the O 0 1.3690956701672974e-10
adrenodoxin O 0 3.397225967205486e-08
cofactor O 0 8.740737911239194e-09
binding O 0 5.819097981252241e-10
residue O 0 2.300628798579396e-09
362Arg O 0 9.685371255008235e-11
to O 0 2.5926194784781087e-12
362Ser O 0 2.7497448762403565e-09
( O 0 2.7551230394329274e-11
CGT O 0 9.082832974627308e-08
362Arg O 0 3.28516713832272e-10
to O 0 1.1296289424700401e-11
AGT O 0 4.2123886601075355e-08
362Ser O 0 6.325381191052415e-11
) O 0 1.4759444073820724e-14
, O 0 5.4922319337315055e-15
and O 0 1.9564201197671063e-14
was O 0 2.4114024579219295e-12
responsible O 0 9.451824739548087e-12
for O 0 8.121465305821474e-12
deficiency O 0 2.7388484369339494e-08
in O 0 2.880431448915033e-10
the O 0 1.5341058201556734e-08
sterol O 0 3.963412746088579e-05
27 O 0 1.3732988918491174e-05
- O 0 1.5338943448739428e-09
hydroxylase O 0 5.871501063126061e-09
activity O 0 5.221617929707101e-11
, O 0 3.411006421977572e-14
as O 0 8.157688764678494e-15
confirmed O 0 2.7389237254073218e-14
by O 0 7.017788670196862e-15
expression O 0 6.294528158250212e-13
of O 0 2.462483342235977e-12
mutant O 0 3.1310936482453755e-11
cDNA O 0 5.436963657068361e-10
into O 0 2.4128577608140134e-11
COS O 0 5.337970492291788e-07
- O 0 1.1695642676556872e-08
1 O 0 2.5805377390497597e-08
cells O 0 8.176307964014029e-10
. O 0 6.717865708161241e-10

Quantitative O 0 7.576257399222186e-10
analysis O 0 2.7161002613684815e-11
showed O 0 5.872884123458988e-11
that O 0 3.938968156638398e-14
the O 0 2.261512591777981e-12
expression O 0 2.4688287872387527e-11
of O 0 2.217773326096406e-10
CYP27 O 0 1.1176206626828389e-08
gene O 0 8.846806750714697e-13
mRNA O 0 1.0826172857497651e-12
in O 0 2.8345861356922353e-13
the O 0 6.200868811478966e-12
patient O 0 3.205308587994615e-11
represented O 0 1.7134944851893152e-10
52 O 0 2.7408239233750464e-08
. O 0 3.6666062186441195e-08

5 O 0 2.4357079908554624e-08
% O 0 2.0713677995054525e-10
of O 0 6.996689339011652e-10
the O 0 1.3641698881627917e-09
normal O 0 4.8504741556598674e-08
level O 0 3.367224280736991e-06
. O 0 7.3297306002473306e-09

As O 0 4.087799196361708e-11
the O 0 2.5594215982693846e-11
mutation O 0 9.21399675307688e-12
occurred O 0 5.706401670635408e-11
at O 0 3.462421668820603e-11
the O 0 9.44949934272854e-12
penultimate O 0 1.456359033369381e-09
nucleotide O 0 1.0853150600453887e-09
of O 0 1.0300521324779766e-08
exon O 0 4.022312083407087e-08
6 O 0 3.149930805079748e-08
( O 0 2.630455532212639e-12
- O 0 2.9029995421425703e-11
2 O 0 2.510986973902618e-10
position O 0 6.024989535058367e-11
of O 0 1.1814647038477233e-09
exon O 0 1.7066888347017084e-08
6 O 0 7.316492656173068e-08
- O 0 1.2741000476879094e-09
intron O 0 8.123538286497478e-09
6 O 0 5.612828868351016e-09
splice O 0 8.520977812231934e-10
site O 0 2.4810740267833253e-11
) O 0 8.363544875915601e-15
of O 0 3.0053925927781e-12
the O 0 8.789407569820273e-12
gene O 0 2.3374566171519007e-12
, O 0 5.87394228309529e-13
we O 0 9.528640897149554e-13
hypothesized O 0 1.991169598994369e-12
that O 0 1.5839948100458516e-14
the O 0 2.953227506291567e-12
mutation O 0 8.609875833121006e-12
may O 0 2.6148332631092952e-12
partially O 0 2.7422734222293244e-11
affect O 0 2.906043461425867e-13
the O 0 4.257604197584891e-13
normal O 0 1.0835990958690811e-11
splicing O 0 4.713612746648499e-12
efficiency O 0 8.570618173497913e-12
in O 0 7.675368587228837e-13
exon O 0 1.944923805341503e-10
6 O 0 1.2264585180776777e-10
and O 0 1.1700527699498586e-12
cause O 0 3.482762342410517e-11
alternative O 0 1.6987262291268124e-11
splicing O 0 1.2894568225674252e-11
elsewhere O 0 1.9885280488213253e-12
, O 0 1.3501880515053629e-14
which O 0 9.348163925891259e-15
resulted O 0 1.1287497629283716e-12
in O 0 1.6008647586805008e-13
decreased O 0 1.3785676593325302e-11
transcript O 0 3.3204428789845863e-11
in O 0 8.854458832807666e-12
the O 0 3.598291109518925e-10
patient O 0 8.236040294207214e-09
. O 0 5.348255172066274e-09

Transfection O 0 3.564339863260102e-07
of O 0 7.627258469256049e-08
constructed O 0 1.8348519148503328e-08
minigenes O 0 2.291153755606956e-08
, O 0 4.32832632582536e-12
with O 0 1.3949892673295605e-13
or O 0 1.7529763448112523e-12
without O 0 1.581944124307011e-11
the O 0 8.811316953849513e-11
mutation O 0 4.0387266447838854e-11
, O 0 2.486762748846183e-12
into O 0 3.3718895731116305e-11
COS O 0 1.8037349946098402e-05
- O 0 1.2215850553332075e-08
1 O 0 2.4886264160528526e-09
cells O 0 2.4642876714914275e-12
confirmed O 0 5.756551377071595e-13
that O 0 7.894646918073407e-15
the O 0 2.577628865560455e-13
mutant O 0 1.2460814324821712e-10
minigene O 0 1.6527310631175851e-09
was O 0 1.3177971214251016e-10
responsible O 0 1.2269655777497057e-11
for O 0 6.728896953522856e-13
a O 0 2.467801137051584e-12
mRNA O 0 9.592816992143316e-12
species O 0 3.448760035689412e-14
alternatively O 0 4.505280155019109e-13
spliced O 0 6.537569791076336e-11
at O 0 2.3359927880939324e-10
an O 0 1.3186556881150668e-12
activated O 0 3.7591725288166344e-09
cryptic O 0 8.858657141175286e-10
5 O 0 1.1945874511809507e-08
splice O 0 4.3853244591218754e-08
site O 0 5.3351834061743375e-09
88 O 0 4.1960843688571e-09
bp O 0 1.0103631820079784e-10
upstream O 0 4.0690653971275914e-12
from O 0 3.689742955614861e-12
the O 0 9.00229335520919e-11
3 O 0 2.513460772846088e-09
end O 0 9.879210782770542e-10
of O 0 2.342776195263241e-09
exon O 0 9.04191850281677e-08
6 O 0 1.1933194343782816e-07
. O 0 5.4753255263051415e-09

Our O 0 2.3960016193314004e-09
data O 0 1.1812026357027605e-10
suggest O 0 4.5938253201427415e-12
that O 0 1.7686527698131116e-13
the O 0 9.571287339082968e-12
C O 0 3.355358213497084e-10
to O 0 9.773024403636477e-13
A O 0 7.856568867703473e-11
mutation O 0 1.2977588838627985e-12
at O 0 4.9320473920200225e-12
the O 0 1.2046594190934234e-12
penultimate O 0 6.272267427664957e-11
nucleotide O 0 2.7748737335686613e-11
of O 0 1.4264447956158222e-10
exon O 0 6.930360729739959e-10
6 O 0 3.0985858323617776e-10
of O 0 7.16337267281375e-11
the O 0 8.198073470078171e-11
CYP27 O 0 6.104232852521818e-08
gene O 0 2.9413886690893287e-12
not O 0 3.3349343929846634e-14
only O 0 7.402376102491268e-14
causes O 0 8.04720439590012e-12
the O 0 7.758359926723912e-11
deficiency B-Disease 0 6.051509870985683e-08
in I-Disease 0 2.368601148550198e-10
the I-Disease 0 7.1738672779986246e-09
sterol I-Disease 0 1.1062761586799752e-05
27 I-Disease 0 6.263683644647244e-06
- I-Disease 0 1.3794633213493057e-09
hydroxylase I-Disease 0 5.431680438761077e-09
activity I-Disease 0 2.2192289672595678e-10
, O 0 2.419953072565345e-13
but O 0 3.481523608902387e-13
also O 0 2.6346130138632518e-12
partially O 0 1.229011059589169e-10
leads O 0 1.314946198802125e-12
to O 0 9.012020594839285e-14
alternative O 0 8.385780264630327e-11
pre O 0 1.54739399071957e-09
- O 0 1.8026843039142815e-12
mRNA O 0 3.4978792865653086e-12
splicing O 0 1.8475795546257778e-11
of O 0 5.347525547372278e-11
the O 0 1.424949186423774e-10
gene O 0 4.826078980890713e-10
. O 0 1.3296289624875612e-09

To O 0 4.260112818066375e-10
our O 0 2.1910577518990948e-10
knowledge O 0 8.972859261158206e-11
, O 0 5.332934072642403e-13
this O 0 1.7414440047869122e-14
is O 0 1.0352092785965473e-14
the O 0 9.678966883617385e-14
first O 0 3.8064812261408287e-13
report O 0 2.483794149087809e-13
regarding O 0 3.0209309446332933e-13
effects O 0 4.3286835921252376e-11
on O 0 6.519663281467913e-11
pre O 0 2.2816097622335718e-10
- O 0 6.813125367696737e-13
mRNA O 0 1.002935581806419e-12
splicing O 0 9.433579785389501e-12
of O 0 4.0104704279730896e-11
a O 0 1.0797390759265113e-11
mutation O 0 1.9988875138432505e-11
at O 0 2.4410914956085605e-10
the O 0 2.7353477816127736e-10
- O 0 2.1209420331125273e-10
2 O 0 1.7190078249740282e-09
position O 0 2.799857012902862e-10
of O 0 3.817985039233918e-09
a O 0 9.862775041113991e-10
5 O 0 2.605205651207143e-08
splice O 0 1.3399613862929982e-07
site O 0 4.202782832862795e-08
. O 0 1.0584225051957219e-08

ATM O 0 8.320674282913387e-07
germline O 0 2.0654914223428023e-08
mutations O 0 7.676500060616043e-12
in O 0 4.193429891524714e-12
classical O 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999059438705444
in O 0 6.683155140407848e-10
the O 0 4.591657609687161e-10
Dutch O 0 8.307085863634711e-08
population O 0 1.0736111652476232e-11
. O 0 2.159018935854462e-10

Germline O 0 6.839363777544349e-07
mutations O 0 7.639170546136498e-11
in O 0 1.3983312771581602e-11
the O 0 4.9208026542402195e-11
ATM O 0 5.927707213970734e-09
gene O 0 2.5312477808236977e-12
are O 0 9.74750480865435e-16
responsible O 0 2.48060036053821e-15
for O 0 1.7569445383150764e-14
the O 0 2.6721748369595844e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.8454241752624512
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.638060339095084e-11
. O 0 1.9914032922674352e-10

In O 0 2.985833358337686e-09
our O 0 5.935555935643322e-10
study O 0 3.641661625031212e-12
, O 0 2.256996889729579e-12
we O 0 1.7936710059937577e-12
have O 0 8.728620988973299e-14
determined O 0 4.899248324738426e-13
the O 0 4.9381093832068235e-12
ATM O 0 1.189455312022858e-09
mutation O 0 9.071730454508764e-13
spectrum O 0 5.279567473308322e-13
in O 0 1.0182471727772369e-13
19 O 0 1.3462511661010979e-10
classical O 1 0.9985877275466919
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.401015745754023e-10
, O 0 3.792507350915478e-14
including O 0 7.794508988983109e-14
some O 0 7.723341958381161e-14
immigrant O 0 2.533585537548011e-12
populations O 0 6.404466258540242e-13
, O 0 5.6676258602733273e-14
as O 0 1.853107917766314e-13
well O 0 8.409910138076904e-13
as O 0 1.9639446319219545e-12
12 O 0 8.392564421200177e-11
of O 0 1.7609336211421578e-10
Dutch O 0 8.307447174615845e-09
ethnic O 0 1.349794304106311e-10
origin O 0 1.8600941620317002e-10
. O 0 1.60072133326139e-09

Both O 0 4.2540634903609487e-10
the O 0 6.807511221396112e-10
protein O 0 1.3072128102198377e-10
truncation O 0 1.4749693910687256e-08
test O 0 8.690866692973032e-09
( O 0 1.0336975199420895e-11
PTT O 0 3.3981639724345314e-09
) O 0 2.2027452290570432e-13
and O 0 3.7650779846284954e-13
the O 0 6.38752505749407e-12
restriction O 0 4.443853618418814e-11
endonuclease O 0 2.8991205269779385e-11
fingerprinting O 0 6.194501162015698e-11
( O 0 5.212796340414716e-13
REF O 0 1.5465250607915593e-11
) O 0 1.1643471594052855e-15
method O 0 1.7704711462629592e-14
were O 0 1.1269807922162714e-13
used O 0 7.816703793300014e-15
and O 0 5.3691843045168205e-14
compared O 0 5.529658220031208e-13
for O 0 3.7370963528599033e-13
their O 0 9.13799960179651e-13
detection O 0 2.6510571515814263e-11
efficiency O 0 4.3753399341095456e-12
, O 0 1.0783296930621904e-14
identifying O 0 8.791947204989103e-14
76 O 0 1.0754740847884747e-11
% O 0 8.777977802097714e-13
and O 0 2.8622064570868466e-13
60 O 0 1.0986289135372918e-11
% O 0 4.2740012917708015e-12
of O 0 2.5327090424909215e-10
the O 0 3.9169345544820544e-10
mutations O 0 5.798885330254855e-11
, O 0 1.3810335687536313e-11
respectively O 0 2.6522435359055407e-09
. O 0 1.1181749748345737e-08

Most O 0 1.1246644504581127e-08
patients O 0 1.3598652204294126e-09
were O 0 7.670039048335298e-10
found O 0 1.6487308046597704e-11
to O 0 1.462420289033428e-11
be O 0 2.300210855121776e-10
compound O 0 1.6974098571154173e-07
heterozygote O 0 1.0357456403653487e-06
. O 0 1.4271238413243736e-08

Seventeen O 0 3.952820648578381e-08
mutations O 0 1.849988912061562e-10
were O 0 1.8228567960631992e-11
distinct O 0 8.70243113682001e-12
, O 0 3.5707894974201793e-12
of O 0 1.4951160309806255e-09
which O 0 2.5974120423932767e-11
10 O 0 5.317564166773536e-10
were O 0 1.565681334581015e-10
not O 0 9.600120177977178e-12
reported O 0 5.440013439717006e-10
previously O 0 4.634423689253708e-08
. O 0 2.4588931779589984e-08

Mutations O 0 1.4529970115972901e-08
are O 0 9.697386643692241e-11
small O 0 5.443798883897344e-11
deletions O 0 1.230369695015554e-09
or O 0 1.4480356913537662e-09
point O 0 1.6524535340067814e-06
mutations O 0 5.7499462968735315e-09
frequently O 0 1.9373966320124225e-10
affecting O 0 5.612654785380755e-10
splice O 0 5.968153971025458e-08
sites O 0 9.78408465357461e-09
. O 0 2.4673873610936425e-08

Moreover O 0 9.619309793151842e-08
, O 0 8.078478441753134e-10
a O 0 2.510480712203389e-09
16 O 0 1.481028277794394e-07
. O 0 4.728480007543112e-08

7 O 0 7.552154670520395e-07
- O 0 1.6512723410855301e-09
kb O 0 3.482435317891941e-08
genomic O 0 2.568686818804622e-09
deletion O 0 5.989176377063643e-10
of O 0 5.278460335489399e-09
the O 0 2.5725443997259845e-10
3 O 0 2.3720023722972883e-09
end O 0 1.9897516967404272e-10
of O 0 1.7281195918705805e-10
the O 0 2.97423509432182e-11
gene O 0 8.721923357157824e-12
, O 0 9.787239378319934e-13
most O 0 8.282084870345208e-13
likely O 0 2.99066782623314e-12
a O 0 7.479101431055735e-13
result O 0 9.126612660059763e-12
of O 0 9.183012857072459e-12
recombination O 0 2.8342939432067504e-13
between O 0 3.692059245136159e-12
two O 0 1.1277194456038586e-11
LINE O 0 3.3765459317436353e-09
elements O 0 1.665191040611802e-10
, O 0 1.9243143536962215e-11
was O 0 2.2386714704225597e-09
identified O 0 3.1689117996336336e-09
. O 0 7.508933030919707e-09

The O 0 9.971503622807631e-09
most O 0 1.4076947073282664e-11
frequently O 0 1.0891663005524466e-12
found O 0 1.4665730652466125e-12
mutation O 0 6.479293013575416e-13
, O 0 5.4227018790034207e-14
identified O 0 5.024258461529263e-13
in O 0 1.1217785597997243e-12
three O 0 1.6072055145088804e-11
unrelated O 0 1.6947021563851195e-09
Turkish O 0 6.16087299931678e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 3.412435048075202e-12
, O 0 2.8732461288677458e-12
was O 0 2.938290999399129e-10
previously O 0 8.591342914865407e-11
described O 0 3.3786025192827918e-12
to O 0 6.202188014472337e-14
be O 0 1.3792474649367004e-13
a O 0 2.5488732218609256e-12
Turkish O 0 8.46932568521197e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 4.586683189700125e-06
mutation O 0 5.293475524581481e-08
. O 0 1.928438964071688e-09

The O 0 1.4719110374983302e-09
presence O 0 6.170292055074356e-11
of O 0 7.103134080921336e-09
a O 0 1.8436178139680237e-09
founder O 0 1.9085599944901332e-07
mutation O 0 7.129136725403384e-10
among O 0 8.886092274333623e-13
relatively O 0 6.44681031648775e-13
small O 0 6.566816047100937e-14
ethnic O 0 2.5404472362572372e-12
population O 0 9.816810314948118e-14
groups O 0 2.1976380947235502e-13
in O 0 4.362390657042248e-12
Western O 0 2.071930893521312e-08
Europe O 0 4.619542082195949e-09
could O 0 2.129461364186458e-11
indicate O 0 1.1942848619772573e-11
a O 0 1.7327264623112626e-11
high O 0 4.4768622836643956e-11
carrier O 0 5.126139313374467e-13
frequency O 0 9.18014102235798e-12
in O 0 5.185508272775863e-12
such O 0 6.390001722200722e-11
communities O 0 7.107386346127953e-10
. O 0 2.1884776213454415e-09

In O 0 6.596269752634498e-09
patients O 0 2.2219438788884105e-10
of O 0 5.061508989712138e-10
Dutch O 0 2.3234996149312792e-08
ethnic O 0 4.6405906894975146e-11
origin O 0 5.881377850014413e-12
, O 0 6.557056872295852e-13
however O 0 7.740664012545473e-12
, O 0 1.3341792948207143e-12
no O 0 3.2446881986780696e-11
significant O 0 4.808438092140932e-10
founder O 0 2.3423931239108242e-08
effect O 0 8.11264087019481e-08
could O 0 3.804280501729096e-10
be O 0 3.0789013699683565e-11
identified O 0 3.333681941608546e-10
. O 0 1.9970070042063526e-09

The O 0 1.2164111939938493e-09
observed O 0 1.8501512821789134e-10
genetic O 0 4.600088365780408e-11
heterogeneity O 0 2.705770607569491e-10
including O 0 4.350840000777456e-12
the O 0 5.142193962304198e-11
relative O 0 1.3498154816105057e-09
high O 0 1.1001088040529794e-08
percentage O 0 3.425547845381516e-09
of O 0 1.3658426212259656e-07
splice O 0 2.4808232410578057e-06
- O 0 6.45732356474582e-08
site O 0 1.292196660784839e-08
mutations O 0 6.008234881837993e-11
had O 0 2.957874223330492e-11
no O 0 5.0498550653588214e-12
reflection O 0 4.2315644044332856e-11
on O 0 2.644000574036909e-09
the O 0 6.226617554894176e-10
phenotype O 0 1.1849067504954292e-08
. O 0 1.7389789608301953e-09

All O 0 2.9143240598550335e-10
patients O 0 3.9836402405957205e-12
manifested O 0 2.9126388800815306e-11
classical O 0 0.0061061568558216095
A B-Disease 1 1.0
- I-Disease 1 0.9999911785125732
T I-Disease 1 1.0
and O 0 8.126455237900121e-12
increased O 0 3.1506412062620726e-11
cellular O 0 1.1624379236963023e-09
radioresistant O 0 1.2492095358140887e-08
DNA O 0 2.6613902193162176e-09
synthesis O 0 7.428925807850817e-10
. O 0 3.7673389408077185e-10

Determination O 0 2.259219300526638e-08
of O 0 7.739996199518373e-09
the O 0 5.7918111279198214e-11
genomic O 0 5.251024060015652e-10
structure O 0 1.226248658170448e-09
of O 0 2.6786493023678304e-09
the O 0 6.526185702959708e-10
COL4A4 O 0 2.3225409506721917e-07
gene O 0 8.682171301344077e-12
and O 0 1.4765813083957718e-13
of O 0 2.8579911874604402e-12
novel O 0 6.760034199082554e-11
mutations O 0 6.3216125667509004e-09
causing O 0 3.389954486010538e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.2922413336345926e-06

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.607422776636838e-10
a O 0 6.228114135531371e-10
progressive O 1 0.999538779258728
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 8.185928379589313e-08
by O 0 1.6907034799951148e-11
glomerular B-Disease 1 0.8822852969169617
basement I-Disease 1 0.999998927116394
membrane I-Disease 0 7.289850714187196e-07
abnormalities I-Disease 1 0.9987554550170898
and O 0 3.728974160704945e-12
associated O 0 8.139799945183768e-11
with O 0 8.600322710938801e-12
mutations O 0 3.967861456066757e-11
in O 0 9.908762699240015e-10
either O 0 1.168328433998056e-09
the O 0 2.344529725917255e-08
COL4A3 O 1 0.8949251770973206
or O 0 8.121814887296352e-10
the O 0 2.2242176989095697e-09
COL4A4 O 0 3.05607130712815e-07
gene O 0 1.1680129953506313e-11
, O 0 2.431287864177595e-13
which O 0 3.5999523674556944e-14
encode O 0 7.324461133093041e-13
the O 0 7.1738323614845e-11
alpha3 O 0 7.815478397787956e-08
and O 0 8.275134466551037e-10
alpha4 O 0 2.046802364930045e-06
type O 0 1.910888840939151e-06
IV O 0 2.5326562536065467e-05
collagen O 0 1.7113065950979944e-06
chains O 0 1.064299112840672e-06
, O 0 5.4096831181293936e-11
respectively O 0 2.529842335619037e-09
. O 0 2.551211686352417e-09

To O 0 9.768300751611392e-11
date O 0 1.7837534116438292e-08
, O 0 8.592387218397946e-12
mutation O 0 7.338080880783804e-13
screening O 0 1.031611688434575e-11
in O 0 1.2080325888924603e-12
the O 0 2.2095304752500766e-11
two O 0 2.8310483297933065e-12
genes O 0 5.284073525957389e-12
has O 0 6.143674436374924e-13
been O 0 3.559148201853768e-12
hampered O 0 5.867814567572793e-10
by O 0 1.7550171385605218e-12
the O 0 1.4196104014541078e-10
lack O 0 2.4275719212596414e-09
of O 0 9.168788644986492e-11
genomic O 0 2.0283432711210025e-09
structure O 0 2.4845476787049847e-09
information O 0 1.0279765233489613e-10
. O 0 4.735337011396723e-09

We O 0 2.9843871818258094e-09
report O 0 5.447569825789422e-11
here O 0 3.5364118317754434e-12
the O 0 1.218641073469362e-12
complete O 0 6.296143467698911e-11
characterization O 0 3.817886284895877e-11
of O 0 1.4792503333360685e-10
the O 0 1.1133812621855199e-10
48 O 0 2.3763766510143114e-09
exons O 0 8.428494169265832e-08
of O 0 3.011871640978825e-08
the O 0 9.761344621495027e-09
COL4A4 O 0 1.6265699741779827e-05
gene O 0 3.0165772657575474e-10
, O 0 8.174004008376645e-13
a O 0 4.831376726639747e-13
comprehensive O 0 1.4058996154753256e-11
gene O 0 7.368427699591673e-14
screen O 0 3.408283312696103e-13
, O 0 1.196057142216489e-13
and O 0 1.6536484638215998e-13
the O 0 7.089449470185083e-13
subsequent O 0 9.332535612360804e-12
detection O 0 9.858820010366642e-11
of O 0 8.286039389349131e-12
10 O 0 3.667802173090706e-12
novel O 0 6.993263390250859e-13
mutations O 0 8.346087492991372e-13
in O 0 7.286615972060262e-13
eight O 0 5.47333900424718e-10
patients O 0 3.350550947800457e-09
diagnosed O 0 4.781732513947645e-06
with O 0 1.0729577226697984e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.4818244759881054e-07

Furthermore O 0 4.3588452847131975e-09
, O 0 8.737795903490664e-11
we O 0 1.77082844915466e-11
identified O 0 2.1317614340432556e-11
a O 0 3.7041647527047417e-11
glycine O 0 8.889055602701035e-10
to O 0 5.5458953401865685e-12
alanine O 0 2.1235001257391417e-10
substitution O 0 1.8364056941777562e-09
in O 0 2.290066747345776e-11
the O 0 2.356087373811544e-11
collagenous O 0 1.720293463236544e-09
domain O 0 1.1862504901982707e-11
that O 0 6.49416162664361e-14
is O 0 5.624710766594099e-14
apparently O 0 7.937762860205089e-13
silent O 0 2.0222953520110387e-11
in O 0 6.115277013073184e-13
the O 0 2.025475273614852e-12
heterozygous O 0 6.7658101343681665e-12
carriers O 0 4.294837597541845e-13
, O 0 2.471714510583062e-13
in O 0 1.6084751586209478e-11
11 O 0 3.9045563227091407e-08
. O 0 1.898578361192449e-08

5 O 0 1.1891588158619015e-08
% O 0 5.0232960152607475e-11
of O 0 1.7143443609146658e-10
all O 0 1.510619060396401e-11
control O 0 6.232772076231186e-10
individuals O 0 1.690772630409676e-13
, O 0 3.6954532316169075e-13
and O 0 5.152989038074984e-13
in O 0 4.526047939212852e-12
one O 0 1.293066782120933e-12
control O 0 6.603047969511167e-11
individual O 0 3.394294461928245e-14
homozygous O 0 2.194364828733697e-11
for O 0 2.339905613019111e-12
this O 0 6.583816391375619e-12
glycine O 0 1.5068975400822637e-08
substitution O 0 5.3295110546969227e-08
. O 0 2.949370525584527e-09

There O 0 9.766628616958428e-10
has O 0 9.299787502581314e-12
been O 0 8.457444271824099e-13
no O 0 2.6900421994102697e-12
previous O 0 3.9917274347045506e-11
finding O 0 6.572076216571077e-11
of O 0 3.5137321940936772e-09
a O 0 3.2458533083534746e-10
glycine O 0 1.8461758788390625e-09
substitution O 0 7.94342369658807e-10
that O 0 2.5610646958197647e-13
is O 0 5.399520958929323e-14
not O 0 1.034183013477654e-14
associated O 0 6.656197674200642e-14
with O 0 2.7563226291768723e-14
any O 0 6.90762811533796e-12
obvious O 0 4.0255368483066434e-11
phenotype O 0 6.576060009033657e-12
in O 0 6.727382323087894e-13
homozygous O 0 8.034882204022153e-10
individuals O 0 1.3803751544583243e-11
. O 0 5.870582686640091e-09

Founder O 0 8.408649591729045e-06
BRCA1 O 0 3.317618180176396e-08
and O 0 3.8467609653203283e-10
BRCA2 O 0 2.325306197592525e-10
mutations O 0 3.156941938767255e-13
in O 0 1.0444280802626021e-13
French O 0 1.1597323101852908e-08
Canadian O 0 5.390920341596939e-05
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.053299017594327e-08
. O 0 4.87737779053532e-08

We O 0 8.727606415348532e-10
have O 0 1.6915186699245632e-12
identified O 0 2.156576132950061e-12
four O 0 3.9436159958265715e-13
mutations O 0 8.809774199210196e-14
in O 0 1.288319765539031e-13
each O 0 3.9910738966085144e-14
of O 0 8.748706203931533e-10
the O 0 5.701052145923313e-07
breast B-Disease 1 0.9896787405014038
cancer I-Disease 0 0.024254100397229195
- O 0 1.98747287072365e-07
susceptibility O 0 1.1717567076630075e-06
genes O 0 5.84685355686787e-11
, O 0 1.2696175491141992e-12
BRCA1 O 0 5.0903187914785875e-11
and O 0 2.223005633739117e-12
BRCA2 O 0 4.805141527730594e-12
, O 0 3.6278044201240155e-15
in O 0 1.925647921013126e-14
French O 0 5.468299146826894e-10
Canadian O 0 2.1379378267738502e-08
breast B-Disease 1 0.9890234470367432
cancer I-Disease 1 0.9896931052207947
and O 0 4.685653402702883e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.562713039670598e-09
from O 0 5.066879693593762e-10
Quebec O 0 6.52374183118809e-06
. O 0 3.316915808682097e-08

To O 0 3.1530175692573437e-10
identify O 0 6.974278932148081e-10
founder O 0 1.2857373121732962e-07
effects O 0 2.2072645151638426e-05
, O 0 6.654367334935074e-11
we O 0 3.338718190804002e-12
examined O 0 2.8850912544425844e-12
independently O 0 1.2115098421000559e-12
ascertained O 0 5.04545072388396e-10
French O 0 4.583609491959351e-09
Canadian O 0 3.3157123713323244e-09
cancer B-Disease 0 4.044643731049291e-09
families O 0 2.177788385824414e-13
for O 0 1.1936004756189084e-13
the O 0 1.071822318399196e-12
distribution O 0 2.2889445547291665e-11
of O 0 2.927466324909034e-10
these O 0 1.1546674207052465e-11
eight O 0 1.8473664820106706e-09
mutations O 0 2.833397072521393e-09
. O 0 9.375368925645944e-09

Mutations O 0 2.545524679931077e-09
were O 0 3.371203316504534e-10
found O 0 2.5296357890336463e-12
in O 0 4.9777508503989765e-12
41 O 0 1.1135303790155149e-09
of O 0 1.0671084460511793e-08
97 O 0 4.537518805136642e-07
families O 0 4.940922115892477e-10
. O 0 9.194103256504604e-09

Six O 0 2.5871846887071115e-09
of O 0 2.9216999930525844e-09
eight O 0 1.5857822832643365e-09
mutations O 0 7.48935843897236e-11
were O 0 5.604115782542607e-11
observed O 0 1.1480315309508882e-10
at O 0 5.638732147872361e-09
least O 0 9.643698062333783e-10
twice O 0 3.9787504846344746e-08
. O 0 1.7298495080808607e-08

The O 0 7.110457289627448e-08
BRCA1 O 0 1.5514732609744897e-08
C4446T O 0 6.1725584643568254e-09
mutation O 0 5.2035830505614555e-11
was O 0 8.030098114231166e-11
the O 0 1.1512718729733695e-11
most O 0 5.87774132750768e-13
common O 0 6.986174225925845e-12
mutation O 0 8.217418065448179e-12
found O 0 3.142457810894478e-13
, O 0 5.224080784388581e-14
followed O 0 4.2612055377311275e-12
by O 0 4.3799152672774344e-12
the O 0 1.6248687950692897e-09
BRCA2 O 0 4.404803632951371e-09
8765delAG O 0 1.2216876399406829e-08
mutation O 0 5.308588679753257e-09
. O 0 2.0908463849167447e-09

Together O 0 5.219051857352497e-10
, O 0 1.4180400777219493e-11
these O 0 1.4971396518348445e-12
mutations O 0 4.20850984270138e-12
were O 0 5.5427546233333125e-12
found O 0 2.2037538081279978e-13
in O 0 8.113658399658275e-13
28 O 0 2.007386701308178e-09
of O 0 8.693850972463224e-09
41 O 0 6.958948528534847e-09
families O 0 4.549486221777643e-12
identified O 0 2.2673012772811418e-11
to O 0 1.3053958955455691e-11
have O 0 4.228555006147161e-11
a O 0 3.889255861810881e-10
mutation O 0 1.4552908211840077e-08
. O 0 3.1081410778455165e-09

The O 0 8.7371043733242e-09
odds O 0 8.496864545293192e-09
of O 0 2.336857374274359e-10
detection O 0 5.261701074843472e-10
of O 0 2.960935108209384e-10
any O 0 9.745559220730726e-11
of O 0 3.153319827475798e-09
the O 0 2.9137863233330563e-09
four O 0 6.869008140064636e-10
BRCA1 O 0 2.615400784833355e-09
mutations O 0 3.0742555723328735e-10
was O 0 1.9860454614217815e-08
18 O 0 2.993396606143506e-07
. O 0 8.975764842489298e-08

7x O 0 1.85617282113526e-05
greater O 0 1.6344369413445747e-08
if O 0 3.332065526273631e-11
one O 0 8.831212128766752e-13
or O 0 8.61213295230874e-14
more O 0 3.3672617442298027e-15
cases O 0 2.6170135936781636e-12
of O 0 0.005612330045551062
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 9.235001016349997e-06
also O 0 3.055679841101888e-12
present O 0 1.407476457430945e-12
in O 0 1.8271590837559692e-11
the O 0 2.0996104854731357e-09
family O 0 7.558071390967314e-10
. O 0 8.403497453457476e-09

The O 0 7.233677212781231e-09
odds O 0 1.1190326887344781e-08
of O 0 3.211331756070024e-10
detection O 0 1.921609538158009e-09
of O 0 2.1446416864634443e-10
any O 0 9.746377316321997e-11
of O 0 7.612241503807127e-09
the O 0 3.404035053833354e-09
four O 0 1.440235042338145e-09
BRCA2 O 0 2.3928823367214136e-09
mutations O 0 4.5259745951042873e-10
was O 0 2.404894416940806e-08
5 O 0 5.550202217818878e-07
. O 0 5.4370314472862447e-08

3x O 0 2.0679500778442161e-07
greater O 0 1.8286321346039358e-09
if O 0 2.55482592546874e-12
there O 0 1.7570535955011013e-12
were O 0 7.220929149759359e-12
at O 0 7.0160058318613494e-12
least O 0 2.3084043899480877e-13
five O 0 3.8272149663863553e-13
cases O 0 8.319450271916662e-13
of O 0 1.1266912736118684e-08
breast B-Disease 0 8.934924699133262e-05
cancer I-Disease 0 2.427412482575164e-06
in O 0 5.4435894014659425e-08
the O 0 1.8698052599575021e-06
family O 0 5.898598054443482e-09
. O 0 4.4770313678554885e-08

Interestingly O 0 1.2397949333831093e-09
, O 0 1.789843338644015e-12
the O 0 7.327534846252037e-13
presence O 0 9.968668685661486e-13
of O 0 2.281758781919052e-09
a O 0 1.4531639180859202e-07
breast B-Disease 0 0.07045463472604752
cancer I-Disease 0 6.320324246189557e-07
case O 0 4.1213790713534593e-10
< O 0 1.1086377149638338e-08
36 O 0 1.624036842506893e-11
years O 0 2.7419477278967097e-12
of O 0 3.744429211138822e-10
age O 0 2.0321254401434174e-10
was O 0 1.7320200829118448e-10
strongly O 0 3.035937657953208e-13
predictive O 0 1.1576222619380516e-11
of O 0 2.9717869831635824e-10
the O 0 5.339267656473412e-12
presence O 0 3.1380377896877976e-13
of O 0 2.9531953271710876e-11
any O 0 1.5659612495610986e-11
of O 0 3.5990324609436186e-10
the O 0 2.979971824856875e-10
eight O 0 7.969678250674406e-10
mutations O 0 3.1037675207734594e-10
screened O 0 9.457883720642712e-08
. O 0 2.692295808515155e-08

Carriers O 0 9.88716053473837e-11
of O 0 1.2834049378795953e-09
the O 0 6.668139651555549e-11
same O 0 9.37067090589494e-12
mutation O 0 2.860783658575894e-12
, O 0 4.050871373366058e-14
from O 0 2.783573542562527e-14
different O 0 1.578306983805039e-14
families O 0 4.858246238029912e-14
, O 0 1.4810040401078833e-13
shared O 0 3.557641594514882e-12
similar O 0 9.963732096329725e-12
haplotypes O 0 2.6895524696257667e-10
, O 0 1.6040747289475243e-12
indicating O 0 3.5882827958966246e-11
that O 0 3.2185869637893494e-13
the O 0 3.820973485529899e-12
mutant O 0 1.7823845177566966e-10
alleles O 0 1.5505883252733832e-12
were O 0 5.426307840561417e-12
likely O 0 2.6185501792071186e-13
to O 0 1.1742143309111455e-14
be O 0 6.74359182319291e-14
identical O 0 8.226917411202628e-13
by O 0 4.955843407091626e-14
descent O 0 7.308639804470829e-12
for O 0 1.276759514085013e-12
a O 0 7.041598640983304e-12
mutation O 0 3.724453037645681e-12
in O 0 1.0847711617856248e-12
the O 0 4.096479058746105e-11
founder O 0 3.124498437756529e-09
population O 0 3.2295485730138296e-11
. O 0 1.9657802052819306e-09

The O 0 2.3078354505212673e-10
identification O 0 4.06467942637434e-10
of O 0 1.0365119873512185e-09
common O 0 1.433826724017706e-09
BRCA1 O 0 1.5410791531778045e-09
and O 0 6.818670628128132e-11
BRCA2 O 0 1.4905394973840913e-10
mutations O 0 7.012616941130811e-13
will O 0 6.530979777168502e-14
facilitate O 0 2.712742411346142e-13
carrier O 0 1.1730150000204692e-13
detection O 0 1.0471519484855918e-11
in O 0 1.2898368354288814e-13
French O 0 1.2229038892641597e-09
Canadian O 0 2.4914013962984427e-08
breast B-Disease 1 0.9981909394264221
cancer I-Disease 1 0.9778655767440796
and O 0 3.5606775782071054e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.0193621708131104e-07
. O 0 2.8358858372712348e-08

Are O 0 6.599714663657608e-10
Dp71 O 0 1.5707175293755427e-07
and O 0 5.213560139161189e-10
Dp140 O 0 9.72240172814054e-08
brain O 0 4.120715502153871e-08
dystrophin O 0 1.1458188176050044e-08
isoforms O 0 4.9310340533015307e-11
related O 0 3.3537680011602733e-12
to O 0 2.5398611165627916e-12
cognitive B-Disease 1 0.9998663663864136
impairment I-Disease 1 1.0
in O 0 4.7537039790768176e-05
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 0 2.2187537979334593e-05

Molecular O 0 1.4678513959864858e-09
study O 0 4.036090905934486e-12
and O 0 7.3178979152419e-13
neuropsychological O 0 2.0501869091305025e-09
analysis O 0 2.528632468343228e-12
were O 0 8.249497547747897e-13
performed O 0 1.0683851806719824e-12
concurrently O 0 7.33164505668793e-13
on O 0 6.04559458050602e-11
49 O 0 5.769894007023879e-10
patients O 0 1.7409759744957398e-10
with O 0 7.01363802591004e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.001054665888659656
DMD B-Disease 1 1.0
) O 0 3.7710142625733967e-13
in O 0 9.738669153871657e-14
order O 0 5.032660486264939e-13
to O 0 4.215719909121153e-14
find O 0 1.234452671377076e-13
a O 0 7.077178469996892e-14
molecular O 0 8.800844168016519e-13
explanation O 0 1.0254350943676369e-13
for O 0 1.2825770346225774e-14
the O 0 1.8892114435342666e-12
cognitive B-Disease 0 2.233092999404107e-07
impairment I-Disease 0 2.9502723819518906e-08
observed O 0 1.1732171224104748e-12
in O 0 4.1983118370669814e-12
most O 0 3.997542852296476e-10
DMD B-Disease 1 1.0
patients O 0 7.234481103068902e-08
. O 0 5.711787043338745e-09

Complete O 0 2.9542293056294966e-09
analysis O 0 2.3871316381929297e-11
of O 0 1.466368249047889e-09
the O 0 8.267514450821523e-10
dystrophin O 0 2.909045626608986e-08
gene O 0 1.1679646139128863e-10
was O 0 6.663537083229087e-11
performed O 0 1.6077880346521134e-11
to O 0 4.161699197063884e-13
define O 0 9.355883255623976e-12
the O 0 1.2044119174214885e-11
localization O 0 6.53536957884171e-09
of O 0 6.725336954005456e-11
deletions O 0 1.2792782458359575e-11
and O 0 2.2154964494924823e-12
duplications O 0 5.237820177583785e-10
in O 0 1.4122638822278155e-11
relation O 0 1.6804742319909138e-10
to O 0 1.1972886224120849e-11
the O 0 1.379223846242894e-09
different O 0 2.857625025498578e-09
DMD B-Disease 1 1.0
promoters O 0 0.000170771949342452
. O 0 1.0178830933682548e-07

Qualitative O 0 1.9799022421551626e-09
analysis O 0 6.75521374948751e-11
of O 0 3.892389965898246e-09
the O 0 6.869715907242835e-10
Dp71 O 0 1.001893963348266e-07
transcript O 0 1.8218435648975628e-09
and O 0 1.3369157343678939e-11
testing O 0 6.575912731010547e-11
for O 0 1.203327476724525e-12
the O 0 3.6678511790289026e-12
specific O 0 1.3172580430945158e-12
first O 0 1.4781382715045588e-11
exon O 0 9.592423522164495e-10
of O 0 4.665139941018026e-10
Dp140 O 0 8.321609179517964e-09
were O 0 1.11737274988144e-09
also O 0 1.1666659825715353e-11
carried O 0 3.897005981801094e-11
out O 0 5.156929883121109e-10
. O 0 6.33550589768106e-09

Neuropsychological O 0 3.831048616120825e-06
analysis O 0 2.556271028186785e-10
assessed O 0 7.184146610939024e-10
verbal O 0 1.0718812504251218e-09
and O 0 8.533659889842227e-11
visuospatial O 0 1.9392145134133898e-07
intelligence O 0 1.8724317929486034e-10
, O 0 9.004332869599896e-12
verbal O 0 1.9968584563656577e-09
memory O 0 0.0009091291576623917
, O 0 2.29607291513112e-10
and O 0 2.032792267847583e-10
reading O 0 1.746056597085044e-07
skills O 0 8.546377472384847e-08
. O 0 1.535487648141043e-08

Comparison O 0 1.041569497317596e-09
of O 0 2.2201784855013784e-09
molecular O 0 1.6384438250582889e-09
and O 0 1.961190411459146e-11
psychometric O 0 9.63920072649671e-08
findings O 0 8.730361052144975e-12
demonstrated O 0 1.2488550991951453e-11
that O 0 9.869227424229646e-14
deletions O 0 6.006169520067495e-12
and O 0 5.854091950779905e-12
duplications O 0 1.0803828942584914e-09
that O 0 2.1347142803440633e-12
were O 0 1.23492249412549e-11
localized O 0 2.1915187442544948e-09
in O 0 4.4568260193500464e-10
the O 0 3.8938280377820433e-10
distal O 0 4.740953463144848e-11
part O 0 1.2354225975563793e-10
of O 0 7.939489954367218e-09
the O 0 2.486258976475142e-09
gene O 0 3.9909528459780574e-10
seemed O 0 3.2266054411644873e-11
to O 0 8.163887860006269e-14
be O 0 1.2275168945544146e-13
preferentially O 0 7.416257278430871e-13
associated O 0 4.262798881243812e-12
with O 0 2.3913060767655203e-11
cognitive B-Disease 1 0.9999979734420776
impairment I-Disease 1 0.9999992847442627
. O 0 3.061881770349828e-08

Two O 0 1.1457402138148609e-08
altered O 0 5.529785518376684e-09
Dp71 O 0 5.182196716191356e-08
transcripts O 0 1.1932500543210267e-09
and O 0 1.6371678318582994e-11
two O 0 4.133199425077061e-12
deleted O 0 1.1541080591204178e-11
Dp140 O 0 2.888078387552895e-10
DNA O 0 9.223843910888263e-12
sequences O 0 7.72013583703185e-13
were O 0 4.462177968702491e-13
found O 0 3.1095680636536796e-14
in O 0 9.115886485337038e-14
four O 0 5.475411356953286e-12
patients O 0 9.501332012828989e-12
with O 0 3.662875211474237e-11
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 2.1323950605278696e-08

These O 0 1.211518108057419e-10
findings O 0 2.4494527933738297e-11
suggest O 0 6.4320753584423684e-12
that O 0 1.7230287292432922e-13
some O 0 1.5849565312541641e-13
sequences O 0 1.95845336475875e-12
located O 0 1.3156072065090285e-10
in O 0 3.349480415248962e-11
the O 0 1.7626676507287442e-10
distal O 0 2.233513027305456e-11
part O 0 9.660643812692271e-12
of O 0 9.640754861095502e-10
the O 0 9.660316990789397e-11
gene O 0 3.758600635589415e-12
and O 0 2.983982689847703e-13
, O 0 2.2401907260639897e-14
in O 0 8.315796781645929e-14
particular O 0 1.6961547184141113e-12
, O 0 2.2165277425989505e-12
some O 0 2.5020742422388054e-11
DMD B-Disease 1 1.0
isoforms O 0 1.21226295668464e-09
expressed O 0 1.0573293109106263e-11
in O 0 1.0301173976323685e-11
the O 0 1.8922173550262045e-10
brain O 0 4.016935228889906e-09
may O 0 2.760039592708541e-12
be O 0 2.695242066910828e-14
related O 0 6.700691298480374e-14
to O 0 2.364362367999681e-14
the O 0 2.7839919605754382e-11
cognitive B-Disease 1 0.8477500677108765
impairment I-Disease 0 0.0002688150270842016
associated O 0 3.650824365042382e-10
with O 0 1.0817679391150747e-10
DMD B-Disease 1 1.0
. O 0 1.05577457887307e-09
. O 0 2.679870769739523e-09

I1307K O 0 1.0668528602764127e-06
APC O 0 6.983736255961048e-08
and O 0 2.9717856647737406e-11
hMLH1 O 0 7.432529258721843e-09
mutations O 0 6.783813788491244e-11
in O 0 1.262294695852928e-11
a O 0 4.471605724587491e-11
non O 0 1.9130311557091773e-08
- O 0 4.5780833984876423e-11
Jewish O 0 4.262833488977158e-11
family O 0 4.3891959836638017e-13
with O 0 2.1991106852192743e-12
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.220018798965611e-07

We O 0 4.285286570038238e-10
describe O 0 1.673366480103855e-11
a O 0 3.95849412276883e-12
French O 0 4.5265274861705507e-10
Canadian O 0 3.2281108897080912e-09
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.675365928794804e-09
HNPCC B-Disease 0 3.567819248928572e-06
) O 0 4.231156440839823e-13
kindred O 0 6.150038811547631e-10
which O 0 1.3217983565322333e-12
carries O 0 1.0246496576563069e-12
a O 0 5.776535933615934e-13
novel O 0 1.9414710724502404e-12
truncating O 0 6.272820596286977e-10
mutation O 0 2.2280665160079316e-11
in O 0 2.2421006024009316e-11
hMLH1 O 0 6.504519234340478e-08
. O 0 1.6496205290650323e-08

Interestingly O 0 2.8450293232396007e-09
, O 0 3.4588970576621136e-11
the O 0 1.109717664982135e-10
I1307K O 0 1.6583747708409646e-08
APC O 0 9.689146152069839e-10
polymorphism O 0 2.120698061602866e-11
, O 0 3.402163398008237e-14
associated O 0 1.6595753905227634e-14
with O 0 6.725858235530075e-16
an O 0 9.21267655905496e-16
increased O 0 3.544143494307872e-12
risk O 0 5.72978020585424e-09
of O 1 0.9716320037841797
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.1382510489710285e-09
is O 0 1.3138405294266242e-12
also O 0 9.895163573074572e-14
present O 0 2.5779730997502193e-13
in O 0 5.088704631284191e-12
this O 0 9.874320978930928e-12
family O 0 5.926084623020245e-11
. O 0 2.4141397769739115e-09

The O 0 6.877507008340444e-09
I1307K O 0 1.485047107507853e-08
polymorphism O 0 1.3447460922577648e-08
has O 0 3.14388827471479e-11
previously O 0 4.763523256401392e-11
only O 0 6.335673630696037e-13
been O 0 3.3533378439483397e-13
identified O 0 2.7861670219217483e-13
in O 0 2.3824079644838014e-13
individuals O 0 9.236228860724782e-14
of O 0 3.0469429201929188e-09
self O 0 1.2005293683614582e-06
- O 0 1.7904751459241197e-08
reported O 0 1.000848404153487e-09
Ashkenazi O 0 1.6074339637128787e-09
Jewish O 0 1.2319264497406834e-09
origins O 0 3.8526540180328084e-08
. O 0 9.582758053738871e-08

In O 0 2.0262271027693401e-10
addition O 0 2.1933061269963083e-11
, O 0 1.7585220389235157e-12
in O 0 7.369924982791876e-12
this O 0 2.6189311136404214e-12
family O 0 3.960397114421976e-12
, O 0 1.6986542381025593e-12
there O 0 2.9899051984250136e-11
appears O 0 4.6664525542305935e-12
to O 0 1.683750659514302e-13
be O 0 3.185278646747336e-13
no O 0 3.533881629165514e-13
relationship O 0 2.748572574171027e-15
between O 0 4.086953215090561e-13
the O 0 7.744592293856822e-12
I1307K O 0 4.938357014983019e-11
polymorphism O 0 5.4565543056162014e-11
and O 0 5.02829440411634e-13
the O 0 5.370582884661745e-12
presence O 0 5.833761425322326e-12
or O 0 4.983013134063352e-12
absence O 0 7.080787955970891e-09
of O 0 1.5828369726023084e-08
cancer B-Disease 0 3.9619243352717604e-07
. O 0 8.987937616389274e-10
. O 0 6.357876447538047e-09

Identification O 0 1.7359765847047015e-09
of O 0 1.4277956594810348e-09
a O 0 9.678847133487434e-12
novel O 0 3.990362727746e-12
mutation O 0 2.2491925856515937e-12
of O 0 5.951956982830353e-11
the O 0 2.352330275012804e-10
CPO O 0 2.3444370071956655e-06
gene O 0 3.197700090828981e-11
in O 0 8.326376046974282e-12
a O 0 6.51631873460623e-11
Japanese O 0 1.0103105552161651e-07
hereditary B-Disease 1 0.9999879598617554
coproporphyria I-Disease 1 0.9998883008956909
family O 0 1.1136970812231084e-07
. O 0 1.2291462780922302e-07

Hereditary B-Disease 1 0.9999992847442627
coproporphyria I-Disease 1 0.999816358089447
( O 0 2.7619813636192703e-07
HCP B-Disease 1 0.5922182202339172
) O 0 2.8255136945432024e-12
is O 0 2.0965248580164658e-13
an O 0 5.748344508726966e-13
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 1.184677217436203e-10
by O 0 1.0369052757261757e-13
a O 0 2.5067028314174067e-11
deficiency B-Disease 0 6.331823669825098e-07
of I-Disease 0 1.8767940446196008e-06
coproporphyrinogen I-Disease 1 0.8132654428482056
oxidase I-Disease 0 5.395398972041221e-08
( O 0 1.099963978408447e-12
CPO O 0 7.841861702218011e-07
) O 0 1.3646660468596018e-14
caused O 0 5.271889695623866e-13
by O 0 2.7522670354254188e-14
a O 0 6.69137163213096e-13
mutation O 0 6.308373962093938e-13
in O 0 9.657213180178092e-13
the O 0 2.0613569184924074e-10
CPO O 0 5.793493528472027e-06
gene O 0 9.33197630281768e-10
. O 0 6.818907660743889e-10

Only O 0 8.851935295872693e-10
11 O 0 2.241863361618357e-09
mutations O 0 1.4003116374783353e-11
of O 0 5.568275840417414e-10
the O 0 1.6312493023029617e-10
gene O 0 1.6646344025428306e-11
have O 0 4.634465012275102e-13
been O 0 3.306920167388261e-13
reported O 0 6.938871352502041e-12
in O 0 8.382889937763593e-10
HCP B-Disease 1 0.9999998807907104
patients O 0 1.205671367188188e-07
. O 0 1.3786776165147785e-08

We O 0 9.734046901854754e-10
report O 0 1.4857871877271833e-11
another O 0 1.9948112172513133e-12
mutation O 0 9.91673149847161e-12
in O 0 5.57194654998705e-12
a O 0 2.4918170304921716e-10
Japanese O 0 4.791523906533257e-07
family O 0 5.31624877453396e-09
. O 0 4.4382698405343035e-08

Polymerase O 0 2.7101414445951377e-09
chain O 0 7.175112504143044e-09
reaction O 0 1.4906468420727848e-11
- O 0 1.807967317524195e-11
single O 0 5.453492258472581e-12
strand O 0 5.541898537297918e-12
conformational O 0 8.801712478431409e-14
polymorphism O 0 1.2117565251993506e-13
and O 0 1.0421425397313553e-15
direct O 0 2.0246005121970362e-14
sequence O 0 6.263697514222871e-14
analyses O 0 7.403707096183265e-13
demonstrated O 0 5.599347808332711e-12
a O 0 4.087002004188323e-12
C O 0 2.692817080429677e-10
to O 0 3.074117566406742e-12
T O 0 6.589548351421115e-11
substitution O 0 1.5708425228980194e-12
in O 0 7.696137292994426e-14
exon O 0 7.56671808543885e-12
1 O 0 3.5113684963145042e-12
of O 0 1.98778862293969e-12
the O 0 1.0022514068674937e-11
CPO O 0 1.1742537608938619e-08
gene O 0 9.276592081303159e-13
at O 0 1.2881613310755657e-11
nucleotide O 0 7.651886763104798e-11
position O 0 8.086505076665418e-11
85 O 0 2.0600363082046158e-10
, O 0 1.3706516390626922e-12
which O 0 2.4358182029553255e-13
lies O 0 5.567325680327917e-12
in O 0 6.576734057524292e-13
the O 0 2.204815323370024e-11
putative O 0 1.1727015192253276e-10
presequence O 0 1.3520005115452705e-09
for O 0 2.371502126619074e-11
targeting O 0 5.390847213071481e-10
to O 0 8.070481088973125e-11
mitochondria O 0 3.873808651633226e-08
. O 0 1.7590387813015695e-08

This O 0 2.4854741528801405e-11
mutation O 0 1.8594015216422122e-11
changes O 0 2.1420068409966353e-12
the O 0 1.0915793442756172e-11
codon O 0 2.072410125453228e-11
for O 0 9.457806716614559e-13
glutamine O 0 4.098039615985094e-12
to O 0 6.219652072016191e-13
a O 0 1.5409893847073697e-11
termination O 0 1.261689419607137e-09
codon O 0 2.0609531858895025e-09
at O 0 2.302666857190161e-08
amino O 0 3.2566468632921897e-08
acid O 0 1.0183268672747658e-09
position O 0 1.4685906934985837e-09
29 O 0 1.0585622334247091e-07
. O 0 1.0254298743461732e-08

MaeI O 0 6.813622235313233e-07
restriction O 0 4.747600090837523e-09
analysis O 0 2.6623876714371164e-11
showed O 0 2.1070954703272804e-10
two O 0 2.5796368079838983e-12
other O 0 5.289555685822345e-13
carriers O 0 9.857962970233336e-13
in O 0 1.8334849263834663e-11
the O 0 2.121210096461823e-09
family O 0 2.791300302007471e-09
. O 0 2.1089309854005478e-08

The O 0 2.16471312342037e-06
C O 1 0.9876063466072083
- O 0 0.0008602674934081733
T O 0 1.2211242506054987e-07
mutation O 0 5.946076530455313e-12
is O 0 7.688474863546974e-15
located O 0 4.1834713319401085e-14
within O 0 1.5708177217733238e-13
a O 0 2.1652386101526228e-13
recently O 0 7.455771568708192e-13
proposed O 0 7.105544993536717e-13
putative O 0 4.238654566224298e-12
alternative O 0 7.127335180379113e-12
translation O 0 2.6974869820478586e-12
initiation O 0 1.1852914483245769e-11
codon O 0 1.844883135149189e-10
( O 0 1.9650910672991406e-12
TIC O 0 2.3145713123895462e-10
- O 0 2.2498469753884365e-10
1 O 0 4.735370429109764e-10
) O 0 3.310004180467896e-14
, O 0 6.135825354747215e-14
supporting O 0 6.757655416148034e-13
that O 0 3.450867250374273e-13
TIC O 0 2.949807897945078e-10
- O 0 3.5757549698978153e-10
1 O 0 1.4576317930448113e-09
is O 0 4.5153794982558115e-13
the O 0 5.7729706431919325e-12
real O 0 1.3432048806549801e-09
TIC O 0 2.7819775372250888e-09
rather O 0 1.0323734055128764e-11
than O 0 3.502269817472897e-13
TIC O 0 7.687790404276029e-10
- O 0 6.765894511318038e-10
2 O 0 1.7444969913071873e-09
. O 0 1.799861128193303e-11
. O 0 2.039896168648525e-10

Human B-Disease 0 3.5765341799276484e-09
complement I-Disease 0 5.630778954213156e-09
factor I-Disease 0 1.9364311754088703e-07
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999793767929077
associated O 0 7.29296019130743e-08
with O 0 2.0059991356902174e-07
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00013258868420962244

This O 0 3.686570580058168e-12
study O 0 2.399005744491839e-13
reports O 0 6.713487730146406e-13
on O 0 1.464558509189917e-11
six O 0 4.0864876586776955e-12
cases O 0 1.1662383298666201e-12
of O 0 1.2488468037474831e-09
deficiency B-Disease 0 4.7865547969649924e-08
in I-Disease 0 1.295467483286572e-10
the I-Disease 0 2.692909506496477e-10
human I-Disease 0 6.081168901772571e-11
complement I-Disease 0 3.950741817027037e-11
regulatory I-Disease 0 2.4746205085079964e-09
protein I-Disease 0 1.4788391622388986e-09
Factor I-Disease 0 3.804454806743962e-10
H I-Disease 1 0.9999998807907104
( O 0 1.2640817212417055e-12
FH O 0 3.3801011989353924e-10
) O 0 2.768174081240794e-16
in O 0 5.542130221137783e-16
the O 0 4.963162449382261e-15
context O 0 2.8263246506631673e-14
of O 0 2.4358274186737916e-13
an O 0 3.091658005993647e-12
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.546274740529043e-07

Five O 0 8.230198744740846e-09
of O 0 6.638844141093614e-09
the O 0 1.2312870167896506e-10
cases O 0 1.5780436853074509e-12
were O 0 5.107147343919038e-13
observed O 0 3.2454274727714005e-13
in O 0 5.932194568469135e-14
children O 0 1.33752926269326e-13
presenting O 0 4.900973377131024e-11
with O 0 4.615224036275123e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.002444556215777993
HUS B-Disease 1 1.0
) O 0 1.7442491184738174e-07
. O 0 3.8791552015027264e-07

Two O 0 5.658766163985085e-11
of O 0 4.5216949629001135e-10
the O 0 7.978069593850279e-11
children O 0 8.288311443421792e-13
exhibited O 0 3.414378779709182e-10
a O 0 2.6171159683840983e-10
homozygous O 0 0.14274200797080994
deficiency O 1 0.9990153312683105
characterized O 0 5.846911843576663e-10
by O 0 1.4814766167298155e-12
the O 0 4.107089390803509e-10
absence O 0 3.2039441322240236e-08
of O 0 5.7173814127509104e-08
the O 0 1.010259653710932e-09
150 O 0 2.147342026415089e-11
- O 0 3.4249807850939007e-12
kD O 0 2.636333339134378e-11
form O 0 6.719614448202904e-12
of O 0 6.906343830159756e-10
Factor O 0 1.6106196376597381e-09
H O 1 1.0
and O 0 1.4418332847099258e-11
the O 0 4.945263382821752e-12
presence O 0 5.166599570047281e-13
, O 0 3.1036428987810463e-14
upon O 0 1.8638912570485833e-13
immunoblotting O 0 1.0993673332793108e-10
, O 0 6.866823190794513e-13
of O 0 3.0173179926817895e-11
the O 0 3.072020762773242e-11
42 O 0 1.4456176533617082e-10
- O 0 3.9991877864853365e-11
kD O 0 1.9518062166490324e-10
Factor O 0 1.9715580557022605e-10
H O 1 0.6840463280677795
- O 0 9.817316959370714e-10
like O 0 1.9830257227959613e-11
protein O 0 2.6679605746871005e-10
1 O 0 1.740379285131155e-09
( O 0 6.039214809662463e-13
FHL O 0 5.1381801036143315e-09
- O 0 5.7387180944779015e-12
1 O 0 1.90650811110471e-11
) O 0 4.3121032799694516e-15
and O 0 4.1305388878134716e-14
other O 0 3.023080917541332e-13
FH O 0 2.7160215410049204e-08
- O 0 1.9495988157203215e-11
related O 0 1.3518418155722411e-11
protein O 0 6.29559113174416e-11
( O 0 2.83958051299979e-13
FHR O 0 2.33800978577392e-08
) O 0 1.7178744321152961e-12
bands O 0 2.379324737233901e-09
. O 0 1.3363741224736714e-09

Southern O 0 7.523355272098797e-09
blot O 0 6.1212062085758134e-09
and O 0 1.2262894692749438e-11
PCR O 0 6.024598181442187e-11
analysis O 0 3.64459222350344e-13
of O 0 1.4285950027115302e-11
DNA O 0 3.0963391572935706e-11
of O 0 1.42300990435551e-10
one O 0 1.1105402621808258e-12
patient O 0 1.1606732935875996e-11
with O 0 4.220109071223499e-12
homozygous O 0 3.6969282518839464e-05
deficiency O 0 0.12633076310157776
ruled O 0 5.9687906173167e-08
out O 0 1.2228979981432353e-11
the O 0 7.253796955458691e-12
presence O 0 1.621448418240301e-12
of O 0 1.2802307824966164e-10
a O 0 4.0818451049751125e-12
large O 0 7.599198505701954e-13
deletion O 0 1.1920114201258158e-11
of O 0 4.119265206714573e-10
the O 0 4.500135819540674e-09
FH O 0 4.275741048331838e-06
gene O 0 7.090457387892712e-11
as O 0 4.926970290086707e-12
the O 0 5.111255516054847e-11
underlying O 0 2.040148956439225e-06
defect O 0 7.06799846739159e-06
for O 0 1.6434515970331631e-09
the O 0 4.548446668195538e-06
deficiency O 1 0.9999995231628418
. O 0 5.582339213106025e-07

The O 0 3.445376206556716e-09
other O 0 1.002681618289536e-11
four O 0 1.3498193014715998e-11
children O 0 2.6143781692473944e-13
presented O 0 7.951056479882368e-12
with O 0 6.397461553564465e-12
heterozygous O 0 1.4062496802580426e-06
deficiency O 0 5.191279706195928e-05
and O 0 1.0891834309467718e-11
exhibited O 0 4.521559127113051e-09
a O 0 9.860098154623742e-11
normal O 0 1.6487010645604983e-09
immunoblotting O 0 1.8246195665483356e-08
pattern O 0 6.669287899718768e-10
of O 0 7.573714433384282e-10
proteins O 0 2.8882861380363778e-11
of O 0 4.369491879430143e-09
the O 0 3.929719838424717e-08
FH O 0 0.0004022944194730371
family O 0 9.99911486943006e-10
. O 0 1.3692877054438668e-08

Factor B-Disease 0 0.0006847989279776812
H I-Disease 1 1.0
deficiency I-Disease 1 0.7814508676528931
is O 0 6.8365599639741426e-12
the O 0 9.438871559352968e-12
only O 0 3.933643688558419e-11
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 5.124187296701166e-08
with O 0 2.536494347893381e-10
HUS B-Disease 1 1.0
. O 0 5.63196351777151e-08

These O 0 3.117625602122587e-11
observations O 0 2.995219350321321e-11
suggest O 0 3.109881449581131e-11
a O 0 2.131101501864907e-12
role O 0 2.8663874659246025e-12
for O 0 1.0960544104265946e-11
FH O 0 1.5510373714278103e-06
and O 0 1.7498981430552618e-10
/ O 0 6.304347976993085e-08
or O 0 6.554878861919633e-10
FH O 0 6.997122454777127e-07
receptors O 0 1.8262242846428522e-12
in O 0 2.5457137483100856e-13
the O 0 6.213086902601139e-12
pathogenesis O 0 3.078495751651644e-07
of O 0 1.4702442596714604e-09
idiopathic O 1 0.9999973773956299
HUS B-Disease 1 1.0
. O 0 9.098886089020652e-09
. O 0 1.5026211386270916e-08

Further O 0 7.722646133689892e-11
evidence O 0 2.2211503469815597e-11
for O 0 3.4527103940674986e-13
a O 0 6.260356274177814e-13
major O 0 1.3890910990910221e-11
ancient O 0 2.0308933701418397e-10
mutation O 0 3.0890289508533897e-06
underlying O 1 0.999998927116394
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 2.168986934503181e-10
linkage O 0 1.0281088869135147e-08
disequilibrium O 0 3.820060712200757e-09
studies O 0 5.514722793004134e-13
in O 0 2.284001167449784e-13
the O 0 3.1779134445492074e-12
Japanese O 0 9.187682281641685e-10
population O 0 7.745745017606609e-12
. O 0 1.0150902340910761e-09

The O 1 0.5081234574317932
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9997825026512146
DM B-Disease 1 1.0
) O 0 3.0311041870900723e-11
mutation O 0 3.2286496393085784e-11
is O 0 1.2151958855410178e-13
an O 0 4.602731634413895e-14
unstable O 0 7.248810995896804e-10
( O 0 6.205033448863917e-12
CTG O 0 5.996702867605563e-08
) O 0 1.8861392211532574e-13
n O 0 2.3627254666647168e-11
repeat O 0 1.651829090176804e-10
, O 0 1.923960123162427e-13
present O 0 6.23737715123307e-13
at O 0 8.123557382333502e-12
a O 0 1.638678071274463e-13
copy O 0 1.1492353292966162e-12
number O 0 1.5219755794201872e-12
of O 0 2.749794662804117e-11
5 O 0 3.196859998944035e-10
- O 0 1.9006369395002665e-11
37 O 0 1.09920744381653e-11
repeats O 0 2.141350291529065e-11
on O 0 1.4393281011493286e-10
normal O 0 5.6631286465824715e-11
chromosomes O 0 9.37611858813081e-13
but O 0 2.638523893729733e-13
amplified O 0 1.3078930299892377e-11
to O 0 4.257265547036315e-12
50 O 0 1.5197869351890603e-10
- O 0 1.629248992662813e-11
3000 O 0 8.233295122062056e-12
copies O 0 5.301490149656196e-11
on O 0 1.902188628832846e-08
DM B-Disease 1 0.9992400407791138
chromosomes O 0 4.009747645028483e-09
. O 0 3.467170328619318e-09

Previous O 0 1.3959669864505031e-08
findings O 0 3.113157301393166e-11
in O 0 3.3680762172305645e-12
Caucasian O 0 2.4668952991468984e-10
populations O 0 2.859513840991479e-11
of O 0 4.081835314195814e-09
a O 0 1.9279932530480437e-06
DM B-Disease 1 1.0
founder O 0 0.14697454869747162
chromosome O 0 2.2059602997615e-06
raise O 0 6.036586785995723e-10
a O 0 8.339599844031653e-12
question O 0 1.718736372842422e-12
about O 0 9.315554851487863e-15
the O 0 1.1968223721098292e-12
molecular O 0 1.0858440015193427e-11
events O 0 4.875257315906101e-12
involved O 0 2.2928716217340828e-12
in O 0 3.1956620509532296e-12
the O 0 6.20873075174444e-11
expansion O 0 7.042106009436111e-09
mutation O 0 3.795686431828926e-09
. O 0 2.2050994363809195e-09

To O 0 1.772147151246628e-10
investigate O 0 9.1023834303261e-11
whether O 0 4.979994541742805e-11
a O 0 1.2544588978702365e-10
founder O 0 3.003906901000164e-09
chromosome O 0 7.399229007276631e-10
for O 0 2.5569538153469296e-10
the O 0 2.0822976409817784e-07
DM B-Disease 1 1.0
mutation O 0 2.068067522786876e-10
exists O 0 2.888780577595118e-12
in O 0 1.633984017968687e-13
the O 0 1.771604564437812e-12
Japanese O 0 2.335297788480517e-10
population O 0 7.337409217537949e-13
, O 0 2.7938209471584097e-12
we O 0 2.994408193623954e-11
genotyped O 0 5.899430721711951e-09
families O 0 1.5277459202225896e-12
using O 0 1.3543678982139151e-12
polymorphic O 0 1.2561779394459904e-10
markers O 0 3.369763079685839e-10
near O 0 6.470614266618213e-08
the O 0 8.931305139903145e-10
( O 0 2.502016996364098e-11
CTG O 0 2.9009116886413722e-08
) O 0 1.1115065031569449e-12
n O 0 1.3353211592015413e-10
repeat O 0 1.5308898593247022e-09
region O 0 8.009406471387592e-10
and O 0 9.785194876599235e-11
constructed O 0 4.917788842817572e-08
haplotypes O 0 1.7485427861174685e-07
. O 0 1.5622999782749503e-08

Six O 0 2.1387278614781735e-09
different O 0 2.878242999840297e-12
haplotypes O 0 5.6920694824214024e-09
were O 0 8.892955816186543e-10
found O 0 4.2693022728190755e-11
and O 0 5.631763944080603e-10
DM B-Disease 1 1.0
alleles O 0 3.175602003580025e-10
were O 0 5.491199162044325e-10
always O 0 2.4262700182298147e-10
haplotype O 0 2.8727642487069716e-08
A O 0 1.8594278117234353e-07
. O 0 1.6695432591973258e-08

To O 0 8.731926640082044e-12
find O 0 8.846047267092871e-13
an O 0 4.898738817479993e-15
origin O 0 2.49573257025959e-13
of O 0 5.7922087265405153e-11
the O 0 4.044153206761436e-11
( O 0 1.3562755519364034e-12
CTG O 0 7.653937927898369e-09
) O 0 1.3591623486408633e-13
n O 0 1.182812320310589e-10
repeat O 0 1.3835871337519734e-09
mutation O 0 1.8235590121262746e-11
and O 0 2.1845445916622575e-13
to O 0 7.604444282388254e-14
investigate O 0 1.5849998180259006e-12
the O 0 6.1474757576118755e-12
mechanism O 0 2.7048918660455e-11
of O 0 1.6522630486015544e-11
the O 0 5.466249414914914e-12
expansion O 0 3.324295699824731e-11
mutation O 0 4.2382075496685823e-13
in O 0 1.0559839135927673e-13
the O 0 8.984804545329739e-13
Japanese O 0 4.122941918427436e-11
population O 0 5.920065734290811e-14
we O 0 2.523023565244309e-13
have O 0 9.586422774305811e-14
studied O 0 2.40224090619634e-11
90 O 0 2.548371513810821e-09
Japanese O 0 5.131777243150282e-07
DM B-Disease 1 1.0
families O 0 2.165843893120467e-11
comprising O 0 4.1325786542811827e-11
190 O 0 7.117720302041164e-11
affected O 0 1.4487414740083082e-11
and O 0 9.402790178414389e-12
130 O 0 8.655262062617908e-10
unaffected O 0 5.18663171078515e-07
members O 0 5.830652627381028e-10
. O 0 3.2279507955479403e-09

The O 0 5.078272380387716e-08
results O 0 2.078056393628458e-09
suggest O 0 6.041686595459339e-11
that O 0 4.066681616021056e-13
a O 0 4.98885221328349e-12
few O 0 2.7153581032973717e-12
common O 0 1.771830945851427e-12
ancestral O 0 1.3307895584124818e-11
mutations O 0 1.3733567234830435e-13
in O 0 1.5617299391635503e-13
both O 0 6.080628622145978e-13
Caucasian O 0 5.2710301401415194e-11
and O 0 5.438576238664394e-12
Japanese O 0 1.1483086481689497e-08
populations O 0 3.256691791242439e-11
have O 0 6.188350884245991e-14
originated O 0 1.6496249556781882e-14
by O 0 8.551434571308497e-15
expansion O 0 2.683657983337806e-11
of O 0 2.4442255511236688e-11
an O 0 6.926566525206068e-14
ancestral O 0 2.7812002700855487e-11
n O 0 3.5025024547330474e-10
= O 0 4.874127768061953e-10
5 O 0 4.3326917054109515e-10
repeat O 0 2.369464069396088e-10
to O 0 5.3468601074468936e-12
n O 0 6.782898687163197e-10
= O 0 6.026693588623289e-10
19 O 0 2.250156949656912e-09
- O 0 1.1192919507907462e-10
37 O 0 9.727062905140471e-11
copies O 0 4.090601746220557e-10
. O 0 7.322600303893978e-10

These O 0 5.1296748099227685e-11
data O 0 4.503256795240773e-11
support O 0 1.510406036353551e-11
multistep O 0 1.0971872299592178e-09
models O 0 5.253107393521361e-10
of O 0 2.830145673371476e-09
triplet O 0 2.430687402465992e-07
repeat O 0 1.515758718539928e-08
expansion O 0 9.65663771168579e-10
that O 0 1.1664295831298466e-12
have O 0 1.4930523722749e-13
been O 0 1.3048419224455376e-13
proposed O 0 5.85645681255853e-13
for O 0 6.901329551237123e-13
both O 0 4.236112849387297e-10
DM B-Disease 1 1.0
and O 0 7.078600816612379e-09
Friedreichs B-Disease 1 0.5620808005332947
ataxia I-Disease 1 1.0
. O 0 1.0270333206108262e-07
. O 0 5.2900539060374285e-08

The O 0 5.421675955408212e-11
molecular O 0 4.5570353046642254e-11
basis O 0 5.665367619478445e-10
of O 0 1.3717988622374833e-05
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 7.370467014489179e-10
the O 0 1.0521596094381636e-10
western O 0 2.341287719254126e-10
Cape O 0 3.900400891154732e-09
, O 0 1.702530260869195e-12
South O 0 6.953451703317626e-10
Africa O 0 3.664449299556338e-10
. O 0 6.98978042112941e-10

Deficiency B-Disease 0 5.8224732129019685e-06
of I-Disease 0 2.445843563236849e-07
the I-Disease 0 1.9875716628092732e-09
sixth I-Disease 0 1.2747400468526848e-08
component I-Disease 0 1.156085449594002e-09
of I-Disease 0 3.668003234480466e-09
human I-Disease 0 9.533746014867006e-10
complement I-Disease 0 1.8860810135912232e-10
( O 0 4.910498396792917e-11
C6 O 0 4.415675903146621e-06
) O 0 5.631433362164595e-13
has O 0 1.573552486228147e-13
been O 0 8.980242629163734e-14
reported O 0 6.733977660428395e-14
in O 0 2.1750735435845103e-13
a O 0 4.04387162861522e-13
number O 0 2.179526524537234e-12
of O 0 1.047550032828859e-10
families O 0 2.2349753748011555e-14
from O 0 1.4610274795545664e-13
the O 0 2.2228371920895995e-11
western O 0 4.915935991611775e-10
Cape O 0 1.6088856469309576e-08
, O 0 1.8351292707663447e-11
South O 0 3.3160791890196606e-09
Africa O 0 2.8384223860200564e-09
. O 0 3.1003846157062753e-09

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999699592590332
is O 0 1.1315913484022389e-11
endemic O 0 1.1284257556143373e-10
in O 0 6.444576209491126e-12
the O 0 1.673335359164696e-10
Cape O 0 3.048950247830362e-08
and O 0 1.3131239802108285e-12
almost O 0 3.368838953458908e-13
all O 0 1.1885276291791202e-13
pedigrees O 0 3.0441749815368624e-11
of O 0 2.3644078361861887e-10
total O 0 3.787899186136201e-05
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 4.463912850471985e-10
C6Q0 O 0 5.0409917093929835e-06
) O 0 5.119075194119638e-13
have O 0 6.358696663828767e-14
been O 0 3.427513061240485e-14
ascertained O 0 1.649202649445236e-11
because O 0 2.0983450979387974e-13
of O 0 9.562314828848173e-11
recurrent O 1 0.9999932050704956
disease O 1 0.9999967813491821
. O 0 4.003101494731709e-08

We O 0 8.791394834339883e-10
have O 0 9.323386247067633e-13
sequenced O 0 7.309897825935607e-11
the O 0 4.728885252130999e-12
expressed O 0 7.2672436644827254e-12
exons O 0 2.488732064875876e-08
of O 0 2.115905317623401e-08
the O 0 2.508108032373002e-08
C6 O 0 4.206289759167703e-06
gene O 0 1.9769567927152565e-11
from O 0 1.59490107752569e-12
selected O 0 2.3987784415063773e-12
cases O 0 2.7917259975106246e-13
and O 0 3.6402985118498543e-13
have O 0 2.700054264372087e-13
found O 0 7.50571046287396e-13
three O 0 8.439895375460249e-13
molecular O 0 2.021522220729821e-07
defects O 0 0.0019985332619398832
leading O 0 9.033305353733923e-11
to O 0 2.3730394819315714e-12
total O 0 1.4464264097568957e-07
deficiency O 1 0.8613656759262085
879delG O 0 3.4968868476425996e-06
, O 0 6.9673845685958025e-12
which O 0 1.583071374726755e-13
is O 0 2.4587543643889848e-14
the O 0 1.0687968522368752e-12
common O 0 3.025282108159999e-11
defect O 0 1.2661492965193588e-09
in O 0 5.3401332834879245e-12
the O 0 9.185785465604113e-11
Cape O 0 3.4454024078200973e-09
and O 0 1.0547586025075328e-12
hitherto O 0 8.754878072503303e-11
unreported O 0 1.6283915188486375e-11
, O 0 5.717563466949016e-13
and O 0 1.1950863475912454e-12
1195delC O 0 3.078744481577189e-10
and O 0 8.84311721072173e-12
1936delG O 0 7.404198920646365e-10
, O 0 1.3646987186144433e-12
which O 0 1.7300298292468458e-13
have O 0 5.4210887894586696e-14
been O 0 6.882620423023442e-14
previously O 0 1.1830728454190198e-12
reported O 0 4.016796931963912e-13
in O 0 1.2356269653290841e-11
African O 0 1.7152937958897496e-09
- O 0 4.711480539043578e-09
Americans O 0 8.5269274974209e-10
. O 0 8.338338908231435e-09

We O 0 1.12848708155866e-08
also O 0 3.2918702486117724e-11
show O 0 1.6277456812985314e-11
that O 0 1.2819541435338255e-13
the O 0 5.370889930716993e-12
879delG O 0 8.233178028227428e-10
and O 0 2.1122126617201253e-11
1195delC O 0 5.126010478306853e-07
defects O 0 0.0013340533478185534
are O 0 1.5246864101120527e-12
associated O 0 2.4142340904198534e-11
with O 0 4.4350304678753005e-11
characteristic O 1 0.999930739402771
C6 O 1 1.0
/ O 1 0.9995633959770203
C7 O 0 0.0027964781038463116
region O 0 3.4823354866375666e-08
DNA O 0 5.879379205708801e-09
marker O 0 3.710582285876285e-09
haplotypes O 0 4.2347964024358475e-10
, O 0 1.9502004178217902e-12
although O 0 3.1983450176492623e-12
small O 0 9.586008202500107e-13
variations O 0 3.218297572882278e-10
were O 0 1.1704026636749632e-09
observed O 0 6.720214162925231e-09
. O 0 5.8561338001084096e-09

The O 0 1.754277612064925e-08
1936delG O 0 8.006845177987998e-07
defect O 0 1.881431899164454e-06
was O 0 1.843508679044703e-09
observed O 0 5.410044287557092e-11
only O 0 1.448232376036196e-12
once O 0 7.134352570520308e-12
in O 0 2.2024521963148747e-12
the O 0 1.4319075092306122e-10
Cape O 0 1.858854581371361e-08
, O 0 1.3821185949197679e-12
but O 0 2.0504213290358647e-13
its O 0 2.0405788603988784e-12
associated O 0 1.7118995457310326e-11
haplotype O 0 3.5126113129280156e-10
could O 0 9.541035322913061e-11
be O 0 2.5923884566791955e-11
deduced O 0 1.422337692069675e-09
. O 0 1.7807543217784882e-09

The O 0 3.3690066292280108e-09
data O 0 3.1568084257749263e-10
from O 0 6.7673072007279345e-12
the O 0 3.7549838238781774e-11
haplotypes O 0 9.268890516223038e-11
indicate O 0 4.566699882829761e-12
that O 0 1.312389731394567e-13
these O 0 5.087091230031315e-13
three O 0 5.9975149846458464e-12
molecular O 0 6.104966843167858e-08
defects O 0 9.862121714832028e-07
account O 0 4.959543518055776e-13
for O 0 1.7888511852359734e-11
the O 0 1.638132118841895e-08
defects O 0 0.020975390449166298
in O 0 3.298138151475172e-10
all O 0 9.658700506065543e-10
the O 0 2.130243315079383e-09
38 O 0 3.3793552400851468e-09
unrelated O 0 9.470095818642221e-10
C6Q0 O 0 3.6441218753680005e-07
individuals O 0 7.063534869858334e-13
we O 0 6.5888410179237855e-12
have O 0 1.9912673940303272e-13
studied O 0 8.103427651118267e-11
from O 0 2.1279143377905818e-11
the O 0 8.338112422734412e-10
Cape O 0 4.794293886334344e-07
. O 0 4.245295670557425e-09

We O 0 1.1345446804256198e-09
have O 0 1.1827412963946737e-12
also O 0 3.018660421996201e-14
observed O 0 2.293159152150226e-13
the O 0 8.624169629302403e-13
879delG O 0 5.478561493355016e-10
defect O 0 1.8132737533704812e-09
in O 0 5.668564229122097e-11
two O 0 1.368023583303568e-09
Dutch O 1 0.9999986886978149
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 0.004414241295307875
, O 0 1.1278721880059184e-11
but O 0 1.1320635184483563e-12
the O 0 2.1743622527492512e-11
879delG O 0 1.9375832494006318e-08
defect O 0 3.6154011695543886e-07
in O 0 3.476001708691001e-10
the O 0 1.5225536387220018e-08
Cape O 0 1.6146701682373532e-06
probably O 0 1.1940190502990333e-10
did O 0 7.059133659559347e-12
not O 0 6.057164860830133e-13
come O 0 3.3902847434812144e-13
from O 0 4.874854317958588e-13
The O 0 6.946793834616827e-11
Netherlands O 0 1.2678317951042573e-08
. O 0 1.787198028457837e-10
. O 0 3.4749825239543952e-09

Complement B-Disease 1 0.9987200498580933
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.1660487020392907e-09
seven O 0 8.47086845112699e-11
further O 0 1.1363539449693594e-11
molecular O 0 2.637872285049525e-07
defects O 0 0.09298659861087799
and O 0 2.420990907747722e-10
their O 0 6.39412578440357e-10
associated O 0 1.0866971322798236e-08
marker O 0 3.0859322919241094e-07
haplotypes O 0 8.097382675487097e-08
. O 0 1.0698148145138475e-08

Seven O 0 8.925309935570169e-10
further O 0 8.749082187897717e-12
molecular O 0 3.192850428490601e-10
bases O 0 6.011863007415741e-09
of O 1 0.9657077789306641
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.956378430951645e-08
described O 0 5.170721184555305e-09
. O 0 6.453910295078913e-09

All O 0 2.2996536619412922e-10
these O 0 1.5506682309734954e-12
new O 0 2.8950316102727136e-11
molecular O 0 7.714277217019117e-09
defects O 0 6.996162227324021e-08
involve O 0 4.346228672097441e-12
single O 0 1.3599760206872702e-10
- O 0 1.4451655150349296e-10
nucleotide O 0 1.991727227590445e-09
events O 0 3.3069441629507423e-10
, O 0 8.739691262360516e-12
deletions O 0 9.937886624733494e-11
and O 0 2.488889823404339e-11
substitutions O 0 5.275357373157874e-10
, O 0 3.016029093139139e-11
some O 0 4.951162310001811e-12
of O 0 1.3428821388217216e-09
which O 0 1.865465247552489e-11
alter O 0 7.969005316743605e-11
splice O 0 6.155836396182224e-10
sites O 0 7.011447672455873e-11
, O 0 1.284405221069207e-11
and O 0 1.402528232441469e-10
others O 0 1.8800767609405966e-09
codons O 0 1.328735095285083e-07
. O 0 2.53183252141298e-08

They O 0 1.3463642700717315e-10
are O 0 1.1339885329581315e-13
distributed O 0 1.217757584224058e-13
along O 0 5.300577685107832e-12
the O 0 2.1489739154834098e-10
C7 O 0 4.4155567024972697e-07
gene O 0 2.4338515577926323e-11
, O 0 5.516384874934555e-13
but O 0 7.317307567158982e-14
predominantly O 0 7.781170591756106e-14
towards O 0 7.094414031932894e-13
the O 0 9.421748103921601e-12
3 O 0 3.4368041745835853e-09
end O 0 7.070261265340605e-09
. O 0 4.113818175000006e-09

All O 0 2.2809201638551713e-08
were O 0 2.5873769793349766e-09
found O 0 3.3071947957985515e-11
in O 0 3.046614349688781e-11
compound O 0 4.165423561630632e-09
heterozygous O 0 5.352497889354879e-10
individuals O 0 8.541340378032114e-12
. O 0 5.932174751421826e-09

The O 0 1.1501056178531144e-05
C6 O 1 0.9982859492301941
/ O 0 0.07970087230205536
C7 O 0 0.0001531129382783547
marker O 0 6.93269299745225e-08
haplotypes O 0 4.589383539865821e-09
associated O 0 3.128993730783236e-10
with O 0 1.1362245866397558e-10
most O 0 6.071650204830803e-08
C7 B-Disease 1 1.0
defects I-Disease 1 1.0
are O 0 2.1779744674432777e-10
tabulated O 0 1.2257348913635724e-08
. O 0 4.0329475869960163e-10
. O 0 4.671838471637102e-09

A O 0 8.022271913432633e-08
genome O 0 1.1350858031278221e-09
- O 0 1.0495459362713788e-10
wide O 0 3.489571132053726e-11
search O 0 6.150361036433294e-12
for O 0 1.109797041591587e-12
chromosomal O 0 6.053599577171553e-07
loci O 0 5.116273626981638e-09
linked O 0 4.286466293024205e-09
to O 0 2.0367032713131117e-11
mental O 1 0.9999996423721313
health O 0 1.7700631360639818e-05
wellness O 0 1.2230675565660931e-06
in O 0 1.9107809952345622e-12
relatives O 0 6.75142016945407e-13
at O 0 1.826528338300104e-11
high O 0 3.543344728740294e-09
risk O 0 3.3066809290716037e-09
for O 0 4.588383284431785e-10
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 3.9468875390191727e-10
the O 0 7.066267571076423e-10
Old O 0 6.456658496745149e-08
Order O 0 2.5261888580985215e-08
Amish O 0 4.506443076479627e-07
. O 0 9.073011675297948e-09

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 7.964880310851186e-09
BPAD B-Disease 1 1.0
; O 0 5.88044167670887e-06
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.9667433874142057e-12
is O 0 2.4443851280651734e-14
characterized O 0 1.598283544358356e-13
by O 0 1.1991608064605003e-14
episodes O 0 6.160299492741217e-10
of O 0 1.0902955693836702e-07
mania B-Disease 0 3.0059029541007476e-06
and O 0 4.268612407987149e-10
/ O 0 1.4722296270974766e-07
or O 0 2.426019940493518e-10
hypomania B-Disease 0 0.0008595391409471631
interspersed O 0 3.199509102103093e-09
with O 0 3.1159476041042744e-12
periods O 0 5.105884497424995e-07
of O 0 3.86902820537216e-06
depression B-Disease 1 0.9997126460075378
. O 0 1.196898296029758e-07

Compelling O 0 3.3741380800478282e-09
evidence O 0 3.805703252535153e-10
supports O 0 4.3616107253674485e-11
a O 0 6.892252610649074e-13
significant O 0 2.952506945527733e-12
genetic O 0 8.077810642603822e-11
component O 0 5.23412480024632e-10
in O 0 2.5615166238113218e-11
the O 0 2.665473120000428e-10
susceptibility O 0 1.178633812770613e-08
to O 0 7.05433211845019e-11
develop O 0 5.8647884770834935e-08
BPAD B-Disease 1 1.0
. O 0 2.643432424065395e-07

To O 0 4.106899195721603e-11
date O 0 8.491032765789441e-09
, O 0 2.5421826102545175e-12
however O 0 1.3924222018457666e-12
, O 0 1.9721041206316459e-13
linkage O 0 1.90756382911772e-10
studies O 0 3.251129400416719e-12
have O 0 9.20415544995723e-13
attempted O 0 4.291910576936786e-11
only O 0 5.324619868282698e-13
to O 0 5.415882586151666e-13
identify O 0 8.341285995250303e-12
chromosomal O 0 9.74746896531542e-08
loci O 0 3.982003338176554e-10
that O 0 3.5371673038492313e-12
cause O 0 8.079398261529036e-11
or O 0 2.8946918646799435e-13
increase O 0 1.4751015079556007e-12
the O 0 2.885230249161097e-11
risk O 0 9.073786166879927e-10
of O 0 1.3019879618880736e-09
developing O 0 2.0814339052321884e-07
BPAD B-Disease 1 1.0
. O 0 1.7796219253796153e-07

To O 0 9.047548127361082e-11
determine O 0 5.0231714621151724e-11
whether O 0 1.931204848815149e-11
there O 0 6.877880209810172e-11
could O 0 3.4538868293187974e-11
be O 0 4.139376775375014e-12
protective O 0 6.332757235272268e-11
alleles O 0 4.059513142307125e-13
that O 0 1.7568640701850873e-14
prevent O 0 1.0006087104719175e-11
or O 0 1.056466004088763e-12
reduce O 0 3.2091624496688453e-11
the O 0 2.3080764730010195e-11
risk O 0 1.1807836652888426e-10
of O 0 1.1674836097874675e-10
developing O 0 9.697137315356485e-09
BPAD B-Disease 1 1.0
, O 0 4.370243750217995e-12
similar O 0 1.6864374480229927e-13
to O 0 2.059372231121362e-14
what O 0 1.9276984183718392e-14
is O 0 7.442433285830637e-16
observed O 0 6.878430574549848e-15
in O 0 9.357368632929072e-15
other O 0 2.0534869377836218e-12
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 5.423842798502054e-13
we O 0 2.32342736630059e-13
used O 0 2.3681200229941357e-12
mental O 1 0.9997228980064392
health O 0 1.7130294054368278e-06
wellness O 0 6.847051849945274e-07
( O 0 1.3673497013463876e-14
absence O 0 6.4716387630781025e-12
of O 0 3.4755621991511276e-11
any O 0 7.400474899554865e-09
psychiatric B-Disease 1 1.0
disorder I-Disease 0 0.0009165414958260953
) O 0 2.364651206234695e-14
as O 0 1.302944297593145e-13
the O 0 3.653502847478229e-12
phenotype O 0 1.1787533622797941e-11
in O 0 4.048704947690052e-12
our O 0 5.440602135475814e-11
genome O 0 5.026458416157453e-11
- O 0 6.598062374241209e-11
wide O 0 2.4888102689857305e-10
linkage O 0 7.70672969885311e-10
scan O 0 1.1213866502046699e-09
of O 0 2.5429880423644136e-08
several O 0 3.060559305989585e-10
large O 0 8.461732980968861e-10
multigeneration O 0 2.7583908490669273e-07
Old O 0 3.7709810385422315e-07
Order O 0 1.4127616410064547e-08
Amish O 0 1.3824588585009678e-08
pedigrees O 0 5.686771054058681e-10
exhibiting O 0 2.2620456896493835e-10
an O 0 1.5144840676689642e-12
extremely O 0 1.519955133977291e-10
high O 0 1.1782561593065566e-08
incidence O 0 0.0014882937539368868
of O 0 5.189087096368894e-05
BPAD B-Disease 1 1.0
. O 0 1.113663620344596e-05

We O 0 9.348156027044752e-09
have O 0 3.7600436653129066e-11
found O 0 5.3681759558388276e-12
strong O 0 4.857158078519497e-12
evidence O 0 5.323444809968159e-12
for O 0 1.945556346236166e-12
a O 0 9.147019947031154e-12
locus O 0 1.1243674047367591e-10
on O 0 1.277214445316588e-09
chromosome O 0 7.123880152448692e-09
4p O 0 4.720460253793135e-07
at O 0 3.42541728315382e-09
D4S2949 O 0 2.3395789749969254e-09
( O 0 1.6248942295848945e-12
maximum O 0 9.804030920435025e-10
GENEHUNTER O 0 2.665633580534177e-08
- O 0 4.420808163985157e-11
PLUS O 0 2.487371073001121e-11
nonparametric O 0 1.1223105084168239e-10
linkage O 0 4.618056978489271e-11
score O 0 3.9873746665586296e-11
= O 0 1.4582727386747152e-11
4 O 0 4.8118117129680726e-11
. O 0 3.926196119521247e-13
05 O 0 4.1578812615128413e-10
, O 0 2.1674793036774442e-12
P O 0 7.841661764373953e-10
= O 0 1.3774925644582936e-11
5 O 0 6.205909484219285e-12
. O 0 2.5053464280922443e-14
22 O 0 5.307666198911543e-13
x O 0 3.758693876976249e-12
10 O 0 7.51469633047952e-12
( O 0 1.0313037452020293e-13
- O 0 8.345243983701178e-13
4 O 0 5.898138748239301e-12
) O 0 4.142592505466079e-15
; O 0 6.028057776384524e-15
SIBPAL O 0 1.107176364478768e-10
Pempirical O 0 9.381656562723606e-11
value O 0 1.0535748488915697e-11
< O 0 3.061783812596808e-11
3 O 0 1.0137736136672792e-11
x O 0 2.9386649363916106e-11
10 O 0 2.779895411086919e-11
( O 0 1.2772630717840239e-13
- O 0 1.2628382497700819e-12
5 O 0 3.0301080655020796e-12
) O 0 1.6607841700659663e-15
) O 0 7.511943456460285e-16
and O 0 1.8935313115652636e-14
suggestive O 0 2.9541047884794336e-13
evidence O 0 3.854628747267108e-13
for O 0 3.322243128929363e-14
a O 0 4.856395775972022e-13
locus O 0 1.6795696777816005e-11
on O 0 8.606206303163333e-10
chromosome O 0 2.405353072276739e-08
4q O 0 2.8881034452865606e-08
at O 0 2.1391184656938123e-10
D4S397 O 0 7.288906145319629e-10
( O 0 1.5643422971930998e-12
maximum O 0 1.5735196479127467e-09
GENEHUNTER O 0 8.11661919897233e-08
- O 0 4.566588773791125e-11
PLUS O 0 3.89804681588668e-11
nonparametric O 0 1.2076098454549822e-10
linkage O 0 3.6394273011941536e-11
score O 0 2.8721022088395998e-11
= O 0 5.2829849869762135e-12
3 O 0 6.656445360186947e-12
. O 0 6.373146368282567e-14
29 O 0 4.1887718987831946e-11
, O 0 1.198279648249867e-12
P O 0 4.6356654626045213e-10
= O 0 7.557256903600873e-12
2 O 0 5.435527028474496e-12
. O 0 4.377138300253047e-14
57 O 0 1.0968549202586275e-12
x O 0 1.6796819143904962e-11
10 O 0 5.223929275266492e-11
( O 0 5.18993864811329e-13
- O 0 2.682909450157922e-12
3 O 0 7.883134249542234e-12
) O 0 9.78495171173599e-15
; O 0 1.8155256757603627e-14
SIBPAL O 0 2.14004869381057e-10
Pempirical O 0 1.0659803595380879e-10
value O 0 3.51181236868392e-11
< O 0 1.34600983137112e-10
1 O 0 2.967322221270052e-11
x O 0 8.242601046148934e-11
10 O 0 1.2947487526560053e-10
( O 0 9.737633876322205e-13
- O 0 4.32794685506499e-12
3 O 0 7.67194814621508e-12
) O 0 1.7785220673716693e-15
) O 0 3.2265605190262396e-16
that O 0 2.246590779958501e-15
are O 0 2.243962563778113e-14
linked O 0 2.166455383145749e-11
to O 0 1.0339677031234729e-11
mental O 1 0.999991774559021
health O 0 0.0005311346612870693
wellness O 0 0.0006128015811555088
. O 0 2.379011432296352e-09

These O 0 4.75784189823969e-10
findings O 0 8.829031949986188e-11
are O 0 8.209675344053591e-13
consistent O 0 4.717122872865964e-11
with O 0 6.255175956197678e-13
the O 0 1.371924102100408e-10
hypothesis O 0 3.280794733107051e-11
that O 0 2.1485022894357324e-14
certain O 0 4.579268388094082e-12
alleles O 0 2.134038388709736e-12
could O 0 2.6658315312177994e-12
prevent O 0 5.148199921922725e-11
or O 0 3.949549454845824e-12
modify O 0 3.180207139297231e-11
the O 0 4.929404974485241e-12
clinical O 0 4.0375756071853175e-09
manifestations O 0 7.064023321845525e-08
of O 0 2.4534495324246564e-08
BPAD B-Disease 1 1.0
and O 0 1.731622831235846e-11
perhaps O 0 5.963223079392954e-13
other O 0 2.0496627940909395e-13
related O 0 4.5613639088060154e-08
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 7.82908387009229e-07

Segregation O 0 0.00016580084047745913
distortion O 0 0.07673046737909317
in O 0 1.72564500644512e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 2.30142759392038e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DM B-Disease 1 1.0
) O 0 2.749060354356736e-11
is O 0 2.63186933184556e-13
an O 0 1.3614352429702076e-13
autosomal B-Disease 1 0.999983549118042
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 1.1935350711228532e-12
, O 0 1.3636928907065013e-14
in O 0 3.936003812373551e-13
the O 0 2.547105582006992e-11
typical O 0 5.727851179471166e-11
pedigree O 0 2.963702200320384e-11
, O 0 7.99504234517967e-14
shows O 0 5.851970817649654e-12
a O 0 5.861399473422457e-12
three O 0 5.529017781807921e-12
generation O 0 1.6115468681743295e-10
anticipation O 0 1.311781683277502e-09
cascade O 0 9.94009923260819e-08
. O 0 4.190128422010275e-08

This O 0 2.909015801681736e-13
results O 0 3.2457263873103548e-12
in O 0 1.8583049595649603e-12
infertility B-Disease 0 0.020565668120980263
and O 0 0.09095078706741333
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.32991773336289e-08
CDM B-Disease 0 4.6871079462107446e-07
) O 0 1.6614051510954221e-15
with O 0 8.417407912789739e-16
the O 0 6.301158596636047e-13
disappearance O 0 1.0049854698435112e-10
of O 0 1.5388534890803385e-08
DM B-Disease 1 1.0
in O 0 7.216420239153365e-10
that O 0 7.744507118934152e-11
pedigree O 0 2.7685233661145503e-08
. O 0 8.135462969960372e-09

The O 0 1.6459698881643448e-10
concept O 0 1.6911752553916415e-10
of O 0 1.2768289203712868e-10
segregation O 0 3.986156471569302e-08
distortion O 0 8.035805798556339e-09
, O 0 9.351913232528986e-14
where O 0 6.463293035540232e-14
there O 0 3.5143664643992253e-14
is O 0 3.4630751466078937e-15
preferential O 0 3.0592722365802016e-12
transmission O 0 2.0899951908015524e-11
of O 0 1.027045531953874e-10
the O 0 2.096151377473099e-11
larger O 0 6.725483342982785e-13
allele O 0 2.1419946979323035e-12
at O 0 1.7461938839336e-10
the O 0 8.866889444902881e-10
DM B-Disease 1 1.0
locus O 0 1.437874486143187e-09
, O 0 5.2793186489097366e-12
has O 0 1.4675637007716125e-12
been O 0 1.7043464079283255e-12
put O 0 1.4486751208353521e-11
forward O 0 2.3945543898423738e-12
to O 0 1.5629367917067982e-13
explain O 0 5.854337847832625e-12
partially O 0 4.5001424808788215e-10
the O 0 1.581696579266989e-11
maintenance O 0 7.643787824918036e-08
of O 0 4.1984844756370876e-07
DM B-Disease 1 1.0
in O 0 4.299745559599444e-10
the O 0 2.619653383106879e-10
population O 0 6.927974253306823e-12
. O 0 8.449814181687998e-10

In O 0 1.8073822993791566e-10
a O 0 2.0822600588221718e-11
survey O 0 9.227297398384238e-11
of O 0 2.2247196085345422e-08
DM B-Disease 1 1.0
in O 0 9.908858178420132e-10
Northern O 0 5.0151278685461875e-08
Ireland O 0 7.762530884747321e-08
, O 0 1.6771632693757255e-10
59 O 0 1.0553724116846297e-08
pedigrees O 0 7.117756695151911e-08
were O 0 1.4133223480428114e-08
ascertained O 0 4.798255304194754e-07
. O 0 1.960041728921169e-08

Sibships O 0 2.5265126168960705e-06
where O 0 6.504190519507347e-10
the O 0 3.2666203075848443e-11
status O 0 5.375258224638024e-11
of O 0 2.0492592345267013e-10
all O 0 2.1370211156224173e-11
the O 0 9.383212956626252e-11
members O 0 1.3574687164272237e-12
had O 0 1.8360465925404412e-11
been O 0 3.87323246392457e-12
identified O 0 1.59311730474343e-11
were O 0 5.308144982590912e-12
examined O 0 2.2863078617818555e-12
to O 0 5.551890666492289e-14
determine O 0 1.8575041678403625e-12
the O 0 5.173969325894534e-12
transmission O 0 2.1219870305344557e-09
of O 0 6.971010435563585e-09
the O 0 6.101683425185911e-08
DM B-Disease 1 1.0
expansion O 0 9.554648627840834e-09
from O 0 2.9024570941116323e-11
affected O 0 1.0802134187137824e-10
parents O 0 5.0225557220173744e-12
to O 0 7.88018695435655e-12
their O 0 1.450573328121152e-09
offspring O 0 1.4644621071369102e-09
. O 0 1.947300543037045e-09

Where O 0 6.056030676937496e-10
the O 0 2.0778176401670123e-10
transmitting O 0 1.2781704583630926e-08
parent O 0 3.981532326058357e-10
was O 0 1.9025369724090524e-08
male O 0 8.914693427897191e-10
, O 0 1.0033861935765387e-10
58 O 0 3.423831884674655e-08
. O 0 3.5774636586438646e-08

3 O 0 5.8822873683084254e-08
% O 0 1.5005832687542409e-10
of O 0 9.739505868466836e-10
the O 0 5.432962413287612e-10
offspring O 0 2.5697294292470474e-10
were O 0 9.656171695571203e-11
affected O 0 1.46409759316235e-11
, O 0 6.833062761446573e-13
and O 0 1.1751050436534238e-12
in O 0 6.010432603009708e-12
the O 0 5.02006804181665e-11
case O 0 9.230848724284257e-12
of O 0 1.444763059188503e-10
a O 0 2.3624368086783143e-11
female O 0 1.928230144998544e-12
transmitting O 0 2.7580702166574156e-09
parent O 0 3.4950814464806967e-10
, O 0 9.45044598132938e-10
68 O 0 6.8696235757670365e-06
. O 0 4.3827282070196816e-07

7 O 0 6.189349051055615e-07
% O 0 2.535271770298664e-09
were O 0 2.3726629549969402e-09
affected O 0 3.0763511738030047e-09
. O 0 1.6325426344110383e-08

Studies O 0 6.877909908276081e-10
on O 0 4.252719065789279e-09
meiotic O 0 4.713096757313906e-07
drive O 0 1.2554822070853788e-08
in O 0 2.3607082955123815e-10
DM B-Disease 1 0.9999998807907104
have O 0 3.072216688947832e-13
shown O 0 3.809719060403685e-14
increased O 0 9.580372926183342e-14
transmission O 0 7.36025997094547e-12
of O 0 1.2580212045698591e-11
the O 0 6.548323949057133e-12
larger O 0 3.1161241664280637e-13
allele O 0 8.239072401758363e-13
at O 0 3.250572727653278e-11
the O 0 2.4695695488574643e-10
DM B-Disease 1 0.9999984502792358
locus O 0 1.8647192123744105e-10
in O 0 5.8012750853153605e-11
non O 0 8.299219189211726e-06
- O 0 4.629958311852533e-06
DM O 1 1.0
heterozygotes O 0 2.2918449360531667e-07
for O 0 5.223174670554442e-10
CTGn O 0 4.516684384725522e-06
. O 0 2.5774781420295767e-08

This O 0 4.441193246496056e-11
study O 0 4.390671853871098e-12
provides O 0 7.241379804817649e-13
further O 0 1.330082826647358e-13
evidence O 0 1.19447854385335e-11
that O 0 3.300224026350773e-12
the O 0 2.5201634556992758e-08
DM B-Disease 1 1.0
expansion O 0 1.5674284270517091e-07
tends O 0 1.9657369482173337e-11
to O 0 1.047045588252471e-12
be O 0 6.206383063728227e-12
transmitted O 0 2.7646931619051962e-11
preferentially O 0 3.3955838141253025e-10
. O 0 7.586162253936379e-10

Diagnosis O 0 0.12045935541391373
of O 0 0.0018144948408007622
hemochromatosis B-Disease 1 1.0
. O 0 2.5156927222269587e-05

If O 0 4.020499932977373e-09
untreated O 0 3.1098592444323e-05
, O 0 7.879594199344808e-10
hemochromatosis B-Disease 1 1.0
can O 0 8.510886440049603e-11
cause O 0 6.759448556437064e-09
serious O 0 9.635420428821817e-05
illness O 1 0.9053210616111755
and O 0 3.5508490679042604e-12
early B-Disease 0 5.279283676884461e-10
death I-Disease 0 7.744392349628981e-10
, O 0 2.342163735093855e-13
but O 0 1.9808993041801198e-13
the O 0 5.067118946655569e-11
disease O 0 1.240696633431071e-06
is O 0 4.618739743965372e-13
still O 0 6.976264184388459e-13
substantially O 0 8.078778097886374e-12
under O 0 9.786100818587329e-09
- O 0 5.9908601542701945e-05
diagnosed O 0 5.367426638258621e-06
. O 0 1.5800889485717562e-08

The O 0 9.985092752629043e-09
cornerstone O 0 6.017774580868718e-07
of O 0 2.7902622434794466e-09
screening O 0 1.7641652583222367e-09
and O 0 5.744872459689798e-12
case O 0 9.865430954797416e-13
detection O 0 6.406598862529478e-11
is O 0 3.2431983531047703e-14
the O 0 1.7186831114106987e-13
measurement O 0 9.817270260614741e-12
of O 0 2.6096591554392035e-10
serum O 0 3.979055626657235e-11
transferrin O 0 2.0018264823562504e-10
saturation O 0 2.6166618871670266e-10
and O 0 2.501414657005152e-12
the O 0 1.3574926772952356e-11
serum O 0 1.611334676798748e-10
ferritin O 0 1.3348417837732995e-07
level O 0 2.8247711725271074e-07
. O 0 3.0439224474321236e-09

Once O 0 1.8903110188261962e-08
the O 0 5.70462010962558e-10
diagnosis O 0 1.6916841616421152e-07
is O 0 8.194176240317042e-12
suspected O 0 1.2600450460809043e-08
, O 0 2.3732033699319643e-11
physicians O 0 1.2819340033942694e-10
must O 0 3.572910023397213e-11
use O 0 4.682107999920415e-12
serum O 0 5.439595648915052e-11
ferritin O 0 4.316883206456623e-08
levels O 0 5.197597019446221e-09
and O 0 3.2178169850904936e-11
hepatic O 1 1.0
iron O 1 0.9525909423828125
stores O 0 6.83515245327726e-05
on O 0 1.7748300251696492e-06
liver O 0 1.1536408237589058e-06
biopsy O 0 2.6272617859035563e-08
specimens O 0 1.445561639140669e-11
to O 0 6.783211687656776e-13
assess O 0 2.912362573326277e-10
patients O 0 2.6676627486871274e-12
for O 0 6.593464381247915e-13
the O 0 1.6831742596923327e-11
presence O 0 8.839023957207814e-11
of O 0 2.787237285417632e-08
iron B-Disease 0 5.046407750342041e-05
overload I-Disease 0 1.5761103213662864e-06
. O 0 5.782679934895896e-08

Liver O 1 0.9992560744285583
biopsy O 1 0.9985007047653198
is O 0 1.4036537265837978e-08
also O 0 1.323340395598116e-11
used O 0 8.728171722698075e-14
to O 0 5.933857463551184e-14
establish O 0 8.840418848354847e-12
the O 0 8.216932342874905e-12
presence O 0 2.589644210876374e-12
or O 0 1.2512625484351059e-12
absence O 0 9.1153307124614e-10
of O 0 5.561018756594649e-09
cirrhosis B-Disease 1 0.9998852014541626
, O 0 8.574885593248815e-12
which O 0 5.661459257129409e-13
can O 0 1.1280351652764864e-12
affect O 0 9.222722585633392e-11
prognosis O 0 6.518522468468291e-07
and O 0 3.5939973219711874e-10
management O 0 2.0578202963861258e-07
. O 0 1.6935267410644883e-08

A O 0 3.10111971657534e-08
DNA O 0 7.701292381590008e-10
- O 0 7.1352238353861175e-12
based O 0 2.6522091814418225e-12
test O 0 1.1689163526007462e-10
for O 0 7.710221350265556e-12
the O 0 3.7780104045204155e-10
HFE O 0 3.263020573740505e-07
gene O 0 3.4840895359739e-12
is O 0 1.9352138028996477e-14
commercially O 0 4.869604068938327e-13
available O 0 6.08831127874021e-13
, O 0 1.029428820832623e-13
but O 0 1.052234268141862e-13
its O 0 6.800298171794061e-13
place O 0 2.909962375230446e-11
in O 0 2.694991582327666e-13
the O 0 7.409446320383317e-12
diagnosis O 0 1.2644702174213762e-08
of O 0 4.1634478975538514e-08
hemochromatosis B-Disease 1 1.0
is O 0 1.0082076284945174e-09
still O 0 1.108368050117825e-10
being O 0 2.164514227576131e-11
evaluated O 0 1.476705535630174e-09
. O 0 3.834646378209072e-09

Currently O 0 3.943518844806704e-09
, O 0 1.1503806587875864e-11
the O 0 2.029343360021585e-11
most O 0 2.4986477188508605e-13
useful O 0 3.4707425735497344e-13
role O 0 8.390714880714134e-13
for O 0 4.713952210348704e-13
this O 0 3.648250321633406e-13
test O 0 7.730542768424886e-12
is O 0 1.9989225389944326e-14
in O 0 3.8447286261796e-14
the O 0 5.733419923721617e-13
detection O 0 4.210296555839932e-10
of O 0 3.902559164714603e-09
hemochromatosis B-Disease 1 1.0
in O 0 4.790369878548972e-09
the O 0 7.53214202120489e-09
family O 0 2.7686564846307604e-11
members O 0 2.176145331642121e-12
of O 0 3.165031847718325e-10
patients O 0 3.63469454187082e-12
with O 0 3.2930288270532904e-13
a O 0 1.3189739578312043e-10
proven O 0 1.335046850847732e-09
case O 0 6.65522983944733e-11
of O 0 1.1788226395026413e-08
the O 0 5.32241017481283e-07
disease O 1 0.9681309461593628
. O 0 1.8869032558654908e-08

It O 0 3.172137552631682e-11
is O 0 4.878382420248073e-12
crucial O 0 9.879191908979124e-10
to O 0 6.364822557891614e-11
diagnose O 1 0.999996542930603
hemochromatosis B-Disease 1 1.0
before O 0 0.0022231668699532747
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 2.7247317735401566e-09
because O 0 1.4227548306156024e-10
phlebotomy O 1 0.9999991655349731
therapy O 0 3.7882282413193025e-06
can O 0 1.855461097266531e-12
avert O 0 8.437805831817968e-07
serious O 1 0.9999998807907104
chronic O 1 1.0
disease O 1 1.0
and O 0 7.365343578091821e-12
can O 0 1.1456411990948268e-13
even O 0 1.8697165397960763e-13
lead O 0 4.1404189105032074e-12
to O 0 5.209732046262093e-14
normal O 0 2.814500854597668e-10
life O 0 5.676177843721986e-12
expectancy O 0 2.9613006491402416e-11
. O 0 8.91236791398381e-13
. O 0 7.66272392760392e-11

Prevalence O 0 2.0811620515814866e-07
of O 0 1.7761317749886985e-08
the O 0 3.1268652112004247e-09
I1307K O 0 2.1834425467659457e-07
APC B-Disease 0 1.8645147648044258e-08
gene O 0 1.2580835678788205e-11
variant O 0 1.1461886995078885e-11
in O 0 6.79873841144367e-14
Israeli O 0 3.169982939338345e-12
Jews O 0 3.1766752314581204e-13
of O 0 5.24985437067027e-13
differing O 0 6.289148482595611e-14
ethnic O 0 5.941425736816219e-13
origin O 0 9.137006472606513e-13
and O 0 4.64436041708316e-12
risk O 0 1.59484883965888e-07
for O 0 6.819330792495748e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0012870486825704575

BACKGROUND O 0 7.295029718079604e-06
& O 0 3.345793402331765e-06
AIMS O 0 2.8121213802023703e-08
Israeli O 0 4.288450983214176e-10
Jews O 0 5.301985586680935e-11
of O 0 9.2888940983471e-10
European O 0 3.870357812019165e-09
birth O 0 5.908103517526797e-08
, O 0 8.612906499116946e-10
i O 0 2.860481018718275e-10
. O 0 3.939107286882182e-12
e O 0 1.2848994871555997e-12
. O 0 6.885078986974824e-13
, O 0 4.547930500080344e-13
Ashkenazim O 0 1.6421410065081687e-10
, O 0 4.7422488028484033e-14
have O 0 2.90441295688372e-14
the O 0 1.6807962356993333e-12
highest O 1 0.9999295473098755
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9551382660865784
of O 0 7.563262793830461e-10
any O 0 2.9265159739999547e-11
Israeli O 0 4.843029977052993e-09
ethnic O 0 1.9287231367570712e-08
group O 0 2.046269464983652e-08
. O 0 4.1841065723247084e-08

The O 0 6.741978353375089e-08
I1307K O 0 4.732752643121785e-07
APC B-Disease 0 6.742467206777292e-08
gene O 0 1.534197907604451e-10
variant O 0 8.917975802269495e-10
was O 0 3.4106295565550226e-10
found O 0 5.6415636051632134e-12
in O 0 4.406799578027254e-11
6 O 0 3.032681945569493e-07
. O 0 2.8511641048112324e-08

1 O 0 3.6180169971089526e-09
% O 0 4.593326153462529e-12
of O 0 2.0249424966672924e-12
American O 0 7.956179660408014e-13
Jews O 0 2.1453392447939867e-12
, O 0 5.807709863156138e-14
28 O 0 1.7246350181299164e-11
% O 0 2.182538438172399e-12
of O 0 9.137660073044174e-11
their O 0 5.409165382275205e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 7.06678591200216e-08
, O 0 1.1068480116824264e-12
but O 0 1.434729342709301e-13
not O 0 1.8013223562502595e-13
in O 0 3.835299265675385e-12
non O 0 3.0801572847849457e-08
- O 0 3.326860176233737e-10
Jews O 0 2.064126647383091e-10
. O 0 1.1115061093747158e-09

We O 0 1.3211046701044893e-09
assessed O 0 7.159223769370726e-10
the O 0 1.2988565084581793e-11
I1307K O 0 9.622586061297511e-10
prevalence O 0 1.956282358328565e-10
in O 0 1.5649711615581957e-13
Israeli O 0 6.878515769123683e-13
Jews O 0 1.3090372427519703e-13
of O 0 5.640657212147016e-13
differing O 0 5.5406983119404493e-14
ethnic O 0 4.702080738661074e-13
origin O 0 5.262576941063302e-13
and O 0 6.056116979430426e-12
risk O 0 1.4156215399907524e-07
for O 0 5.452845016407082e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00044335873099043965

METHODS O 0 1.2060981191552855e-07
DNA O 0 7.211934383022367e-10
samples O 0 1.1543018277326844e-11
from O 0 8.141690446827887e-12
500 O 0 8.353385691495241e-12
unrelated O 0 5.659389623602351e-12
Jews O 0 7.952602985861201e-12
of O 0 3.2822375928276415e-09
European O 0 7.689407333089093e-09
or O 0 7.569002369312017e-11
non O 0 2.3202539978228742e-07
- O 0 2.437657853349151e-10
European O 0 1.2425972750751413e-10
origin O 0 5.4906175092628295e-12
, O 0 2.0780641476255551e-13
with O 0 4.105522277936084e-14
or O 0 1.4498740749657735e-12
without O 0 2.400179881234532e-11
a O 0 2.4250091951866226e-12
personal O 0 8.183508558301522e-12
and O 0 4.371588160911877e-11
/ O 0 6.671329089158462e-08
or O 0 4.283315369058016e-11
family O 0 1.4556125402243048e-12
history O 0 4.8169173511025676e-11
of O 0 4.328828406841012e-09
neoplasia B-Disease 0 1.2053970976921846e-06
, O 0 9.090758007479494e-11
were O 0 1.1992869197730016e-10
examined O 0 5.641889386232002e-11
for O 0 9.753513101340427e-12
the O 0 8.680023366736123e-11
I1307K O 0 1.2892441558776113e-09
variant O 0 3.258157632579639e-11
by O 0 1.8260224061983354e-12
the O 0 2.584937819349875e-11
allele O 0 8.702779816238682e-12
- O 0 1.2172431465562461e-11
specific O 0 1.3924175180923815e-11
oligonucleotide O 0 1.395125881487047e-08
( O 0 1.0857513499384908e-10
ASO O 0 0.0122187165543437
) O 0 1.658837477103159e-11
method O 0 1.1213503459117646e-09
. O 0 3.072621490574079e-09

RESULTS O 0 1.3456075143025714e-09
In O 0 4.644572920708967e-12
persons O 0 1.0541873363828502e-12
at O 0 7.07459438253899e-12
average O 0 1.345285341458613e-11
risk O 0 1.4043366469707053e-08
for O 0 1.8164010384680296e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.942199817113078e-10
I1307K O 0 5.857541118814424e-09
was O 0 4.3443348918259517e-10
found O 0 2.3597694978616524e-12
in O 0 8.230233335126957e-12
5 O 0 1.25562111819022e-08
. O 0 2.1844615005761625e-09

0 O 0 2.8093014137198224e-08
% O 0 6.699654025998925e-11
of O 0 1.7484468040063206e-10
120 O 0 2.1938678651522991e-10
European O 0 2.741868065925246e-09
and O 0 4.132154896030471e-10
1 O 0 4.193730660517758e-07
. O 0 1.085013323631756e-08

6 O 0 2.409610431186593e-07
% O 0 2.615454519627747e-10
of O 0 1.0738293587664316e-09
188 O 0 8.651680483140467e-10
non O 0 4.978482692763464e-08
- O 0 5.786623957781956e-10
European O 0 6.096826932200372e-10
Jews O 0 1.2578250940809e-10
( O 0 1.6261568480668842e-11
P O 0 2.0115642485052376e-07
= O 0 2.063045290157106e-09
0 O 0 1.6080105025295666e-09
. O 0 5.344535577989085e-12
08 O 0 5.332431371463109e-11
) O 0 3.88463106083467e-13
. O 0 2.6552829379689058e-11

It O 0 1.77815345780985e-10
occurred O 0 3.3721438974509965e-09
in O 0 5.211273079730461e-10
15 O 0 9.675746781567796e-08
. O 0 2.173237767522096e-08

4 O 0 2.3300412266280546e-08
% O 0 4.464685565697124e-11
of O 0 9.855303378936142e-11
52 O 0 3.2841396269134293e-10
Ashkenazi O 0 1.8649040645080106e-10
Israelis O 0 1.2860776332779267e-10
with O 0 1.3373595633692226e-11
familial O 0 0.06059184670448303
cancer B-Disease 1 0.998714804649353
( O 0 2.0064019889964868e-10
P O 0 0.00011448184523032978
= O 0 4.7174877337852195e-09
0 O 0 4.856125501717656e-10
. O 0 2.3516090333700057e-13
02 O 0 1.669515220514839e-11
) O 0 3.829518540249049e-15
and O 0 1.680756126995215e-14
was O 0 1.3946787518273607e-12
not O 0 1.2196768761792414e-14
detected O 0 9.997611462655986e-13
in O 0 3.9496680123533856e-13
51 O 0 9.788442972835654e-11
non O 0 1.1490119078416683e-08
- O 0 2.4950402854884146e-11
European O 0 1.62375182743979e-11
Jews O 0 3.1347728232655747e-12
at O 0 6.075417946505013e-11
increased O 0 9.092739894356328e-10
cancer B-Disease 0 8.715253443369875e-07
risk O 0 6.18238800598192e-07
. O 0 7.989468642222164e-09

Colorectal B-Disease 1 0.999923586845398
neoplasia I-Disease 1 0.9179505109786987
occurred O 0 1.5212467587844003e-05
personally O 0 4.107904294503584e-10
or O 0 5.705854625587259e-12
in O 0 5.8463481451831445e-12
the O 0 5.80875972322481e-11
families O 0 1.7617909897887224e-13
of O 0 2.573422863694219e-10
13 O 0 9.429115266357257e-09
of O 0 5.229579969068254e-08
20 O 0 1.718575859399607e-08
Ashkenazi O 0 9.845745330139266e-10
I1307K O 0 1.3489713790448832e-09
carriers O 0 2.009406313216444e-12
, O 0 7.911447647175607e-13
8 O 0 9.22427523253333e-10
of O 0 3.366295908691086e-09
whom O 0 9.2876362156602e-10
also O 0 6.62229826531302e-10
had O 0 8.212632240933715e-10
a O 0 7.288818854034318e-11
personal O 0 6.126832929886916e-10
or O 0 2.194336518046569e-10
family O 0 2.551462340016908e-11
history O 0 4.5096112955000933e-10
of O 0 9.530245392852521e-08
noncolonic O 0 0.00025068127433769405
neoplasia B-Disease 1 0.9081501960754395
. O 0 2.0795023374375887e-06

CONCLUSIONS O 0 2.1046618314812804e-07
The O 0 8.009685359411378e-09
I1307K O 0 5.036600896346499e-07
APC O 0 1.2704903440408088e-07
variant O 0 3.240838264417789e-09
may O 0 3.52069207121275e-11
represent O 0 4.118899665783715e-12
a O 0 8.149489763575879e-12
susceptibility O 0 1.921363956824962e-09
gene O 0 5.4580322900177336e-11
for O 0 7.740770524566898e-11
colorectal B-Disease 1 1.0
, I-Disease 0 1.788309639261243e-10
or I-Disease 0 3.0416270196953477e-11
other I-Disease 0 2.7048299364174078e-11
, I-Disease 0 1.1764360319244105e-10
cancers I-Disease 0 4.1327452890982386e-06
in O 0 1.1540910588303532e-10
Ashkenazi O 0 2.2502921401268416e-11
Jews O 0 1.1278760043975655e-12
, O 0 1.7159774848892612e-13
and O 0 1.265131012104237e-12
partially O 0 1.4265379988387394e-09
explains O 0 1.9547846414474934e-12
the O 0 1.4309259072781133e-12
higher O 0 1.6507645250740666e-10
incidence O 0 0.3736861050128937
of O 1 0.9979713559150696
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.3946414628994717e-08
European O 0 6.837457267039326e-09
Israelis O 0 6.403575447677667e-09
. O 0 6.751665893034442e-09

Systematic O 0 1.3961307110399446e-10
analysis O 0 8.829498764073573e-12
of O 0 2.0214635521043078e-10
coproporphyrinogen O 0 1.0845539009096683e-06
oxidase O 0 1.6653473267069785e-06
gene O 0 1.268768556883515e-07
defects O 0 0.0007979559013620019
in O 0 5.958138982187222e-10
hereditary B-Disease 1 0.9999994039535522
coproporphyria I-Disease 1 0.9999881982803345
and O 0 1.678573013919049e-08
mutation O 0 2.611070826219475e-08
update O 0 5.4028550522389196e-08
. O 0 1.2885343458890475e-08

Hereditary B-Disease 1 0.9999974966049194
coproporphyria I-Disease 1 0.999461829662323
( O 0 1.9695340469638722e-08
HC B-Disease 1 0.9757753610610962
) O 0 1.1108479587573772e-11
is O 0 1.607332566740463e-13
an O 0 1.0288026940780126e-13
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 7.650788234059291e-07
autosomal O 1 0.9999979734420776
dominant O 1 0.8339549899101257
inheritance O 0 7.788124811725083e-09
caused O 0 3.134859871689599e-10
by O 0 2.2217582049295637e-13
deficient B-Disease 0 9.386023208657335e-11
activity I-Disease 0 4.286690793997572e-11
of I-Disease 0 4.3123524195998186e-10
coproporphyrinogen I-Disease 0 4.996071538698743e-07
III I-Disease 0 1.4593359765058267e-06
oxidase I-Disease 0 6.6536633980263105e-09
( O 0 9.670802353367591e-12
CPO O 0 5.849259991919098e-07
) O 0 7.449719660601595e-12
. O 0 1.9746440593770842e-10

Clinical O 0 6.624824209211511e-07
manifestations O 0 3.835136158159003e-05
of O 0 2.9804868972860277e-07
the O 0 2.1588359544466584e-08
disease O 0 0.0007893145084381104
are O 0 3.666161883623953e-14
characterized O 0 1.3413741146474367e-13
by O 0 2.0726520136684148e-14
acute O 0 1.2893580787931569e-05
attacks O 0 2.179496583210039e-09
of O 1 0.9990035891532898
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 8.038649607078341e-11
precipitated O 0 2.2724272116803057e-11
by O 0 2.801123861941729e-13
drugs O 0 9.184488586333472e-11
, O 0 6.886230816257818e-14
fasting O 0 4.067696179888003e-10
, O 0 4.791559943956303e-12
cyclical O 0 8.62387594224856e-07
hormonal O 0 9.060339323241351e-08
changes O 0 7.554929459807624e-10
, O 0 3.5843548181618834e-12
or O 0 1.1323050275180435e-09
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 2.0879504347703914e-08

Skin O 1 0.9999992847442627
photosensitivity O 1 0.9999878406524658
may O 0 5.522690571524436e-06
also O 0 4.318550794746301e-10
be O 0 1.2724328535274054e-11
present O 0 3.970308803946665e-10
. O 0 4.3782679703952e-09

The O 0 1.1692162793508487e-08
seven O 0 2.2488397810604965e-09
exons O 0 2.417943392174493e-07
, O 0 5.613209203003677e-11
the O 0 2.83588291738468e-10
exon O 0 6.145550734970584e-09
/ O 0 5.12869913205094e-10
intron O 0 3.457249764249326e-10
boundaries O 0 5.242895007029347e-11
and O 0 7.006974753025197e-13
part O 0 2.003390509042191e-12
of O 0 9.446764898113358e-11
3 O 0 3.141689686181337e-10
noncoding O 0 5.941908076678715e-11
sequence O 0 2.7594079365228508e-12
of O 0 4.6094181249678456e-10
the O 0 9.164614067636023e-10
CPO O 0 1.4174291891322355e-06
gene O 0 1.3768990288209881e-11
were O 0 4.401589336067158e-12
systematically O 0 1.2748128290843153e-12
analyzed O 0 2.5098532193540413e-13
by O 0 1.822632349950462e-13
an O 0 5.227233034442447e-13
exon O 0 3.8027134219298375e-10
- O 0 3.053723940382724e-11
by O 0 2.0700605118939563e-10
- O 0 2.68562843075415e-08
exon O 0 1.7882913994071714e-07
denaturing O 0 1.8324443544770475e-06
gradient O 0 7.960293757491854e-09
gel O 0 3.041860652253092e-10
electrophoresis O 0 1.2194461586345628e-11
( O 0 2.8932470568648894e-12
DGGE O 0 1.7398821938741094e-08
) O 0 1.8313894508976275e-13
strategy O 0 4.698154300493418e-13
followed O 0 1.3909820052780773e-14
by O 0 1.4064545867189821e-15
direct O 0 1.9182439382585403e-13
sequencing O 0 4.2202111488580385e-13
in O 0 8.782063617984726e-13
seven O 0 3.951570667903859e-11
unrelated O 0 9.022908531441942e-10
heterozygous O 0 2.9126043799010404e-08
HC B-Disease 1 0.999980092048645
patients O 0 4.5691525563107405e-10
from O 0 1.335666993673712e-11
France O 0 2.34439561097588e-08
, O 0 1.619508173400508e-11
Holland O 0 2.4082806859837547e-09
, O 0 6.210219838376219e-12
and O 0 5.158498628254904e-12
Czech O 0 4.3571856167545775e-07
Republic O 0 1.3791557194053894e-06
. O 0 3.459750530510064e-07

Seven O 0 2.9056614891942445e-09
novel O 0 1.0612818263089352e-10
mutations O 0 1.527866201611605e-11
and O 0 4.531152796721782e-12
two O 0 5.330760572547222e-12
new O 0 8.514441929285965e-11
polymorphisms O 0 5.9471890523354887e-08
were O 0 1.5981839851519908e-08
detected O 0 9.852742266502901e-08
. O 0 9.648858423361162e-08

Among O 0 4.479019377612303e-09
these O 0 1.2500472879040103e-10
mutations O 0 8.989767263933857e-11
two O 0 3.040223281458587e-11
are O 0 8.802241921457288e-12
missense O 0 1.2446289332501692e-08
( O 0 5.772566105677335e-11
G197W O 0 5.349798470888345e-08
, O 0 9.411981610751852e-11
W427R O 0 3.4400440274140465e-09
) O 0 1.4625171733395614e-12
, O 0 9.844115540086351e-13
two O 0 3.0743519709164335e-12
are O 0 1.1901207016412618e-12
nonsense O 0 2.927779130246222e-10
( O 0 1.0243096518550154e-12
Q306X O 0 2.1968658836524213e-10
, O 0 3.032536244687578e-12
Q385X O 0 1.209781580469027e-10
) O 0 1.5043665640458725e-13
, O 0 2.6388158151646746e-13
two O 0 8.542021256996435e-13
are O 0 2.301497480008269e-13
small O 0 2.3313033361421764e-12
deletions O 0 6.534839336325149e-11
( O 0 2.2301912920574818e-12
662de14bp O 0 4.0008532598001523e-10
; O 0 1.4466539077773177e-11
1168del3bp O 0 3.6683271531501305e-08
removing O 0 5.460133323254013e-08
a O 0 7.96036569994385e-10
glycine O 0 1.1925310738902795e-09
at O 0 1.1049090531400907e-09
position O 0 9.777061105165075e-11
390 O 0 3.997058326682401e-12
) O 0 4.304142694924566e-14
, O 0 6.49267491441459e-14
and O 0 2.6973058118648363e-13
one O 0 3.48010926716838e-13
is O 0 1.6939813267391468e-13
a O 0 2.808791827596524e-12
splicing O 0 5.076659648217685e-10
mutation O 0 1.9493384337265773e-11
( O 0 4.98219358564117e-13
IVS1 O 0 2.2502785412825688e-08
- O 0 1.5494251714986973e-10
15c O 0 6.013514575187173e-09
- O 0 3.762628264514234e-10
- O 0 7.92426194107243e-11
> O 0 2.5361557298708703e-10
g O 0 3.5080698762568474e-11
) O 0 1.3976517968146418e-14
which O 0 1.3433397901268119e-14
creates O 0 6.516362427953781e-13
a O 0 2.764897685803014e-12
new O 0 2.8466657850390042e-11
acceptor O 0 2.0674000705822593e-11
splice O 0 5.97892979570247e-09
site O 0 2.7656823498034555e-09
. O 0 1.024498819113262e-09

The O 0 4.015133225898637e-10
pathological O 0 1.58912278891421e-08
significance O 0 8.097962855835306e-10
of O 0 7.684359815129937e-10
the O 0 6.08592620743309e-11
point O 0 3.5141325960275083e-10
mutations O 0 9.599680425576018e-12
G197W O 0 2.443518165584635e-10
, O 0 2.3480425503236146e-12
W427R O 0 1.7212158365254027e-09
, O 0 7.0507779302564355e-12
and O 0 7.070871232278675e-12
the O 0 9.452334748250024e-11
in O 0 2.783239194670273e-10
- O 0 8.462733847025561e-10
frame O 0 2.6484672233095807e-09
deletion O 0 3.1839109126963194e-10
390delGly O 0 1.3113888863713896e-09
were O 0 4.85488177437432e-11
assessed O 0 1.359731598149505e-11
by O 0 5.466715947109735e-13
their O 0 3.047089490448851e-12
respective O 0 4.898783635687298e-12
expression O 0 1.749409991869122e-11
in O 0 3.6312435263557985e-12
a O 0 2.1905873382604968e-12
prokaryotic O 0 1.4458036547496111e-12
system O 0 1.0031234523588672e-11
using O 0 1.293826699423628e-12
site O 0 3.3706887281326203e-10
- O 0 8.948453783519383e-11
directed O 0 1.0045063392194464e-10
mutagenesis O 0 4.9243123356745855e-08
. O 0 6.054117207554555e-09

These O 0 4.805996572931903e-11
mutations O 0 1.3995801045885159e-11
resulted O 0 6.134427601306447e-12
in O 0 8.661788734182219e-13
the O 0 2.7147329523247166e-11
absence O 0 9.44089695309458e-10
or O 0 3.5099757302037293e-12
a O 0 4.939541397436242e-12
dramatic O 0 3.571801188151369e-10
decrease O 0 4.464510983126502e-09
of O 0 2.00639519221113e-07
CPO O 1 0.561332643032074
activity O 0 3.4934797099595016e-07
. O 0 2.070903626361087e-08

The O 0 1.1566567703624742e-09
two O 0 8.928809080988032e-12
polymorphisms O 0 4.903761841035248e-10
were O 0 3.6014873808914993e-12
localized O 0 5.18830083062749e-11
in O 0 4.269968059689155e-12
noncoding O 0 2.4538493459402844e-10
part O 0 9.146304373597314e-12
of O 0 4.116610385906938e-10
the O 0 6.379747424789528e-11
gene O 0 3.096762863502578e-12
1 O 0 1.0683333384609028e-10
) O 0 1.4321450113059103e-14
a O 0 8.974424935831449e-13
C O 0 2.334015203331319e-10
/ O 0 3.640324708342746e-10
G O 0 8.927013017689944e-10
polymorphism O 0 1.0520331827912344e-10
in O 0 4.0766084084820076e-12
the O 0 2.194218244599977e-11
promotor O 0 9.11088626764922e-09
region O 0 2.8595631071381966e-11
, O 0 1.038976630424182e-12
142 O 0 2.670178834984771e-11
bp O 0 1.0948238843289104e-11
upstream O 0 8.871866457628441e-13
from O 0 2.0475370802065102e-13
the O 0 6.079008390419416e-12
transcriptional O 0 1.4080948212980005e-11
initiation O 0 7.207086490101933e-12
site O 0 4.111952531943297e-12
( O 0 2.3970834201587042e-14
- O 0 7.110548044461651e-13
142C O 0 4.052492369455152e-11
/ O 0 3.535835235712881e-10
G O 0 1.9751938973300298e-10
) O 0 1.8853721819975418e-14
, O 0 1.7434580797288934e-14
and O 0 9.959503518121651e-14
2 O 0 1.5242977019491732e-11
) O 0 1.6412798176752494e-14
a O 0 6.176290490329805e-13
6 O 0 2.480766286838687e-11
bp O 0 1.9151364793069253e-13
deletion O 0 7.229438402089894e-14
polymorphism O 0 6.408376975776398e-13
in O 0 3.7669024258342454e-13
the O 0 3.6208278129251648e-12
3 O 0 5.935768543352538e-11
noncoding O 0 3.794090389086513e-11
part O 0 4.519207490866206e-12
of O 0 1.0353811558116988e-10
the O 0 1.3946296895106514e-10
CPO O 0 2.462249426571361e-07
gene O 0 7.783434487207419e-12
, O 0 5.738102050803495e-13
574 O 0 9.94254591851762e-12
bp O 0 2.5009946370835312e-12
downstream O 0 7.970761095425771e-13
of O 0 1.1978413920477049e-11
the O 0 1.5696333122150463e-11
last O 0 1.6102310457233315e-11
base O 0 2.945151414412983e-11
of O 0 1.1203556832262151e-10
the O 0 1.1464385690773682e-10
normal O 0 1.1138936439891722e-09
termination O 0 1.627343926280389e-09
codon O 0 1.8596435502615805e-10
( O 0 1.430388359840995e-12
+ O 0 5.609420219987449e-11
574 O 0 3.4246447344621345e-10
delATTCTT O 0 9.473478890242859e-09
) O 0 5.084806881106019e-11
. O 0 1.1659242460382302e-09

Five O 0 6.483462300366227e-08
intragenic O 0 1.6668457192281494e-06
dimorphisms O 0 3.2189993817155482e-06
are O 0 2.5183769999936878e-11
now O 0 1.636392518884755e-12
well O 0 2.422114158545652e-13
characterized O 0 2.0812028315997377e-12
and O 0 7.516881404432893e-14
the O 0 1.152018259432952e-12
high O 0 8.2171673979059e-12
degree O 0 1.4602608011671236e-10
of O 0 5.666240393553679e-11
allelic O 0 3.806765125347056e-09
heterogeneity O 0 1.6703832761422177e-09
in O 0 5.992006890664925e-11
HC B-Disease 0 0.00015226934920065105
is O 0 1.5352686136282934e-11
demonstrated O 0 1.0918125778469623e-11
with O 0 1.5553387028820198e-13
seven O 0 2.714855684010642e-12
new O 0 8.042843192661298e-13
different O 0 1.7853885823102336e-14
mutations O 0 1.7386702429351975e-13
making O 0 1.2522312830762217e-13
a O 0 1.305162981813865e-13
total O 0 2.763242325926063e-12
of O 0 2.0206386563970113e-10
nineteen O 0 2.7524075107976387e-07
CPO O 1 0.9991720914840698
gene B-Disease 0 4.0280897906086466e-07
defects I-Disease 0 7.89511796028819e-06
reported O 0 1.120522355457787e-10
so O 0 1.0927251291314999e-11
far O 0 3.104772341999684e-11
. O 0 9.97952345760389e-11
. O 0 6.5872680643508374e-09

Coincidence O 0 6.5282059757976185e-09
of O 0 8.594334133249504e-09
two O 0 9.348266084840962e-12
novel O 0 3.2431907853736064e-11
arylsulfatase O 0 1.4216928967414333e-08
A O 0 6.926976769960902e-10
alleles O 0 6.625892542966305e-12
and O 0 7.379066975510273e-12
mutation O 0 1.4796283642759533e-10
459 O 0 8.41024416775582e-10
+ O 0 1.1762981699803277e-08
1G O 0 0.0004044387023895979
> O 0 3.4582760122248146e-07
A O 0 6.274878949774632e-10
within O 0 2.5702377726144476e-11
a O 0 8.019655252378133e-12
family O 0 1.1571933732426598e-12
with O 0 1.1289634158084816e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.4888196578355384e-11
molecular O 0 1.6487308046597704e-11
basis O 0 1.806767756240557e-11
of O 0 4.409069290223222e-11
phenotypic O 0 9.53304422068868e-08
heterogeneity O 0 1.137327600986282e-07
. O 0 2.843511914818464e-08

In O 0 8.684834185146428e-09
a O 0 4.817057308592609e-10
family O 0 1.1612396157503757e-12
with O 0 1.170554972396154e-12
three O 0 7.443303612353347e-11
siblings O 0 5.632889293893939e-11
, O 0 6.451496780378319e-13
one O 0 1.0580019526489418e-13
developed O 0 8.19262886697647e-12
classical O 0 3.6083704912925896e-08
late O 0 0.05884585902094841
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.3097266604589208e-09
MLD B-Disease 1 1.0
) O 0 4.127125724506797e-12
, O 0 3.241117443875119e-12
fatal O 0 3.2804866378910447e-08
at O 0 2.4732615955258552e-09
age O 0 1.0409260120525232e-09
5 O 0 3.7364906724235425e-09
years O 0 1.2469104741785753e-11
, O 0 3.299573884518042e-13
with O 0 1.0404084278131664e-12
deficient O 0 6.596398094416145e-08
arylsulfatase O 0 4.944023999087221e-07
A O 0 3.3018924483485534e-08
( O 0 2.2133677269470242e-12
ARSA O 0 3.4940853765874635e-08
) O 0 2.955997263371507e-14
activity O 0 1.5611648258861965e-12
and O 0 1.467182359762495e-13
increased O 0 3.0778036369527584e-11
galactosylsulfatide O 0 4.576038747927669e-08
( O 0 9.71108859992853e-10
GS O 1 0.9999998807907104
) O 0 5.429251145883107e-11
excretion O 0 2.470051274627849e-09
. O 0 1.2518135417138865e-09

The O 0 5.905690159124788e-09
two O 0 6.709628685985791e-11
other O 0 3.0697482750197125e-11
siblings O 0 9.177418824890538e-10
, O 0 5.798012070457048e-11
apparently O 0 5.287246640506282e-09
healthy O 0 8.409365648276435e-09
at O 0 2.2006299005283836e-08
12 O 0 1.7801575324938312e-08
( O 0 5.199770735514475e-12
1 O 0 1.022681672679937e-08
/ O 0 2.7034865457409296e-09
2 O 0 5.219389920263495e-10
) O 0 1.0236758238768486e-14
and O 0 4.0198147409483895e-14
15 O 0 1.558719191045721e-12
years O 0 3.235624658828873e-13
, O 0 5.3021392750493904e-14
respectively O 0 5.434480122856744e-12
, O 0 5.542096187353962e-13
and O 0 2.061732295305374e-12
their O 0 6.3633382417493944e-12
father O 0 1.7200752974733113e-11
, O 0 8.277983333526695e-12
apparently O 0 1.000811586382433e-10
healthy O 0 1.0878796127822277e-11
as O 0 2.3684531983217405e-13
well O 0 6.071565776186172e-13
, O 0 4.2363164300292244e-13
presented O 0 3.649717472686831e-10
ARSA O 0 1.13897658593487e-05
and O 0 1.8487552599921742e-09
GS O 1 0.9998937845230103
values O 0 6.8511314677e-11
within O 0 8.365264210496992e-12
the O 0 7.655561948261003e-12
range O 0 9.950941182168549e-10
of O 0 1.6993185525393528e-08
MLD B-Disease 1 1.0
patients O 0 4.821786774300563e-07
. O 0 2.695419887288608e-08

Mutation O 0 3.800552927923917e-10
screening O 0 1.714609149106039e-10
and O 0 9.21814057378012e-13
sequence O 0 1.2558796233866354e-12
analysis O 0 1.1575178749528847e-12
disclosed O 0 1.8634097737058042e-11
the O 0 1.9194756895046794e-11
involvement O 0 5.700494937199707e-11
of O 0 1.869007171251269e-09
three O 0 5.922366763666531e-11
different O 0 1.3520868452632229e-11
ARSA O 0 1.6142628737725317e-05
mutations O 0 7.410298069610022e-11
being O 0 4.337913708796215e-12
the O 0 8.503072920253152e-13
molecular O 0 5.1055041271064194e-12
basis O 0 3.2617828576997354e-11
of O 0 3.3254135556326503e-10
intrafamilial O 0 2.717185623168916e-07
phenotypic O 0 1.4292193100118311e-06
heterogeneity O 0 2.0722807221318362e-06
. O 0 5.799137525741571e-08

The O 0 9.933993183608436e-09
late O 0 6.137389050309139e-07
infantile O 0 0.04233401268720627
patient O 0 6.422289811069959e-09
inherited O 0 1.6446902728617374e-09
from O 0 4.902824327079891e-11
his O 0 4.069333758849325e-10
mother O 0 2.085094874537674e-10
the O 0 7.495235543331091e-10
frequent O 0 3.7220160287176896e-09
0 O 0 1.3693170330952853e-07
- O 0 8.866364864523746e-10
type O 0 7.202723972810077e-10
mutation O 0 1.9018020491756715e-10
459 O 0 1.9594041666959328e-10
+ O 0 1.4512036017322316e-10
1G O 0 9.222864605362702e-07
> O 0 3.652044888724504e-09
A O 0 8.272400126019264e-11
, O 0 3.737479008464155e-14
and O 0 4.166176274409891e-14
from O 0 3.045484058081943e-13
his O 0 7.88311863703095e-12
father O 0 6.8914678651166295e-12
a O 0 1.3608388504601776e-12
novel O 0 1.1672819828778547e-12
, O 0 1.8737577678687445e-13
single O 0 3.783371619464626e-12
basepair O 0 2.416724376175239e-09
microdeletion O 0 1.2633059043309913e-08
of O 0 4.416733201395573e-09
guanine O 0 7.88152210162707e-09
at O 0 6.8684880005775995e-09
nucleotide O 0 5.0883146585078975e-09
7 O 0 2.233150020458652e-08
in O 0 2.907311891231501e-10
exon O 0 6.9636749699952816e-09
1 O 0 3.950399118934911e-09
( O 0 3.1349044454093145e-12
7delG O 0 2.6864468427589827e-09
) O 0 2.7837477115100207e-11
. O 0 7.566726134555779e-10

The O 0 3.609332388521125e-09
two O 0 1.8154461267627653e-10
clinically O 0 5.989061833133746e-07
unaffected O 0 2.913660921421979e-07
siblings O 0 1.255761827856361e-09
carried O 0 4.9385832229242865e-11
the O 0 1.1516854137028076e-10
maternal O 0 2.1539814376581035e-09
mutation O 0 4.91976348548917e-10
459 O 0 6.751688097494934e-10
+ O 0 1.0320535537289288e-09
1G O 0 2.9506547889468493e-06
> O 0 2.2319404990867042e-08
A O 0 2.669620080553159e-10
and O 0 2.8392988914854866e-13
, O 0 4.133092522742854e-14
on O 0 8.463112155521202e-12
their O 0 5.484240448924704e-13
paternal O 0 3.829960979438718e-13
allele O 0 5.141296459745814e-13
, O 0 7.4765158799249e-14
a O 0 1.1236795998889604e-13
novel O 0 5.915395126857015e-13
cytosine O 0 2.383673813888265e-11
to O 0 5.178508446709862e-13
thymidine O 0 2.854480263270176e-10
transition O 0 5.632462829474605e-10
at O 0 5.160058491604502e-10
nucleotide O 0 1.3487860828220732e-09
2435 O 0 3.161210315738572e-08
in O 0 2.6187826213108778e-11
exon O 0 2.76461720183363e-09
8 O 0 6.449439871047957e-10
, O 0 2.7767767469058513e-13
resulting O 0 2.218260704246397e-13
in O 0 1.2596141577697617e-13
substitution O 0 1.6248485196213025e-11
of O 0 1.0618812079643547e-10
alanine O 0 3.564211425999275e-11
464 O 0 3.7463636359813535e-11
by O 0 4.590481814115144e-11
valine O 0 1.876570792092025e-07
( O 0 1.2680282171495527e-11
A464V O 0 8.168004939079765e-09
) O 0 2.3680489860677945e-11
. O 0 9.367713271757339e-10

The O 0 1.4507739365399175e-07
fathers O 0 1.107997249505388e-08
genotype O 0 3.2582234688049994e-09
thus O 0 2.0068384454230426e-10
was O 0 6.470262658986314e-10
7delG O 0 9.940933409779973e-08
/ O 0 6.242986501092673e-07
A464V O 0 1.2321784197411034e-06
. O 0 4.098673400676489e-08

Mutation O 0 1.3049024083500171e-08
A464V O 0 2.788146424848037e-08
was O 0 9.258028788039496e-10
not O 0 8.367765031228047e-13
found O 0 4.574543868707259e-13
in O 0 4.677464470435877e-13
18 O 0 1.6095201837984519e-09
unrelated O 0 3.4035116414088407e-07
MLD B-Disease 1 1.0
patients O 0 7.778266919444832e-09
and O 0 1.5262474617472321e-10
50 O 0 9.662833200252408e-09
controls O 0 3.192645863236976e-06
. O 0 2.435015922230832e-08

A464V O 0 2.3481776167955104e-07
, O 0 1.6769234612024064e-10
although O 0 1.3968551315635125e-10
clearly O 0 1.8609386254198057e-10
modifying O 0 1.3098715445636344e-09
ARSA O 0 9.227231203112751e-05
and O 0 3.954230720637497e-08
GS O 1 1.0
levels O 0 2.0944344214512967e-07
, O 0 1.6239407388263238e-11
apparently O 0 6.244573608205073e-11
bears O 0 2.4834839046361523e-11
little O 0 3.8640510062470934e-13
significance O 0 4.354376668264104e-12
for O 0 3.332329258452088e-13
clinical O 0 6.439974664651515e-10
manifestation O 0 7.451752281895097e-08
of O 0 1.0060013977408744e-07
MLD B-Disease 1 1.0
, O 0 2.0916431087147913e-10
mimicking O 0 4.739258763208909e-09
the O 0 1.9331822809220967e-09
frequent O 0 3.264420556092773e-08
ARSA O 0 0.0026184578891843557
pseudodeficiency O 0 2.7205142032471485e-05
allele O 0 2.758225150500948e-07
. O 0 5.123229485093361e-08

Our O 0 9.547544088661652e-09
results O 0 8.633691678250344e-11
demonstrate O 0 2.3625091466472625e-11
that O 0 2.6915584900298085e-14
in O 0 1.8895203056281534e-13
certain O 0 9.969472296311732e-12
genetic O 0 9.023911395900086e-09
conditions O 0 8.850557787809521e-05
MLD B-Disease 1 1.0
- O 0 1.946271140695899e-06
like O 0 2.429892731470318e-09
ARSA O 1 0.9739511609077454
and O 0 2.265350751429196e-08
GS O 1 1.0
values O 0 6.001045216308398e-10
need O 0 2.1955861607969585e-12
not O 0 1.2410693708885066e-14
be O 0 2.5906877503851936e-15
paralleled O 0 1.3494987191522284e-13
by O 0 2.5709891098122002e-14
clinical O 0 4.54976589026046e-06
disease O 0 2.0019560906803235e-06
, O 0 1.7278270014828984e-13
a O 0 2.3909387382274605e-13
finding O 0 1.1849042797287823e-12
with O 0 6.861033280142897e-14
serious O 0 3.749048183010473e-09
diagnostic O 0 7.493756015719555e-08
and O 0 9.117848143169738e-11
prognostic O 0 0.06483257561922073
implications O 0 1.565481966281368e-07
. O 0 1.0586950871527279e-08

Moreover O 0 3.964123251876117e-08
, O 0 1.8506594867684356e-10
further O 0 3.8319611372905626e-10
ARSA O 0 7.148026270442642e-06
alleles O 0 1.5293014077322198e-10
functionally O 0 1.622034589976451e-10
similar O 0 1.1716964204433467e-12
to O 0 5.677918530309911e-13
A464V O 0 6.702648436274217e-10
might O 0 1.0292998007740972e-12
exist O 0 1.6068368424021484e-12
which O 0 1.7015197844444385e-13
, O 0 3.1461388805579735e-14
together O 0 3.351066304871711e-14
with O 0 2.5300641031018867e-13
0 O 0 1.5426738997348366e-08
- O 0 8.891119090970179e-11
type O 0 1.191970393915609e-11
mutations O 0 3.4228973821992525e-12
, O 0 1.238124050983655e-13
may O 0 4.5024218728317855e-12
cause O 0 2.9196040030043946e-10
pathological O 0 0.07234185189008713
ARSA O 1 0.91143399477005
and O 0 3.4769847001570042e-09
GS O 1 1.0
levels O 0 1.0103984315890102e-09
, O 0 1.1130732057893725e-14
but O 0 1.60130879876244e-15
not O 0 1.9484870632930067e-15
clinical O 0 2.8219496184256343e-11
outbreak O 0 2.5437957296148284e-10
of O 0 2.3321197750725275e-10
the O 0 6.607145941472936e-10
disease O 0 9.254241462031132e-08
. O 0 1.8901278112104514e-11
. O 0 5.055421081756606e-10

Human O 0 0.0005311979330144823
MLH1 O 1 0.9999998807907104
deficiency O 1 0.9999024868011475
predisposes O 0 8.195036116376286e-08
to O 0 2.4356092698241127e-09
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 1.2394287978167995e-06
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9979694485664368
1 I-Disease 1 0.9997538924217224
. O 0 1.0113497950214878e-07

Heterozygous O 0 3.342975318787467e-08
germ O 0 1.4626981510446058e-06
- O 0 4.533787567595482e-09
line O 0 8.986241195607647e-10
mutations O 0 3.0351461361571852e-12
in O 0 3.963539023897622e-13
the O 0 3.286957858672501e-11
DNA O 0 2.3821218331221417e-09
mismatch O 0 1.957219410542166e-06
repair O 0 1.5529022334703768e-07
genes O 0 1.8116481925734007e-10
lead O 0 2.803518750482681e-09
to O 0 2.4229401818232077e-10
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.5876730092022626e-07

The O 0 1.7119714357249904e-07
disease O 0 4.089115009264788e-06
susceptibility O 0 1.1453424875185192e-08
of O 0 4.879487480735634e-09
individuals O 0 2.203956418408981e-12
who O 0 4.2928294252675414e-10
constitutionally O 0 0.0009473450481891632
lack O 0 0.055584609508514404
both O 0 3.7153202736561752e-09
wild O 0 9.45597776080831e-07
- O 0 3.351476041135726e-10
type O 0 7.194098095020252e-11
alleles O 0 3.1814429563015167e-12
is O 0 1.2487544635494952e-12
unknown O 0 1.104700553256066e-09
. O 0 1.6181759265876394e-09

We O 0 3.6847186413169197e-10
have O 0 4.4334189639762267e-13
identified O 0 1.0371432445505091e-12
three O 0 1.270379878766728e-13
offspring O 0 1.6086636959577322e-13
in O 0 1.5353900605346443e-13
a O 0 6.54670415101144e-11
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.98652960747836e-09
who O 0 2.094336856717227e-11
developed O 0 3.868898446057756e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 1.5369195693892834e-07
a O 0 2.9054036954079265e-11
very O 0 3.234625024425841e-13
early O 0 3.848683871598979e-10
age O 0 4.3308576169742707e-10
, O 0 5.670345703395752e-12
and O 0 6.788133423418774e-12
at O 0 8.667454531874341e-10
least O 0 7.174745172977559e-12
two O 0 1.3017031029460835e-12
of O 0 9.604410322605617e-11
them O 0 5.029800360933923e-13
displayed O 0 3.1488406326829477e-10
signs O 0 1.913185059265743e-07
of O 0 2.725476555553996e-08
neurofibromatosis B-Disease 0 0.09959258884191513
type I-Disease 0 6.393473199750588e-07
1 I-Disease 0 1.12807047116803e-05
( O 0 1.970836133180498e-10
NF1 B-Disease 0 2.3877878447819967e-06
) O 0 1.0638517150551863e-10
. O 0 3.196636066959968e-09

DNA O 0 5.960276161509626e-10
sequence O 0 5.554099281185332e-12
analysis O 0 3.2679821305656165e-13
and O 0 1.2260731438364786e-13
allele O 0 1.5259337847114973e-13
- O 0 6.191930648768995e-13
specific O 0 4.684303075638829e-13
amplification O 0 6.27623734233973e-12
in O 0 3.0415730697952448e-12
two O 0 8.24498715829014e-12
siblings O 0 5.1983153892543044e-11
revealed O 0 4.4878337157605586e-10
a O 0 1.5814652365442328e-10
homozygous O 0 9.93138158378315e-08
MLH1 O 0 0.0004995224298909307
mutation O 0 7.304507554373174e-10
( O 0 1.8633306703152996e-12
C676T O 0 1.2059883758297474e-08
- O 0 9.000331857578203e-08
- O 0 1.8502309018231244e-08
> O 0 3.197643749786039e-08
Arg226Stop O 0 7.020865666618192e-08
) O 0 9.10727569747305e-12
. O 0 1.1261230142833867e-10

Thus O 0 1.916079295227746e-09
, O 0 4.78059605790726e-12
a O 0 4.936197717936297e-12
homozygous O 0 9.14655740036352e-10
germ O 0 5.971711743768537e-06
- O 0 8.142607299532756e-08
line O 0 3.868374420790133e-08
MLH1 O 0 1.3049372682871763e-05
mutation O 0 1.4657468294654308e-10
and O 0 7.403791663952719e-13
consequent O 0 1.0116526993897423e-07
mismatch O 1 0.9999978542327881
repair O 1 0.9999996423721313
deficiency O 1 1.0
results O 0 5.903505240212326e-09
in O 0 2.670881744937237e-11
a O 0 7.196966633760127e-11
mutator O 0 1.7487358491052873e-05
phenotype O 0 1.4481951748912536e-10
characterized O 0 8.628579621638988e-13
by O 0 3.386870726365329e-14
leukemia B-Disease 0 3.938376539736055e-05
and O 0 2.754824979245285e-10
/ O 1 0.9999990463256836
or O 1 0.9939660429954529
lymphoma B-Disease 1 1.0
associated O 1 0.9999738931655884
with O 0 7.452288564024911e-09
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 0.02073446661233902
1 I-Disease 0 0.04298273101449013
. O 0 2.6604701774957107e-10
. O 0 5.971951266836584e-10

Missense O 0 2.500905338820303e-06
mutations O 0 9.191538086206208e-10
in O 0 1.1371741048815664e-10
the O 0 2.0655288590631926e-10
most O 0 1.3975999177406884e-12
ancient O 0 9.932352856845128e-11
residues O 0 4.1035857378801666e-08
of O 0 6.123146789605016e-08
the O 0 1.0672509098696992e-08
PAX6 O 0 2.918521022365894e-05
paired O 0 7.801947421448574e-10
domain O 0 3.258209257950284e-10
underlie O 0 3.326872666242764e-10
a O 0 2.2834707215368955e-12
spectrum O 0 3.060395548093453e-10
of O 0 3.6057523633559185e-10
human O 0 0.00024031041539274156
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 8.986314128378581e-07

Mutations O 0 2.046026459368022e-09
of O 0 1.8331580697861227e-09
the O 0 1.4714611473731765e-10
human O 0 8.211504254340696e-10
PAX6 O 0 3.920498056686483e-05
gene O 0 9.210988416441523e-09
underlie O 0 2.132866256943089e-06
aniridia B-Disease 1 1.0
( O 0 1.4695193385705352e-05
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999940395355225
of I-Disease 1 0.9766449928283691
the I-Disease 0 6.47967937084104e-08
iris I-Disease 0 7.370920318550134e-09
) O 0 1.1999538732446191e-12
, O 0 7.713644176524093e-13
a O 0 1.3297543621781927e-11
rare O 0 5.35589379069279e-07
dominant O 1 0.9999974966049194
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9999980926513672
eye I-Disease 1 1.0
. O 0 1.3833208640789962e-06

The O 0 9.752518792538467e-10
spectrum O 0 1.0087986446194463e-08
of O 0 7.96205501529812e-09
PAX6 O 0 6.997859600232914e-05
mutations O 0 9.738262418679255e-10
in O 0 4.1218589652558535e-10
aniridia B-Disease 1 1.0
patients O 0 1.4552963278902098e-08
is O 0 2.5186400274407328e-12
highly O 0 7.471976162798377e-12
biased O 0 5.584966625456211e-13
, O 0 8.636308966689273e-15
with O 0 7.066761574108264e-15
92 O 0 1.8671462986841192e-10
% O 0 2.762725812011091e-12
of O 0 3.293986958197159e-11
all O 0 1.1721529996622237e-11
reported O 0 1.2146595361473e-11
mutations O 0 6.8996878523075456e-12
leading O 0 8.494215053556076e-11
to O 0 1.4185702959523816e-11
premature O 0 6.175710498546039e-10
truncation O 0 3.2475039546397966e-08
of O 0 8.585343636013931e-08
the O 0 1.0004952422093538e-09
protein O 0 1.7704038235422104e-10
( O 0 6.957513992017494e-13
nonsense O 0 1.839061680719567e-10
, O 0 1.5040173967362236e-12
splicing O 0 1.8064714654708602e-11
, O 0 2.2838531738532397e-13
insertions O 0 2.857102575359871e-12
and O 0 3.041908088266543e-13
deletions O 0 4.715843167357736e-12
) O 0 8.109940670408822e-14
and O 0 9.646258401427299e-13
just O 0 9.107623509529983e-12
2 O 0 8.1966343434825e-11
% O 0 1.1807554716955493e-12
leading O 0 1.995054945899688e-12
to O 0 8.168249063245092e-14
substitution O 0 2.2916049266519245e-11
of O 0 4.1314615617515926e-10
one O 0 3.095087727778001e-11
amino O 0 2.0422981361623016e-10
acid O 0 9.265983163045388e-13
by O 0 6.365395678002012e-14
another O 0 1.1958501680217615e-12
( O 0 5.733441607765066e-13
missense O 0 4.795160268855625e-09
) O 0 7.060965527549978e-12
. O 0 7.796621681599447e-10

The O 0 1.774068891791103e-09
extraordinary O 0 3.4917635449716045e-10
conservation O 0 1.6763357368887455e-09
of O 0 1.78539905082431e-10
the O 0 2.300974411006962e-10
PAX6 O 0 8.654855037093512e-07
protein O 0 2.0633406094816564e-09
at O 0 4.689059363016668e-09
the O 0 5.468760555515928e-09
amino O 0 1.0202330003039606e-07
acid O 0 2.7315747441747362e-09
level O 0 2.5271967274420604e-07
amongst O 0 3.429050099423847e-10
vertebrates O 0 8.50568171451016e-10
predicts O 0 1.4993159491716312e-10
that O 0 8.854859662350834e-13
pathological O 0 9.643896191846579e-05
missense O 0 1.401078435492309e-07
mutations O 0 1.659014592370056e-11
should O 0 1.2771759561394647e-12
in O 0 8.767770580744849e-13
fact O 0 4.2256744978153016e-12
be O 0 5.2322035593022065e-12
common O 0 1.4241006811299695e-11
even O 0 6.2426175340135615e-12
though O 0 3.5818672246973327e-12
they O 0 1.2950414395376808e-12
are O 0 1.8311030859988198e-13
hardly O 0 1.4156511032870078e-11
ever O 0 4.334315892307039e-12
seen O 0 4.763832384124811e-11
in O 0 2.4153407052196485e-10
aniridia B-Disease 1 1.0
patients O 0 1.8646964861090964e-07
. O 0 9.830175784486528e-09

This O 0 3.866620218451189e-11
indicates O 0 3.018290825607117e-11
that O 0 1.337108185674521e-13
there O 0 2.2491151736164783e-12
is O 0 1.0427407635266173e-12
a O 0 6.743161584665813e-12
heavy O 0 8.157774900041659e-09
ascertainment O 0 1.35742061502242e-06
bias O 0 5.396083024855614e-10
in O 0 4.1508086030817015e-12
the O 0 5.230996191762927e-12
selection O 0 9.203142588287694e-12
of O 0 6.431918886384835e-11
patients O 0 1.6031449171644008e-12
for O 0 4.074198877573876e-12
PAX6 O 0 2.976503765239613e-06
mutation O 0 2.54174771507909e-11
analysis O 0 4.294247791560013e-13
and O 0 1.1844659367904464e-12
that O 0 2.36812891345195e-12
the O 0 1.2857300779600678e-09
missing O 0 3.064639741978681e-08
PAX6 O 0 0.0012840243289247155
missense O 0 4.5085848796588834e-06
mutations O 0 1.4750052290679605e-09
frequently O 0 1.3300511733649323e-11
may O 0 5.588361370878481e-11
underlie O 0 2.585669900412313e-09
phenotypes O 0 2.328609527424419e-09
distinct O 0 4.6356654626045213e-10
from O 0 3.876022280913105e-10
textbook O 0 0.002668672241270542
aniridia B-Disease 1 1.0
. O 0 1.519280544926005e-06

Here O 0 7.414659997095896e-09
we O 0 1.3733267127669091e-11
present O 0 2.4941728370142524e-12
four O 0 8.075096147308614e-12
novel O 0 8.11609668360802e-11
PAX6 O 0 3.3274077395617496e-06
missense O 0 3.659005187728326e-08
mutations O 0 5.165156843900398e-11
, O 0 1.509702302407434e-12
two O 0 1.3771766929973617e-12
in O 0 7.582180022724927e-11
association O 0 3.0763142033762847e-10
with O 0 5.346951614110251e-12
atypical O 0 2.030450474421741e-07
phenotypes O 0 1.806136573634376e-08
ectopia B-Disease 0 1.9437339915384655e-07
pupillae I-Disease 0 6.6467649162405e-08
( O 0 3.1567571907170633e-12
displaced B-Disease 0 2.6854298298961687e-11
pupils I-Disease 0 3.443651266921144e-11
) O 0 4.9779785328551984e-12
and O 0 4.101363160202709e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999998807907104
( O 0 7.29766663765119e-11
searching B-Disease 0 6.912432848338312e-10
gaze I-Disease 0 3.1962885671532604e-09
) O 0 1.9978640866235436e-13
, O 0 1.881981441347047e-13
and O 0 8.609690109288859e-13
two O 0 1.7897341594852456e-12
in O 0 6.281821590681247e-11
association O 0 1.532525079062097e-10
with O 0 2.313659680508451e-12
more O 0 1.4316882748777182e-11
recognizable O 0 5.770510256297712e-07
aniridia B-Disease 1 1.0
phenotypes O 0 1.2398592161844135e-06
. O 0 6.51617693137041e-09

Strikingly O 0 2.0443813752990536e-08
, O 0 5.173737549490909e-10
all O 0 8.998367051482603e-10
four O 0 3.3817196265495397e-10
mutations O 0 2.8627719986240585e-11
are O 0 2.2796586666984364e-12
located O 0 1.9884466295749803e-10
within O 0 2.7541908753647704e-09
the O 0 1.0180982279450745e-08
PAX6 O 0 6.023818059475161e-05
paired O 0 1.474501742926293e-09
domain O 0 1.4435738160401002e-09
and O 0 1.4791402824787525e-10
affect O 0 4.4771211737959504e-10
amino O 0 1.607581179285944e-09
acids O 0 1.2479693493883115e-11
which O 0 8.931597323715013e-13
are O 0 6.55781649144295e-14
highly O 0 4.545398345906504e-13
conserved O 0 3.764548568707671e-12
in O 0 3.72322441974382e-12
all O 0 3.534249282122204e-11
known O 0 2.517192010387248e-10
paired O 0 2.7008928427108003e-10
domain O 0 2.898723761024513e-10
proteins O 0 5.331515784412488e-11
. O 0 7.989952033327086e-10

Our O 0 6.4509939612378275e-09
results O 0 3.024216155278481e-10
support O 0 5.1849573245998926e-11
the O 0 5.0172154625327536e-11
hypothesis O 0 1.9636721068638785e-11
that O 0 2.3121134794614785e-14
the O 0 4.637276890609443e-13
under O 0 2.1463991608378086e-12
- O 0 6.391531184521404e-13
representation O 0 8.917031175947887e-12
of O 0 7.424445780390698e-11
missense O 0 7.57253673100422e-08
mutations O 0 8.008531338088432e-11
is O 0 5.029205676042314e-13
caused O 0 2.058880496647042e-11
by O 0 2.754853636877108e-12
ascertainment O 0 3.806075983447954e-05
bias O 0 6.981591837984524e-08
and O 0 8.331300059560842e-12
suggest O 0 5.512453774697557e-12
that O 0 7.923343377886846e-14
a O 0 1.0631304864228142e-12
substantial O 0 1.2736621479714216e-10
burden O 0 8.83830286735332e-10
of O 0 1.0329017641197424e-06
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999961853027344
related I-Disease 0 0.11172934621572495
disease I-Disease 1 0.9999995231628418
remains O 0 3.357179778618047e-08
to O 0 9.647970356657654e-13
be O 0 4.200570447032703e-12
uncovered O 0 1.8314244565331705e-09
. O 0 3.450273677874094e-10
. O 0 8.915411520149519e-09

The O 0 4.550056775798339e-09
chromosomal O 0 2.1324015619939019e-07
order O 0 1.4940383374906219e-09
of O 0 4.427445077226366e-09
genes O 0 6.365587223999825e-11
controlling O 0 2.0936599121057498e-09
the O 0 1.178822039982208e-09
major O 0 8.105757842713501e-08
histocompatibility O 0 1.370173094983329e-06
complex O 0 3.954457028498837e-08
, O 0 6.3267655003862444e-12
properdin O 0 6.991970558090088e-09
factor O 0 4.823079158278176e-10
B O 0 3.861769215518507e-08
, O 0 5.902074076864772e-13
and O 0 2.979093534360988e-12
deficiency B-Disease 0 2.9899609899075585e-08
of I-Disease 0 3.8674235725011386e-07
the I-Disease 0 4.277955323317428e-09
second I-Disease 0 1.302703389605142e-09
component I-Disease 0 6.746671221691258e-09
of I-Disease 0 1.3607922788594351e-08
complement I-Disease 0 5.4466635646122086e-08
. O 0 5.082516452148411e-08

The O 0 9.414177215560926e-10
relationship O 0 4.564374919691083e-12
of O 0 1.2479109967600266e-09
the O 0 1.061913612598886e-10
genes O 0 1.7781245226222708e-12
coding O 0 2.5014348231655603e-11
for O 0 2.9646786327969243e-12
HLA O 0 1.7022819265299916e-10
to O 0 1.8354285105659507e-13
those O 0 2.286363372933087e-13
coding O 0 1.2966888673915378e-10
for O 0 2.153838522464535e-12
properdin O 0 4.0050696092919225e-09
Factor O 0 1.2314889386022543e-10
B O 0 1.0903964398067956e-09
allotypes O 0 1.25915736171045e-10
and O 0 5.30776757181467e-13
for O 0 3.0263192125901117e-12
deficiency B-Disease 0 8.201486156877991e-10
of I-Disease 0 1.4942834747344591e-09
the I-Disease 0 1.0287472956838073e-10
second I-Disease 0 5.7348473192497806e-11
component I-Disease 0 4.413244769629898e-10
of I-Disease 0 7.639004095949531e-09
complement I-Disease 0 8.89979823170961e-09
( O 0 3.075152910092527e-10
C2 O 0 9.477667539670165e-10
) O 0 3.5600137475531174e-14
was O 0 3.0688565837849735e-12
studied O 0 7.462305946781544e-12
in O 0 1.5016669548464923e-12
families O 0 1.208377744654071e-13
of O 0 6.227089677235398e-11
patients O 0 4.707813583415543e-10
with O 0 1.4179873941699839e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 1.944621908478439e-05

Patients O 0 3.6714137507942723e-08
were O 0 6.981465960897992e-10
selected O 0 7.305005905733353e-11
because O 0 1.3141920711390309e-11
they O 0 4.62399563083693e-12
were O 0 7.302898737127084e-12
heterozygous O 0 1.2569185969812935e-10
or O 0 1.1944261552043756e-11
homozygous O 0 3.586181662740273e-07
for O 0 2.047839188890066e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.326516922972587e-07

12 O 0 1.0090318625088912e-07
families O 0 4.747031760732323e-12
with O 0 2.0635106037086848e-12
15 O 0 1.411155858832558e-09
matings O 0 2.294871315200453e-08
informative O 0 1.4378807478010458e-08
for O 0 1.146312683886208e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 7.174075022930992e-08
found O 0 1.2580561037367488e-09
. O 0 3.3052305337122334e-09

Of O 0 2.508625414066046e-07
57 O 0 4.213963933352716e-08
informative O 0 3.216162058894412e-10
meioses O 0 2.8946990582312537e-08
, O 0 6.5015549367830605e-12
two O 0 4.080176680461983e-13
crossovers O 0 7.289663664367119e-12
were O 0 3.243028458624342e-12
noted O 0 2.919534189058104e-12
between O 0 8.37042379853159e-11
the O 0 0.002121714875102043
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.4321279405427045e-11
and O 0 3.307954767311355e-13
the O 0 3.901042683329692e-12
HLA O 0 1.491034962164406e-09
- O 0 4.4931439124873407e-10
B O 0 1.2270394700308884e-09
gene O 0 5.118011049687343e-13
, O 0 2.4291439560254584e-15
with O 0 7.211472812102806e-16
a O 0 1.1953410266815623e-13
recombinant O 0 2.589575255618204e-12
fraction O 0 9.187883093231264e-12
of O 0 9.96758120486163e-10
0 O 0 1.533979343548708e-07
. O 0 2.729887205177306e-09

035 O 0 0.007832408882677555
. O 0 2.8203508009028155e-06

A O 0 1.5515027484980237e-08
lod O 0 4.2973479708052764e-07
score O 0 1.2074078403756516e-09
of O 0 4.405826814490865e-10
13 O 0 2.7263369339891597e-10
was O 0 1.1467267239939627e-11
calculated O 0 6.397238966858454e-13
for O 0 1.7899585622298958e-13
linkage O 0 1.1641719765975722e-07
between O 0 1.6404184862039983e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 6.31175042786758e-11
HLA O 0 1.4407468107435761e-08
- O 0 1.428165224970357e-10
B O 0 4.2056574889315357e-10
at O 0 1.7501466855612824e-12
a O 0 8.881169251081546e-15
maximum O 0 1.233955971256806e-13
likelihood O 0 1.0292482334082684e-13
value O 0 7.039778916057005e-14
of O 0 2.014547654128479e-13
the O 0 1.1286371820852861e-13
recombinant O 0 1.6614446905934e-13
fraction O 0 8.022619027436839e-13
of O 0 6.482117620443262e-11
0 O 0 4.737101377827457e-08
. O 0 2.3741342225491735e-09

04 O 0 0.0016266318270936608
. O 0 2.258361519125174e-06

18 O 0 9.548221413524516e-08
families O 0 3.37152116121342e-12
with O 0 5.40045113663068e-13
21 O 0 1.6059996665873655e-09
informative O 0 1.055338715721943e-11
matings O 0 1.707816180140931e-11
for O 0 1.7193133852386189e-12
both O 0 7.603117788135272e-12
properdin O 0 2.9010001512119743e-08
Factor O 0 1.9354806646276757e-09
B O 0 3.2219613643746925e-08
allotype O 0 6.924813611419722e-09
and O 0 4.6727698099768844e-11
HLA O 0 2.3049527442253748e-07
- O 0 3.6740757991537976e-08
B O 0 1.182399032018111e-07
were O 0 3.6666727987189063e-10
found O 0 3.0630688957478114e-11
. O 0 5.302352446001635e-10

Of O 0 1.7398031104676193e-06
72 O 0 8.988097306428244e-07
informative O 0 2.757328809721571e-09
meioses O 0 1.085746674789334e-07
, O 0 7.037775223706078e-11
three O 0 6.385542788978071e-11
recombinants O 0 4.094485106520551e-08
were O 0 1.7533469121033818e-09
found O 0 1.4199400336090129e-11
, O 0 1.239102787389812e-12
giving O 0 6.760959847529335e-12
a O 0 4.944527426387069e-12
recombinant O 0 2.0157797306352698e-11
fraction O 0 2.9190958678038115e-11
of O 0 7.327018991531986e-09
0 O 0 5.690221200893575e-07
. O 0 8.449963395662508e-09

042 O 0 0.0007471214048564434
. O 0 2.006999011427979e-06

A O 0 4.500015915454014e-09
lod O 0 1.714395949647951e-07
score O 0 9.234802367252826e-10
of O 0 3.3576311175842477e-10
16 O 0 2.313988584079496e-10
between O 0 3.0753035534791806e-11
HLA O 0 1.1819074785535122e-07
- O 0 1.766323531882108e-09
B O 0 3.4332074960730097e-09
and O 0 1.2807400539410763e-12
Factor O 0 1.064447835430471e-11
B O 0 2.674175880734708e-10
allotypes O 0 2.693916478779812e-10
was O 0 6.9484600365155025e-12
calculated O 0 5.049650476408873e-13
at O 0 2.450610461085523e-12
a O 0 8.63507873603668e-14
maximum O 0 9.99845063513749e-13
likelihood O 0 5.841641189871516e-13
value O 0 1.40517502147941e-12
of O 0 2.8825282005068287e-12
the O 0 9.976715634185673e-13
recombinant O 0 1.1293958390029557e-12
fraction O 0 1.0384734521959316e-12
of O 0 5.046567608246733e-10
0 O 0 1.52826842736431e-07
. O 0 7.190100070886274e-09

04 O 0 0.0017521422123536468
. O 0 2.0535203475446906e-06

A O 0 1.6181975759366196e-09
crossover O 0 3.9092024062270525e-10
was O 0 2.976539154042612e-11
shown O 0 3.6405069497175147e-13
to O 0 5.3139845225969734e-14
have O 0 2.0190704034910023e-14
occurred O 0 2.9754405319812327e-13
between O 0 5.006002411239068e-15
genes O 0 2.876450705228961e-14
for O 0 1.1620404345800278e-14
Factor O 0 1.230755081182977e-12
B O 0 1.6063789187725774e-10
and O 0 1.0703024837938058e-12
HLA O 0 5.939353009409842e-09
- O 0 1.6967495186648307e-09
D O 0 8.494397962799383e-10
, O 0 4.559819251240098e-14
in O 0 1.4556923917143083e-13
which O 0 1.10743499873861e-12
HLA O 0 1.0405573291905057e-08
- O 0 2.6815272224922637e-09
D O 0 2.335557525157128e-09
segregared O 0 1.094578538918256e-09
with O 0 9.720450356090482e-13
HLA O 0 1.8380394095629526e-08
- O 0 2.854159131260303e-10
A O 0 1.8854263983403285e-10
and O 0 8.877931376161108e-12
B O 0 2.4171729506861084e-08
. O 0 3.3018263123629765e-10

These O 0 2.3591588751981085e-11
studies O 0 6.074372341929868e-12
suggest O 0 9.400417727220556e-13
that O 0 2.2686647550254797e-14
the O 0 4.933474961020534e-13
genes O 0 1.1543974868903628e-13
for O 0 1.4023522198081811e-13
Factor O 0 9.117783195122797e-10
B O 1 0.999992847442627
and O 0 0.15869341790676117
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.3926399096420017e-12
located O 0 6.5791963890782235e-12
outside O 0 1.6004510217104695e-11
those O 0 1.2177528408395533e-13
for O 0 1.0915164171815261e-12
HLA O 0 3.8962224557792524e-09
, O 0 2.7694773557795926e-13
that O 0 1.393818379805253e-14
the O 0 3.880077140659688e-13
order O 0 2.2554258807816474e-12
of O 0 1.465824510382685e-11
genese O 0 4.2209583051011634e-10
is O 0 8.606045563686049e-13
HLA O 0 4.8749060344022155e-11
- O 0 6.2595957063538155e-12
A O 0 8.956239916368958e-11
, O 0 6.00543323837216e-13
- O 0 1.2969700834142284e-11
B O 0 1.2351121236875429e-09
, O 0 2.3533870165126647e-12
- O 0 4.260720248838723e-11
D O 0 8.072297691397168e-11
, O 0 5.717582847062849e-14
Factor O 0 9.166422829109955e-12
B O 0 1.619967981980608e-08
allotype O 0 3.3593178159208037e-06
, O 0 1.3989421177029726e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 3.1323491841766735e-14
that O 0 5.070073465677041e-16
the O 0 2.5766100204501798e-14
genes O 0 1.6186573294826173e-13
coding O 0 1.4643419810056457e-09
for O 0 7.059592377345325e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.0937937147968988e-11
Factor O 0 4.6050920021745156e-11
B O 0 8.452860633667569e-10
allotypes O 0 2.473708737849023e-10
are O 0 2.2882686549633227e-14
approximately O 0 2.562519457966015e-14
3 O 0 8.419223651578989e-12
- O 0 8.547562072198922e-13
- O 0 7.865392365191681e-13
5 O 0 2.1345228102404024e-12
centimorgans O 0 6.98886695044143e-12
from O 0 4.827192316117675e-14
the O 0 1.4125379468529764e-12
HLA O 0 9.926520022629504e-11
- O 0 4.66070628271642e-12
A O 0 1.2022406507827821e-11
and O 0 3.0807837834642693e-13
HLA O 0 1.8039932048186103e-10
- O 0 6.132227971938908e-12
B O 0 6.250957650805189e-12
loci O 0 8.687893611990238e-14
, O 0 2.32955299846085e-15
and O 0 8.866777949549458e-16
that O 0 2.347294262359769e-16
the O 0 3.8757703508173966e-14
apparent O 0 9.965328041927624e-12
lack O 0 2.0873948403110631e-10
of O 0 1.759811393831079e-11
recombinants O 0 7.698704174163851e-11
between O 0 1.6905219628673973e-12
the O 0 1.549164442560258e-11
Factor O 0 1.9487485236613367e-10
B O 0 2.405125087534543e-06
gene O 0 5.008532184547221e-07
and O 0 0.3562150001525879
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.706448564206767e-10
suggests O 0 1.4845511972505498e-12
that O 0 9.374517661979182e-15
these O 0 1.333241802142825e-14
two O 0 1.6790234025169937e-13
genes O 0 6.620861085944452e-13
lie O 0 2.1611396699983132e-11
in O 0 1.8073700088633293e-12
close O 0 9.746191353965372e-11
proximity O 0 3.927350000765273e-09
to O 0 6.834790372556299e-11
one O 0 3.30414473559415e-10
another O 0 3.5916007945502315e-09
. O 0 4.054462365843392e-08

Distribution O 0 1.8721042494007634e-09
of O 0 1.0090507096549572e-08
emerin O 0 2.6323536417294235e-07
and O 0 3.2072058897547606e-10
lamins O 0 4.5585548491544614e-07
in O 0 1.521997389231089e-10
the O 0 1.2522100023559801e-09
heart O 0 9.968959346906558e-08
and O 0 1.837560138773231e-11
implications O 0 1.623925993676778e-10
for O 0 2.427870404719812e-11
Emery B-Disease 1 0.9999886751174927
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.3344512808544096e-05

Emerin O 0 2.1291052689775825e-05
is O 0 8.301170861813034e-10
a O 0 6.606461905311889e-11
nuclear O 0 3.759581534978906e-09
membrane O 0 2.351961334023933e-11
protein O 0 1.2294558600356442e-11
which O 0 6.835053763211071e-14
is O 0 3.7224341447802956e-13
missing O 0 4.5372608448168705e-11
or O 0 2.7728206883348427e-11
defective O 0 1.0596567179277372e-08
in O 0 7.697870674228113e-10
Emery B-Disease 1 1.0
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.9624833902962564e-07
EDMD B-Disease 1 1.0
) O 0 3.6656305768545394e-10
. O 0 6.448234723954727e-10

It O 0 9.981769577560584e-11
is O 0 1.285208918455627e-11
one O 0 1.956243110209921e-12
member O 0 7.908197013906104e-11
of O 0 7.277300539954012e-08
a O 0 7.2715251597799124e-09
family O 0 1.200724242256257e-10
of O 0 2.6824756105270353e-07
lamina O 1 0.9998874664306641
- O 0 2.266263408046143e-07
associated O 0 1.938843929849554e-08
proteins O 0 7.737744472935404e-11
which O 0 1.0721352191461753e-12
includes O 0 1.3493661916996746e-11
LAP1 O 0 1.662589284023852e-06
, O 0 1.162107077234964e-10
LAP2 O 0 1.8939430447062477e-05
and O 0 5.48833289926165e-09
lamin O 0 1.6029476682888344e-05
B O 0 2.5093814315368945e-07
receptor O 0 2.627088546702794e-10
( O 0 2.001100153636859e-11
LBR O 0 2.1202144750986918e-07
) O 0 3.734748621475603e-11
. O 0 1.4179495355648442e-09

A O 0 1.6192084331123624e-06
panel O 0 1.3772162965608459e-08
of O 0 3.533194625759961e-09
16 O 0 4.414998144852689e-09
monoclonal O 0 2.201899912401828e-10
antibodies O 0 1.3698629904024262e-11
( O 0 2.8139721455766598e-12
mAbs O 0 3.276194038281943e-10
) O 0 5.40407833499873e-13
has O 0 7.083124234710803e-13
been O 0 7.347491755640978e-13
mapped O 0 3.371482780456514e-12
to O 0 9.37574345417913e-13
six O 0 9.304773097851271e-12
specific O 0 1.4888019202879965e-12
sites O 0 4.5804065401666705e-11
throughout O 0 1.8437151805272833e-10
the O 0 1.9657837579956094e-09
emerin O 0 4.84847610948691e-08
molecule O 0 1.7926184842087522e-11
using O 0 3.7887228077071455e-12
phage O 0 4.2879828160424793e-11
- O 0 2.3935406608111e-12
displayed O 0 1.5408894646351534e-11
peptide O 0 2.9113764350718885e-12
libraries O 0 1.7955133907454623e-11
and O 0 3.1430890876094075e-12
has O 0 4.871034673704921e-13
been O 0 2.7095881961758383e-13
used O 0 1.9394419880844338e-13
to O 0 4.942309582423032e-13
localize O 0 5.973728733899009e-10
emerin O 0 4.628237793014023e-09
in O 0 2.5177093049277843e-11
human O 0 2.710925928184338e-10
and O 0 1.5911806594548494e-10
rabbit O 0 1.1805663007180556e-06
heart O 0 3.169772753608413e-05
. O 0 1.4373932799571776e-07

Several O 0 5.543788539341676e-09
mAbs O 0 7.84220759442178e-08
against O 0 2.0514463461296373e-09
different O 0 2.695544308595199e-11
emerin O 0 2.0026978120313288e-07
epitopes O 0 1.440142938236022e-07
did O 0 6.89352255833775e-11
not O 0 4.0219794183483926e-13
recognize O 0 5.354483783442943e-12
intercalated O 0 3.247054569666119e-10
discs O 0 6.101855909435017e-09
in O 0 4.439312806248097e-11
the O 0 5.612183495706802e-10
heart O 0 1.9835304954085586e-07
, O 0 6.598021608239524e-12
though O 0 4.078420760833534e-12
they O 0 3.2490446422693553e-13
recognized O 0 9.381902373040152e-12
cardiomyocyte O 0 1.8317669603362674e-09
nuclei O 0 3.799819139893579e-11
strongly O 0 1.1467966333500446e-11
, O 0 9.824833004448696e-13
both O 0 5.110173048605837e-11
at O 0 9.642786835684092e-08
the O 0 3.3408525723643834e-08
rim O 0 1.6753553211401595e-08
and O 0 6.7044820216410894e-12
in O 0 3.3568543778006443e-11
intranuclear O 0 2.985271052580174e-08
spots O 0 3.115251168139821e-09
or O 0 5.55651809286406e-11
channels O 0 7.540479352030616e-09
. O 0 3.1568539782256266e-08

A O 0 9.874151629674088e-08
polyclonal O 0 2.5548538928887865e-07
rabbit O 0 3.6582097351356424e-08
antiserum O 0 2.9666757939139643e-08
against O 0 4.177724832743479e-09
emerin O 0 1.3864996617485303e-07
did O 0 5.840020828040693e-11
recognize O 0 6.211123282362507e-11
both O 0 3.3864540945754973e-12
nuclear O 0 5.823295179396837e-10
membrane O 0 5.404387332617888e-13
and O 0 4.7227155454583614e-14
intercalated O 0 2.1431684552042363e-11
discs O 0 1.2880808919479847e-10
but O 0 2.258123701047443e-13
, O 0 6.264626455256125e-15
after O 0 4.523376505717429e-14
affinity O 0 8.132230511822408e-14
purification O 0 1.0333525701788915e-11
against O 0 4.5632799622330467e-11
a O 0 1.7908107288744368e-11
pure O 0 3.096259693080583e-09
- O 0 1.5509329931440163e-10
emerin O 0 9.316010185500545e-09
band O 0 9.177593685016916e-10
on O 0 5.313154360919725e-10
a O 0 2.0742439883758568e-12
western O 0 2.398006272719133e-11
blot O 0 2.424152434343796e-09
, O 0 3.001865075957788e-11
it O 0 3.9049505816401986e-12
stained O 0 8.746441793050508e-09
only O 0 4.627315197680559e-11
the O 0 2.9129848533315794e-10
nuclear O 0 1.0010553808115219e-07
membrane O 0 2.216015371203639e-09
. O 0 8.972693144038146e-10

These O 0 3.9834924248083325e-10
results O 0 7.390230094550532e-10
would O 0 9.31558736400051e-12
not O 0 1.3370783430097233e-12
be O 0 4.0616736861863456e-13
expected O 0 3.499280509453029e-12
if O 0 1.2317695691557717e-12
immunostaining O 0 1.5917489548655794e-09
at O 0 2.707375990063099e-10
intercalated O 0 4.3050302211966596e-10
discs O 0 6.838057231561834e-09
were O 0 4.482057086585556e-11
due O 0 1.7157182619076394e-10
to O 0 6.415689919429812e-13
a O 0 3.146597782680005e-12
product O 0 3.75422470888509e-11
of O 0 3.0137820017372974e-10
the O 0 1.412606698281138e-10
emerin O 0 1.4886999188945538e-08
gene O 0 2.0407201969940836e-11
and O 0 3.2382317313728315e-12
, O 0 2.1950029413433242e-13
therefore O 0 6.70133436589393e-13
, O 0 3.943658686287113e-14
cast O 0 7.620477057539154e-13
some O 0 5.3301252436266724e-14
doubt O 0 3.478253058838976e-12
upon O 0 2.431603095959245e-13
the O 0 3.1370262290608686e-13
hypothesis O 0 2.217073313132145e-12
that O 0 4.434659630074729e-14
cardiac B-Disease 1 0.9999996423721313
defects I-Disease 1 0.9997610449790955
in O 0 5.530115032570393e-08
EDMD B-Disease 1 1.0
are O 0 4.757387817022618e-10
caused O 0 2.3351195976850647e-10
by O 0 4.218829278979097e-12
absence O 0 1.0355366697467616e-07
of O 0 1.526156694353631e-07
emerin O 0 3.7355098356783856e-06
from O 0 1.7483376968385755e-09
intercalated O 0 1.1396764421078842e-06
discs O 0 3.6492387152975425e-05
. O 0 1.165230472111034e-07

Although O 0 3.1618900830920893e-09
emerin O 0 1.3218583205798495e-07
was O 0 1.1165248725575339e-09
abundant O 0 7.688358283353125e-11
in O 0 1.1085366999341595e-11
the O 0 3.0914177467922244e-11
membranes O 0 3.778967069822947e-11
of O 0 3.3264793697362904e-10
cardiomyocyte O 0 8.709451826405257e-09
nuclei O 0 1.3883183491714135e-10
, O 0 3.3594149597554468e-12
it O 0 3.754652838638961e-12
was O 0 2.5709661066741774e-09
absent O 0 1.0913708159421276e-08
from O 0 2.1840676836526463e-11
many O 0 3.6062389185964605e-11
non O 0 3.512689374929323e-07
- O 0 1.8556548520010097e-09
myocyte O 0 2.4494616468473396e-07
cells O 0 1.721333076076803e-10
in O 0 4.48439133049483e-11
the O 0 2.4910673523947935e-09
heart O 0 1.0233049579255749e-05
. O 0 4.9249699429765315e-08

This O 0 1.791021541144855e-12
distribution O 0 2.492985158586425e-11
of O 0 8.436962795066449e-10
emerin O 0 9.692943336858661e-08
was O 0 2.2288000334214075e-09
similar O 0 1.238127005434575e-12
to O 0 9.833470436581074e-14
that O 0 1.5451551984516781e-13
of O 0 8.257113326415322e-10
lamin O 0 1.130066948462627e-06
A O 0 3.6978013984168e-09
, O 0 3.2632932814302684e-12
a O 0 7.023825531610184e-12
candidate O 0 9.690082763968988e-11
gene O 0 8.496673850610925e-12
for O 0 1.288839044169543e-12
an O 0 1.3825246286333637e-12
autosomal O 0 6.514896622178412e-09
form O 0 3.810994897435194e-08
of O 1 0.6057150363922119
EDMD B-Disease 1 1.0
. O 0 1.572385599502013e-06

In O 0 5.962675353465841e-10
contrast O 0 2.237429352902609e-09
, O 0 2.4197963632843766e-09
lamin O 0 0.13620729744434357
B1 O 0 0.00023218797286972404
was O 0 3.8737422158874324e-08
absent O 0 8.488522773575369e-09
from O 0 4.835419564752641e-11
cardiomyocyte O 0 2.5008567661188863e-08
nuclei O 0 2.868813242518087e-10
, O 0 2.316971918145394e-12
showing O 0 1.4637835388242593e-09
that O 0 3.115677438270126e-10
lamin O 0 0.05746566131711006
B1 O 0 1.1672670297002696e-07
is O 0 1.484709165507081e-13
not O 0 1.782448869763493e-14
essential O 0 2.8154215070408384e-12
for O 0 4.677695947599703e-13
localization O 0 4.433692524230537e-08
of O 0 5.116895795964638e-10
emerin O 0 6.905162219794647e-09
to O 0 2.7905204189049293e-11
the O 0 1.2645900993035752e-09
nuclear O 0 1.9250553577876417e-06
lamina O 0 2.221222166554071e-05
. O 0 7.97969406107768e-08

Lamin O 1 0.9991533756256104
B1 O 0 0.0005056770169176161
is O 0 2.572431434533229e-10
also O 0 3.333642389913294e-11
almost O 0 9.099952735791561e-11
completely O 0 1.2097278556666424e-07
absent O 0 6.062369948267587e-07
from O 0 4.515793516901567e-09
skeletal O 0 0.32285165786743164
muscle O 0 0.0006092695402912796
nuclei O 0 4.758146133099217e-06
. O 0 1.0903288227837038e-07

In O 0 2.479511707065285e-08
EDMD B-Disease 1 1.0
, O 0 2.093346503084792e-11
the O 0 2.3038133900588065e-12
additional O 0 3.558345566985477e-13
absence O 0 7.068235441387571e-10
of O 0 2.1682197370864742e-08
lamin O 1 0.9882916808128357
B1 O 0 0.002688246313482523
from O 0 7.284782554961566e-09
heart O 1 0.9999996423721313
and O 0 3.247917993576266e-05
skeletal O 1 1.0
muscle O 1 0.9999954700469971
nuclei O 0 1.180017352453433e-05
which O 0 3.249198132770914e-10
already O 0 6.145899345000316e-10
lack O 0 2.23053757508751e-06
emerin O 0 6.257427230593748e-06
may O 0 1.8609173924044597e-10
offer O 0 5.119972913518456e-13
an O 0 2.1569934559187778e-14
alternative O 0 8.342165153107928e-11
explanation O 0 6.307270677963217e-12
of O 0 5.721256454704893e-11
why O 0 4.7720599173628475e-12
these O 0 2.2816847695082687e-13
tissues O 0 1.8038272264764288e-11
are O 0 3.585454144954675e-13
particularly O 0 9.642304316104244e-13
affected O 0 1.307164229288893e-12
. O 0 2.2874039468101515e-11
. O 0 4.062727931852805e-09

Genetic O 0 1.4561672978530282e-09
mapping O 0 3.8653394374144057e-10
of O 0 9.448648974341722e-09
the O 0 5.4288422646209256e-09
copper B-Disease 0 8.453158528709537e-08
toxicosis I-Disease 0 2.2599813291890314e-06
locus O 0 3.725780128860379e-09
in O 0 5.701106808864154e-10
Bedlington O 0 5.761925763181353e-07
terriers O 0 8.415723584676016e-08
to O 0 1.213386613407863e-10
dog O 0 4.9239714527971046e-09
chromosome O 0 5.876472641830333e-10
10 O 0 1.772917923581474e-10
, O 0 6.189474930848315e-13
in O 0 2.5091270207389105e-12
a O 0 8.994479640256348e-12
region O 0 1.1433202301569523e-10
syntenic O 0 4.1810968021138706e-09
to O 0 4.845147720533571e-12
human O 0 3.722679456363842e-11
chromosome O 0 9.84304082685128e-10
region O 0 1.0382986692647478e-09
2p13 O 0 3.642391277480783e-08
- O 0 1.8243829558173275e-08
p16 O 0 9.020056701558588e-09
. O 0 2.1708008723919647e-09

Abnormal O 1 0.9999969005584717
hepatic B-Disease 1 1.0
copper I-Disease 0 2.3189222702058032e-05
accumulation I-Disease 0 5.768689703700147e-08
is O 0 1.652918600603126e-11
recognized O 0 3.437639756187494e-11
as O 0 5.318674754090091e-12
an O 0 1.9171303433651588e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 5.342191755630665e-08
man O 0 9.2096663628638e-10
, O 0 7.891166886597745e-12
mouse O 0 4.6594177405268056e-08
, O 0 7.981864058592691e-10
rat O 0 3.1895672236714745e-07
and O 0 5.388156587571302e-09
dog O 0 1.4926084759281366e-06
. O 0 5.863457275268047e-08

The O 0 1.7503637650406745e-08
major O 0 1.2254898251740087e-07
cause O 0 1.968491915249615e-06
of O 0 0.013342637568712234
hepatic B-Disease 1 1.0
copper I-Disease 0 0.0052676089107990265
accumulation I-Disease 0 9.786008376977406e-07
in O 0 1.445597490601358e-07
man O 0 9.611769158368588e-09
is O 0 6.8194473505645e-12
a O 0 3.101528756044303e-11
dysfunctional O 0 4.485908033924346e-10
ATP7B O 0 4.924603445033426e-07
gene O 0 1.0075534850884083e-10
, O 0 7.165415179602452e-13
causing O 0 6.323502277361115e-10
Wilson B-Disease 0 1.8199550311237545e-08
disease I-Disease 0 0.00014716980513185263
( O 0 6.981582673093456e-11
WD B-Disease 1 1.0
) O 0 1.5656073104608481e-09
. O 0 2.0846394832574333e-08

Mutations O 0 3.4668463655407322e-09
in O 0 1.1622207640726856e-09
the O 0 2.7771953625688184e-09
ATP7B O 0 2.762110170806409e-06
genes O 0 7.41530309378291e-11
have O 0 2.885426923435186e-12
also O 0 3.089009625346917e-13
been O 0 3.232639037096391e-13
demonstrated O 0 2.5567624406530598e-11
in O 0 8.435269149842384e-11
mouse O 0 1.1880052852575318e-07
and O 0 1.710635544327488e-08
rat O 0 1.5952473404468037e-06
. O 0 2.0027833613767143e-08

The O 0 3.771275558506204e-08
ATP7B O 0 1.9025254005100578e-05
gene O 0 3.723235331154484e-10
has O 0 1.3329075256723888e-12
been O 0 1.4134292423539224e-13
excluded O 0 1.8171662091726049e-12
in O 0 1.6376814184274058e-13
the O 0 1.6501961472639715e-12
much O 0 1.3851958859459335e-12
rarer O 0 4.2905207164878334e-10
human O 0 5.496420207862229e-09
copper B-Disease 0 1.6680271528457524e-06
overload I-Disease 1 0.5569301843643188
disease O 1 0.9999998807907104
non B-Disease 0 0.00018615758744999766
- I-Disease 0 2.041356639281844e-09
Indian I-Disease 0 9.093741037968783e-11
childhood I-Disease 0 2.5352210286655463e-06
cirrhosis I-Disease 1 0.9998722076416016
, O 0 1.4980860302271637e-11
indicating O 0 8.0141587810445e-10
genetic O 0 1.66273608215306e-08
heterogeneity O 0 2.7013729209102166e-07
. O 0 2.5324796482095735e-08

By O 0 5.755931495321498e-11
investigating O 0 4.1751738177886466e-10
the O 0 7.839418558752698e-10
common O 0 5.6872650588957185e-08
autosomal O 0 0.0004590543976519257
recessive O 0 6.0696707805618644e-05
copper B-Disease 0 6.49052017251961e-05
toxicosis I-Disease 1 0.9997420907020569
( O 0 7.562624138035545e-11
CT B-Disease 0 9.71240865510481e-07
) O 0 2.060985496848966e-12
in O 0 1.489532629184165e-11
Bedlington O 0 4.7277499248821186e-08
terriers O 0 9.968651681901974e-09
, O 0 2.24886645763811e-12
we O 0 4.494276858221097e-13
have O 0 1.47316563109531e-14
identified O 0 5.518820721462292e-15
a O 0 2.6994027350993885e-15
new O 0 4.487060476323669e-15
locus O 0 1.2808621351056981e-12
involved O 0 1.4874755073501778e-13
in O 0 2.1033691455230041e-10
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.0688622751331422e-06

We O 0 1.1704874847140445e-09
examined O 0 1.020023440712059e-10
whether O 0 3.8223803462689165e-12
the O 0 1.8720817951400903e-10
WD B-Disease 1 0.9999058246612549
gene O 0 1.1678120692693028e-08
ATP7B O 0 2.9915418053860776e-05
was O 0 4.22724477644465e-09
also O 0 1.2764429270506472e-12
causative O 0 1.2158370664427931e-11
for O 0 2.490655034645406e-12
CT B-Disease 0 4.1342143042299995e-09
by O 0 2.2514416546381977e-12
investigating O 0 6.757014652664095e-12
the O 0 1.7553928796654183e-11
chromosomal O 0 6.10187407801277e-06
co O 0 2.3080167466105195e-07
- O 0 4.608330161914864e-09
localization O 0 7.083181117195636e-07
of O 0 7.865453177657855e-09
ATP7B O 0 4.2379843989692745e-07
and O 0 4.713765835995254e-12
C04107 O 0 1.9515865312680347e-10
, O 0 1.3763041270889453e-13
using O 0 1.3981211377707154e-14
fluorescence O 0 3.3726965447886115e-13
in O 0 6.022708373687458e-13
situ O 0 3.0752056456861965e-10
hybridization O 0 5.7065869391026425e-11
( O 0 2.100321305764652e-11
FISH O 0 1.2898720314069578e-08
) O 0 7.530651449649817e-12
. O 0 3.2650399051092904e-10

C04107 O 0 1.3583128293248592e-06
is O 0 1.046862874165555e-10
an O 0 1.1366482841751457e-12
anonymous O 0 5.541319486601637e-11
microsatellite O 0 1.59218927819893e-07
marker O 0 1.5408498654778668e-07
closely O 0 1.0716809661914795e-09
linked O 0 1.7089657688984516e-08
to O 0 7.681956737393136e-10
CT B-Disease 0 0.007946706376969814
. O 0 2.678978319181624e-07

However O 0 9.337001394271738e-09
, O 0 8.725742350890187e-10
BAC O 0 9.156268561127945e-07
clones O 0 1.313542519199018e-08
containing O 0 5.891263588075901e-10
ATP7B O 0 4.3259174731247185e-07
and O 0 1.2187352516068728e-10
C04107 O 0 4.8331560975611865e-09
mapped O 0 7.343272656612498e-10
to O 0 2.5110384258009155e-11
the O 0 4.075811910198013e-10
canine O 0 2.5389654823015917e-08
chromosome O 0 8.669673867700567e-09
regions O 0 3.741547072166895e-09
CFA22q11 O 0 4.225675240832061e-07
and O 0 4.785892793179869e-10
CFA10q26 O 0 9.31857258024138e-08
, O 0 1.6460286259012413e-11
respectively O 0 3.885798627312198e-11
, O 0 4.745789265042655e-13
demonstrating O 0 2.741227557445658e-11
that O 0 4.641190209930812e-12
WD B-Disease 1 0.9881519675254822
cannot O 0 6.088297643813689e-10
be O 0 2.600087463042189e-12
homologous O 0 2.4899438413883423e-11
to O 0 6.426437854090139e-11
CT B-Disease 0 2.6606194296618924e-05
. O 0 3.456785080402369e-08

The O 0 2.1947096229268936e-07
copper O 0 1.4623142874370387e-07
transport O 0 2.885095495841483e-09
genes O 0 4.335080905359945e-10
CTR1 O 0 3.113506750196393e-07
and O 0 2.377463503844268e-10
CTR2 O 0 1.552176763652824e-05
were O 0 2.2691855061651722e-09
also O 0 1.1190032407626394e-11
excluded O 0 9.209608770044397e-11
as O 0 2.512009697475115e-12
candidate O 0 2.0054484115017424e-11
genes O 0 5.337309912610555e-13
for O 0 3.89718070098119e-13
CT B-Disease 0 3.270983484071621e-08
since O 0 6.974611443943957e-10
they O 0 2.8777709382143968e-12
both O 0 7.409329768649775e-13
mapped O 0 1.3039233581757514e-10
to O 0 1.73008447845735e-11
canine O 0 4.316084556421629e-08
chromosome O 0 4.975786538352622e-08
region O 0 4.420157395657043e-08
CFA11q22 O 0 1.1926967090403195e-05
. O 0 2.482624097410735e-07

2 O 0 4.0839429857442155e-05
- O 0 3.4044754215756257e-07
22 O 0 8.485143609959778e-08
. O 0 2.340151361579501e-08

5 O 0 2.116816358466167e-05
. O 0 3.135868098524952e-07

A O 0 4.895484462252853e-09
transcribed O 0 1.2980789186600727e-11
sequence O 0 5.135536527284268e-12
identified O 0 3.0862905547185404e-12
from O 0 1.980359886494254e-12
the O 0 6.707823879681385e-11
C04107 O 0 7.515152056214447e-09
- O 0 4.4026682299858066e-10
containing O 0 6.452048340044314e-10
BAC O 0 7.007928104485472e-08
was O 0 9.711639131770866e-11
found O 0 3.1302483391795755e-13
to O 0 4.363217821984691e-14
be O 0 1.5582664553235454e-13
homologous O 0 1.1058604119235094e-12
to O 0 3.280491113130668e-13
a O 0 2.7510259695273653e-12
gene O 0 2.2973190190456183e-12
expressed O 0 2.3488922937763e-13
from O 0 1.6394408075028066e-13
human O 0 6.480186179325109e-12
chromosome O 0 1.8722352834732447e-10
2p13 O 0 2.2923853926215543e-09
- O 0 2.2506195518356975e-10
p16 O 0 6.999155421905101e-11
, O 0 1.9379998636697565e-13
a O 0 2.0941428658435152e-13
region O 0 6.186787193662724e-12
devoid O 0 2.2349555539591393e-09
of O 0 2.5102291772993723e-11
any O 0 2.23643725066891e-11
positional O 0 5.368340438849373e-08
candidate O 0 1.451919384720668e-08
genes O 0 3.2721862996965e-09
. O 0 4.873163206298159e-09

Molecular O 0 7.020993231243722e-10
analysis O 0 2.0822283133825614e-11
of O 0 6.567042465377426e-10
the O 0 1.439674823799919e-09
APC B-Disease 0 1.3840939505627148e-09
gene O 0 2.7811724277737593e-12
in O 0 4.251252561787711e-12
205 O 0 3.319727132078398e-11
families O 0 4.0281366024859377e-13
: O 0 3.858453812531637e-13
extended O 0 3.285643146444528e-10
genotype O 0 2.1469592770273493e-09
- O 0 1.9265702921877903e-10
phenotype O 0 3.079635851888085e-11
correlations O 0 6.832492471103846e-12
in O 0 6.903462176910402e-13
FAP B-Disease 0 6.78693282130105e-11
and O 0 2.5208960895313492e-14
evidence O 0 2.0033130156919127e-13
for O 0 2.8455543314449133e-14
the O 0 8.046356549801237e-13
role O 0 2.683626107793935e-12
of O 0 1.7688183140407432e-09
APC B-Disease 0 5.350716847374315e-08
amino O 0 5.055394325381712e-09
acid O 0 2.762623185770252e-10
changes O 0 1.2131134985438052e-10
in O 0 9.665067324249321e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 0.00452501280233264
. O 0 1.7637860949548667e-08

BACKGROUND O 0 3.729379827177581e-08
/ O 0 6.654652828785856e-09
AIMS O 0 3.1323257876358923e-10
The O 0 2.3522741914028256e-12
development O 0 5.883142584206524e-11
of O 0 1.1941664013193076e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.682164031488689e-11
a O 0 7.113925876330029e-13
variable O 0 3.900677957718868e-12
range O 0 3.4195630268379906e-12
of O 0 7.489897591028694e-12
extracolonic O 0 2.3804608062505395e-08
manifestations O 0 1.7480771930422634e-05
in O 0 1.5522344654073095e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.002302466053152e-07
FAP B-Disease 0 5.102934892420308e-07
) O 0 2.750672953300004e-13
is O 0 4.191202709869467e-14
the O 0 4.749040245256853e-13
result O 0 1.531156972045533e-11
of O 0 2.9707214466156984e-10
the O 0 1.9162868514221998e-10
dominant O 0 1.0676703077194816e-08
inheritance O 0 1.609428035287408e-09
of O 0 2.46983148599611e-07
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 6.46817142069267e-08
APC B-Disease 0 4.8301082244961435e-08
) O 0 2.2141205535675113e-11
gene O 0 1.7868035939727633e-09
mutations O 0 8.356457747993318e-09
. O 0 1.3117599451106798e-08

In O 0 6.95304994136059e-11
this O 0 3.2054580886321793e-13
study O 0 1.0995774467814287e-13
, O 0 6.122939019004162e-15
direct O 0 2.467889445318533e-13
mutation O 0 5.841440612469606e-13
analysis O 0 7.853050485286464e-14
of O 0 1.6232161448304083e-11
the O 0 1.9116176697142606e-10
APC B-Disease 0 7.217315078911213e-10
gene O 0 4.949594553660397e-12
was O 0 2.972012219659703e-11
performed O 0 1.1880187805735076e-11
to O 0 1.590845185618639e-12
determine O 0 3.5098635803310074e-11
genotype O 0 7.395504209029014e-10
- O 0 7.620194059088092e-11
phenotype O 0 1.0262676992944808e-11
correlations O 0 3.842555180294527e-12
for O 0 1.0010320480521862e-12
nine O 0 2.8530308324170583e-11
extracolonic O 0 1.3238642404544976e-09
manifestations O 0 1.8093327724955088e-08
and O 0 2.4365255906627636e-12
to O 0 5.1325246543066846e-14
investigate O 0 5.269256168546899e-13
the O 0 1.943560763717489e-12
incidence O 0 1.9924273786386948e-08
of O 0 1.4140549842167616e-09
APC B-Disease 0 6.619637282767599e-09
mutations O 0 3.367628398365241e-11
in O 0 3.1598684779865494e-10
non O 1 0.9999998807907104
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.218659576807113e-06

METHODS O 0 1.581043704845797e-07
The O 0 8.924037508961646e-09
APC B-Disease 0 9.226567065923064e-09
gene O 0 1.3598430541328366e-11
was O 0 1.9903202350124438e-11
analysed O 0 1.3675761911802198e-11
in O 0 2.669668305865791e-12
190 O 0 6.379589218008519e-11
unrelated O 0 8.295247128087269e-11
FAP B-Disease 0 1.880090971795312e-09
and O 0 5.1778984745676215e-12
15 O 0 1.9159807074231594e-09
non O 1 0.987485945224762
- O 1 0.9999967813491821
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.5443806233861324e-09
using O 0 3.3891097393767833e-12
denaturing O 0 3.0790527461022066e-08
gradient O 0 3.3197225524084217e-10
gel O 0 6.588137153873408e-12
electrophoresis O 0 3.851218931434641e-13
, O 0 2.291279145583136e-13
the O 0 5.9307966523980404e-12
protein O 0 1.4473660117642062e-11
truncation O 0 1.5575327694250518e-09
test O 0 1.985865499820605e-10
, O 0 2.0901684517297264e-13
and O 0 7.580462407959232e-14
direct O 0 8.294863060309687e-12
sequencing O 0 1.4135095871559145e-10
. O 0 1.6072654318577406e-09

RESULTS O 0 1.1786223694798537e-06
Chain O 0 1.1050702397596979e-07
terminating O 0 6.169497801522539e-09
signals O 0 5.184702667193619e-10
were O 0 4.6831108435618773e-11
only O 0 1.0592383090438084e-12
identified O 0 1.8635946952283433e-11
in O 0 2.2637320837293196e-11
patients O 0 1.118284197881847e-11
belonging O 0 1.0203989736501384e-10
to O 0 1.2157187583017315e-11
the O 0 9.93327287091006e-09
FAP B-Disease 0 1.5741680954306503e-06
group O 0 4.116139373788741e-10
( O 0 4.5368257761690955e-12
105 O 0 8.509385196475705e-09
patients O 0 7.376064203867827e-10
) O 0 4.945461574978882e-12
. O 0 5.478686393445287e-10

Amino O 0 6.900384619257238e-07
acid O 0 4.2064435268329703e-10
changes O 0 7.530263738952936e-12
were O 0 1.2491880359982721e-12
identified O 0 2.142275479189923e-13
in O 0 1.8796793548742086e-12
four O 0 1.463681606472811e-11
patients O 0 3.538267335373435e-12
, O 0 9.257131736509217e-13
three O 0 1.1465254093345756e-11
of O 0 8.069815748967812e-08
whom O 0 1.383083203521096e-09
belonged O 0 7.539185276073113e-09
to O 0 2.1942517247630633e-11
the O 0 3.0011693130660433e-09
non O 0 3.521418693708256e-05
- O 0 1.0206885292518564e-07
FAP O 0 1.1741236676243716e-06
group O 0 1.012980255232776e-09
of O 0 0.0004819909518118948
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.00038043883978389204
. O 0 5.492668098128206e-09

Genotype O 0 5.883616267965408e-06
- O 0 1.260913506939687e-07
phenotype O 0 1.8983745686540487e-09
correlations O 0 4.134946274270135e-10
identified O 0 3.484109268453439e-12
significant O 0 4.595402617463273e-12
differences O 0 4.623563251010543e-12
in O 0 1.0453061159709787e-11
the O 0 1.8768358395204743e-11
nature O 0 1.256640486113625e-10
of O 0 3.121536362726829e-10
certain O 0 1.0553834195459189e-10
extracolonic O 0 8.629950087879479e-08
manifestations O 0 2.748375891314936e-07
in O 0 8.758490599447555e-10
FAP B-Disease 0 5.004120566809434e-07
patients O 0 1.0493377694542616e-10
belonging O 0 7.66330887636002e-11
to O 0 1.7047373929157672e-11
three O 0 1.9776076332078674e-09
mutation O 0 2.856954210983531e-07
subgroups O 0 1.1290734619251452e-05
. O 0 1.0289351592973617e-07

CONCLUSIONS O 0 6.050528611467598e-08
Extended O 0 3.311010354778432e-09
genotype O 0 8.633421089143667e-09
- O 0 6.51585008171196e-10
phenotype O 0 2.1730936494712694e-11
correlations O 0 1.643101973924921e-11
made O 0 5.274967745591552e-13
in O 0 2.6820280480018e-13
this O 0 3.625696409228184e-14
study O 0 1.3450891333914583e-13
may O 0 8.709417735619507e-13
have O 0 1.2608303615567473e-13
the O 0 6.609152244582694e-13
potential O 0 3.686315846757743e-13
to O 0 1.8549565841143555e-14
determine O 0 1.3916707413200169e-12
the O 0 3.60141170357986e-12
most O 0 8.115604271507343e-14
appropriate O 0 2.744447193375049e-13
surveillance O 0 1.160638460340202e-10
and O 0 4.6310034799990074e-12
prophylactic O 0 3.4830797801532754e-08
treatment O 0 4.1734141142946157e-10
regimens O 0 1.6494362820029806e-10
for O 0 2.4795872820282394e-12
those O 0 3.2516005946808813e-12
patients O 0 3.220263411398555e-13
with O 0 2.416271257512856e-14
mutations O 0 1.3704032483449757e-12
associated O 0 2.4607744227717054e-12
with O 0 8.102198924796189e-13
life O 0 2.3455920539205977e-10
threatening O 0 3.2534309468701395e-08
conditions O 0 0.0003420331049710512
. O 0 2.4310667257054774e-08

This O 0 9.757048467784468e-12
study O 0 1.1745784466582476e-12
also O 0 6.053016025691846e-14
provided O 0 1.2181192672925355e-14
evidence O 0 1.3595902019231804e-13
for O 0 1.6771533570573635e-14
the O 0 1.7723473242411275e-13
pathological O 0 1.8960006897827952e-09
nature O 0 2.1304687181089577e-11
of O 0 1.6262320656768026e-10
amino O 0 3.3020766676550295e-11
acid O 0 5.715034023280607e-13
changes O 0 3.9297100187622724e-13
in O 0 3.973858568595556e-12
APC O 0 6.794548257360589e-11
associated O 0 9.351168927737574e-13
with O 0 1.0543637767338951e-13
both O 0 8.425488605412479e-12
FAP B-Disease 0 1.1012803113885639e-08
and O 0 9.104883513799678e-11
non O 1 0.9999996423721313
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.9909995785383217e-07
. O 0 4.9952916802986636e-11
. O 0 5.252606682937255e-10

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 5.422332833404653e-06
cancer B-Disease 1 0.9927411079406738
risk O 0 1.0203405508946162e-05
of O 0 5.297412371874088e-06
the O 0 5.388836825659382e-07
APC O 0 5.521377488548751e-07
I1307K O 0 4.755723637117626e-07
polymorphism O 0 7.729155413471744e-07
. O 0 3.603927112294514e-08

Germ O 0 4.479118069866672e-05
- O 0 9.065733053148506e-08
line O 0 4.086914806578079e-09
and O 0 5.7022104052451006e-12
somatic O 0 4.5408821147674416e-10
truncating O 0 1.6733009422509326e-09
mutations O 0 4.236359093384712e-12
of O 0 1.0356537849531833e-10
the O 0 4.1639763859180334e-10
APC B-Disease 0 2.8790323458594003e-09
gene O 0 2.8707220628421126e-11
are O 0 2.6995083685782406e-13
thought O 0 2.19656215959263e-12
to O 0 1.6706675105837565e-12
initiate O 0 1.3966226219963573e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 2.2855283532408066e-07
formation O 0 1.6152457149587462e-10
in O 0 1.4523111879771733e-10
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 8.094510661749155e-08
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 0.9999972581863403
, O 0 1.9259935313264975e-10
respectively O 0 2.672484455956692e-09
. O 0 9.872264783439277e-09

Recently O 0 4.480711357501832e-09
, O 0 1.3211789301470489e-11
an O 0 3.308013368438778e-12
isoleucine O 0 2.0190310578982462e-07
- O 0 2.3917566593922857e-08
- O 0 2.2866919024977506e-08
> O 0 8.75856613902215e-08
lysine O 0 1.6575707206811785e-07
polymorphism O 0 1.9554392827192402e-10
at O 0 9.957106666957927e-11
codon O 0 4.855835525341412e-11
1307 O 0 2.5830155722661452e-11
( O 0 5.0977824121289234e-14
I1307K O 0 4.188681519690096e-12
) O 0 1.0639915428475432e-14
of O 0 2.2224715557489505e-12
the O 0 4.904330414001734e-11
APC B-Disease 0 2.6238186623395165e-10
gene O 0 1.5035383962164195e-12
has O 0 1.1078084386243955e-13
been O 0 4.9083932990127976e-14
identified O 0 2.00328238698054e-13
in O 0 5.572283628442476e-13
6 O 0 8.536544804371715e-10
% O 0 2.394683583373247e-11
- O 0 4.257284108577508e-11
7 O 0 2.0539248080098105e-09
% O 0 2.7489661588719905e-11
of O 0 7.582762751034977e-10
the O 0 5.894860710675687e-10
Ashkenazi O 0 1.8413605362699315e-10
Jewish O 0 1.0395029975684977e-10
population O 0 2.6230018157491486e-11
. O 0 1.7651043959787671e-09

To O 0 5.0110849497686516e-11
assess O 0 4.8479625869291e-10
the O 0 4.7339056286066494e-11
risk O 0 8.87234938296011e-11
of O 0 2.1157124663329085e-11
this O 0 1.0542115140912967e-12
common O 0 1.4605003317846865e-10
APC B-Disease 0 3.732053333038721e-09
allelic O 0 2.72649565147276e-08
variant O 0 9.780767129541346e-08
in O 0 9.634676167991074e-09
colorectal O 1 1.0
carcinogenesis O 1 0.996994137763977
, O 0 5.919603141002483e-10
we O 0 6.309463368436852e-11
have O 0 7.981683890212476e-13
analyzed O 0 2.4523965757444754e-12
a O 0 6.071129276391529e-12
large O 0 9.01295878208419e-12
cohort O 0 2.2691282186571016e-10
of O 0 6.417413267456595e-10
unselected O 0 1.8398445718048606e-06
Ashkenazi O 0 1.984015174372189e-09
Jewish O 0 9.839545150880369e-11
subjects O 0 9.00698626793428e-10
with O 0 4.1702613584604364e-11
adenomatous B-Disease 0 0.00019661294936668128
polyps I-Disease 0 7.035020826151595e-05
and O 0 5.928246782360702e-10
. O 0 1.055682474770947e-08
or O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 7.945242241902406e-10
for O 0 8.070696194684146e-11
the O 0 4.263724484587783e-09
APC O 0 2.1809281491869115e-08
I1307K O 0 3.736927567388193e-08
polymorphism O 0 6.786761019839105e-08
. O 0 3.6001877035118923e-09

The O 0 1.7885319891774998e-07
APC O 0 7.104235066890396e-08
I1307K O 0 4.586635515835269e-09
allele O 0 5.249208706592512e-11
was O 0 5.784326143065677e-11
identified O 0 3.3409924132810076e-12
in O 0 1.5196346785095738e-12
48 O 0 1.8950888081015194e-10
( O 0 6.411971105978187e-13
10 O 0 4.294692206030515e-12
. O 0 1.2538589415876655e-13
1 O 0 1.2911426268413795e-11
% O 0 4.070926809627423e-13
) O 0 1.3622423467843283e-14
of O 0 7.541388520604375e-12
476 O 0 2.719491853930833e-10
patients O 0 1.3220499139876551e-09
. O 0 2.559146006220203e-09

Compared O 0 1.481644147649508e-11
with O 0 7.892302669688586e-14
the O 0 4.676893637992063e-13
frequency O 0 1.0475129878090295e-12
in O 0 3.624377545047991e-13
two O 0 2.868528575479881e-14
separate O 0 1.6546329193942166e-13
population O 0 2.4089637348703036e-14
control O 0 4.028071973194436e-11
groups O 0 4.565820378027441e-12
, O 0 1.856087549281793e-12
the O 0 3.166118756059433e-10
APC O 0 5.713693962405841e-09
I1307K O 0 1.7487045145259117e-09
allele O 0 2.080902117285177e-11
is O 0 3.402656709996718e-14
associated O 0 2.7977213644739263e-14
with O 0 1.8227206700758723e-15
an O 0 4.046351774966098e-15
estimated O 0 5.174322342121895e-13
relative O 0 1.25032387221502e-10
risk O 0 1.8590734507384354e-09
of O 0 6.566343913050332e-09
1 O 0 6.087610927352216e-06
. O 0 2.8351339054211167e-08

5 O 0 3.122143607470207e-05
- O 0 8.686716341799183e-07
1 O 0 6.054557957213547e-07
. O 0 1.4730211717051134e-08

7 O 0 2.396671561655239e-06
for O 0 4.2533216060292034e-08
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 0.0074395122937858105
( O 0 6.06123096158484e-10
both O 0 6.690565323985709e-10
P O 0 6.0489301176858135e-06
= O 0 2.6090134497280815e-09
. O 0 2.1221710153063178e-11
01 O 0 2.982611713164829e-09
) O 0 2.1098843158706693e-12
. O 0 9.087255947726192e-11

Furthermore O 0 9.757189500803065e-10
, O 0 3.316162665648048e-12
compared O 0 1.388854634597203e-12
with O 0 1.2078114116492733e-12
noncarriers O 0 1.966454732382772e-07
, O 0 3.495348455118119e-10
APC O 0 4.944280540541968e-09
I1307K O 0 1.1685022949237123e-09
carriers O 0 1.0319811411668711e-12
had O 0 3.0561970597482724e-13
increased O 0 9.496013865647676e-14
numbers O 0 6.933876758354052e-14
of O 0 2.9786350469462874e-11
adenomas B-Disease 1 0.9999970197677612
and O 0 6.815384040237404e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9998204112052917
per O 0 1.4403112036376342e-10
patient O 0 1.2833836215975225e-08
( O 0 2.566955502325552e-11
P O 0 4.976222044206224e-06
= O 0 4.843951351141129e-10
. O 0 8.143488054029868e-13
03 O 0 9.121778332676911e-11
) O 0 6.1465284630687206e-15
, O 0 6.501494983791054e-15
as O 0 3.3695184094078776e-14
well O 0 4.953669581735792e-14
as O 0 2.685355193418615e-13
a O 0 4.768720574671592e-12
younger O 0 3.0000431392590565e-12
age O 0 8.572976356591155e-11
at O 0 5.644671841054105e-09
diagnosis O 0 1.2706009329122026e-06
. O 0 6.6366032669407105e-09

We O 0 2.114180636114682e-10
conclude O 0 2.282480177084878e-10
that O 0 6.22603802281213e-13
the O 0 4.5988424873799616e-11
APC O 0 5.244460421494068e-09
I1307K O 0 5.648721490558728e-09
variant O 0 1.1650310938193797e-08
leads O 0 9.235959913533875e-11
to O 0 1.4283300020165313e-12
increased O 0 7.166058413332621e-09
adenoma B-Disease 1 1.0
formation O 0 2.6102864314481167e-10
and O 0 3.0283286728965964e-12
directly O 0 2.5639372217131293e-14
contributes O 0 1.1766356592941667e-14
to O 0 7.012891549212311e-15
3 O 0 6.471259639262428e-11
% O 0 1.337404904704076e-12
- O 0 5.587183276797858e-13
4 O 0 9.482793023041225e-12
% O 0 2.599490989216996e-13
of O 0 1.3758901786994904e-12
all O 0 6.80486916815326e-12
Ashkenazi O 0 8.92429330434652e-09
Jewish O 0 1.7037377801898401e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.317908625736891e-07

The O 0 4.1787109883451024e-10
estimated O 0 1.9986207133726452e-11
relative O 0 5.556605731094066e-10
risk O 0 2.7585109196870405e-10
for O 0 1.746382010357761e-12
carriers O 0 3.961318686268589e-12
may O 0 3.930303998922469e-12
justify O 0 1.0414850405704446e-11
specific O 0 7.414645069800385e-13
clinical O 0 1.3339364335340775e-10
screening O 0 2.2709974525914056e-11
for O 0 2.0426729426849255e-13
the O 0 3.934001562011513e-12
360 O 0 1.3225959390184006e-11
, O 0 1.6914178662275764e-13
000 O 0 4.435789843076909e-12
Americans O 0 7.568572098258855e-14
expected O 0 2.2807884053621663e-13
to O 0 1.141357651836608e-13
harbor O 0 2.0478917173161193e-10
this O 0 5.123936756661063e-14
allele O 0 4.860074473943266e-13
, O 0 2.1918139639408654e-14
and O 0 7.143386630912435e-14
genetic O 0 5.60315118955379e-12
testing O 0 1.9052285790688295e-11
in O 0 3.7701656033228836e-13
the O 0 4.007340900086254e-12
setting O 0 4.012545573583992e-10
of O 0 1.511363395545473e-10
long O 0 6.670260264268757e-12
- O 0 4.108448390521824e-12
term O 0 2.2146780936926902e-11
- O 0 1.7831715921554081e-12
outcome O 0 7.497830481484336e-12
studies O 0 2.304260298194305e-13
may O 0 1.69339978779888e-13
impact O 0 3.645727383178032e-12
significantly O 0 3.5332969189338925e-12
on O 0 3.499953209029627e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 6.641733421020035e-07
in O 0 1.4001473591651603e-13
this O 0 5.3335929965127316e-14
population O 0 2.398813840707309e-13
. O 0 7.721379785552429e-11

Localization O 0 3.9986073829823e-07
of O 0 3.5247875729282896e-09
human O 0 5.846789163932442e-10
BRCA1 O 0 5.847845818696129e-11
and O 0 7.722388267045188e-13
its O 0 1.1417505829669494e-11
loss O 0 1.8097003062766959e-10
in O 0 1.377619407438857e-10
high O 0 5.247525223239791e-07
- O 0 1.2453365449971443e-08
grade O 0 1.756601591296203e-06
, O 0 7.232210941232609e-10
non B-Disease 1 0.9999988079071045
- I-Disease 1 0.9998828172683716
inherited I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 8.501442607666831e-06

Although O 0 1.4360648781241991e-10
the O 0 3.1589453275415735e-11
link O 0 5.962137727966166e-11
between O 0 4.591077518156794e-11
the O 0 2.0675874345954526e-09
BRCA1 O 0 7.60399920807231e-09
tumour B-Disease 1 1.0
- O 0 4.488869553842534e-10
suppressor O 0 8.6282964106843e-10
gene O 0 4.475852848073725e-12
and O 0 4.745709901443629e-12
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 3.874983889318173e-08
established O 0 8.969202602848725e-10
, O 0 1.4101629477840383e-13
the O 0 2.770725923001427e-12
role O 0 2.1589715692299505e-12
, O 0 8.734816526762695e-14
if O 0 3.1753655829963937e-14
any O 0 1.3207903737724735e-12
, O 0 2.643369735339657e-13
of O 0 7.981661859224332e-11
BRCA1 O 0 2.8074020885782147e-10
in O 0 2.916542840569747e-10
non B-Disease 0 0.11711934953927994
- I-Disease 0 1.2240512660355307e-05
familial I-Disease 1 0.9984473586082458
cancers I-Disease 1 0.9999995231628418
is O 0 8.150710661958271e-10
unclear O 0 1.494321288930678e-08
. O 0 5.784552836729517e-09

BRCA1 O 0 7.734096385547673e-08
mutations O 0 8.933855738524343e-11
are O 0 5.694509669579642e-14
rare O 0 1.0662639391215145e-12
in O 0 5.923117898931629e-13
sporadic B-Disease 0 3.4114000300178304e-05
cancers I-Disease 0 0.09513973444700241
, O 0 6.756770056653982e-12
but O 0 1.5637583242189557e-11
loss O 0 1.76176193633637e-08
of O 0 1.6780533087512595e-06
BRCA1 O 0 8.01128552385677e-10
resulting O 0 1.0878880261910862e-11
from O 0 4.293486139533842e-13
reduced O 0 1.1373302993833434e-10
expression O 0 1.079496041167527e-11
or O 0 7.612400293455224e-13
incorrect O 0 2.6787997167709854e-11
subcellular O 0 4.0129478406925045e-08
localization O 0 1.500644088991976e-07
is O 0 1.736403582768345e-13
postulated O 0 4.4112014930576537e-13
to O 0 4.175258331076941e-15
be O 0 4.093393020241287e-15
important O 0 4.021356340912392e-14
in O 0 4.857331442446877e-13
non B-Disease 0 7.244048561005911e-07
- I-Disease 0 5.902213047193072e-07
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9729911088943481

Epigenetic O 0 5.761186002928298e-06
loss O 0 5.66689664083242e-07
, O 0 3.407259543952712e-11
however O 0 1.7629491616544257e-11
, O 0 4.456037318648076e-13
has O 0 5.38195925542731e-14
not O 0 4.77712521504501e-15
received O 0 8.578061899038383e-15
general O 0 4.953785320317705e-13
acceptance O 0 5.388312625947966e-12
due O 0 4.2028883845413034e-11
to O 0 5.417997796827549e-14
controversy O 0 3.458649111467288e-13
regarding O 0 5.766057119618861e-13
the O 0 5.829397836838723e-13
subcellular O 0 5.44819833692145e-09
localization O 0 5.042271311594959e-08
of O 0 2.0146824208922e-09
BRCA1 O 0 8.004148038809333e-11
proteins O 0 7.511406861088199e-14
, O 0 1.2178643781380477e-13
reports O 0 1.9103436280781816e-12
of O 0 3.258271430439663e-10
which O 0 7.66927060052991e-12
have O 0 1.897604252551477e-12
ranged O 0 7.0284893356753475e-12
from O 0 1.4051153090447605e-13
exclusively O 0 3.437533244166069e-12
nuclear O 0 2.3473116783634396e-09
, O 0 1.4026143256833795e-13
to O 0 8.456165048785838e-14
conditionally O 0 6.277033337553917e-10
nuclear O 0 1.4564202066580378e-09
, O 0 4.214468129950383e-13
to O 0 5.961119727178332e-13
the O 0 1.49599652110588e-10
ER O 0 6.110604999776115e-08
/ O 0 1.904638224914379e-09
golgi O 0 5.529300128870318e-09
, O 0 1.913458801128254e-11
to O 0 9.687805245517378e-12
cytoplasmic O 0 3.5523446406671155e-09
invaginations O 0 8.042951193942827e-09
into O 0 7.43615238829598e-11
the O 0 3.9573808119364173e-10
nucleus O 0 3.76399189594423e-10
. O 0 1.3601453296985255e-09

In O 0 4.758134330984376e-09
an O 0 1.439794117263915e-11
attempt O 0 5.116368995139453e-10
to O 0 6.370235502289878e-12
resolve O 0 2.90543811232169e-10
this O 0 1.3298450882159862e-12
issue O 0 7.111555701960759e-12
, O 0 5.890805421585044e-13
we O 0 1.2084565119419022e-12
have O 0 2.7093298850082437e-13
comprehensively O 0 6.058942236819576e-10
characterized O 0 1.1709960778816253e-10
19 O 0 9.641808240701266e-09
anti O 0 4.3875499500245496e-07
- O 0 4.114118823395074e-08
BRCA1 O 0 6.477341329969022e-09
antibodies O 0 1.603898958091321e-10
. O 0 1.1956923229305971e-09

These O 0 1.4583966256864755e-09
reagents O 0 9.595209959911699e-09
detect O 0 2.152445555125837e-09
a O 0 9.609014695044493e-10
220 O 0 3.2385932824396946e-10
- O 0 4.4037853919043357e-10
kD O 0 1.1603601413057163e-09
protein O 0 3.670785203579996e-11
localized O 0 5.7322667446069175e-11
in O 0 1.8582483642115566e-12
discrete O 0 2.4860963288020343e-10
nuclear O 0 7.422600845075067e-08
foci O 0 4.0311903148904094e-08
in O 0 5.348912632263669e-11
all O 0 1.8789634778637598e-11
epithelial O 0 2.072324117863289e-10
cell O 0 2.382544606049919e-09
lines O 0 8.047788997711525e-12
, O 0 3.935663711704569e-14
including O 0 3.341672641724025e-13
those O 0 2.0485772366657384e-12
derived O 0 8.001412032943023e-12
from O 0 3.521983260590389e-10
breast B-Disease 0 2.647868313943036e-06
malignancies I-Disease 0 0.00014445946726482362
. O 0 5.579848334491544e-07

Immunohistochemical O 0 1.7788629520509858e-06
staining O 0 1.0265574701406877e-07
of O 0 2.5350200871798734e-07
human O 0 2.484009655745467e-07
breast O 0 4.360327920949203e-08
specimens O 0 1.0501152170050432e-09
also O 0 3.516559543559339e-10
revealed O 0 9.904534969962242e-09
BRCA1 O 0 5.502335920226642e-09
nuclear O 0 3.739701242011506e-07
foci O 0 5.962259365333011e-06
in O 0 1.3067648074738258e-09
benign O 1 0.9999998807907104
breast O 1 0.8906367421150208
, O 0 4.550109178325101e-09
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.00859815813601017
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 4.41490101366071e-06

Conversely O 0 5.710163897276743e-09
, O 0 1.5390867746933878e-10
BRCA1 O 0 4.692797261895976e-10
expression O 0 3.018769956231182e-10
was O 0 7.196677975773724e-11
reduced O 0 3.0675122164591784e-11
or O 0 1.395701757563473e-14
undetectable O 0 1.825765580387717e-11
in O 0 1.0107818309559521e-13
the O 0 2.8830434675893024e-13
majority O 0 5.157531845177699e-13
of O 0 2.9190459077677033e-11
high O 0 6.069056723845279e-08
- O 0 3.6087541843699e-09
grade O 0 1.2412743721768038e-08
, O 0 2.5624452212880122e-11
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 3.3428745882524424e-11
suggesting O 0 3.2148599754533436e-11
that O 0 1.0045091928395644e-12
absence O 0 6.010077413520776e-08
of O 0 3.895897862093989e-07
BRCA1 O 0 9.668007505680976e-10
may O 0 1.8875905612864008e-12
contribute O 0 2.8348659614966902e-14
to O 0 5.745305896613304e-14
the O 0 4.2810997802344986e-12
pathogenesis O 0 6.821539333401461e-09
of O 0 2.9984313643094396e-11
a O 0 5.8985856563748e-13
significant O 0 3.1608420308221197e-12
percentage O 0 3.55687666819815e-11
of O 0 4.961054900221029e-10
sporadic B-Disease 1 0.9999997615814209
breast I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999940395355225
. O 0 1.606218802407966e-07
. O 0 1.1301640370220412e-06

